1	nature	NN	O	nature	nn	5	SENT_1	[p1l21t124r112b145],
2	publishing	NN	O	publishing	nn	5	SENT_1	[p1l121t121r269b152],
3	group	NN	O	group	nn	5	SENT_1	[p1l278t128r362b152],
4	S	NN	O	s	nn	5	SENT_1	[p1l1761t108r1783b145],
5	wA	NN	O	wa	_	0	SENT_1	[p1l1790t108r1873b145],
6	+	CC	O	+	_	0	SENT_1	[p1l1790t108r1873b145],
7	E	NN	O	e	conj_+	5	SENT_1	[p1l1882t108r1902b145],
8	A	DT	O	a	det	10	SENT_1	[p1l2045t108r2073b145],
9	`	``	O	`	_	0	SENT_1	[p1l2082t108r2139b145],
10	A	NN	O	a	dep	5	SENT_1	[p1l2082t108r2139b145],
11	+	CC	O	+	rcmod	10	SENT_1	[p1l2082t108r2139b145],

1	Antiobesity	NNP	O	Antiobesity	nn	2	SENT_2	[p1l22t260r516b358],
2	Pharmacotherapy	NNP	O	Pharmacotherapy	_	0	SENT_2	[p1l542t260r1327b358],
3	:	:	O	:	_	0	SENT_2	[p1l542t260r1327b358],
4	New	NNP	O	New	nn	5	SENT_2	[p1l1355t264r1543b336],
5	Drugs	NNPS	O	Drugs	dep	2	SENT_2	[p1l1570t263r1818b357],
6	and	CC	O	and	_	0	SENT_2	[p1l1843t260r1999b336],
7	Emerging	VBG	O	emerge	amod	8	SENT_2	[p1l27t376r433b468],
8	Targets	NNS	O	target	dep	2	SENT_2	[p1l453t376r763b468],

1	GW	NNP	O	GW	nn	3	SENT_3	[p1l21t522r104b557],
2	Kim	NNP	PERSON	Kim	nn	3	SENT_3	[p1l114t515r232b562],
3	‘	NNP	O	‘	_	0	SENT_3	[p1l114t515r232b562],
4	,	,	O	,	_	0	SENT_3	[p1l114t515r232b562],
5	IE	JJ	O	ie	amod	6	SENT_3	[p1l243t523r288b564],
6	Linl	NN	O	linl	conj_and	3	SENT_3	[p1l299t515r396b562],
7	,	,	O	,	_	0	SENT_3	[p1l299t515r396b562],
8	ES	NN	O	e	nn	9	SENT_3	[p1l408t522r459b557],
9	Blomainl	NN	O	blomainl	conj_and	3	SENT_3	[p1l471t515r660b557],
10	and	CC	O	and	_	0	SENT_3	[p1l674t520r749b557],
11	SA	NNP	O	SA	nn	12	SENT_3	[p1l760t522r817b557],
12	Waldmanl	NNP	O	Waldmanl	conj_and	3	SENT_3	[p1l827t515r1041b557],

1	Obesity	NN	O	obesity	nsubj	5	SENT_4	[p1l20t639r157b678],
2	is	VBZ	O	be	cop	5	SENT_4	[p1l166t640r190b670],
3	a	DT	O	a	det	5	SENT_4	[p1l199t648r217b670],
4	growing	VBG	O	grow	amod	5	SENT_4	[p1l227t640r373b678],
5	pandemic	NN	O	pandemic	_	0	SENT_4	[p1l384t639r568b677],
6	,	,	O	,	_	0	SENT_4	[p1l384t639r568b677],
7	and	CC	O	and	_	0	SENT_4	[p1l577t639r642b670],
8	related	JJ	O	related	amod	9	SENT_4	[p1l653t639r775b670],
9	health	NN	O	health	nsubj	14	SENT_4	[p1l786t639r896b670],
10	and	CC	O	and	_	0	SENT_4	[p1l906t639r971b670],
11	economic	JJ	O	economic	amod	12	SENT_4	[p1l981t640r1153b670],
12	costs	NNS	O	cost	nsubj	14	SENT_4	[p1l1162t643r1250b670],
13	are	VBP	O	be	aux	14	SENT_4	[p1l1259t648r1313b670],
14	staggering	VBG	O	stagger	conj_and	5	SENT_4	[p1l1322t640r1522b678],
15	.	.	O	.	_	0	SENT_4	[p1l1322t640r1522b678],

1	Pharmacotherapy	NNP	O	Pharmacotherapy	nsubj	8	SENT_5	[p1l1533t639r1855b678],
2	,	,	O	,	_	0	SENT_5	[p1l1533t639r1855b678],
3	partnered	VBN	O	partner	partmod	1	SENT_5	[p1l1865t639r2041b678],
4	with	IN	O	with	_	0	SENT_5	[p1l2050t639r2127b670],
5	lifestyle	NN	O	lifestyle	nn	6	SENT_5	[p1l22t692r157b732],
6	modifications	NNS	O	modification	prep_with	3	SENT_5	[p1l167t692r417b728],
7	,	,	O	,	_	0	SENT_5	[p1l167t692r417b728],
8	forms	VBZ	O	form	_	0	SENT_5	[p1l425t692r527b723],
9	the	DT	O	the	det	10	SENT_5	[p1l535t692r593b723],
10	core	NN	O	core	nsubj	15	SENT_5	[p1l602t701r676b723],
11	of	IN	O	of	_	0	SENT_5	[p1l685t692r722b723],
12	current	JJ	DATE	current	amod	13	SENT_5	[p1l728t697r856b723],
13	strategies	NNS	O	strategy	prep_of	10	SENT_5	[p1l865t693r1037b732],
14	to	TO	O	to	aux	15	SENT_5	[p1l1045t697r1081b723],
15	reduce	VB	O	reduce	xcomp	8	SENT_5	[p1l1091t692r1210b723],
16	the	DT	O	the	det	17	SENT_5	[p1l1218t692r1276b723],
17	burden	NN	O	burden	dobj	15	SENT_5	[p1l1286t692r1412b723],
18	of	IN	O	of	_	0	SENT_5	[p1l1422t692r1458b723],
19	this	DT	O	this	det	20	SENT_5	[p1l1464t692r1528b723],
20	disease	NN	O	disease	prep_of	17	SENT_5	[p1l1537t692r1667b723],
21	and	CC	O	and	_	0	SENT_5	[p1l1676t692r1741b723],
22	its	PRP$	O	its	poss	23	SENT_5	[p1l1752t693r1791b723],
23	sequelae	NN	O	sequela	prep_of	17	SENT_5	[p1l1800t692r1966b731],
24	.	.	O	.	_	0	SENT_5	[p1l1800t692r1966b731],

1	However	RB	O	however	advmod	7	SENT_6	[p1l1977t694r2139b728],
2	,	,	O	,	_	0	SENT_6	[p1l1977t694r2139b728],
3	therapies	NNS	O	therapy	nsubj	7	SENT_6	[p1l20t747r186b785],
4	targeting	VBG	O	target	partmod	3	SENT_6	[p1l194t747r358b786],
5	weight	NN	O	weight	nn	6	SENT_6	[p1l367t747r490b786],
6	loss	NN	O	loss	dobj	4	SENT_6	[p1l500t747r564b777],
7	have	VBP	O	have	_	0	SENT_6	[p1l575t747r657b777],
8	a	DT	O	a	det	10	SENT_6	[p1l666t756r684b777],
9	significant	JJ	O	significant	amod	10	SENT_6	[p1l694t746r878b786],
10	history	NN	O	history	dobj	7	SENT_6	[p1l888t747r1010b786],
11	of	IN	O	of	_	0	SENT_6	[p1l1018t746r1055b777],
12	safety	NN	O	safety	nn	13	SENT_6	[p1l1061t746r1167b786],
13	risks	NNS	O	risk	prep_of	10	SENT_6	[p1l1176t747r1262b782],
14	,	,	O	,	_	0	SENT_6	[p1l1176t747r1262b782],
15	including	VBG	O	include	_	0	SENT_6	[p1l1272t747r1436b786],
16	cardiovascular	JJ	O	cardiovascular	amod	19	SENT_6	[p1l1447t747r1703b777],
17	and	CC	O	and	_	0	SENT_6	[p1l1711t747r1776b777],
18	psychiatric	JJ	O	psychiatric	conj_and	16	SENT_6	[p1l1788t747r1977b786],
19	events	NNS	O	event	prep_including	10	SENT_6	[p1l1986t751r2111b777],
20	.	.	O	.	_	0	SENT_6	[p1l1986t751r2111b777],

1	Here	RB	O	here	advmod	20	SENT_7	[p1l22t802r112b835],
2	,	,	O	,	_	0	SENT_7	[p1l22t802r112b835],
3	evolving	VBG	O	evolve	dep	20	SENT_7	[p1l121t800r271b839],
4	strategies	NNS	O	strategy	dobj	3	SENT_7	[p1l282t801r454b839],
5	for	IN	O	for	_	0	SENT_7	[p1l462t800r512b831],
6	developing	VBG	O	develop	prepc_for	3	SENT_7	[p1l520t800r719b839],
7	antiobesity	JJ	O	antiobesity	amod	8	SENT_7	[p1l729t800r929b839],
8	therapies	NNS	O	therapy	dobj	6	SENT_7	[p1l936t800r1111b839],
9	,	,	O	,	_	0	SENT_7	[p1l936t800r1111b839],
10	including	VBG	O	include	_	0	SENT_7	[p1l1121t800r1285b839],
11	targets	NNS	O	target	prep_including	20	SENT_7	[p1l1295t804r1428b839],
12	,	,	O	,	_	0	SENT_7	[p1l1295t804r1428b839],
13	mechanisms	NNS	O	mechanism	conj_and	11	SENT_7	[p1l1439t800r1667b835],
14	,	,	O	,	_	0	SENT_7	[p1l1439t800r1667b835],
15	and	CC	O	and	_	0	SENT_7	[p1l1676t800r1742b831],
16	developmental	JJ	O	developmental	amod	17	SENT_7	[p1l1752t800r2019b839],
17	status	NN	O	status	conj_and	11	SENT_7	[p1l21t858r135b889],
18	,	,	O	,	_	0	SENT_7	[p1l21t858r135b889],
19	are	VBP	O	be	auxpass	20	SENT_7	[p1l144t862r198b884],
20	highlighted	VBN	O	highlight	_	0	SENT_7	[p1l208t853r423b893],
21	.	.	O	.	_	0	SENT_7	[p1l208t853r423b893],

1	Progress	NNP	O	Progress	nsubjpass	6	SENT_8	[p1l433t855r583b893],
2	in	IN	O	in	_	0	SENT_8	[p1l593t854r622b884],
3	this	DT	O	this	det	4	SENT_8	[p1l632t853r696b884],
4	field	NN	O	field	prep_in	1	SENT_8	[p1l704t853r781b884],
5	is	VBZ	O	be	auxpass	6	SENT_8	[p1l792t854r816b884],
6	underscored	VBN	O	underscore	_	0	SENT_8	[p1l827t853r1047b884],
7	by	IN	O	by	_	0	SENT_8	[p1l1058t853r1100b893],
8	Belviq	NNP	PERSON	Belviq	agent	6	SENT_8	[p1l1110t853r1216b892],
9	(	CD	NUMBER	(	num	11	SENT_8	[p1l1227t853r1422b889],
10	lorcaserin	NN	O	lorcaserin	nn	11	SENT_8	[p1l1227t853r1422b889],
11	)	NN	O	)	dep	8	SENT_8	[p1l1227t853r1422b889],
12	and	CC	O	and	_	0	SENT_8	[p1l1432t853r1498b884],
13	Qsymia	NN	O	qsymium	nn	16	SENT_8	[p1l1508t854r1638b893],
14	(	CD	NUMBER	(	num	16	SENT_8	[p1l1649t853r2125b892],
15	phentermine/topiramate	NN	O	phentermine/topiramate	nn	16	SENT_8	[p1l1649t853r2125b892],
16	)	NN	O	)	agent	6	SENT_8	[p1l1649t853r2125b892],
17	,	,	O	,	_	0	SENT_8	[p1l1649t853r2125b892],
18	the	DT	O	the	det	20	SENT_8	[p1l20t908r78b938],
19	first	JJ	ORDINAL	first	amod	20	SENT_8	[p1l86t907r154b938],
20	agents	NNS	O	agent	appos	16	SENT_8	[p1l163t912r281b947],
21	in	IN	O	in	_	0	SENT_8	[p1l291t908r321b938],
22	more	JJR	DURATION	more	mwe	23	SENT_8	[p1l332t917r423b938],
23	than	IN	DURATION	than	quantmod	24	SENT_8	[p1l431t908r511b938],
24	10	CD	DURATION	10	num	25	SENT_8	[p1l524t910r563b938],
25	years	NNS	NUMBER	year	prep_in	20	SENT_8	[p1l571t917r664b947],
26	to	TO	O	to	aux	27	SENT_8	[p1l672t912r708b938],
27	achieve	VB	O	achieve	xcomp	6	SENT_8	[p1l717t908r851b938],
28	regulatory	JJ	O	regulatory	amod	29	SENT_8	[p1l862t908r1047b947],
29	approval	NN	O	approval	dobj	27	SENT_8	[p1l1055t908r1210b946],
30	for	IN	O	for	_	0	SENT_8	[p1l1219t907r1269b938],
31	chronic	JJ	O	chronic	amod	33	SENT_8	[p1l1277t908r1407b938],
32	weight	NN	O	weight	nn	33	SENT_8	[p1l1415t908r1538b947],
33	management	NN	O	management	prep_for	27	SENT_8	[p1l1548t912r1785b947],
34	in	IN	O	in	_	0	SENT_8	[p1l1794t908r1824b938],
35	obese	JJ	O	obese	amod	36	SENT_8	[p1l1834t908r1939b938],
36	patients	NNS	O	patient	prep_in	33	SENT_8	[p1l1949t908r2101b946],
37	.	.	O	.	_	0	SENT_8	[p1l1949t908r2101b946],

1	On	IN	O	on	_	0	SENT_9	[p1l20t963r70b993],
2	the	DT	O	the	det	3	SENT_9	[p1l79t962r137b993],
3	horizon	NN	O	horizon	prep_on	12	SENT_9	[p1l147t962r290b997],
4	,	,	O	,	_	0	SENT_9	[p1l147t962r290b997],
5	novel	JJ	O	novel	amod	6	SENT_9	[p1l301t962r395b993],
6	insights	NNS	O	insight	nsubj	12	SENT_9	[p1l406t962r543b1001],
7	into	IN	O	into	_	0	SENT_9	[p1l553t963r621b993],
8	metabolism	NN	O	metabolism	nn	11	SENT_9	[p1l631t962r839b993],
9	and	CC	O	and	_	0	SENT_9	[p1l849t962r914b993],
10	energy	NN	O	energy	nn	11	SENT_9	[p1l925t971r1048b1001],
11	homeostasis	NN	O	homeostasis	prep_into	6	SENT_9	[p1l1057t962r1278b993],
12	reveal	VBP	O	reveal	_	0	SENT_9	[p1l1288t962r1392b993],
13	guanosine	NN	O	guanosine	dobj	12	SENT_9	[p1l1402t963r1587b1001],
14	3	CD	NUMBER	3	num	13	SENT_9	[p1l1597t960r1779b1001],
15	’	NN	O	’	dep	13	SENT_9	[p1l1597t960r1779b1001],
16	,5	CD	NUMBER	,5	num	15	SENT_9	[p1l1597t960r1779b1001],
17	’	SYM	O	’	dep	13	SENT_9	[p1l1597t960r1779b1001],
18	-	:	O	-	_	0	SENT_9	[p1l1597t960r1779b1001],
19	cyclic	JJ	O	cyclic	amod	20	SENT_9	[p1l1597t960r1779b1001],
20	monophosphate	NN	O	monophosphate	nsubj	25	SENT_9	[p1l1789t962r2083b1001],
21	(	CD	NUMBER	(	num	25	SENT_9	[p1l21t1016r145b1051],
22	cGMP	NN	O	cgmp	nn	25	SENT_9	[p1l21t1016r145b1051],
23	)	NN	O	)	nn	25	SENT_9	[p1l21t1016r145b1051],
24	signaling	NN	O	signaling	nn	25	SENT_9	[p1l155t1015r315b1055],
25	circuits	NNS	O	circuit	parataxis	12	SENT_9	[p1l326t1016r451b1046],
26	as	IN	O	as	_	0	SENT_9	[p1l460t1024r495b1046],
27	emerging	VBG	O	emerge	amod	28	SENT_9	[p1l504t1016r674b1055],
28	targets	NNS	O	target	prep_as	25	SENT_9	[p1l684t1020r808b1055],
29	for	IN	O	for	_	0	SENT_9	[p1l816t1015r866b1046],
30	antiobesity	JJ	O	antiobesity	amod	31	SENT_9	[p1l874t1015r1074b1055],
31	pharmacotherapy	NN	O	pharmacotherapy	prep_for	28	SENT_9	[p1l1083t1015r1408b1055],
32	.	.	O	.	_	0	SENT_9	[p1l1083t1015r1408b1055],

1	These	DT	O	these	det	2	SENT_10	[p1l1414t1015r1517b1046],
2	innovations	NNS	O	innovation	nsubj	8	SENT_10	[p1l1527t1016r1735b1046],
3	in	IN	O	in	_	0	SENT_10	[p1l1745t1016r1775b1046],
4	molecular	JJ	O	molecular	amod	5	SENT_10	[p1l1786t1015r1962b1046],
5	discovery	NN	O	discovery	prep_in	2	SENT_10	[p1l1970t1015r2139b1055],
6	may	MD	O	may	aux	8	SENT_10	[p1l21t1079r95b1109],
7	elegantly	RB	O	elegantly	advmod	8	SENT_10	[p1l103t1070r269b1109],
8	align	VB	O	align	_	0	SENT_10	[p1l277t1070r362b1109],
9	with	IN	O	with	_	0	SENT_10	[p1l372t1070r448b1100],
10	practical	JJ	O	practical	amod	14	SENT_10	[p1l460t1070r608b1108],
11	off-the	JJ	O	off-the	amod	14	SENT_10	[p1l619t1069r840b1100],
12	—	NN	O	—	nn	14	SENT_10	[p1l619t1069r840b1100],
13	shelf	NN	O	shelf	nn	14	SENT_10	[p1l619t1069r840b1100],
14	approaches	NNS	O	approach	prep_with	8	SENT_10	[p1l847t1070r1062b1108],
15	,	,	O	,	_	0	SENT_10	[p1l847t1070r1062b1108],
16	leveraging	VBG	O	leverage	xcomp	8	SENT_10	[p1l1072t1070r1258b1109],
17	existing	VBG	O	exist	dobj	16	SENT_10	[p1l1268t1070r1405b1109],
18	approved	VBN	O	approve	partmod	17	SENT_10	[p1l1415t1070r1584b1108],
19	drugs	NNS	O	drug	dobj	18	SENT_10	[p1l1594t1070r1695b1109],
20	that	WDT	O	that	nsubj	21	SENT_10	[p1l1703t1070r1775b1100],
21	modulate	VBP	O	modulate	rcmod	19	SENT_10	[p1l1785t1070r1954b1100],
22	cGMP	NN	O	cgmp	nn	23	SENT_10	[p1l1963t1071r2064b1100],
23	levels	NNS	O	level	dobj	21	SENT_10	[p1l11t1141r214b1203],
24	for	IN	O	for	_	0	SENT_10	[p1l231t1140r335b1204],
25	the	DT	O	the	det	26	SENT_10	[p1l350t1141r471b1204],
26	management	NN	O	management	prep_for	21	SENT_10	[p1l492t1149r984b1221],
27	of	IN	O	of	_	0	SENT_10	[p1l1002t1140r1079b1204],
28	obesity	NN	O	obesity	prep_of	26	SENT_10	[p1l1092t1141r1378b1221],
29	.	.	O	.	_	0	SENT_10	[p1l1092t1141r1378b1221],

1	Obesity	NN	O	obesity	nsubj	7	SENT_11	[p1l10t1377r273b1461],
2	is	VBZ	O	be	cop	7	SENT_11	[p1l291t1383r340b1440],
3	a	DT	O	a	det	7	SENT_11	[p1l362t1400r396b1440],
4	global	JJ	O	global	amod	7	SENT_11	[p1l416t1377r623b1461],
5	public	JJ	O	public	amod	7	SENT_11	[p1l642t1377r853b1460],
6	health	NN	O	health	nn	7	SENT_11	[p1l872t1377r1084b1440],
7	problem	NN	O	problem	_	0	SENT_11	[p1l1103t1377r1407b1460],
8	.	.	O	.	_	0	SENT_11	[p1l1103t1377r1407b1460],

1	The	DT	O	the	det	2	SENT_12	[p1l1431t1377r1555b1440],
2	obesity	NN	O	obesity	nsubj	6	SENT_12	[p1l1577t1377r1819b1461],
3	epidemic	JJ	O	epidemic	advmod	6	SENT_12	[p1l1838t1377r2148b1460],
4	has	VBZ	O	have	aux	6	SENT_12	[p1l8t1480r122b1543],
5	been	VBN	O	be	aux	6	SENT_12	[p1l144t1480r312b1543],
6	growing	VBG	O	grow	_	0	SENT_12	[p1l336t1486r624b1564],
7	in	IN	O	in	_	0	SENT_12	[p1l647t1486r715b1542],
8	developed	VBN	O	develop	amod	9	SENT_12	[p1l739t1480r1097b1563],
9	nations	NNS	O	nation	prep_in	6	SENT_12	[p1l1120t1486r1396b1552],
10	,	,	O	,	_	0	SENT_12	[p1l1120t1486r1396b1552],
11	including	VBG	O	include	_	0	SENT_12	[p1l1422t1480r1756b1564],
12	the	DT	O	the	det	14	SENT_12	[p1l1777t1480r1886b1543],
13	United	NNP	LOCATION	United	nn	14	SENT_12	[p1l1911t1480r2151b1543],
14	States	NNPS	LOCATION	States	prep_including	9	SENT_12	[p1l10t1587r234b1656],
15	,	,	O	,	_	0	SENT_12	[p1l10t1587r234b1656],
16	for	IN	O	for	_	0	SENT_12	[p1l263t1583r366b1647],
17	decades	NNS	DURATION	decade	prep_for	9	SENT_12	[p1l393t1575r726b1647],
18	?	.	O	?	_	0	SENT_12	[p1l393t1575r726b1647],

1	Moreover	RB	O	moreover	advmod	6	SENT_13	[p1l758t1589r1123b1656],
2	,	,	O	,	_	0	SENT_13	[p1l758t1589r1123b1656],
3	this	DT	O	this	det	4	SENT_13	[p1l1152t1583r1284b1647],
4	epidemic	JJ	O	epidemic	nsubj	6	SENT_13	[p1l1312t1583r1643b1667],
5	has	VBZ	O	have	aux	6	SENT_13	[p1l1669t1583r1787b1647],
6	spread	VBN	O	spread	_	0	SENT_13	[p1l1816t1583r2052b1667],
7	to	TO	O	to	_	0	SENT_13	[p1l2078t1595r2147b1647],
8	developing	VBG	O	develop	amod	9	SENT_13	[p1l9t1686r385b1771],
9	nations	NNS	O	nation	prep_to	6	SENT_13	[p1l404t1678r703b1750],
10	?	.	O	?	_	0	SENT_13	[p1l404t1678r703b1750],

1	Growing	VBG	O	grow	amod	2	SENT_14	[p1l730t1690r1031b1771],
2	affluence	NN	O	affluence	nsubjpass	5	SENT_14	[p1l1051t1686r1355b1750],
3	has	VBZ	O	have	aux	5	SENT_14	[p1l1375t1686r1487b1750],
4	been	VBN	O	be	auxpass	5	SENT_14	[p1l1507t1686r1671b1750],
5	accompanied	VBN	O	accompany	_	0	SENT_14	[p1l1693t1686r2149b1770],
6	by	IN	O	by	_	0	SENT_14	[p1l7t1790r92b1874],
7	the	DT	O	the	det	8	SENT_14	[p1l112t1790r221b1853],
8	emergence	NN	O	emergence	agent	5	SENT_14	[p1l246t1813r624b1874],
9	of	IN	O	of	_	0	SENT_14	[p1l649t1790r725b1853],
10	overweight	JJ	O	overweight	prep_of	8	SENT_14	[p1l739t1790r1132b1874],
11	and	CC	O	and	_	0	SENT_14	[p1l1155t1790r1285b1853],
12	obesity	NN	O	obesity	conj_and	10	SENT_14	[p1l1308t1790r1569b1874],
13	,	,	O	,	_	0	SENT_14	[p1l1308t1790r1569b1874],
14	so	RB	O	so	advmod	16	SENT_14	[p1l1596t1813r1668b1853],
15	much	RB	O	much	advmod	16	SENT_14	[p1l1693t1790r1892b1853],
16	so	IN	O	so	advmod	5	SENT_14	[p1l1917t1813r1989b1853],
17	that	IN	O	that	dep	25	SENT_14	[p1l2013t1790r2151b1853],
18	the	DT	O	the	det	19	SENT_14	[p1l8t1893r115b1956],
19	proportions	NNS	O	proportion	nsubj	25	SENT_14	[p1l138t1899r554b1976],
20	of	IN	O	of	_	0	SENT_14	[p1l580t1893r654b1956],
21	underweight	JJ	O	underweight	prep_of	19	SENT_14	[p1l668t1893r1114b1977],
22	and	CC	O	and	_	0	SENT_14	[p1l1138t1893r1266b1956],
23	overweight	JJ	O	overweight	prep_of	19	SENT_14	[p1l1289t1893r1677b1977],
24	have	VBP	O	have	aux	25	SENT_14	[p1l1698t1893r1856b1956],
25	become	VBN	O	become	ccomp	16	SENT_14	[p1l1878t1893r2149b1956],
26	inverted	VBN	O	invert	dep	25	SENT_14	[p1l9t1987r357b2059],
27	?	.	O	?	_	0	SENT_14	[p1l9t1987r357b2059],

1	The	DT	O	the	det	3	SENT_15	[p1l388t1995r517b2059],
2	worldwide	JJ	O	worldwide	amod	3	SENT_15	[p1l543t1995r926b2059],
3	burden	NN	O	burden	nsubjpass	5	SENT_15	[p1l951t1995r1212b2059],
4	is	VBZ	O	be	auxpass	5	SENT_15	[p1l1239t2002r1291b2059],
5	estimated	VBN	O	estimate	_	0	SENT_15	[p1l1320t1995r1669b2059],
6	at	IN	O	at	_	0	SENT_15	[p1l1696t2007r1758b2059],
7	1.5	CD	NUMBER	1.5	number	8	SENT_15	[p1l1791t2002r1886b2059],
8	billion	CD	NUMBER	billion	num	9	SENT_15	[p1l1914t1995r2149b2059],
9	overweight	JJ	O	overweight	prep_at	5	SENT_15	[p1l9t2098r403b2183],
10	and	CC	O	and	_	0	SENT_15	[p1l427t2098r556b2162],
11	500	CD	NUMBER	500	number	12	SENT_15	[p1l582t2105r703b2162],
12	million	CD	NUMBER	million	num	14	SENT_15	[p1l728t2098r986b2162],
13	obese	JJ	O	obese	amod	14	SENT_15	[p1l1011t2098r1206b2162],
14	individuals	NNS	O	individual	conj_and	9	SENT_15	[p1l1231t2090r1679b2162],
15	?	.	O	?	_	0	SENT_15	[p1l1231t2090r1679b2162],

1	The	DT	O	the	det	3	SENT_16	[p1l1704t2098r1832b2162],
2	negative	JJ	O	negative	amod	3	SENT_16	[p1l1856t2105r2149b2183],
3	consequences	NNS	O	consequence	nsubjpass	8	SENT_16	[p1l9t2225r505b2285],
4	of	IN	O	of	_	0	SENT_16	[p1l534t2202r611b2265],
5	obesity	NN	O	obesity	prep_of	3	SENT_16	[p1l629t2202r888b2286],
6	have	VBP	O	have	aux	8	SENT_16	[p1l911t2202r1074b2265],
7	been	VBN	O	be	auxpass	8	SENT_16	[p1l1100t2202r1272b2265],
8	quantiﬁed	VBN	O	quantiﬁed	_	0	SENT_16	[p1l1301t2202r1668b2285],
9	as	IN	O	as	_	0	SENT_16	[p1l1696t2225r1763b2265],
10	exceeding	VBG	O	exceed	prepc_as	8	SENT_16	[p1l1792t2202r2152b2286],
11	those	DT	O	those	dobj	10	SENT_16	[p1l8t2304r193b2368],
12	of	IN	O	of	_	0	SENT_16	[p1l217t2304r292b2368],
13	either	CC	O	either	preconj	15	SENT_16	[p1l306t2304r507b2368],
14	alcohol	NN	O	alcohol	nn	15	SENT_16	[p1l530t2304r781b2368],
15	abuse	NN	O	abuse	prep_of	11	SENT_16	[p1l805t2304r997b2368],
16	or	CC	O	or	_	0	SENT_16	[p1l1022t2327r1094b2368],
17	smoking	NN	O	smoking	prep_of	11	SENT_16	[p1l1118t2296r1469b2389],
18	?	.	O	?	_	0	SENT_16	[p1l1118t2296r1469b2389],

1	Obesity-associated	JJ	O	obesity-associated	amod	2	SENT_17	[p1l1494t2304r2149b2389],
2	comorbidities	NNS	O	comorbidity	nsubj	18	SENT_17	[p1l9t2408r501b2480],
3	,	,	O	,	_	0	SENT_17	[p1l9t2408r501b2480],
4	including	VBG	O	include	_	0	SENT_17	[p1l524t2408r851b2492],
5	major	JJ	O	major	amod	6	SENT_17	[p1l870t2414r1072b2492],
6	diseases	NNS	O	disease	prep_including	2	SENT_17	[p1l1093t2408r1365b2471],
7	such	JJ	O	such	_	0	SENT_17	[p1l1387t2408r1542b2471],
8	as	IN	O	as	_	0	SENT_17	[p1l1563t2431r1628b2471],
9	cardiovascular	JJ	O	cardiovascular	amod	10	SENT_17	[p1l1650t2408r2149b2471],
10	disease	NN	O	disease	prep_such_as	6	SENT_17	[p1l9t2510r269b2583],
11	,	,	O	,	_	0	SENT_17	[p1l9t2510r269b2583],
12	cancer	NN	O	cancer	prep_such_as	6	SENT_17	[p1l292t2533r528b2583],
13	,	,	O	,	_	0	SENT_17	[p1l292t2533r528b2583],
14	and	CC	O	and	_	0	SENT_17	[p1l552t2510r678b2574],
15	diabetes	NN	O	diabetes	prep_such_as	6	SENT_17	[p1l699t2510r996b2583],
16	,	,	O	,	_	0	SENT_17	[p1l699t2510r996b2583],
17	are	VBP	O	be	cop	18	SENT_17	[p1l1020t2533r1120b2574],
18	legion	NN	O	legion	_	0	SENT_17	[p1l1141t2502r1400b2595],
19	?	.	O	?	_	0	SENT_17	[p1l1141t2502r1400b2595],

1	Overweight	JJ	O	overweight	nsubj	4	SENT_18	[p1l1425t2510r1830b2595],
2	and	CC	O	and	_	0	SENT_18	[p1l1850t2510r1977b2574],
3	obesity	NN	O	obesity	conj_and	1	SENT_18	[p1l1998t2510r2147b2574, p1l10t2620r131b2698],
4	constitute	VBP	O	constitute	_	0	SENT_18	[p1l151t2620r493b2677],
5	the	DT	O	the	det	8	SENT_18	[p1l516t2613r624b2677],
6	ﬁfth	JJ	O	ﬁfth	amod	8	SENT_18	[p1l648t2613r790b2677],
7	leading	VBG	O	lead	amod	8	SENT_18	[p1l812t2613r1069b2698],
8	risk	NN	O	risk	dobj	4	SENT_18	[p1l1091t2613r1223b2677],
9	for	IN	O	for	_	0	SENT_18	[p1l1243t2613r1342b2677],
10	global	JJ	O	global	amod	11	SENT_18	[p1l1364t2613r1577b2698],
11	deaths	NNS	O	death	prep_for	8	SENT_18	[p1l1600t2605r1874b2677],
12	?	.	O	?	_	0	SENT_18	[p1l1600t2605r1874b2677],

1	In	IN	O	in	_	0	SENT_19	[p1l1900t2619r1971b2676],
2	Iune	JJ	O	iune	amod	3	SENT_19	[p1l1996t2618r2149b2690],
3	2013	CD	DATE	2013	prep_in	10	SENT_19	[p1l9t2724r191b2789],
4	,	,	O	,	_	0	SENT_19	[p1l9t2724r191b2789],
5	the	DT	O	the	det	8	SENT_19	[p1l216t2717r324b2780],
6	American	NNP	ORGANIZATION	American	nn	8	SENT_19	[p1l347t2721r693b2780],
7	Medical	NNP	ORGANIZATION	Medical	nn	8	SENT_19	[p1l716t2717r996b2780],
8	Association	NNP	ORGANIZATION	Association	nsubj	10	SENT_19	[p1l1018t2721r1426b2780],
9	officially	RB	O	officially	advmod	10	SENT_19	[p1l1451t2717r1748b2801],
10	recognized	VBD	O	recognize	_	0	SENT_19	[p1l1769t2717r2152b2801],
11	obesity	NN	O	obesity	dobj	10	SENT_19	[p1l9t2819r257b2904],
12	as	IN	O	as	_	0	SENT_19	[p1l276t2842r341b2883],
13	a	DT	O	a	det	15	SENT_19	[p1l365t2842r399b2883],
14	disease	NN	O	disease	nn	15	SENT_19	[p1l422t2811r717b2883],
15	.4	NN	NUMBER	.4	prep_as	10	SENT_19	[p1l422t2811r717b2883],

1	The	DT	O	the	det	2	SENT_20	[p1l82t2923r207b2986],
2	evidence	NN	O	evidence	nsubj	8	SENT_20	[p1l230t2923r529b2986],
3	has	VBZ	O	have	aux	6	SENT_20	[p1l550t2923r662b2986],
4	been	VBN	O	be	cop	6	SENT_20	[p1l682t2923r847b2986],
5	readily	RB	O	readily	advmod	6	SENT_20	[p1l868t2923r1105b3007],
6	available	JJ	O	available	_	0	SENT_20	[p1l1124t2923r1418b2986],
7	and	CC	O	and	_	0	SENT_20	[p1l1440t2923r1567b2986],
8	mounting	VBG	O	mount	conj_and	6	SENT_20	[p1l1587t2929r1945b3007],
9	,	,	O	,	_	0	SENT_20	[p1l1587t2929r1945b3007],
10	demonstrating	VBG	O	demonstrate	dep	8	SENT_20	[p1l1969t2923r2146b2986, p1l9t3032r365b3110],
11	the	DT	O	the	det	13	SENT_20	[p1l385t3026r493b3089],
12	profound	JJ	O	profound	amod	13	SENT_20	[p1l515t3026r842b3109],
13	impact	NN	O	impact	dobj	8	SENT_20	[p1l865t3032r1105b3109],
14	of	IN	O	of	_	0	SENT_20	[p1l1127t3026r1202b3089],
15	obesity	NN	O	obesity	prep_of	13	SENT_20	[p1l1216t3026r1464b3110],
16	on	IN	O	on	_	0	SENT_20	[p1l1484t3049r1571b3089],
17	morbidity	NN	O	morbidity	nn	24	SENT_20	[p1l1593t3026r1952b3110],
18	,	,	O	,	_	0	SENT_20	[p1l1593t3026r1952b3110],
19	mortality	NN	O	mortality	dep	24	SENT_20	[p1l1977t3049r2146b3089, p1l8t3129r195b3213],
20	,	,	O	,	_	0	SENT_20	[p1l1977t3049r2146b3089, p1l8t3129r195b3213],
21	health	NN	O	health	dep	24	SENT_20	[p1l219t3129r610b3192],
22	—	CD	NUMBER	—	num	24	SENT_20	[p1l219t3129r610b3192],
23	care	NN	O	care	nn	24	SENT_20	[p1l219t3129r610b3192],
24	costs	NNS	O	cost	prep_on	15	SENT_20	[p1l634t3141r821b3201],
25	,	,	O	,	_	0	SENT_20	[p1l634t3141r821b3201],
26	and	CC	O	and	_	0	SENT_20	[p1l846t3129r975b3192],
27	professional	JJ	O	professional	amod	30	SENT_20	[p1l995t3129r1417b3212],
28	and	CC	O	and	_	0	SENT_20	[p1l1440t3129r1568b3192],
29	personal	JJ	O	personal	conj_and	27	SENT_20	[p1l1589t3129r1889b3212],
30	quality	NN	O	quality	dobj	8	SENT_20	[p1l1912t3129r2153b3213],
31	of	IN	O	of	_	0	SENT_20	[p1l9t3231r85b3295],
32	life	NN	O	life	prep_of	30	SENT_20	[p1l100t3223r261b3295],
33	?	.	O	?	_	0	SENT_20	[p1l100t3223r261b3295],

1	The	DT	O	the	det	2	SENT_21	[p1l287t3231r415b3295],
2	awareness	NN	O	awareness	nsubj	7	SENT_21	[p1l442t3254r798b3295],
3	of	IN	O	of	_	0	SENT_21	[p1l825t3231r901b3295],
4	this	DT	O	this	det	5	SENT_21	[p1l916t3231r1045b3295],
5	crisis	NN	O	crisis	prep_of	2	SENT_21	[p1l1072t3238r1253b3295],
6	has	VBZ	O	have	aux	7	SENT_21	[p1l1278t3231r1394b3295],
7	done	VBN	O	do	_	0	SENT_21	[p1l1421t3231r1595b3295],
8	little	JJ	O	little	acomp	7	SENT_21	[p1l1619t3231r1779b3295],
9	to	TO	O	to	aux	10	SENT_21	[p1l1804t3243r1872b3295],
10	reverse	VB	O	reverse	xcomp	8	SENT_21	[p1l1899t3254r2150b3295],
11	the	DT	O	the	det	13	SENT_21	[p2l8t27r117b90],
12	obesity	NN	O	obesity	nn	13	SENT_21	[p2l143t27r397b111],
13	trends	NNS	O	trend	dobj	10	SENT_21	[p2l417t27r640b90],
14	among	IN	O	among	_	0	SENT_21	[p2l666t50r909b111],
15	the	DT	O	the	det	17	SENT_21	[p2l931t27r1041b90],
16	global	JJ	O	global	amod	17	SENT_21	[p2l1066t27r1282b111],
17	population	NN	O	population	prep_among	10	SENT_21	[p2l1305t27r1712b110],
18	.	.	O	.	_	0	SENT_21	[p2l1305t27r1712b110],

1	Neither	DT	O	neither	nsubj	2	SENT_22	[p2l1740t27r2010b90],
2	has	VBZ	O	have	_	0	SENT_22	[p2l2032t27r2148b90],
3	the	DT	O	the	det	4	SENT_22	[p2l8t130r115b193],
4	awareness	NN	O	awareness	dobj	2	SENT_22	[p2l140t153r487b193],
5	that	WDT	O	that	dobj	14	SENT_22	[p2l510t130r646b193],
6	healthier	JJR	O	healthier	amod	7	SENT_22	[p2l667t130r977b193],
7	habits	NNS	O	habit	nsubj	14	SENT_22	[p2l998t130r1204b193],
8	for	IN	O	for	_	0	SENT_22	[p2l1228t130r1327b193],
9	eating	NN	O	eating	prep_for	7	SENT_22	[p2l1350t136r1561b214],
10	and	CC	O	and	_	0	SENT_22	[p2l1583t130r1711b193],
11	exercise	NN	O	exercise	prep_for	7	SENT_22	[p2l1734t136r2006b193],
12	can	MD	O	can	aux	14	SENT_22	[p2l2031t153r2149b193],
13	be	VB	O	be	cop	14	SENT_22	[p2l7t233r88b296],
14	curative	JJ	O	curative	rcmod	4	SENT_22	[p2l114t239r396b296],
15	proved	JJ	O	proved	dep	14	SENT_22	[p2l419t233r666b316],
16	particularly	RB	O	particularly	advmod	17	SENT_22	[p2l688t233r1105b317],
17	effective	JJ	O	effective	amod	15	SENT_22	[p2l1127t233r1433b296],
18	.	.	O	.	_	0	SENT_22	[p2l1127t233r1433b296],

1	To	TO	O	to	aux	2	SENT_23	[p2l1461t236r1548b296],
2	blame	VB	O	blame	_	0	SENT_23	[p2l1571t233r1786b296],
3	are	VBP	O	be	cop	5	SENT_23	[p2l1812t256r1915b296],
4	a	DT	O	a	det	5	SENT_23	[p2l1941t256r1976b296],
5	host	NN	O	host	ccomp	2	SENT_23	[p2l1998t233r2149b296],
6	of	IN	O	of	_	0	SENT_23	[p2l9t336r86b399],
7	factors	NNS	O	factor	prep_of	5	SENT_23	[p2l105t336r367b399],
8	:	:	O	:	_	0	SENT_23	[p2l105t336r367b399],
9	the	DT	O	the	det	10	SENT_23	[p2l398t336r509b399],
10	lack	NN	O	lack	dep	5	SENT_23	[p2l537t336r684b399],
11	of	IN	O	of	_	0	SENT_23	[p2l710t336r787b399],
12	access	NN	O	access	prep_of	10	SENT_23	[p2l807t359r1025b399],
13	to	TO	O	to	_	0	SENT_23	[p2l1053t348r1122b399],
14	healthy	JJ	O	healthy	amod	17	SENT_23	[p2l1151t336r1429b420],
15	,	,	O	,	_	0	SENT_23	[p2l1151t336r1429b420],
16	affordable	JJ	O	affordable	amod	17	SENT_23	[p2l1461t336r1819b399],
17	foods	NNS	O	food	prep_to	12	SENT_23	[p2l1848t336r2046b399],
18	or	CC	O	or	_	0	SENT_23	[p2l2076t359r2151b399],
19	safe	JJ	O	safe	amod	20	SENT_23	[p2l10t439r139b502],
20	places	NNS	O	place	prep_to	12	SENT_23	[p2l163t439r376b522],
21	for	IN	O	for	_	0	SENT_23	[p2l401t439r501b502],
22	physical	JJ	O	physical	amod	23	SENT_23	[p2l523t439r811b523],
23	activity	NN	O	activity	prep_for	20	SENT_23	[p2l835t445r1105b523],
24	,	,	O	,	_	0	SENT_23	[p2l835t445r1105b523],
25	particularly	RB	O	particularly	advmod	12	SENT_23	[p2l1129t439r1546b523],
26	in	IN	O	in	_	0	SENT_23	[p2l1566t445r1635b501],
27	lower-income	JJ	O	lower-income	amod	28	SENT_23	[p2l1658t439r2148b502],
28	neighborhoods	NNS	O	neighborhood	prep_in	12	SENT_23	[p2l8t542r558b626],
29	and	CC	O	and	_	0	SENT_23	[p2l588t542r720b605],
30	communities	NNS	O	community	prep_in	12	SENT_23	[p2l748t548r1241b614],
31	;	:	O	;	_	0	SENT_23	[p2l748t548r1241b614],
32	the	DT	O	the	det	33	SENT_23	[p2l1270t542r1382b605],
33	inferiority	NN	O	inferiority	dep	5	SENT_23	[p2l1411t542r1784b626],
34	of	IN	O	of	_	0	SENT_23	[p2l1810t542r1887b605],
35	freshly	RB	O	freshly	advmod	37	SENT_23	[p2l1905t542r2152b626],
36	prepared	JJ	O	prepared	amod	37	SENT_23	[p2l8t645r326b728],
37	foods	NNS	O	food	prep_of	33	SENT_23	[p2l351t645r545b708],
38	vs.	CC	O	vs.	prep	37	SENT_23	[p2l569t668r659b708],
39	fast	JJ	O	fast	amod	40	SENT_23	[p2l688t645r811b708],
40	foods	NNS	O	food	dep	38	SENT_23	[p2l835t645r1029b708],
41	or	CC	O	or	_	0	SENT_23	[p2l1056t668r1130b708],
42	prepackaged	JJ	O	prepackaged	amod	43	SENT_23	[p2l1153t645r1603b729],
43	foods	NNS	O	food	conj_or	37	SENT_23	[p2l1627t645r1821b708],
44	in	IN	O	in	_	0	SENT_23	[p2l1847t651r1916b707],
45	terms	NNS	O	term	prep_in	43	SENT_23	[p2l1940t657r2141b708],
46	of	IN	O	of	_	0	SENT_23	[p2l10t748r85b811],
47	preservation	NN	O	preservation	prep_of	45	SENT_23	[p2l97t754r553b831],
48	,	,	O	,	_	0	SENT_23	[p2l97t754r553b831],
49	portability	NN	O	portability	prep_of	45	SENT_23	[p2l577t748r957b832],
50	,	,	O	,	_	0	SENT_23	[p2l577t748r957b832],
51	and	CC	O	and	_	0	SENT_23	[p2l982t748r1110b811],
52	palatability	NN	O	palatability	prep_of	45	SENT_23	[p2l1132t748r1541b832],
53	;	:	O	;	_	0	SENT_23	[p2l1132t748r1541b832],
54	the	DT	O	the	det	55	SENT_23	[p2l1565t748r1673b811],
55	marketing	NN	O	marketing	dep	5	SENT_23	[p2l1696t748r2056b832],
56	of	IN	O	of	_	0	SENT_23	[p2l2078t748r2153b811],
57	mostly	RB	O	mostly	advmod	59	SENT_23	[p2l9t851r243b935],
58	unhealthy	JJ	O	unhealthy	amod	59	SENT_23	[p2l262t851r608b935],
59	products	NNS	O	product	prep_of	55	SENT_23	[p2l626t851r928b934],
60	by	IN	O	by	_	0	SENT_23	[p2l949t851r1033b935],
61	the	DT	O	the	det	65	SENT_23	[p2l1052t851r1158b914],
62	food	NN	O	food	nn	65	SENT_23	[p2l1180t851r1338b914],
63	and	CC	O	and	_	0	SENT_23	[p2l1360t851r1486b914],
64	beverage	NN	O	beverage	conj_and	62	SENT_23	[p2l1506t851r1808b935],
65	industry	NN	O	industry	prep_by	59	SENT_23	[p2l1831t851r2140b935],
66	;	:	O	;	_	0	SENT_23	[p2l1831t851r2140b935],
67	and	CC	O	and	_	0	SENT_23	[p2l10t954r137b1017],
68	modern	JJ	O	modern	amod	70	SENT_23	[p2l158t954r434b1017],
69	cultural	JJ	O	cultural	amod	70	SENT_23	[p2l458t954r724b1017],
70	habits	NNS	O	habit	conj_and	5	SENT_23	[p2l746t954r950b1017],
71	that	WDT	O	that	nsubj	72	SENT_23	[p2l972t954r1107b1017],
72	increase	VBP	O	increase	rcmod	70	SENT_23	[p2l1129t960r1409b1017],
73	sedentary	JJ	O	sedentary	amod	74	SENT_23	[p2l1433t954r1770b1038],
74	behaviors	NNS	O	behavior	dobj	72	SENT_23	[p2l1787t954r2139b1026],
75	,	,	O	,	_	0	SENT_23	[p2l1787t954r2139b1026],
76	degrade	VB	O	degrade	conj_and	2	SENT_23	[p2l10t1057r283b1141],
77	eating	VBG	O	eat	xcomp	76	SENT_23	[p2l306t1063r515b1141],
78	cadences	NNS	O	cadence	dobj	77	SENT_23	[p2l537t1057r843b1120],
79	and	CC	O	and	_	0	SENT_23	[p2l867t1057r994b1120],
80	locations	NNS	O	location	dobj	77	SENT_23	[p2l1015t1057r1343b1129],
81	,	,	O	,	_	0	SENT_23	[p2l1015t1057r1343b1129],
82	and	CC	O	and	_	0	SENT_23	[p2l1369t1057r1496b1120],
83	incur	VB	O	incur	conj_and	2	SENT_23	[p2l1517t1063r1701b1120],
84	excess	JJ	O	excess	amod	86	SENT_23	[p2l1724t1080r1933b1120],
85	stress	NN	O	stress	nn	86	SENT_23	[p2l1957t1069r2142b1120],
86	levels	NNS	O	level	dobj	83	SENT_23	[p2l8t1159r193b1222],
87	and	CC	O	and	_	0	SENT_23	[p2l216t1159r342b1222],
88	sleep	VB	O	sleep	conj_and	83	SENT_23	[p2l363t1159r530b1242],
89	debt	NN	O	debt	nn	91	SENT_23	[p2l553t1151r796b1222],
90	.1	NN	NUMBER	.1	nn	91	SENT_23	[p2l553t1151r796b1222],
91	’	NN	O	’	dobj	88	SENT_23	[p2l553t1151r796b1222],
92	2	CD	NUMBER	2	dep	91	SENT_23	[p2l553t1151r796b1222],

1	Amid	IN	O	amid	_	0	SENT_24	[p2l82t1262r278b1325],
2	the	DT	O	the	det	3	SENT_24	[p2l296t1262r402b1325],
3	waves	NNS	O	wave	nsubj	6	SENT_24	[p2l420t1285r620b1325],
4	of	IN	O	of	_	0	SENT_24	[p2l641t1262r714b1325],
5	reports	NNS	O	report	prep_of	3	SENT_24	[p2l725t1274r967b1345],
6	publicizing	VBG	O	publicize	prepc_amid	11	SENT_24	[p2l987t1262r1367b1346],
7	these	DT	O	these	det	8	SENT_24	[p2l1385t1262r1559b1325],
8	threats	NNS	O	threat	dobj	6	SENT_24	[p2l1579t1262r1828b1334],
9	,	,	O	,	_	0	SENT_24	[p2l1579t1262r1828b1334],
10	there	EX	O	there	expl	11	SENT_24	[p2l1849t1262r2022b1325],
11	are	VBP	O	be	_	0	SENT_24	[p2l2043t1285r2142b1325],
12	glimmers	NNS	O	glimmer	nsubj	11	SENT_24	[p2l9t1365r339b1449],
13	of	IN	O	of	_	0	SENT_24	[p2l363t1365r438b1428],
14	hope	NN	O	hope	prep_of	12	SENT_24	[p2l451t1365r640b1448],
15	.	.	O	.	_	0	SENT_24	[p2l451t1365r640b1448],

1	Among	IN	O	among	_	0	SENT_25	[p2l665t1369r929b1449],
2	the	DT	O	the	det	6	SENT_25	[p2l949t1365r1057b1428],
3	most	RBS	O	most	advmod	4	SENT_25	[p2l1081t1377r1254b1428],
4	troubling	JJ	O	troubling	amod	6	SENT_25	[p2l1275t1365r1603b1449],
5	obesity-related	JJ	O	obesity-related	amod	6	SENT_25	[p2l1625t1365r2143b1449],
6	trends	NNS	O	trend	prep_among	28	SENT_25	[p2l8t1468r219b1531],
7	has	VBZ	O	have	aux	11	SENT_25	[p2l238t1468r347b1531],
8	been	VBN	O	be	cop	11	SENT_25	[p2l366t1468r527b1531],
9	the	DT	O	the	det	11	SENT_25	[p2l546t1468r650b1531],
10	threefold	JJ	O	threefold	amod	11	SENT_25	[p2l669t1468r974b1531],
11	increase	NN	O	increase	rcmod	6	SENT_25	[p2l993t1474r1264b1531],
12	in	IN	O	in	_	0	SENT_25	[p2l1284t1474r1349b1530],
13	childhood	NN	O	childhood	nn	15	SENT_25	[p2l1370t1468r1714b1531],
14	obesity	NN	O	obesity	nn	15	SENT_25	[p2l1733t1468r1972b1552],
15	rates	NNS	O	rate	prep_in	11	SENT_25	[p2l1989t1480r2143b1531],
16	in	IN	O	in	_	0	SENT_25	[p2l10t1576r77b1632],
17	the	DT	DURATION	the	det	20	SENT_25	[p2l100t1570r209b1633],
18	past	JJ	DURATION	past	amod	20	SENT_25	[p2l231t1582r374b1653],
19	30	CD	DURATION	30	num	20	SENT_25	[p2l398t1577r476b1633],
20	years	NNS	NUMBER	year	prep_in	11	SENT_25	[p2l498t1563r730b1654],
21	.5	CD	NUMBER	.5	tmod	11	SENT_25	[p2l498t1563r730b1654],
22	Consequently	RB	O	consequently	advmod	21	SENT_25	[p2l755t1570r1252b1654],
23	,	,	O	,	_	0	SENT_25	[p2l755t1570r1252b1654],
24	children	NNS	O	child	nsubjpass	28	SENT_25	[p2l1278t1570r1569b1633],
25	are	VBP	O	be	aux	28	SENT_25	[p2l1593t1593r1696b1633],
26	increasingly	RB	O	increasingly	advmod	28	SENT_25	[p2l1720t1570r2146b1654],
27	being	VBG	O	be	auxpass	28	SENT_25	[p2l7t1673r199b1757],
28	diagnosed	VBN	O	diagnose	ccomp	54	SENT_25	[p2l218t1673r568b1757],
29	with	IN	O	with	_	0	SENT_25	[p2l585t1673r738b1736],
30	traditionally	RB	O	traditionally	advmod	32	SENT_25	[p2l757t1673r1184b1757],
31	adult-onset	JJ	O	adult-onset	amod	32	SENT_25	[p2l1202t1673r1589b1736],
32	diseases	NNS	O	disease	prep_with	28	SENT_25	[p2l1610t1673r1881b1736],
33	such	JJ	O	such	_	0	SENT_25	[p2l1903t1673r2058b1736],
34	as	IN	O	as	_	0	SENT_25	[p2l2079t1696r2143b1736],
35	heart	NN	O	heart	nn	36	SENT_25	[p2l8t1775r186b1838],
36	disease	NN	O	disease	prep_such_as	32	SENT_25	[p2l206t1775r446b1838],
37	and	CC	O	and	_	0	SENT_25	[p2l468t1775r594b1838],
38	type	NN	O	type	prep_such_as	32	SENT_25	[p2l613t1787r759b1859],
39	2	CD	NUMBER	2	num	38	SENT_25	[p2l780t1782r816b1837],
40	diabetes	NN	O	diabetes	dep	38	SENT_25	[p2l839t1768r1166b1838],
41	.5	CD	NUMBER	.5	num	40	SENT_25	[p2l839t1768r1166b1838],
42	Furthermore	RB	O	furthermore	advmod	28	SENT_25	[p2l1189t1775r1647b1847],
43	,	,	O	,	_	0	SENT_25	[p2l1189t1775r1647b1847],
44	the	DT	O	the	det	45	SENT_25	[p2l1669t1775r1775b1838],
45	likelihood	NN	O	likelihood	nsubjpass	54	SENT_25	[p2l1795t1775r2144b1838],
46	and	CC	O	and	_	0	SENT_25	[p2l10t1878r136b1941],
47	severity	NN	O	severity	nsubjpass	54	SENT_25	[p2l156t1884r422b1962],
48	of	IN	O	of	_	0	SENT_25	[p2l439t1878r513b1941],
49	obesity	NN	O	obesity	prep_of	45	SENT_25	[p2l524t1878r769b1962],
50	in	IN	O	in	_	0	SENT_25	[p2l786t1884r852b1940],
51	adulthood	NN	O	adulthood	prep_in	49	SENT_25	[p2l873t1878r1227b1941],
52	is	VBZ	O	be	auxpass	54	SENT_25	[p2l1247t1884r1297b1941],
53	dramatically	RB	O	dramatically	advmod	54	SENT_25	[p2l1318t1878r1747b1962],
54	heightened	VBN	O	heighten	_	0	SENT_25	[p2l1763t1878r2145b1962],
55	by	IN	O	by	_	0	SENT_25	[p2l7t1980r93b2064],
56	obesity	NN	O	obesity	agent	54	SENT_25	[p2l114t1980r364b2064],
57	in	IN	O	in	_	0	SENT_25	[p2l384t1986r452b2042],
58	childhood	NN	O	childhood	prep_in	54	SENT_25	[p2l476t1973r886b2043],
59	.5	CD	NUMBER	.5	num	58	SENT_25	[p2l476t1973r886b2043],
60	This	DT	O	this	det	61	SENT_25	[p2l911t1980r1056b2043],
61	problem	NN	O	problem	nsubjpass	64	SENT_25	[p2l1080t1980r1376b2063],
62	has	VBZ	O	have	aux	64	SENT_25	[p2l1398t1980r1512b2043],
63	been	VBN	O	be	auxpass	64	SENT_25	[p2l1535t1980r1702b2043],
64	met	VBN	O	meet	rcmod	58	SENT_25	[p2l1726t1992r1860b2043],
65	with	IN	O	with	_	0	SENT_25	[p2l1880t1980r2037b2043],
66	an	DT	O	a	det	68	SENT_25	[p2l2061t2003r2142b2043],
67	extensive	JJ	O	extensive	amod	68	SENT_25	[p2l10t2089r337b2146],
68	ﬁght	NN	O	ﬁght	prep_with	64	SENT_25	[p2l365t2083r527b2167],
69	to	TO	O	to	aux	70	SENT_25	[p2l551t2095r620b2146],
70	limit	VB	O	limit	xcomp	64	SENT_25	[p2l647t2083r817b2146],
71	and	CC	O	and	_	0	SENT_25	[p2l844t2083r975b2146],
72	reverse	VB	O	reverse	conj_and	70	SENT_25	[p2l1001t2106r1253b2146],
73	this	DT	O	this	det	74	SENT_25	[p2l1280t2083r1410b2146],
74	disease	NN	O	disease	dobj	70	SENT_25	[p2l1439t2083r1708b2146],
75	.	.	O	.	_	0	SENT_25	[p2l1439t2083r1708b2146],

1	Public	JJ	O	public	amod	2	SENT_26	[p2l1739t2083r1964b2146],
2	programs	NNS	O	program	nsubj	4	SENT_26	[p2l1989t2105r2140b2166, p2l9t2210r218b2271],
3	have	VBP	O	have	aux	4	SENT_26	[p2l241t2187r397b2250],
4	developed	VBN	O	develop	_	0	SENT_26	[p2l421t2187r772b2270],
5	health	NN	O	health	dobj	4	SENT_26	[p2l794t2187r1008b2250],
6	promotional	JJ	O	promotional	amod	7	SENT_26	[p2l1029t2187r1463b2270],
7	campaigns	NNS	O	campaign	nsubj	8	SENT_26	[p2l1485t2193r1851b2271],
8	focused	VBD	O	focus	rcmod	5	SENT_26	[p2l1875t2187r2142b2250],
9	on	IN	O	on	prt	8	SENT_26	[p2l10t2313r96b2353],
10	(	NN	O	(	dobj	8	SENT_26	[p2l122t2290r194b2367],
11	i	FW	O	i	nn	10	SENT_26	[p2l122t2290r194b2367],
12	)	FW	O	)	dep	10	SENT_26	[p2l122t2290r194b2367],
13	raising	VBG	O	raise	dep	8	SENT_26	[p2l222t2296r455b2374],
14	a	DT	O	a	det	16	SENT_26	[p2l477t2313r512b2353],
15	new	JJ	O	new	amod	16	SENT_26	[p2l533t2313r677b2353],
16	generation	NN	O	generation	dobj	13	SENT_26	[p2l696t2296r1064b2374],
17	of	IN	O	of	_	0	SENT_26	[p2l1087t2290r1162b2353],
18	children	NNS	O	child	prep_of	16	SENT_26	[p2l1175t2290r1461b2353],
19	with	IN	O	with	_	0	SENT_26	[p2l1482t2290r1636b2353],
20	healthier	JJR	O	healthier	amod	21	SENT_26	[p2l1658t2290r1965b2353],
21	habits	NNS	O	habit	prep_with	13	SENT_26	[p2l1986t2290r2139b2353, p2l10t2399r88b2456],
22	regarding	VBG	O	regard	_	0	SENT_26	[p2l115t2393r457b2477],
23	diet	NN	O	diet	prep_regarding	21	SENT_26	[p2l482t2393r615b2456],
24	and	CC	O	and	_	0	SENT_26	[p2l640t2393r770b2456],
25	physical	JJ	O	physical	amod	26	SENT_26	[p2l794t2393r1083b2477],
26	activity	NN	O	activity	prep_regarding	21	SENT_26	[p2l1109t2399r1371b2477],
27	and	CC	O	and	_	0	SENT_26	[p2l1394t2393r1524b2456],
28	(	CD	NUMBER	(	dep	30	SENT_26	[p2l1553t2394r1651b2469],
29	ii	LS	O	ii	dep	30	SENT_26	[p2l1553t2394r1651b2469],
30	)	CD	NUMBER	)	advmod	13	SENT_26	[p2l1553t2394r1651b2469],
31	changing	VBG	O	change	conj_and	13	SENT_26	[p2l1682t2393r2008b2477],
32	the	DT	O	the	det	33	SENT_26	[p2l2030t2393r2141b2456],
33	complexion	NN	O	complexion	dobj	31	SENT_26	[p2l10t2496r417b2579],
34	of	IN	O	of	_	0	SENT_26	[p2l441t2496r515b2559],
35	school	NN	O	school	nn	36	SENT_26	[p2l529t2496r753b2559],
36	foods	NNS	O	food	prep_of	33	SENT_26	[p2l775t2496r965b2559],
37	and	CC	O	and	_	0	SENT_26	[p2l990t2496r1117b2559],
38	beverages	NNS	O	beverage	prep_of	33	SENT_26	[p2l1137t2496r1475b2580],
39	from	IN	O	from	_	0	SENT_26	[p2l1499t2496r1668b2559],
40	high-calorie	JJ	O	high-calorie	prep_from	31	SENT_26	[p2l1690t2496r2141b2580],
41	/	:	O	/	punct	44	SENT_26	[p2l1690t2496r2141b2580],
42	high-fat/high-sodium	NN	O	high-fat/high-sodium	nn	44	SENT_26	[p2l8t2599r755b2683],
43	junk	NN	O	junk	nn	44	SENT_26	[p2l770t2599r932b2683],
44	foods	NNS	O	food	dep	40	SENT_26	[p2l948t2599r1135b2662],
45	and	CC	O	and	_	0	SENT_26	[p2l1157t2599r1282b2662],
46	sugar-rich	JJ	O	sugar-rich	amod	47	SENT_26	[p2l1303t2599r1649b2683],
47	sodas	NNS	O	soda	conj_and	44	SENT_26	[p2l1671t2599r1857b2662],
48	to	TO	O	to	dep	40	SENT_26	[p2l1877t2611r1942b2662],
49	more	RBR	O	more	advmod	50	SENT_26	[p2l1964t2622r2140b2662],
50	fresh	JJ	O	fresh	amod	51	SENT_26	[p2l9t2702r180b2765],
51	fruits	NNS	O	fruit	dep	40	SENT_26	[p2l203t2702r387b2765],
52	and	CC	O	and	_	0	SENT_26	[p2l411t2702r539b2765],
53	vegetables	NNS	O	vegetable	conj_and	40	SENT_26	[p2l558t2702r932b2786],
54	,	,	O	,	_	0	SENT_26	[p2l558t2702r932b2786],
55	whole	JJ	O	whole	amod	56	SENT_26	[p2l954t2702r1163b2765],
56	grains	NNS	O	grain	conj_and	40	SENT_26	[p2l1187t2708r1416b2786],
57	,	,	O	,	_	0	SENT_26	[p2l1187t2708r1416b2786],
58	and	CC	O	and	_	0	SENT_26	[p2l1442t2702r1569b2765],
59	healthier	JJR	O	healthier	amod	60	SENT_26	[p2l1591t2702r1901b2765],
60	beverages	NNS	O	beverage	conj_and	40	SENT_26	[p2l1921t2702r2140b2765, p2l10t2828r169b2889],
61	.	.	O	.	_	0	SENT_26	[p2l1921t2702r2140b2765, p2l10t2828r169b2889],

1	Public	JJ	O	public	amod	3	SENT_27	[p2l196t2805r412b2868],
2	policy	NN	O	policy	nn	3	SENT_27	[p2l434t2805r648b2889],
3	measures	NNS	O	measure	nsubj	15	SENT_27	[p2l667t2828r1006b2877],
4	,	,	O	,	_	0	SENT_27	[p2l667t2828r1006b2877],
5	such	JJ	O	such	_	0	SENT_27	[p2l1032t2805r1188b2868],
6	as	IN	O	as	_	0	SENT_27	[p2l1211t2828r1276b2868],
7	container	NN	O	container	nn	9	SENT_27	[p2l1300t2811r1628b2868],
8	size	NN	O	size	nn	9	SENT_27	[p2l1650t2811r1774b2868],
9	limits	NNS	O	limit	prep_such_as	3	SENT_27	[p2l1796t2805r1990b2868],
10	and	CC	O	and	_	0	SENT_27	[p2l2014t2805r2142b2868],
11	sugar	NN	O	sugar	nn	12	SENT_27	[p2l10t2931r191b2992],
12	taxes	NNS	O	tax	conj_and	9	SENT_27	[p2l209t2920r395b2980],
13	,	,	O	,	_	0	SENT_27	[p2l209t2920r395b2980],
14	are	VBP	O	be	aux	15	SENT_27	[p2l417t2931r515b2971],
15	curbing	VBG	O	curb	dep	27	SENT_27	[p2l537t2908r798b2992],
16	the	DT	O	the	det	17	SENT_27	[p2l815t2908r920b2971],
17	consumption	NN	O	consumption	dobj	15	SENT_27	[p2l941t2914r1388b2991],
18	of	IN	O	of	_	0	SENT_27	[p2l1408t2908r1481b2971],
19	sugary	JJ	O	sugary	amod	23	SENT_27	[p2l1493t2931r1717b2992],
20	high	JJ	O	high	amod	23	SENT_27	[p2l1733t2908r2144b2992],
21	—	NN	O	—	nn	23	SENT_27	[p2l1733t2908r2144b2992],
22	calorie	NN	O	calorie	nn	23	SENT_27	[p2l1733t2908r2144b2992],
23	drinks	NNS	O	drink	prep_of	17	SENT_27	[p2l10t3002r287b3073],
24	.6	CD	NUMBER	.6	num	26	SENT_27	[p2l10t3002r287b3073],
25	Recent	JJ	O	recent	amod	26	SENT_27	[p2l312t3015r551b3073],
26	data	NNS	O	datum	nsubj	27	SENT_27	[p2l574t3010r721b3073],
27	suggest	VBP	O	suggest	_	0	SENT_27	[p2l745t3022r1000b3094],
28	that	IN	O	that	complm	32	SENT_27	[p2l1022t3010r1159b3073],
29	these	DT	O	these	det	30	SENT_27	[p2l1180t3010r1360b3073],
30	efforts	NNS	O	effort	nsubj	32	SENT_27	[p2l1385t3010r1604b3073],
31	are	VBP	O	be	aux	32	SENT_27	[p2l1629t3033r1731b3073],
32	succeeding	VBG	O	succeed	ccomp	27	SENT_27	[p2l1756t3010r2144b3094],
33	modestly	RB	O	modestly	advmod	32	SENT_27	[p2l9t3113r321b3197],
34	in	IN	O	in	_	0	SENT_27	[p2l338t3119r403b3175],
35	trimming	VBG	O	trim	prepc_in	32	SENT_27	[p2l423t3119r751b3197],
36	the	DT	O	the	det	37	SENT_27	[p2l769t3113r873b3176],
37	growth	NN	O	growth	dobj	35	SENT_27	[p2l893t3113r1133b3197],
38	of	IN	O	of	_	0	SENT_27	[p2l1153t3113r1226b3176],
39	the	DT	O	the	det	41	SENT_27	[p2l1236t3113r1341b3176],
40	overweight	JJ	O	overweight	amod	41	SENT_27	[p2l1362t3113r1736b3197],
41	population	NN	O	population	prep_of	37	SENT_27	[p2l1754t3113r2142b3196],
42	;	:	O	;	_	0	SENT_27	[p2l1754t3113r2142b3196],

1	‘	NNP	O	‘	nn	2	SENT_28	[p2l21t3281r191b3314],
2	Department	NNP	O	Department	_	0	SENT_28	[p2l21t3281r191b3314],
3	of	IN	O	of	_	0	SENT_28	[p2l198t3284r224b3308],
4	Pharmacology	NNP	O	Pharmacology	prep_of	2	SENT_28	[p2l230t3284r416b3314],
5	and	CC	O	and	_	0	SENT_28	[p2l422t3285r469b3308],
6	Experimental	JJ	O	experimental	amod	7	SENT_28	[p2l479t3284r647b3314],
7	Therapeutics	NNS	O	therapeutics	conj_and	4	SENT_28	[p2l653t3284r934b3314],
8	,	,	O	,	_	0	SENT_28	[p2l653t3284r934b3314],
9	Thomas	NNP	PERSON	Thomas	nn	11	SENT_28	[p2l653t3284r934b3314],
10	Jefferson	NNP	PERSON	Jefferson	nn	11	SENT_28	[p2l940t3284r1056b3308],
11	University	NNP	ORGANIZATION	University	appos	2	SENT_28	[p2l1066t3286r1198b3314],
12	,	,	O	,	_	0	SENT_28	[p2l1066t3286r1198b3314],
13	Philadelphia	NNP	LOCATION	Philadelphia	appos	2	SENT_28	[p2l1207t3284r1372b3314],
14	,	,	O	,	_	0	SENT_28	[p2l1207t3284r1372b3314],
15	Pennsylvania	NNP	LOCATION	Pennsylvania	appos	2	SENT_28	[p2l1380t3284r1554b3314],
16	,	,	O	,	_	0	SENT_28	[p2l1380t3284r1554b3314],
17	USA	NNP	LOCATION	USA	appos	2	SENT_28	[p2l1562t3285r1620b3308],
18	.	.	O	.	_	0	SENT_28	[p2l1562t3285r1620b3308],

1	Correspondence	NN	O	correspondence	_	0	SENT_29	[p2l1628t3284r1848b3314],
2	:	:	O	:	_	0	SENT_29	[p2l1628t3284r1848b3314],
3	SA	NNP	O	SA	nn	5	SENT_29	[p2l1855t3285r1888b3308],
4	Waldman	NNP	PERSON	Waldman	nn	5	SENT_29	[p2l1893t3284r2015b3308],
5	(	NNP	O	(	dep	1	SENT_29	[p2l21t3322r421b3352],
6	scott	NN	O	scott	dep	5	SENT_29	[p2l21t3322r421b3352],
7	.	.	O	.	_	0	SENT_29	[p2l21t3322r421b3352],

1	wa	NN	O	wa	_	0	SENT_30	[p2l21t3322r421b3352],
2	|	SYM	O	|	dep	4	SENT_30	[p2l21t3322r421b3352],
3	dman@jefferson.edu	FW	O	dman@jefferson.edu	nn	4	SENT_30	[p2l21t3322r421b3352],
4	)	FW	O	)	rcmod	1	SENT_30	[p2l21t3322r421b3352],
5	Received	VBN	O	receive	dep	1	SENT_30	[p2l21t3366r130b3389],
6	3	CD	DATE	3	num	7	SENT_30	[p2l139t3368r151b3389],
7	September	NNP	DATE	September	dobj	5	SENT_30	[p2l159t3366r297b3395],
8	201	CD	NUMBER	201	num	7	SENT_30	[p2l304t3368r342b3389],
9	3	CD	NUMBER	3	dep	7	SENT_30	[p2l350t3368r368b3393],
10	;	:	O	;	_	0	SENT_30	[p2l350t3368r368b3393],
11	accepted	VBN	O	accept	dep	5	SENT_30	[p2l375t3366r488b3395],
12	18	CD	DATE	18	num	13	SENT_30	[p2l499t3368r525b3389],
13	September	NNP	DATE	September	dobj	11	SENT_30	[p2l533t3366r671b3395],
14	201	CD	NUMBER	201	num	13	SENT_30	[p2l678t3368r716b3389],
15	3	CD	NUMBER	3	dep	13	SENT_30	[p2l723t3368r742b3393],
16	;	:	O	;	_	0	SENT_30	[p2l723t3368r742b3393],
17	advance	NN	O	advance	dep	13	SENT_30	[p2l749t3366r852b3389],
18	online	NN	O	online	prep	17	SENT_30	[p2l860t3366r936b3389],
19	publication	NN	O	publication	dep	18	SENT_30	[p2l945t3366r1083b3395],
20	13	CD	DATE	13	num	19	SENT_30	[p2l1094t3368r1119b3389],
21	November	NNP	DATE	November	tmod	11	SENT_30	[p2l1129t3366r1259b3389],
22	201	CD	NUMBER	201	num	21	SENT_30	[p2l1266t3368r1304b3389],
23	3	CD	NUMBER	3	dobj	5	SENT_30	[p2l1312t3368r1330b3389],
24	.	.	O	.	_	0	SENT_30	[p2l1312t3368r1330b3389],

1	doi	FW	O	doi	nn	2	SENT_31	[p2l1337t3366r1391b3389],
2	:1	FW	O	:1	dep	10	SENT_31	[p2l1337t3366r1391b3389],
3	0.1	CD	NUMBER	0.1	num	4	SENT_31	[p2l1398t3368r1427b3389],
4	O38/c	NN	O	o38/c	dep	2	SENT_31	[p2l1434t3366r1582b3395],
5	|	CD	NUMBER	|	num	6	SENT_31	[p2l1434t3366r1582b3395],
6	pt	NN	O	pt	dep	10	SENT_31	[p2l1434t3366r1582b3395],
7	.201	CD	NUMBER	.201	num	10	SENT_31	[p2l1434t3366r1582b3395],
8	3.204	CD	NUMBER	3.204	num	10	SENT_31	[p2l1590t3368r1654b3389],
9	CLINICAL	NNP	O	CLINICAL	nn	10	SENT_31	[p2l20t3412r140b3433],
10	PHARMACOLOGY	NNP	O	PHARMACOLOGY	dep	18	SENT_31	[p2l149t3412r373b3433],
11	&	CC	O	&	_	0	SENT_31	[p2l380t3412r600b3433],
12	THERAPEUT	NNP	O	THERAPEUT	conj_and	10	SENT_31	[p2l380t3412r600b3433],
13	|	CD	NUMBER	|	num	16	SENT_31	[p2l380t3412r600b3433],
14	CS	NNP	O	CS	nn	16	SENT_31	[p2l380t3412r600b3433],
15	[	CD	NUMBER	[	num	16	SENT_31	[p2l610t3410r728b3440],
16	VOLUME	NNP	O	VOLUME	dep	10	SENT_31	[p2l610t3410r728b3440],
17	95	CD	NUMBER	95	num	18	SENT_31	[p2l736t3412r763b3433],
18	NUMBER	NN	O	number	dep	23	SENT_31	[p2l774t3412r881b3433],
19	1	CD	NUMBER	1	number	20	SENT_31	[p2l891t3413r898b3433],
20	|	CD	NUMBER	|	dep	18	SENT_31	[p2l912t3410r914b3440],
21	JANUARY	NNP	DATE	JANUARY	dep	20	SENT_31	[p2l923t3412r1041b3433],
22	2014	CD	DATE	2014	num	23	SENT_31	[p2l1049t3412r1107b3433],
23	53	CD	DATE	53	_	0	SENT_31	[p2l2109t3412r2139b3433],

1	however	RB	O	however	advmod	13	SENT_32	[p3l8t85r321b157],
2	,	,	O	,	_	0	SENT_32	[p3l8t85r321b157],
3	the	DT	O	the	det	5	SENT_32	[p3l348t85r457b148],
4	overall	JJ	O	overall	amod	5	SENT_32	[p3l484t85r723b148],
5	rates	NNS	O	rate	nsubj	13	SENT_32	[p3l748t97r912b148],
6	of	IN	O	of	_	0	SENT_32	[p3l939t85r1015b148],
7	overweight	JJ	O	overweight	amod	8	SENT_32	[p3l1031t85r1426b169],
8	adults	NNS	O	adult	prep_of	5	SENT_32	[p3l1452t85r1662b148],
9	and	CC	O	and	_	0	SENT_32	[p3l1689t85r1819b148],
10	children	NNS	O	child	prep_of	5	SENT_32	[p3l1845t85r2140b148],
11	remain	VBP	O	remain	cop	13	SENT_32	[p3l9t193r250b250],
12	stubbornly	RB	O	stubbornly	advmod	13	SENT_32	[p3l273t187r646b271],
13	large	JJ	O	large	_	0	SENT_32	[p3l663t180r878b271],
14	.7	CD	NUMBER	.7	tmod	13	SENT_32	[p3l663t180r878b271],

1	Bariatric	JJ	MISC	bariatric	amod	2	SENT_33	[p3l82t295r386b353],
2	surgery	NN	O	surgery	nsubj	10	SENT_33	[p3l410t313r675b374],
3	reduces	VBZ	O	reduce	dep	29	SENT_33	[p3l695t290r960b353],
4	the	DT	O	the	det	5	SENT_33	[p3l983t290r1092b353],
5	size	NN	O	size	dobj	3	SENT_33	[p3l1117t296r1243b353],
6	of	IN	O	of	_	0	SENT_33	[p3l1267t290r1342b353],
7	the	DT	O	the	det	8	SENT_33	[p3l1355t290r1464b353],
8	stomach	NN	O	stomach	prep_of	5	SENT_33	[p3l1489t290r1800b362],
9	,	,	O	,	_	0	SENT_33	[p3l1489t290r1800b362],
10	increases	VBZ	O	increase	dep	29	SENT_33	[p3l1825t296r2142b353],
11	the	DT	O	the	det	12	SENT_33	[p3l8t392r114b455],
12	feeling	NN	O	feeling	dobj	10	SENT_33	[p3l136t392r364b476],
13	of	IN	O	of	_	0	SENT_33	[p3l385t392r459b455],
14	fullness	NN	O	fullness	prep_of	12	SENT_33	[p3l471t392r749b464],
15	,	,	O	,	_	0	SENT_33	[p3l471t392r749b464],
16	and	CC	O	and	_	0	SENT_33	[p3l774t392r900b455],
17	reduces	VBZ	O	reduce	dep	29	SENT_33	[p3l921t392r1180b455],
18	the	DT	O	the	det	19	SENT_33	[p3l1202t392r1308b455],
19	amount	NN	O	amount	dobj	17	SENT_33	[p3l1331t404r1596b455],
20	of	IN	O	of	_	0	SENT_33	[p3l1618t392r1692b455],
21	food	NN	O	food	nn	25	SENT_33	[p3l1704t392r1861b455],
22	intake	NN	O	intake	nn	25	SENT_33	[p3l1882t384r2141b455],
23	.8	CD	NUMBER	.8	num	25	SENT_33	[p3l1882t384r2141b455],
24	Different	JJ	O	different	amod	25	SENT_33	[p3l9t495r342b558],
25	types	NNS	O	type	prep_of	19	SENT_33	[p3l371t507r560b579],
26	of	IN	O	of	_	0	SENT_33	[p3l592t495r670b558],
27	bariatric	JJ	O	bariatric	amod	28	SENT_33	[p3l689t495r1002b558],
28	surgery	NN	O	surgery	prep_of	19	SENT_33	[p3l1033t518r1309b579],
29	include	VBP	O	include	_	0	SENT_33	[p3l1336t495r1604b558],
30	the	DT	O	the	det	33	SENT_33	[p3l1634t495r1747b558],
31	following	NN	O	following	nn	33	SENT_33	[p3l1778t495r2140b579],
32	:	:	O	:	_	0	SENT_33	[p3l1778t495r2140b579],
33	Roux-en-Y	NN	O	roux-en-y	dobj	29	SENT_33	[p3l9t603r392b661],
34	gastric	JJ	O	gastric	amod	35	SENT_33	[p3l413t604r640b682],
35	bypass	NN	O	bypass	nsubj	29	SENT_33	[p3l660t598r906b682],
36	,	,	O	,	_	0	SENT_33	[p3l660t598r906b682],
37	biliopancreatic	JJ	O	biliopancreatic	amod	38	SENT_33	[p3l928t598r1442b681],
38	diversion	NN	O	diversion	appos	35	SENT_33	[p3l1465t598r1783b661],
39	with	IN	O	with	_	0	SENT_33	[p3l1804t598r1957b661],
40	duodenal	JJ	O	duodenal	amod	41	SENT_33	[p3l1981t598r2139b661, p3l9t701r194b764],
41	switch	NN	O	switch	prep_with	38	SENT_33	[p3l215t701r449b773],
42	,	,	O	,	_	0	SENT_33	[p3l215t701r449b773],
43	vertical	JJ	O	vertical	amod	45	SENT_33	[p3l468t701r723b764],
44	sleeve	NN	O	sleeve	nn	45	SENT_33	[p3l744t701r942b764],
45	gastrectomy	NN	O	gastrectomy	prep_with	38	SENT_33	[p3l963t713r1388b785],
46	,	,	O	,	_	0	SENT_33	[p3l963t713r1388b785],
47	and	CC	O	and	_	0	SENT_33	[p3l1411t701r1536b764],
48	adjustable	JJ	O	adjustable	amod	50	SENT_33	[p3l1557t701r1898b785],
49	gastric	JJ	O	gastric	amod	50	SENT_33	[p3l1918t707r2143b785],
50	banding	NN	O	banding	conj_and	41	SENT_33	[p3l7t804r306b888],
51	.	.	O	.	_	0	SENT_33	[p3l7t804r306b888],

1	Bariatric	JJ	O	bariatric	amod	2	SENT_34	[p3l331t809r627b867],
2	surgery	NN	O	surgery	nsubj	4	SENT_34	[p3l649t827r907b888],
3	has	VBZ	O	have	aux	4	SENT_34	[p3l924t804r1036b867],
4	demonstrated	VBN	O	demonstrate	_	0	SENT_34	[p3l1059t804r1533b867],
5	efﬁcacy	NN	O	efﬁcacy	dobj	4	SENT_34	[p3l1555t804r1811b888],
6	in	IN	O	in	_	0	SENT_34	[p3l1830t810r1896b866],
7	inducing	VBG	O	induce	prepc_in	4	SENT_34	[p3l1918t804r2139b867, p3l9t913r116b991],
8	sustained	JJ	O	sustained	amod	10	SENT_34	[p3l137t907r458b970],
9	weight	NN	O	weight	nn	10	SENT_34	[p3l476t907r706b991],
10	loss	NN	O	loss	dobj	7	SENT_34	[p3l724t907r850b970],
11	and	CC	O	and	_	0	SENT_34	[p3l873t907r999b970],
12	improvements	NNS	O	improvement	conj_and	10	SENT_34	[p3l1019t913r1511b990],
13	in	IN	O	in	_	0	SENT_34	[p3l1533t913r1600b969],
14	blood	NN	O	blood	nn	15	SENT_34	[p3l1619t907r1818b970],
15	pressure	NN	O	pressure	prep_in	7	SENT_34	[p3l1837t929r2140b990],
16	,	,	O	,	_	0	SENT_34	[p3l1837t929r2140b990],
17	glycemic	JJ	O	glycemic	amod	18	SENT_34	[p3l8t1010r308b1094],
18	control	NN	O	control	prep_in	7	SENT_34	[p3l328t1010r588b1082],
19	,	,	O	,	_	0	SENT_34	[p3l328t1010r588b1082],
20	and	CC	O	and	_	0	SENT_34	[p3l611t1010r736b1073],
21	lipid	NN	O	lipid	nn	22	SENT_34	[p3l754t1010r909b1093],
22	proﬁles	NNS	O	proﬁles	prep_in	7	SENT_34	[p3l927t1010r1194b1093],
23	.	.	O	.	_	0	SENT_34	[p3l927t1010r1194b1093],

1	Improvements	NNP	O	Improvements	nsubj	8	SENT_35	[p3l1219t1015r1712b1093],
2	and	CC	O	and	_	0	SENT_35	[p3l1734t1010r1859b1073],
3	innovations	NNS	O	innovation	conj_and	1	SENT_35	[p3l1878t1016r2139b1073, p3l8t1119r178b1176],
4	in	IN	O	in	_	0	SENT_35	[p3l202t1119r270b1175],
5	surgical	JJ	O	surgical	amod	6	SENT_35	[p3l294t1113r565b1197],
6	techniques	NNS	O	technique	prep_in	3	SENT_35	[p3l586t1113r963b1196],
7	have	VBP	O	have	aux	8	SENT_35	[p3l986t1113r1143b1176],
8	reduced	VBN	O	reduce	_	0	SENT_35	[p3l1167t1113r1447b1176],
9	invasiveness	NN	O	invasiveness	dobj	8	SENT_35	[p3l1469t1119r1915b1185],
10	,	,	O	,	_	0	SENT_35	[p3l1469t1119r1915b1185],
11	surgical	JJ	O	surgical	amod	12	SENT_35	[p3l1941t1119r2140b1197, p3l9t1216r103b1279],
12	risk	NN	O	risk	conj_and	9	SENT_35	[p3l125t1216r270b1288],
13	,	,	O	,	_	0	SENT_35	[p3l125t1216r270b1288],
14	and	CC	O	and	_	0	SENT_35	[p3l295t1216r422b1279],
15	recovery	NN	O	recovery	nn	16	SENT_35	[p3l444t1239r743b1300],
16	times	NNS	O	time	dobj	8	SENT_35	[p3l761t1222r965b1279],
17	.	.	O	.	_	0	SENT_35	[p3l761t1222r965b1279],

1	Furthermore	RB	O	furthermore	advmod	3	SENT_36	[p3l992t1216r1454b1288],
2	,	,	O	,	_	0	SENT_36	[p3l992t1216r1454b1288],
3	evolving	VBG	O	evolve	_	0	SENT_36	[p3l1479t1216r1770b1300],
4	guidelines	NNS	O	guideline	dobj	3	SENT_36	[p3l1791t1216r2141b1300],
5	have	VBP	O	have	aux	6	SENT_36	[p3l8t1319r168b1382],
6	lowered	VBN	O	lower	dep	3	SENT_36	[p3l192t1319r474b1382],
7	the	DT	O	the	det	11	SENT_36	[p3l496t1319r606b1382],
8	body	NN	O	body	nn	11	SENT_36	[p3l629t1319r811b1403],
9	mass	NN	O	mass	nn	11	SENT_36	[p3l832t1342r1004b1382],
10	index	NN	O	index	nn	11	SENT_36	[p3l1030t1319r1228b1382],
11	thresholds	NNS	O	threshold	dobj	6	SENT_36	[p3l1250t1319r1619b1382],
12	and	CC	O	and	_	0	SENT_36	[p3l1646t1319r1776b1382],
13	expanded	VBD	O	expand	dep	3	SENT_36	[p3l1801t1319r2144b1402],
14	the	DT	O	the	det	17	SENT_36	[p3l8t1422r114b1485],
15	patient	NN	O	patient	nn	17	SENT_36	[p3l134t1428r373b1505],
16	population	NN	O	population	nn	17	SENT_36	[p3l392t1422r768b1505],
17	eligible	NN	O	eligible	dobj	13	SENT_36	[p3l790t1422r1032b1506],
18	for	IN	O	for	_	0	SENT_36	[p3l1053t1422r1151b1485],
19	this	DT	O	this	det	21	SENT_36	[p3l1169t1422r1294b1485],
20	treatment	NN	O	treatment	nn	21	SENT_36	[p3l1314t1434r1650b1485],
21	option	NN	O	option	prep_for	13	SENT_36	[p3l1671t1428r1912b1505],
22	,	,	O	,	_	0	SENT_36	[p3l1671t1428r1912b1505],
23	which	WDT	O	which	nsubjpass	27	SENT_36	[p3l1933t1422r2142b1485],
24	has	VBZ	O	have	aux	27	SENT_36	[p3l8t1525r121b1588],
25	traditionally	RB	O	traditionally	advmod	27	SENT_36	[p3l144t1525r580b1609],
26	been	VBN	O	be	auxpass	27	SENT_36	[p3l598t1525r765b1588],
27	indicated	VBN	O	indicate	rcmod	21	SENT_36	[p3l789t1525r1113b1588],
28	for	IN	O	for	_	0	SENT_36	[p3l1135t1525r1234b1588],
29	only	RB	O	only	advmod	30	SENT_36	[p3l1257t1525r1411b1609],
30	the	DT	O	the	prep_for	27	SENT_36	[p3l1429t1525r1538b1588],
31	extremely	RB	O	extremely	advmod	32	SENT_36	[p3l1562t1525r1908b1609],
32	obese	JJ	O	obese	amod	30	SENT_36	[p3l1928t1525r2138b1588],
33	.	.	O	.	_	0	SENT_36	[p3l1928t1525r2138b1588],

1	Notably	RB	O	notably	advmod	8	SENT_37	[p3l8t1628r294b1712],
2	,	,	O	,	_	0	SENT_37	[p3l8t1628r294b1712],
3	bariatric	JJ	O	bariatric	amod	4	SENT_37	[p3l317t1628r612b1691],
4	surgery	NN	O	surgery	nsubj	8	SENT_37	[p3l636t1651r898b1712],
5	has	VBZ	O	have	aux	8	SENT_37	[p3l916t1628r1029b1691],
6	been	VBN	O	be	cop	8	SENT_37	[p3l1051t1628r1217b1691],
7	increasingly	RB	O	increasingly	advmod	8	SENT_37	[p3l1241t1628r1662b1712],
8	prominent	JJ	O	prominent	_	0	SENT_37	[p3l1680t1634r2052b1711],
9	in	IN	O	in	_	0	SENT_37	[p3l2074t1634r2141b1690],
10	diabetes	NN	O	diabetes	nn	11	SENT_37	[p3l9t1731r286b1794],
11	management	NN	O	management	prep_in	8	SENT_37	[p3l309t1743r771b1815],
12	,	,	O	,	_	0	SENT_37	[p3l309t1743r771b1815],
13	with	IN	O	with	_	0	SENT_37	[p3l794t1731r946b1794],
14	a	DT	O	a	det	16	SENT_37	[p3l969t1754r1004b1794],
15	dramatic	JJ	O	dramatic	amod	16	SENT_37	[p3l1026t1731r1330b1794],
16	effect	NN	O	effect	prep_with	8	SENT_37	[p3l1352t1731r1534b1794],
17	on	IN	O	on	_	0	SENT_37	[p3l1556t1754r1642b1794],
18	glycemic	JJ	O	glycemic	amod	19	SENT_37	[p3l1665t1731r1966b1815],
19	control	NN	O	control	prep_on	16	SENT_37	[p3l1989t1754r2139b1794, p3l8t1833r128b1896],
20	independent	JJ	O	independent	amod	19	SENT_37	[p3l148t1833r579b1916],
21	of	IN	O	of	_	0	SENT_37	[p3l599t1833r673b1896],
22	weight	NN	O	weight	nn	23	SENT_37	[p3l681t1833r910b1917],
23	loss	NN	O	loss	prep_of	19	SENT_37	[p3l927t1825r1104b1896],
24	.9	CD	NUMBER	.9	num	23	SENT_37	[p3l927t1825r1104b1896],
25	Nonetheless	RB	O	nonetheless	advmod	8	SENT_37	[p3l1124t1833r1557b1905],
26	,	,	O	,	_	0	SENT_37	[p3l1124t1833r1557b1905],
27	bariatric	JJ	O	bariatric	amod	28	SENT_37	[p3l1577t1833r1866b1896],
28	surgery	NN	O	surgery	nsubj	30	SENT_37	[p3l1887t1856r2144b1917],
29	still	RB	O	still	advmod	30	SENT_37	[p3l9t1936r133b1999],
30	has	VBZ	O	have	ccomp	8	SENT_37	[p3l154t1936r267b1999],
31	serious	JJ	O	serious	amod	32	SENT_37	[p3l292t1942r535b1999],
32	risks	NNS	O	risk	dobj	30	SENT_37	[p3l559t1936r717b1999],
33	of	IN	O	of	_	0	SENT_37	[p3l742t1936r816b1999],
34	surgical	JJ	O	surgical	amod	37	SENT_37	[p3l831t1936r1100b2020],
35	and	CC	O	and	_	0	SENT_37	[p3l1123t1936r1250b1999],
36	metabolic	JJ	O	metabolic	conj_and	34	SENT_37	[p3l1272t1936r1614b1999],
37	complications	NNS	O	complication	prep_of	32	SENT_37	[p3l1637t1936r2140b2019],
38	,	,	O	,	_	0	SENT_37	[p3l1637t1936r2140b2019],
39	and	CC	O	and	_	0	SENT_37	[p3l9t2039r136b2102],
40	it	PRP	O	it	nsubj	43	SENT_37	[p3l157t2045r203b2102],
41	remains	VBZ	O	remain	cop	43	SENT_37	[p3l225t2045r497b2102],
42	very	RB	O	very	advmod	43	SENT_37	[p3l517t2062r671b2123],
43	expensive	JJ	O	expensive	conj_and	8	SENT_37	[p3l690t2045r1041b2122],
44	,	,	O	,	_	0	SENT_37	[p3l690t2045r1041b2122],
45	making	VBG	O	make	xcomp	43	SENT_37	[p3l1065t2039r1326b2123],
46	it	PRP	O	it	nsubj	47	SENT_37	[p3l1346t2045r1392b2102],
47	less	JJR	O	less	xcomp	45	SENT_37	[p3l1413t2039r1531b2102],
48	than	IN	O	than	_	0	SENT_37	[p3l1553t2039r1708b2102],
49	ideal	NN	O	ideal	prep_than	45	SENT_37	[p3l1731t2039r1894b2102],
50	for	IN	O	for	_	0	SENT_37	[p3l1915t2039r2013b2102],
51	the	DT	O	the	det	52	SENT_37	[p3l2034t2039r2140b2102],
52	majority	NN	O	majority	prep_for	45	SENT_37	[p3l8t2148r302b2226],
53	of	IN	O	of	_	0	SENT_37	[p3l320t2142r394b2205],
54	the	DT	O	the	det	56	SENT_37	[p3l405t2142r511b2205],
55	obese	JJ	O	obese	amod	56	SENT_37	[p3l533t2142r723b2205],
56	population	NN	O	population	prep_of	52	SENT_37	[p3l743t2142r1135b2225],
57	.	.	O	.	_	0	SENT_37	[p3l743t2142r1135b2225],

1	Given	VBN	O	give	prep	29	SENT_38	[p3l83t2249r285b2308],
2	the	DT	O	the	det	3	SENT_38	[p3l304t2245r411b2308],
3	failure	NN	O	failure	dep	1	SENT_38	[p3l431t2245r648b2308],
4	of	IN	O	of	_	0	SENT_38	[p3l669t2245r743b2308],
5	lifestyle	NN	O	lifestyle	nn	6	SENT_38	[p3l753t2245r1013b2329],
6	modiﬁcations	NNS	O	modiﬁcations	prep_of	3	SENT_38	[p3l1034t2245r1504b2308],
7	to	TO	O	to	_	0	SENT_38	[p3l1524t2257r1590b2308],
8	effect	NN	O	effect	nn	10	SENT_38	[p3l1612t2245r1794b2308],
9	meaningful	JJ	O	meaningful	amod	10	SENT_38	[p3l1813t2251r2139b2329, p3l8t2348r102b2411],
10	change	NN	O	change	prep_to	6	SENT_38	[p3l127t2348r371b2432],
11	and	CC	O	and	_	0	SENT_38	[p3l397t2348r527b2411],
12	the	DT	O	the	det	13	SENT_38	[p3l549t2348r658b2411],
13	limitations	NNS	O	limitation	prep_to	6	SENT_38	[p3l681t2348r1063b2411],
14	of	IN	O	of	_	0	SENT_38	[p3l1088t2348r1164b2411],
15	bariatric	JJ	O	bariatric	amod	16	SENT_38	[p3l1177t2348r1478b2411],
16	surgery	NN	O	surgery	prep_of	13	SENT_38	[p3l1503t2371r1778b2432],
17	,	,	O	,	_	0	SENT_38	[p3l1503t2371r1778b2432],
18	the	DT	O	the	det	19	SENT_38	[p3l1803t2348r1913b2411],
19	use	NN	O	use	nsubj	29	SENT_38	[p3l1937t2371r2051b2411],
20	of	IN	O	of	_	0	SENT_38	[p3l2076t2348r2152b2411],
21	antiobesity	JJ	O	antiobesity	amod	22	SENT_38	[p3l9t2451r379b2535],
22	drugs	NNS	O	drug	prep_of	19	SENT_38	[p3l396t2451r584b2535],
23	as	IN	O	as	_	0	SENT_38	[p3l605t2474r669b2514],
24	adjuncts	NNS	O	adjunct	prep_as	22	SENT_38	[p3l690t2451r971b2535],
25	in	IN	O	in	_	0	SENT_38	[p3l992t2457r1057b2513],
26	obesity	NN	O	obesity	nn	27	SENT_38	[p3l1078t2451r1318b2535],
27	therapy	NN	O	therapy	prep_in	24	SENT_38	[p3l1333t2451r1590b2535],
28	is	VBZ	O	be	cop	29	SENT_38	[p3l1607t2457r1656b2514],
29	vital	JJ	O	vital	_	0	SENT_38	[p3l1674t2451r1835b2514],
30	.	.	O	.	_	0	SENT_38	[p3l1674t2451r1835b2514],

1	The	DT	O	the	det	2	SENT_39	[p3l1858t2451r1981b2514],
2	goal	NN	O	goal	nsubj	3	SENT_39	[p3l2001t2451r2140b2535],
3	is	VBZ	O	be	_	0	SENT_39	[p3l9t2560r59b2617],
4	not	RB	O	not	neg	3	SENT_39	[p3l80t2566r194b2617],
5	to	TO	O	to	_	0	SENT_39	[p3l213t2566r279b2617],
6	hunt	NN	O	hunt	prep_to	3	SENT_39	[p3l300t2554r461b2617],
7	for	IN	O	for	_	0	SENT_39	[p3l481t2554r578b2617],
8	a	DT	O	a	det	10	SENT_39	[p3l599t2577r633b2617],
9	magic	JJ	O	magic	amod	10	SENT_39	[p3l653t2560r858b2638],
10	pill	NN	O	pill	prep_for	6	SENT_39	[p3l878t2554r1004b2637],
11	,	,	O	,	_	0	SENT_39	[p3l878t2554r1004b2637],
12	as	IN	O	as	mark	20	SENT_39	[p3l1028t2577r1092b2617],
13	the	DT	O	the	det	15	SENT_39	[p3l1113t2554r1219b2617],
14	long	JJ	O	long	amod	15	SENT_39	[p3l1239t2554r1390b2638],
15	history	NN	O	history	nsubj	20	SENT_39	[p3l1409t2554r1653b2638],
16	of	IN	O	of	_	0	SENT_39	[p3l1671t2554r1745b2617],
17	weight-loss	JJ	O	weight-loss	amod	18	SENT_39	[p3l1754t2554r2142b2638],
18	drugs	NNS	O	drug	prep_of	15	SENT_39	[p3l9t2657r202b2741],
19	has	VBZ	O	have	aux	20	SENT_39	[p3l224t2657r337b2720],
20	seen	VBN	O	see	advcl	3	SENT_39	[p3l361t2680r510b2720],
21	the	DT	O	the	det	22	SENT_39	[p3l532t2657r639b2720],
22	rise	NN	O	rise	dobj	20	SENT_39	[p3l662t2663r784b2720],
23	and	CC	O	and	_	0	SENT_39	[p3l807t2657r934b2720],
24	fall	NN	DATE	fall	dobj	20	SENT_39	[p3l955t2657r1061b2720],
25	of	IN	O	of	_	0	SENT_39	[p3l1084t2657r1158b2720],
26	countless	JJ	O	countless	amod	27	SENT_39	[p3l1172t2657r1488b2720],
27	agents	NNS	O	agent	prep_of	22	SENT_39	[p3l1513t2669r1726b2741],
28	that	WDT	O	that	nsubj	29	SENT_39	[p3l1749t2657r1883b2720],
29	proved	VBD	O	prove	rcmod	22	SENT_39	[p3l1904t2657r2143b2740],
30	highly	RB	O	highly	advmod	31	SENT_39	[p3l8t2760r226b2844],
31	effective	JJ	O	effective	acomp	29	SENT_39	[p3l246t2760r525b2823],
32	but	CC	O	but	_	0	SENT_39	[p3l546t2760r660b2823],
33	ultimately	RB	O	ultimately	advmod	34	SENT_39	[p3l681t2760r1028b2844],
34	dangerous	JJ	O	dangerous	acomp	29	SENT_39	[p3l1048t2760r1401b2844],
35	(	CD	NUMBER	(	dep	34	SENT_39	[p3l1427t2761r1646b2836],
36	Table	NNP	O	Table	dep	31	SENT_39	[p3l1427t2761r1646b2836],
37	1	CD	NUMBER	1	num	36	SENT_39	[p3l1673t2761r1754b2836],
38	)	CD	NUMBER	)	tmod	29	SENT_39	[p3l1673t2761r1754b2836],
39	.	.	O	.	_	0	SENT_39	[p3l1673t2761r1754b2836],

1	The	DT	O	the	det	2	SENT_40	[p3l1780t2760r1905b2823],
2	goal	NN	O	goal	nsubj	3	SENT_40	[p3l1928t2760r2069b2844],
3	is	VBZ	O	be	_	0	SENT_40	[p3l2091t2766r2141b2823],
4	to	TO	O	to	aux	5	SENT_40	[p3l8t2875r75b2926],
5	use	VB	O	use	xcomp	3	SENT_40	[p3l99t2886r212b2926],
6	a	DT	O	a	det	11	SENT_40	[p3l237t2886r272b2926],
7	safe	JJ	O	safe	amod	11	SENT_40	[p3l295t2863r423b2926],
8	and	CC	O	and	_	0	SENT_40	[p3l448t2863r576b2926],
9	effective	JJ	O	effective	amod	11	SENT_40	[p3l599t2863r884b2926],
10	drug	NN	O	drug	nn	11	SENT_40	[p3l909t2863r1074b2947],
11	regimen	NNS	O	regimen	nsubj	22	SENT_40	[p3l1096t2869r1402b2947],
12	,	,	O	,	_	0	SENT_40	[p3l1096t2869r1402b2947],
13	in	IN	O	in	_	0	SENT_40	[p3l1428t2869r1495b2925],
14	combination	NN	O	combination	prep_in	11	SENT_40	[p3l1519t2863r1963b2926],
15	with	IN	O	with	_	0	SENT_40	[p3l1985t2863r2140b2926],
16	improved	VBN	O	improve	amod	17	SENT_40	[p3l9t2966r330b3049],
17	diet	NN	O	diet	prep_with	14	SENT_40	[p3l349t2966r474b3029],
18	and	CC	O	and	_	0	SENT_40	[p3l492t2966r616b3029],
19	exercise	NN	O	exercise	conj_and	17	SENT_40	[p3l635t2972r912b3038],
20	,	,	O	,	_	0	SENT_40	[p3l635t2972r912b3038],
21	to	TO	O	to	aux	22	SENT_40	[p3l933t2978r997b3029],
22	achieve	VB	O	achieve	xcomp	5	SENT_40	[p3l1018t2966r1264b3029],
23	a	DT	O	a	det	27	SENT_40	[p3l1284t2989r1318b3029],
24	meaningful	JJ	O	meaningful	amod	27	SENT_40	[p3l1336t2966r1720b3050],
25	and	CC	O	and	_	0	SENT_40	[p3l1739t2966r1862b3029],
26	sustainable	JJ	O	sustainable	amod	27	SENT_40	[p3l1881t2972r2140b3029, p3l9t3069r140b3132],
27	reduction	NN	O	reduction	dobj	22	SENT_40	[p3l159t3069r481b3132],
28	in	IN	O	in	_	0	SENT_40	[p3l500t3075r565b3131],
29	body	NN	O	body	nn	30	SENT_40	[p3l582t3069r753b3153],
30	weight	NN	O	weight	prep_in	27	SENT_40	[p3l767t3069r990b3153],
31	and	CC	O	and	_	0	SENT_40	[p3l1008t3069r1131b3132],
32	enjoy	VB	O	enjoy	conj_and	22	SENT_40	[p3l1150t3075r1331b3153],
33	the	DT	O	the	det	35	SENT_40	[p3l1345t3069r1449b3132],
34	consequent	JJ	O	consequent	amod	35	SENT_40	[p3l1469t3081r1847b3152],
35	beneﬁts	NNS	O	beneﬁts	dobj	32	SENT_40	[p3l1864t3069r2138b3132],
36	.	.	O	.	_	0	SENT_40	[p3l1864t3069r2138b3132],

1	For	IN	O	for	_	0	SENT_41	[p3l83t3177r205b3235],
2	regulatory	JJ	O	regulatory	amod	3	SENT_41	[p3l237t3172r620b3256],
3	agencies	NNS	O	agency	prep_for	18	SENT_41	[p3l649t3178r955b3256],
4	such	JJ	O	such	_	0	SENT_41	[p3l989t3172r1153b3235],
5	as	IN	O	as	_	0	SENT_41	[p3l1186t3195r1254b3235],
6	the	DT	O	the	det	8	SENT_41	[p3l1286t3172r1399b3235],
7	US	NNP	ORGANIZATION	US	nn	8	SENT_41	[p3l1431t3176r1535b3235],
8	Food	NNP	ORGANIZATION	Food	prep_such_as	3	SENT_41	[p3l1569t3172r1755b3235],
9	and	CC	ORGANIZATION	and	_	0	SENT_41	[p3l1788t3172r1921b3235],
10	Drug	NNP	ORGANIZATION	Drug	nn	11	SENT_41	[p3l1952t3177r2143b3256],
11	Administration	NNP	ORGANIZATION	Administration	prep_such_as	3	SENT_41	[p3l8t3275r553b3338],
12	(	CD	NUMBER	(	num	13	SENT_41	[p3l580t3275r823b3352],
13	FDA	NNP	ORGANIZATION	FDA	dep	8	SENT_41	[p3l580t3275r823b3352],
14	)	CD	NUMBER	)	num	13	SENT_41	[p3l580t3275r823b3352],
15	,	,	O	,	_	0	SENT_41	[p3l580t3275r823b3352],
16	caution	NN	O	caution	nsubj	18	SENT_41	[p3l849t3281r1110b3338],
17	is	VBZ	O	be	cop	18	SENT_41	[p3l1134t3281r1185b3338],
18	key	JJ	O	key	_	0	SENT_41	[p3l1208t3275r1338b3359],
19	.	.	O	.	_	0	SENT_41	[p3l1208t3275r1338b3359],

1	Efﬁcacy	NNP	O	Efﬁcacy	nsubj	3	SENT_42	[p3l1365t3275r1642b3359],
2	must	MD	O	must	aux	3	SENT_42	[p3l1662t3287r1837b3338],
3	go	VB	O	go	_	0	SENT_42	[p3l1859t3298r1940b3359],
4	hand	NN	O	hand	dobj	3	SENT_42	[p3l1963t3275r2142b3338],
5	in	IN	O	in	_	0	SENT_42	[p3l9t3384r76b3440],
6	hand	NN	O	hand	prep_in	4	SENT_42	[p3l97t3378r273b3441],
7	with	IN	O	with	_	0	SENT_42	[p3l292t3378r446b3441],
8	safety	NN	O	safety	prep_with	3	SENT_42	[p3l470t3378r674b3462],
9	.	.	O	.	_	0	SENT_42	[p3l470t3378r674b3462],

1	The	DT	O	the	dep	101	SENT_43	[p3l700t3378r826b3441],
2	FDA	NNP	ORGANIZATION	FDA	dep	101	SENT_43	[p3l850t3378r1042b3441],
3	’s	POS	O	’s	dep	101	SENT_43	[p3l850t3378r1042b3441],
4	efﬁcacy	NN	O	efﬁcacy	dep	101	SENT_43	[p3l1066t3378r1325b3462],
5	benchmarks	NNS	O	benchmark	dep	101	SENT_43	[p3l1342t3378r1768b3441],
6	require	VBP	O	require	dep	101	SENT_43	[p3l1792t3384r2037b3461],
7	(	NN	O	(	dep	101	SENT_43	[p3l2064t3378r2136b3455],
8	i	FW	O	i	dep	101	SENT_43	[p3l2064t3378r2136b3455],
9	)	FW	O	)	dep	101	SENT_43	[p3l2064t3378r2136b3455],
10	that	IN	O	that	dep	101	SENT_43	[p3l8t3481r144b3544],
11	the	DT	O	the	dep	101	SENT_43	[p3l166t3481r275b3544],
12	difference	NN	O	difference	dep	101	SENT_43	[p3l299t3481r643b3544],
13	in	IN	O	in	dep	101	SENT_43	[p3l667t3487r735b3543],
14	mean	JJ	O	mean	dep	101	SENT_43	[p3l758t3504r951b3544],
15	weight	NN	O	weight	dep	101	SENT_43	[p3l972t3481r1207b3565],
16	loss	NN	O	loss	dep	101	SENT_43	[p3l1228t3481r1357b3544],
17	between	IN	O	between	dep	101	SENT_43	[p3l1379t3481r1672b3544],
18	the	DT	O	the	dep	101	SENT_43	[p3l1694t3481r1803b3544],
19	drug	NN	O	drug	dep	101	SENT_43	[p3l1827t3481r1993b3565],
20	and	CC	O	and	dep	101	SENT_43	[p3l2016t3481r2145b3544],
21	the	DT	O	the	dep	101	SENT_43	[p3l8t3584r114b3647],
22	placebo	NN	O	placebo	dep	101	SENT_43	[p3l136t3584r400b3667],
23	groups	NNS	O	group	dep	101	SENT_43	[p3l424t3606r658b3668],
24	is	VBZ	O	be	dep	101	SENT_43	[p3l682t3590r732b3647],
25	at	IN	O	at	dep	101	SENT_43	[p3l756t3596r816b3647],
26	least	JJS	O	least	dep	101	SENT_43	[p3l836t3584r990b3647],
27	5	CD	PERCENT	5	dep	101	SENT_43	[p3l1013t3590r1113b3648],
28	%	NN	PERCENT	%	dep	101	SENT_43	[p3l1013t3590r1113b3648],
29	for	IN	O	for	dep	101	SENT_43	[p3l1138t3584r1235b3647],
30	at	IN	DURATION	at	dep	101	SENT_43	[p3l1258t3596r1317b3647],
31	least	JJS	DURATION	least	dep	101	SENT_43	[p3l1338t3584r1492b3647],
32	1	CD	DURATION	1	dep	101	SENT_43	[p3l1520t3591r1545b3646],
33	year	NN	NUMBER	year	dep	101	SENT_43	[p3l1571t3607r1717b3668],
34	and	CC	O	and	dep	101	SENT_43	[p3l1740t3584r1866b3647],
35	statistically	RB	O	statistically	dep	101	SENT_43	[p3l1889t3590r2139b3647, p3l9t3687r172b3771],
36	signiﬁcant	JJ	O	signiﬁcant	dep	101	SENT_43	[p3l194t3687r578b3771],
37	,	,	O	,	_	0	SENT_43	[p3l194t3687r578b3771],
38	and	CC	O	and	dep	101	SENT_43	[p3l605t3687r734b3750],
39	(	CD	NUMBER	(	dep	101	SENT_43	[p3l762t3688r859b3763],
40	ii	LS	O	ii	dep	101	SENT_43	[p3l762t3688r859b3763],
41	)	NN	O	)	dep	101	SENT_43	[p3l762t3688r859b3763],
42	that	IN	O	that	dep	101	SENT_43	[p3l887t3687r1025b3750],
43	the	DT	O	the	dep	101	SENT_43	[p3l1048t3687r1157b3750],
44	proportion	NN	O	proportion	dep	101	SENT_43	[p3l1180t3693r1571b3770],
45	of	IN	O	of	dep	101	SENT_43	[p3l1595t3687r1671b3750],
46	subjects	NNS	O	subject	dep	101	SENT_43	[p3l1687t3687r1965b3771],
47	who	WP	O	who	dep	101	SENT_43	[p3l1988t3687r2139b3750],
48	lose	VBP	O	lose	dep	101	SENT_43	[p4l7t16r143b79],
49	at	IN	O	at	dep	101	SENT_43	[p4l168t28r229b79],
50	least	JJS	O	least	dep	101	SENT_43	[p4l250t16r408b79],
51	5	CD	PERCENT	5	dep	101	SENT_43	[p4l433t21r534b81],
52	%	NN	PERCENT	%	dep	101	SENT_43	[p4l433t21r534b81],
53	of	IN	O	of	dep	101	SENT_43	[p4l561t16r636b79],
54	baseline	NN	O	baseline	dep	101	SENT_43	[p4l648t16r934b79],
55	body	NN	O	body	dep	101	SENT_43	[p4l956t16r1137b100],
56	weight	NN	O	weight	dep	101	SENT_43	[p4l1156t16r1392b100],
57	in	IN	O	in	dep	101	SENT_43	[p4l1415t22r1482b78],
58	the	DT	O	the	dep	101	SENT_43	[p4l1506t16r1615b79],
59	active	JJ	O	active	dep	101	SENT_43	[p4l1640t22r1841b79],
60	product	NN	O	product	dep	101	SENT_43	[p4l1864t16r2145b99],
61	group	NN	O	group	dep	101	SENT_43	[p4l8t141r211b203],
62	is	VBZ	O	be	dep	101	SENT_43	[p4l236t125r286b182],
63	at	IN	O	at	dep	101	SENT_43	[p4l311t131r371b182],
64	least	JJS	O	least	dep	101	SENT_43	[p4l392t119r547b182],
65	35	CD	PERCENT	35	dep	101	SENT_43	[p4l571t125r713b183],
66	%	NN	PERCENT	%	dep	101	SENT_43	[p4l571t125r713b183],
67	and	CC	O	and	dep	101	SENT_43	[p4l739t119r867b182],
68	is	VBZ	O	be	dep	101	SENT_43	[p4l889t125r940b182],
69	approximately	RB	O	approximately	dep	101	SENT_43	[p4l965t119r1463b203],
70	double	RB	O	double	dep	101	SENT_43	[p4l1483t119r1718b182],
71	the	DT	O	the	dep	101	SENT_43	[p4l1740t119r1848b182],
72	proportion	NN	O	proportion	dep	101	SENT_43	[p4l1871t141r2139b202, p4l8t227r146b284],
73	in	IN	O	in	dep	101	SENT_43	[p4l169t227r235b283],
74	the	DT	O	the	dep	101	SENT_43	[p4l257t221r364b284],
75	p1acebo	NN	O	p1acebo	dep	101	SENT_43	[p4l386t221r924b304],
76	—	NN	O	—	dep	101	SENT_43	[p4l386t221r924b304],
77	treated	VBN	O	treat	dep	101	SENT_43	[p4l386t221r924b304],
78	group	NN	O	group	dep	101	SENT_43	[p4l946t214r1196b305],
79	.5	CD	NUMBER	.5	dep	101	SENT_43	[p4l946t214r1196b305],
80	Moreover	RB	O	moreover	dep	101	SENT_43	[p4l1220t226r1567b293],
81	,	,	O	,	_	0	SENT_43	[p4l1220t226r1567b293],
82	the	DT	O	the	dep	101	SENT_43	[p4l1591t221r1697b284],
83	obese	JJ	O	obese	dep	101	SENT_43	[p4l1721t221r1912b284],
84	population	NN	O	population	dep	101	SENT_43	[p4l1933t243r2139b304, p4l7t324r203b387],
85	is	VBZ	O	be	dep	101	SENT_43	[p4l225t330r275b387],
86	heterogeneous	JJ	O	heterogeneous	dep	101	SENT_43	[p4l296t324r812b408],
87	,	,	O	,	_	0	SENT_43	[p4l296t324r812b408],
88	with	IN	O	with	dep	101	SENT_43	[p4l833t324r986b387],
89	variations	NNS	O	variation	dep	101	SENT_43	[p4l1005t330r1344b387],
90	in	IN	O	in	dep	101	SENT_43	[p4l1366t330r1432b386],
91	degree	NN	O	degree	dep	101	SENT_43	[p4l1455t324r1677b408],
92	and	CC	O	and	dep	101	SENT_43	[p4l1700t324r1826b387],
93	duration	NN	O	duration	dep	101	SENT_43	[p4l1847t324r2142b387],
94	of	IN	O	of	dep	101	SENT_43	[p4l9t427r85b490],
95	overweight	JJ	O	overweight	dep	101	SENT_43	[p4l102t427r516b511],
96	,	,	O	,	_	0	SENT_43	[p4l102t427r516b511],
97	age	NN	O	age	dep	101	SENT_43	[p4l545t450r677b511],
98	,	,	O	,	_	0	SENT_43	[p4l545t450r677b511],
99	and	CC	O	and	dep	101	SENT_43	[p4l706t427r836b490],
100	associated	VBN	O	associate	dep	101	SENT_43	[p4l862t427r1224b490],
101	comorbidities	NNS	O	comorbidity	_	0	SENT_43	[p4l1250t427r1761b490],
102	.	.	O	.	_	0	SENT_43	[p4l1250t427r1761b490],

1	A	DT	O	a	det	3	SENT_44	[p4l1789t431r1847b489],
2	weightloss	NN	O	weightloss	nn	3	SENT_44	[p4l1871t427r2138b511, p4l7t530r135b593],
3	drug	NN	O	drug	nsubj	6	SENT_44	[p4l159t530r323b614],
4	must	MD	O	must	aux	6	SENT_44	[p4l344t542r516b593],
5	be	VB	O	be	cop	6	SENT_44	[p4l535t530r616b593],
6	compatible	JJ	O	compatible	_	0	SENT_44	[p4l639t530r1022b613],
7	with	IN	O	with	_	0	SENT_44	[p4l1043t530r1197b593],
8	the	DT	O	the	det	9	SENT_44	[p4l1220t530r1327b593],
9	proﬁle	NN	O	proﬁle	prep_with	6	SENT_44	[p4l1349t530r1572b613],
10	of	IN	O	of	_	0	SENT_44	[p4l1596t530r1671b593],
11	an	DT	O	a	det	14	SENT_44	[p4l1685t553r1765b593],
12	individual	JJ	O	individual	amod	14	SENT_44	[p4l1789t530r2142b593],
13	obese	JJ	O	obese	amod	14	SENT_44	[p4l9t633r198b696],
14	patient	NN	O	patient	prep_of	9	SENT_44	[p4l218t639r457b716],
15	to	TO	O	to	aux	18	SENT_44	[p4l476t645r542b696],
16	be	VB	O	be	cop	18	SENT_44	[p4l562t633r641b696],
17	truly	RB	O	truly	advmod	18	SENT_44	[p4l661t633r829b717],
18	meaningful	JJ	O	meaningful	xcomp	6	SENT_44	[p4l846t633r1240b717],
19	in	IN	O	in	_	0	SENT_44	[p4l1260t639r1326b695],
20	terms	NNS	O	term	prep_in	18	SENT_44	[p4l1346t645r1539b696],
21	of	IN	O	of	_	0	SENT_44	[p4l1562t633r1636b696],
22	efﬁcacy	NN	O	efﬁcacy	prep_of	20	SENT_44	[p4l1647t633r1912b717],
23	,	,	O	,	_	0	SENT_44	[p4l1647t633r1912b717],
24	safety	NN	O	safety	prep_of	20	SENT_44	[p4l1936t633r2140b717],
25	,	,	O	,	_	0	SENT_44	[p4l1936t633r2140b717],
26	and	CC	O	and	_	0	SENT_44	[p4l9t736r138b799],
27	durability	NN	O	durability	prep_of	20	SENT_44	[p4l161t736r512b820],
28	.	.	O	.	_	0	SENT_44	[p4l161t736r512b820],

1	These	DT	O	these	det	5	SENT_45	[p4l538t736r736b799],
2	necessary	JJ	O	necessary	amod	5	SENT_45	[p4l759t759r1099b820],
3	but	CC	O	but	_	0	SENT_45	[p4l1117t736r1233b799],
4	demanding	VBG	O	demand	amod	5	SENT_45	[p4l1256t736r1654b820],
5	requirements	NNS	O	requirement	nsubj	7	SENT_45	[p4l1676t742r2140b819],
6	have	VBP	O	have	aux	7	SENT_45	[p4l8t839r169b902],
7	resulted	VBN	O	result	_	0	SENT_45	[p4l196t839r479b902],
8	in	IN	O	in	_	0	SENT_45	[p4l505t845r573b901],
9	very	RB	O	very	advmod	10	SENT_45	[p4l597t862r756b923],
10	limited	JJ	O	limited	amod	12	SENT_45	[p4l777t839r1033b902],
11	pharmacotherapeutic	JJ	O	pharmacotherapeutic	amod	12	SENT_45	[p4l1057t839r1827b922],
12	options	NNS	O	option	prep_in	7	SENT_45	[p4l1854t845r2137b922],
13	.	.	O	.	_	0	SENT_45	[p4l1854t845r2137b922],

1	As	IN	O	as	_	0	SENT_46	[p4l8t946r96b1005],
2	of	IN	O	of	prepc_as_of	10	SENT_46	[p4l123t942r199b1005],
3	September	NNP	DATE	September	pobj	10	SENT_46	[p4l216t942r595b1025],
4	2013	CD	DATE	2013	num	3	SENT_46	[p4l619t949r806b1014],
5	,	,	O	,	_	0	SENT_46	[p4l619t949r806b1014],
6	only	RB	O	only	advmod	8	SENT_46	[p4l834t942r990b1026],
7	three	CD	NUMBER	three	num	8	SENT_46	[p4l1010t942r1192b1005],
8	drugs	NNS	O	drug	nsubjpass	10	SENT_46	[p4l1219t942r1417b1026],
9	are	VBP	O	be	auxpass	10	SENT_46	[p4l1444t965r1547b1005],
10	approved	VBN	O	approve	_	0	SENT_46	[p4l1574t942r1902b1025],
11	by	IN	O	by	_	0	SENT_46	[p4l1925t942r2011b1026],
12	the	DT	O	the	det	13	SENT_46	[p4l2032t942r2142b1005],
13	FDA	NNP	ORGANIZATION	FDA	agent	10	SENT_46	[p4l9t1049r176b1107],
14	as	IN	O	as	_	0	SENT_46	[p4l202t1068r267b1108],
15	adjunctive	JJ	O	adjunctive	amod	16	SENT_46	[p4l295t1045r663b1129],
16	therapy	NN	O	therapy	prep_as	10	SENT_46	[p4l688t1045r960b1129],
17	for	IN	O	for	_	0	SENT_46	[p4l981t1045r1082b1108],
18	chronic	JJ	O	chronic	amod	20	SENT_46	[p4l1107t1045r1376b1108],
19	weight	NN	O	weight	nn	20	SENT_46	[p4l1399t1045r1637b1129],
20	management	NN	O	management	prep_for	16	SENT_46	[p4l1661t1057r2139b1129],
21	:	:	O	:	_	0	SENT_46	[p4l1661t1057r2139b1129],
22	orlistat	NN	O	orlistat	nn	24	SENT_46	[p4l9t1148r253b1211],
23	(	CD	NUMBER	(	num	24	SENT_46	[p4l278t1148r450b1224],
24	Alli	NNP	PERSON	Alli	dep	16	SENT_46	[p4l278t1148r450b1224],
25	,	,	O	,	_	0	SENT_46	[p4l278t1148r450b1224],
26	GlaXoSmithKline	NNP	ORGANIZATION	GlaXoSmithKline	appos	24	SENT_46	[p4l476t1148r1104b1220],
27	;	:	O	;	_	0	SENT_46	[p4l476t1148r1104b1220],
28	Xenical	NNP	O	Xenical	dep	16	SENT_46	[p4l1128t1148r1410b1220],
29	,	,	O	,	_	0	SENT_46	[p4l1128t1148r1410b1220],
30	Roche	NNP	ORGANIZATION	Roche	appos	28	SENT_46	[p4l1435t1148r1702b1224],
31	)	CD	NUMBER	)	num	30	SENT_46	[p4l1435t1148r1702b1224],
32	,	,	O	,	_	0	SENT_46	[p4l1435t1148r1702b1224],
33	approved	VBN	O	approve	partmod	16	SENT_46	[p4l1729t1148r2053b1231],
34	in	IN	O	in	_	0	SENT_46	[p4l2076t1154r2144b1210],
35	1999	CD	DATE	1999	prep_in	33	SENT_46	[p4l15t1258r189b1323],
36	;	:	O	;	_	0	SENT_46	[p4l15t1258r189b1323],
37	lorcaserin	NN	O	lorcaserin	nn	39	SENT_46	[p4l212t1251r554b1314],
38	(	CD	NUMBER	(	num	39	SENT_46	[p4l580t1251r839b1334],
39	Belviq	NNP	PERSON	Belviq	nsubj	45	SENT_46	[p4l580t1251r839b1334],
40	,	,	O	,	_	0	SENT_46	[p4l580t1251r839b1334],
41	Arena	NNP	ORGANIZATION	Arena	nn	43	SENT_46	[p4l863t1255r1074b1314],
42	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	43	SENT_46	[p4l1096t1251r1711b1328],
43	)	NN	O	)	appos	39	SENT_46	[p4l1096t1251r1711b1328],
44	,	,	O	,	_	0	SENT_46	[p4l1096t1251r1711b1328],
45	approved	VBN	O	approve	conj_and	10	SENT_46	[p4l1736t1251r2055b1334],
46	in	IN	O	in	_	0	SENT_46	[p4l2077t1257r2143b1313],
47	2012	CD	DATE	2012	prep_in	45	SENT_46	[p4l9t1361r190b1426],
48	;	:	O	;	_	0	SENT_46	[p4l9t1361r190b1426],
49	and	CC	O	and	_	0	SENT_46	[p4l215t1354r341b1417],
50	phentermine/topiramate	VB	O	phentermine/topiramate	csubj	62	SENT_46	[p4l362t1354r1213b1437],
51	eXtended	JJ	O	extended	amod	53	SENT_46	[p4l1237t1354r1815b1417],
52	—	NN	O	—	nn	53	SENT_46	[p4l1237t1354r1815b1417],
53	release	NN	O	release	nsubj	56	SENT_46	[p4l1237t1354r1815b1417],
54	formulation	NN	O	formulation	nn	56	SENT_46	[p4l1838t1354r2139b1417, p4l8t1463r144b1520],
55	(	CD	NUMBER	(	num	56	SENT_46	[p4l168t1458r474b1541],
56	Qsymia	NNP	O	Qsymia	xcomp	50	SENT_46	[p4l168t1458r474b1541],
57	,	,	O	,	_	0	SENT_46	[p4l168t1458r474b1541],
58	Vivus	NNP	ORGANIZATION	Vivus	nn	59	SENT_46	[p4l494t1458r735b1533],
59	)	NNP	O	)	appos	56	SENT_46	[p4l494t1458r735b1533],
60	,	,	O	,	_	0	SENT_46	[p4l494t1458r735b1533],
61	also	RB	O	also	advmod	62	SENT_46	[p4l757t1457r887b1520],
62	approved	VBN	O	approve	conj_and	10	SENT_46	[p4l909t1457r1224b1540],
63	in	IN	O	in	_	0	SENT_46	[p4l1243t1463r1309b1519],
64	2012	CD	DATE	2012	prep_in	62	SENT_46	[p4l1330t1464r1507b1520],
65	.	.	O	.	_	0	SENT_46	[p4l1330t1464r1507b1520],

1	Nonetheless	RB	O	nonetheless	advmod	8	SENT_47	[p4l1530t1457r1961b1529],
2	,	,	O	,	_	0	SENT_47	[p4l1530t1457r1961b1529],
3	drug	NN	O	drug	nn	5	SENT_47	[p4l1983t1457r2144b1541],
4	development	NN	O	development	nn	5	SENT_47	[p4l9t1560r458b1643],
5	programs	NNS	O	program	nsubj	8	SENT_47	[p4l479t1582r811b1644],
6	have	VBP	O	have	aux	8	SENT_47	[p4l833t1560r990b1623],
7	been	VBN	O	be	aux	8	SENT_47	[p4l1011t1560r1177b1623],
8	investigating	VBG	O	investigate	_	0	SENT_47	[p4l1200t1566r1643b1644],
9	the	DT	O	the	det	11	SENT_47	[p4l1663t1560r1771b1623],
10	molecular	JJ	O	molecular	amod	11	SENT_47	[p4l1794t1560r2143b1623],
11	mechanisms	NNS	O	mechanism	dobj	8	SENT_47	[p4l8t1663r431b1726],
12	underlying	VBG	O	underlie	partmod	11	SENT_47	[p4l453t1663r826b1747],
13	the	DT	O	the	det	14	SENT_47	[p4l844t1663r950b1726],
14	regulation	NN	O	regulation	dobj	12	SENT_47	[p4l970t1663r1317b1747],
15	of	IN	O	of	_	0	SENT_47	[p4l1338t1663r1411b1726],
16	appetite	NN	O	appetite	prep_of	14	SENT_47	[p4l1422t1669r1691b1746],
17	and	CC	O	and	_	0	SENT_47	[p4l1712t1663r1837b1726],
18	metabolism	NN	O	metabolism	nn	20	SENT_47	[p4l1856t1663r2139b1726, p4l7t1766r157b1829],
19	(	CD	NUMBER	(	num	20	SENT_47	[p4l185t1766r453b1849],
20	Figure	NN	O	figure	dobj	12	SENT_47	[p4l185t1766r453b1849],
21	1	CD	NUMBER	1	num	22	SENT_47	[p4l482t1767r543b1843],
22	)	NN	O	)	dep	20	SENT_47	[p4l482t1767r543b1843],
23	and	CC	O	and	_	0	SENT_47	[p4l573t1766r703b1829],
24	translation	NN	O	translation	conj_and	14	SENT_47	[p4l726t1766r1110b1829],
25	of	IN	O	of	_	0	SENT_47	[p4l1136t1766r1212b1829],
26	their	PRP$	O	they	poss	27	SENT_47	[p4l1226t1766r1395b1829],
27	discoveries	NNS	O	discovery	prep_of	24	SENT_47	[p4l1419t1766r1809b1829],
28	into	IN	O	into	_	0	SENT_47	[p4l1835t1772r1973b1829],
29	new	JJ	O	new	amod	31	SENT_47	[p4l1999t1789r2146b1829],
30	pharmacotherapeutic	JJ	O	pharmacotherapeutic	amod	31	SENT_47	[p4l7t1869r755b1952],
31	agents	NNS	O	agent	prep_into	12	SENT_47	[p4l779t1881r994b1953],
32	and	CC	O	and	_	0	SENT_47	[p4l1019t1869r1146b1932],
33	molecular	JJ	O	molecular	amod	34	SENT_47	[p4l1168t1869r1518b1932],
34	targets	NNS	O	target	conj_and	31	SENT_47	[p4l1539t1881r1768b1953],
35	to	TO	O	to	aux	36	SENT_47	[p4l1791t1881r1858b1932],
36	address	VB	O	address	xcomp	12	SENT_47	[p4l1883t1869r2141b1932],
37	the	DT	O	the	det	39	SENT_47	[p4l8t1972r114b2035],
38	dual	JJ	O	dual	amod	39	SENT_47	[p4l136t1972r283b2035],
39	mandate	NN	O	mandate	dobj	36	SENT_47	[p4l304t1972r599b2035],
40	of	IN	O	of	_	0	SENT_47	[p4l622t1972r695b2035],
41	safety	NN	O	safety	prep_of	39	SENT_47	[p4l708t1972r904b2056],
42	and	CC	O	and	_	0	SENT_47	[p4l923t1972r1049b2035],
43	efﬁcacy	NN	O	efﬁcacy	prep_of	39	SENT_47	[p4l1070t1972r1334b2056],
44	.	.	O	.	_	0	SENT_47	[p4l1070t1972r1334b2056],

1	SAFETY	NN	O	safety	nn	2	SENT_48	[p4l10t2389r284b2444],
2	ISSUES	NNS	O	issue	dep	6	SENT_48	[p4l303t2389r550b2444],
3	WITH	IN	O	with	_	0	SENT_48	[p4l565t2389r754b2443],
4	WEIGHT-LOSS	JJ	O	weight-loss	amod	5	SENT_48	[p4l772t2388r1274b2444],
5	DRUGS	NNS	O	drug	prep_with	2	SENT_48	[p4l1296t2389r1546b2444],
6	Drugs	NNS	O	drug	nsubj	10	SENT_48	[p4l9t2489r226b2568],
7	can	MD	O	can	aux	10	SENT_48	[p4l252t2507r372b2547],
8	be	VB	O	be	cop	10	SENT_48	[p4l395t2484r477b2547],
9	very	RB	O	very	advmod	10	SENT_48	[p4l499t2507r657b2568],
10	effective	JJ	O	effective	_	0	SENT_48	[p4l679t2484r969b2547],
11	in	IN	O	in	_	0	SENT_48	[p4l995t2490r1063b2546],
12	inducing	VBG	O	induce	prepc_in	10	SENT_48	[p4l1088t2484r1404b2568],
13	weight	NN	O	weight	nn	14	SENT_48	[p4l1426t2484r1663b2568],
14	loss	NN	O	loss	dobj	12	SENT_48	[p4l1686t2484r1835b2547],
15	.	.	O	.	_	0	SENT_48	[p4l1686t2484r1835b2547],

1	The	DT	O	the	det	2	SENT_49	[p4l1863t2484r1991b2547],
2	history	NN	O	history	nsubj	7	SENT_49	[p4l2015t2484r2145b2547, p4l7t2599r156b2671],
3	of	IN	O	of	_	0	SENT_49	[p4l177t2587r253b2650],
4	dietary	JJ	O	dietary	amod	5	SENT_49	[p4l269t2587r520b2671],
5	supplements	NNS	O	supplement	prep_of	2	SENT_49	[p4l542t2587r987b2670],
6	is	VBZ	O	be	cop	7	SENT_49	[p4l1012t2593r1064b2650],
7	full	JJ	O	full	_	0	SENT_49	[p4l1089t2587r1206b2650],
8	of	IN	O	of	_	0	SENT_49	[p4l1231t2587r1307b2650],
9	success	NN	O	success	nn	10	SENT_49	[p4l1323t2610r1576b2650],
10	stories	NNS	O	story	prep_of	7	SENT_49	[p4l1602t2593r1829b2650],
11	in	IN	O	in	_	0	SENT_49	[p4l1855t2593r1923b2649],
12	terms	NNS	O	term	prep_in	10	SENT_49	[p4l1947t2599r2147b2650],
13	of	IN	O	of	_	0	SENT_49	[p4l9t2690r84b2753],
14	efficacy	NN	O	efficacy	prep_of	12	SENT_49	[p4l99t2690r370b2774],
15	,	,	O	,	_	0	SENT_49	[p4l99t2690r370b2774],
16	but	CC	O	but	_	0	SENT_49	[p4l394t2690r510b2753],
17	this	DT	O	this	det	18	SENT_49	[p4l531t2690r658b2753],
18	success	NN	O	success	nsubjpass	20	SENT_49	[p4l684t2713r934b2753],
19	is	VBZ	O	be	auxpass	20	SENT_49	[p4l959t2696r1010b2753],
20	matched	VBN	O	match	conj_but	7	SENT_49	[p4l1034t2690r1336b2753],
21	by	IN	O	by	_	0	SENT_49	[p4l1356t2690r1442b2774],
22	tragedy	NN	O	tragedy	agent	20	SENT_49	[p4l1461t2690r1726b2774],
23	with	IN	O	with	_	0	SENT_49	[p4l1744t2690r1900b2753],
24	regard	NN	O	regard	prep_with	20	SENT_49	[p4l1924t2690r2148b2774],
25	to	TO	O	to	_	0	SENT_49	[p4l7t2805r74b2856],
26	safety	NN	O	safety	prep_to	20	SENT_49	[p4l100t2793r308b2877],
27	.	.	O	.	_	0	SENT_49	[p4l100t2793r308b2877],

1	Perhaps	RB	O	perhaps	advmod	9	SENT_50	[p4l335t2793r609b2876],
2	the	DT	O	the	det	4	SENT_50	[p4l632t2793r741b2856],
3	most	RBS	O	most	advmod	4	SENT_50	[p4l764t2805r937b2856],
4	infamous	JJ	O	infamous	nsubj	9	SENT_50	[p4l960t2793r1286b2856],
5	is	VBZ	O	be	cop	9	SENT_50	[p4l1310t2799r1361b2856],
6	the	DT	O	the	det	9	SENT_50	[p4l1384t2793r1493b2856],
7	combination	NN	O	combination	nn	9	SENT_50	[p4l1517t2793r1961b2856],
8	drug	NN	O	drug	nn	9	SENT_50	[p4l1985t2793r2151b2877],
9	Fen	NNP	O	Fen	_	0	SENT_50	[p4l9t2896r386b2959],
10	.	.	O	.	_	0	SENT_50	[p4l9t2896r386b2959],

1	—	NN	O	—	_	0	SENT_51	[p4l9t2896r386b2959],
2	.	.	O	.	_	0	SENT_51	[p4l9t2896r386b2959],

1	Phen	NNP	O	Phen	_	0	SENT_52	[p4l9t2896r386b2959],
2	.	.	O	.	_	0	SENT_52	[p4l9t2896r386b2959],

1	A	DT	O	a	det	2	SENT_53	[p4l414t2900r472b2958],
2	combination	NN	O	combination	_	0	SENT_53	[p4l498t2896r949b2959],
3	of	IN	O	of	_	0	SENT_53	[p4l975t2896r1051b2959],
4	the	DT	O	the	det	7	SENT_53	[p4l1066t2896r1175b2959],
5	amphetamine	NN	O	amphetamine	nn	7	SENT_53	[p4l1202t2896r1690b2979],
6	analogs	NNS	O	analog	nn	7	SENT_53	[p4l1716t2896r1982b2980],
7	fenﬂuramine	NN	O	fenﬂuramine	prep_of	2	SENT_53	[p4l2007t2896r2145b2959, p4l8t2999r352b3062],
8	and	CC	O	and	_	0	SENT_53	[p4l377t2999r507b3062],
9	phentermine	NN	O	phentermine	prep_of	2	SENT_53	[p4l528t2999r1003b3082],
10	,	,	O	,	_	0	SENT_53	[p4l528t2999r1003b3082],
11	Fen	NN	O	fen	appos	9	SENT_53	[p4l1029t2999r1423b3062],
12	.	.	O	.	_	0	SENT_53	[p4l1029t2999r1423b3062],

1	—	NN	O	—	_	0	SENT_54	[p4l1029t2999r1423b3062],
2	.	.	O	.	_	0	SENT_54	[p4l1029t2999r1423b3062],

1	Phen	NNP	PERSON	Phen	poss	3	SENT_55	[p4l1029t2999r1423b3062],
2	’s	POS	O	’s	_	0	SENT_55	[p4l1029t2999r1423b3062],
3	effectiveness	NN	O	effectiveness	nsubj	4	SENT_55	[p4l1448t2999r1887b3062],
4	helped	VBD	O	help	_	0	SENT_55	[p4l1911t2999r2148b3082],
5	it	PRP	O	it	nsubj	7	SENT_55	[p4l9t3108r55b3165],
6	to	TO	O	to	aux	7	SENT_55	[p4l76t3114r143b3165],
7	achieve	VB	O	achieve	xcomp	4	SENT_55	[p4l169t3102r426b3165],
8	extensive	JJ	O	extensive	amod	9	SENT_55	[p4l450t3108r769b3165],
9	popularity	NN	O	popularity	dobj	7	SENT_55	[p4l792t3102r1161b3186],
10	in	IN	O	in	_	0	SENT_55	[p4l1180t3108r1248b3164],
11	the	DT	DATE	the	det	12	SENT_55	[p4l1270t3102r1379b3165],
12	1990s	CD	DATE	1990s	prep_in	7	SENT_55	[p4l1409t3109r1617b3165],
13	.	.	O	.	_	0	SENT_55	[p4l1409t3109r1617b3165],

1	Unfortunately	RB	O	unfortunately	advmod	5	SENT_56	[p4l1644t3102r2148b3186],
2	,	,	O	,	_	0	SENT_56	[p4l1644t3102r2148b3186],
3	it	PRP	O	it	nsubj	5	SENT_56	[p4l9t3211r57b3268],
4	also	RB	O	also	advmod	5	SENT_56	[p4l87t3205r226b3268],
5	caused	VBD	O	cause	_	0	SENT_56	[p4l258t3205r503b3268],
6	pulmonary	JJ	O	pulmonary	amod	7	SENT_56	[p4l531t3205r939b3289],
7	hypertension	NN	O	hypertension	dobj	5	SENT_56	[p4l965t3205r1446b3289],
8	and	CC	O	and	_	0	SENT_56	[p4l1478t3205r1610b3268],
9	valvular	JJ	O	valvular	amod	11	SENT_56	[p4l1636t3205r1933b3268],
10	heart	NN	O	heart	nn	11	SENT_56	[p4l1961t3205r2150b3268],
11	disease	NN	O	disease	dobj	5	SENT_56	[p4l9t3307r286b3379],
12	,	,	O	,	_	0	SENT_56	[p4l9t3307r286b3379],
13	which	WDT	O	which	nsubj	21	SENT_56	[p4l316t3307r538b3371],
14	forced	VBD	O	force	rcmod	7	SENT_56	[p4l568t3307r798b3371],
15	its	PRP$	O	its	poss	16	SENT_56	[p4l828t3313r908b3371],
16	withdrawal	NN	O	withdrawal	dobj	14	SENT_56	[p4l938t3307r1350b3371],
17	from	IN	O	from	_	0	SENT_56	[p4l1379t3307r1556b3371],
18	the	DT	O	the	det	19	SENT_56	[p4l1586t3307r1698b3371],
19	market	NN	O	market	prep_from	14	SENT_56	[p4l1729t3307r1986b3371],
20	and	CC	O	and	_	0	SENT_56	[p4l2016t3307r2148b3371],
21	birthed	VBD	O	birthe	rcmod	7	SENT_56	[p5l6t26r271b90],
22	a	DT	O	a	det	26	SENT_56	[p5l298t49r333b90],
23	legal	JJ	O	legal	amod	26	SENT_56	[p5l357t26r522b111],
24	and	CC	O	and	_	0	SENT_56	[p5l548t26r679b90],
25	ﬁnancial	JJ	O	ﬁnancial	conj_and	23	SENT_56	[p5l705t26r1012b90],
26	disaster	NN	O	disaster	dobj	21	SENT_56	[p5l1039t18r1393b90],
27	.	.	O	.	_	0	SENT_56	[p5l1039t18r1393b90],

1	”	NN	O	”	nsubj	8	SENT_57	[p5l1039t18r1393b90],
2	Other	JJ	O	other	amod	4	SENT_57	[p5l1420t26r1631b90],
3	amphetamine	NN	O	amphetamine	nn	4	SENT_57	[p5l1658t26r2148b110],
4	analogs	NNS	O	analog	dep	1	SENT_57	[p5l9t130r265b214],
5	and	CC	O	and	_	0	SENT_57	[p5l290t130r416b193],
6	sympathomimetics	NNS	O	sympathomimetic	dep	1	SENT_57	[p5l439t130r1094b214],
7	have	VBP	O	have	aux	8	SENT_57	[p5l1116t130r1272b193],
8	had	VBN	O	have	_	0	SENT_57	[p5l1294t130r1422b193],
9	similarly	RB	O	similarly	advmod	10	SENT_57	[p5l1444t130r1746b214],
10	grave	JJ	O	grave	amod	11	SENT_57	[p5l1765t153r1947b214],
11	risks	NNS	O	risk	dobj	8	SENT_57	[p5l1970t130r2146b202],
12	,	,	O	,	_	0	SENT_57	[p5l1970t130r2146b202],
13	including	VBG	O	include	_	0	SENT_57	[p5l8t232r340b317],
14	addiction	NN	O	addiction	prep_including	11	SENT_57	[p5l363t232r712b305],
15	,	,	O	,	_	0	SENT_57	[p5l363t232r712b305],
16	myocardial	JJ	O	myocardial	amod	17	SENT_57	[p5l737t232r1128b317],
17	toxicity	NN	O	toxicity	prep_including	11	SENT_57	[p5l1149t239r1420b317],
18	,	,	O	,	_	0	SENT_57	[p5l1149t239r1420b317],
19	and	CC	O	and	_	0	SENT_57	[p5l1446t232r1574b296],
20	sudden	JJ	O	sudden	amod	21	SENT_57	[p5l1597t232r1849b296],
21	death	NN	O	death	prep_including	11	SENT_57	[p5l1873t224r2145b296],
22	.	.	O	.	_	0	SENT_57	[p5l1873t224r2145b296],

1	“	NN	O	“	nn	2	SENT_58	[p5l1873t224r2145b296],
2	Aminorex	NN	O	aminorex	nsubj	3	SENT_58	[p5l7t340r365b399],
3	caused	VBD	O	cause	_	0	SENT_58	[p5l387t336r622b399],
4	chronic	JJ	O	chronic	amod	6	SENT_58	[p5l645t336r909b399],
5	pulmonary	JJ	O	pulmonary	amod	6	SENT_58	[p5l931t336r1323b420],
6	hypertension	NN	O	hypertension	nsubj	13	SENT_58	[p5l1342t336r1802b420],
7	with	IN	O	with	_	0	SENT_58	[p5l1823t336r1978b399],
8	50	CD	PERCENT	50	number	9	SENT_58	[p5l2003t341r2147b401],
9	%	NN	PERCENT	%	amod	12	SENT_58	[p5l2003t341r2147b401],
10	mortality	NN	O	mortality	nn	12	SENT_58	[p5l8t432r370b524],
11	.5	CD	NUMBER	.5	num	12	SENT_58	[p5l8t432r370b524],
12	Phenylpropanolamine	NN	MISC	phenylpropanolamine	prep_with	6	SENT_58	[p5l395t439r1158b524],
13	caused	VBD	O	cause	ccomp	3	SENT_58	[p5l1181t439r1413b503],
14	intracranial	JJ	O	intracranial	amod	15	SENT_58	[p5l1434t440r1835b503],
15	bleeding	NN	O	bleeding	dobj	13	SENT_58	[p5l1854t439r2150b524],
16	and	CC	O	and	_	0	SENT_58	[p5l9t542r139b606],
17	strokes	NNS	O	stroke	conj_and	15	SENT_58	[p5l163t534r493b606],
18	.	.	O	.	_	0	SENT_58	[p5l163t534r493b606],

1	”	NN	O	”	nn	2	SENT_59	[p5l163t534r493b606],
2	Ephedrine	NN	O	ephedrine	nsubj	3	SENT_59	[p5l518t542r886b626],
3	caused	VBD	O	cause	_	0	SENT_59	[p5l911t542r1148b606],
4	heart	NN	O	heart	nn	5	SENT_59	[p5l1171t542r1354b606],
5	attacks	NNS	O	attack	dobj	3	SENT_59	[p5l1378t542r1637b615],
6	,	,	O	,	_	0	SENT_59	[p5l1378t542r1637b615],
7	hypertension	NN	O	hypertension	dobj	3	SENT_59	[p5l1662t542r2147b627],
8	,	,	O	,	_	0	SENT_59	[p5l1662t542r2147b627],
9	palpitations	NNS	O	palpitation	dobj	3	SENT_59	[p5l7t646r434b730],
10	,	,	O	,	_	0	SENT_59	[p5l7t646r434b730],
11	strokes	NNS	O	stroke	dobj	3	SENT_59	[p5l460t646r720b719],
12	,	,	O	,	_	0	SENT_59	[p5l460t646r720b719],
13	and	CC	O	and	_	0	SENT_59	[p5l746t646r873b710],
14	sudden	JJ	O	sudden	amod	15	SENT_59	[p5l896t646r1147b710],
15	death	NN	O	death	conj_and	5	SENT_59	[p5l1171t638r1442b710],
16	.	.	O	.	_	0	SENT_59	[p5l1171t638r1442b710],

1	”	NN	O	”	nn	2	SENT_60	[p5l1171t638r1442b710],
2	Sibutramine	NN	MISC	sibutramine	nsubj	3	SENT_60	[p5l1467t646r1893b710],
3	caused	VBD	O	cause	_	0	SENT_60	[p5l1917t646r2150b710],
4	increased	VBN	O	increase	amod	6	SENT_60	[p5l8t749r331b813],
5	cardiovascular	JJ	O	cardiovascular	amod	6	SENT_60	[p5l351t749r847b813],
6	events	NNS	O	event	dobj	3	SENT_60	[p5l866t741r1159b813],
7	.	.	O	.	_	0	SENT_60	[p5l866t741r1159b813],

1	”	NN	O	”	nn	2	SENT_61	[p5l866t741r1159b813],
2	Rimonabant	NN	MISC	rimonabant	nsubj	13	SENT_61	[p5l1179t749r1619b822],
3	,	,	O	,	_	0	SENT_61	[p5l1179t749r1619b822],
4	an	DT	O	a	det	6	SENT_61	[p5l1642t772r1721b813],
5	inverse	JJ	O	inverse	amod	6	SENT_61	[p5l1742t756r1981b813],
6	agonist	NN	O	agonist	appos	2	SENT_61	[p5l2003t772r2146b834, p5l8t859r138b916],
7	of	IN	O	of	_	0	SENT_61	[p5l162t853r238b916],
8	the	DT	O	the	det	11	SENT_61	[p5l252t853r362b916],
9	endocannabinoid	NN	O	endocannabinoid	nn	11	SENT_61	[p5l388t853r1011b916],
10	receptor	NN	O	receptor	nn	11	SENT_61	[p5l1035t865r1330b936],
11	CB1	NN	O	cb1	prep_of	6	SENT_61	[p5l1355t857r1523b925],
12	,	,	O	,	_	0	SENT_61	[p5l1355t857r1523b925],
13	caused	VBD	O	cause	_	0	SENT_61	[p5l1550t853r1789b916],
14	increased	VBN	O	increase	amod	15	SENT_61	[p5l1813t853r2150b916],
15	depression	NN	O	depression	dobj	13	SENT_61	[p5l9t955r391b1039],
16	and	CC	O	and	_	0	SENT_61	[p5l417t955r548b1019],
17	suicide	NN	O	suicide	conj_and	15	SENT_61	[p5l573t947r906b1019],
18	.	.	O	.	_	0	SENT_61	[p5l573t947r906b1019],

1	”	NN	O	”	nsubj	6	SENT_62	[p5l573t947r906b1019],
2	These	DT	O	these	det	4	SENT_62	[p5l932t955r1133b1019],
3	unsafe	JJ	O	unsafe	amod	4	SENT_62	[p5l1159t955r1387b1019],
4	drugs	NNS	O	drug	dep	1	SENT_62	[p5l1414t955r1613b1040],
5	have	VBP	O	have	aux	6	SENT_62	[p5l1638t955r1799b1019],
6	had	VBN	O	have	_	0	SENT_62	[p5l1824t955r1956b1019],
7	their	PRP$	O	they	poss	9	SENT_62	[p5l1980t955r2150b1019],
8	regulatory	JJ	O	regulatory	amod	9	SENT_62	[p5l9t1059r363b1143],
9	approval	NN	O	approval	dobj	6	SENT_62	[p5l380t1059r674b1142],
10	withdrawn	VBN	O	withdraw	partmod	9	SENT_62	[p5l692t1059r1082b1131],
11	,	,	O	,	_	0	SENT_62	[p5l692t1059r1082b1131],
12	although	IN	O	although	mark	17	SENT_62	[p5l1104t1059r1407b1143],
13	their	PRP$	O	they	poss	15	SENT_62	[p5l1427t1059r1589b1122],
14	unregulated	JJ	O	unregulated	amod	15	SENT_62	[p5l1608t1059r2019b1143],
15	use	NN	O	use	nsubj	17	SENT_62	[p5l2038t1082r2148b1122],
16	may	MD	O	may	aux	17	SENT_62	[p5l8t1184r155b1246],
17	continue	VB	O	continue	advcl	6	SENT_62	[p5l173t1168r473b1225],
18	to	TO	O	to	_	0	SENT_62	[p5l494t1174r560b1225],
19	some	DT	O	some	det	20	SENT_62	[p5l584t1184r762b1225],
20	extent	NN	O	extent	prep_to	17	SENT_62	[p5l784t1174r1009b1225],
21	.	.	O	.	_	0	SENT_62	[p5l784t1174r1009b1225],

1	As	IN	O	as	_	0	SENT_63	[p5l81t1269r172b1328],
2	of	IN	O	of	prepc_as_of	14	SENT_63	[p5l203t1265r281b1328],
3	September	NNP	DATE	September	pobj	14	SENT_63	[p5l302t1265r693b1348],
4	2013	CD	DATE	2013	num	3	SENT_63	[p5l722t1272r915b1337],
5	,	,	O	,	_	0	SENT_63	[p5l722t1272r915b1337],
6	only	RB	O	only	advmod	8	SENT_63	[p5l947t1265r1108b1349],
7	one	CD	NUMBER	one	num	8	SENT_63	[p5l1135t1288r1264b1328],
8	drug	NN	O	drug	nsubjpass	14	SENT_63	[p5l1295t1265r1486b1349],
9	,	,	O	,	_	0	SENT_63	[p5l1295t1265r1486b1349],
10	orlistat	NN	O	orlistat	appos	8	SENT_63	[p5l1518t1265r1796b1337],
11	,	,	O	,	_	0	SENT_63	[p5l1518t1265r1796b1337],
12	has	VBZ	O	have	aux	14	SENT_63	[p5l1826t1265r1945b1328],
13	been	VBN	O	be	auxpass	14	SENT_63	[p5l1974t1265r2148b1328],
14	approved	VBN	O	approve	_	0	SENT_63	[p5l9t1368r354b1451],
15	by	IN	O	by	_	0	SENT_63	[p5l384t1368r473b1452],
16	both	CC	O	both	preconj	18	SENT_63	[p5l501t1368r673b1431],
17	the	DT	O	the	det	18	SENT_63	[p5l705t1368r820b1431],
18	FDA	NNP	ORGANIZATION	FDA	agent	14	SENT_63	[p5l854t1372r1025b1430],
19	and	CC	O	and	_	0	SENT_63	[p5l1059t1368r1194b1431],
20	the	DT	O	the	det	26	SENT_63	[p5l1225t1368r1340b1431],
21	European	JJ	ORGANIZATION	european	amod	26	SENT_63	[p5l1373t1373r1733b1451],
22	Medicines	NNP	ORGANIZATION	Medicines	nn	26	SENT_63	[p5l1766t1368r2149b1431],
23	Agency	NNP	ORGANIZATION	Agency	nn	26	SENT_63	[p5l8t1475r281b1555],
24	(	CD	NUMBER	(	num	26	SENT_63	[p5l307t1472r553b1547],
25	EMA	NN	O	ema	nn	26	SENT_63	[p5l307t1472r553b1547],
26	)	NN	O	)	conj_and	18	SENT_63	[p5l307t1472r553b1547],
27	for	IN	O	for	_	0	SENT_63	[p5l584t1471r686b1534],
28	chronic	JJ	O	chronic	amod	30	SENT_63	[p5l712t1471r986b1534],
29	weight	NN	O	weight	nn	30	SENT_63	[p5l1011t1471r1253b1555],
30	management	NN	O	management	prep_for	14	SENT_63	[p5l1278t1483r1765b1555],
31	.	.	O	.	_	0	SENT_63	[p5l1278t1483r1765b1555],

1	Orlistat	NNP	O	Orlistat	nsubj	8	SENT_64	[p5l1796t1471r2070b1534],
2	is	VBZ	O	be	cop	8	SENT_64	[p5l2096t1477r2148b1534],
3	also	RB	O	also	advmod	8	SENT_64	[p5l9t1574r142b1637],
4	the	DT	O	the	det	8	SENT_64	[p5l165t1574r273b1637],
5	only	JJ	O	only	amod	8	SENT_64	[p5l297t1574r450b1658],
6	FDA-approved	JJ	MISC	fda-approved	amod	8	SENT_64	[p5l470t1574r990b1657],
7	Weight-loss	JJ	MISC	weight-loss	amod	8	SENT_64	[p5l1010t1574r1407b1658],
8	drug	NN	O	drug	_	0	SENT_64	[p5l1431t1574r1596b1658],
9	that	WDT	O	that	nsubj	11	SENT_64	[p5l1615t1574r1752b1637],
10	is	VBZ	O	be	cop	11	SENT_64	[p5l1773t1580r1824b1637],
11	available	JJ	O	available	rcmod	8	SENT_64	[p5l1848t1574r2149b1637],
12	without	IN	O	without	_	0	SENT_64	[p5l7t1677r283b1740],
13	a	DT	O	a	det	14	SENT_64	[p5l307t1700r342b1740],
14	prescription	NN	O	prescription	prep_without	11	SENT_64	[p5l365t1683r814b1760],
15	.	.	O	.	_	0	SENT_64	[p5l365t1683r814b1760],

1	It	PRP	O	it	nsubjpass	3	SENT_65	[p5l843t1682r894b1740],
2	was	VBD	O	be	auxpass	3	SENT_65	[p5l915t1700r1044b1740],
3	approved	VBN	O	approve	conj_and	3	SENT_65	[p5l1071t1677r1398b1760],
4	in	IN	O	in	_	0	SENT_65	[p5l1422t1683r1490b1739],
5	1999	CD	DATE	1999	prep_in	3	SENT_65	[p5l1521t1684r1680b1740],
6	for	IN	O	for	_	0	SENT_65	[p5l1706t1677r1806b1740],
7	prescription	NN	O	prescription	nn	8	SENT_65	[p5l1828t1683r2146b1760, p5l7t1785r144b1842],
8	sale	NN	O	sale	prep_for	3	SENT_65	[p5l166t1779r290b1842],
9	and	CC	O	and	_	0	SENT_65	[p5l313t1779r438b1842],
10	in	IN	O	in	_	0	SENT_65	[p5l458t1785r524b1841],
11	2007	CD	DATE	2007	prep_in	3	SENT_65	[p5l545t1786r706b1842],
12	for	IN	O	for	prep	3	SENT_65	[p5l728t1779r824b1842],
13	over	IN	O	over	pcomp	12	SENT_65	[p5l845t1779r1426b1842],
14	—	CD	NUMBER	—	num	16	SENT_65	[p5l845t1779r1426b1842],
15	the-counter	JJ	O	the-counter	amod	16	SENT_65	[p5l845t1779r1426b1842],
16	sale	NN	O	sale	pobj	13	SENT_65	[p5l1448t1779r1588b1842],
17	.	.	O	.	_	0	SENT_65	[p5l1448t1779r1588b1842],

1	Orlistat	NN	O	orlistat	nsubj	2	SENT_66	[p5l1613t1779r1871b1842],
2	inhibits	VBZ	O	inhibit	_	0	SENT_66	[p5l1891t1779r2149b1842],
3	gastrointestinal	JJ	O	gastrointestinal	amod	4	SENT_66	[p5l8t1882r558b1966],
4	lipases	NNS	O	lipase	dobj	2	SENT_66	[p5l581t1882r835b1965],
5	,	,	O	,	_	0	SENT_66	[p5l581t1882r835b1965],
6	reducing	VBG	O	reduce	partmod	2	SENT_66	[p5l862t1882r1176b1966],
7	fat	JJ	O	fat	amod	8	SENT_66	[p5l1199t1882r1289b1945],
8	absorption	NN	O	absorption	nsubj	12	SENT_66	[p5l1313t1882r1697b1965],
9	(	CD	NUMBER	(	num	12	SENT_66	[p5l1725t1883r1994b1965],
10	Figure	NNP	O	Figure	nn	12	SENT_66	[p5l1725t1883r1994b1965],
11	2c	JJ	O	2c	amod	12	SENT_66	[p5l2018t1882r2144b1959],
12	)	NN	O	)	xcomp	6	SENT_66	[p5l2018t1882r2144b1959],
13	.	.	O	.	_	0	SENT_66	[p5l2018t1882r2144b1959],

1	Consequently	RB	O	consequently	advmod	9	SENT_67	[p5l10t1985r505b2069],
2	,	,	O	,	_	0	SENT_67	[p5l10t1985r505b2069],
3	its	PRP$	O	its	poss	7	SENT_67	[p5l531t1991r609b2048],
4	most	RBS	O	most	advmod	6	SENT_67	[p5l633t1997r806b2048],
5	common	JJ	O	common	amod	6	SENT_67	[p5l830t2008r1142b2048],
6	adverse	JJ	O	adverse	amod	7	SENT_67	[p5l1167t1985r1427b2048],
7	effect	NN	O	effect	nsubj	9	SENT_67	[p5l1453t1985r1638b2048],
8	is	VBZ	O	be	cop	9	SENT_67	[p5l1662t1991r1712b2048],
9	steatorrhea	NN	O	steatorrhea	_	0	SENT_67	[p5l1738t1985r2146b2048],
10	.	.	O	.	_	0	SENT_67	[p5l1738t1985r2146b2048],

1	Despite	IN	O	despite	_	0	SENT_68	[p5l9t2093r268b2171],
2	its	PRP$	O	its	poss	4	SENT_68	[p5l290t2094r367b2151],
3	approved	VBN	O	approve	amod	4	SENT_68	[p5l390t2088r710b2171],
4	status	NN	O	status	prep_despite	8	SENT_68	[p5l732t2100r946b2160],
5	,	,	O	,	_	0	SENT_68	[p5l732t2100r946b2160],
6	orlistat	NN	O	orlistat	nsubj	8	SENT_68	[p5l970t2088r1211b2151],
7	has	VBZ	O	have	aux	8	SENT_68	[p5l1230t2088r1343b2151],
8	had	VBN	O	have	_	0	SENT_68	[p5l1364t2088r1493b2151],
9	a	DT	O	a	det	10	SENT_68	[p5l1515t2111r1549b2151],
10	number	NN	O	number	dobj	8	SENT_68	[p5l1569t2088r1844b2151],
11	of	IN	O	of	_	0	SENT_68	[p5l1865t2088r1939b2151],
12	safety	NN	O	safety	nn	13	SENT_68	[p5l1952t2088r2151b2172],
13	issues	NNS	O	issue	prep_of	10	SENT_68	[p5l9t2198r230b2264],
14	,	,	O	,	_	0	SENT_68	[p5l9t2198r230b2264],
15	including	VBG	O	include	_	0	SENT_68	[p5l256t2192r593b2276],
16	hepatotoxicity	NN	O	hepatotoxicity	prep_including	10	SENT_68	[p5l615t2192r1132b2276],
17	,	,	O	,	_	0	SENT_68	[p5l615t2192r1132b2276],
18	nephrotoxicity	NN	O	nephrotoxicity	conj_and	16	SENT_68	[p5l1158t2192r1690b2276],
19	,	,	O	,	_	0	SENT_68	[p5l1158t2192r1690b2276],
20	pancreatitis	NN	O	pancreatitis	prep_including	10	SENT_68	[p5l1715t2198r2146b2275],
21	,	,	O	,	_	0	SENT_68	[p5l1715t2198r2146b2275],
22	and	CC	O	and	_	0	SENT_68	[p5l9t2295r137b2359],
23	kidney	NN	O	kidney	nn	24	SENT_68	[p5l158t2295r400b2380],
24	stones	NNS	O	stone	prep_including	10	SENT_68	[p5l421t2288r688b2359],
25	.5	CD	NUMBER	.5	dep	24	SENT_68	[p5l421t2288r688b2359],

1	In	IN	O	in	_	0	SENT_69	[p5l83t2404r155b2461],
2	2010	CD	DATE	2010	prep_in	6	SENT_69	[p5l179t2406r363b2471],
3	,	,	O	,	_	0	SENT_69	[p5l179t2406r363b2471],
4	the	DT	O	the	det	5	SENT_69	[p5l387t2399r496b2462],
5	FDA	NNP	ORGANIZATION	FDA	nsubj	6	SENT_69	[p5l520t2403r685b2461],
6	rejected	VBD	O	reject	dep	16	SENT_69	[p5l709t2399r986b2483],
7	two	CD	NUMBER	two	iobj	6	SENT_69	[p5l1007t2411r1135b2462],
8	proposed	VBN	O	propose	amod	10	SENT_69	[p5l1158t2399r1488b2482],
9	Weight-loss	JJ	MISC	weight-loss	amod	10	SENT_69	[p5l1509t2399r1906b2483],
10	drugs	NNS	O	drug	dobj	6	SENT_69	[p5l1930t2399r2146b2483],
11	,	,	O	,	_	0	SENT_69	[p5l1930t2399r2146b2483],
12	lorcaserin	NN	O	lorcaserin	nn	15	SENT_69	[p5l7t2502r348b2565],
13	and	CC	O	and	_	0	SENT_69	[p5l372t2502r498b2565],
14	phentermine/topiramate	NN	O	phentermine/topiramate	nn	15	SENT_69	[p5l519t2502r1369b2585],
15	(	NN	O	(	appos	10	SENT_69	[p5l1395t2502r1999b2578],
16	extended	VBD	O	extend	_	0	SENT_69	[p5l1395t2502r1999b2578],
17	—	CD	NUMBER	—	num	20	SENT_69	[p5l1395t2502r1999b2578],
18	release	NN	O	release	nn	20	SENT_69	[p5l1395t2502r1999b2578],
19	formulation	NN	O	formulation	nn	20	SENT_69	[p5l2022t2502r2146b2565, p5l8t2605r341b2682],
20	)	NN	O	)	nsubj	16	SENT_69	[p5l2022t2502r2146b2565, p5l8t2605r341b2682],
21	due	JJ	O	due	_	0	SENT_69	[p5l366t2605r487b2668],
22	to	TO	O	to	_	0	SENT_69	[p5l506t2617r572b2668],
23	safety	NN	O	safety	nn	26	SENT_69	[p5l594t2605r788b2689],
24	and	CC	O	and	_	0	SENT_69	[p5l806t2605r931b2668],
25	efﬁcacy	NN	O	efﬁcacy	nn	26	SENT_69	[p5l950t2605r1205b2689],
26	issues	NNS	O	issue	prep_due_to	16	SENT_69	[p5l1222t2611r1432b2668],
27	.	.	O	.	_	0	SENT_69	[p5l1222t2611r1432b2668],

1	Major	JJ	O	major	amod	2	SENT_70	[p5l1455t2610r1660b2689],
2	concerns	NNS	O	concern	nsubj	5	SENT_70	[p5l1680t2628r1982b2668],
3	over	IN	O	over	_	0	SENT_70	[p5l2004t2628r2150b2668],
4	lorcaserin	NN	O	lorcaserin	prep_over	2	SENT_70	[p5l7t2708r348b2771],
5	included	VBD	O	include	_	0	SENT_70	[p5l371t2708r671b2771],
6	limited	JJ	O	limited	amod	7	SENT_70	[p5l691t2708r937b2771],
7	efﬁcacy	NN	O	efﬁcacy	dobj	5	SENT_70	[p5l960t2708r1226b2792],
8	,	,	O	,	_	0	SENT_70	[p5l960t2708r1226b2792],
9	carcinogenesis	NN	O	carcinogenesis	dobj	5	SENT_70	[p5l1251t2714r1769b2792],
10	,	,	O	,	_	0	SENT_70	[p5l1251t2714r1769b2792],
11	cardiovascular	JJ	O	cardiovascular	amod	12	SENT_70	[p5l1794t2708r2144b2771, p5l9t2811r182b2874],
12	events	NNS	O	event	dobj	5	SENT_70	[p5l205t2823r438b2883],
13	,	,	O	,	_	0	SENT_70	[p5l205t2823r438b2883],
14	cognitive	JJ	O	cognitive	amod	15	SENT_70	[p5l464t2817r779b2895],
15	impairment	NN	O	impairment	conj_and	7	SENT_70	[p5l802t2817r1231b2894],
16	,	,	O	,	_	0	SENT_70	[p5l802t2817r1231b2894],
17	and	CC	O	and	_	0	SENT_70	[p5l1256t2811r1384b2874],
18	psychiatric	JJ	O	psychiatric	amod	19	SENT_70	[p5l1405t2811r1784b2895],
19	disorders	NNS	O	disorder	dobj	5	SENT_70	[p5l1807t2811r2144b2874],
20	.	.	O	.	_	0	SENT_70	[p5l1807t2811r2144b2874],

1	Major	JJ	O	major	amod	2	SENT_71	[p5l8t2919r214b2998],
2	concerns	NNS	O	concern	nsubj	5	SENT_71	[p5l234t2937r539b2977],
3	over	IN	O	over	_	0	SENT_71	[p5l560t2937r707b2977],
4	phentermine/topiramate	NN	O	phentermine/topiramate	prep_over	2	SENT_71	[p5l725t2914r1568b2997],
5	included	VBD	O	include	_	0	SENT_71	[p5l1589t2914r1886b2977],
6	cardiovascular	JJ	O	cardiovascular	amod	7	SENT_71	[p5l1906t2914r2146b2977, p5l6t3017r289b3080],
7	events	NNS	O	event	dobj	5	SENT_71	[p5l308t3029r538b3089],
8	,	,	O	,	_	0	SENT_71	[p5l308t3029r538b3089],
9	fetal	JJ	O	fetal	amod	10	SENT_71	[p5l559t3017r704b3080],
10	toxicity	NN	O	toxicity	dobj	5	SENT_71	[p5l723t3023r987b3101],
11	,	,	O	,	_	0	SENT_71	[p5l723t3023r987b3101],
12	and	CC	O	and	_	0	SENT_71	[p5l1010t3017r1135b3080],
13	suicidal	JJ	O	suicidal	amod	14	SENT_71	[p5l1155t3017r1416b3080],
14	ideation	NN	O	ideation	dobj	5	SENT_71	[p5l1435t3017r1729b3080],
15	.	.	O	.	_	0	SENT_71	[p5l1435t3017r1729b3080],

1	In	IN	O	in	_	0	SENT_72	[p5l1752t3022r1823b3079],
2	2012	CD	DATE	2012	prep_in	6	SENT_72	[p5l1843t3024r2022b3089],
3	,	,	O	,	_	0	SENT_72	[p5l1843t3024r2022b3089],
4	the	DT	O	the	det	5	SENT_72	[p5l2043t3017r2149b3080],
5	FDA	NNP	ORGANIZATION	FDA	nsubj	10	SENT_72	[p5l9t3124r173b3182],
6	reversed	VBD	O	reverse	_	0	SENT_72	[p5l195t3120r488b3183],
7	its	PRP$	O	its	poss	8	SENT_72	[p5l510t3126r587b3183],
8	position	NN	O	position	dobj	6	SENT_72	[p5l609t3126r895b3203],
9	and	CC	O	and	_	0	SENT_72	[p5l919t3120r1046b3183],
10	granted	VBN	O	grant	conj_and	6	SENT_72	[p5l1068t3120r1334b3204],
11	approval	NN	O	approval	dobj	10	SENT_72	[p5l1356t3120r1656b3203],
12	to	TO	O	to	_	0	SENT_72	[p5l1677t3132r1743b3183],
13	both	DT	O	both	preconj	14	SENT_72	[p5l1766t3120r1927b3183],
14	lorcaserin	NN	O	lorcaserin	prep_to	10	SENT_72	[p5l1949t3120r2147b3183, p5l9t3229r179b3286],
15	and	CC	O	and	_	0	SENT_72	[p5l203t3223r331b3286],
16	phentermine/topiramate	NN	O	phentermine/topiramate	conj_and	14	SENT_72	[p5l351t3223r1228b3306],
17	.	.	O	.	_	0	SENT_72	[p5l351t3223r1228b3306],

1	Nonetheless	RB	O	nonetheless	advmod	6	SENT_73	[p5l1253t3223r1694b3295],
2	,	,	O	,	_	0	SENT_73	[p5l1253t3223r1694b3295],
3	the	DT	O	the	det	4	SENT_73	[p5l1718t3223r1826b3286],
4	FDA	NNP	ORGANIZATION	FDA	nsubj	6	SENT_73	[p5l1850t3227r2014b3285],
5	has	VBZ	O	have	aux	6	SENT_73	[p5l2035t3223r2149b3286],
6	required	VBN	O	require	_	0	SENT_73	[p5l9t3326r309b3409],
7	postmarketing	VBG	O	postmarket	xcomp	6	SENT_73	[p5l330t3326r848b3410],
8	safety	NN	O	safety	nn	9	SENT_73	[p5l871t3326r1073b3410],
9	studies	NNS	O	study	dobj	7	SENT_73	[p5l1095t3326r1336b3389],
10	to	TO	O	to	aux	11	SENT_73	[p5l1360t3338r1427b3389],
11	address	VB	O	address	xcomp	7	SENT_73	[p5l1453t3326r1715b3389],
12	the	DT	O	the	det	15	SENT_73	[p5l1739t3326r1848b3389],
13	original	JJ	O	original	amod	15	SENT_73	[p5l1873t3326r2148b3410],
14	cardiovascular	JJ	O	cardiovascular	amod	15	SENT_73	[p5l9t3429r519b3492],
15	concerns	NNS	O	concern	dobj	11	SENT_73	[p5l542t3452r872b3492],
16	.	.	O	.	_	0	SENT_73	[p5l542t3452r872b3492],

1	Furthermore	RB	O	furthermore	advmod	6	SENT_74	[p5l900t3429r1369b3501],
2	,	,	O	,	_	0	SENT_74	[p5l900t3429r1369b3501],
3	the	DT	O	the	det	4	SENT_74	[p5l1393t3429r1502b3492],
4	EMA	NNP	ORGANIZATION	EMA	nsubj	6	SENT_74	[p5l1526t3433r1712b3491],
5	has	VBZ	O	have	aux	6	SENT_74	[p5l1734t3429r1848b3492],
6	rejected	VBN	O	reject	_	0	SENT_74	[p5l1873t3429r2149b3513],
7	both	DT	O	both	preconj	8	SENT_74	[p5l6t3532r162b3595],
8	lorcaserin	NN	O	lorcaserin	dobj	6	SENT_74	[p5l181t3532r513b3595],
9	and	CC	O	and	_	0	SENT_74	[p5l533t3532r657b3595],
10	phentermine/topiramate	NN	O	phentermine/topiramate	dobj	6	SENT_74	[p5l675t3532r1519b3615],
11	.	.	O	.	_	0	SENT_74	[p5l675t3532r1519b3615],

1	The	DT	O	the	det	2	SENT_75	[p5l1542t3532r1665b3595],
2	EMA	NN	O	ema	nsubj	29	SENT_75	[p5l1685t3536r1864b3594],
3	rejected	VBD	O	reject	_	0	SENT_75	[p5l1883t3532r2148b3616],
4	lorcaserin	NN	O	lorcaserin	dobj	3	SENT_75	[p5l7t3635r343b3698],
5	due	JJ	O	due	amod	4	SENT_75	[p5l364t3635r485b3698],
6	to	TO	O	to	_	0	SENT_75	[p5l505t3647r570b3698],
7	its	PRP$	O	its	poss	8	SENT_75	[p5l591t3641r666b3698],
8	opinion	NN	O	opinion	prep_to	5	SENT_75	[p5l687t3641r952b3718],
9	that	IN	O	that	complm	16	SENT_75	[p5l970t3635r1103b3698],
10	the	DT	O	the	det	11	SENT_75	[p5l1121t3635r1226b3698],
11	drug	NN	O	drug	poss	13	SENT_75	[p5l1247t3635r1446b3719],
12	’s	POS	O	’s	_	0	SENT_75	[p5l1247t3635r1446b3719],
13	beneﬁts	NNS	O	beneﬁts	nsubj	16	SENT_75	[p5l1464t3635r1728b3698],
14	did	VBD	O	do	aux	16	SENT_75	[p5l1749t3635r1859b3698],
15	not	RB	O	not	neg	16	SENT_75	[p5l1878t3647r1991b3698],
16	outweigh	VB	O	outweigh	ccomp	3	SENT_75	[p5l2010t3647r2146b3698, p5l7t3737r211b3822],
17	its	PRP$	O	its	poss	18	SENT_75	[p5l233t3744r308b3801],
18	risks	NNS	O	risk	dobj	16	SENT_75	[p5l331t3737r507b3810],
19	,	,	O	,	_	0	SENT_75	[p5l331t3737r507b3810],
20	particularly	RB	O	particularly	advmod	23	SENT_75	[p5l530t3737r933b3822],
21	the	DT	O	the	det	23	SENT_75	[p5l951t3737r1058b3801],
22	potential	JJ	O	potential	amod	23	SENT_75	[p5l1078t3737r1385b3821],
23	risk	NN	O	risk	dep	29	SENT_75	[p5l1407t3737r1536b3801],
24	for	IN	O	for	_	0	SENT_75	[p5l1555t3737r1653b3801],
25	tumors	NNS	O	tumor	prep_for	23	SENT_75	[p5l1672t3729r2000b3810],
26	,16	CD	NUMBER	,16	num	25	SENT_75	[p5l1672t3729r2000b3810],
27	and	CC	O	and	_	0	SENT_75	[p5l2023t3737r2150b3801],
28	phentermine/topiramate	NN	O	phentermine/topiramate	prep_for	23	SENT_75	[p6l7t20r841b103],
29	due	JJ	O	due	conj_and	3	SENT_75	[p6l862t20r982b83],
30	to	TO	O	to	_	0	SENT_75	[p6l1001t32r1066b83],
31	concerns	NNS	O	concern	prep_to	29	SENT_75	[p6l1088t43r1389b83],
32	over	IN	O	over	_	0	SENT_75	[p6l1411t43r1556b83],
33	the	DT	O	the	det	35	SENT_75	[p6l1574t20r1679b83],
34	potential	JJ	O	potential	amod	35	SENT_75	[p6l1698t20r1999b103],
35	cardiovascular	JJ	O	cardiovascular	prep_over	31	SENT_75	[p6l2019t43r2146b83, p6l9t123r404b186],
36	and	CC	O	and	_	0	SENT_75	[p6l426t123r553b186],
37	central	JJ	O	central	amod	40	SENT_75	[p6l575t123r810b186],
38	nervous	JJ	O	nervous	amod	40	SENT_75	[p6l833t146r1107b186],
39	system	NN	O	system	nn	40	SENT_75	[p6l1132t135r1364b207],
40	effects	NNS	O	effect	nsubj	41	SENT_75	[p6l1387t123r1600b186],
41	associated	VBN	O	associate	conj_and	3	SENT_75	[p6l1624t123r1973b186],
42	with	IN	O	with	_	0	SENT_75	[p6l1993t123r2147b186],
43	its	PRP$	O	its	poss	45	SENT_75	[p6l8t232r82b289],
44	long-term	JJ	O	long-term	amod	45	SENT_75	[p6l101t226r439b310],
45	use	NN	O	use	prep_with	41	SENT_75	[p6l459t249r584b298],
46	,	,	O	,	_	0	SENT_75	[p6l459t249r584b298],
47	its	PRP$	O	its	poss	49	SENT_75	[p6l606t232r679b289],
48	teratogenic	JJ	O	teratogenic	amod	49	SENT_75	[p6l699t232r1071b310],
49	potential	NN	O	potential	prep_with	41	SENT_75	[p6l1090t226r1404b309],
50	,	,	O	,	_	0	SENT_75	[p6l1090t226r1404b309],
51	and	CC	O	and	_	0	SENT_75	[p6l1427t226r1550b289],
52	its	PRP$	O	its	poss	53	SENT_75	[p6l1569t232r1642b289],
53	use	NN	O	use	conj_and	45	SENT_75	[p6l1663t249r1771b289],
54	by	IN	O	by	_	0	SENT_75	[p6l1789t226r1871b310],
55	patients	NNS	O	patient	prep_by	41	SENT_75	[p6l1886t232r2149b309],
56	for	IN	O	for	_	0	SENT_75	[p6l8t328r106b392],
57	whom	WP	O	whom	dobj	61	SENT_75	[p6l124t328r342b392],
58	it	PRP	O	it	nsubjpass	61	SENT_75	[p6l364t335r410b392],
59	is	VBZ	O	be	auxpass	61	SENT_75	[p6l430t335r480b392],
60	not	RB	O	not	neg	61	SENT_75	[p6l502t340r617b392],
61	indicated	VBN	O	indicate	prepc_for	55	SENT_75	[p6l637t320r1037b392],
62	.	.	O	.	_	0	SENT_75	[p6l637t320r1037b392],

1	”	NN	O	”	_	0	SENT_76	[p6l637t320r1037b392],

1	Despite	IN	O	despite	_	0	SENT_77	[p6l82t437r337b515],
2	their	PRP$	O	they	poss	3	SENT_77	[p6l357t432r519b495],
3	limitations	NNS	O	limitation	prep_despite	8	SENT_77	[p6l537t432r922b504],
4	,	,	O	,	_	0	SENT_77	[p6l537t432r922b504],
5	lorcaserin	NN	O	lorcaserin	nsubj	8	SENT_77	[p6l943t432r1281b495],
6	and	CC	O	and	_	0	SENT_77	[p6l1302t432r1427b495],
7	phentermine/topiramate	NN	O	phentermine/topiramate	conj_and	5	SENT_77	[p6l1445t432r2147b515, p6l8t547r179b598],
8	represent	VBP	O	represent	_	0	SENT_77	[p6l203t547r531b618],
9	the	DT	O	the	det	14	SENT_77	[p6l553t535r663b598],
10	ﬁrst	JJ	O	ﬁrst	amod	14	SENT_77	[p6l686t535r824b598],
11	new	JJ	O	new	amod	14	SENT_77	[p6l846t558r993b598],
12	antiobesity	NN	O	antiobesity	nn	14	SENT_77	[p6l1015t535r1404b619],
13	drug	NN	O	drug	nn	14	SENT_77	[p6l1426t535r1592b619],
14	approvals	NNS	O	approval	dobj	8	SENT_77	[p6l1615t535r1951b618],
15	in	IN	O	in	_	0	SENT_77	[p6l1976t541r2044b597],
16	13	CD	DURATION	13	num	17	SENT_77	[p6l2075t542r2146b598],
17	years	NNS	NUMBER	year	prep_in	14	SENT_77	[p6l6t661r187b722],
18	(	CD	NUMBER	(	num	20	SENT_77	[p6l216t639r484b721],
19	Figure	NN	O	figure	nn	20	SENT_77	[p6l216t639r484b721],
20	2a	NN	O	2a	tmod	8	SENT_77	[p6l507t639r706b714],
21	,	,	O	,	_	0	SENT_77	[p6l507t639r706b714],
22	b	NN	O	b	nn	23	SENT_77	[p6l507t639r706b714],
23	)	NN	O	)	appos	20	SENT_77	[p6l507t639r706b714],
24	.	.	O	.	_	0	SENT_77	[p6l507t639r706b714],

1	In	IN	O	in	_	0	SENT_78	[p6l735t643r808b700],
2	this	DT	O	this	det	3	SENT_78	[p6l832t638r960b701],
3	article	NN	O	article	prep_in	6	SENT_78	[p6l987t638r1223b710],
4	,	,	O	,	_	0	SENT_78	[p6l987t638r1223b710],
5	we	PRP	O	we	nsubj	6	SENT_78	[p6l1248t661r1344b701],
6	discuss	VBP	O	discuss	_	0	SENT_78	[p6l1370t638r1620b701],
7	these	DT	O	these	det	10	SENT_78	[p6l1645t638r1827b701],
8	two	CD	NUMBER	two	num	10	SENT_78	[p6l1851t650r1980b701],
9	new	JJ	O	new	amod	10	SENT_78	[p6l2006t661r2153b701],
10	drugs	NNS	O	drug	dobj	6	SENT_78	[p6l9t741r202b825],
11	in	IN	O	in	_	0	SENT_78	[p6l226t747r293b803],
12	more	JJR	O	more	amod	13	SENT_78	[p6l316t764r494b804],
13	detail	NN	O	detail	prep_in	10	SENT_78	[p6l518t741r724b804],
14	.	.	O	.	_	0	SENT_78	[p6l518t741r724b804],

1	We	PRP	O	we	nsubj	3	SENT_79	[p6l749t746r859b804],
2	also	RB	O	also	advmod	3	SENT_79	[p6l883t741r1015b804],
3	discuss	VBP	O	discuss	_	0	SENT_79	[p6l1040t741r1284b804],
4	other	JJ	O	other	amod	7	SENT_79	[p6l1308t741r1491b804],
5	promising	JJ	O	promising	amod	7	SENT_79	[p6l1511t747r1868b825],
6	weightloss	NN	O	weightloss	nn	7	SENT_79	[p6l1887t741r2146b825, p6l7t844r135b907],
7	agents	NNS	O	agent	dobj	3	SENT_79	[p6l160t856r377b928],
8	that	WDT	O	that	nsubj	9	SENT_79	[p6l400t844r537b907],
9	are	VBP	O	be	rcmod	7	SENT_79	[p6l559t867r661b907],
10	currently	RB	DATE	currently	advmod	11	SENT_79	[p6l685t844r1008b928],
11	in	IN	O	in	dep	9	SENT_79	[p6l1028t850r1095b906],
12	development	NN	O	development	pobj	11	SENT_79	[p6l1120t844r1573b927],
13	and	CC	O	and	_	0	SENT_79	[p6l1595t844r1724b907],
14	undergoing	VBG	O	undergo	dep	9	SENT_79	[p6l1746t844r2152b928],

1	VOLUME	NN	O	volume	nn	3	SENT_80	[p6l543t1063r767b1105],
2	95	CD	NUMBER	95	num	3	SENT_80	[p6l784t1064r840b1105],
3	NUMBER1	NN	O	number1	_	0	SENT_80	[p6l862t1063r1120b1105],
4	[	CD	NUMBER	[	num	5	SENT_80	[p6l1150t1059r1418b1120],
5	JANUARY	NNP	DATE	JANUARY	dep	3	SENT_80	[p6l1150t1059r1418b1120],
6	2014	CD	DATE	2014	num	5	SENT_80	[p6l1434t1064r1556b1105],
7	|	CD	NUMBER	|	num	8	SENT_80	[p6l1574t1059r1579b1120],
8	www.nature.com/cpt	NN	O	www.nature.com/cpt	dep	3	SENT_80	[p6l1598t1063r2149b1116],

1	S	NN	O	s	_	0	SENT_81	[p6l1761t1235r1783b1272],
2	TAT	NN	O	tat	nn	5	SENT_81	[p6l1790t1235r1873b1272],
3	E	NN	O	e	nn	5	SENT_81	[p6l1882t1235r1902b1272],
4	A	NN	O	a	nn	5	SENT_81	[p6l2045t1235r2073b1272],
5	RT	NN	O	rt	dep	1	SENT_81	[p6l2082t1235r2139b1272],

1	T	NN	O	t	_	0	SENT_82	[p6l1928t1288r2022b1312],

1	Table	NNP	O	Table	_	0	SENT_83	[p6l19t1387r106b1414],
2	1	CD	NUMBER	1	num	6	SENT_83	[p6l115t1389r127b1414],
3	Current	JJ	O	current	amod	6	SENT_83	[p6l157t1388r279b1414],
4	antiobesity	JJ	O	antiobesity	amod	6	SENT_83	[p6l286t1387r468b1422],
5	medications	NNS	O	medication	nn	6	SENT_83	[p6l476t1387r672b1414],
6	Mechanism	NN	O	mechanism	dep	1	SENT_83	[p6l21t1447r183b1472],
7	of	IN	O	of	_	0	SENT_83	[p6l191t1447r221b1472],
8	action	NN	O	action	nn	10	SENT_83	[p6l226t1448r314b1472],
9	Drug	NN	O	drug	nn	10	SENT_83	[p6l485t1448r554b1479],
10	Effects	NNS	O	effect	nn	17	SENT_83	[p6l883t1447r976b1472],
11	and	CC	O	and	_	0	SENT_83	[p6l984t1447r1036b1472],
12	safety	NN	O	safety	nn	13	SENT_83	[p6l1045t1447r1131b1479],
13	concerns	NNS	O	concern	nn	17	SENT_83	[p6l1137t1454r1264b1472],
14	Efficacy	NNP	O	Efficacy	nn	17	SENT_83	[p6l1631t1447r1740b1479],
15	Status	NNP	O	Status	nn	17	SENT_83	[p6l1968t1448r2056b1472],
16	Appetite	NN	O	appetite	nn	17	SENT_83	[p6l20t1507r139b1537],
17	suppressant	NN	O	suppressant	prep_of	6	SENT_83	[p6l147t1510r321b1537],
18	.	.	O	.	_	0	SENT_83	[p6l147t1510r321b1537],

1	Phentermine	NNP	O	Phentermine	nn	3	SENT_84	[p6l411t1506r588b1530],
2	Appetite	NNP	O	Appetite	nn	3	SENT_84	[p6l655t1507r778b1537],
3	suppression	NN	O	suppression	dep	9	SENT_84	[p6l787t1507r957b1537],
4	and	CC	O	and	_	0	SENT_84	[p6l966t1506r1018b1530],
5	weight	NN	O	weight	nn	8	SENT_84	[p6l1027t1506r1125b1537],
6	loss	NN	O	loss	nn	8	SENT_84	[p6l1134t1506r1185b1530],
7	Weight	NNP	O	Weight	nn	8	SENT_84	[p6l1509t1506r1608b1537],
8	loss	NN	O	loss	dep	9	SENT_84	[p6l1616t1506r1665b1530],
9	greater	JJR	O	greater	ccomp	30	SENT_84	[p6l1673t1510r1772b1537],
10	than	IN	O	than	mark	14	SENT_84	[p6l1778t1506r1840b1530],
11	Approved	VBN	O	approve	csubj	14	SENT_84	[p6l1885t1506r2021b1537],
12	by	IN	O	by	_	0	SENT_84	[p6l2030t1506r2062b1537],
13	the	DT	O	the	prep_by	11	SENT_84	[p6l2069t1506r2114b1530],
14	Stimulates	VBZ	O	stimulate	ccomp	9	SENT_84	[p6l20t1545r164b1570],
15	anorexic	JJ	O	anorexic	amod	17	SENT_84	[p6l172t1546r288b1570],
16	Side	NN	O	side	nn	17	SENT_84	[p6l656t1545r713b1569],
17	effects	NNS	O	effect	nsubj	18	SENT_84	[p6l721t1545r811b1569],
18	include	VBP	O	include	ccomp	14	SENT_84	[p6l819t1545r920b1569],
19	dizziness	NN	O	dizziness	dobj	18	SENT_84	[p6l927t1545r1056b1573],
20	,	,	O	,	_	0	SENT_84	[p6l927t1545r1056b1573],
21	dry	JJ	O	dry	dep	22	SENT_84	[p6l1064t1545r1109b1576],
22	mouth	NN	O	mouth	amod	19	SENT_84	[p6l1117t1545r1215b1573],
23	,	,	O	,	_	0	SENT_84	[p6l1117t1545r1215b1573],
24	difﬁculty	JJ	O	difﬁculty	amod	25	SENT_84	[p6l1222t1545r1343b1576],
25	placebo	NN	O	placebo	nsubj	30	SENT_84	[p6l1511t1545r1619b1576],
26	was	VBD	O	be	cop	30	SENT_84	[p6l1626t1552r1678b1569],
27	3.6	CD	NUMBER	3.6	num	30	SENT_84	[p6l1686t1547r1725b1569],
28	kg	NN	O	kg	nn	30	SENT_84	[p6l1733t1545r1763b1576],
29	(	NN	O	(	nn	30	SENT_84	[p6l1772t1545r1813b1573],
30	CI	NN	O	ci	_	0	SENT_84	[p6l1772t1545r1813b1573],
31	:	:	O	:	_	0	SENT_84	[p6l1772t1545r1813b1573],
32	FDA	NNP	ORGANIZATION	FDA	dep	30	SENT_84	[p6l1887t1546r1942b1569],
33	in	IN	O	in	_	0	SENT_84	[p6l1951t1546r1973b1569],
34	1959	CD	DATE	1959	num	35	SENT_84	[p6l1984t1547r2048b1569],
35	signaling	NN	O	signaling	prep_in	32	SENT_84	[p6l20t1584r141b1616],
36	in	IN	O	in	_	0	SENT_84	[p6l150t1585r172b1609],
37	hypothalamus	NN	O	hypothalamus	prep_in	35	SENT_84	[p6l181t1584r374b1616],
38	in	IN	O	in	_	0	SENT_84	[p6l656t1585r679b1609],
39	sleeping	VBG	O	sleep	prep_in	37	SENT_84	[p6l688t1584r810b1616],
40	,	,	O	,	_	0	SENT_84	[p6l688t1584r810b1616],
41	irritability	NN	O	irritability	dep	30	SENT_84	[p6l819t1584r956b1616],
42	,	,	O	,	_	0	SENT_84	[p6l819t1584r956b1616],
43	nausea	NN	O	nausea	appos	41	SENT_84	[p6l964t1591r1067b1613],
44	,	,	O	,	_	0	SENT_84	[p6l964t1591r1067b1613],
45	vomiting	VBG	O	vomit	dep	30	SENT_84	[p6l1074t1585r1205b1616],
46	,	,	O	,	_	0	SENT_84	[p6l1074t1585r1205b1616],
47	diarrhea	NN	O	diarrhea	appos	45	SENT_84	[p6l1212t1584r1333b1613],
48	,	,	O	,	_	0	SENT_84	[p6l1212t1584r1333b1613],
49	or	CC	O	or	_	0	SENT_84	[p6l1341t1591r1369b1609],
50	0.6-6	CD	NUMBER	0.6-6	number	51	SENT_84	[p6l1510t1586r1607b1609],
51	.0	CD	NUMBER	.0	num	53	SENT_84	[p6l1510t1586r1607b1609],
52	kg	NN	O	kg	nn	53	SENT_84	[p6l1614t1584r1653b1616],
53	)	NN	O	)	conj_or	30	SENT_84	[p6l1614t1584r1653b1616],
54	or	CC	O	or	_	0	SENT_84	[p6l20t1631r48b1648],
55	dopamine	NN	O	dopamine	nn	57	SENT_84	[p6l55t1624r196b1655],
56	receptor	NN	O	receptor	nn	57	SENT_84	[p6l205t1628r320b1655],
57	constipation	NN	O	constipation	conj_or	53	SENT_84	[p6l655t1624r894b1654],
58	.	.	O	.	_	0	SENT_84	[p6l655t1624r894b1654],

1	This	DT	O	this	det	2	SENT_85	[p6l655t1624r894b1654],
2	drug	NN	O	drug	nsubj	3	SENT_85	[p6l902t1624r966b1655],
3	has	VBZ	O	have	_	0	SENT_85	[p6l976t1624r1020b1648],
4	withdrawal	NN	O	withdrawal	nn	5	SENT_85	[p6l1028t1624r1180b1648],
5	symptoms	NNS	O	symptom	dobj	3	SENT_85	[p6l1189t1627r1333b1655],
6	in	IN	O	in	_	0	SENT_85	[p6l21t1664r43b1687],
7	the	DT	O	the	det	8	SENT_85	[p6l51t1663r96b1687],
8	hippocampus	NN	O	hippocampus	prep_in	5	SENT_85	[p6l105t1663r300b1694],
9	.	.	O	.	_	0	SENT_85	[p6l105t1663r300b1694],

1	Sympathomimetic	JJ	MISC	sympathomimetic	amod	2	SENT_86	[p6l20t1702r274b1734],
2	agent	NN	O	agent	_	0	SENT_86	[p6l282t1706r361b1733],

1	Amphetamine	NN	O	amphetamine	_	0	SENT_87	[p6l409t1681r604b1712],

1	Anorexia	NN	O	anorexia	_	0	SENT_88	[p6l655t1683r776b1706],
2	and	CC	O	and	_	0	SENT_88	[p6l785t1681r835b1706],
3	weight	NN	O	weight	nn	4	SENT_88	[p6l843t1681r939b1713],
4	loss	NN	O	loss	conj_and	1	SENT_88	[p6l947t1681r997b1706],

1	Weight	NNP	O	Weight	_	0	SENT_89	[p6l1509t1681r1608b1712],
2	loss	NN	O	loss	dep	1	SENT_89	[p6l1616t1681r1665b1706],
3	greater	JJR	O	greater	amod	2	SENT_89	[p6l1673t1685r1772b1712],
4	than	IN	O	than	prep	3	SENT_89	[p6l1778t1681r1840b1706],

1	Off-label	JJ	O	off-label	amod	2	SENT_90	[p6l1886t1681r2003b1706],
2	usage	NN	O	usage	nsubj	24	SENT_90	[p6l2013t1688r2100b1712],
3	;	:	O	;	_	0	SENT_90	[p6l2013t1688r2100b1712],
4	Similar	JJ	O	similar	nsubj	9	SENT_90	[p6l20t1742r110b1767],
5	to	TO	O	to	_	0	SENT_90	[p6l117t1746r144b1767],
6	norepinephrine	NN	O	norepinephrine	nn	8	SENT_90	[p6l153t1742r368b1773],
7	Side	NN	O	side	nn	8	SENT_90	[p6l656t1721r713b1746],
8	effects	NNS	O	effect	prep_to	4	SENT_90	[p6l721t1721r811b1746],
9	include	VBP	O	include	rcmod	2	SENT_90	[p6l819t1721r920b1746],
10	nervousness	NN	O	nervousness	dep	18	SENT_90	[p6l928t1728r1106b1749],
11	,	,	O	,	_	0	SENT_90	[p6l928t1728r1106b1749],
12	restlessness	NN	O	restlessness	appos	10	SENT_90	[p6l1115t1721r1282b1749],
13	,	,	O	,	_	0	SENT_90	[p6l1115t1721r1282b1749],
14	excitability	NN	O	excitability	appos	10	SENT_90	[p6l1290t1721r1444b1752],
15	,	,	O	,	_	0	SENT_90	[p6l1290t1721r1444b1752],
16	placebo	NN	O	placebo	appos	10	SENT_90	[p6l1511t1721r1619b1752],
17	was	VBD	O	be	cop	18	SENT_90	[p6l1626t1728r1678b1745],
18	<	JJR	O	<	dep	9	SENT_90	[p6l1687t1723r1716b1745],
19	1	CD	NUMBER	1	num	22	SENT_90	[p6l1687t1723r1716b1745],
20	kg	NN	O	kg	nn	22	SENT_90	[p6l1728t1721r1758b1752],
21	(	NN	O	(	nn	22	SENT_90	[p6l1768t1721r1809b1749],
22	CI	NN	O	ci	nsubj	18	SENT_90	[p6l1768t1721r1809b1749],
23	:	:	O	:	_	0	SENT_90	[p6l1768t1721r1809b1749],
24	approved	VBN	O	approve	_	0	SENT_90	[p6l1886t1721r2016b1752],
25	for	IN	O	for	dep	24	SENT_90	[p6l2024t1721r2062b1745],
26	with	IN	O	with	_	0	SENT_90	[p6l20t1782r79b1806],
27	Central	NNP	O	Central	nn	29	SENT_90	[p6l88t1782r180b1806],
28	nervous	JJ	O	nervous	amod	29	SENT_90	[p6l190t1789r299b1806],
29	dizziness	NN	O	dizziness	prep_with	24	SENT_90	[p6l655t1761r781b1789],
30	,	,	O	,	_	0	SENT_90	[p6l655t1761r781b1789],
31	headache	NN	O	headache	appos	29	SENT_90	[p6l790t1761r927b1789],
32	,	,	O	,	_	0	SENT_90	[p6l790t1761r927b1789],
33	fear	NN	O	fear	appos	29	SENT_90	[p6l933t1760r988b1789],
34	,	,	O	,	_	0	SENT_90	[p6l933t1760r988b1789],
35	anxiety	NN	O	anxiety	appos	29	SENT_90	[p6l995t1762r1098b1792],
36	,	,	O	,	_	0	SENT_90	[p6l995t1762r1098b1792],
37	and	CC	O	and	_	0	SENT_90	[p6l1105t1761r1155b1785],
38	tremor	NN	O	tremor	appos	29	SENT_90	[p6l1162t1764r1259b1785],
39	.	.	O	.	_	0	SENT_90	[p6l1162t1764r1259b1785],

1	Blood	NN	O	blood	nn	2	SENT_91	[p6l1268t1761r1343b1785],
2	pressure	NN	O	pressure	nsubj	13	SENT_91	[p6l1352t1768r1465b1791],
3	0.5-1	CD	NUMBER	0.5-1	num	4	SENT_91	[p6l1510t1762r1607b1785],
4	.6	CD	NUMBER	.6	dep	2	SENT_91	[p6l1510t1762r1607b1785],
5	kg	NN	O	kg	nn	8	SENT_91	[p6l1614t1760r1653b1792],
6	)	CD	NUMBER	)	num	8	SENT_91	[p6l1614t1760r1653b1792],
7	attention-deficit	NN	O	attention-deficit	nn	8	SENT_91	[p6l1886t1760r2110b1785],
8	. . .	NN	O	. . .	dep	2	SENT_91	[p6l346t1822r350b1826],[p6l145t1822r149b1826],
9	and	CC	O	and	_	0	SENT_91	[p6l655t1800r706b1825],
10	heart	NN	O	heart	nn	11	SENT_91	[p6l716t1800r787b1825],
11	rate	NN	O	rate	conj_and	8	SENT_91	[p6l795t1804r846b1825],
12	may	MD	O	may	aux	13	SENT_91	[p6l855t1807r912b1831],
13	increase	VB	O	increase	_	0	SENT_91	[p6l920t1801r1038b1825],
14	.	.	O	.	_	0	SENT_91	[p6l920t1801r1038b1825],

1	Chronic	JJ	O	chronic	amod	2	SENT_92	[p6l1046t1800r1152b1825],
2	use	NN	O	use	nsubj	4	SENT_92	[p6l1160t1807r1205b1825],
3	may	MD	O	may	aux	4	SENT_92	[p6l1214t1807r1271b1831],
4	lead	VB	O	lead	_	0	SENT_92	[p6l1279t1800r1334b1825],
5	to	TO	O	to	_	0	SENT_92	[p6l1343t1804r1370b1825],
6	hyperactivity	NN	O	hyperactivity	prep_to	4	SENT_92	[p6l1887t1800r2066b1831],

1	System	NNP	O	System	_	0	SENT_93	[p6l20t1825r113b1852],
2	snmulatory	JJ	O	snmulatory	amod	4	SENT_93	[p6l121t1821r275b1853],
3	actmty	NN	O	actmty	nn	4	SENT_93	[p6l281t1825r379b1852],
4	dependence	NN	O	dependence	dep	1	SENT_93	[p6l655t1840r835b1870],
5	.	.	O	.	_	0	SENT_93	[p6l655t1840r835b1870],

1	These	DT	O	these	det	2	SENT_94	[p6l840t1840r921b1864],
2	drugs	NNS	O	drug	nsubj	3	SENT_94	[p6l928t1840r1006b1871],
3	have	VBP	O	have	_	0	SENT_94	[p6l1015t1840r1079b1864],
4	withdrawal	NN	O	withdrawal	nn	6	SENT_94	[p6l1086t1840r1239b1864],
5	symptoms	NNS	O	symptom	nn	6	SENT_94	[p6l1248t1844r1391b1871],
6	disorder	NN	O	disorder	dobj	3	SENT_94	[p6l1886t1840r1999b1864],

1	Serotonin	NN	MISC	serotonin	dep	11	SENT_95	[p6l20t1900r161b1928],
2	,	,	O	,	_	0	SENT_95	[p6l20t1900r161b1928],
3	dopamine	NN	O	dopamine	conj_and	1	SENT_95	[p6l169t1899r316b1931],
4	,	,	O	,	_	0	SENT_95	[p6l169t1899r316b1931],
5	and	CC	O	and	_	0	SENT_95	[p6l324t1899r374b1924],
6	Lorcaserin	NNP	O	Lorcaserin	nn	7	SENT_95	[p6l411t1901r549b1924],
7	Limited	NNP	O	Limited	conj_and	1	SENT_95	[p6l657t1899r753b1924],
8	weight-loss	JJ	O	weight-loss	amod	9	SENT_95	[p6l759t1899r909b1931],
9	efﬁcacyand	NN	O	efﬁcacyand	dep	11	SENT_95	[p6l915t1899r1068b1931],
10	possible	JJ	O	possible	amod	11	SENT_95	[p6l1076t1899r1182b1931],
11	increase	NN	O	increase	dep	18	SENT_95	[p6l1189t1901r1295b1924],
12	in	IN	O	in	_	0	SENT_95	[p6l1302t1901r1323b1924],
13	cancer	NN	O	cancer	nn	14	SENT_95	[p6l1330t1907r1417b1924],
14	risk	NN	O	risk	prep_in	11	SENT_95	[p6l1423t1899r1466b1924],
15	Mean	NN	O	mean	nn	18	SENT_95	[p6l1510t1900r1585b1924],
16	body	NN	O	body	nn	18	SENT_95	[p6l1595t1899r1664b1931],
17	weight	NN	O	weight	nn	18	SENT_95	[p6l1670t1899r1766b1931],
18	loss	NN	O	loss	dep	30	SENT_95	[p6l1774t1899r1831b1924],
19	:	:	O	:	_	0	SENT_95	[p6l1774t1899r1831b1924],
20	Approved	VBN	O	approve	dep	30	SENT_95	[p6l1885t1899r2021b1930],
21	by	IN	O	by	_	0	SENT_95	[p6l2030t1899r2063b1931],
22	the	DT	O	the	det	24	SENT_95	[p6l2069t1899r2114b1924],
23	norepinephrine	NN	O	norepinephrine	nn	24	SENT_95	[p6l21t1938r236b1969],
24	reuptake	NN	O	reuptake	prep_by	20	SENT_95	[p6l244t1938r365b1969],
25	(	CD	NUMBER	(	num	29	SENT_95	[p6l411t1938r511b1969],
26	Belviq	NNP	O	Belviq	nn	29	SENT_95	[p6l411t1938r511b1969],
27	)	CD	NUMBER	)	num	29	SENT_95	[p6l411t1938r511b1969],
28	Side	NN	O	side	nn	29	SENT_95	[p6l656t1938r713b1963],
29	effects	NNS	O	effect	nsubj	30	SENT_95	[p6l721t1938r811b1963],
30	include	VBP	O	include	_	0	SENT_95	[p6l819t1938r920b1963],
31	headache	NN	O	headache	nn	39	SENT_95	[p6l928t1938r1068b1967],
32	,	,	O	,	_	0	SENT_95	[p6l928t1938r1068b1967],
33	infection	NN	O	infection	dep	39	SENT_95	[p6l1076t1938r1204b1967],
34	,	,	O	,	_	0	SENT_95	[p6l1076t1938r1204b1967],
35	sinusitis	NN	O	sinusitis	dep	39	SENT_95	[p6l1212t1940r1327b1967],
36	,	,	O	,	_	0	SENT_95	[p6l1212t1940r1327b1967],
37	nausea	NN	O	nausea	dep	39	SENT_95	[p6l1336t1946r1438b1967],
38	,	,	O	,	_	0	SENT_95	[p6l1336t1946r1438b1967],
39	lorcaserin	NN	O	lorcaserin	dobj	30	SENT_95	[p6l1511t1938r1642b1963],
40	5.8	CD	NUMBER	5.8	number	41	SENT_95	[p6l1651t1940r1689b1963],
41	1	CD	NUMBER	1	dep	39	SENT_95	[p6l1696t1943r1713b1962],
42	0.2	CD	NUMBER	0.2	num	43	SENT_95	[p6l1719t1940r1758b1963],
43	kg	NN	O	kg	dep	41	SENT_95	[p6l1766t1938r1804b1969],
44	;	:	O	;	_	0	SENT_95	[p6l1766t1938r1804b1969],
45	FDA	NNP	ORGANIZATION	FDA	dep	39	SENT_95	[p6l1887t1939r1942b1963],
46	in	IN	O	in	_	0	SENT_95	[p6l1951t1939r1973b1962],
47	2012	CD	DATE	2012	num	48	SENT_95	[p6l1982t1940r2047b1963],
48	inhibitor	NN	O	inhibitor	prep_in	45	SENT_95	[p6l21t1977r138b2002],
49	that	WDT	O	that	nsubj	50	SENT_95	[p6l145t1977r200b2002],
50	potentiates	VBZ	O	potentiate	rcmod	48	SENT_95	[p6l208t1978r364b2008],
51	the	DT	O	the	det	53	SENT_95	[p6l19t2017r64b2042],
52	neurotransmitter	NN	O	neurotransmitter	nn	53	SENT_95	[p6l73t2018r308b2042],
53	activity	NN	O	activity	dobj	50	SENT_95	[p6l20t2059r120b2089],
54	in	IN	O	in	_	0	SENT_95	[p6l128t2059r150b2082],
55	the	DT	O	the	det	57	SENT_95	[p6l158t2058r203b2082],
56	central	JJ	O	central	amod	57	SENT_95	[p6l211t2058r303b2082],
57	depression	NN	O	depression	prep_in	50	SENT_95	[p6l655t1977r808b2008],
58	,	,	O	,	_	0	SENT_95	[p6l655t1977r808b2008],
59	anxiety	NN	O	anxiety	conj_and	57	SENT_95	[p6l815t1978r916b2009],
60	,	,	O	,	_	0	SENT_95	[p6l815t1978r916b2009],
61	and	CC	O	and	_	0	SENT_95	[p6l923t1977r972b2002],
62	suicidal	JJ	O	suicidal	amod	63	SENT_95	[p6l980t1977r1078b2002],
63	thoughts	NNS	O	thought	conj_and	57	SENT_95	[p6l1085t1977r1214b2009],
64	.	.	O	.	_	0	SENT_95	[p6l1085t1977r1214b2009],

1	Possible	JJ	O	possible	amod	2	SENT_96	[p6l1222t1977r1328b2002],
2	concerns	NNS	O	concern	_	0	SENT_96	[p6l1335t1984r1455b2002],
3	of	IN	O	of	_	0	SENT_96	[p6l655t2017r684b2042],
4	cancer	NN	O	cancer	nn	6	SENT_96	[p6l689t2024r780b2042],
5	risk	NN	O	risk	nn	6	SENT_96	[p6l788t2017r834b2042],
6	placebo	NN	O	placebo	prep_of	2	SENT_96	[p6l1511t1977r1619b2008],
7	2.2	CD	NUMBER	2.2	number	8	SENT_96	[p6l1627t1979r1665b2002],
8	1	CD	NUMBER	1	dep	2	SENT_96	[p6l1672t1981r1690b2002],
9	0.1	CD	NUMBER	0.1	num	10	SENT_96	[p6l1696t1979r1730b2002],
10	kg	NN	O	kg	dep	8	SENT_96	[p6l1744t1977r1774b2008],

1	Desvenlafaxine	NN	O	desvenlafaxine	_	0	SENT_97	[p6l411t2076r615b2101],

1	Anorexia	NN	O	anorexia	_	0	SENT_98	[p6l655t2077r784b2104],
2	,	,	O	,	_	0	SENT_98	[p6l655t2077r784b2104],
3	but	CC	O	but	_	0	SENT_98	[p6l793t2076r838b2101],
4	effect	NN	O	effect	nsubj	9	SENT_98	[p6l846t2076r923b2101],
5	on	IN	O	on	_	0	SENT_98	[p6l930t2083r964b2101],
6	body	NN	O	body	nn	7	SENT_98	[p6l974t2076r1043b2108],
7	weight	NN	O	weight	prep_on	4	SENT_98	[p6l1049t2076r1145b2107],
8	is	VBZ	O	be	cop	9	SENT_98	[p6l1153t2077r1171b2101],
9	unclear	JJ	O	unclear	conj_but	1	SENT_98	[p6l1180t2076r1281b2101],

1	Mean	NN	O	mean	nn	4	SENT_99	[p6l1510t2077r1585b2101],
2	body	NN	O	body	nn	4	SENT_99	[p6l1595t2076r1664b2108],
3	weight	NN	O	weight	nn	4	SENT_99	[p6l1670t2076r1766b2107],
4	loss	NN	O	loss	_	0	SENT_99	[p6l1774t2076r1824b2101],

1	Off	IN	O	off	dep	26	SENT_100	[p6l1886t2076r2003b2101],
2	—	CD	NUMBER	—	number	3	SENT_100	[p6l1886t2076r2003b2101],
3	|	CD	NUMBER	|	pobj	1	SENT_100	[p6l1886t2076r2003b2101],
4	abe	NN	O	abe	nn	6	SENT_100	[p6l1886t2076r2003b2101],
5	|	NN	O	|	nn	6	SENT_100	[p6l1886t2076r2003b2101],
6	usage	NN	O	usage	dep	3	SENT_100	[p6l2013t2083r2100b2107],
7	;	:	O	;	_	0	SENT_100	[p6l2013t2083r2100b2107],
8	nervous	JJ	O	nervous	amod	9	SENT_100	[p6l21t2104r131b2122],
9	system	NN	O	system	dep	3	SENT_100	[p6l139t2101r232b2129],
10	(	CD	NUMBER	(	num	14	SENT_100	[p6l410t2116r512b2147],
11	Pristiq	NNP	O	Pristiq	nn	14	SENT_100	[p6l410t2116r512b2147],
12	)	CD	NUMBER	)	num	14	SENT_100	[p6l410t2116r512b2147],
13	Vision	NNP	O	Vision	nn	14	SENT_100	[p6l654t2117r734b2140],
14	problems	NNS	O	problem	dep	9	SENT_100	[p6l743t2116r877b2147],
15	,	,	O	,	_	0	SENT_100	[p6l743t2116r877b2147],
16	headache	NN	O	headache	appos	14	SENT_100	[p6l885t2116r1022b2144],
17	,	,	O	,	_	0	SENT_100	[p6l885t2116r1022b2144],
18	low	JJ	O	low	amod	19	SENT_100	[p6l1030t2116r1077b2140],
19	libido	NN	O	libido	appos	14	SENT_100	[p6l1085t2116r1165b2144],
20	,	,	O	,	_	0	SENT_100	[p6l1085t2116r1165b2144],
21	dry	JJ	O	dry	amod	22	SENT_100	[p6l1172t2116r1217b2147],
22	mouth	NN	O	mouth	appos	14	SENT_100	[p6l1224t2116r1320b2144],
23	,	,	O	,	_	0	SENT_100	[p6l1224t2116r1320b2144],
24	dizziness	NN	O	dizziness	appos	14	SENT_100	[p6l1327t2116r1453b2144],
25	,	,	O	,	_	0	SENT_100	[p6l1327t2116r1453b2144],
26	greater	JJR	O	greater	_	0	SENT_100	[p6l1510t2120r1608b2147],
27	than	IN	O	than	mark	30	SENT_100	[p6l1615t2116r1676b2140],
28	placebo	NN	O	placebo	nsubjpass	30	SENT_100	[p6l1686t2116r1795b2147],
29	was	VBD	O	be	auxpass	30	SENT_100	[p6l1802t2123r1854b2140],
30	approved	VBN	O	approve	ccomp	26	SENT_100	[p6l1886t2116r2016b2147],
31	for	IN	O	for	_	0	SENT_100	[p6l2024t2115r2062b2140],
32	insomnia	NN	O	insomnia	prep_for	30	SENT_100	[p6l656t2156r788b2183],
33	,	,	O	,	_	0	SENT_100	[p6l656t2156r788b2183],
34	taste	NN	O	taste	nn	35	SENT_100	[p6l795t2159r862b2179],
35	problems	NNS	O	problem	appos	32	SENT_100	[p6l870t2155r1006b2186],
36	,	,	O	,	_	0	SENT_100	[p6l870t2155r1006b2186],
37	vomiting	VBG	O	vomit	appos	32	SENT_100	[p6l1013t2156r1144b2186],
38	,	,	O	,	_	0	SENT_100	[p6l1013t2156r1144b2186],
39	anxiety	NN	O	anxiety	appos	32	SENT_100	[p6l1152t2156r1257b2186],
40	,	,	O	,	_	0	SENT_100	[p6l1152t2156r1257b2186],
41	sexual	JJ	O	sexual	amod	46	SENT_100	[p6l1265t2155r1349b2179],
42	0.22-1	CD	NUMBER	0.22-1	tmod	41	SENT_100	[p6l1510t2157r1636b2179],
43	.41	CD	NUMBER	.41	num	46	SENT_100	[p6l1510t2157r1636b2179],
44	kg	NN	O	kg	nn	46	SENT_100	[p6l1649t2155r1679b2186],
45	depression	NN	O	depression	nn	46	SENT_100	[p6l1886t2155r2035b2186],
46	dysfunction	NN	O	dysfunction	appos	39	SENT_100	[p6l655t2194r820b2226],
47	,	,	O	,	_	0	SENT_100	[p6l655t2194r820b2226],
48	depression	NN	O	depression	appos	46	SENT_100	[p6l827t2194r979b2225],
49	,	,	O	,	_	0	SENT_100	[p6l827t2194r979b2225],
50	high	JJ	O	high	amod	52	SENT_100	[p6l987t2194r1045b2226],
51	blood	NN	O	blood	nn	52	SENT_100	[p6l1054t2194r1130b2219],
52	pressure	NN	O	pressure	appos	46	SENT_100	[p6l1138t2201r1256b2225],
53	,	,	O	,	_	0	SENT_100	[p6l1138t2201r1256b2225],
54	stomach	NN	O	stomach	nn	55	SENT_100	[p6l1263t2194r1376b2219],
55	ache	NN	O	ache	appos	46	SENT_100	[p6l1384t2194r1453b2223],
56	,	,	O	,	_	0	SENT_100	[p6l1384t2194r1453b2223],
57	numbness	NN	O	numbness	appos	46	SENT_100	[p6l656t2233r797b2258],
58	and	CC	O	and	_	0	SENT_100	[p6l805t2233r855b2258],
59	tingling	JJ	O	tingling	appos	46	SENT_100	[p6l863t2233r975b2265],
60	,	,	O	,	_	0	SENT_100	[p6l863t2233r975b2265],
61	fatigue	NN	O	fatigue	appos	46	SENT_100	[p6l982t2233r1084b2265],
62	,	,	O	,	_	0	SENT_100	[p6l982t2233r1084b2265],
63	and	CC	O	and	_	0	SENT_100	[p6l1091t2233r1141b2258],
64	involuntary	JJ	O	involuntary	appos	32	SENT_100	[p6l1150t2233r1306b2265],
65	quivering	VBG	O	quiver	amod	64	SENT_100	[p6l1312t2234r1441b2265],

1	Sibutramine	NNP	O	Sibutramine	nn	4	SENT_101	[p6l410t2309r578b2334],
2	Limited	NNP	O	Limited	nn	4	SENT_101	[p6l657t2309r758b2334],
3	weight-loss	JJ	O	weight-loss	amod	4	SENT_101	[p6l766t2309r924b2341],
4	efficacy	NN	O	efficacy	nsubj	5	SENT_101	[p6l932t2309r1037b2341],
5	Approved	VBN	O	approve	_	0	SENT_101	[p6l1885t2309r2022b2341],
6	by	IN	O	by	_	0	SENT_101	[p6l2032t2309r2064b2341],
7	the	DT	O	the	det	8	SENT_101	[p6l2071t2309r2116b2334],
8	(	CD	NUMBER	(	prep_by	5	SENT_101	[p6l410t2348r531b2377],
9	Meridia	NNP	ORGANIZATION	Meridia	dobj	5	SENT_101	[p6l410t2348r531b2377],
10	)	CD	NUMBER	)	num	9	SENT_101	[p6l410t2348r531b2377],
11	Increased	VBN	O	increase	dep	9	SENT_101	[p6l657t2348r786b2373],
12	riskfor	NN	O	riskfor	iobj	11	SENT_101	[p6l796t2348r886b2373],
13	cardiovascular	JJ	O	cardiovascular	amod	14	SENT_101	[p6l892t2348r1091b2373],
14	events	NNS	O	event	dobj	11	SENT_101	[p6l1098t2352r1187b2373],
15	and	CC	O	and	_	0	SENT_101	[p6l1195t2348r1245b2373],
16	stroke	NN	O	stroke	nn	18	SENT_101	[p6l1254t2348r1337b2373],
17	FDA	NNP	ORGANIZATION	FDA	nn	18	SENT_101	[p6l1887t2349r1943b2373],
18	approval	NN	O	approval	dobj	11	SENT_101	[p6l1950t2348r2071b2379],
19	in	IN	O	in	_	0	SENT_101	[p6l1886t2389r1909b2413],
20	1997	CD	DATE	1997	prep_in	14	SENT_101	[p6l1920t2390r1985b2413],
21	but	CC	O	but	_	0	SENT_101	[p6l1994t2388r2040b2413],
22	withdrawn	VBN	O	withdraw	dep	9	SENT_101	[p6l1885t2428r2034b2453],
23	in	IN	O	in	_	0	SENT_101	[p6l2044t2429r2067b2453],
24	2010	CD	DATE	2010	prep_in	22	SENT_101	[p6l1886t2470r1953b2493],
25	due	JJ	O	due	_	0	SENT_101	[p6l1961t2468r2013b2493],
26	to	TO	O	to	_	0	SENT_101	[p6l2020t2472r2048b2493],
27	cardiovascular	JJ	O	cardiovascular	amod	28	SENT_101	[p6l1886t2508r2086b2532],
28	effects	NNS	O	effect	prep_due_to	24	SENT_101	[p6l1886t2547r1977b2572],

1	Inhibits	VBZ	O	inhibit	_	0	SENT_102	[p6l21t2607r122b2632],
2	the	DT	O	the	det	8	SENT_102	[p6l129t2607r174b2632],
3	neuronal	JJ	O	neuronal	amod	8	SENT_102	[p6l183t2607r303b2632],
4	Bupropion	NNP	O	Bupropion	nn	8	SENT_102	[p6l411t2608r554b2638],
5	Modest	NNP	O	Modest	nn	8	SENT_102	[p6l656t2606r759b2631],
6	weight	NN	O	weight	nn	8	SENT_102	[p6l766t2606r861b2638],
7	loss	NN	O	loss	nn	8	SENT_102	[p6l870t2606r919b2631],
8	%	NN	O	%	iobj	1	SENT_102	[p6l1509t2606r1639b2638],
9	Weight	NNP	O	Weight	nn	10	SENT_102	[p6l1509t2606r1639b2638],
10	loss	NN	O	loss	dobj	1	SENT_102	[p6l1647t2606r1696b2631],
11	greater	JJR	O	greater	amod	13	SENT_102	[p6l1704t2610r1803b2638],
12	Off-label	NN	MISC	off-label	nn	13	SENT_102	[p6l1886t2606r2003b2631],
13	usage	NN	O	usage	dep	10	SENT_102	[p6l2013t2614r2100b2638],
14	;	:	O	;	_	0	SENT_102	[p6l2013t2614r2100b2638],
15	uptake	NN	O	uptake	nn	16	SENT_102	[p6l21t2646r115b2676],
16	ofdopamine	NN	O	ofdopamine	dep	10	SENT_102	[p6l123t2645r304b2676],
17	,	,	O	,	_	0	SENT_102	[p6l123t2645r304b2676],
18	(	CD	NUMBER	(	appos	16	SENT_102	[p6l410t2646r571b2674],
19	We	PRP	O	we	nsubj	20	SENT_102	[p6l410t2646r571b2674],
20	|	VBP	O	|	rcmod	18	SENT_102	[p6l410t2646r571b2674],
21	|	JJ	O	|	amod	22	SENT_102	[p6l410t2646r571b2674],
22	butrin	NN	O	butrin	dobj	20	SENT_102	[p6l410t2646r571b2674],
23	,	,	O	,	_	0	SENT_102	[p6l410t2646r571b2674],
24	Nausea	NN	MISC	nausea	nn	29	SENT_102	[p6l657t2647r763b2674],
25	,	,	O	,	_	0	SENT_102	[p6l657t2647r763b2674],
26	vomiting	VBG	O	vomit	amod	29	SENT_102	[p6l770t2647r900b2677],
27	,	,	O	,	_	0	SENT_102	[p6l770t2647r900b2677],
28	dry	JJ	O	dry	amod	29	SENT_102	[p6l908t2645r953b2677],
29	mouth	NN	O	mouth	appos	22	SENT_102	[p6l961t2645r1059b2674],
30	,	,	O	,	_	0	SENT_102	[p6l961t2645r1059b2674],
31	headache	NN	O	headache	nsubj	1	SENT_102	[p6l1068t2645r1207b2674],
32	,	,	O	,	_	0	SENT_102	[p6l1068t2645r1207b2674],
33	constipation	NN	O	constipation	appos	31	SENT_102	[p6l1215t2647r1394b2676],
34	,	,	O	,	_	0	SENT_102	[p6l1215t2647r1394b2676],
35	than	IN	O	than	_	0	SENT_102	[p6l1509t2645r1571b2670],
36	placebo	NN	O	placebo	prep_than	33	SENT_102	[p6l1580t2645r1696b2676],
37	:	:	O	:	_	0	SENT_102	[p6l1580t2645r1696b2676],
38	bupropion	NN	O	bupropion	nsubj	39	SENT_102	[p6l1705t2645r1849b2676],
39	approved	VBD	O	approve	dep	1	SENT_102	[p6l1886t2645r2016b2676],
40	for	IN	O	for	_	0	SENT_102	[p6l2024t2645r2062b2670],
41	norepinephrine	NN	O	norepinephrine	prep_for	39	SENT_102	[p6l21t2684r242b2715],
42	,	,	O	,	_	0	SENT_102	[p6l21t2684r242b2715],
43	and	CC	O	and	_	0	SENT_102	[p6l250t2684r300b2709],
44	Zyban	NNP	MISC	Zyban	nsubj	46	SENT_102	[p6l409t2684r504b2716],
45	)	CD	NUMBER	)	num	44	SENT_102	[p6l409t2684r504b2716],
46	increased	VBD	O	increase	dep	1	SENT_102	[p6l656t2684r786b2709],
47	sweating	NN	O	sweating	nsubj	55	SENT_102	[p6l795t2685r994b2716],
48	,	,	O	,	_	0	SENT_102	[p6l795t2685r994b2716],
49	joint	JJ	O	joint	amod	50	SENT_102	[p6l795t2685r994b2716],
50	aches	NNS	O	ache	appos	47	SENT_102	[p6l1002t2684r1086b2713],
51	,	,	O	,	_	0	SENT_102	[p6l1002t2684r1086b2713],
52	sore	JJ	O	sore	amod	53	SENT_102	[p6l1093t2691r1150b2709],
53	throat	NN	O	throat	appos	50	SENT_102	[p6l1157t2684r1248b2713],
54	,	,	O	,	_	0	SENT_102	[p6l1157t2684r1248b2713],
55	blurred	VBD	O	blur	ccomp	46	SENT_102	[p6l1257t2684r1355b2709],
56	SR	JJ	O	sr	amod	57	SENT_102	[p6l1510t2685r1542b2709],
57	400	CD	NUMBER	400	nsubj	90	SENT_102	[p6l1549t2686r1599b2709],
58	mg/day	JJ	O	mg/day	amod	63	SENT_102	[p6l1606t2684r1712b2716],
59	5.1	CD	PERCENT	5.1	number	60	SENT_102	[p6l1719t2686r1785b2709],
60	%	NN	PERCENT	%	amod	63	SENT_102	[p6l1719t2686r1785b2709],
61	depression	NN	O	depression	nn	63	SENT_102	[p6l1886t2684r2035b2715],
62	serotonin	NN	O	serotonin	nn	63	SENT_102	[p6l20t2724r150b2748],
63	vision	NN	O	vision	dep	57	SENT_102	[p6l655t2724r742b2751],
64	,	,	O	,	_	0	SENT_102	[p6l655t2724r742b2751],
65	strange	JJ	O	strange	amod	66	SENT_102	[p6l750t2727r853b2754],
66	taste	NN	O	taste	conj_or	57	SENT_102	[p6l859t2727r926b2748],
67	in	IN	O	in	_	0	SENT_102	[p6l934t2724r957b2747],
68	the	DT	O	the	det	69	SENT_102	[p6l965t2723r1010b2748],
69	mouth	NN	O	mouth	prep_in	66	SENT_102	[p6l1019t2723r1116b2751],
70	,	,	O	,	_	0	SENT_102	[p6l1019t2723r1116b2751],
71	agitation	NN	O	agitation	conj_or	57	SENT_102	[p6l1124t2724r1246b2754],
72	and	CC	O	and	_	0	SENT_102	[p6l1255t2723r1305b2748],
73	insomnia	NN	O	insomnia	conj_or	57	SENT_102	[p6l1314t2724r1447b2751],
74	,	,	O	,	_	0	SENT_102	[p6l1314t2724r1447b2751],
75	(	CD	NUMBER	(	num	76	SENT_102	[p6l1510t2724r1551b2751],
76	CI	NN	O	ci	appos	71	SENT_102	[p6l1510t2724r1551b2751],
77	:	:	O	:	_	0	SENT_102	[p6l1510t2724r1551b2751],
78	6.9	CD	PERCENT	6.9	number	79	SENT_102	[p6l1558t2724r1698b2751],
79	—	CD	PERCENT	—	dep	71	SENT_102	[p6l1558t2724r1698b2751],
80	3.2	CD	PERCENT	3.2	num	81	SENT_102	[p6l1558t2724r1698b2751],
81	%	NN	PERCENT	%	dep	79	SENT_102	[p6l1558t2724r1698b2751],
82	)	CD	NUMBER	)	dep	79	SENT_102	[p6l1558t2724r1698b2751],
83	;	:	O	;	_	0	SENT_102	[p6l1558t2724r1698b2751],
84	bupropion	NN	O	bupropion	dep	71	SENT_102	[p6l1707t2723r1852b2754],
85	tremor	NN	O	tremor	dep	84	SENT_102	[p6l655t2766r754b2791],
86	,	,	O	,	_	0	SENT_102	[p6l655t2766r754b2791],
87	or	CC	O	or	_	0	SENT_102	[p6l762t2769r789b2787],
88	dizziness	NN	O	dizziness	conj_or	57	SENT_102	[p6l796t2762r919b2787],
89	may	MD	O	may	aux	90	SENT_102	[p6l928t2769r985b2794],
90	occur	VB	O	occur	ccomp	55	SENT_102	[p6l992t2769r1072b2787],
91	.	.	O	.	_	0	SENT_102	[p6l992t2769r1072b2787],

1	Rare	JJ	O	rare	amod	3	SENT_103	[p6l1081t2763r1139b2787],
2	side	JJ	O	side	amod	3	SENT_103	[p6l1147t2762r1201b2787],
3	effects	NNS	O	effect	nsubj	4	SENT_103	[p6l1209t2762r1299b2787],
4	include	VBP	O	include	_	0	SENT_103	[p6l1308t2762r1408b2787],
5	SR	JJ	O	sr	amod	11	SENT_103	[p6l1510t2763r1542b2787],
6	300	CD	NUMBER	300	num	11	SENT_103	[p6l1550t2764r1599b2787],
7	mg/day	JJ	O	mg/day	amod	11	SENT_103	[p6l1606t2762r1712b2794],
8	2.2	CD	PERCENT	2.2	num	9	SENT_103	[p6l1719t2764r1785b2787],
9	%	NN	PERCENT	%	dep	7	SENT_103	[p6l1719t2764r1785b2787],
10	cardiovascular	JJ	O	cardiovascular	amod	11	SENT_103	[p6l655t2801r854b2826],
11	effects	NNS	O	effect	dep	4	SENT_103	[p6l861t2801r957b2830],
12	,	,	O	,	_	0	SENT_103	[p6l861t2801r957b2830],
13	hearing	VBG	O	hear	xcomp	4	SENT_103	[p6l966t2801r1069b2833],
14	problems	NNS	O	problem	dobj	13	SENT_103	[p6l1079t2801r1215b2833],
15	,	,	O	,	_	0	SENT_103	[p6l1079t2801r1215b2833],
16	severe	JJ	O	severe	amod	17	SENT_103	[p6l1222t2808r1310b2826],
17	headache	NN	O	headache	appos	14	SENT_103	[p6l1319t2801r1458b2830],
18	,	,	O	,	_	0	SENT_103	[p6l1319t2801r1458b2830],
19	(	CD	NUMBER	(	num	20	SENT_103	[p6l1510t2802r1551b2830],
20	CI	NN	O	ci	appos	14	SENT_103	[p6l1510t2802r1551b2830],
21	;	:	O	;	_	0	SENT_103	[p6l1510t2802r1551b2830],
22	4.0	CD	NUMBER	4.0	advmod	13	SENT_103	[p6l1558t2802r1690b2830],
23	.	.	O	.	_	0	SENT_103	[p6l1558t2802r1690b2830],

1	—	NN	O	—	_	0	SENT_104	[p6l1558t2802r1690b2830],
2	.	.	O	.	_	0	SENT_104	[p6l1558t2802r1690b2830],

1	O.	NNP	O	O.	dep	6	SENT_105	[p6l1558t2802r1690b2830],
2	4	CD	PERCENT	4	num	3	SENT_105	[p6l1558t2802r1690b2830],
3	%	NN	PERCENT	%	dep	1	SENT_105	[p6l1558t2802r1690b2830],
4	)	CD	NUMBER	)	dep	6	SENT_105	[p6l1558t2802r1690b2830],
5	an	DT	O	a	det	6	SENT_105	[p6l655t2848r687b2865],
6	increase	NN	O	increase	_	0	SENT_105	[p6l697t2842r808b2865],
7	in	IN	O	in	_	0	SENT_105	[p6l817t2842r839b2865],
8	suicide	NN	O	suicide	nn	9	SENT_105	[p6l848t2841r943b2865],
9	risk	NN	O	risk	prep_in	6	SENT_105	[p6l952t2841r1004b2869],
10	,	,	O	,	_	0	SENT_105	[p6l952t2841r1004b2869],
11	and	CC	O	and	_	0	SENT_105	[p6l1012t2841r1062b2865],
12	respiratory	JJ	O	respiratory	amod	13	SENT_105	[p6l1072t2842r1220b2872],
13	problems	NNS	O	problem	conj_and	9	SENT_105	[p6l1228t2841r1357b2872],

1	Reversible	JJ	MISC	reversible	amod	2	SENT_106	[p6l21t2917r161b2942],
2	inhibitor	NN	O	inhibitor	nsubj	31	SENT_106	[p6l169t2917r286b2942],
3	of	IN	O	of	_	0	SENT_106	[p6l293t2917r322b2942],
4	Orlistat	NNP	O	Orlistat	nn	5	SENT_106	[p6l410t2917r509b2942],
5	Weight	NNP	O	Weight	prep_of	2	SENT_106	[p6l655t2917r753b2949],
6	loss	NN	O	loss	nn	10	SENT_106	[p6l762t2917r811b2942],
7	Mean	NN	O	mean	nn	10	SENT_106	[p6l1510t2918r1585b2942],
8	body	NN	O	body	nn	10	SENT_106	[p6l1595t2917r1664b2949],
9	weight	NN	O	weight	nn	10	SENT_106	[p6l1670t2917r1766b2949],
10	loss	NN	O	loss	nsubj	16	SENT_106	[p6l1774t2917r1824b2942],
11	Approved	VBN	O	approve	partmod	10	SENT_106	[p6l1885t2917r2021b2948],
12	by	IN	O	by	_	0	SENT_106	[p6l2030t2917r2063b2949],
13	the	DT	O	the	det	15	SENT_106	[p6l2069t2917r2114b2942],
14	intestinal	JJ	O	intestinal	amod	15	SENT_106	[p6l21t2956r145b2981],
15	Iipases	NNS	O	iipase	agent	11	SENT_106	[p6l155t2956r246b2987],
16	(	VBP	O	(	rcmod	5	SENT_106	[p6l411t2956r527b2984],
17	Xenica	NNP	O	Xenica	nsubj	21	SENT_106	[p6l411t2956r527b2984],
18	|	CD	NUMBER	|	number	19	SENT_106	[p6l411t2956r527b2984],
19	)	CD	NUMBER	)	num	21	SENT_106	[p6l411t2956r527b2984],
20	Increased	VBN	O	increase	amod	21	SENT_106	[p6l657t2956r786b2981],
21	number	NN	O	number	xcomp	16	SENT_106	[p6l796t2956r905b2981],
22	of	IN	O	of	_	0	SENT_106	[p6l912t2956r940b2981],
23	bowel	NN	O	bowel	nn	24	SENT_106	[p6l946t2956r1028b2981],
24	movements	NNS	O	movement	prep_of	21	SENT_106	[p6l1038t2960r1200b2981],
25	and	CC	O	and	_	0	SENT_106	[p6l1208t2956r1258b2981],
26	potential	JJ	O	potential	amod	27	SENT_106	[p6l1268t2956r1390b2987],
27	greater	JJR	O	greater	prep_of	21	SENT_106	[p6l1510t2960r1608b2987],
28	than	IN	O	than	_	0	SENT_106	[p6l1615t2956r1676b2981],
29	placebo	NN	O	placebo	prep_than	21	SENT_106	[p6l1686t2956r1795b2987],
30	was	VBD	O	be	cop	31	SENT_106	[p6l1802t2963r1854b2981],
31	FDA	NNP	ORGANIZATION	FDA	_	0	SENT_106	[p6l1887t2957r1942b2980],
32	in	IN	O	in	_	0	SENT_106	[p6l1951t2957r1973b2980],
33	1999	CD	DATE	1999	prep_in	31	SENT_106	[p6l1984t2958r2048b2981],

1	changes	NNS	O	change	_	0	SENT_107	[p6l655t2995r770b3026],
2	in	IN	O	in	_	0	SENT_107	[p6l778t2996r801b3019],
3	the	DT	O	the	det	5	SENT_107	[p6l809t2995r854b3020],
4	bowel	NN	O	bowel	nn	5	SENT_107	[p6l863t2995r944b3020],
5	function	NN	O	function	prep_in	1	SENT_107	[p6l952t2995r1067b3020],
6	and	CC	O	and	_	0	SENT_107	[p6l1076t2995r1126b3020],
7	microbiota	NN	O	microbiota	prep_in	1	SENT_107	[p6l1136t2995r1284b3020],

1	4.2	CD	NUMBER	4.2	num	2	SENT_108	[p6l1509t2997r1548b3020],
2	kg	NN	O	kg	_	0	SENT_108	[p6l1558t2995r1588b3026],

1	Enhancing	NN	O	enhancing	nn	2	SENT_109	[p6l21t3070r165b3102],
2	GABA	NN	O	gaba	nsubj	3	SENT_109	[p6l174t3071r252b3095],
3	signaling	NN	O	signaling	ccomp	39	SENT_109	[p6l260t3070r383b3102],
4	Topiramate	NNP	O	Topiramate	nn	6	SENT_109	[p6l408t3072r565b3102],
5	Appetite	NNP	O	Appetite	nn	6	SENT_109	[p6l655t3072r775b3102],
6	suppression	NN	O	suppression	nsubj	12	SENT_109	[p6l783t3072r947b3102],
7	and	CC	O	and	_	0	SENT_109	[p6l956t3070r1006b3095],
8	weight	NN	O	weight	nn	11	SENT_109	[p6l1014t3070r1110b3102],
9	loss	NN	O	loss	nn	11	SENT_109	[p6l1118t3070r1168b3095],
10	Weight	NNP	O	Weight	nn	11	SENT_109	[p6l1509t3070r1608b3102],
11	loss	NN	O	loss	nsubj	12	SENT_109	[p6l1616t3070r1665b3095],
12	greater	JJR	O	greater	xcomp	3	SENT_109	[p6l1673t3074r1772b3102],
13	than	IN	O	than	_	0	SENT_109	[p6l1778t3070r1840b3095],
14	Off-label	JJ	O	off-label	amod	15	SENT_109	[p6l1886t3070r2003b3095],
15	usage	NN	O	usage	prep_than	12	SENT_109	[p6l2013t3078r2100b3102],
16	;	:	O	;	_	0	SENT_109	[p6l2013t3078r2100b3102],
17	to	TO	O	to	aux	18	SENT_109	[p6l19t3113r47b3135],
18	promote	VB	O	promote	infmod	15	SENT_109	[p6l56t3113r174b3141],
19	anorexigenic	JJ	O	anorexigenic	amod	20	SENT_109	[p6l182t3111r360b3141],
20	(	NN	O	(	dobj	18	SENT_109	[p6l410t3110r554b3141],
21	Topamax	NN	ORGANIZATION	topamax	nn	23	SENT_109	[p6l410t3110r554b3141],
22	)	CD	NUMBER	)	num	23	SENT_109	[p6l410t3110r554b3141],
23	Fatigue	NNP	O	Fatigue	dep	18	SENT_109	[p6l657t3111r762b3141],
24	,	,	O	,	_	0	SENT_109	[p6l657t3111r762b3141],
25	drowsiness	NN	O	drowsiness	appos	23	SENT_109	[p6l769t3109r926b3138],
26	,	,	O	,	_	0	SENT_109	[p6l769t3109r926b3138],
27	dizziness	NN	O	dizziness	appos	23	SENT_109	[p6l934t3109r1061b3138],
28	,	,	O	,	_	0	SENT_109	[p6l934t3109r1061b3138],
29	loss	NN	O	loss	appos	23	SENT_109	[p6l1070t3109r1119b3134],
30	of	IN	O	of	_	0	SENT_109	[p6l1126t3109r1154b3134],
31	coordination	NN	O	coordination	prep_of	29	SENT_109	[p6l1159t3109r1341b3138],
32	,	,	O	,	_	0	SENT_109	[p6l1159t3109r1341b3138],
33	tingling	VBG	O	tingle	amod	34	SENT_109	[p6l1348t3109r1453b3141],
34	placebo	NN	O	placebo	nsubj	39	SENT_109	[p6l1511t3109r1619b3141],
35	was	VBD	O	be	cop	39	SENT_109	[p6l1626t3117r1678b3134],
36	6.5	CD	NUMBER	6.5	num	39	SENT_109	[p6l1686t3111r1724b3134],
37	kg	NN	O	kg	nn	39	SENT_109	[p6l1733t3109r1763b3141],
38	(	NN	O	(	nn	39	SENT_109	[p6l1772t3110r1813b3138],
39	CI	NN	O	ci	_	0	SENT_109	[p6l1772t3110r1813b3138],
40	:	:	O	:	_	0	SENT_109	[p6l1772t3110r1813b3138],
41	approved	VBN	O	approve	partmod	39	SENT_109	[p6l1886t3109r2016b3141],
42	for	IN	O	for	_	0	SENT_109	[p6l2024t3109r2062b3134],
43	signaling	NN	O	signaling	prep_for	41	SENT_109	[p6l20t3149r151b3180],
44	.	.	O	.	_	0	SENT_109	[p6l20t3149r151b3180],

1	Inhibiting	VBG	O	inhibit	_	0	SENT_110	[p6l160t3149r292b3180],
2	ofthe	NN	O	ofthe	nn	3	SENT_110	[p6l655t3149r733b3174],
3	hands/feet	NN	O	hands/feet	dobj	1	SENT_110	[p6l741t3149r893b3177],
4	,	,	O	,	_	0	SENT_110	[p6l741t3149r893b3177],
5	bad	JJ	O	bad	amod	6	SENT_110	[p6l902t3149r951b3174],
6	taste	NN	O	taste	dobj	1	SENT_110	[p6l959t3153r1025b3174],
7	in	IN	O	in	_	0	SENT_110	[p6l1033t3150r1055b3173],
8	the	DT	O	the	det	9	SENT_110	[p6l1063t3149r1107b3174],
9	mouth	NN	O	mouth	prep_in	6	SENT_110	[p6l1116t3149r1213b3177],
10	,	,	O	,	_	0	SENT_110	[p6l1116t3149r1213b3177],
11	and	CC	O	and	_	0	SENT_110	[p6l1220t3149r1270b3174],
12	diarrhea	NN	O	diarrhea	dobj	1	SENT_110	[p6l1278t3149r1398b3174],
13	.	.	O	.	_	0	SENT_110	[p6l1278t3149r1398b3174],

1	4.8-8	CD	NUMBER	4.8-8	num	3	SENT_111	[p6l1509t3151r1606b3174],
2	.3	NN	NUMBER	.3	nn	3	SENT_111	[p6l1509t3151r1606b3174],
3	kg	NN	O	kg	nsubj	44	SENT_111	[p6l1614t3149r1653b3180],
4	)	NN	O	)	nn	9	SENT_111	[p6l1614t3149r1653b3180],
5	epilepsy	NN	O	epilepsy	nn	9	SENT_111	[p6l1886t3149r2000b3180],
6	vo	NN	O	vo	nn	9	SENT_111	[p6l19t3188r214b3219],
7	|	CD	NUMBER	|	num	9	SENT_111	[p6l19t3188r214b3219],
8	tage	NN	O	tage	nn	9	SENT_111	[p6l19t3188r214b3219],
9	—	NN	O	—	nsubj	18	SENT_111	[p6l19t3188r214b3219],
10	gated	VBN	O	gate	partmod	9	SENT_111	[p6l19t3188r214b3219],
11	channels	NNS	O	channel	nsubj	13	SENT_111	[p6l223t3188r345b3213],
12	Mental	JJ	O	mental	amod	13	SENT_111	[p6l656t3188r748b3213],
13	problems	NNS	O	problem	xcomp	10	SENT_111	[p6l757t3188r884b3219],
14	such	JJ	O	such	_	0	SENT_111	[p6l891t3188r952b3213],
15	as	IN	O	as	_	0	SENT_111	[p6l960t3195r987b3213],
16	confusion	NN	O	confusion	prep_such_as	13	SENT_111	[p6l994t3188r1133b3216],
17	,	,	O	,	_	0	SENT_111	[p6l994t3188r1133b3216],
18	slowed	VBD	O	slow	rcmod	3	SENT_111	[p6l1140t3188r1234b3213],
19	thinking	NN	O	thinking	nn	24	SENT_111	[p6l1242t3188r1361b3219],
20	,	,	O	,	_	0	SENT_111	[p6l1242t3188r1361b3219],
21	trouble	NN	O	trouble	nn	24	SENT_111	[p6l1367t3188r1466b3213],
22	and	CC	O	and	_	0	SENT_111	[p6l20t3227r70b3251],
23	AMPA	NN	O	ampa	nn	24	SENT_111	[p6l79t3228r160b3251],
24	receptor	NN	O	receptor	dobj	18	SENT_111	[p6l168t3231r284b3258],
25	in	IN	O	in	_	0	SENT_111	[p6l291t3228r314b3251],
26	the	DT	O	the	det	30	SENT_111	[p6l322t3227r367b3251],
27	concentrating	VBG	O	concentrate	dep	30	SENT_111	[p6l655t3228r845b3258],
28	or	CC	O	or	_	0	SENT_111	[p6l854t3234r882b3251],
29	paying	VBG	O	pay	dep	30	SENT_111	[p6l889t3228r980b3258],
30	attention	NN	O	attention	prep_in	24	SENT_111	[p6l988t3228r1120b3255],
31	,	,	O	,	_	0	SENT_111	[p6l988t3228r1120b3255],
32	nervousness	NN	O	nervousness	nn	36	SENT_111	[p6l1128t3234r1304b3255],
33	,	,	O	,	_	0	SENT_111	[p6l1128t3234r1304b3255],
34	memory	NN	O	memory	nn	36	SENT_111	[p6l1312t3234r1427b3258],
35	orexigenic	JJ	O	orexigenic	amod	36	SENT_111	[p6l20t3267r164b3297],
36	neurons	NNS	O	neuron	dobj	18	SENT_111	[p6l172t3273r283b3290],
37	problems	NNS	O	problem	dep	36	SENT_111	[p6l656t3266r791b3297],
38	,	,	O	,	_	0	SENT_111	[p6l656t3266r791b3297],
39	or	CC	O	or	_	0	SENT_111	[p6l798t3273r826b3290],
40	speech/language	NN	O	speech/language	nn	41	SENT_111	[p6l833t3266r1070b3297],
41	problems	NNS	O	problem	dobj	18	SENT_111	[p6l1078t3266r1206b3297],
42	may	MD	O	may	aux	44	SENT_111	[p6l1215t3273r1271b3297],
43	also	RB	O	also	advmod	44	SENT_111	[p6l1278t3266r1331b3290],
44	occur	VB	O	occur	_	0	SENT_111	[p6l1338t3273r1418b3290],
45	.	.	O	.	_	0	SENT_111	[p6l1338t3273r1418b3290],

1	Rare	JJ	O	rare	amod	3	SENT_112	[p6l657t3305r715b3329],
2	side	JJ	O	side	amod	3	SENT_112	[p6l722t3304r776b3329],
3	effects	NNS	O	effect	nsubj	4	SENT_112	[p6l783t3304r872b3329],
4	include	VBP	O	include	_	0	SENT_112	[p6l880t3304r980b3329],
5	kidney	NN	O	kidney	nn	6	SENT_112	[p6l988t3304r1079b3336],
6	stones	NNS	O	stone	dobj	4	SENT_112	[p6l1085t3308r1179b3333],
7	,	,	O	,	_	0	SENT_112	[p6l1085t3308r1179b3333],
8	depression	NN	O	depression	dobj	4	SENT_112	[p6l1187t3304r1343b3336],
9	,	,	O	,	_	0	SENT_112	[p6l1187t3304r1343b3336],
10	suicidal	JJ	O	suicidal	amod	11	SENT_112	[p6l1350t3304r1450b3329],
11	thoughts/attempts	NNS	O	thoughts/attempts	dobj	4	SENT_112	[p6l655t3344r921b3375],
12	,	,	O	,	_	0	SENT_112	[p6l655t3344r921b3375],
13	and	CC	O	and	_	0	SENT_112	[p6l929t3344r979b3368],
14	vision	NN	O	vision	nn	15	SENT_112	[p6l987t3345r1065b3368],
15	loss	NN	O	loss	conj_and	6	SENT_112	[p6l1074t3344r1123b3368],

1	GLP-1	NN	O	glp-1	nn	4	SENT_113	[p6l20t3420r95b3444],
2	receptor	NN	O	receptor	nn	4	SENT_113	[p6l109t3423r224b3450],
3	agonist	NN	O	agonist	nn	4	SENT_113	[p6l231t3420r333b3451],
4	Exenatide	NNP	MISC	Exenatide	nsubj	5	SENT_113	[p6l411t3419r544b3444],
5	Decreased	VBN	MISC	decrease	partmod	27	SENT_113	[p6l657t3419r798b3444],
6	blood	NN	O	blood	nn	8	SENT_113	[p6l808t3419r886b3444],
7	glucose	NN	O	glucose	nn	8	SENT_113	[p6l895t3419r1001b3451],
8	level	NN	O	level	dep	5	SENT_113	[p6l1010t3419r1070b3444],
9	and	CC	O	and	_	0	SENT_113	[p6l1079t3419r1129b3444],
10	body	NN	O	body	nn	14	SENT_113	[p6l1139t3419r1209b3451],
11	weight	NN	O	weight	nn	14	SENT_113	[p6l1215t3419r1311b3451],
12	Mean	NN	O	mean	nn	14	SENT_113	[p6l1510t3420r1585b3444],
13	body	NN	O	body	nn	14	SENT_113	[p6l1595t3419r1664b3451],
14	weight	NN	O	weight	dep	5	SENT_113	[p6l1670t3419r1766b3451],
15	Off	IN	O	off	dep	8	SENT_113	[p6l1886t3419r2003b3444],
16	—	CD	NUMBER	—	number	17	SENT_113	[p6l1886t3419r2003b3444],
17	|	CD	NUMBER	|	pobj	15	SENT_113	[p6l1886t3419r2003b3444],
18	abe	NN	O	abe	nn	20	SENT_113	[p6l1886t3419r2003b3444],
19	|	NN	O	|	nn	20	SENT_113	[p6l1886t3419r2003b3444],
20	usage	NN	O	usage	dep	17	SENT_113	[p6l2013t3426r2100b3451],
21	;	:	O	;	_	0	SENT_113	[p6l2013t3426r2100b3451],
22	(	CD	NUMBER	(	dep	17	SENT_113	[p6l410t3459r512b3490],
23	Byetta	NNP	LOCATION	Byetta	dep	22	SENT_113	[p6l410t3459r512b3490],
24	,	,	O	,	_	0	SENT_113	[p6l410t3459r512b3490],
25	Side	NNP	O	Side	nn	26	SENT_113	[p6l656t3458r713b3483],
26	effects	NNS	O	effect	nsubj	27	SENT_113	[p6l721t3458r811b3483],
27	include	VBP	O	include	_	0	SENT_113	[p6l819t3458r920b3483],
28	gastrointestinal	JJ	O	gastrointestinal	amod	29	SENT_113	[p6l927t3458r1140b3490],
29	symptoms	NNS	O	symptom	dobj	27	SENT_113	[p6l1149t3462r1299b3490],
30	,	,	O	,	_	0	SENT_113	[p6l1149t3462r1299b3490],
31	acute	JJ	O	acute	amod	32	SENT_113	[p6l1307t3462r1382b3483],
32	change	NN	O	change	appos	29	SENT_113	[p6l1510t3458r1618b3490],
33	:	:	O	:	_	0	SENT_113	[p6l1510t3458r1618b3490],
34	exenatide	NN	O	exenatide	nsubj	35	SENT_113	[p6l1626t3458r1761b3483],
35	approved	VBD	O	approve	dep	29	SENT_113	[p6l1886t3458r2016b3489],
36	for	IN	O	for	_	0	SENT_113	[p6l2024t3458r2062b3483],
37	Bydureon	NNP	O	Bydureon	prep_for	35	SENT_113	[p6l411t3497r551b3529],
38	)	CD	NUMBER	)	num	37	SENT_113	[p6l411t3497r551b3529],
39	pancreatitis	NN	O	pancreatitis	dobj	35	SENT_113	[p6l656t3499r823b3529],
40	,	,	O	,	_	0	SENT_113	[p6l656t3499r823b3529],
41	dizziness	NN	O	dizziness	dobj	35	SENT_113	[p6l830t3497r959b3526],
42	,	,	O	,	_	0	SENT_113	[p6l830t3497r959b3526],
43	and	CC	O	and	_	0	SENT_113	[p6l967t3497r1017b3522],
44	headache	NN	O	headache	dobj	35	SENT_113	[p6l1027t3497r1167b3522],
45	.	.	O	.	_	0	SENT_113	[p6l1027t3497r1167b3522],

1	It	PRP	O	it	nsubj	3	SENT_114	[p6l1176t3498r1192b3522],
2	might	MD	O	might	aux	3	SENT_114	[p6l1201t3497r1282b3529],
3	increase	VB	O	increase	_	0	SENT_114	[p6l1290t3498r1401b3522],
4	risks	NNS	O	risk	dobj	3	SENT_114	[p6l1410t3497r1468b3522],
5	—	CD	NUMBER	—	num	4	SENT_114	[p6l1510t3498r1690b3526],
6	(	CD	NUMBER	(	number	7	SENT_114	[p6l1510t3498r1690b3526],
7	2.49	CD	NUMBER	2.49	num	8	SENT_114	[p6l1510t3498r1690b3526],
8	i0	NN	O	i0	dep	4	SENT_114	[p6l1510t3498r1690b3526],
9	.66	CD	NUMBER	.66	number	10	SENT_114	[p6l1510t3498r1690b3526],
10	)	CD	NUMBER	)	num	11	SENT_114	[p6l1510t3498r1690b3526],
11	kg	NN	O	kg	dep	4	SENT_114	[p6l1700t3497r1737b3529],
12	,	,	O	,	_	0	SENT_114	[p6l1700t3497r1737b3529],
13	placebo	NN	O	placebo	nn	14	SENT_114	[p6l1746t3497r1855b3528],
14	diabetes	NN	O	diabetes	dobj	3	SENT_114	[p6l1886t3497r2003b3522],
15	ofsulfonylurea-induced	JJ	O	ofsulfonylurea-induced	amod	16	SENT_114	[p6l655t3536r980b3568],
16	hypoglycemia	NN	O	hypoglycemia	dep	14	SENT_114	[p6l990t3536r1182b3568],
17	and	CC	O	and	_	0	SENT_114	[p6l1191t3536r1241b3561],
18	thyroid	NN	O	thyroid	nn	19	SENT_114	[p6l1249t3536r1347b3568],
19	cancer	NN	O	cancer	conj_and	4	SENT_114	[p6l1356t3543r1446b3561],
20	+	CC	O	+	_	0	SENT_114	[p6l1510t3537r1594b3565],
21	(	CD	NUMBER	(	num	22	SENT_114	[p6l1510t3537r1594b3565],
22	0.43	CD	NUMBER	0.43	conj_and	4	SENT_114	[p6l1510t3537r1594b3565],
23	i	FW	O	i	dep	22	SENT_114	[p6l1601t3541r1619b3561],
24	0.63	CD	NUMBER	0.63	number	25	SENT_114	[p6l1625t3537r1690b3565],
25	)	CD	NUMBER	)	num	26	SENT_114	[p6l1625t3537r1690b3565],
26	kg	NN	O	kg	dep	23	SENT_114	[p6l1700t3536r1730b3568],

1	Liraglutide	NNP	O	Liraglutide	nn	5	SENT_115	[p6l411t3612r557b3644],
2	Maintained	NNP	O	Maintained	nn	5	SENT_115	[p6l656t3612r811b3637],
3	normal	JJ	O	normal	amod	5	SENT_115	[p6l820t3612r916b3637],
4	blood	NN	O	blood	nn	5	SENT_115	[p6l925t3612r1004b3637],
5	glucose	NN	O	glucose	nsubjpass	47	SENT_115	[p6l1012t3612r1118b3644],
6	and	CC	O	and	_	0	SENT_115	[p6l1126t3612r1176b3637],
7	body	NN	O	body	nn	9	SENT_115	[p6l1186t3612r1255b3644],
8	weight	NN	O	weight	nn	9	SENT_115	[p6l1262t3612r1357b3644],
9	Weight	NNP	O	Weight	nsubjpass	47	SENT_115	[p6l1509t3612r1608b3644],
10	loss	NN	O	loss	nn	11	SENT_115	[p6l1616t3612r1665b3637],
11	greaterthan	NN	O	greaterthan	npadvmod	42	SENT_115	[p6l1673t3612r1840b3644],
12	Off	IN	O	off	_	0	SENT_115	[p6l1886t3612r2003b3637],
13	—	CD	NUMBER	—	number	14	SENT_115	[p6l1886t3612r2003b3637],
14	|	CD	NUMBER	|	prep_off	42	SENT_115	[p6l1886t3612r2003b3637],
15	abe	NN	O	abe	nn	17	SENT_115	[p6l1886t3612r2003b3637],
16	|	NN	O	|	nn	17	SENT_115	[p6l1886t3612r2003b3637],
17	usage	NN	O	usage	dep	14	SENT_115	[p6l2013t3619r2100b3644],
18	;	:	O	;	_	0	SENT_115	[p6l2013t3619r2100b3644],
19	(	CD	NUMBER	(	num	20	SENT_115	[p6l410t3652r528b3680],
20	Victoza	NNP	LOCATION	Victoza	dep	14	SENT_115	[p6l410t3652r528b3680],
21	)	CD	NUMBER	)	num	20	SENT_115	[p6l410t3652r528b3680],
22	Increased	VBN	O	increase	amod	23	SENT_115	[p6l657t3651r786b3676],
23	risks	NNS	O	risk	nsubj	42	SENT_115	[p6l796t3651r854b3676],
24	of	IN	O	of	_	0	SENT_115	[p6l861t3651r890b3676],
25	C	NN	O	c	nn	27	SENT_115	[p6l895t3651r969b3676],
26	—	CD	NUMBER	—	num	27	SENT_115	[p6l895t3651r969b3676],
27	ce	NN	O	ce	prep_of	23	SENT_115	[p6l895t3651r969b3676],
28	|	CD	NUMBER	|	num	27	SENT_115	[p6l895t3651r969b3676],
29	|	JJ	O	|	amod	30	SENT_115	[p6l895t3651r969b3676],
30	carcinoma	NN	O	carcinoma	dep	37	SENT_115	[p6l978t3652r1120b3676],
31	and	CC	O	and	_	0	SENT_115	[p6l1129t3651r1179b3676],
32	thyroid	NN	O	thyroid	nn	33	SENT_115	[p6l1187t3651r1285b3683],
33	C	NN	O	c	conj_and	30	SENT_115	[p6l1294t3651r1368b3676],
34	—	CD	NUMBER	—	num	35	SENT_115	[p6l1294t3651r1368b3676],
35	ce	NN	O	ce	dep	37	SENT_115	[p6l1294t3651r1368b3676],
36	|	CD	NUMBER	|	num	37	SENT_115	[p6l1294t3651r1368b3676],
37	|	NN	O	|	dep	23	SENT_115	[p6l1294t3651r1368b3676],
38	focal	JJ	O	focal	amod	39	SENT_115	[p6l1376t3651r1440b3676],
39	placebo	NN	O	placebo	dep	37	SENT_115	[p6l1511t3651r1619b3682],
40	was	VBD	O	be	cop	42	SENT_115	[p6l1626t3658r1678b3676],
41	4.4	CD	NUMBER	4.4	num	42	SENT_115	[p6l1685t3653r1726b3676],
42	kg	NN	O	kg	rcmod	5	SENT_115	[p6l1733t3651r1763b3683],
43	approved	VBN	O	approve	partmod	42	SENT_115	[p6l1886t3651r2016b3682],
44	for	IN	O	for	_	0	SENT_115	[p6l2024t3651r2062b3676],
45	hyperplasia	NN	O	hyperplasium	prep_for	43	SENT_115	[p6l657t3690r813b3722],
46	were	VBD	O	be	auxpass	47	SENT_115	[p6l821t3697r888b3715],
47	observed	VBN	O	observe	dep	52	SENT_115	[p6l895t3690r1022b3715],
48	in	IN	O	in	_	0	SENT_115	[p6l1032t3691r1054b3715],
49	rats	NNS	O	rat	prep_in	47	SENT_115	[p6l1064t3694r1112b3715],
50	and	CC	O	and	_	0	SENT_115	[p6l1120t3690r1170b3715],
51	mice	NNS	O	mouse	prep_in	47	SENT_115	[p6l1180t3691r1244b3715],
52	(	VBP	O	(	_	0	SENT_115	[p6l1510t3691r1551b3719],
53	CI	NN	O	ci	dobj	52	SENT_115	[p6l1510t3691r1551b3719],
54	:	:	O	:	_	0	SENT_115	[p6l1510t3691r1551b3719],
55	2.9-6	CD	NUMBER	2.9-6	dep	53	SENT_115	[p6l1559t3692r1655b3715],
56	.0	CD	NUMBER	.0	num	59	SENT_115	[p6l1559t3692r1655b3715],
57	kg	NN	O	kg	nn	59	SENT_115	[p6l1663t3690r1702b3722],
58	)	NN	O	)	nn	59	SENT_115	[p6l1663t3690r1702b3722],
59	diabetes	NN	O	diabetes	nsubj	52	SENT_115	[p6l1886t3690r2003b3715],

1	Amylin	NNP	ORGANIZATION	Amylin	nn	3	SENT_116	[p7l20t35r115b67],
2	analog	NN	O	analog	nn	3	SENT_116	[p7l123t35r216b67],
3	Pramlintide	NNP	MISC	Pramlintide	nsubj	25	SENT_116	[p7l411t35r568b60],
4	Decreased	VBN	MISC	decrease	partmod	3	SENT_116	[p7l657t35r798b60],
5	blood	NN	O	blood	dobj	4	SENT_116	[p7l808t35r886b60],
6	glucose	NN	O	glucose	nn	7	SENT_116	[p7l895t35r1001b67],
7	level	NN	O	level	num	11	SENT_116	[p7l1010t35r1070b60],
8	and	CC	O	and	_	0	SENT_116	[p7l1079t35r1129b60],
9	body	NN	O	body	nn	10	SENT_116	[p7l1139t35r1209b67],
10	weight	NN	O	weight	conj_and	7	SENT_116	[p7l1215t35r1311b67],
11	%	NN	O	%	dep	5	SENT_116	[p7l1509t35r1639b67],
12	Weight	NNP	O	Weight	nn	13	SENT_116	[p7l1509t35r1639b67],
13	loss	NN	O	loss	dep	5	SENT_116	[p7l1647t35r1696b60],
14	greater	JJR	O	greater	amod	16	SENT_116	[p7l1704t39r1803b67],
15	Off-label	NN	MISC	off-label	nn	16	SENT_116	[p7l1886t35r2003b60],
16	usage	NN	O	usage	dep	13	SENT_116	[p7l2013t43r2100b67],
17	;	:	O	;	_	0	SENT_116	[p7l2013t43r2100b67],
18	(	CD	NUMBER	(	num	20	SENT_116	[p7l410t74r519b106],
19	Sym	NN	O	sym	nn	20	SENT_116	[p7l410t74r519b106],
20	|	NN	O	|	dep	5	SENT_116	[p7l410t74r519b106],
21	in	IN	O	in	_	0	SENT_116	[p7l410t74r519b106],
22	)	CD	NUMBER	)	num	24	SENT_116	[p7l410t74r519b106],
23	Side	NN	O	side	nn	24	SENT_116	[p7l656t74r713b99],
24	effects	NNS	O	effect	prep_in	20	SENT_116	[p7l721t74r811b99],
25	include	VBP	O	include	_	0	SENT_116	[p7l819t74r920b99],
26	nausea	NN	O	nausea	dobj	25	SENT_116	[p7l928t81r1031b103],
27	,	,	O	,	_	0	SENT_116	[p7l928t81r1031b103],
28	hypoglycemia	NN	O	hypoglycemia	appos	26	SENT_116	[p7l1040t74r1240b106],
29	,	,	O	,	_	0	SENT_116	[p7l1040t74r1240b106],
30	vomiting	VBG	O	vomit	appos	28	SENT_116	[p7l1247t75r1377b106],
31	,	,	O	,	_	0	SENT_116	[p7l1247t75r1377b106],
32	than	IN	O	than	mark	35	SENT_116	[p7l1509t74r1571b99],
33	placebo	NN	O	placebo	nsubjpass	35	SENT_116	[p7l1580t74r1689b105],
34	was	VBD	O	be	auxpass	35	SENT_116	[p7l1696t81r1748b99],
35	approved	VBN	O	approve	dep	28	SENT_116	[p7l1886t74r2016b105],
36	for	IN	O	for	_	0	SENT_116	[p7l2024t74r2062b99],
37	headache	NN	O	headache	prep_for	35	SENT_116	[p7l657t113r796b141],
38	,	,	O	,	_	0	SENT_116	[p7l657t113r796b141],
39	abdominal	JJ	O	abdominal	amod	40	SENT_116	[p7l804t113r951b138],
40	pain	NN	O	pain	prep_for	35	SENT_116	[p7l961t114r1026b144],
41	,	,	O	,	_	0	SENT_116	[p7l961t114r1026b144],
42	and	CC	O	and	_	0	SENT_116	[p7l1034t113r1084b138],
43	fatigue	NN	O	fatigue	conj_and	37	SENT_116	[p7l1092t113r1189b144],
44	2.2	CD	PERCENT	2.2	number	45	SENT_116	[p7l1510t115r1548b138],
45	10.7	CD	PERCENT	10.7	dep	46	SENT_116	[p7l1555t115r1645b138],
46	%	NN	PERCENT	%	dep	47	SENT_116	[p7l1555t115r1645b138],
47	diabetes	NN	O	diabetes	dep	43	SENT_116	[p7l1886t113r2003b138],

1	Cocktail	NN	O	cocktail	nn	2	SENT_117	[p7l20t187r127b212],
2	drug	NN	O	drug	nsubj	21	SENT_117	[p7l136t187r200b219],
3	Phenterminel	NNP	MISC	Phenterminel	nsubj	4	SENT_117	[p7l411t187r601b213],
4	See	VB	MISC	see	rcmod	2	SENT_117	[p7l656t188r704b212],
5	above	IN	O	above	_	0	SENT_117	[p7l711t187r795b212],
6	effects	NNS	O	effect	prep_above	4	SENT_117	[p7l802t187r892b212],
7	from	IN	O	from	_	0	SENT_117	[p7l899t187r963b212],
8	individual	JJ	O	individual	prep_from	4	SENT_117	[p7l973t187r1107b212],
9	drugs	NNS	O	drug	num	10	SENT_117	[p7l1116t187r1193b219],
10	%	NN	O	%	tmod	4	SENT_117	[p7l1509t189r1534b212],
11	Weight	NNP	O	Weight	nn	12	SENT_117	[p7l1540t187r1639b219],
12	loss	NN	O	loss	nsubj	14	SENT_117	[p7l1647t187r1696b212],
13	from	IN	O	from	prep	12	SENT_117	[p7l1703t187r1767b212],
14	Approved	VBN	O	approve	rcmod	10	SENT_117	[p7l1885t187r2021b219],
15	by	IN	O	by	_	0	SENT_117	[p7l2030t187r2063b219],
16	the	DT	O	the	det	18	SENT_117	[p7l2069t187r2114b212],
17	topiramate	NN	O	topiramate	nn	18	SENT_117	[p7l409t228r562b258],
18	baseline	NN	O	baseline	prep_by	14	SENT_117	[p7l1511t227r1623b252],
19	was	VBD	O	be	cop	21	SENT_117	[p7l1631t234r1683b252],
20	placebo	NN	O	placebo	nn	21	SENT_117	[p7l1691t227r1800b258],
21	FDA	NNP	ORGANIZATION	FDA	_	0	SENT_117	[p7l1887t228r1942b252],
22	in	IN	O	in	_	0	SENT_117	[p7l1951t228r1973b251],
23	2012	CD	DATE	2012	num	24	SENT_117	[p7l1982t228r2047b252],
24	(	CD	NUMBER	(	prep_in	21	SENT_117	[p7l410t267r529b298],
25	Osymia	NNP	LOCATION	Osymia	dep	21	SENT_117	[p7l410t267r529b298],
26	)	CD	PERCENT	)	num	25	SENT_117	[p7l410t267r529b298],
27	-2.2	CD	PERCENT	-2.2	num	28	SENT_117	[p7l1509t268r1599b295],
28	%	NN	PERCENT	%	dep	25	SENT_117	[p7l1509t268r1599b295],
29	,	,	O	,	_	0	SENT_117	[p7l1509t268r1599b295],
30	(	CD	NUMBER	(	num	31	SENT_117	[p7l1607t267r1690b295],
31	PHEN	NN	O	phen	conj_and	21	SENT_117	[p7l1607t267r1690b295],
32	7.5	CD	NUMBER	7.5	num	33	SENT_117	[p7l1700t268r1737b291],
33	mg	NN	O	mg	dep	31	SENT_117	[p7l1746t267r1801b298],
34	/	:	O	/	punct	38	SENT_117	[p7l1746t267r1801b298],
35	TPM	NN	O	tpm	nn	38	SENT_117	[p7l1508t307r1568b330],
36	46	CD	NUMBER	46	num	38	SENT_117	[p7l1575t307r1608b330],
37	mg	NN	O	mg	nn	38	SENT_117	[p7l1615t306r1667b337],
38	)	NN	O	)	dep	33	SENT_117	[p7l1615t306r1667b337],
39	CR	NN	O	cr	dep	38	SENT_117	[p7l1676t306r1711b330],
40	-9.3	CD	PERCENT	-9.3	num	41	SENT_117	[p7l1719t307r1808b334],
41	%	NN	PERCENT	%	dep	39	SENT_117	[p7l1719t307r1808b334],
42	,	,	O	,	_	0	SENT_117	[p7l1719t307r1808b334],
43	and	CC	O	and	_	0	SENT_117	[p7l1510t345r1560b370],
44	(	CD	NUMBER	(	num	45	SENT_117	[p7l1569t345r1653b373],
45	PHEN	NN	O	phen	conj_and	21	SENT_117	[p7l1569t345r1653b373],
46	15	CD	NUMBER	15	num	47	SENT_117	[p7l1664t347r1693b370],
47	mg/TPM	NN	O	mg/tpm	dep	45	SENT_117	[p7l1701t345r1816b376],
48	92	CD	NUMBER	92	num	51	SENT_117	[p7l1510t386r1541b409],
49	mg	NN	O	mg	nn	51	SENT_117	[p7l1549t385r1601b415],
50	)	NN	O	)	nn	51	SENT_117	[p7l1549t385r1601b415],
51	CR	NN	O	cr	dep	45	SENT_117	[p7l1609t385r1645b409],
52	—	CD	PERCENT	—	number	53	SENT_117	[p7l1652t386r1752b409],
53	10.7	CD	PERCENT	10.7	num	54	SENT_117	[p7l1652t386r1752b409],
54	%	NN	PERCENT	%	dep	51	SENT_117	[p7l1652t386r1752b409],

1	The	DT	O	the	det	3	SENT_118	[p7l19t447r63b469],
2	various	JJ	O	various	amod	3	SENT_118	[p7l70t448r156b469],
3	shades	NNS	O	shades	nsubj	12	SENT_118	[p7l163t447r246b469],
4	(	RB	O	(	dep	3	SENT_118	[p7l253t447r308b473],
5	low	JJ	O	low	dep	4	SENT_118	[p7l253t447r308b473],
6	,	,	O	,	_	0	SENT_118	[p7l253t447r308b473],
7	medium	NN	O	medium	dep	3	SENT_118	[p7l316t447r422b473],
8	,	,	O	,	_	0	SENT_118	[p7l316t447r422b473],
9	and	CC	O	and	_	0	SENT_118	[p7l428t447r472b469],
10	high	JJ	O	high	amod	11	SENT_118	[p7l481t447r541b475],
11	)	NN	O	)	dep	3	SENT_118	[p7l481t447r541b475],
12	represent	VBP	O	represent	_	0	SENT_118	[p7l550t451r664b475],
13	FDA	NNP	ORGANIZATION	FDA	nn	15	SENT_118	[p7l671t448r719b469],
14	approval	NN	O	approval	nn	15	SENT_118	[p7l726t447r830b475],
15	status	NN	O	status	dobj	12	SENT_118	[p7l838t451r909b469],
16	and	CC	O	and	_	0	SENT_118	[p7l915t447r959b469],
17	off-label	JJ	O	off-label	amod	19	SENT_118	[p7l967t447r1065b469],
18	usage	NN	O	usage	nn	19	SENT_118	[p7l1074t454r1144b475],
19	ofdrugs	NNS	O	ofdrug	dobj	12	SENT_118	[p7l1150t447r1254b475],
20	.	.	O	.	_	0	SENT_118	[p7l1150t447r1254b475],

1	AMPA	NN	O	ampa	_	0	SENT_119	[p7l20t493r96b517],
2	,	,	O	,	_	0	SENT_119	[p7l20t493r96b517],
3	or-amino-3	NN	O	or-amino-3	appos	1	SENT_119	[p7l103t492r600b520],
4	.	.	O	.	_	0	SENT_119	[p7l103t492r600b520],

1	—	NN	O	—	_	0	SENT_120	[p7l103t492r600b520],
2	.	.	O	.	_	0	SENT_120	[p7l103t492r600b520],

1	hydroxy-S-methy	JJ	O	hydroxy-s-methy	amod	2	SENT_121	[p7l103t492r600b520],
2	|	NN	O	|	_	0	SENT_121	[p7l103t492r600b520],
3	.	.	O	.	_	0	SENT_121	[p7l103t492r600b520],

1	—	NN	O	—	_	0	SENT_122	[p7l103t492r600b520],
2	.	.	O	.	_	0	SENT_122	[p7l103t492r600b520],

1	4	LS	NUMBER	4	_	0	SENT_123	[p7l103t492r600b520],
2	.	.	O	.	_	0	SENT_123	[p7l103t492r600b520],

1	—	NN	O	—	_	0	SENT_124	[p7l103t492r600b520],
2	.	.	O	.	_	0	SENT_124	[p7l103t492r600b520],

1	isoxazo	NN	O	isoxazo	nn	2	SENT_125	[p7l103t492r600b520],
2	|	NN	O	|	_	0	SENT_125	[p7l103t492r600b520],
3	e	SYM	O	e	dep	4	SENT_125	[p7l103t492r600b520],
4	propionate	NN	O	propionate	rcmod	2	SENT_125	[p7l607t493r746b520],
5	;	:	O	;	_	0	SENT_125	[p7l607t493r746b520],
6	Cl	NNP	O	Cl	dep	2	SENT_125	[p7l753t493r781b517],
7	,	,	O	,	_	0	SENT_125	[p7l753t493r781b517],
8	conﬁdence	NN	O	conﬁdence	nn	9	SENT_125	[p7l788t492r921b514],
9	interval	NN	O	interval	appos	6	SENT_125	[p7l929t492r1024b517],
10	;	:	O	;	_	0	SENT_125	[p7l929t492r1024b517],
11	CR	NN	O	cr	dep	2	SENT_125	[p7l1031t493r1068b517],
12	,	,	O	,	_	0	SENT_125	[p7l1031t493r1068b517],
13	controlled	VBN	O	control	amod	14	SENT_125	[p7l1074t492r1197b514],
14	release	NN	O	release	appos	11	SENT_125	[p7l1205t492r1294b517],
15	;	:	O	;	_	0	SENT_125	[p7l1205t492r1294b517],
16	FDA	NNP	ORGANIZATION	FDA	dep	11	SENT_125	[p7l1302t493r1356b517],
17	,	,	O	,	_	0	SENT_125	[p7l1302t493r1356b517],
18	US	NNP	ORGANIZATION	US	nn	19	SENT_125	[p7l1364t493r1394b514],
19	Food	NNP	ORGANIZATION	Food	dep	11	SENT_125	[p7l1402t492r1460b514],
20	and	CC	ORGANIZATION	and	_	0	SENT_125	[p7l1468t492r1512b514],
21	Drug	NNP	ORGANIZATION	Drug	nn	22	SENT_125	[p7l1520t493r1578b520],
22	Administration	NNP	ORGANIZATION	Administration	dep	11	SENT_125	[p7l1586t492r1772b517],
23	;	:	O	;	_	0	SENT_125	[p7l1586t492r1772b517],
24	GABA,y-aminobutyric	JJ	O	gaba,y-aminobutyric	amod	25	SENT_125	[p7l1778t492r2042b520],
25	acid	NN	O	acid	dep	11	SENT_125	[p7l2048t492r2103b517],
26	;	:	O	;	_	0	SENT_125	[p7l2048t492r2103b517],
27	GLP	NN	O	glp	nn	28	SENT_125	[p7l20t528r85b548],
28	—	NN	O	—	dep	25	SENT_125	[p7l20t528r85b548],
29	1	CD	NUMBER	1	dep	28	SENT_125	[p7l20t528r85b548],
30	,	,	O	,	_	0	SENT_125	[p7l91t544r96b552],
31	g	NN	O	g	nn	37	SENT_125	[p7l103t527r267b554],
32	|	NN	O	|	nn	37	SENT_125	[p7l103t527r267b554],
33	ucagon	NN	O	ucagon	nn	37	SENT_125	[p7l103t527r267b554],
34	—	CD	NUMBER	—	num	37	SENT_125	[p7l103t527r267b554],
35	|	NN	O	|	nn	37	SENT_125	[p7l103t527r267b554],
36	ike	NN	O	ike	nn	37	SENT_125	[p7l103t527r267b554],
37	peptide	NN	O	peptide	appos	11	SENT_125	[p7l274t527r367b554],
38	1	CD	NUMBER	1	dep	37	SENT_125	[p7l376t529r393b552],
39	;	:	O	;	_	0	SENT_125	[p7l376t529r393b552],
40	PHEN	NNP	O	PHEN	dep	11	SENT_125	[p7l401t528r472b552],
41	,	,	O	,	_	0	SENT_125	[p7l401t528r472b552],
42	phentermine	NN	O	phentermine	appos	40	SENT_125	[p7l480t527r642b554],
43	;	:	O	;	_	0	SENT_125	[p7l480t527r642b554],
44	SR	NN	O	sr	dep	11	SENT_125	[p7l649t528r683b552],
45	,	,	O	,	_	0	SENT_125	[p7l649t528r683b552],
46	sustained	JJ	O	sustained	amod	49	SENT_125	[p7l690t527r804b548],
47	re	NN	O	re	nn	49	SENT_125	[p7l813t527r964b552],
48	|	NNS	O	|	nn	49	SENT_125	[p7l813t527r964b552],
49	ease	NN	O	ease	appos	44	SENT_125	[p7l813t527r964b552],
50	;	:	O	;	_	0	SENT_125	[p7l813t527r964b552],
51	TPM	NNP	O	TPM	dep	11	SENT_125	[p7l813t527r964b552],
52	,	,	O	,	_	0	SENT_125	[p7l813t527r964b552],
53	topiramate	NN	O	topiramate	appos	51	SENT_125	[p7l971t528r1110b554],
54	.	.	O	.	_	0	SENT_125	[p7l971t528r1110b554],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_126	[p7l20t603r140b624],
2	PHARMACOLOGY	NNP	O	PHARMACOLOGY	dep	12	SENT_126	[p7l149t603r373b624],
3	&	CC	O	&	_	0	SENT_126	[p7l380t603r600b624],
4	THERAPEUT	NNP	O	THERAPEUT	nn	6	SENT_126	[p7l380t603r600b624],
5	|	CD	NUMBER	|	num	6	SENT_126	[p7l380t603r600b624],
6	CS	NNP	O	CS	conj_and	2	SENT_126	[p7l380t603r600b624],
7	[	CD	NUMBER	[	num	8	SENT_126	[p7l610t601r728b631],
8	VOLUME	NNP	O	VOLUME	dep	2	SENT_126	[p7l610t601r728b631],
9	95	CD	NUMBER	95	num	8	SENT_126	[p7l736t603r764b624],
10	NUMBER	NN	O	number	dep	12	SENT_126	[p7l774t603r881b624],
11	1	CD	NUMBER	1	num	10	SENT_126	[p7l891t604r898b624],
12	|	CD	NUMBER	|	dep	15	SENT_126	[p7l912t601r914b631],
13	JANUARY	NNP	DATE	JANUARY	dep	12	SENT_126	[p7l923t603r1041b624],
14	2014	CD	DATE	2014	num	15	SENT_126	[p7l1049t603r1107b624],
15	55	CD	DATE	55	_	0	SENT_126	[p7l2109t604r2139b624],

1	PVN	NN	O	pvn	_	0	SENT_127	[p7l1108t972r1163b993],
2	’	CD	NUMBER	’	num	4	SENT_127	[p7l1345t978r1347b980],
3	V	NN	O	v	nn	4	SENT_127	[p7l1367t994r1371b1000],
4	Hypothalamus	NN	O	hypothalamus	dep	1	SENT_127	[p7l1456t972r1639b999],

1	CRH	NNP	O	CRH	_	0	SENT_128	[p7l1183t995r1235b1014],
2	TFlH	NN	O	tflh	dep	1	SENT_128	[p7l1265t995r1315b1014],

1	.	.	O	.	_	0	SENT_129	[p7l1128t1056r1132b1062],

1	Y15Fl	NN	O	y15fl	_	0	SENT_130	[p7l1157t1044r1242b1074],
2	MC34	NN	O	mc34	dep	1	SENT_130	[p7l1258t1044r1344b1074],
3	-	:	O	-	_	0	SENT_130	[p7l1388t1033r1407b1065],
4	,	,	O	,	_	0	SENT_130	[p7l1460t1066r1461b1069],

1	LHA	NN	O	lha	_	0	SENT_131	[p7l1499t1107r1553b1128],

1	OFlX	NN	O	oflx	nsubj	4	SENT_132	[p7l1581t1136r1650b1164],
2	>	JJR	O	>	dep	4	SENT_132	[p7l1581t1136r1650b1164],
3	“	CD	NUMBER	“	num	4	SENT_132	[p7l1581t1136r1650b1164],
4	@A	NN	O	@a	_	0	SENT_132	[p7l1663t1138r1669b1150],
5	+	CC	O	+	_	0	SENT_132	[p7l1663t1138r1669b1150],
6	aMSH	NN	O	amsh	conj_+	4	SENT_132	[p7l1303t1168r1375b1187],
7	—	SYM	O	—	dep	4	SENT_132	[p7l1451t1177r1454b1178],
8	-	:	O	-	_	0	SENT_132	[p7l1665t1176r1669b1186],
9	.	.	O	.	_	0	SENT_132	[p7l1665t1176r1669b1186],

1	I	PRP	O	I	_	0	SENT_133	[p7l1415t1180r1463b1234],
2	,	,	O	,	_	0	SENT_133	[p7l1515t1214r1516b1218],
3	‘	CD	NUMBER	‘	num	5	SENT_133	[p7l1548t1192r1652b1221],
4	MC3/4Fl	NN	O	mc3/4fl	nn	5	SENT_133	[p7l1548t1192r1652b1221],
5	|	NN	O	|	appos	1	SENT_133	[p7l1670t1189r1675b1218],
6	8	CD	NUMBER	8	dep	1	SENT_133	[p7l1670t1189r1675b1218],
7	+	CC	O	+	cc	6	SENT_133	[p7l1670t1189r1675b1218],

1	1_sR	NN	O	1_sr	_	0	SENT_134	[p7l1132t1231r1218b1262],
2	MC3/4R	NN	O	mc3/4r	dep	1	SENT_134	[p7l1234t1231r1335b1252],
3	,	,	O	,	_	0	SENT_134	[p7l1234t1231r1335b1252],

1	‘	NN	O	‘	_	0	SENT_135	[p7l204t1350r208b1358],
2	.	.	O	.	_	0	SENT_135	[p7l230t1367r232b1370],

1	VMN	NNP	O	VMN	dep	10	SENT_136	[p7l1101t1350r1163b1372],
2	»	CD	NUMBER	»	num	4	SENT_136	[p7l1187t1362r1199b1370],
3	p	NN	O	p	nn	4	SENT_136	[p7l1280t1359r1303b1370],
4	g	NN	O	g	dep	1	SENT_136	[p7l1280t1359r1303b1370],
5	+	CC	O	+	_	0	SENT_136	[p7l1280t1359r1303b1370],
6	V	NN	O	v	dep	1	SENT_136	[p7l1321t1378r1323b1381],
7	Vagal	JJ	O	vagal	amod	8	SENT_136	[p7l113t1383r183b1410],
8	““	NN	O	““	dep	10	SENT_136	[p7l274t1380r323b1390],
9	‘	CD	NUMBER	‘	num	10	SENT_136	[p7l274t1380r323b1390],
10	_	NN	O	_	_	0	SENT_136	[p7l1155t1388r1165b1394],
11	+	CC	O	+	cc	12	SENT_136	[p7l1155t1388r1165b1394],
12	BDNF	NN	O	bdnf	dep	10	SENT_136	[p7l1211t1385r1278b1405],
13	‘	SYM	O	‘	dep	15	SENT_136	[p7l1305t1390r1311b1394],
14	-	:	O	-	_	0	SENT_136	[p7l1305t1390r1311b1394],
15	"	``	O	"	dep	10	SENT_136	[p7l1325t1382r1331b1389],
16	!	.	O	!	_	0	SENT_136	[p7l1167t1411r1179b1430],

1	.	.	O	.	_	0	SENT_137	[p7l1167t1411r1179b1430],

1	.	.	O	.	_	0	SENT_138	[p7l1299t1426r1301b1428],

1	<	JJR	O	<	_	0	SENT_139	[p7l1320t1414r1333b1429],
2	8	CD	NUMBER	8	dep	1	SENT_139	[p7l1320t1414r1333b1429],
3	+	CC	O	+	cc	2	SENT_139	[p7l1320t1414r1333b1429],

1	afferents	NNS	O	afferent	nsubj	2	SENT_140	[p7l113t1417r224b1440],
2	pl	VBP	O	pl	_	0	SENT_140	[p7l284t1444r294b1458],
3	Dorsalvagal	JJ	O	dorsalvagal	nsubj	7	SENT_140	[p7l350t1438r507b1465],
4	I	PRP	O	I	nsubj	5	SENT_140	[p7l527t1450r550b1462],
5	epR	VBP	O	epr	rcmod	3	SENT_140	[p7l570t1433r615b1457],
6	,	,	O	,	_	0	SENT_140	[p7l1147t1429r1165b1449],
7	_	VBP	O	_	ccomp	2	SENT_140	[p7l1147t1429r1165b1449],
8	p	NN	O	p	nn	9	SENT_140	[p7l1183t1448r1189b1462],
9	MC3/4R	NN	O	mc3/4r	dobj	7	SENT_140	[p7l1200t1415r1329b1466],
10	.	.	O	.	_	0	SENT_140	[p7l1200t1415r1329b1466],

1	I	PRP	O	I	nsubj	2	SENT_141	[p7l1415t1415r1463b1442],
2	‘	VBP	O	‘	_	0	SENT_141	[p7l1415t1415r1463b1442],
3	l	NN	O	l	dobj	2	SENT_141	[p7l82t1475r83b1506],
4	_	NN	O	_	dep	3	SENT_141	[p7l292t1493r298b1502],
5	4	CD	NUMBER	4	num	4	SENT_141	[p7l310t1484r312b1490],
6	,	,	O	,	_	0	SENT_141	[p7l345t1486r358b1498],
7	complex	JJ	O	complex	amod	8	SENT_141	[p7l375t1473r482b1500],
8	AQHP	NN	O	aqhp	appos	4	SENT_141	[p7l1087t1469r1153b1492],

1	Com	NNP	O	Com	_	0	SENT_142	[p7l224t1504r307b1538],
2	;	:	O	;	_	0	SENT_142	[p7l224t1504r307b1538],
3	LP	NN	O	lp	dep	1	SENT_142	[p7l577t1507r645b1526],
4	-	:	O	-	_	0	SENT_142	[p7l577t1507r645b1526],
5	‘	CD	NUMBER	‘	num	10	SENT_142	[p7l577t1507r645b1526],
6	IR	NNP	O	IR	nn	10	SENT_142	[p7l577t1507r645b1526],
7	Npy	NNP	O	Npy	nn	10	SENT_142	[p7l950t1511r1002b1529],
8	NPY	NNP	O	NPY	nn	10	SENT_142	[p7l1166t1501r1219b1519],
9	AgHP	NN	O	aghp	nn	10	SENT_142	[p7l1348t1508r1415b1531],
10	ocMSH	NN	O	ocmsh	dep	3	SENT_142	[p7l1479t1502r1551b1522],

1	~	NN	O	~	_	0	SENT_143	[p7l1163t1584r1164b1590],
2	Arcuate	NNP	O	Arcuate	nn	3	SENT_143	[p7l1246t1579r1345b1601],
3	Energy	NNP	O	Energy	dep	1	SENT_143	[p7l1765t1573r1855b1601],
4	expenditure	NN	O	expenditure	dep	1	SENT_143	[p7l1865t1573r2014b1601],

1	-	:	O	-	_	0	SENT_144	[p7l1044t1609r1047b1610],
2	NPY/AQRP	NN	O	npy/aqrp	nn	3	SENT_144	[p7l1065t1599r1186b1623],
3	POMC/CART	NN	O	pomc/cart	_	0	SENT_144	[p7l1406t1604r1556b1624],
4	.	.	O	.	_	0	SENT_144	[p7l1406t1604r1556b1624],

1	.	.	O	.	_	0	SENT_145	[p7l1855t1615r1858b1619],

1	GHSR	NNP	O	GHSR	dep	2	SENT_146	[p7l959t1624r1030b1643],
2	_	VBD	O	_	_	0	SENT_146	[p7l1155t1639r1157b1642],
3	nucleus	NN	O	nucleus	dobj	2	SENT_146	[p7l1248t1614r1345b1636],
4	’	CD	NUMBER	’	num	7	SENT_146	[p7l1459t1642r1461b1645],
5	g	NN	O	g	nn	7	SENT_146	[p7l1539t1640r1541b1642],
6	GLP_1R	NN	O	glp_1r	nn	7	SENT_146	[p7l1578t1633r1666b1654],
7	Metabolism	NN	O	metabolism	nsubj	2	SENT_146	[p7l1766t1615r1891b1634],

1	H	NN	O	h	_	0	SENT_147	[p7l1095t1638r1132b1663],
2	l	NN	O	l	nn	3	SENT_147	[p7l1159t1638r1411b1686],
3	~	NN	O	~	dep	1	SENT_147	[p7l1159t1638r1411b1686],
4	.	.	O	.	_	0	SENT_147	[p7l1159t1638r1411b1686],

1	_	NN	O	_	_	0	SENT_148	[p7l1159t1638r1411b1686],
2	‘	CD	NUMBER	‘	num	3	SENT_148	[p7l1159t1638r1411b1686],
3	_	NN	O	_	dep	1	SENT_148	[p7l1159t1638r1411b1686],
4	*	CD	NUMBER	*	num	5	SENT_148	[p7l1159t1638r1411b1686],
5	__	NN	O	__	dep	3	SENT_148	[p7l1159t1638r1411b1686],
6	;	:	O	;	_	0	SENT_148	[p7l1159t1638r1411b1686],
7	r	NN	O	r	nn	8	SENT_148	[p7l1159t1638r1411b1686],
8	h	NN	O	h	dep	3	SENT_148	[p7l1427t1635r1467b1667],
9	I	PRP	O	I	dep	8	SENT_148	[p7l1511t1642r1519b1667],
10	,	,	O	,	_	0	SENT_148	[p7l1511t1642r1519b1667],
11	V29	NNP	O	V29	nn	13	SENT_148	[p7l1051t1667r1098b1686],
12	Lep	NNP	O	Lep	nn	13	SENT_148	[p7l1141t1673r1180b1696],
13	Y1/Y5R	NNP	O	Y1/Y5R	appos	9	SENT_148	[p7l1399t1676r1484b1696],
14	LepR	NN	O	lepr	dep	1	SENT_148	[p7l1514t1673r1571b1697],

1	R	NN	O	r	nn	2	SENT_149	[p7l1183t1673r1198b1691],
2	NPY	NN	O	npy	_	0	SENT_149	[p7l1260t1691r1313b1709],
3	‘	CD	NUMBER	‘	dep	2	SENT_149	[p7l1631t1699r1632b1762],

1	Adipose	NN	O	adipose	nn	2	SENT_150	[p7l1431t1846r1535b1874],
2	tissue	NN	O	tissue	_	0	SENT_150	[p7l1544t1846r1632b1868],
3	‘	CD	NUMBER	‘	num	4	SENT_150	[p7l1544t1846r1632b1868],
4	V	NN	O	v	dep	2	SENT_150	[p7l1657t1831r1659b1835],
5	3	CD	NUMBER	3	num	8	SENT_150	[p7l1683t1835r1689b1842],
6	V	NN	O	v	nn	8	SENT_150	[p7l1739t1827r1741b1829],
7	Leptin	NN	O	leptin	nn	8	SENT_150	[p7l1767t1849r1834b1873],
8	‘	NN	O	‘	dep	4	SENT_150	[p7l2014t1862r2054b1882],
9	m	NN	O	m	nn	12	SENT_150	[p7l2014t1862r2054b1882],
10	»	CD	NUMBER	»	num	12	SENT_150	[p7l1395t1896r1397b1899],
11	~	NN	O	~	nn	12	SENT_150	[p7l1655t1891r1657b1897],
12	lrml	NN	O	lrml	dep	2	SENT_150	[p7l2006t1862r2062b1907],

1	Figure	NNP	O	Figure	_	0	SENT_151	[p7l21t1979r111b2010],
2	1	CD	NUMBER	1	num	1	SENT_151	[p7l120t1981r130b2003],
3	Central	JJ	O	central	amod	4	SENT_151	[p7l158t1979r251b2003],
4	regulation	NN	O	regulation	dep	1	SENT_151	[p7l261t1979r396b2010],
5	of	IN	O	of	_	0	SENT_151	[p7l405t1979r432b2003],
6	appetite	NN	O	appetite	nn	9	SENT_151	[p7l438t1980r549b2009],
7	and	CC	O	and	_	0	SENT_151	[p7l557t1979r605b2003],
8	energy	NN	O	energy	nn	9	SENT_151	[p7l614t1986r707b2010],
9	homoeostasis	NN	O	homoeostasis	prep_of	4	SENT_151	[p7l715t1979r958b2003],
10	.	.	O	.	_	0	SENT_151	[p7l715t1979r958b2003],

1	The	DT	O	the	det	2	SENT_152	[p7l715t1979r958b2003],
2	hypothalamus	NN	O	hypothalamus	nsubj	7	SENT_152	[p7l967t1979r1157b2010],
3	is	VBZ	O	be	cop	7	SENT_152	[p7l1166t1980r1183b2003],
4	the	DT	O	the	det	7	SENT_152	[p7l1191t1979r1234b2003],
5	major	JJ	O	major	amod	7	SENT_152	[p7l1243t1980r1319b2010],
6	site	NN	O	site	nn	7	SENT_152	[p7l1327t1980r1371b2003],
7	ofintegration	NN	O	ofintegration	_	0	SENT_152	[p7l1379t1979r1558b2010],
8	ofanorexigenic	JJ	O	ofanorexigenic	amod	7	SENT_152	[p7l1567t1979r1772b2010],
9	and	CC	O	and	_	0	SENT_152	[p7l1779t1979r1828b2003],
10	orexigenic	JJ	O	orexigenic	dep	11	SENT_152	[p7l1837t1980r1975b2010],
11	signaling	NN	O	signaling	conj_and	8	SENT_152	[p7l1983t1979r2110b2010],
12	.	.	O	.	_	0	SENT_152	[p7l1983t1979r2110b2010],

1	Peripheral	JJ	O	peripheral	amod	3	SENT_153	[p7l21t2020r153b2051],
2	satiety	NN	O	satiety	nn	3	SENT_153	[p7l163t2021r249b2051],
3	hormones	NNS	O	hormone	nsubj	20	SENT_153	[p7l258t2020r398b2048],
4	,	,	O	,	_	0	SENT_153	[p7l258t2020r398b2048],
5	such	JJ	O	such	_	0	SENT_153	[p7l407t2020r466b2045],
6	as	IN	O	as	_	0	SENT_153	[p7l475t2027r501b2045],
7	ghrelin	NN	O	ghrelin	prep_such_as	3	SENT_153	[p7l509t2020r601b2051],
8	from	IN	O	from	_	0	SENT_153	[p7l609t2020r672b2045],
9	the	DT	O	the	det	10	SENT_153	[p7l680t2020r723b2045],
10	stomach	NN	O	stomach	prep_from	7	SENT_153	[p7l731t2020r844b2045],
11	and	CC	O	and	_	0	SENT_153	[p7l853t2020r901b2045],
12	leptin	NN	O	leptin	conj_and	10	SENT_153	[p7l911t2020r985b2051],
13	from	IN	O	from	_	0	SENT_153	[p7l993t2020r1055b2045],
14	adipose	NN	O	adipose	nn	15	SENT_153	[p7l1064t2020r1168b2051],
15	tissue	NN	O	tissue	prep_from	10	SENT_153	[p7l1176t2021r1258b2048],
16	,	,	O	,	_	0	SENT_153	[p7l1176t2021r1258b2048],
17	primarily	RB	O	primarily	advmod	18	SENT_153	[p7l1267t2020r1384b2051],
18	bind	VBP	O	bind	_	0	SENT_153	[p7l1392t2020r1450b2045],
19	and	CC	O	and	_	0	SENT_153	[p7l1459t2020r1508b2045],
20	activate	VBP	O	activate	conj_and	18	SENT_153	[p7l1517t2021r1621b2045],
21	their	PRP$	O	they	poss	23	SENT_153	[p7l1628t2020r1690b2045],
22	cognate	JJ	O	cognate	amod	23	SENT_153	[p7l1697t2024r1805b2051],
23	receptors	NNS	O	receptor	dobj	18	SENT_153	[p7l1814t2024r1937b2051],
24	directly	RB	O	directly	advmod	18	SENT_153	[p7l1945t2020r2044b2051],
25	in	IN	O	in	_	0	SENT_153	[p7l2052t2021r2073b2044],
26	the	DT	O	the	det	27	SENT_153	[p7l19t2062r63b2086],
27	hypothalamus	NN	O	hypothalamus	prep_in	18	SENT_153	[p7l72t2062r268b2093],
28	,	,	O	,	_	0	SENT_153	[p7l72t2062r268b2093],
29	particularly	RB	O	particularly	advmod	30	SENT_153	[p7l277t2062r426b2093],
30	in	IN	O	in	conj_and	18	SENT_153	[p7l434t2063r456b2086],
31	the	DT	O	the	det	33	SENT_153	[p7l464t2062r508b2086],
32	arcuate	NN	O	arcuate	nn	33	SENT_153	[p7l515t2066r613b2086],
33	nucleus	NN	O	nucleus	pobj	30	SENT_153	[p7l622t2062r730b2090],
34	,	,	O	,	_	0	SENT_153	[p7l622t2062r730b2090],
35	or	CC	O	or	_	0	SENT_153	[p7l738t2069r765b2086],
36	in	IN	O	in	conj_or	30	SENT_153	[p7l773t2063r794b2086],
37	the	DT	O	the	det	40	SENT_153	[p7l803t2062r846b2086],
38	dorsal	NN	O	dorsal	nn	40	SENT_153	[p7l854t2062r933b2086],
39	vagal	NN	O	vagal	nn	40	SENT_153	[p7l941t2062r1011b2093],
40	complex	NN	O	complex	pobj	36	SENT_153	[p7l1020t2062r1134b2092],
41	in	IN	O	in	_	0	SENT_153	[p7l1142t2063r1164b2086],
42	the	DT	O	the	det	43	SENT_153	[p7l1172t2062r1216b2086],
43	medulla	NN	O	medullum	prep_in	40	SENT_153	[p7l1224t2062r1338b2090],
44	,	,	O	,	_	0	SENT_153	[p7l1224t2062r1338b2090],
45	which	WDT	O	which	nsubj	46	SENT_153	[p7l1345t2062r1424b2086],
46	communicates	VBZ	O	communicate	rcmod	43	SENT_153	[p7l1433t2063r1629b2086],
47	with	IN	O	with	_	0	SENT_153	[p7l1636t2062r1694b2086],
48	the	DT	O	the	det	49	SENT_153	[p7l1702t2062r1745b2086],
49	hypothalamus	NN	O	hypothalamus	prep_with	46	SENT_153	[p7l1754t2062r1950b2093],
50	.	.	O	.	_	0	SENT_153	[p7l1754t2062r1950b2093],

1	Among	IN	O	among	_	0	SENT_154	[p7l1958t2063r2056b2093],
2	the	DT	O	the	det	3	SENT_154	[p7l19t2103r63b2127],
3	neurons	NNS	O	neuron	prep_among	10	SENT_154	[p7l72t2110r179b2127],
4	in	IN	O	in	_	0	SENT_154	[p7l188t2104r209b2127],
5	the	DT	O	the	det	7	SENT_154	[p7l218t2103r261b2127],
6	arcuate	NN	O	arcuate	nn	7	SENT_154	[p7l269t2107r367b2127],
7	nucleus	NN	O	nucleus	prep_in	3	SENT_154	[p7l376t2103r483b2131],
8	,	,	O	,	_	0	SENT_154	[p7l376t2103r483b2131],
9	there	EX	O	there	expl	10	SENT_154	[p7l490t2103r560b2127],
10	exist	VBP	O	exist	_	0	SENT_154	[p7l568t2104r628b2127],
11	two	CD	NUMBER	two	num	12	SENT_154	[p7l635t2107r686b2127],
12	populations	NNS	O	population	dobj	10	SENT_154	[p7l695t2103r853b2133],
13	of	IN	O	of	_	0	SENT_154	[p7l861t2103r889b2127],
14	neurons	NNS	O	neuron	prep_of	12	SENT_154	[p7l895t2110r1009b2127],
15	:	:	O	:	_	0	SENT_154	[p7l895t2110r1009b2127],
16	those	DT	O	those	conj_and	12	SENT_154	[p7l1016t2103r1090b2127],
17	expressing	VBG	O	express	partmod	16	SENT_154	[p7l1098t2104r1239b2133],
18	the	DT	O	the	det	22	SENT_154	[p7l1247t2103r1291b2127],
19	orexigenic	JJ	O	orexigenic	amod	22	SENT_154	[p7l1299t2104r1437b2133],
20	neuropeptideY	NN	O	neuropeptidey	nn	22	SENT_154	[p7l1446t2103r1650b2133],
21	(	CD	NUMBER	(	num	22	SENT_154	[p7l1658t2103r1730b2130],
22	NPY	NN	MISC	npy	nsubj	29	SENT_154	[p7l1658t2103r1730b2130],
23	)	CD	NUMBER	)	num	22	SENT_154	[p7l1658t2103r1730b2130],
24	or	CC	O	or	_	0	SENT_154	[p7l1739t2110r1766b2127],
25	agouti-related	JJ	O	agouti-related	amod	26	SENT_154	[p7l1773t2103r1961b2133],
26	peptide	NN	O	peptide	conj_or	22	SENT_154	[p7l1971t2103r2073b2133],
27	(	CD	NUMBER	(	num	29	SENT_154	[p7l21t2144r114b2174],
28	AgRP	NN	O	agrp	nn	29	SENT_154	[p7l21t2144r114b2174],
29	)	NN	O	)	xcomp	17	SENT_154	[p7l21t2144r114b2174],
30	,	,	O	,	_	0	SENT_154	[p7l21t2144r114b2174],
31	and	CC	O	and	_	0	SENT_154	[p7l122t2144r171b2168],
32	those	DT	O	those	dobj	10	SENT_154	[p7l179t2144r253b2168],
33	expressing	VBG	O	express	partmod	32	SENT_154	[p7l261t2145r402b2174],
34	the	DT	O	the	det	39	SENT_154	[p7l411t2144r454b2168],
35	anorexigenic	JJ	O	anorexigenic	amod	39	SENT_154	[p7l462t2145r633b2174],
36	pro-opiomelanocortin	JJ	O	pro-opiomelanocortin	amod	39	SENT_154	[p7l642t2144r937b2174],
37	(	NN	O	(	nn	39	SENT_154	[p7l947t2144r1046b2171],
38	POMC	JJ	O	pomc	amod	39	SENT_154	[p7l947t2144r1046b2171],
39	)	NN	O	)	dobj	33	SENT_154	[p7l947t2144r1046b2171],
40	and	CC	O	and	_	0	SENT_154	[p7l1055t2144r1104b2168],
41	cocaine	NN	O	cocaine	conj_and	39	SENT_154	[p7l1113t2145r1225b2168],
42	-	:	O	-	_	0	SENT_154	[p7l1113t2145r1225b2168],
43	and	CC	O	and	_	0	SENT_154	[p7l1232t2144r1281b2168],
44	amphetamine-regulated	JJ	O	amphetamine-regulated	amod	45	SENT_154	[p7l1290t2144r1617b2174],
45	transcript	NN	O	transcript	conj_and	32	SENT_154	[p7l1625t2145r1753b2174],
46	(	CD	NUMBER	(	num	48	SENT_154	[p7l1761t2144r1857b2171],
47	CART	NN	O	cart	nn	48	SENT_154	[p7l1761t2144r1857b2171],
48	)	NN	O	)	dep	45	SENT_154	[p7l1761t2144r1857b2171],
49	.	.	O	.	_	0	SENT_154	[p7l1761t2144r1857b2171],

1	Several	JJ	O	several	amod	3	SENT_155	[p7l1865t2144r1958b2168],
2	satiety	NN	O	satiety	nn	3	SENT_155	[p7l1968t2145r2055b2174],
3	hormones	NNS	O	hormone	nsubj	4	SENT_155	[p7l21t2184r156b2208],
4	induce	VBP	O	induce	_	0	SENT_155	[p7l164t2184r253b2208],
5	their	PRP$	O	they	poss	7	SENT_155	[p7l261t2184r323b2208],
6	anorectic	JJ	O	anorectic	amod	7	SENT_155	[p7l330t2185r453b2208],
7	effects	NNS	O	effect	dobj	4	SENT_155	[p7l460t2184r547b2208],
8	by	IN	O	by	_	0	SENT_155	[p7l556t2184r587b2215],
9	either	CC	O	either	preconj	10	SENT_155	[p7l594t2184r672b2208],
10	inhibiting	VBG	O	inhibit	prepc_by	4	SENT_155	[p7l680t2184r806b2215],
11	the	DT	O	the	det	12	SENT_155	[p7l815t2184r858b2208],
12	activity	NN	O	activity	dobj	10	SENT_155	[p7l866t2185r962b2215],
13	of	IN	O	of	_	0	SENT_155	[p7l969t2184r997b2208],
14	NPY/AgRP	NN	O	npy/agrp	nn	15	SENT_155	[p7l1004t2185r1139b2215],
15	neurons	NNS	O	neuron	prep_of	12	SENT_155	[p7l1148t2191r1255b2208],
16	or	CC	O	or	_	0	SENT_155	[p7l1263t2191r1290b2208],
17	activating	VBG	O	activate	conj_or	10	SENT_155	[p7l1297t2185r1427b2215],
18	POMC/CART	NN	O	pomc/cart	nn	19	SENT_155	[p7l1437t2185r1603b2209],
19	neurons	NNS	O	neuron	dobj	17	SENT_155	[p7l1610t2184r1807b2208],
20	.	.	O	.	_	0	SENT_155	[p7l1610t2184r1807b2208],

1	These	DT	O	these	det	2	SENT_156	[p7l1610t2184r1807b2208],
2	neurons	NNS	O	neuron	_	0	SENT_156	[p7l1816t2191r1923b2208],
3	in	IN	O	in	_	0	SENT_156	[p7l1932t2185r1954b2208],
4	the	DT	O	the	det	7	SENT_156	[p7l1962t2184r2005b2208],
5	arcuate	NN	O	arcuate	nn	7	SENT_156	[p7l2013t2188r2111b2208],
6	nucleus	NN	O	nucleus	nn	7	SENT_156	[p7l21t2225r122b2249],
7	project	NN	O	project	prep_in	2	SENT_156	[p7l131t2226r224b2256],
8	to	TO	O	to	_	0	SENT_156	[p7l231t2229r258b2249],
9	second-order	JJ	O	second-order	amod	10	SENT_156	[p7l266t2225r444b2249],
10	neurons	NNS	O	neuron	prep_to	7	SENT_156	[p7l453t2232r560b2249],
11	in	IN	O	in	_	0	SENT_156	[p7l569t2226r590b2249],
12	other	JJ	O	other	amod	14	SENT_156	[p7l599t2225r671b2249],
13	hypothalamic	JJ	O	hypothalamic	amod	14	SENT_156	[p7l679t2225r861b2256],
14	nuclei	NNS	O	nucleus	prep_in	10	SENT_156	[p7l869t2225r954b2253],
15	,	,	O	,	_	0	SENT_156	[p7l869t2225r954b2253],
16	including	VBG	O	include	_	0	SENT_156	[p7l963t2225r1086b2256],
17	the	DT	O	the	det	22	SENT_156	[p7l1094t2225r1137b2249],
18	paraventricular	JJ	O	paraventricular	amod	22	SENT_156	[p7l1146t2225r1347b2255],
19	nucleus	NN	O	nucleus	nn	22	SENT_156	[p7l1355t2225r1456b2249],
20	(	CD	NUMBER	(	num	22	SENT_156	[p7l1465t2225r1543b2253],
21	PVN	NN	O	pvn	nn	22	SENT_156	[p7l1465t2225r1543b2253],
22	)	NN	O	)	prep_including	10	SENT_156	[p7l1465t2225r1543b2253],
23	,	,	O	,	_	0	SENT_156	[p7l1465t2225r1543b2253],
24	dorsomedial	JJ	O	dorsomedial	amod	25	SENT_156	[p7l1551t2225r1716b2249],
25	nucleus	NN	O	nucleus	prep_including	10	SENT_156	[p7l1727t2225r1828b2249],
26	(	CD	NUMBER	(	num	27	SENT_156	[p7l1837t2225r1927b2253],
27	DMN	NNP	ORGANIZATION	DMN	dep	25	SENT_156	[p7l1837t2225r1927b2253],
28	)	CD	NUMBER	)	num	27	SENT_156	[p7l1837t2225r1927b2253],
29	,	,	O	,	_	0	SENT_156	[p7l1837t2225r1927b2253],
30	ventromedial	JJ	O	ventromedial	amod	34	SENT_156	[p7l1935t2225r2111b2249],
31	nucleus	NN	O	nucleus	nn	34	SENT_156	[p7l21t2267r122b2291],
32	(	NN	O	(	nn	34	SENT_156	[p7l131t2267r220b2294],
33	VMN	NN	O	vmn	nn	34	SENT_156	[p7l131t2267r220b2294],
34	)	NN	O	)	appos	27	SENT_156	[p7l131t2267r220b2294],
35	,	,	O	,	_	0	SENT_156	[p7l131t2267r220b2294],
36	and	CC	O	and	_	0	SENT_156	[p7l228t2267r277b2291],
37	lateral	JJ	O	lateral	amod	40	SENT_156	[p7l286t2267r365b2291],
38	hypothalamic	JJ	O	hypothalamic	amod	40	SENT_156	[p7l375t2267r557b2297],
39	area	NN	O	area	nn	40	SENT_156	[p7l565t2274r619b2291],
40	(	NN	O	(	conj_and	22	SENT_156	[p7l629t2267r706b2294],
41	LHA	NN	O	lha	dep	40	SENT_156	[p7l629t2267r706b2294],
42	)	CD	NUMBER	)	num	41	SENT_156	[p7l629t2267r706b2294],
43	.	.	O	.	_	0	SENT_156	[p7l629t2267r706b2294],

1	These	DT	O	these	det	4	SENT_157	[p7l712t2267r790b2291],
2	second-order	JJ	O	second-order	amod	4	SENT_157	[p7l798t2267r976b2291],
3	hypothalamic	JJ	O	hypothalamic	amod	4	SENT_157	[p7l984t2267r1166b2297],
4	neurons	NNS	O	neuron	nsubj	5	SENT_157	[p7l1175t2274r1282b2291],
5	express	VBP	O	express	dep	8	SENT_157	[p7l1290t2274r1389b2297],
6	anorexigenic	JJ	O	anorexigenic	amod	7	SENT_157	[p7l1397t2268r1569b2297],
7	neuropeptides	NNS	O	neuropeptide	dobj	5	SENT_157	[p7l1577t2267r1772b2297],
8	(	VBP	O	(	_	0	SENT_157	[p7l1781t2267r2092b2297],
9	corticotropin-releasing	JJ	O	corticotropin-releasing	amod	10	SENT_157	[p7l1781t2267r2092b2297],
10	hormone	NN	O	hormone	dobj	8	SENT_157	[p7l21t2307r143b2332],
11	(	CD	NUMBER	(	num	12	SENT_157	[p7l152t2308r230b2335],
12	CRH	NNP	O	CRH	nsubj	8	SENT_157	[p7l152t2308r230b2335],
13	)	CD	NUMBER	)	num	12	SENT_157	[p7l152t2308r230b2335],
14	,	,	O	,	_	0	SENT_157	[p7l152t2308r230b2335],
15	thyrotropin	NN	O	thyrotropin	nn	18	SENT_157	[p7l238t2307r520b2338],
16	—	CD	NUMBER	—	num	18	SENT_157	[p7l238t2307r520b2338],
17	re	NN	O	re	nn	18	SENT_157	[p7l238t2307r520b2338],
18	|	NN	O	|	appos	12	SENT_157	[p7l238t2307r520b2338],
19	easing	VBG	O	ease	partmod	18	SENT_157	[p7l238t2307r520b2338],
20	hormone	NN	O	hormone	nn	23	SENT_157	[p7l530t2307r652b2332],
21	(	CD	NUMBER	(	num	23	SENT_157	[p7l660t2308r738b2335],
22	TRH	NN	O	trh	nn	23	SENT_157	[p7l660t2308r738b2335],
23	)	NN	O	)	dobj	19	SENT_157	[p7l660t2308r738b2335],
24	,	,	O	,	_	0	SENT_157	[p7l660t2308r738b2335],
25	and	CC	O	and	_	0	SENT_157	[p7l746t2307r795b2332],
26	brain	NN	O	brain	nn	27	SENT_157	[p7l805t2307r983b2332],
27	—	NN	O	—	conj_and	23	SENT_157	[p7l805t2307r983b2332],
28	derived	VBN	O	derive	partmod	27	SENT_157	[p7l805t2307r983b2332],
29	neurotrophic	JJ	O	neurotrophic	dep	38	SENT_157	[p7l992t2307r1166b2338],
30	factor	NN	O	factor	nn	32	SENT_157	[p7l1173t2307r1251b2332],
31	(	CD	NUMBER	(	num	32	SENT_157	[p7l1259t2308r1358b2335],
32	BDNF	NN	ORGANIZATION	bdnf	dep	38	SENT_157	[p7l1259t2308r1358b2335],
33	)	CD	NUMBER	)	num	34	SENT_157	[p7l1259t2308r1358b2335],
34	)	NN	O	)	dep	32	SENT_157	[p7l1259t2308r1358b2335],
35	and	CC	O	and	_	0	SENT_157	[p7l1367t2307r1416b2332],
36	orexigenic	JJ	O	orexigenic	amod	37	SENT_157	[p7l1424t2308r1563b2338],
37	neuropeptides	NNS	O	neuropeptide	conj_and	34	SENT_157	[p7l1571t2307r1766b2338],
38	(	VBP	O	(	acomp	28	SENT_157	[p7l1775t2308r1864b2335],
39	orexin	NN	O	orexin	nn	42	SENT_157	[p7l1775t2308r1864b2335],
40	(	CD	NUMBER	(	num	42	SENT_157	[p7l1874t2308r1946b2335],
41	ORX	NN	O	orx	nn	42	SENT_157	[p7l1874t2308r1946b2335],
42	)	NN	O	)	dobj	38	SENT_157	[p7l1874t2308r1946b2335],
43	and	CC	O	and	_	0	SENT_157	[p7l1955t2307r2004b2332],
44	melaninconcentrating	NN	O	melaninconcentrating	nn	45	SENT_157	[p7l2014t2307r2130b2332, p7l20t2349r205b2379],
45	hormone	NN	O	hormone	conj_and	42	SENT_157	[p7l215t2348r337b2372],
46	(	CD	NUMBER	(	num	49	SENT_157	[p7l346t2348r443b2376],
47	MCH	NN	O	mch	nn	49	SENT_157	[p7l346t2348r443b2376],
48	)	CD	NUMBER	)	num	49	SENT_157	[p7l346t2348r443b2376],
49	)	NN	O	)	nsubj	38	SENT_157	[p7l346t2348r443b2376],
50	,	,	O	,	_	0	SENT_157	[p7l346t2348r443b2376],
51	which	WDT	O	which	nsubj	52	SENT_157	[p7l450t2348r529b2372],
52	modulate	VBP	O	modulate	rcmod	23	SENT_157	[p7l539t2348r666b2372],
53	appetite	NN	O	appetite	nn	56	SENT_157	[p7l674t2349r785b2379],
54	and	CC	O	and	_	0	SENT_157	[p7l793t2348r841b2372],
55	energy	NN	O	energy	nn	56	SENT_157	[p7l850t2355r943b2379],
56	homeostasis	NN	O	homeostasis	dobj	52	SENT_157	[p7l951t2348r1122b2372],
57	.	.	O	.	_	0	SENT_157	[p7l951t2348r1122b2372],

1	Furthermore	RB	O	furthermore	advmod	8	SENT_158	[p7l1131t2348r1304b2376],
2	,	,	O	,	_	0	SENT_158	[p7l1131t2348r1304b2376],
3	the	DT	O	the	det	4	SENT_158	[p7l1311t2348r1355b2372],
4	regulation	NN	O	regulation	nsubj	8	SENT_158	[p7l1363t2348r1498b2379],
5	of	IN	O	of	_	0	SENT_158	[p7l1507t2348r1535b2372],
6	energy	NN	O	energy	nn	7	SENT_158	[p7l1540t2355r1632b2379],
7	balance	NN	O	balance	prep_of	4	SENT_158	[p7l1641t2348r1743b2372],
8	involves	VBZ	O	involve	_	0	SENT_158	[p7l1752t2348r1858b2372],
9	an	DT	O	a	det	10	SENT_158	[p7l1866t2355r1897b2372],
10	integration	NN	O	integration	dobj	8	SENT_158	[p7l1906t2349r2051b2379],
11	of	IN	O	of	_	0	SENT_158	[p7l2060t2348r2088b2372],
12	signaling	NN	O	signaling	prep_of	10	SENT_158	[p7l20t2389r139b2420],
13	from	IN	O	from	_	0	SENT_158	[p7l148t2389r210b2414],
14	the	DT	O	the	det	15	SENT_158	[p7l218t2389r261b2414],
15	hypothalamus	NN	O	hypothalamus	prep_from	8	SENT_158	[p7l270t2389r467b2420],
16	,	,	O	,	_	0	SENT_158	[p7l270t2389r467b2420],
17	brain	NN	O	brain	nn	18	SENT_158	[p7l475t2389r541b2414],
18	stem	NN	O	stem	prep_from	8	SENT_158	[p7l550t2393r621b2417],
19	,	,	O	,	_	0	SENT_158	[p7l550t2393r621b2417],
20	and	CC	O	and	_	0	SENT_158	[p7l629t2389r677b2414],
21	reward	NN	O	reward	nn	22	SENT_158	[p7l687t2389r777b2414],
22	pathways	NNS	O	pathway	prep_from	8	SENT_158	[p7l787t2389r912b2420],
23	of	IN	O	of	_	0	SENT_158	[p7l920t2389r948b2414],
24	the	DT	O	the	det	26	SENT_158	[p7l953t2389r996b2414],
25	mesolimbic	JJ	O	mesolimbic	amod	26	SENT_158	[p7l1005t2389r1158b2414],
26	system	NN	O	system	prep_of	22	SENT_158	[p7l1166t2393r1264b2420],
27	.	.	O	.	_	0	SENT_158	[p7l1166t2393r1264b2420],

1	Symbols	NNS	O	symbol	_	0	SENT_159	[p7l1272t2389r1391b2420],
2	:	:	O	:	_	0	SENT_159	[p7l1272t2389r1391b2420],
3	blue	JJ	O	blue	amod	4	SENT_159	[p7l1399t2389r1456b2414],
4	receptor	NN	O	receptor	dep	1	SENT_159	[p7l1465t2393r1581b2420],
5	,	,	O	,	_	0	SENT_159	[p7l1465t2393r1581b2420],
6	activating	VBG	O	activate	appos	4	SENT_159	[p7l1589t2390r1727b2420],
7	;	:	O	;	_	0	SENT_159	[p7l1589t2390r1727b2420],
8	red	JJ	O	red	amod	9	SENT_159	[p7l1735t2389r1776b2414],
9	receptor	NN	O	receptor	dep	4	SENT_159	[p7l1786t2393r1901b2420],
10	,	,	O	,	_	0	SENT_159	[p7l1786t2393r1901b2420],
11	inhibiting	VBG	O	inhibit	appos	9	SENT_159	[p7l1910t2389r2044b2420],
12	;	:	O	;	_	0	SENT_159	[p7l1910t2389r2044b2420],
13	blue	JJ	O	blue	amod	14	SENT_159	[p7l2053t2389r2110b2414],
14	arrow	NN	O	arrow	dep	4	SENT_159	[p7l20t2438r101b2458],
15	,	,	O	,	_	0	SENT_159	[p7l20t2438r101b2458],
16	appetite-stimulating	JJ	O	appetite-stimulating	amod	17	SENT_159	[p7l109t2431r382b2461],
17	pathway	NN	O	pathway	appos	14	SENT_159	[p7l392t2431r512b2461],
18	;	:	O	;	_	0	SENT_159	[p7l392t2431r512b2461],
19	red	JJ	O	red	amod	20	SENT_159	[p7l521t2431r562b2455],
20	arrow	NN	O	arrow	dep	4	SENT_159	[p7l570t2438r651b2458],
21	,	,	O	,	_	0	SENT_159	[p7l570t2438r651b2458],
22	appetite-suppressing	JJ	O	appetite-suppressing	amod	23	SENT_159	[p7l659t2432r942b2461],
23	pathway	NN	O	pathway	appos	20	SENT_159	[p7l952t2431r1070b2461],
24	.	.	O	.	_	0	SENT_159	[p7l952t2431r1070b2461],

1	GLP-1	NN	O	glp-1	nn	2	SENT_160	[p7l1078t2432r1150b2455],
2	R	NN	O	r	_	0	SENT_160	[p7l1158t2432r1179b2458],
3	,	,	O	,	_	0	SENT_160	[p7l1158t2432r1179b2458],
4	glucagon-like	JJ	O	glucagon-like	amod	5	SENT_160	[p7l1187t2431r1368b2461],
5	peptide	NN	O	peptide	appos	2	SENT_160	[p7l1377t2431r1479b2461],
6	1	CD	NUMBER	1	num	7	SENT_160	[p7l1489t2433r1496b2454],
7	receptor	NN	O	receptor	dep	5	SENT_160	[p7l1510t2434r1626b2461],
8	.	.	O	.	_	0	SENT_160	[p7l1510t2434r1626b2461],

1	Ghrel/I7	NN	O	ghrel/i7	_	0	SENT_161	[p7l633t1870r711b1889],

1	Illustrated	NNP	O	Illustrated	_	0	SENT_162	[p7l2099t1820r2118b1926],
2	by	IN	O	by	dep	1	SENT_162	[p7l2099t1787r2122b1811],
3	Zina	NNP	PERSON	Zina	nn	4	SENT_162	[p7l2099t1731r2117b1779],
4	Deretsky	NNP	PERSON	Deretsky	pobj	2	SENT_162	[p7l2099t1626r2122b1722],

1	Gastrointestinal	JJ	O	gastrointestinal	amod	2	SENT_163	[p7l229t1880r429b1903],
2	system	NN	O	system	_	0	SENT_163	[p7l439t1882r529b1908],
3	clinical	JJ	O	clinical	amod	4	SENT_163	[p7l9t2617r252b2680],
4	trials	NNS	O	trial	dep	2	SENT_163	[p7l271t2617r459b2689],
5	,	,	O	,	_	0	SENT_163	[p7l271t2617r459b2689],
6	as	IN	O	as	_	0	SENT_163	[p7l482t2640r545b2680],
7	Well	NNP	O	Well	prep_as	2	SENT_163	[p7l564t2617r701b2680],
8	as	IN	O	as	_	0	SENT_163	[p7l722t2640r785b2680],
9	future	JJ	DATE	future	amod	10	SENT_163	[p7l806t2617r1011b2680],
10	directions	NNS	O	direction	prep_as	7	SENT_163	[p7l1032t2617r1370b2680],
11	in	IN	O	in	_	0	SENT_163	[p7l1391t2623r1457b2679],
12	medical	JJ	O	medical	amod	14	SENT_163	[p7l1477t2617r1746b2680],
13	weight-loss	JJ	O	weight-loss	amod	14	SENT_163	[p7l1764t2617r2149b2701],
14	strategies	NNS	O	strategy	prep_in	10	SENT_163	[p7l10t2727r343b2805],
15	.	.	O	.	_	0	SENT_163	[p7l10t2727r343b2805],

1	ORLISTAT	NNP	O	ORLISTAT	nsubj	12	SENT_164	[p7l10t2935r352b2991],
2	(	CD	NUMBER	(	num	1	SENT_164	[p7l372t2932r572b3000],
3	ALLI	NNP	ORGANIZATION	ALLI	nn	7	SENT_164	[p7l372t2932r572b3000],
4	,	,	O	,	_	0	SENT_164	[p7l372t2932r572b3000],
5	XENICAL	NNP	O	XENICAL	appos	7	SENT_164	[p7l589t2932r927b2997],
6	)	CD	NUMBER	)	num	7	SENT_164	[p7l589t2932r927b2997],
7	Orlistat	NNP	O	Orlistat	dep	1	SENT_164	[p7l10t3032r268b3095],
8	is	VBZ	O	be	cop	12	SENT_164	[p7l289t3038r338b3095],
9	a	DT	O	a	det	12	SENT_164	[p7l361t3055r395b3095],
10	gastrointestinal	JJ	O	gastrointestinal	amod	12	SENT_164	[p7l415t3032r943b3116],
11	lipase	NN	O	lipase	nn	12	SENT_164	[p7l963t3032r1157b3115],
12	inhibitor	NN	O	inhibitor	_	0	SENT_164	[p7l1178t3032r1492b3095],
13	.	.	O	.	_	0	SENT_164	[p7l1178t3032r1492b3095],

1	It	PRP	O	it	nsubjpass	3	SENT_165	[p7l1517t3037r1566b3095],
2	was	VBD	O	be	auxpass	3	SENT_165	[p7l1584t3055r1710b3095],
3	approved	VBN	O	approve	_	0	SENT_165	[p7l1733t3032r2050b3115],
4	by	IN	O	by	_	0	SENT_165	[p7l2068t3032r2153b3116],
5	the	DT	O	the	det	6	SENT_165	[p7l8t3135r114b3198],
6	FDA	NNP	ORGANIZATION	FDA	agent	3	SENT_165	[p7l137t3139r299b3197],
7	for	IN	O	for	_	0	SENT_165	[p7l321t3135r418b3198],
8	prescription	NN	O	prescription	nn	9	SENT_165	[p7l438t3141r856b3218],
9	sale	NN	O	sale	prep_for	3	SENT_165	[p7l879t3135r1004b3198],
10	in	IN	O	in	_	0	SENT_165	[p7l1026t3141r1093b3197],
11	1999	CD	DATE	1999	prep_in	9	SENT_165	[p7l1121t3142r1275b3199],
12	and	CC	O	and	_	0	SENT_165	[p7l1300t3135r1426b3198],
13	for	IN	O	for	_	0	SENT_165	[p7l1447t3135r1545b3198],
14	over	IN	O	over	pcomp	3	SENT_165	[p7l1566t3135r2150b3198],
15	—	CD	NUMBER	—	num	17	SENT_165	[p7l1566t3135r2150b3198],
16	the-counter	JJ	O	the-counter	amod	17	SENT_165	[p7l1566t3135r2150b3198],
17	sale	NN	O	sale	pobj	14	SENT_165	[p7l9t3238r134b3301],
18	in	IN	O	in	_	0	SENT_165	[p7l157t3244r223b3300],
19	2007	CD	DATE	2007	prep_in	17	SENT_165	[p7l245t3245r424b3301],
20	.	.	O	.	_	0	SENT_165	[p7l245t3245r424b3301],

1	Because	IN	O	because	_	0	SENT_166	[p7l450t3243r724b3301],
2	of	IN	O	of	prepc_because_of	17	SENT_166	[p7l746t3238r821b3301],
3	the	DT	O	the	det	5	SENT_166	[p7l832t3238r938b3301],
4	safety-related	JJ	O	safety-related	amod	5	SENT_166	[p7l962t3238r1422b3322],
5	withdrawals	NNS	O	withdrawal	pobj	17	SENT_166	[p7l1440t3238r1858b3301],
6	of	IN	O	of	_	0	SENT_166	[p7l1882t3238r1956b3301],
7	other	JJ	O	other	amod	8	SENT_166	[p7l1969t3238r2150b3301],
8	drugs	NNS	O	drug	prep_of	5	SENT_166	[p7l9t3341r210b3425],
9	from	IN	O	from	_	0	SENT_166	[p7l238t3341r413b3404],
10	the	DT	O	the	det	11	SENT_166	[p7l440t3341r551b3404],
11	market	NN	O	market	prep_from	8	SENT_166	[p7l579t3341r851b3413],
12	,	,	O	,	_	0	SENT_166	[p7l579t3341r851b3413],
13	orlistat	NN	O	orlistat	nsubj	17	SENT_166	[p7l881t3341r1132b3404],
14	was	VBD	O	be	cop	17	SENT_166	[p7l1157t3364r1288b3404],
15	the	DT	O	the	det	17	SENT_166	[p7l1315t3341r1427b3404],
16	sole	JJ	O	sole	amod	17	SENT_166	[p7l1456t3341r1592b3404],
17	drug	NN	O	drug	_	0	SENT_166	[p7l1620t3341r1790b3425],
18	approved	VBN	O	approve	partmod	17	SENT_166	[p7l1817t3341r2149b3424],
19	by	IN	O	by	_	0	SENT_166	[p7l7t3444r93b3528],
20	the	DT	O	the	det	21	SENT_166	[p7l114t3444r224b3507],
21	FDA	NNP	ORGANIZATION	FDA	agent	18	SENT_166	[p7l250t3448r417b3506],
22	for	IN	O	for	_	0	SENT_166	[p7l442t3444r543b3507],
23	adjunctive	JJ	O	adjunctive	amod	24	SENT_166	[p7l568t3444r937b3528],
24	use	NN	O	use	prep_for	18	SENT_166	[p7l962t3467r1077b3507],
25	in	IN	O	in	_	0	SENT_166	[p7l1102t3450r1171b3506],
26	long	JJ	O	long	amod	30	SENT_166	[p7l1195t3444r1555b3528],
27	—	JJ	O	—	amod	30	SENT_166	[p7l1195t3444r1555b3528],
28	term	NN	O	term	nn	30	SENT_166	[p7l1195t3444r1555b3528],
29	weight	NN	O	weight	nn	30	SENT_166	[p7l1579t3444r1817b3528],
30	management	NN	O	management	prep_in	24	SENT_166	[p7l1841t3467r2144b3528, p7l8t3559r187b3610],
31	until	IN	O	until	mark	40	SENT_166	[p7l209t3547r372b3610],
32	the	DT	O	the	dep	34	SENT_166	[p7l394t3547r501b3610],
33	2012	CD	DATE	2012	num	34	SENT_166	[p7l525t3554r688b3610],
34	approvals	NNS	O	approval	dep	40	SENT_166	[p7l713t3547r1042b3630],
35	of	IN	O	of	_	0	SENT_166	[p7l1067t3547r1142b3610],
36	lorcaserin	NN	O	lorcaserin	prep_of	34	SENT_166	[p7l1154t3547r1499b3610],
37	and	CC	O	and	_	0	SENT_166	[p7l1523t3547r1651b3610],
38	phentermine	NN	O	phentermine	prep_of	34	SENT_166	[p7l1671t3547r2149b3630],
39	/	:	O	/	punct	40	SENT_166	[p7l1671t3547r2149b3630],
40	topiramate	NN	O	topiramate	dep	24	SENT_166	[p7l8t3656r389b3733],
41	.	.	O	.	_	0	SENT_166	[p7l8t3656r389b3733],

1	Moreover	RB	O	moreover	advmod	8	SENT_167	[p7l411t3655r752b3722],
2	,	,	O	,	_	0	SENT_167	[p7l411t3655r752b3722],
3	orlistat	NN	O	orlistat	nsubj	8	SENT_167	[p7l774t3650r1007b3713],
4	remains	VBZ	O	remain	cop	8	SENT_167	[p7l1026t3656r1294b3713],
5	the	DT	O	the	det	8	SENT_167	[p7l1313t3650r1418b3713],
6	only	JJ	O	only	amod	8	SENT_167	[p7l1438t3650r1587b3734],
7	antiobesity	NN	O	antiobesity	nn	8	SENT_167	[p7l1604t3650r1974b3734],
8	drug	NN	O	drug	_	0	SENT_167	[p7l1992t3650r2151b3734],
9	approved	VBN	O	approve	partmod	8	SENT_167	[p8l9t16r332b99],
10	by	IN	O	by	_	0	SENT_167	[p8l352t16r437b100],
11	the	DT	O	the	det	12	SENT_167	[p8l456t16r564b79],
12	EMA	NNP	O	EMA	agent	9	SENT_167	[p8l587t20r789b79],
13	.	.	O	.	_	0	SENT_167	[p8l587t20r789b79],

1	Orlistat	NNP	O	Orlistat	nsubj	2	SENT_168	[p8l817t16r1080b79],
2	acts	VBZ	O	act	_	0	SENT_168	[p8l1102t28r1233b79],
3	by	IN	O	by	_	0	SENT_168	[p8l1254t16r1340b100],
4	binding	NN	O	binding	nn	7	SENT_168	[p8l1357t16r1630b100],
5	and	CC	O	and	_	0	SENT_168	[p8l1653t16r1781b79],
6	inhibiting	VBG	O	inhibit	nn	7	SENT_168	[p8l1803t16r2149b100],
7	lipases	NNS	O	lipase	prep_by	2	SENT_168	[p8l7t119r232b202],
8	that	WDT	O	that	nsubjpass	10	SENT_168	[p8l252t119r385b182],
9	are	VBP	O	be	auxpass	10	SENT_168	[p8l405t142r505b182],
10	produced	VBN	O	produce	rcmod	7	SENT_168	[p8l525t119r852b202],
11	by	IN	O	by	_	0	SENT_168	[p8l870t119r954b203],
12	the	DT	O	the	det	13	SENT_168	[p8l969t119r1076b182],
13	pancreas	NN	O	pancreas	agent	10	SENT_168	[p8l1095t141r1395b202],
14	and	CC	O	and	_	0	SENT_168	[p8l1417t119r1543b182],
15	stomach	NN	O	stomach	agent	10	SENT_168	[p8l1564t119r1849b182],
16	and	CC	O	and	_	0	SENT_168	[p8l1870t119r1996b182],
17	that	IN	O	that	dep	24	SENT_168	[p8l2014t119r2148b182],
18	act	NN	O	act	nsubj	24	SENT_168	[p8l9t234r105b285],
19	in	IN	O	in	_	0	SENT_168	[p8l124t228r189b284],
20	the	DT	O	the	det	22	SENT_168	[p8l207t222r312b285],
21	small	JJ	O	small	amod	22	SENT_168	[p8l332t222r509b285],
22	intestine	NN	O	intestine	prep_in	18	SENT_168	[p8l529t228r813b285],
23	to	TO	O	to	aux	24	SENT_168	[p8l833t234r897b285],
24	break	VB	O	break	conj_and	10	SENT_168	[p8l916t222r1106b285],
25	down	RP	O	down	prt	24	SENT_168	[p8l1123t222r1310b285],
26	dietary	JJ	O	dietary	amod	27	SENT_168	[p8l1330t222r1568b306],
27	triglycerides	NNS	O	triglyceride	dobj	24	SENT_168	[p8l1583t222r1996b306],
28	into	IN	O	into	_	0	SENT_168	[p8l2017t228r2147b285],
29	free	JJ	O	free	amod	31	SENT_168	[p8l8t325r133b388],
30	fatty	JJ	O	fatty	amod	31	SENT_168	[p8l152t325r303b409],
31	acids	NNS	O	acid	prep_into	24	SENT_168	[p8l319t325r503b397],
32	,	,	O	,	_	0	SENT_168	[p8l319t325r503b397],
33	which	WDT	O	which	nsubjpass	36	SENT_168	[p8l523t325r728b388],
34	can	MD	O	can	aux	36	SENT_168	[p8l748t348r862b388],
35	be	VB	O	be	auxpass	36	SENT_168	[p8l880t325r958b388],
36	absorbed	VBN	O	absorb	rcmod	31	SENT_168	[p8l978t325r1284b388],
37	via	IN	O	via	_	0	SENT_168	[p8l1300t331r1400b388],
38	fatty	JJ	O	fatty	amod	40	SENT_168	[p8l1418t325r1568b409],
39	acid	NN	O	acid	nn	40	SENT_168	[p8l1585t325r1722b388],
40	transporters	NNS	O	transporter	prep_via	36	SENT_168	[p8l1739t337r2148b408],
41	expressed	VBN	O	express	partmod	40	SENT_168	[p8l9t428r342b511],
42	by	IN	O	by	_	0	SENT_168	[p8l361t428r445b512],
43	the	DT	O	the	det	46	SENT_168	[p8l463t428r569b491],
44	intestinal	JJ	O	intestinal	amod	46	SENT_168	[p8l591t428r909b491],
45	epithelial	JJ	O	epithelial	amod	46	SENT_168	[p8l931t428r1245b511],
46	cells	NNS	O	cell	agent	41	SENT_168	[p8l1267t428r1411b491],
47	(	CD	NUMBER	(	num	48	SENT_168	[p8l1437t429r1696b511],
48	Figure	NN	O	figure	tmod	41	SENT_168	[p8l1437t429r1696b511],
49	2c	JJ	O	2c	amod	50	SENT_168	[p8l1717t429r1839b505],
50	)	NN	O	)	dep	48	SENT_168	[p8l1717t429r1839b505],
51	.	.	O	.	_	0	SENT_168	[p8l1717t429r1839b505],

1	Thus	RB	O	thus	advmod	9	SENT_169	[p8l1864t428r2047b500],
2	,	,	O	,	_	0	SENT_169	[p8l1864t428r2047b500],
3	by	IN	O	by	_	0	SENT_169	[p8l2068t428r2152b512],
4	inhibiting	VBG	O	inhibit	prepc_by	9	SENT_169	[p8l9t531r345b615],
5	these	DT	O	these	det	6	SENT_169	[p8l362t531r536b594],
6	lipases	NNS	O	lipase	dobj	4	SENT_169	[p8l555t531r796b614],
7	,	,	O	,	_	0	SENT_169	[p8l555t531r796b614],
8	orlistat	NN	O	orlistat	nsubj	9	SENT_169	[p8l818t531r1053b594],
9	reduces	VBZ	O	reduce	_	0	SENT_169	[p8l1072t531r1329b594],
10	systemic	JJ	O	systemic	amod	12	SENT_169	[p8l1351t537r1639b615],
11	fat	NN	O	fat	nn	12	SENT_169	[p8l1659t531r1743b594],
12	absorption	NN	O	absorption	dobj	9	SENT_169	[p8l1763t531r2146b614],
13	.	.	O	.	_	0	SENT_169	[p8l1763t531r2146b614],

1	Unsurprisingly	RB	O	unsurprisingly	advmod	8	SENT_170	[p8l9t634r548b718],
2	,	,	O	,	_	0	SENT_170	[p8l9t634r548b718],
3	a	DT	O	a	det	6	SENT_170	[p8l574t657r608b697],
4	major	JJ	O	major	amod	6	SENT_170	[p8l631t640r836b718],
5	adverse	JJ	O	adverse	amod	6	SENT_170	[p8l860t634r1120b697],
6	effect	NN	O	effect	nsubj	8	SENT_170	[p8l1144t634r1329b697],
7	is	VBZ	O	be	cop	8	SENT_170	[p8l1352t640r1403b697],
8	steatorrhea	NN	O	steatorrhea	_	0	SENT_170	[p8l1428t634r1834b697],
9	.	.	O	.	_	0	SENT_170	[p8l1428t634r1834b697],

1	In	IN	O	in	_	0	SENT_171	[p8l1861t639r1933b696],
2	obese	JJ	O	obese	amod	3	SENT_171	[p8l1957t634r2150b697],
3	patients	NNS	O	patient	prep_in	4	SENT_171	[p8l7t743r287b820],
4	started	VBD	O	start	_	0	SENT_171	[p8l314t737r555b800],
5	on	IN	O	on	_	0	SENT_171	[p8l580t760r669b800],
6	a	DT	O	a	det	8	SENT_171	[p8l694t760r729b800],
7	controlled-energy	JJ	O	controlled-energy	amod	8	SENT_171	[p8l754t737r1395b821],
8	diet	NN	O	diet	prep_on	4	SENT_171	[p8l1417t737r1568b809],
9	,	,	O	,	_	0	SENT_171	[p8l1417t737r1568b809],
10	orlistat	NN	O	orlistat	nn	11	SENT_171	[p8l1596t737r1842b800],
11	(	NN	O	(	appos	8	SENT_171	[p8l1870t738r2021b813],
12	120	CD	NUMBER	120	num	15	SENT_171	[p8l1870t738r2021b813],
13	mg	NN	O	mg	nn	15	SENT_171	[p8l2039t760r2151b821],
14	t.i.d.	NN	O	t.i.d.	nn	15	SENT_171	[p8l8t840r183b917],
15	)	NN	O	)	nsubj	16	SENT_171	[p8l8t840r183b917],
16	induced	VBD	O	induce	rcmod	11	SENT_171	[p8l208t840r485b903],
17	more	JJR	O	more	amod	19	SENT_171	[p8l504t863r681b903],
18	weight	NN	O	weight	nn	19	SENT_171	[p8l700t840r929b924],
19	loss	NN	O	loss	dobj	16	SENT_171	[p8l947t840r1072b903],
20	(	CD	PERCENT	(	number	21	SENT_171	[p8l1097t841r1252b916],
21	3	CD	PERCENT	3	num	22	SENT_171	[p8l1097t841r1252b916],
22	%	NN	PERCENT	%	nsubj	4	SENT_171	[p8l1097t841r1252b916],
23	)	CD	NUMBER	)	nsubj	28	SENT_171	[p8l1097t841r1252b916],
24	after	IN	O	after	_	0	SENT_171	[p8l1278t840r1429b903],
25	1	CD	DURATION	1	num	26	SENT_171	[p8l1456t847r1480b902],
26	year	NN	NUMBER	year	prep_after	28	SENT_171	[p8l1505t863r1661b924],
27	,	,	O	,	_	0	SENT_171	[p8l1505t863r1661b924],
28	produced	VBD	O	produce	dep	22	SENT_171	[p8l1682t840r2010b923],
29	less	JJR	O	less	amod	30	SENT_171	[p8l2028t840r2146b903],
30	weight	NN	O	weight	nsubj	31	SENT_171	[p8l7t943r241b1027],
31	regain	VB	O	regain	ccomp	28	SENT_171	[p8l264t949r481b1027],
32	after	IN	O	after	_	0	SENT_171	[p8l505t943r661b1006],
33	2	CD	DURATION	2	num	34	SENT_171	[p8l684t950r720b1005],
34	years	NNS	NUMBER	year	prep_after	31	SENT_171	[p8l743t966r940b1027],
35	,	,	O	,	_	0	SENT_171	[p8l743t966r940b1027],
36	and	CC	O	and	_	0	SENT_171	[p8l967t943r1096b1006],
37	was	VBD	O	be	auxpass	38	SENT_171	[p8l1117t966r1245b1006],
38	associated	VBN	O	associate	dep	22	SENT_171	[p8l1270t943r1626b1006],
39	with	IN	O	with	_	0	SENT_171	[p8l1647t943r1803b1006],
40	improvements	NNS	O	improvement	prep_with	38	SENT_171	[p8l1827t949r2144b1026, p8l8t1058r213b1109],
41	in	IN	O	in	_	0	SENT_171	[p8l235t1052r300b1108],
42	fasting	VBG	O	fast	prepc_in	38	SENT_171	[p8l320t1046r548b1130],
43	low	JJ	O	low	amod	47	SENT_171	[p8l565t1046r966b1130],
44	—	NN	O	—	nn	47	SENT_171	[p8l565t1046r966b1130],
45	density	NN	O	density	nn	47	SENT_171	[p8l565t1046r966b1130],
46	lipoprotein	NN	O	lipoprotein	nn	47	SENT_171	[p8l982t1046r1361b1129],
47	cholesterol	NN	O	cholesterol	dobj	42	SENT_171	[p8l1381t1046r1748b1109],
48	and	CC	O	and	_	0	SENT_171	[p8l1769t1046r1894b1109],
49	insulin	NN	O	insulin	nn	50	SENT_171	[p8l1913t1046r2147b1109],
50	levels	NNS	O	level	conj_and	47	SENT_171	[p8l7t1148r197b1212],
51	vs.	CC	O	vs.	prep	47	SENT_171	[p8l218t1171r308b1212],
52	placebo	NN	O	placebo	dep	51	SENT_171	[p8l333t1140r684b1232],
53	.18	CD	NUMBER	.18	num	52	SENT_171	[p8l333t1140r684b1232],
54	Although	IN	O	although	mark	57	SENT_171	[p8l708t1148r1042b1233],
55	orlistat	NN	O	orlistat	nsubj	57	SENT_171	[p8l1066t1148r1309b1212],
56	has	VBZ	O	have	aux	57	SENT_171	[p8l1330t1148r1445b1212],
57	remained	VBN	O	remain	dep	28	SENT_171	[p8l1469t1148r1802b1212],
58	approved	VBN	O	approve	dep	57	SENT_171	[p8l1825t1148r2149b1232],

1	56	CD	NUMBER	56	ccomp	11	SENT_172	[p8l9t1369r72b1411],
2	and	CC	O	and	_	0	SENT_172	[p8l9t1451r141b1514],
3	has	VBZ	O	have	conj_and	1	SENT_172	[p8l168t1451r285b1514],
4	modest	JJ	O	modest	dobj	3	SENT_172	[p8l315t1451r581b1514],
5	but	CC	O	but	_	0	SENT_172	[p8l607t1451r726b1514],
6	demonstrated	VBD	O	demonstrate	conj_and	1	SENT_172	[p8l755t1451r1257b1514],
7	efficacy	NN	O	efficacy	dobj	6	SENT_172	[p8l1285t1451r1576b1535],
8	,	,	O	,	_	0	SENT_172	[p8l1285t1451r1576b1535],
9	it	PRP	O	it	nsubj	11	SENT_172	[p8l1607t1457r1655b1514],
10	has	VBZ	O	have	aux	11	SENT_172	[p8l1682t1451r1800b1514],
11	garnered	VBN	O	garner	_	0	SENT_172	[p8l1830t1451r2152b1535],
12	attention	NN	O	attention	dobj	11	SENT_172	[p8l9t1560r316b1617],
13	by	IN	O	by	_	0	SENT_172	[p8l334t1554r419b1638],
14	the	DT	O	the	det	18	SENT_172	[p8l434t1554r541b1617],
15	FDA	NNP	ORGANIZATION	FDA	nn	18	SENT_172	[p8l563t1558r725b1616],
16	and	CC	O	and	_	0	SENT_172	[p8l746t1554r872b1617],
17	Public	NNP	ORGANIZATION	Public	nn	18	SENT_172	[p8l893t1554r1108b1617],
18	Citizen	NNP	ORGANIZATION	Citizen	prep_by	12	SENT_172	[p8l1130t1558r1393b1626],
19	,	,	O	,	_	0	SENT_172	[p8l1130t1558r1393b1626],
20	a	DT	O	a	det	25	SENT_172	[p8l1416t1577r1451b1617],
21	nonproﬁt	JJ	O	nonproﬁt	amod	25	SENT_172	[p8l1470t1554r1794b1637],
22	consumer	NN	O	consumer	nn	25	SENT_172	[p8l1814t1577r2154b1617],
23	rights	NNS	O	rights	nn	25	SENT_172	[p8l9t1657r209b1741],
24	advocacy	NN	O	advocacy	nn	25	SENT_172	[p8l234t1657r562b1741],
25	group	NN	O	group	appos	18	SENT_172	[p8l582t1679r805b1741],
26	,	,	O	,	_	0	SENT_172	[p8l582t1679r805b1741],
27	because	IN	O	because	mark	28	SENT_172	[p8l828t1657r1103b1720],
28	of	IN	O	of	advcl	11	SENT_172	[p8l1128t1657r1204b1720],
29	safety	NN	O	safety	nn	30	SENT_172	[p8l1218t1657r1421b1741],
30	issues	NNS	O	issue	pobj	28	SENT_172	[p8l1440t1663r1659b1720],
31	.	.	O	.	_	0	SENT_172	[p8l1440t1663r1659b1720],

1	Risks	NNS	O	risk	nsubj	2	SENT_173	[p8l1687t1657r1870b1720],
2	include	VBP	O	include	_	0	SENT_173	[p8l1894t1657r2153b1720],
3	severe	JJ	O	severe	amod	5	SENT_173	[p8l9t1783r219b1823],
4	liver	NN	O	liver	nn	5	SENT_173	[p8l240t1760r393b1823],
5	damage	NN	O	damage	dobj	2	SENT_173	[p8l415t1760r697b1844],
6	,	,	O	,	_	0	SENT_173	[p8l415t1760r697b1844],
7	acute	JJ	O	acute	amod	8	SENT_173	[p8l722t1772r901b1823],
8	pancreatitis	NN	O	pancreatitis	dobj	2	SENT_173	[p8l923t1766r1342b1843],
9	,	,	O	,	_	0	SENT_173	[p8l923t1766r1342b1843],
10	acute	JJ	O	acute	amod	12	SENT_173	[p8l1367t1772r1546b1823],
11	renal	JJ	O	renal	amod	12	SENT_173	[p8l1569t1760r1741b1823],
12	failure	NN	O	failure	conj_and	5	SENT_173	[p8l1763t1760r1999b1832],
13	,	,	O	,	_	0	SENT_173	[p8l1763t1760r1999b1832],
14	and	CC	O	and	_	0	SENT_173	[p8l2025t1760r2151b1823],
15	precancerous	JJ	O	precancerous	amod	17	SENT_173	[p8l7t1885r464b1946],
16	colon	NN	O	colon	nn	17	SENT_173	[p8l486t1863r674b1926],
17	lesions	NNS	O	lesion	conj_and	5	SENT_173	[p8l693t1854r1008b1926],
18	.	.	O	.	_	0	SENT_173	[p8l693t1854r1008b1926],

1	”	NN	O	”	nsubj	17	SENT_174	[p8l693t1854r1008b1926],
2	In	IN	O	in	_	0	SENT_174	[p8l1030t1868r1101b1925],
3	summary	NN	O	summary	prep_in	17	SENT_174	[p8l1123t1885r1461b1947],
4	,	,	O	,	_	0	SENT_174	[p8l1123t1885r1461b1947],
5	the	DT	O	the	det	7	SENT_174	[p8l1483t1862r1589b1926],
6	modest	JJ	O	modest	amod	7	SENT_174	[p8l1610t1863r1864b1926],
7	eﬂicacy	NN	O	eﬂicacy	prep_in	17	SENT_174	[p8l1884t1862r2150b1947],
8	,	,	O	,	_	0	SENT_174	[p8l1884t1862r2150b1947],
9	undesirable	JJ	O	undesirable	amod	11	SENT_174	[p8l8t1965r404b2029],
10	adverse	JJ	O	adverse	amod	11	SENT_174	[p8l426t1965r680b2029],
11	effects	NNS	O	effect	conj_and	3	SENT_174	[p8l702t1965r931b2037],
12	,	,	O	,	_	0	SENT_174	[p8l702t1965r931b2037],
13	and	CC	O	and	_	0	SENT_174	[p8l955t1965r1080b2029],
14	serious	JJ	O	serious	amod	16	SENT_174	[p8l1101t1971r1340b2029],
15	health	NN	O	health	nn	16	SENT_174	[p8l1360t1965r1572b2029],
16	risks	NNS	O	risk	conj_and	3	SENT_174	[p8l1593t1965r1749b2029],
17	combine	VBP	O	combine	_	0	SENT_174	[p8l1771t1965r2065b2029],
18	to	TO	O	to	aux	19	SENT_174	[p8l2085t1977r2150b2029],
19	highlight	VB	O	highlight	xcomp	17	SENT_174	[p8l7t2069r315b2153],
20	the	DT	O	the	det	21	SENT_174	[p8l333t2069r438b2132],
21	deﬁciencies	NNS	O	deﬁciencies	dobj	19	SENT_174	[p8l459t2069r849b2132],
22	of	IN	O	of	_	0	SENT_174	[p8l870t2069r943b2132],
23	orlistat	NN	O	orlistat	prep_of	21	SENT_174	[p8l954t2069r1187b2132],
24	and	CC	O	and	_	0	SENT_174	[p8l1207t2069r1331b2132],
25	underscore	VBP	O	underscore	conj_and	17	SENT_174	[p8l1351t2069r1728b2132],
26	the	DT	O	the	det	28	SENT_174	[p8l1747t2069r1852b2132],
27	pressing	VBG	O	press	amod	28	SENT_174	[p8l1871t2075r2151b2153],
28	need	NN	O	need	dobj	25	SENT_174	[p8l8t2172r173b2235],
29	for	IN	O	for	_	0	SENT_174	[p8l193t2172r291b2235],
30	other	JJ	O	other	amod	33	SENT_174	[p8l312t2172r494b2235],
31	antiobesity	JJ	O	antiobesity	amod	33	SENT_174	[p8l515t2172r894b2256],
32	drug	NN	O	drug	nn	33	SENT_174	[p8l913t2172r1075b2256],
33	options	NNS	O	option	prep_for	28	SENT_174	[p8l1096t2178r1368b2255],
34	.	.	O	.	_	0	SENT_174	[p8l1096t2178r1368b2255],

1	LORCASERIN	NNP	O	LORCASERIN	_	0	SENT_175	[p8l12t2387r465b2443],
2	(	CD	NUMBER	(	num	1	SENT_175	[p8l489t2384r795b2451],
3	BELVIQ	NNP	O	BELVIQ	nn	5	SENT_175	[p8l489t2384r795b2451],
4	)	CD	NUMBER	)	num	5	SENT_175	[p8l489t2384r795b2451],
5	Serotonin	NN	O	serotonin	dep	1	SENT_175	[p8l9t2488r378b2556],
6	,	,	O	,	_	0	SENT_175	[p8l9t2488r378b2556],
7	or	CC	O	or	_	0	SENT_175	[p8l406t2507r480b2547],
8	5	CD	NUMBER	5	num	10	SENT_175	[p8l506t2484r1275b2568],
9	—	NN	O	—	nn	10	SENT_175	[p8l506t2484r1275b2568],
10	hydroxytryptamine	NN	O	hydroxytryptamine	conj_or	5	SENT_175	[p8l506t2484r1275b2568],
11	(	CD	NUMBER	(	number	12	SENT_175	[p8l1304t2485r1578b2561],
12	5	CD	NUMBER	5	dep	10	SENT_175	[p8l1304t2485r1578b2561],
13	.	.	O	.	_	0	SENT_175	[p8l1304t2485r1578b2561],

1	—	NN	O	—	_	0	SENT_176	[p8l1304t2485r1578b2561],
2	.	.	O	.	_	0	SENT_176	[p8l1304t2485r1578b2561],

1	HT	JJ	O	ht	amod	2	SENT_177	[p8l1304t2485r1578b2561],
2	)	NN	O	)	nsubj	34	SENT_177	[p8l1304t2485r1578b2561],
3	,	,	O	,	_	0	SENT_177	[p8l1304t2485r1578b2561],
4	is	VBZ	O	be	cop	7	SENT_177	[p8l1605t2490r1657b2547],
5	an	DT	O	a	det	7	SENT_177	[p8l1684t2507r1767b2547],
6	important	JJ	O	important	amod	7	SENT_177	[p8l1792t2490r2154b2567],
7	neurotransmitter	NN	O	neurotransmitter	ccomp	34	SENT_177	[p8l8t2593r608b2650],
8	that	WDT	O	that	nsubj	9	SENT_177	[p8l630t2587r766b2650],
9	regulates	VBZ	O	regulate	rcmod	7	SENT_177	[p8l788t2587r1097b2671],
10	food	NN	O	food	nn	12	SENT_177	[p8l1121t2587r1281b2650],
11	intake	NN	O	intake	nn	12	SENT_177	[p8l1304t2587r1516b2650],
12	behaviors	NNS	O	behavior	dep	9	SENT_177	[p8l1537t2587r1875b2650],
13	in	IN	O	in	_	0	SENT_177	[p8l1899t2593r1967b2649],
14	both	DT	O	both	preconj	15	SENT_177	[p8l1988t2587r2150b2650],
15	invertebrates	NNS	O	invertebrate	prep_in	12	SENT_177	[p8l9t2690r453b2754],
16	and	CC	O	and	_	0	SENT_177	[p8l478t2690r605b2754],
17	vertebrates	NNS	O	vertebrate	conj_and	15	SENT_177	[p8l624t2690r1002b2754],
18	(	CD	NUMBER	(	num	19	SENT_177	[p8l1030t2691r1291b2774],
19	Figure	NN	O	figure	dep	15	SENT_177	[p8l1030t2691r1291b2774],
20	2	CD	NUMBER	2	number	21	SENT_177	[p8l1312t2682r1537b2768],
21	)	CD	NUMBER	)	num	22	SENT_177	[p8l1312t2682r1537b2768],
22	.2	NN	NUMBER	.2	dep	19	SENT_177	[p8l1312t2682r1537b2768],
23	°	CD	NUMBER	°	number	24	SENT_177	[p8l1312t2682r1537b2768],
24	’21	CD	NUMBER	’21	num	22	SENT_177	[p8l1312t2682r1537b2768],
25	In	IN	O	in	dep	12	SENT_177	[p8l1564t2696r1636b2753],
26	more	JJR	O	more	amod	28	SENT_177	[p8l1659t2713r1838b2754],
27	complex	JJ	O	complex	amod	28	SENT_177	[p8l1861t2691r2154b2774],
28	animals	NNS	O	animal	pobj	25	SENT_177	[p8l9t2794r298b2866],
29	,	,	O	,	_	0	SENT_177	[p8l9t2794r298b2866],
30	including	VBG	O	include	_	0	SENT_177	[p8l323t2794r656b2878],
31	humans	NNS	O	human	prep_including	34	SENT_177	[p8l677t2794r974b2866],
32	,	,	O	,	_	0	SENT_177	[p8l677t2794r974b2866],
33	serotonin	NN	O	serotonin	nsubj	34	SENT_177	[p8l1000t2800r1331b2857],
34	mediates	VBZ	O	mediate	_	0	SENT_177	[p8l1355t2794r1664b2857],
35	multiple	JJ	O	multiple	amod	36	SENT_177	[p8l1687t2794r1978b2877],
36	processes	NNS	O	process	dobj	34	SENT_177	[p8l2000t2816r2149b2877, p8l9t2920r211b2960],
37	in	IN	O	in	_	0	SENT_177	[p8l235t2903r302b2959],
38	the	DT	O	the	det	41	SENT_177	[p8l325t2897r432b2960],
39	central	JJ	O	central	amod	41	SENT_177	[p8l456t2897r693b2960],
40	nervous	JJ	O	nervous	amod	41	SENT_177	[p8l715t2920r992b2960],
41	system	NN	O	system	prep_in	36	SENT_177	[p8l1016t2909r1250b2981],
42	through	IN	O	through	_	0	SENT_177	[p8l1272t2897r1553b2981],
43	14	CD	NUMBER	14	num	46	SENT_177	[p8l1583t2904r1655b2959],
44	distinct	JJ	O	distinct	amod	46	SENT_177	[p8l1679t2897r1939b2960],
45	5-HT	NN	O	5-ht	nn	46	SENT_177	[p8l1963t2900r2151b2960],
46	receptors	NNS	O	receptor	prep_through	34	SENT_177	[p8l9t3011r325b3083],
47	belonging	VBG	O	belong	partmod	46	SENT_177	[p8l346t2999r694b3084],
48	to	TO	O	to	_	0	SENT_177	[p8l714t3011r780b3063],
49	seven	CD	NUMBER	seven	num	50	SENT_177	[p8l805t3022r996b3063],
50	families	NNS	O	family	prep_to	47	SENT_177	[p8l1018t2991r1367b3063],
51	.	.	O	.	_	0	SENT_177	[p8l1018t2991r1367b3063],

1	”	NN	O	”	nsubj	17	SENT_178	[p8l1018t2991r1367b3063],
2	The	DT	O	the	det	4	SENT_178	[p8l1393t2999r1520b3063],
3	serotonergic	JJ	O	serotonergic	amod	4	SENT_178	[p8l1543t3006r1971b3084],
4	neurons	NNS	O	neuron	dep	1	SENT_178	[p8l1993t3022r2149b3063, p8l9t3126r162b3166],
5	project	NN	O	project	nn	6	SENT_178	[p8l188t3109r439b3187],
6	axons	NNS	O	axon	dep	1	SENT_178	[p8l464t3126r667b3166],
7	into	IN	O	into	_	0	SENT_178	[p8l693t3109r832b3166],
8	almost	RB	O	almost	advmod	11	SENT_178	[p8l861t3103r1099b3166],
9	all	DT	O	all	det	11	SENT_178	[p8l1125t3103r1207b3166],
10	brain	NN	O	brain	nn	11	SENT_178	[p8l1231t3103r1419b3166],
11	areas	NNS	O	area	prep_into	6	SENT_178	[p8l1446t3126r1623b3166],
12	and	CC	O	and	_	0	SENT_178	[p8l1650t3103r1781b3166],
13	the	DT	O	the	det	15	SENT_178	[p8l1805t3103r1916b3166],
14	spinal	JJ	O	spinal	amod	15	SENT_178	[p8l1943t3103r2154b3186],
15	cord	NN	O	cord	conj_and	11	SENT_178	[p8l9t3206r168b3270],
16	to	TO	O	to	aux	17	SENT_178	[p8l191t3218r258b3270],
17	release	VB	O	release	dep	44	SENT_178	[p8l285t3206r524b3270],
18	5-HT	NN	O	5-ht	dobj	17	SENT_178	[p8l551t3209r744b3270],
19	to	TO	O	to	aux	20	SENT_178	[p8l768t3218r836b3270],
20	activate	VB	O	activate	xcomp	17	SENT_178	[p8l864t3212r1133b3270],
21	serotonin-sensitive	JJ	O	serotonin-sensitive	amod	22	SENT_178	[p8l1160t3212r1839b3270],
22	neurons	NNS	O	neuron	dobj	20	SENT_178	[p8l1864t3229r2152b3270],
23	in	IN	O	in	_	0	SENT_178	[p8l9t3316r77b3372],
24	virtually	RB	O	virtually	advmod	26	SENT_178	[p8l99t3310r403b3394],
25	all	DT	O	all	det	26	SENT_178	[p8l426t3310r507b3373],
26	regions	NNS	O	region	prep_in	20	SENT_178	[p8l532t3316r790b3394],
27	of	IN	O	of	_	0	SENT_178	[p8l816t3310r892b3373],
28	the	DT	O	the	det	31	SENT_178	[p8l906t3310r1017b3373],
29	central	JJ	O	central	amod	31	SENT_178	[p8l1042t3310r1286b3373],
30	nervous	JJ	O	nervous	amod	31	SENT_178	[p8l1310t3333r1594b3373],
31	system	NN	O	system	prep_of	26	SENT_178	[p8l1621t3322r1880b3394],
32	,	,	O	,	_	0	SENT_178	[p8l1621t3322r1880b3394],
33	mainly	RB	O	mainly	advmod	20	SENT_178	[p8l1906t3310r2154b3394],
34	from	IN	O	from	_	0	SENT_178	[p8l8t3413r180b3477],
35	the	DT	O	the	det	37	SENT_178	[p8l203t3413r312b3477],
36	raphe	NN	O	raphe	nn	37	SENT_178	[p8l336t3413r533b3497],
37	nuclei	NNS	O	nucleus	prep_from	20	SENT_178	[p8l557t3413r770b3477],
38	of	IN	O	of	_	0	SENT_178	[p8l793t3413r869b3477],
39	the	DT	O	the	det	41	SENT_178	[p8l882t3413r991b3477],
40	midbrain	JJ	O	midbrain	amod	41	SENT_178	[p8l1015t3405r1423b3477],
41	.21	CD	NUMBER	.21	prep_of	37	SENT_178	[p8l1015t3405r1423b3477],
42	It	PRP	O	it	nsubj	44	SENT_178	[p8l1452t3419r1502b3477],
43	is	VBZ	O	be	cop	44	SENT_178	[p8l1525t3420r1576b3477],
44	notable	JJ	O	notable	_	0	SENT_178	[p8l1601t3413r1860b3477],
45	that	IN	O	that	complm	53	SENT_178	[p8l1883t3413r2021b3477],
46	the	DT	O	the	det	47	SENT_178	[p8l2042t3413r2151b3477],
47	majority	NN	O	majority	nsubj	53	SENT_178	[p8l8t3523r299b3601],
48	of	IN	O	of	_	0	SENT_178	[p8l316t3517r389b3580],
49	the	DT	O	the	det	51	SENT_178	[p8l398t3517r504b3580],
50	serotonin-sensitive	JJ	O	serotonin-sensitive	amod	51	SENT_178	[p8l526t3523r1169b3580],
51	neurons	NNS	O	neuron	prep_of	47	SENT_178	[p8l1190t3540r1465b3580],
52	are	VBP	O	be	cop	53	SENT_178	[p8l1486t3540r1585b3580],
53	heteroreceptors	NNS	O	heteroreceptor	ccomp	44	SENT_178	[p8l1605t3517r2151b3600],
54	,	,	O	,	_	0	SENT_178	[p8l1605t3517r2151b3600],
55	which	WDT	O	which	nsubj	56	SENT_178	[p8l7t3620r217b3684],
56	release	VBP	O	release	rcmod	53	SENT_178	[p8l239t3620r469b3684],
57	different	JJ	O	different	amod	58	SENT_178	[p8l493t3620r783b3684],
58	neurotransmitters	NNS	O	neurotransmitter	dobj	56	SENT_178	[p8l805t3626r1425b3684],
59	from	IN	O	from	_	0	SENT_178	[p8l1449t3620r1617b3684],
60	those	DT	O	those	prep_from	56	SENT_178	[p8l1638t3620r1822b3684],
61	that	WDT	O	that	nsubj	62	SENT_178	[p8l1844t3620r1978b3684],
62	activate	VBP	O	activate	rcmod	60	SENT_178	[p8l2000t3626r2149b3684, p8l6t3736r145b3787],
63	them	PRP	O	they	dobj	62	SENT_178	[p8l167t3715r425b3787],
64	.	.	O	.	_	0	SENT_178	[p8l167t3715r425b3787],

1	“	NNP	O	“	_	0	SENT_179	[p8l167t3715r425b3787],
2	One	CD	NUMBER	one	num	1	SENT_179	[p8l454t3727r598b3787],
3	of	IN	O	of	_	0	SENT_179	[p8l621t3723r696b3787],
4	the	DT	O	the	det	6	SENT_179	[p8l709t3723r816b3787],
5	physiological	JJ	O	physiological	amod	6	SENT_179	[p8l838t3723r1295b3808],
6	processes	NNS	O	process	prep_of	1	SENT_179	[p8l1316t3745r1642b3807],
7	that	WDT	O	that	rcmod	6	SENT_179	[p8l1665t3723r1800b3787],
8	serotonin	NN	O	serotonin	dep	1	SENT_179	[p8l1823t3730r2151b3787],

1	VOLUME	NN	O	volume	nn	3	SENT_180	[p9l543t129r768b171],
2	95	CD	NUMBER	95	num	3	SENT_180	[p9l785t130r842b171],
3	NUMBER	NN	O	number	_	0	SENT_180	[p9l863t129r1087b171],
4	1	CD	NUMBER	1	number	5	SENT_180	[p9l1109t131r1122b171],
5	|	CD	NUMBER	|	dep	3	SENT_180	[p9l1152t125r1156b186],
6	JANUARY	NNP	DATE	JANUARY	dep	5	SENT_180	[p9l1175t129r1420b171],
7	2014	CD	DATE	2014	num	6	SENT_180	[p9l1437t130r1558b171],
8	|	CD	NUMBER	|	num	9	SENT_180	[p9l1577t125r1581b186],
9	www.nature.com/cpt	NN	O	www.nature.com/cpt	dep	3	SENT_180	[p9l1600t129r2152b182],

1	.	.	O	.	_	0	SENT_181	[p9l194t511r200b513],

1	.	.	O	.	_	0	SENT_182	[p9l194t511r200b513],

1	,	,	O	,	_	0	SENT_183	[p9l234t515r245b516],
2	,	,	O	,	_	0	SENT_183	[p9l234t515r245b516],
3	Re_C9Pt	NN	O	re_c9pt	nn	5	SENT_183	[p9l262t489r379b523],
4	°	CD	NUMBER	°	num	5	SENT_183	[p9l262t489r379b523],
5	f51	NN	O	f51	appos	1	SENT_183	[p9l262t489r379b523],
6	Anorexigenic	JJ	O	anorexigenic	amod	7	SENT_183	[p9l483t495r640b519],
7	Anorexigenic	JJ	O	anorexigenic	dep	5	SENT_183	[p9l1081t495r1238b519],
8	Orexigenic	JJ	O	orexigenic	amod	14	SENT_183	[p9l1673t495r1800b519],
9	"	``	O	"	punct	14	SENT_183	[p9l205t513r254b545],
10	II	CD	NUMBER	ii	num	14	SENT_183	[p9l205t513r254b545],
11	"	``	O	"	punct	14	SENT_183	[p9l205t513r254b545],
12	3	CD	NUMBER	3	num	14	SENT_183	[p9l261t519r382b544],
13	“	NN	O	“	nn	14	SENT_183	[p9l261t519r382b544],
14	mU'at	NN	O	mu'at	rcmod	7	SENT_183	[p9l261t519r382b544],
15	'	''	O	'	_	0	SENT_183	[p9l261t519r382b544],
16	“	CD	NUMBER	“	number	17	SENT_183	[p9l261t519r382b544],
17	9	CD	NUMBER	9	num	21	SENT_183	[p9l261t519r382b544],
18	signaling	NN	O	signaling	nn	21	SENT_183	[p9l508t525r616b549],
19	signaling	NN	O	signaling	nn	21	SENT_183	[p9l1105t525r1213b549],
20	signaling	NN	O	signaling	nn	21	SENT_183	[p9l1682t525r1790b549],
21	Illjll	NN	O	illjll	dep	1	SENT_183	[p9l205t549r254b581],
22	Inhibitory	JJ	O	inhibitory	amod	23	SENT_183	[p9l263t559r363b583],
23	‘	NN	O	‘	dep	21	SENT_183	[p9l554t557r564b641],

1	r	NN	O	r	nn	3	SENT_184	[p9l330t641r337b653],
2	’	CD	NUMBER	’	num	3	SENT_184	[p9l330t641r337b653],
3	L	NN	O	l	_	0	SENT_184	[p9l327t657r340b673],
4	_	CD	NUMBER	_	num	6	SENT_184	[p9l352t675r355b677],
5	Nucleus	NNP	O	Nucleus	nn	6	SENT_184	[p9l385t653r473b672],
6	accumbens	NNS	O	accumben	dep	3	SENT_184	[p9l481t653r608b672],
7	neuron	NN	O	neuron	dep	3	SENT_184	[p9l617t658r692b681],

1	MC3/4R	NN	O	mc3/4r	dep	3	SENT_185	[p9l1175t716r1265b735],
2	I	PRP	O	I	nsubj	3	SENT_185	[p9l1281t741r1283b745],
3	_	VBP	O	_	_	0	SENT_185	[p9l1331t735r1341b745],
4	.	.	O	.	_	0	SENT_185	[p9l1331t735r1341b745],
5	'	''	O	'	_	0	SENT_185	[p9l1227t749r1240b753],

1	C	NN	O	c	_	0	SENT_186	[p9l1249t749r1261b771],
2	}	NN	O	}	dep	1	SENT_186	[p9l1249t749r1261b771],
3	.	.	O	.	_	0	SENT_186	[p9l1249t749r1261b771],

1	_	NN	O	_	_	0	SENT_187	[p9l1267t745r1329b777],
2	.	.	O	.	_	0	SENT_187	[p9l1267t745r1329b777],

1	/	:	O	/	punct	2	SENT_188	[p9l1267t745r1329b777],
2	‘	CD	NUMBER	‘	_	0	SENT_188	[p9l1267t745r1329b777],
3	i	FW	O	i	dep	2	SENT_188	[p9l1267t745r1329b777],

1	E	NN	O	e	_	0	SENT_189	[p9l1829t933r1834b965],
2	‘	CD	NUMBER	‘	num	5	SENT_189	[p9l1829t933r1834b965],
3	Serotonergic	JJ	O	serotonergic	amod	5	SENT_189	[p9l1841t921r1983b953],
4	~	NN	O	~	nn	5	SENT_189	[p9l1833t965r1836b973],
5	neuron	NN	O	neuron	dep	1	SENT_189	[p9l1875t964r1950b978],

1	T	NN	O	t	_	0	SENT_190	[p9l234t907r236b909],
2	Dopaminergic	SYM	MISC	dopaminergic	dep	1	SENT_190	[p9l246t915r405b940],
3	-	:	O	-	_	0	SENT_190	[p9l415t927r417b929],
4	T	NN	O	t	dep	1	SENT_190	[p9l427t910r429b913],

1	neuron	NN	O	neuron	nn	2	SENT_191	[p9l284t950r359b965],
2	V	NN	O	v	_	0	SENT_191	[p9l426t961r429b965],
3	_	IN	O	_	dep	2	SENT_191	[p9l522t955r525b957, p9l229t1000r232b1001],

1	.	.	O	.	_	0	SENT_192	[p9l300t980r369b981],

1	—	NN	O	—	_	0	SENT_193	[p9l300t980r369b981],
2	.	.	O	.	_	0	SENT_193	[p9l300t980r369b981],

1	.	.	O	.	_	0	SENT_194	[p9l300t980r369b981],

1	—	NN	O	—	_	0	SENT_195	[p9l300t980r369b981],
2	.	.	O	.	_	0	SENT_195	[p9l300t980r369b981],

1	~	NN	O	~	_	0	SENT_196	[p9l300t980r369b981],
2	.	.	O	.	_	0	SENT_196	[p9l300t980r369b981],

1	—	NN	O	—	_	0	SENT_197	[p9l300t980r369b981],
2	.	.	O	.	_	0	SENT_197	[p9l300t980r369b981],

1	*	SYM	O	*	_	0	SENT_198	[p9l300t980r369b981],
2	-	:	O	-	_	0	SENT_198	[p9l388t980r391b981],
3	.	.	O	.	_	0	SENT_198	[p9l406t990r414b1001],

1	_	NN	O	_	_	0	SENT_199	[p9l406t990r414b1001],
2	A	NN	O	a	nn	3	SENT_199	[p9l426t985r429b989],
3	NPY	NN	O	npy	dep	1	SENT_199	[p9l970t975r1022b993],

1	_	NN	O	_	_	0	SENT_200	[p9l1261t1085r1269b1089],
2	,	,	O	,	_	0	SENT_200	[p9l1261t1085r1269b1089],
3	XNPY/AGFiP	NN	O	xnpy/agfip	appos	1	SENT_200	[p9l1281t1095r1299b1113, p9l1090t1112r1216b1132],
4	'	''	O	'	_	0	SENT_200	[p9l1299t1113r1305b1137],
5	,	,	O	,	_	0	SENT_200	[p9l1299t1113r1305b1137],

1	(	NN	O	(	_	0	SENT_201	[p9l993t1114r1001b1126],
2	IV	CD	NUMBER	iv	num	1	SENT_201	[p9l993t1129r997b1141],

1	1	LS	NUMBER	1	_	0	SENT_202	[p9l650t1143r651b1156],
2	.	.	O	.	_	0	SENT_202	[p9l737t1150r739b1153],

1	.	.	O	.	_	0	SENT_203	[p9l763t1150r766b1153],

1	‘	NN	O	‘	_	0	SENT_204	[p9l816t1145r817b1150],
2	'	''	O	'	_	0	SENT_204	[p9l997t1141r1009b1153],
3	\	SYM	O	\	dep	4	SENT_204	[p9l997t1141r1009b1153],
4	«	CD	NUMBER	«	rcmod	1	SENT_204	[p9l997t1141r1009b1153],
5	.	.	O	.	_	0	SENT_204	[p9l997t1141r1009b1153],

1	,	,	O	,	_	0	SENT_205	[p9l997t1141r1009b1153],
2	@	IN	O	@	nsubj	12	SENT_205	[p9l1295t1141r1301b1149],
3	b	NN	O	b	pobj	2	SENT_205	[p9l1295t1141r1301b1149],
4	+	CC	O	+	_	0	SENT_205	[p9l1295t1141r1301b1149],
5	‘	CD	NUMBER	‘	num	6	SENT_205	[p9l645t1152r646b1157],
6	Pramllntlde	NN	O	pramllntlde	conj_+	3	SENT_205	[p9l672t1150r794b1169],
7	'	''	O	'	_	0	SENT_205	[p9l1111t1159r1113b1161],
8	`	``	O	`	_	0	SENT_205	[p9l1241t1161r1279b1175],
9	+	CC	O	+	_	0	SENT_205	[p9l1241t1161r1279b1175],
10	Davelintide	NN	O	davelintide	nn	12	SENT_205	[p9l673t1180r793b1199],
11	P	NN	O	p	nn	12	SENT_205	[p9l816t1153r817b1204],
12	r	NN	O	r	_	0	SENT_205	[p9l816t1153r817b1204],
13	+	CC	O	+	_	0	SENT_205	[p9l816t1153r817b1204],
14	GH5	NN	O	gh5	conj_+	12	SENT_205	[p9l979t1176r1031b1195],
15	"	''	O	"	punct	14	SENT_205	[p9l1081t1161r1161b1214],
16	'	''	DATE	'	_	0	SENT_205	[p9l1081t1161r1161b1214],
17	53	CD	DATE	53	dep	14	SENT_205	[p9l1081t1161r1161b1214],
18	!	.	O	!	_	0	SENT_205	[p9l1081t1161r1161b1214],

1	”	NN	O	”	_	0	SENT_206	[p9l1185t1165r1284b1212],
2	[	CD	NUMBER	[	num	3	SENT_206	[p9l1185t1165r1284b1212],
3	gpR	NN	O	gpr	dep	1	SENT_206	[p9l1185t1165r1284b1212],

1	Obinepitide	NNP	O	Obinepitide	_	0	SENT_207	[p9l1048t1330r1173b1354],
2	\	IN	O	\	dep	1	SENT_207	[p9l1188t1337r1193b1349],

1	‘	NN	O	‘	nn	2	SENT_208	[p9l1377t1378r1378b1382],
2	Metreleptin	NN	O	metreleptin	_	0	SENT_208	[p9l1401t1372r1521b1396],

1	Excitatory	JJ	O	excitatory	amod	2	SENT_209	[p10l442t162r725b224],
2	‘	NN	O	‘	_	0	SENT_209	[p10l391t242r404b267],
3	=	JJ	O	=	amod	4	SENT_209	[p10l391t242r404b267],
4	neuron	NN	O	neuron	dep	2	SENT_209	[p10l483t253r679b289],

1	Voltage-gated	JJ	O	voltage-gated	amod	2	SENT_210	[p10l101t512r499b575],
2	LV	NN	O	lv	_	0	SENT_210	[p10l522t495r528b506],
3	calcium	NN	O	calcium	nn	4	SENT_210	[p10l282t591r499b640],
4	channels	NNS	O	channel	dep	2	SENT_210	[p10l243t670r501b718],
5	»	IN	O	»	amod	4	SENT_210	[p10l549t695r552b698],

1	GABA	NN	O	gaba	nn	2	SENT_211	[p10l142t1903r320b1953],
2	reuptake	NN	O	reuptake	_	0	SENT_211	[p10l338t1904r586b1965],
3	+	CC	O	+	prep	2	SENT_211	[p10l630t1895r643b1962],
4	transporter	NN	O	transporter	dep	3	SENT_211	[p10l205t1985r523b2044],
5	'	''	O	'	_	0	SENT_211	[p10l603t1989r606b1992],
6	'	''	O	'	_	0	SENT_211	[p10l626t1977r629b1980],

1	T	NN	O	t	nn	3	SENT_212	[p10l312t2416r315b2417],
2	|	CD	NUMBER	|	num	3	SENT_212	[p10l387t2430r592b2503],
3	nhibit_o	NN	O	nhibit_o	_	0	SENT_212	[p10l387t2430r592b2503],
4	W	NN	O	w	dep	3	SENT_212	[p10l634t2436r648b2449],
5	"	''	O	"	punct	4	SENT_212	[p10l634t2436r648b2449],
6	:	:	O	:	_	0	SENT_212	[p10l670t2416r684b2431],
7	+	CC	O	+	dep	4	SENT_212	[p10l670t2416r684b2431],

1	ne	NN	O	ne	_	0	SENT_213	[p10l417t2521r496b2575],

1	%	NN	O	%	_	0	SENT_214	[p10l889t146r890b149],
2	sodium	NN	O	sodium	nn	3	SENT_214	[p10l975t159r1180b207],
3	channels	NNS	O	channel	dep	1	SENT_214	[p10l1204t158r1473b230],
4	?	.	O	?	_	0	SENT_214	[p10l1204t158r1473b230],

1	Voltage-gated	JJ	O	voltage-gated	amod	2	SENT_215	[p10l974t80r1372b142],
2	t	NN	O	t	_	0	SENT_215	[p10l989t431r990b434],
3	Voltage-gtae	JJ	O	voltage-gtae	amod	7	SENT_215	[p10l1191t349r1590b443],
4	TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT	NN	O	ttttttttttttttttttttttttttttttttt	nn	7	SENT_215	[p10l1591t349r1722b350],
5	w	NN	O	w	nn	7	SENT_215	[p10l1723t349r1730b350],
6	A	NN	O	a	nn	7	SENT_215	[p10l1039t480r1042b483],
7	r	NN	O	r	dep	2	SENT_215	[p10l1081t492r1082b495],
8	+	CC	O	+	rcmod	7	SENT_215	[p10l1109t480r1148b531],
9	.	.	O	.	_	0	SENT_215	[p10l1168t503r1170b506],

1	potassium	NN	O	potassium	nn	2	SENT_216	[p10l1193t460r1485b521],
2	channels	NNS	O	channel	_	0	SENT_216	[p10l1508t459r1767b508],

1	1	CD	NUMBER	1	_	0	SENT_217	[p10l1621t678r1625b690],
2	‘	CD	NUMBER	‘	num	4	SENT_217	[p10l1645t624r1648b627],
3	opiramate	NN	O	opiramate	nn	4	SENT_217	[p10l1685t641r1931b695],
4	ovh	NN	O	ovh	dep	1	SENT_217	[p10l1953t622r1980b695],
5	+	CC	O	+	_	0	SENT_217	[p10l1953t622r1980b695],
6	NMDA	NN	O	nmda	nn	7	SENT_217	[p10l1802t932r1987b980],
7	receptor	NN	O	receptor	conj_+	4	SENT_217	[p10l1802t1014r2038b1072],

1	/	:	O	/	punct	5	SENT_218	[p10l1201t1225r1230b1252],
2	+	CC	O	+	nsubj	5	SENT_218	[p10l1201t1225r1230b1252],
3	AM	VBP	O	be	cop	5	SENT_218	[p10l1307t1246r1400b1295],
4	PA	NN	O	pa	nn	5	SENT_218	[p10l1410t1222r1484b1295],
5	receptor	NN	O	receptor	_	0	SENT_218	[p10l1280t1328r1516b1387],

1	M	NN	O	m	_	0	SENT_219	[p10l1141t1586r1145b1589],
2	GABAA	NN	O	gabaa	nn	3	SENT_219	[p10l1163t1547r1373b1615],
3	receptor	NN	O	receptor	dep	1	SENT_219	[p10l1165t1630r1402b1688],

1	_	NNP	O	_	nn	2	SENT_220	[p10l1035t2525r1325b2590],
2	Topiramate	NNP	O	Topiramate	_	0	SENT_220	[p10l1035t2525r1325b2590],

1	Postsynaptic	JJ	O	postsynaptic	_	0	SENT_221	[p10l1615t2165r1977b2227],
2	-	:	O	-	_	0	SENT_221	[p10l2016t2179r2019b2182],
3	.	.	O	.	_	0	SENT_221	[p10l2049t2200r2052b2208],

1	Illustrated	NNP	O	Illustrated	_	0	SENT_222	[p10l2101t2439r2143b2676],
2	by	IN	O	by	dep	1	SENT_222	[p10l2101t2364r2154b2418],
3	Zina	NNP	PERSON	Zina	nn	4	SENT_222	[p10l2101t2239r2143b2347],
4	Deretsky	NNP	PERSON	Deretsky	pobj	2	SENT_222	[p10l2101t2002r2154b2218],

1	Intestine	NN	O	intestine	nn	2	SENT_223	[p11l114t247r363b298],
2	܋	NN	O	܋	_	0	SENT_223	[p11l443t253r493b307],
3	+	CC	O	+	cc	4	SENT_223	[p11l443t253r493b307],
4	g	NN	O	g	dep	2	SENT_223	[p11l878t321r881b322],
5	r	NN	O	r	rcmod	4	SENT_223	[p11l974t272r982b275],
6	-	:	O	-	_	0	SENT_223	[p11l974t272r982b275],
7	W	NN	O	w	dep	5	SENT_223	[p11l1073t234r1269b317],
8	+	CC	O	+	rcmod	7	SENT_223	[p11l1073t234r1269b317],
9	'	''	O	'	_	0	SENT_223	[p11l1701t281r1705b289],
10	Lipid	NN	O	lipid	advmod	5	SENT_223	[p11l1778t257r1928b322],

1	”	NN	O	”	_	0	SENT_224	[p11l528t336r572b350],
2	T	NN	O	t	dep	1	SENT_224	[p11l621t340r624b341],
3	"	''	O	"	punct	2	SENT_224	[p11l1292t332r1305b344],
4	“	CD	NUMBER	“	number	5	SENT_224	[p11l1524t342r1542b348],
5	‘	CD	NUMBER	‘	num	6	SENT_224	[p11l1730t339r1733b341],
6	absorption	NN	O	absorption	dep	2	SENT_224	[p11l1789t339r2103b403],

1	Triglyceride	NN	O	triglyceride	_	0	SENT_225	[p11l1351t656r1693b721],
2	T	NN	O	t	nn	3	SENT_225	[p11l1307t742r1328b765],
3	hydrolysis	NN	O	hydrolysis	dep	1	SENT_225	[p11l1355t738r1649b801],

1	T	NN	O	t	_	0	SENT_226	[p11l1659t1091r1662b1092],
2	Cetilistat	NN	MISC	cetilistat	nn	3	SENT_226	[p11l1682t1105r1939b1156],
3	orlistat	NN	O	orlistat	dep	1	SENT_226	[p11l1682t1187r1880b1238],

1	Figure	NN	O	figure	_	0	SENT_227	[p11l22t1463r112b1494],
2	2	CD	NUMBER	2	num	4	SENT_227	[p11l119t1465r135b1487],
3	Molecular	JJ	O	molecular	amod	4	SENT_227	[p11l159t1463r291b1487],
4	targets	NNS	O	target	dep	1	SENT_227	[p11l297t1467r390b1494],
5	for	IN	O	for	_	0	SENT_227	[p11l397t1463r434b1487],
6	antiobesity	JJ	O	antiobesity	amod	7	SENT_227	[p11l441t1463r589b1494],
7	pharmacotherapeutics	NNS	O	pharmacotherapeutic	prep_for	4	SENT_227	[p11l597t1463r905b1494],
8	.	.	O	.	_	0	SENT_227	[p11l597t1463r905b1494],

1	(	NN	O	(	nsubj	5	SENT_228	[p11l914t1464r945b1491],
2	a	DT	O	a	det	4	SENT_228	[p11l914t1464r945b1491],
3	)	NN	O	)	nn	4	SENT_228	[p11l914t1464r945b1491],
4	Phentermine	NN	O	phentermine	dep	1	SENT_228	[p11l955t1463r1127b1487],
5	stimulates	VBZ	O	stimulate	_	0	SENT_228	[p11l1135t1463r1270b1487],
6	the	DT	O	the	det	7	SENT_228	[p11l1277t1463r1321b1487],
7	release	NN	O	release	dobj	5	SENT_228	[p11l1330t1463r1421b1487],
8	of	IN	O	of	_	0	SENT_228	[p11l1429t1463r1457b1487],
9	dopamine	NN	O	dopamine	prep_of	7	SENT_228	[p11l1462t1463r1598b1494],
10	(	CD	NUMBER	(	num	9	SENT_228	[p11l1607t1464r1662b1491],
11	DA	NNP	O	DA	tmod	5	SENT_228	[p11l1607t1464r1662b1491],
12	)	CD	NUMBER	)	num	11	SENT_228	[p11l1607t1464r1662b1491],
13	into	IN	O	into	_	0	SENT_228	[p11l1672t1464r1722b1487],
14	the	DT	O	the	det	15	SENT_228	[p11l1730t1463r1773b1487],
15	synapse	NN	O	synapse	prep_into	5	SENT_228	[p11l1781t1470r1888b1494],
16	from	IN	O	from	_	0	SENT_228	[p11l1895t1463r1957b1487],
17	the	DT	O	the	det	20	SENT_228	[p11l1965t1463r2008b1487],
18	presynaptic	JJ	O	presynaptic	amod	20	SENT_228	[p11l22t1505r176b1535],
19	dopaminergic	JJ	O	dopaminergic	amod	20	SENT_228	[p11l183t1504r370b1535],
20	neurons	NNS	O	neuron	prep_from	15	SENT_228	[p11l378t1511r486b1529],
21	from	IN	O	from	_	0	SENT_228	[p11l493t1504r555b1529],
22	the	DT	O	the	det	27	SENT_228	[p11l563t1504r606b1529],
23	ventral	JJ	O	ventral	amod	27	SENT_228	[p11l614t1504r704b1529],
24	tegmental	JJ	O	tegmental	amod	27	SENT_228	[p11l713t1504r849b1535],
25	area	NN	O	area	nn	27	SENT_228	[p11l858t1511r913b1529],
26	(	NN	O	(	nn	27	SENT_228	[p11l922t1504r1056b1532],
27	VTA	NN	O	vta	prep_from	5	SENT_228	[p11l922t1504r1056b1532],
28	)	CD	NUMBER	)	dep	27	SENT_228	[p11l922t1504r1056b1532],
29	.	.	O	.	_	0	SENT_228	[p11l922t1504r1056b1532],

1	This	DT	O	this	nsubj	6	SENT_229	[p11l922t1504r1056b1532],
2	released	VBN	O	release	partmod	1	SENT_229	[p11l1065t1504r1174b1529],
3	dopamine	NN	O	dopamine	dobj	2	SENT_229	[p11l1183t1504r1319b1535],
4	binds	VBZ	O	bind	_	0	SENT_229	[p11l1328t1504r1400b1529],
5	and	CC	O	and	_	0	SENT_229	[p11l1408t1504r1456b1529],
6	activates	VBZ	O	activate	conj_and	4	SENT_229	[p11l1465t1506r1582b1529],
7	dopamine	NN	O	dopamine	nn	8	SENT_229	[p11l1590t1504r1726b1535],
8	receptors	NNS	O	receptor	dobj	4	SENT_229	[p11l1735t1508r1864b1535],
9	,	,	O	,	_	0	SENT_229	[p11l1735t1508r1864b1535],
10	including	VBG	O	include	_	0	SENT_229	[p11l1873t1504r1996b1535],
11	D1	NN	O	d1	prep_including	8	SENT_229	[p11l2006t1505r2036b1528],
12	and	CC	O	and	_	0	SENT_229	[p11l2049t1504r2097b1529],
13	D2	NN	O	d2	prep_including	8	SENT_229	[p11l22t1546r63b1573],
14	,	,	O	,	_	0	SENT_229	[p11l22t1546r63b1573],
15	on	IN	O	on	_	0	SENT_229	[p11l71t1552r104b1569],
16	postsynaptic	JJ	O	postsynaptic	amod	17	SENT_229	[p11l114t1546r283b1576],
17	neurons	NNS	O	neuron	prep_on	8	SENT_229	[p11l291t1552r398b1569],
18	in	IN	O	in	_	0	SENT_229	[p11l407t1546r429b1569],
19	the	DT	O	the	det	21	SENT_229	[p11l437t1545r481b1569],
20	nucleus	NN	O	nucleus	nn	21	SENT_229	[p11l489t1545r591b1569],
21	accumbens	NNS	O	accumben	prep_in	17	SENT_229	[p11l598t1545r757b1569],
22	.	.	O	.	_	0	SENT_229	[p11l598t1545r757b1569],

1	Dopamine	NN	O	dopamine	nsubjpass	3	SENT_230	[p11l766t1546r904b1575],
2	is	VBZ	O	be	auxpass	3	SENT_230	[p11l913t1546r931b1569],
3	taken	VBN	O	take	_	0	SENT_230	[p11l938t1545r1011b1569],
4	back	RB	O	back	advmod	5	SENT_230	[p11l1021t1545r1082b1569],
5	up	RB	O	up	advmod	3	SENT_230	[p11l1090t1552r1124b1575],
6	into	IN	O	into	_	0	SENT_230	[p11l1132t1546r1183b1569],
7	the	DT	O	the	det	9	SENT_230	[p11l1190t1545r1233b1569],
8	presynaptic	JJ	O	presynaptic	amod	9	SENT_230	[p11l1242t1546r1396b1576],
9	neuron	NN	O	neuron	prep_into	3	SENT_230	[p11l1405t1552r1499b1569],
10	by	IN	O	by	_	0	SENT_230	[p11l1509t1545r1540b1576],
11	the	DT	O	the	det	13	SENT_230	[p11l1546t1545r1590b1569],
12	dopamine	NN	O	dopamine	nn	13	SENT_230	[p11l1597t1545r1734b1575],
13	transporter	NN	O	transporter	agent	3	SENT_230	[p11l1741t1549r1892b1575],
14	(	CD	NUMBER	(	num	15	SENT_230	[p11l1900t1545r1978b1573],
15	DAT	NNP	MISC	DAT	tmod	13	SENT_230	[p11l1900t1545r1978b1573],
16	)	CD	NUMBER	)	num	15	SENT_230	[p11l1900t1545r1978b1573],
17	,	,	O	,	_	0	SENT_230	[p11l1900t1545r1978b1573],
18	which	WDT	O	which	nsubjpass	22	SENT_230	[p11l1985t1545r2064b1569],
19	is	VBZ	O	be	auxpass	20	SENT_230	[p11l21t1587r39b1610],
20	bound	VBN	O	bind	rcmod	15	SENT_230	[p11l48t1586r134b1610],
21	and	CC	O	and	_	0	SENT_230	[p11l143t1586r191b1610],
22	inhibited	VBN	O	inhibit	rcmod	15	SENT_230	[p11l201t1586r319b1610],
23	by	IN	O	by	_	0	SENT_230	[p11l328t1586r360b1617],
24	bupropion	NN	O	bupropion	agent	20	SENT_230	[p11l368t1586r515b1617],
25	.	.	O	.	_	0	SENT_230	[p11l368t1586r515b1617],

1	Pramlintide	NNP	MISC	Pramlintide	nsubj	6	SENT_231	[p11l524t1586r676b1610],
2	and	CC	O	and	_	0	SENT_231	[p11l683t1586r732b1610],
3	davalintide	NN	O	davalintide	conj_and	1	SENT_231	[p11l741t1586r888b1610],
4	are	VBP	O	be	cop	6	SENT_231	[p11l896t1593r936b1610],
5	amylin	NN	O	amylin	nn	6	SENT_231	[p11l944t1586r1031b1617],
6	analogs	NNS	O	analog	_	0	SENT_231	[p11l1040t1586r1143b1617],
7	that	WDT	O	that	nsubj	8	SENT_231	[p11l1151t1586r1204b1610],
8	activate	VBP	O	activate	rcmod	6	SENT_231	[p11l1212t1587r1316b1610],
9	amylin	NN	O	amylin	nn	10	SENT_231	[p11l1323t1586r1411b1617],
10	receptors	NNS	O	receptor	nsubj	11	SENT_231	[p11l1420t1590r1544b1617],
11	(	VBP	O	(	ccomp	8	SENT_231	[p11l1552t1587r1620b1614],
12	CTR	NN	O	ctr	nn	13	SENT_231	[p11l1552t1587r1620b1614],
13	)	NN	O	)	dobj	11	SENT_231	[p11l1552t1587r1620b1614],
14	in	IN	O	in	_	0	SENT_231	[p11l1629t1587r1651b1610],
15	the	DT	O	the	det	18	SENT_231	[p11l1659t1586r1703b1610],
16	dorsal	NN	O	dorsal	nn	18	SENT_231	[p11l1710t1586r1789b1610],
17	vagal	NN	O	vagal	nn	18	SENT_231	[p11l1798t1586r1867b1617],
18	complex	NN	O	complex	prep_in	11	SENT_231	[p11l1876t1586r1991b1617],
19	(	CD	NUMBER	(	num	20	SENT_231	[p11l1999t1587r2080b1614],
20	DVC	NNP	O	DVC	dep	18	SENT_231	[p11l1999t1587r2080b1614],
21	)	CD	NUMBER	)	num	20	SENT_231	[p11l1999t1587r2080b1614],
22	.	.	O	.	_	0	SENT_231	[p11l1999t1587r2080b1614],

1	Exenatide	NNP	O	Exenatide	nsubj	9	SENT_232	[p11l22t1628r157b1656],
2	,	,	O	,	_	0	SENT_232	[p11l22t1628r157b1656],
3	liraglutide	NN	O	liraglutide	nsubj	9	SENT_232	[p11l166t1628r305b1659],
4	,	,	O	,	_	0	SENT_232	[p11l166t1628r305b1659],
5	and	CC	O	and	_	0	SENT_232	[p11l313t1628r362b1652],
6	NN9924	NN	O	nn9924	conj_and	1	SENT_232	[p11l372t1629r478b1652],
7	are	VBP	O	be	cop	9	SENT_232	[p11l485t1635r526b1652],
8	GLP-1	NN	O	glp-1	nn	9	SENT_232	[p11l533t1629r606b1652],
9	analogs	NNS	O	analog	_	0	SENT_232	[p11l618t1628r721b1659],
10	that	WDT	O	that	nsubj	11	SENT_232	[p11l729t1628r782b1652],
11	activate	VBP	O	activate	rcmod	9	SENT_232	[p11l790t1629r893b1652],
12	GLP-1	NN	O	glp-1	nn	13	SENT_232	[p11l901t1629r974b1652],
13	receptors	NNS	O	receptor	nsubj	14	SENT_232	[p11l987t1632r1111b1658],
14	(	VBP	O	(	ccomp	11	SENT_232	[p11l1119t1628r1199b1656],
15	GLP-1	NN	O	glp-1	nn	16	SENT_232	[p11l1119t1628r1199b1656],
16	R	NN	O	r	dobj	14	SENT_232	[p11l1207t1628r1230b1656],
17	)	CD	NUMBER	)	num	16	SENT_232	[p11l1207t1628r1230b1656],
18	in	IN	O	in	_	0	SENT_232	[p11l1240t1629r1261b1652],
19	the	DT	O	the	det	20	SENT_232	[p11l1269t1628r1313b1652],
20	hypothalamus	NN	O	hypothalamus	prep_in	14	SENT_232	[p11l1322t1628r1512b1659],
21	and	CC	O	and	_	0	SENT_232	[p11l1520t1628r1569b1652],
22	DVC	NN	O	dvc	prep_in	14	SENT_232	[p11l1579t1629r1640b1652],
23	.	.	O	.	_	0	SENT_232	[p11l1579t1629r1640b1652],

1	S-2367	NN	MISC	s-2367	nsubj	2	SENT_233	[p11l1648t1629r1738b1652],
2	binds	VBZ	O	bind	_	0	SENT_233	[p11l1747t1628r1819b1652],
3	and	CC	O	and	_	0	SENT_233	[p11l1827t1628r1875b1652],
4	inhibits	VBZ	O	inhibit	conj_and	2	SENT_233	[p11l1885t1628r1982b1652],
5	Y5	NN	O	y5	nn	6	SENT_233	[p11l1988t1629r2020b1652],
6	receptors	NNS	O	receptor	dobj	4	SENT_233	[p11l22t1673r145b1699],
7	in	IN	O	in	_	0	SENT_233	[p11l154t1670r175b1693],
8	the	DT	O	the	det	13	SENT_233	[p11l184t1669r227b1693],
9	hypothalamic	JJ	O	hypothalamic	amod	13	SENT_233	[p11l236t1669r418b1700],
10	paraventricular	JJ	O	paraventricular	amod	13	SENT_233	[p11l426t1669r627b1699],
11	nucleus	NN	O	nucleus	nn	13	SENT_233	[p11l635t1669r736b1693],
12	(	NN	O	(	nn	13	SENT_233	[p11l745t1669r816b1697],
13	PVN	NN	O	pvn	prep_in	6	SENT_233	[p11l745t1669r816b1697],
14	)	CD	NUMBER	)	dep	13	SENT_233	[p11l745t1669r816b1697],
15	to	TO	O	to	aux	16	SENT_233	[p11l824t1673r851b1693],
16	suppress	VB	O	suppress	xcomp	4	SENT_233	[p11l859t1676r976b1699],
17	neuropeptideY	NN	O	neuropeptidey	dobj	16	SENT_233	[p11l985t1669r1190b1699],
18	(	CD	NUMBER	(	num	21	SENT_233	[p11l1197t1669r1269b1697],
19	NPY	NN	O	npy	nn	21	SENT_233	[p11l1197t1669r1269b1697],
20	)	NN	O	)	nn	21	SENT_233	[p11l1197t1669r1269b1697],
21	signaling	NN	O	signaling	dobj	2	SENT_233	[p11l1278t1669r1404b1700],
22	.	.	O	.	_	0	SENT_233	[p11l1278t1669r1404b1700],

1	RM-493	NN	O	rm-493	nsubj	8	SENT_234	[p11l1413t1670r1512b1693],
2	is	VBZ	O	be	cop	8	SENT_234	[p11l1522t1670r1539b1693],
3	a	DT	O	a	det	8	SENT_234	[p11l1547t1676r1560b1693],
4	melanocortin	NN	O	melanocortin	nn	8	SENT_234	[p11l1570t1669r1747b1693],
5	4	CD	NUMBER	4	num	8	SENT_234	[p11l1755t1671r1771b1693],
6	receptor	NN	O	receptor	nn	8	SENT_234	[p11l1779t1673r1891b1699],
7	(	NN	O	(	nn	8	SENT_234	[p11l1899t1669r1992b1697],
8	MC4R	NN	O	mc4r	_	0	SENT_234	[p11l1899t1669r1992b1697],
9	)	CD	NUMBER	)	num	10	SENT_234	[p11l1899t1669r1992b1697],
10	agonist	NN	O	agonist	dep	8	SENT_234	[p11l2000t1670r2099b1700],
11	that	WDT	O	that	nsubj	14	SENT_234	[p11l20t1710r74b1734],
12	binds	VBZ	O	bind	rcmod	8	SENT_234	[p11l82t1710r154b1734],
13	and	CC	O	and	_	0	SENT_234	[p11l162t1710r210b1734],
14	activates	VBZ	O	activate	conj_and	12	SENT_234	[p11l219t1711r336b1734],
15	MC4R	NN	O	mc4r	dobj	12	SENT_234	[p11l344t1711r421b1734],
16	in	IN	O	in	_	0	SENT_234	[p11l429t1711r451b1734],
17	the	DT	O	the	det	18	SENT_234	[p11l459t1710r502b1734],
18	PVN	NN	O	pvn	prep_in	15	SENT_234	[p11l511t1711r564b1734],
19	and	CC	O	and	_	0	SENT_234	[p11l572t1710r621b1734],
20	lateral	JJ	O	lateral	amod	23	SENT_234	[p11l631t1710r710b1734],
21	hypothalamic	JJ	O	hypothalamic	amod	23	SENT_234	[p11l720t1710r902b1741],
22	area	NN	O	area	nn	23	SENT_234	[p11l909t1717r964b1734],
23	(	NN	O	(	dobj	12	SENT_234	[p11l974t1711r1051b1738],
24	LHA	NN	O	lha	dep	23	SENT_234	[p11l974t1711r1051b1738],
25	)	CD	NUMBER	)	num	24	SENT_234	[p11l974t1711r1051b1738],
26	.	.	O	.	_	0	SENT_234	[p11l974t1711r1051b1738],

1	Topiramate	NN	O	topiramate	nsubj	2	SENT_235	[p11l1057t1711r1208b1740],
2	induces	VBZ	O	induce	_	0	SENT_235	[p11l1217t1710r1318b1734],
3	y-aminobutyric	JJ	O	y-aminobutyric	amod	4	SENT_235	[p11l1325t1710r1528b1741],
4	acid	NN	O	acid	dobj	2	SENT_235	[p11l1535t1710r1588b1734],
5	(	CD	NUMBER	(	num	7	SENT_235	[p11l1597t1711r1689b1738],
6	GABA	NN	O	gaba	nn	7	SENT_235	[p11l1597t1711r1689b1738],
7	)	NN	O	)	tmod	2	SENT_235	[p11l1597t1711r1689b1738],
8	receptor	NN	O	receptor	nn	9	SENT_235	[p11l1699t1710r1953b1740],
9	—	NN	O	—	nsubj	10	SENT_235	[p11l1699t1710r1953b1740],
10	mediated	VBD	O	mediate	rcmod	7	SENT_235	[p11l1699t1710r1953b1740],
11	inhibitory	JJ	O	inhibitory	amod	12	SENT_235	[p11l1963t1710r2092b1741],
12	currents	NNS	O	current	dobj	10	SENT_235	[p11l21t1752r254b1775],
13	.	.	O	.	_	0	SENT_235	[p11l21t1752r254b1775],

1	TKS122S	NN	O	tks122	nsubj	5	SENT_236	[p11l21t1752r254b1775],
2	and	CC	O	and	_	0	SENT_236	[p11l263t1751r312b1775],
3	OXY-RPEG	NN	O	oxy-rpeg	conj_and	1	SENT_236	[p11l321t1752r455b1775],
4	are	VBP	O	be	cop	5	SENT_236	[p11l463t1758r503b1775],
5	oxyntomodulin	NN	O	oxyntomodulin	_	0	SENT_236	[p11l511t1751r715b1782],
6	(	CD	NUMBER	(	num	9	SENT_236	[p11l725t1751r805b1779],
7	OXM	NN	O	oxm	nn	9	SENT_236	[p11l725t1751r805b1779],
8	)	NN	O	)	nn	9	SENT_236	[p11l725t1751r805b1779],
9	analogs	NNS	O	analog	dep	5	SENT_236	[p11l814t1751r917b1782],
10	that	WDT	O	that	nsubj	13	SENT_236	[p11l924t1751r978b1775],
11	bind	VBP	O	bind	rcmod	5	SENT_236	[p11l986t1751r1044b1775],
12	and	CC	O	and	_	0	SENT_236	[p11l1053t1751r1102b1775],
13	activate	VBP	O	activate	conj_and	11	SENT_236	[p11l1110t1752r1214b1775],
14	GLP-1	NN	O	glp-1	nn	15	SENT_236	[p11l1222t1752r1294b1775],
15	R	NN	O	r	dobj	11	SENT_236	[p11l1302t1752r1317b1775],
16	in	IN	O	in	_	0	SENT_236	[p11l1325t1752r1347b1775],
17	the	DT	O	the	det	19	SENT_236	[p11l1355t1751r1399b1775],
18	arcuate	NN	O	arcuate	nn	19	SENT_236	[p11l1407t1755r1504b1775],
19	nucleus	NN	O	nucleus	prep_in	11	SENT_236	[p11l1513t1751r1615b1775],
20	and	CC	O	and	_	0	SENT_236	[p11l1622t1751r1671b1775],
21	DVC	NN	O	dvc	conj_and	19	SENT_236	[p11l1681t1752r1743b1775],
22	.	.	O	.	_	0	SENT_236	[p11l1681t1752r1743b1775],

1	Lorcaserin	NNP	O	Lorcaserin	nsubj	5	SENT_237	[p11l1752t1752r1885b1775],
2	selectively	RB	O	selectively	advmod	3	SENT_237	[p11l1894t1751r2032b1782],
3	binds	VBZ	O	bind	_	0	SENT_237	[p11l2040t1751r2112b1775],
4	and	CC	O	and	_	0	SENT_237	[p11l21t1791r69b1815],
5	activates	VBZ	O	activate	conj_and	3	SENT_237	[p11l78t1793r195b1815],
6	5	CD	NUMBER	5	dobj	3	SENT_237	[p11l203t1793r295b1815],
7	.	.	O	.	_	0	SENT_237	[p11l203t1793r295b1815],

1	—	NN	O	—	_	0	SENT_238	[p11l203t1793r295b1815],
2	.	.	O	.	_	0	SENT_238	[p11l203t1793r295b1815],

1	HT2c	NN	O	ht2c	nn	3	SENT_239	[p11l203t1793r295b1815],
2	serotonin	NN	O	serotonin	nn	3	SENT_239	[p11l303t1793r428b1815],
3	receptors	NNS	O	receptor	_	0	SENT_239	[p11l438t1795r561b1821],
4	in	IN	O	in	_	0	SENT_239	[p11l570t1793r592b1815],
5	the	DT	O	the	det	7	SENT_239	[p11l600t1791r643b1815],
6	arcuate	NN	O	arcuate	nn	7	SENT_239	[p11l651t1795r749b1815],
7	nucleus	NN	O	nucleus	prep_in	3	SENT_239	[p11l758t1791r865b1815],
8	.	.	O	.	_	0	SENT_239	[p11l758t1791r865b1815],

1	Symbols	NNS	O	symbol	_	0	SENT_240	[p11l873t1791r992b1822],
2	:	:	O	:	_	0	SENT_240	[p11l873t1791r992b1822],
3	blue	JJ	O	blue	amod	4	SENT_240	[p11l1001t1791r1058b1815],
4	receptor	NN	O	receptor	dep	1	SENT_240	[p11l1067t1795r1182b1821],
5	,	,	O	,	_	0	SENT_240	[p11l1067t1795r1182b1821],
6	activating	VBG	O	activate	appos	4	SENT_240	[p11l1190t1793r1328b1822],
7	;	:	O	;	_	0	SENT_240	[p11l1190t1793r1328b1822],
8	red	JJ	O	red	amod	9	SENT_240	[p11l1337t1791r1377b1815],
9	receptor	NN	O	receptor	dep	1	SENT_240	[p11l1387t1795r1503b1821],
10	,	,	O	,	_	0	SENT_240	[p11l1387t1795r1503b1821],
11	inhibiting	VBG	O	inhibit	appos	9	SENT_240	[p11l1511t1791r1645b1822],
12	.	.	O	.	_	0	SENT_240	[p11l1511t1791r1645b1822],

1	(	NN	O	(	nn	2	SENT_241	[p11l1654t1791r1688b1819],
2	b	NN	O	b	nsubj	14	SENT_241	[p11l1654t1791r1688b1819],
3	)	CD	NUMBER	)	dep	2	SENT_241	[p11l1654t1791r1688b1819],
4	Topiramate	NNP	O	Topiramate	poss	7	SENT_241	[p11l1694t1792r1861b1821],
5	’s	POS	O	’s	_	0	SENT_241	[p11l1694t1792r1861b1821],
6	exact	JJ	O	exact	amod	7	SENT_241	[p11l1869t1795r1939b1815],
7	mechanism	NN	O	mechanism	dep	2	SENT_241	[p11l1948t1791r2100b1815],
8	of	IN	O	of	_	0	SENT_241	[p11l2109t1791r2136b1815],
9	action	NN	O	action	prep_of	7	SENT_241	[p11l21t1833r102b1856],
10	is	VBZ	O	be	cop	11	SENT_241	[p11l111t1833r129b1856],
11	unknown	JJ	O	unknown	ccomp	27	SENT_241	[p11l138t1832r262b1856],
12	but	CC	O	but	_	0	SENT_241	[p11l272t1832r316b1856],
13	may	MD	O	may	aux	14	SENT_241	[p11l325t1839r380b1863],
14	involve	VB	O	involve	conj_but	11	SENT_241	[p11l388t1832r482b1856],
15	its	PRP$	O	its	poss	16	SENT_241	[p11l491t1833r519b1856],
16	ability	NN	O	ability	dobj	14	SENT_241	[p11l526t1832r608b1863],
17	to	TO	O	to	_	0	SENT_241	[p11l614t1836r641b1856],
18	blockvoltage-gated	JJ	O	blockvoltage-gated	amod	20	SENT_241	[p11l650t1832r915b1863],
19	sodium	NN	O	sodium	nn	20	SENT_241	[p11l924t1832r1022b1856],
20	channels	NNS	O	channel	prep_to	14	SENT_241	[p11l1031t1832r1149b1856],
21	in	IN	O	in	_	0	SENT_241	[p11l1158t1833r1179b1856],
22	the	DT	O	the	det	25	SENT_241	[p11l1187t1832r1231b1856],
23	presynaptic	JJ	O	presynaptic	amod	25	SENT_241	[p11l1240t1833r1394b1863],
24	excitatory	JJ	O	excitatory	amod	25	SENT_241	[p11l1401t1833r1533b1863],
25	neuron	NN	O	neuron	prep_in	20	SENT_241	[p11l1541t1839r1642b1860],
26	,	,	O	,	_	0	SENT_241	[p11l1541t1839r1642b1860],
27	antagonize	VBP	O	antagonize	_	0	SENT_241	[p11l1650t1833r1799b1863],
28	oc-amino-3-hydroxy-5-methyl-4-isoxazolepropionic	JJ	O	oc-amino-3-hydroxy-5-methyl-4-isoxazolepropionic	amod	29	SENT_241	[p11l21t1874r697b1904],
29	acid/N-methyl-o	NN	O	acid/n-methyl-o	dobj	27	SENT_241	[p11l705t1874r1055b1904],
30	-	:	O	-	_	0	SENT_241	[p11l705t1874r1055b1904],
31	aspartate	NN	O	aspartate	dep	29	SENT_241	[p11l705t1874r1055b1904],
32	(	CD	NUMBER	(	num	36	SENT_241	[p11l1064t1874r1257b1901],
33	AMPA/NMDA	NNP	O	AMPA/NMDA	nn	36	SENT_241	[p11l1064t1874r1257b1901],
34	)	CD	NUMBER	)	num	36	SENT_241	[p11l1064t1874r1257b1901],
35	glutamate	NN	O	glutamate	nn	36	SENT_241	[p11l1265t1874r1402b1904],
36	receptors	NNS	O	receptor	dep	31	SENT_241	[p11l1410t1878r1534b1904],
37	on	IN	O	on	_	0	SENT_241	[p11l1542t1881r1574b1898],
38	postsynaptic	JJ	O	postsynaptic	amod	39	SENT_241	[p11l1584t1875r1753b1904],
39	neurons	NNS	O	neuron	prep_on	27	SENT_241	[p11l1762t1881r1875b1901],
40	,	,	O	,	_	0	SENT_241	[p11l1762t1881r1875b1901],
41	and	CC	O	and	_	0	SENT_241	[p11l1883t1874r1932b1898],
42	enhance	VBP	O	enhance	conj_and	27	SENT_241	[p11l1941t1874r2055b1898],
43	the	DT	O	the	det	44	SENT_241	[p11l2062t1874r2105b1898],
44	activity	NN	O	activity	dobj	42	SENT_241	[p11l21t1916r117b1945],
45	of	IN	O	of	_	0	SENT_241	[p11l124t1914r151b1938],
46	inhibitory	JJ	O	inhibitory	amod	47	SENT_241	[p11l158t1914r287b1945],
47	y	NN	O	y	prep_of	44	SENT_241	[p11l293t1914r495b1945],
48	—	CD	NUMBER	—	num	50	SENT_241	[p11l293t1914r495b1945],
49	aminobutyric	JJ	O	aminobutyric	amod	50	SENT_241	[p11l293t1914r495b1945],
50	acid	NN	O	acid	dep	27	SENT_241	[p11l503t1914r556b1938],
51	(	CD	NUMBER	(	num	54	SENT_241	[p11l565t1915r657b1942],
52	GABA	NN	O	gaba	nn	54	SENT_241	[p11l565t1915r657b1942],
53	)	CD	NUMBER	)	num	54	SENT_241	[p11l565t1915r657b1942],
54	neurons	NNS	O	neuron	dep	50	SENT_241	[p11l667t1921r780b1938],
55	.	.	O	.	_	0	SENT_241	[p11l667t1921r780b1938],

1	(	NN	O	(	nn	2	SENT_242	[p11l789t1915r818b1942],
2	c	NN	O	c	nsubj	5	SENT_242	[p11l789t1915r818b1942],
3	)	CD	NUMBER	)	num	4	SENT_242	[p11l789t1915r818b1942],
4	Orlistat	NN	O	orlistat	dep	2	SENT_242	[p11l827t1914r923b1938],
5	binds	VBZ	O	bind	_	0	SENT_242	[p11l931t1914r1003b1938],
6	and	CC	O	and	_	0	SENT_242	[p11l1011t1914r1059b1938],
7	inhibits	VBZ	O	inhibit	conj_and	5	SENT_242	[p11l1069t1914r1166b1938],
8	gastric	JJ	O	gastric	amod	11	SENT_242	[p11l1174t1916r1262b1945],
9	and	CC	O	and	_	0	SENT_242	[p11l1269t1914r1318b1938],
10	pancreatic	JJ	O	pancreatic	amod	11	SENT_242	[p11l1328t1916r1466b1944],
11	lipases	NNS	O	lipase	dobj	5	SENT_242	[p11l1474t1914r1562b1944],
12	in	IN	O	in	_	0	SENT_242	[p11l1571t1916r1592b1938],
13	the	DT	O	the	det	14	SENT_242	[p11l1600t1914r1644b1938],
14	intestine	NN	O	intestine	prep_in	11	SENT_242	[p11l1653t1916r1772b1938],
15	.	.	O	.	_	0	SENT_242	[p11l1653t1916r1772b1938],

1	These	DT	O	these	det	2	SENT_243	[p11l1778t1914r1856b1938],
2	lipases	NNS	O	lipase	nsubj	3	SENT_243	[p11l1865t1914r1952b1944],
3	hydrolyze	VBP	O	hydrolyze	_	0	SENT_243	[p11l1961t1914r2089b1945],
4	dietary	JJ	O	dietary	amod	5	SENT_243	[p11l21t1955r114b1986],
5	triglycerides	NNS	O	triglyceride	dobj	3	SENT_243	[p11l120t1955r283b1986],
6	into	IN	O	into	_	0	SENT_243	[p11l292t1956r343b1979],
7	free	JJ	O	free	amod	9	SENT_243	[p11l350t1955r401b1979],
8	fatty	JJ	O	fatty	amod	9	SENT_243	[p11l408t1955r469b1986],
9	acids	NNS	O	acid	prep_into	3	SENT_243	[p11l476t1955r542b1979],
10	that	WDT	O	that	nsubjpass	13	SENT_243	[p11l549t1955r603b1979],
11	can	MD	O	can	aux	13	SENT_243	[p11l611t1962r655b1979],
12	be	VB	O	be	auxpass	13	SENT_243	[p11l665t1955r697b1979],
13	absorbed	VBN	O	absorb	rcmod	9	SENT_243	[p11l705t1955r829b1979],
14	by	IN	O	by	_	0	SENT_243	[p11l839t1955r871b1986],
15	intestinal	JJ	O	intestinal	amod	17	SENT_243	[p11l878t1955r998b1979],
16	epithelial	JJ	O	epithelial	amod	17	SENT_243	[p11l1007t1955r1129b1986],
17	cells	NNS	O	cell	agent	13	SENT_243	[p11l1138t1955r1194b1979],
18	via	IN	O	via	_	0	SENT_243	[p11l1201t1956r1238b1979],
19	fatty	JJ	O	fatty	amod	21	SENT_243	[p11l1245t1955r1307b1986],
20	acid	NN	O	acid	nn	21	SENT_243	[p11l1314t1955r1366b1979],
21	transporters	NNS	O	transporter	prep_via	17	SENT_243	[p11l1375t1959r1544b1986],
22	.	.	O	.	_	0	SENT_243	[p11l1375t1959r1544b1986],

1	Thus	RB	O	thus	advmod	4	SENT_244	[p11l1549t1955r1619b1983],
2	,	,	O	,	_	0	SENT_244	[p11l1549t1955r1619b1983],
3	orlistat	NN	O	orlistat	nsubj	4	SENT_244	[p11l1627t1955r1718b1979],
4	suppresses	VBZ	O	suppress	_	0	SENT_244	[p11l1725t1962r1871b1986],
5	systemic	JJ	O	systemic	amod	7	SENT_244	[p11l1879t1956r1993b1986],
6	lipid	NN	O	lipid	nn	7	SENT_244	[p11l2002t1955r2056b1986],
7	absorption	NN	O	absorption	dobj	4	SENT_244	[p11l21t1997r172b2027],
8	.	.	O	.	_	0	SENT_244	[p11l21t1997r172b2027],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_245	[p11l21t2087r140b2108],
2	PHARMACOLOGY	NNP	O	PHARMACOLOGY	dep	12	SENT_245	[p11l149t2087r374b2108],
3	&	CC	O	&	_	0	SENT_245	[p11l381t2087r601b2108],
4	THERAPEUT	NNP	O	THERAPEUT	nn	6	SENT_245	[p11l381t2087r601b2108],
5	|	CD	NUMBER	|	num	6	SENT_245	[p11l381t2087r601b2108],
6	CS	NNP	O	CS	conj_and	2	SENT_245	[p11l381t2087r601b2108],
7	|	NNP	O	|	nn	8	SENT_245	[p11l611t2085r613b2115],
8	VOLUME	NNP	O	VOLUME	dep	2	SENT_245	[p11l621t2087r729b2108],
9	95	CD	NUMBER	95	num	10	SENT_245	[p11l737t2087r764b2108],
10	NUMBER	NN	O	number	dep	12	SENT_245	[p11l774t2087r882b2108],
11	1	CD	NUMBER	1	num	12	SENT_245	[p11l892t2088r899b2108],
12	|	CD	NUMBER	|	dep	15	SENT_245	[p11l913t2085r915b2115],
13	JANUARY	NNP	DATE	JANUARY	dep	12	SENT_245	[p11l924t2087r1042b2108],
14	2014	CD	DATE	2014	num	15	SENT_245	[p11l1049t2087r1108b2108],
15	57	CD	DATE	57	_	0	SENT_245	[p11l2110t2088r2140b2108],

1	regulates	VBZ	O	regulate	csubj	4	SENT_246	[p11l8t2463r302b2547],
2	is	VBZ	O	be	cop	4	SENT_246	[p11l322t2469r371b2526],
3	postprandial	JJ	O	postprandial	amod	4	SENT_246	[p11l390t2463r812b2546],
4	satiety	NN	O	satiety	_	0	SENT_246	[p11l832t2469r1046b2547],
5	through	IN	O	through	_	0	SENT_246	[p11l1061t2463r1331b2547],
6	hypothalamic	JJ	O	hypothalamic	amod	9	SENT_246	[p11l1349t2463r1808b2547],
7	serotonin	NN	O	serotonin	nn	9	SENT_246	[p11l1829t2469r2145b2526],
8	5-HTZC	NN	O	5-htzc	nn	9	SENT_246	[p11l9t2570r277b2659],
9	receptors	NNS	O	receptor	prep_through	4	SENT_246	[p11l301t2579r623b2650],
10	and	CC	O	and	dep	15	SENT_246	[p11l648t2567r795b2639],
11	,	,	O	,	_	0	SENT_246	[p11l648t2567r795b2639],
12	possibly	RB	O	possibly	dep	15	SENT_246	[p11l819t2567r1117b2651],
13	,	,	O	,	_	0	SENT_246	[p11l819t2567r1117b2651],
14	5-HT1	NN	O	5-ht1	nn	15	SENT_246	[p11l1145t2570r1364b2658],
15	A	NN	O	a	dep	4	SENT_246	[p11l1371t2614r1433b2658],
16	,	,	O	,	_	0	SENT_246	[p11l1371t2614r1433b2658],
17	5-HTIB	NN	O	5-htib	dep	4	SENT_246	[p11l1460t2570r1740b2658],
18	,	,	O	,	_	0	SENT_246	[p11l1460t2570r1740b2658],
19	and	CC	O	and	_	0	SENT_246	[p11l1767t2567r1896b2630],
20	5-HT6	NN	O	5-ht6	nn	21	SENT_246	[p11l1920t2570r2144b2659],
21	receptors	NNS	O	receptor	dep	4	SENT_246	[p11l8t2662r403b2754],
22	.	.	O	.	_	0	SENT_246	[p11l8t2662r403b2754],

1	”	NN	O	”	_	0	SENT_247	[p11l8t2662r403b2754],

1	These	DT	O	these	det	2	SENT_248	[p11l81t2775r275b2838],
2	receptors	NNS	O	receptor	nsubj	3	SENT_248	[p11l296t2787r609b2858],
3	receive	VBP	O	receive	_	0	SENT_248	[p11l631t2781r867b2838],
4	serotonin	NN	O	serotonin	dobj	3	SENT_248	[p11l888t2781r1213b2838],
5	secreted	VBN	O	secrete	partmod	4	SENT_248	[p11l1235t2775r1514b2838],
6	from	IN	O	from	_	0	SENT_248	[p11l1533t2775r1701b2838],
7	serotonergic	JJ	O	serotonergic	amod	8	SENT_248	[p11l1722t2781r2145b2859],
8	neurons	NNS	O	neuron	prep_from	5	SENT_248	[p11l7t2901r293b2941],
9	that	WDT	O	that	nsubj	10	SENT_248	[p11l316t2878r454b2941],
10	project	VBP	O	project	rcmod	8	SENT_248	[p11l474t2884r722b2962],
11	from	IN	O	from	_	0	SENT_248	[p11l744t2878r916b2941],
12	the	DT	O	the	det	14	SENT_248	[p11l938t2878r1047b2941],
13	brain	NN	O	brain	nn	14	SENT_248	[p11l1069t2878r1255b2941],
14	stem	NN	O	stem	prep_from	10	SENT_248	[p11l1280t2890r1444b2941],
15	into	IN	O	into	_	0	SENT_248	[p11l1468t2884r1605b2941],
16	the	DT	O	the	det	17	SENT_248	[p11l1629t2878r1738b2941],
17	hypothalamus	NN	O	hypothalamus	prep_into	10	SENT_248	[p11l1761t2878r2140b2962, p11l7t3004r154b3044],
18	to	TO	O	to	aux	19	SENT_248	[p11l177t2993r245b3044],
19	orchestrate	VB	O	orchestrate	infmod	17	SENT_248	[p11l270t2981r659b3044],
20	feeding	NN	O	feeding	nn	21	SENT_248	[p11l684t2981r945b3065],
21	behavior	NN	O	behavior	dobj	19	SENT_248	[p11l964t2981r1275b3044],
22	through	IN	O	through	_	0	SENT_248	[p11l1296t2981r1582b3065],
23	the	DT	O	the	det	24	SENT_248	[p11l1605t2981r1715b3044],
24	melanocortin	NN	O	melanocortin	prep_through	19	SENT_248	[p11l1739t2981r2141b3044, p11l7t3089r105b3146],
25	(	CD	NUMBER	(	num	28	SENT_248	[p11l135t3083r323b3160],
26	MC	NNP	O	MC	nn	28	SENT_248	[p11l135t3083r323b3160],
27	)	NN	O	)	nn	28	SENT_248	[p11l135t3083r323b3160],
28	system	NN	O	system	dep	24	SENT_248	[p11l355t3075r681b3167],
29	.	.	O	.	_	0	SENT_248	[p11l355t3075r681b3167],

1	”	NN	O	”	ccomp	5	SENT_249	[p11l355t3075r681b3167],
2	Speciﬁcally	RB	O	speciﬁcally	advmod	1	SENT_249	[p11l709t3083r1122b3167],
3	,	,	O	,	_	0	SENT_249	[p11l709t3083r1122b3167],
4	serotonin	NN	O	serotonin	nsubj	5	SENT_249	[p11l1151t3089r1491b3146],
5	regulates	VBZ	O	regulate	_	0	SENT_249	[p11l1517t3083r1834b3167],
6	appetite	NN	O	appetite	nn	9	SENT_249	[p11l1861t3089r2144b3166],
7	and	CC	O	and	_	0	SENT_249	[p11l8t3186r135b3249],
8	body	NN	O	body	nn	9	SENT_249	[p11l155t3186r332b3270],
9	weight	NN	O	weight	dobj	5	SENT_249	[p11l349t3186r580b3270],
10	through	IN	O	through	_	0	SENT_249	[p11l601t3186r880b3270],
11	MC4R	NN	O	mc4r	prep_through	5	SENT_249	[p11l903t3190r1132b3249],
12	in	IN	O	in	_	0	SENT_249	[p11l1152t3192r1220b3248],
13	the	DT	O	the	det	17	SENT_249	[p11l1241t3186r1348b3249],
14	arcuate	NN	O	arcuate	nn	17	SENT_249	[p11l1372t3198r1619b3249],
15	nucleus	NN	O	nucleus	nn	17	SENT_249	[p11l1642t3186r1903b3249],
16	(	CD	NUMBER	(	num	17	SENT_249	[p11l1930t3187r2142b3262],
17	ARC	NN	ORGANIZATION	arc	prep_in	11	SENT_249	[p11l1930t3187r2142b3262],
18	;	:	O	;	_	0	SENT_249	[p11l1930t3187r2142b3262],
19	Figure	NNP	O	Figure	dep	17	SENT_249	[p11l8t3294r243b3373],
20	1	CD	NUMBER	1	number	21	SENT_249	[p11l270t3290r351b3366],
21	)	CD	NUMBER	)	dep	19	SENT_249	[p11l270t3290r351b3366],
22	.	.	O	.	_	0	SENT_249	[p11l270t3290r351b3366],

1	Activation	NN	O	activation	_	0	SENT_250	[p11l376t3294r739b3353],
2	of	IN	O	of	_	0	SENT_250	[p11l763t3290r837b3353],
3	5	CD	NUMBER	5	prep_of	1	SENT_250	[p11l852t3293r1116b3382],
4	.	.	O	.	_	0	SENT_250	[p11l852t3293r1116b3382],

1	—	NN	O	—	_	0	SENT_251	[p11l852t3293r1116b3382],
2	.	.	O	.	_	0	SENT_251	[p11l852t3293r1116b3382],

1	HT2c	NN	O	ht2c	nn	4	SENT_252	[p11l852t3293r1116b3382],
2	and	CC	O	and	_	0	SENT_252	[p11l1140t3290r1268b3353],
3	5-HTIB	NN	O	5-htib	nn	4	SENT_252	[p11l1291t3293r1549b3381],
4	receptors	NNS	O	receptor	_	0	SENT_252	[p11l1573t3301r1890b3373],
5	by	IN	O	by	_	0	SENT_252	[p11l1912t3290r1997b3374],
6	serotonin	NN	O	serotonin	prep_by	4	SENT_252	[p11l2017t3313r2141b3353, p12l8t28r240b85],

1	increases	VBZ	O	increase	dep	115	SENT_253	[p12l264t28r581b85],
2	the	DT	O	the	dep	115	SENT_253	[p12l605t22r714b85],
3	anorexigenic	JJ	O	anorexigenic	dep	115	SENT_253	[p12l739t28r1190b106],
4	oc-melanocyte-stimulating	JJ	O	oc-melanocyte-stimulating	dep	115	SENT_253	[p12l1214t22r2145b106],
5	hormone	NN	O	hormone	dep	115	SENT_253	[p12l7t125r328b188],
6	and	CC	O	and	dep	115	SENT_253	[p12l353t125r481b188],
7	decreases	VBZ	O	decrease	dep	115	SENT_253	[p12l504t125r832b188],
8	the	DT	O	the	dep	115	SENT_253	[p12l855t125r963b188],
9	orexigenic	JJ	O	orexigenic	dep	115	SENT_253	[p12l988t131r1349b209],
10	agouti-related	JJ	O	agouti-related	dep	115	SENT_253	[p12l1373t125r1860b209],
11	peptide	NN	O	peptide	dep	115	SENT_253	[p12l1882t125r2143b208],
12	(	CD	NUMBER	(	dep	115	SENT_253	[p12l11t228r257b312],
13	AgRP	NN	O	agrp	dep	115	SENT_253	[p12l11t228r257b312],
14	)	NN	O	)	dep	115	SENT_253	[p12l11t228r257b312],
15	in	IN	O	in	dep	115	SENT_253	[p12l281t234r347b290],
16	the	DT	O	the	dep	115	SENT_253	[p12l365t228r470b291],
17	presynaptic	JJ	O	presynaptic	dep	115	SENT_253	[p12l489t234r878b312],
18	area	NN	O	area	dep	115	SENT_253	[p12l899t251r1037b291],
19	of	IN	O	of	dep	115	SENT_253	[p12l1056t228r1129b291],
20	the	DT	O	the	dep	115	SENT_253	[p12l1138t228r1243b291],
21	ARC	NNP	ORGANIZATION	ARC	dep	115	SENT_253	[p12l1262t232r1427b291],
22	and	CC	O	and	dep	115	SENT_253	[p12l1448t228r1573b291],
23	promotes	VBZ	O	promote	dep	115	SENT_253	[p12l1590t240r1908b311],
24	satiety	NN	O	satiety	dep	115	SENT_253	[p12l1930t234r2146b312],
25	through	IN	O	through	dep	115	SENT_253	[p12l7t330r280b414],
26	MC4R-expressing	JJ	O	mc4r-expressing	dep	115	SENT_253	[p12l300t334r908b414],
27	neurons	NNS	O	neuron	dep	115	SENT_253	[p12l927t322r1357b393],
28	.23	NN	NUMBER	.23	dep	115	SENT_253	[p12l927t322r1357b393],
29	=	JJ	O	=	dep	115	SENT_253	[p12l927t322r1357b393],
30	24	CD	NUMBER	24	dep	115	SENT_253	[p12l927t322r1357b393],
31	Silencing	NN	O	silencing	dep	115	SENT_253	[p12l1377t330r1686b414],
32	Mc4r	NN	O	mc4r	dep	115	SENT_253	[p12l1702t335r1881b393],
33	in	IN	O	in	dep	115	SENT_253	[p12l1897t336r1963b392],
34	mice	NNS	O	mouse	dep	115	SENT_253	[p12l1983t336r2144b393],
35	eliminates	VBZ	O	eliminate	dep	115	SENT_253	[p12l8t432r352b495],
36	the	DT	O	the	dep	115	SENT_253	[p12l372t432r478b495],
37	appetite-suppressing	JJ	O	appetite-suppressing	dep	115	SENT_253	[p12l499t438r1200b516],
38	effects	NNS	O	effect	dep	115	SENT_253	[p12l1219t432r1428b495],
39	mediated	VBN	O	mediate	dep	115	SENT_253	[p12l1449t432r1765b495],
40	by	IN	O	by	dep	115	SENT_253	[p12l1782t432r1865b516],
41	5-HTZC	NN	O	5-htzc	dep	115	SENT_253	[p12l1884t435r2144b524],
42	and	CC	O	and	dep	115	SENT_253	[p12l8t534r136b597],
43	5-HTIB	NN	O	5-htib	dep	115	SENT_253	[p12l160t537r419b625],
44	agonists	NNS	O	agonist	dep	115	SENT_253	[p12l444t540r742b618],
45	,	,	O	,	_	0	SENT_253	[p12l444t540r742b618],
46	whereas	IN	O	whereas	dep	115	SENT_253	[p12l766t534r1048b597],
47	expression	NN	O	expression	dep	115	SENT_253	[p12l1072t540r1440b617],
48	of	IN	O	of	dep	115	SENT_253	[p12l1464t534r1539b597],
49	Mc4r	NN	O	mc4r	dep	115	SENT_253	[p12l1550t539r1735b597],
50	in	IN	O	in	dep	115	SENT_253	[p12l1754t540r1821b596],
51	the	DT	O	the	dep	115	SENT_253	[p12l1844t534r1952b597],
52	ARC	NNP	ORGANIZATION	ARC	dep	115	SENT_253	[p12l1974t538r2144b597],
53	restores	VBZ	O	restore	dep	115	SENT_253	[p12l8t648r267b699],
54	the	DT	O	the	dep	115	SENT_253	[p12l286t636r391b699],
55	ability	NN	O	ability	dep	115	SENT_253	[p12l413t636r623b720],
56	of	IN	O	of	dep	115	SENT_253	[p12l640t636r713b699],
57	5-HT	NN	O	5-ht	dep	115	SENT_253	[p12l725t639r908b699],
58	compounds	NNS	O	compound	dep	115	SENT_253	[p12l930t636r1327b719],
59	to	TO	O	to	dep	115	SENT_253	[p12l1347t648r1412b699],
60	regulate	VB	O	regulate	dep	115	SENT_253	[p12l1434t636r1701b720],
61	appetite	NN	O	appetite	dep	115	SENT_253	[p12l1722t628r2143b719],
62	.24	CD	NUMBER	.24	dep	115	SENT_253	[p12l1722t628r2143b719],
63	’25	CD	NUMBER	’25	dep	115	SENT_253	[p12l1722t628r2143b719],
64	Genetic	JJ	O	genetic	dep	115	SENT_253	[p12l82t743r351b802],
65	manipulation	NN	O	manipulation	dep	115	SENT_253	[p12l373t739r842b822],
66	of	IN	O	of	dep	115	SENT_253	[p12l865t739r940b802],
67	5-HT	NN	O	5-ht	dep	115	SENT_253	[p12l955t742r1144b802],
68	receptors	NNS	O	receptor	dep	115	SENT_253	[p12l1167t751r1484b822],
69	revealed	VBD	O	reveal	dep	115	SENT_253	[p12l1508t739r1797b802],
70	that	IN	O	that	dep	115	SENT_253	[p12l1817t739r1953b802],
71	ablation	NN	O	ablation	dep	115	SENT_253	[p12l1975t739r2141b802, p12l7t847r146b904],
72	of	IN	O	of	dep	115	SENT_253	[p12l171t841r246b904],
73	5-HT	NN	O	5-ht	dep	115	SENT_253	[p12l261t844r451b904],
74	receptors	NNS	O	receptor	dep	115	SENT_253	[p12l474t853r794b924],
75	resulted	VBD	O	result	dep	115	SENT_253	[p12l819t841r1096b904],
76	in	IN	O	in	dep	115	SENT_253	[p12l1118t847r1186b903],
77	hyperphagia	NN	O	hyperphagium	dep	115	SENT_253	[p12l1208t841r1645b925],
78	and	CC	O	and	dep	115	SENT_253	[p12l1668t841r1797b904],
79	obesity	NN	O	obesity	dep	115	SENT_253	[p12l1820t833r2143b925],
80	.22	CD	NUMBER	.22	dep	115	SENT_253	[p12l1820t833r2143b925],
81	Elimination	NN	O	elimination	dep	115	SENT_253	[p12l7t943r440b1006],
82	of	IN	O	of	dep	115	SENT_253	[p12l471t943r548b1006],
83	the	DT	O	the	dep	115	SENT_253	[p12l567t943r679b1006],
84	Gi-coupled	JJ	O	gi-coupled	dep	115	SENT_253	[p12l711t943r1112b1034],
85	5-HTIB	NN	O	5-htib	dep	115	SENT_253	[p12l1143t946r1411b1034],
86	receptor	NN	O	receptor	dep	115	SENT_253	[p12l1441t955r1742b1026],
87	(	NN	O	(	dep	115	SENT_253	[p12l1775t944r1960b1019],
88	Htrl	NNP	O	Htrl	dep	115	SENT_253	[p12l1775t944r1960b1019],
89	la	NNP	O	la	dep	115	SENT_253	[p12l1976t943r2040b1019],
90	)	NNP	O	)	dep	115	SENT_253	[p12l1976t943r2040b1019],
91	in	IN	O	in	dep	115	SENT_253	[p12l2075t949r2144b1005],
92	mice	NNS	O	mouse	dep	115	SENT_253	[p12l7t1052r176b1109],
93	exhibited	VBD	O	exhibit	dep	115	SENT_253	[p12l203t1046r532b1109],
94	only	RB	O	only	dep	115	SENT_253	[p12l558t1046r714b1130],
95	a	DT	O	a	dep	115	SENT_253	[p12l738t1069r773b1109],
96	limited	JJ	O	limited	dep	115	SENT_253	[p12l797t1046r1051b1109],
97	increase	NN	O	increase	dep	115	SENT_253	[p12l1076t1052r1365b1109],
98	in	IN	O	in	dep	115	SENT_253	[p12l1391t1052r1460b1108],
99	food	NN	O	food	dep	115	SENT_253	[p12l1486t1046r1649b1109],
100	consumption	NN	O	consumption	dep	115	SENT_253	[p12l1675t1052r2144b1129],
101	and	CC	O	and	dep	115	SENT_253	[p12l8t1148r135b1212],
102	body	NN	O	body	dep	115	SENT_253	[p12l154t1148r332b1233],
103	Weight	NNP	O	Weight	dep	115	SENT_253	[p12l348t1140r738b1233],
104	.25	CD	NUMBER	.25	dep	115	SENT_253	[p12l348t1140r738b1233],
105	’26	CD	NUMBER	’26	dep	115	SENT_253	[p12l348t1140r738b1233],
106	However	RB	O	however	dep	115	SENT_253	[p12l761t1154r1082b1221],
107	,	,	O	,	_	0	SENT_253	[p12l761t1154r1082b1221],
108	genetic	JJ	O	genetic	dep	115	SENT_253	[p12l1105t1155r1350b1233],
109	inactivation	NN	O	inactivation	dep	115	SENT_253	[p12l1372t1155r1781b1212],
110	of	IN	O	of	dep	115	SENT_253	[p12l1804t1148r1878b1212],
111	the	DT	O	the	dep	115	SENT_253	[p12l1890t1148r1997b1212],
112	G	NN	O	g	dep	115	SENT_253	[p12l2021t1152r2078b1212],
113	qcoupled	JJ	O	qcoupled	dep	115	SENT_253	[p12l2083t1188r2141b1255, p12l8t1252r286b1336],
114	receptor	NN	O	receptor	dep	115	SENT_253	[p12l310t1264r602b1336],
115	5	CD	NUMBER	5	_	0	SENT_253	[p12l628t1256r954b1345],
116	.	.	O	.	_	0	SENT_253	[p12l628t1256r954b1345],

1	—	NN	O	—	_	0	SENT_254	[p12l628t1256r954b1345],
2	.	.	O	.	_	0	SENT_254	[p12l628t1256r954b1345],

1	HT2CR	NN	O	ht2cr	dep	110	SENT_255	[p12l628t1256r954b1345],
2	(	CD	NUMBER	(	dep	110	SENT_255	[p12l980t1253r1229b1329],
3	Htr2c	NN	O	htr2c	dep	110	SENT_255	[p12l980t1253r1229b1329],
4	)	NN	O	)	dep	110	SENT_255	[p12l980t1253r1229b1329],
5	leads	VBZ	O	lead	dep	110	SENT_255	[p12l1257t1253r1433b1316],
6	to	TO	O	to	dep	110	SENT_255	[p12l1457t1265r1525b1316],
7	hyperphagia	NN	O	hyperphagium	dep	110	SENT_255	[p12l1550t1253r1990b1337],
8	and	CC	O	and	dep	110	SENT_255	[p12l2015t1253r2144b1316],
9	obesity	NN	O	obesity	dep	110	SENT_255	[p12l8t1355r260b1439],
10	,	,	O	,	_	0	SENT_255	[p12l8t1355r260b1439],
11	accompanied	VBN	O	accompany	dep	110	SENT_255	[p12l284t1355r740b1438],
12	by	IN	O	by	dep	110	SENT_255	[p12l759t1355r843b1439],
13	partial	JJ	O	partial	dep	110	SENT_255	[p12l860t1355r1084b1438],
14	leptin	NN	O	leptin	dep	110	SENT_255	[p12l1104t1355r1301b1438],
15	and	CC	O	and	dep	110	SENT_255	[p12l1324t1355r1450b1418],
16	insulin	NN	O	insulin	dep	110	SENT_255	[p12l1471t1355r1706b1418],
17	resistance	NN	O	resistance	dep	110	SENT_255	[p12l1728t1347r2144b1418],
18	.27	CD	NUMBER	.27	dep	110	SENT_255	[p12l1728t1347r2144b1418],
19	Reinstating	VBG	O	reinstate	dep	110	SENT_255	[p12l8t1464r399b1544],
20	5-HTZCR	NN	O	5-htzcr	dep	110	SENT_255	[p12l421t1462r739b1551],
21	on	IN	O	on	dep	110	SENT_255	[p12l760t1482r846b1523],
22	pro	JJ	O	pro	dep	110	SENT_255	[p12l867t1459r1638b1543],
23	—	NN	O	—	dep	110	SENT_255	[p12l867t1459r1638b1543],
24	opiomelanocortin	NN	O	opiomelanocortin	dep	110	SENT_255	[p12l867t1459r1638b1543],
25	(	CD	NUMBER	(	dep	110	SENT_255	[p12l1665t1460r1960b1536],
26	POMC	JJ	O	pomc	dep	110	SENT_255	[p12l1665t1460r1960b1536],
27	)	NN	O	)	dep	110	SENT_255	[p12l1665t1460r1960b1536],
28	neurons	NNS	O	neuron	dep	110	SENT_255	[p12l1987t1482r2141b1523, p12l8t1586r151b1627],
29	in	IN	O	in	dep	110	SENT_255	[p12l171t1570r236b1626],
30	Htr2c	NN	O	htr2c	dep	110	SENT_255	[p12l253t1553r530b1627],
31	'	''	O	'	_	0	SENT_255	[p12l253t1553r530b1627],
32	/	:	O	/	dep	110	SENT_255	[p12l253t1553r530b1627],
33	'	''	O	'	_	0	SENT_255	[p12l253t1553r530b1627],
34	mice	NNS	O	mouse	dep	110	SENT_255	[p12l550t1570r709b1627],
35	is	VBZ	O	be	dep	110	SENT_255	[p12l728t1570r776b1627],
36	suﬂicient	JJ	O	suﬂicient	dep	110	SENT_255	[p12l797t1563r1098b1627],
37	to	TO	O	to	dep	110	SENT_255	[p12l1115t1575r1179b1627],
38	mediate	VB	O	mediate	dep	110	SENT_255	[p12l1199t1563r1462b1627],
39	the	DT	O	the	dep	110	SENT_255	[p12l1480t1563r1583b1627],
40	serotonin	NN	O	serotonin	dep	110	SENT_255	[p12l1604t1570r1918b1627],
41	effects	NNS	O	effect	dep	110	SENT_255	[p12l1938t1563r2143b1627],
42	on	IN	O	on	dep	110	SENT_255	[p12l8t1690r92b1730],
43	appetite	NN	O	appetite	dep	110	SENT_255	[p12l112t1673r373b1750],
44	and	CC	O	and	dep	110	SENT_255	[p12l393t1667r516b1730],
45	correct	VB	O	correct	dep	110	SENT_255	[p12l534t1679r768b1730],
46	the	DT	O	the	dep	110	SENT_255	[p12l784t1667r888b1730],
47	hyperphagic	JJ	O	hyperphagic	dep	110	SENT_255	[p12l906t1667r1319b1751],
48	and	CC	O	and	dep	110	SENT_255	[p12l1339t1667r1462b1730],
49	obese	JJ	O	obese	dep	110	SENT_255	[p12l1480t1667r1664b1730],
50	phenotypes	NNS	O	phenotype	dep	110	SENT_255	[p12l1682t1659r2144b1751],
51	.27	CD	NUMBER	.27	dep	110	SENT_255	[p12l1682t1659r2144b1751],
52	In	IN	O	in	dep	110	SENT_255	[p12l8t1774r79b1831],
53	addition	NN	O	addition	dep	110	SENT_255	[p12l99t1769r400b1841],
54	,	,	O	,	_	0	SENT_255	[p12l99t1769r400b1841],
55	pharmacologic	JJ	O	pharmacologic	dep	110	SENT_255	[p12l421t1769r928b1853],
56	or	CC	O	or	dep	110	SENT_255	[p12l948t1792r1019b1832],
57	genetic	JJ	O	genetic	dep	110	SENT_255	[p12l1038t1775r1278b1853],
58	inactivation	NN	O	inactivation	dep	110	SENT_255	[p12l1298t1775r1700b1832],
59	of	IN	O	of	dep	110	SENT_255	[p12l1721t1769r1794b1832],
60	the	DT	O	the	dep	110	SENT_255	[p12l1803t1769r1908b1832],
61	5-HT3	NN	O	5-ht3	dep	110	SENT_255	[p12l1930t1772r2142b1860],
62	receptor	NN	O	receptor	dep	110	SENT_255	[p12l8t1884r285b1955],
63	in	IN	O	in	dep	110	SENT_255	[p12l303t1878r368b1934],
64	the	DT	O	the	dep	110	SENT_255	[p12l387t1872r491b1935],
65	nucleus	NN	O	nucleus	dep	110	SENT_255	[p12l510t1872r763b1935],
66	tractus	NN	O	tractus	dep	110	SENT_255	[p12l782t1884r1010b1935],
67	solitarius	NN	O	solitarius	dep	110	SENT_255	[p12l1031t1872r1333b1935],
68	of	IN	O	of	dep	110	SENT_255	[p12l1353t1872r1426b1935],
69	the	DT	O	the	dep	110	SENT_255	[p12l1434t1872r1539b1935],
70	dorsal	NN	O	dorsal	dep	110	SENT_255	[p12l1559t1872r1763b1935],
71	vagal	NN	O	vagal	dep	110	SENT_255	[p12l1779t1872r1953b1956],
72	complex	NN	O	complex	dep	110	SENT_255	[p12l1972t1895r2142b1935, p12l6t1974r152b2058],
73	(	CD	NUMBER	(	dep	110	SENT_255	[p12l176t1975r438b2058],
74	Figure	NN	O	figure	dep	110	SENT_255	[p12l176t1975r438b2058],
75	1	CD	NUMBER	1	dep	110	SENT_255	[p12l465t1975r525b2051],
76	)	NN	O	)	dep	110	SENT_255	[p12l465t1975r525b2051],
77	promotes	VBZ	O	promote	dep	110	SENT_255	[p12l551t1987r877b2058],
78	food	NN	O	food	dep	110	SENT_255	[p12l901t1974r1060b2038],
79	intake	NN	O	intake	dep	110	SENT_255	[p12l1082t1974r1293b2038],
80	in	IN	O	in	dep	110	SENT_255	[p12l1316t1981r1383b2037],
81	AgrpDTR	NN	O	agrpdtr	dep	110	SENT_255	[p12l1402t1963r1696b2059],
82	mice	NNS	O	mouse	dep	110	SENT_255	[p12l1718t1981r1901b2047],
83	,	,	O	,	_	0	SENT_255	[p12l1718t1981r1901b2047],
84	whose	WP$	O	whose	dep	110	SENT_255	[p12l1924t1974r2143b2038],
85	orexigenic	JJ	O	orexigenic	dep	110	SENT_255	[p12l8t2083r370b2161],
86	AgRP	NN	O	agrp	dep	110	SENT_255	[p12l393t2081r594b2161],
87	neurons	NNS	O	neuron	dep	110	SENT_255	[p12l619t2100r903b2140],
88	were	VBD	O	be	dep	110	SENT_255	[p12l926t2100r1090b2140],
89	ablated	VBN	O	ablate	dep	110	SENT_255	[p12l1115t2077r1364b2140],
90	by	IN	O	by	dep	110	SENT_255	[p12l1385t2077r1470b2161],
91	diphtheria	NN	O	diphtheria	dep	110	SENT_255	[p12l1491t2077r1856b2160],
92	toxin	NN	O	toxin	dep	110	SENT_255	[p12l1878t2069r2143b2140],
93	.28	CD	NUMBER	.28	dep	110	SENT_255	[p12l1878t2069r2143b2140],
94	Accordingly	RB	O	accordingly	dep	110	SENT_255	[p12l7t2180r447b2264],
95	,	,	O	,	_	0	SENT_255	[p12l7t2180r447b2264],
96	central	JJ	O	central	dep	110	SENT_255	[p12l473t2180r713b2243],
97	serotonergic	JJ	O	serotonergic	dep	110	SENT_255	[p12l737t2186r1170b2264],
98	neurons	NNS	O	neuron	dep	110	SENT_255	[p12l1193t2203r1476b2243],
99	may	MD	O	may	dep	110	SENT_255	[p12l1501t2203r1651b2264],
100	be	VB	O	be	dep	110	SENT_255	[p12l1668t2180r1749b2243],
101	a	DT	O	a	dep	110	SENT_255	[p12l1774t2203r1809b2243],
102	potential	JJ	O	potential	dep	110	SENT_255	[p12l1830t2180r2143b2263],
103	target	NN	O	target	dep	110	SENT_255	[p12l7t2295r201b2367],
104	to	TO	O	to	dep	110	SENT_255	[p12l220t2295r285b2346],
105	modulate	VB	O	modulate	dep	110	SENT_255	[p12l307t2283r627b2346],
106	food	NN	O	food	dep	110	SENT_255	[p12l648t2283r804b2346],
107	intake	NN	O	intake	dep	110	SENT_255	[p12l824t2283r1031b2346],
108	and	CC	O	and	dep	110	SENT_255	[p12l1052t2283r1178b2346],
109	energy	NN	O	energy	dep	110	SENT_255	[p12l1198t2306r1429b2367],
110	homeostasis	NN	O	homeostasis	_	0	SENT_255	[p12l1446t2283r1877b2346],
111	.	.	O	.	_	0	SENT_255	[p12l1446t2283r1877b2346],

1	Lorcaserin	NNP	O	Lorcaserin	nsubj	19	SENT_256	[p12l82t2391r464b2449],
2	(	CD	NUMBER	(	num	1	SENT_256	[p12l495t2386r899b2470],
3	previously	RB	DATE	previously	advmod	4	SENT_256	[p12l495t2386r899b2470],
4	known	VBN	O	know	partmod	1	SENT_256	[p12l921t2386r1168b2449],
5	as	IN	O	as	_	0	SENT_256	[p12l1197t2409r1263b2449],
6	APD-356	NN	O	apd-356	prep_as	4	SENT_256	[p12l1291t2386r1680b2463],
7	)	CD	NUMBER	)	num	6	SENT_256	[p12l1291t2386r1680b2463],
8	,	,	O	,	_	0	SENT_256	[p12l1291t2386r1680b2463],
9	marketed	VBN	O	market	partmod	1	SENT_256	[p12l1709t2386r2049b2449],
10	as	IN	O	as	_	0	SENT_256	[p12l2076t2409r2143b2449],
11	Belviq	NN	PERSON	belviq	prep_as	9	SENT_256	[p12l8t2490r226b2573],
12	by	IN	O	by	_	0	SENT_256	[p12l245t2490r329b2574],
13	Arena	NNP	ORGANIZATION	Arena	nn	14	SENT_256	[p12l347t2494r560b2553],
14	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	agent	9	SENT_256	[p12l582t2490r1171b2562],
15	,	,	O	,	_	0	SENT_256	[p12l582t2490r1171b2562],
16	is	VBZ	O	be	cop	19	SENT_256	[p12l1195t2496r1246b2553],
17	a	DT	O	a	det	19	SENT_256	[p12l1270t2513r1305b2553],
18	selective	JJ	O	selective	amod	19	SENT_256	[p12l1327t2490r1616b2553],
19	5	CD	NUMBER	5	_	0	SENT_256	[p12l1641t2493r1905b2582],
20	.	.	O	.	_	0	SENT_256	[p12l1641t2493r1905b2582],

1	—	NN	O	—	_	0	SENT_257	[p12l1641t2493r1905b2582],
2	.	.	O	.	_	0	SENT_257	[p12l1641t2493r1905b2582],

1	HT2C	NN	O	ht2c	nn	3	SENT_258	[p12l1641t2493r1905b2582],
2	receptor	NN	O	receptor	nn	3	SENT_258	[p12l1928t2512r2141b2573, p12l7t2604r103b2655],
3	agonist	NN	O	agonist	_	0	SENT_258	[p12l123t2598r361b2676],
4	that	WDT	O	that	nsubj	6	SENT_258	[p12l379t2592r509b2655],
5	speciﬁcally	RB	O	speciﬁcally	advmod	6	SENT_258	[p12l529t2592r897b2676],
6	activates	VBZ	O	activate	rcmod	3	SENT_258	[p12l914t2598r1196b2655],
7	5-HTZC	NN	O	5-htzc	nn	8	SENT_258	[p12l1218t2595r1473b2684],
8	receptors	NNS	O	receptor	dobj	6	SENT_258	[p12l1493t2604r1798b2675],
9	relative	JJ	O	relative	advmod	6	SENT_258	[p12l1819t2592r2060b2655],
10	to	TO	O	to	_	0	SENT_258	[p12l2078t2604r2143b2655],
11	other	JJ	O	other	amod	14	SENT_258	[p12l8t2695r190b2758],
12	5-HT	NN	O	5-ht	nn	14	SENT_258	[p12l213t2698r399b2758],
13	receptor	NN	O	receptor	nn	14	SENT_258	[p12l422t2707r707b2778],
14	subtypes	NNS	O	subtype	prep_to	9	SENT_258	[p12l729t2695r1042b2779],
15	.	.	O	.	_	0	SENT_258	[p12l729t2695r1042b2779],

1	This	DT	O	this	det	2	SENT_259	[p12l1068t2695r1211b2758],
2	characteristic	NN	O	characteristic	nsubj	5	SENT_259	[p12l1235t2695r1693b2758],
3	of	IN	O	of	_	0	SENT_259	[p12l1717t2695r1791b2758],
4	lorcaserin	NN	O	lorcaserin	prep_of	2	SENT_259	[p12l1802t2695r2143b2758],
5	limits	VBZ	O	limit	_	0	SENT_259	[p12l6t2797r203b2860],
6	the	DT	O	the	det	7	SENT_259	[p12l226t2797r334b2860],
7	risk	NN	O	risk	dobj	5	SENT_259	[p12l358t2797r490b2860],
8	of	IN	O	of	_	0	SENT_259	[p12l510t2797r585b2860],
9	hallucinations	NNS	O	hallucination	prep_of	7	SENT_259	[p12l598t2797r1092b2860],
10	due	JJ	O	due	_	0	SENT_259	[p12l1117t2797r1242b2860],
11	to	TO	O	to	_	0	SENT_259	[p12l1264t2809r1331b2860],
12	5-HTZA	JJ	O	5-htza	amod	13	SENT_259	[p12l1358t2800r1626b2888],
13	activation	NN	O	activation	prep_due_to	9	SENT_259	[p12l1649t2803r1992b2860],
14	and	CC	O	and	_	0	SENT_259	[p12l2017t2797r2145b2860],
15	the	DT	O	the	det	16	SENT_259	[p12l7t2900r115b2963],
16	risk	NN	O	risk	prep_due_to	9	SENT_259	[p12l139t2900r272b2963],
17	of	IN	O	of	_	0	SENT_259	[p12l292t2900r367b2963],
18	cardiovascular	JJ	O	cardiovascular	amod	20	SENT_259	[p12l382t2900r893b2963],
19	side	JJ	O	side	amod	20	SENT_259	[p12l916t2900r1052b2963],
20	effects	NNS	O	effect	prep_of	9	SENT_259	[p12l1076t2900r1312b2972],
21	,	,	O	,	_	0	SENT_259	[p12l1076t2900r1312b2972],
22	including	VBG	O	include	_	0	SENT_259	[p12l1337t2900r1672b2984],
23	valvulopathy	NN	O	valvulopathy	prep_including	9	SENT_259	[p12l1691t2900r2148b2984],
24	and	CC	O	and	_	0	SENT_259	[p12l8t3002r132b3066],
25	pulmonary	JJ	O	pulmonary	amod	26	SENT_259	[p12l150t3002r529b3087],
26	hypertension	NN	O	hypertension	conj_and	23	SENT_259	[p12l545t3002r1006b3087],
27	,	,	O	,	_	0	SENT_259	[p12l545t3002r1006b3087],
28	through	IN	O	through	_	0	SENT_259	[p12l1026t3002r1299b3087],
29	5-HTZB	NN	O	5-htzb	nn	30	SENT_259	[p12l1320t3005r1573b3094],
30	receptors	NNS	O	receptor	prep_through	5	SENT_259	[p12l1593t2994r1981b3086],
31	.25	CD	NUMBER	.25	nsubj	62	SENT_259	[p12l1593t2994r1981b3086],
32	This	DT	O	this	det	34	SENT_259	[p12l2002t3002r2143b3066],
33	preferential	JJ	O	preferential	amod	34	SENT_259	[p12l6t3105r399b3188],
34	affinity	NN	O	affinity	nsubj	38	SENT_259	[p12l419t3105r658b3189],
35	to	TO	O	to	_	0	SENT_259	[p12l674t3117r739b3168],
36	5-HTZC	NN	O	5-htzc	nn	37	SENT_259	[p12l763t3108r1021b3197],
37	receptors	NNS	O	receptor	prep_to	34	SENT_259	[p12l1042t3117r1352b3188],
38	provides	VBZ	O	provide	rcmod	31	SENT_259	[p12l1372t3105r1662b3188],
39	lorcaserin	NN	O	lorcaserin	iobj	38	SENT_259	[p12l1682t3105r2020b3168],
40	the	DT	O	the	det	41	SENT_259	[p12l2039t3105r2145b3168],
41	efficacy	NN	O	efficacy	dobj	38	SENT_259	[p12l8t3208r263b3292],
42	of	IN	O	of	_	0	SENT_259	[p12l280t3208r353b3271],
43	previous	JJ	O	previous	amod	46	SENT_259	[p12l362t3214r652b3291],
44	serotonergic	JJ	O	serotonergic	amod	46	SENT_259	[p12l673t3214r1092b3292],
45	antiobesity	NN	O	antiobesity	nn	46	SENT_259	[p12l1112t3208r1485b3292],
46	treatments	NNS	O	treatment	prep_of	41	SENT_259	[p12l1500t3220r1861b3271],
47	without	IN	O	without	_	0	SENT_259	[p12l1880t3208r2145b3271],
48	the	DT	O	the	det	51	SENT_259	[p12l7t3310r111b3373],
49	undesirable	JJ	O	undesirable	amod	51	SENT_259	[p12l131t3310r523b3373],
50	safety	NN	O	safety	nn	51	SENT_259	[p12l545t3310r738b3394],
51	concerns	NNS	O	concern	prep_without	38	SENT_259	[p12l755t3333r1057b3373],
52	that	WDT	O	that	nsubj	53	SENT_259	[p12l1076t3310r1208b3373],
53	led	VBD	O	lead	rcmod	51	SENT_259	[p12l1226t3310r1328b3373],
54	to	TO	O	to	_	0	SENT_259	[p12l1345t3322r1410b3373],
55	their	PRP$	O	they	poss	61	SENT_259	[p12l1431t3310r1591b3373],
56	withdrawal	NN	O	withdrawal	npadvmod	58	SENT_259	[p12l1609t3302r2144b3373],
57	.29	CD	NUMBER	.29	num	56	SENT_259	[p12l1609t3302r2144b3373],
58	>	JJR	O	>	amod	61	SENT_259	[p12l1609t3302r2144b3373],
59	3	CD	NUMBER	3	num	61	SENT_259	[p12l1609t3302r2144b3373],
60	°	NN	O	°	nn	61	SENT_259	[p12l1609t3302r2144b3373],
61	Lorcaserin	NN	O	lorcaserin	prep_to	53	SENT_259	[p12l8t3417r363b3475],
62	has	VBZ	O	have	rcmod	30	SENT_259	[p12l382t3412r491b3475],
63	a	DT	O	a	det	64	SENT_259	[p12l512t3435r546b3475],
64	half-life	NN	O	half-life	dobj	62	SENT_259	[p12l563t3412r823b3475],
65	of	IN	O	of	_	0	SENT_259	[p12l844t3412r916b3475],
66	about	RB	DURATION	about	quantmod	67	SENT_259	[p12l927t3412r1115b3475],
67	11	CD	DURATION	11	num	68	SENT_259	[p12l1140t3419r1205b3474],
68	hours	NNS	NUMBER	hour	prep_of	64	SENT_259	[p12l1230t3412r1420b3475],
69	and	CC	O	and	_	0	SENT_259	[p12l1441t3412r1565b3475],
70	a	DT	O	a	det	72	SENT_259	[p12l1584t3435r1618b3475],
71	median	JJ	O	median	amod	72	SENT_259	[p12l1636t3412r1888b3475],
72	time	NN	O	time	conj_and	68	SENT_259	[p12l1907t3418r2058b3475],
73	to	TO	O	to	_	0	SENT_259	[p12l2076t3424r2141b3475],
74	maximum	NN	O	maximum	nn	75	SENT_259	[p12l7t3521r356b3578],
75	concentration	NN	O	concentration	prep_to	72	SENT_259	[p12l376t3521r844b3578],
76	of	IN	O	of	_	0	SENT_259	[p12l864t3514r937b3578],
77	1.5-2	CD	NUMBER	1.5-2	num	78	SENT_259	[p12l954t3521r1127b3578],
78	h.	NN	O	h.	prep_of	75	SENT_259	[p12l1142t3506r1264b3578],
79	25	CD	NUMBER	25	num	80	SENT_259	[p12l1142t3506r1264b3578],
80	Lorcaserin	NN	O	lorcaserin	nsubjpass	82	SENT_259	[p12l1286t3520r1642b3578],
81	is	VBZ	O	be	auxpass	82	SENT_259	[p12l1663t3521r1712b3578],
82	metabolized	VBN	O	metabolize	rcmod	64	SENT_259	[p12l1731t3514r2145b3578],
83	by	IN	O	by	_	0	SENT_259	[p13l6t27r89b111],
84	multiple	JJ	O	multiple	amod	86	SENT_259	[p13l106t27r389b110],
85	hepatic	JJ	O	hepatic	amod	86	SENT_259	[p13l409t27r656b110],
86	pathways	NNS	O	pathway	agent	82	SENT_259	[p13l675t27r990b111],
87	to	TO	O	to	_	0	SENT_259	[p13l1010t39r1076b90],
88	inactive	JJ	O	inactive	amod	89	SENT_259	[p13l1097t33r1363b90],
89	metabolites	NNS	O	metabolite	prep_to	82	SENT_259	[p13l1383t27r1793b99],
90	,	,	O	,	_	0	SENT_259	[p13l1383t27r1793b99],
91	which	WDT	O	which	nsubjpass	94	SENT_259	[p13l1813t27r2022b90],
92	are	VBP	O	be	auxpass	94	SENT_259	[p13l2043t50r2143b90],
93	thereafter	RB	O	thereafter	advmod	94	SENT_259	[p13l7t130r338b193],
94	excreted	VBN	O	excrete	rcmod	89	SENT_259	[p13l360t130r647b193],
95	in	IN	O	in	_	0	SENT_259	[p13l667t136r734b192],
96	the	DT	O	the	det	97	SENT_259	[p13l754t130r861b193],
97	urine	NN	O	urine	prep_in	94	SENT_259	[p13l883t136r1081b193],
98	.	.	O	.	_	0	SENT_259	[p13l883t136r1081b193],

1	This	DT	O	this	dep	105	SENT_260	[p13l1106t130r1249b193],
2	drug	NN	O	drug	dep	105	SENT_260	[p13l1272t130r1434b214],
3	inhibits	VBZ	O	inhibit	dep	105	SENT_260	[p13l1454t130r1713b193],
4	cytochrome	NN	O	cytochrome	dep	105	SENT_260	[p13l1736t130r2144b214],
5	P450	NN	O	p450	dep	105	SENT_260	[p13l8t237r173b295],
6	2D6	NN	O	2d6	dep	105	SENT_260	[p13l195t237r334b295],
7	metabolism	NN	O	metabolism	dep	105	SENT_260	[p13l356t232r754b295],
8	and	CC	O	and	dep	105	SENT_260	[p13l774t232r899b295],
9	can	MD	O	can	dep	105	SENT_260	[p13l918t244r1150b295],
10	not	RB	O	not	dep	105	SENT_260	[p13l918t244r1150b295],
11	be	VB	O	be	dep	105	SENT_260	[p13l1167t232r1245b295],
12	cleared	VBN	O	clear	dep	105	SENT_260	[p13l1266t232r1505b295],
13	by	IN	O	by	dep	105	SENT_260	[p13l1522t232r1605b316],
14	hemodialysis	NN	O	hemodialysis	dep	105	SENT_260	[p13l1621t224r2143b316],
15	.25	CD	NUMBER	.25	dep	105	SENT_260	[p13l1621t224r2143b316],
16	Preclinical	JJ	O	preclinical	dep	105	SENT_260	[p13l82t334r439b397],
17	studies	NNS	O	study	dep	105	SENT_260	[p13l461t334r693b397],
18	demonstrated	VBD	O	demonstrate	dep	105	SENT_260	[p13l715t334r1187b397],
19	that	IN	O	that	dep	105	SENT_260	[p13l1206t334r1339b397],
20	chronic	JJ	O	chronic	dep	105	SENT_260	[p13l1360t334r1617b397],
21	administration	NN	O	administration	dep	105	SENT_260	[p13l1639t334r2145b397],
22	of	IN	O	of	dep	105	SENT_260	[p13l8t437r82b500],
23	lorcaserin	NN	O	lorcaserin	dep	105	SENT_260	[p13l92t437r429b500],
24	at	IN	O	at	dep	105	SENT_260	[p13l451t449r511b500],
25	doses	NNS	O	dose	dep	105	SENT_260	[p13l531t437r716b500],
26	of	IN	O	of	dep	105	SENT_260	[p13l738t437r812b500],
27	4.5	CD	NUMBER	4.5	dep	105	SENT_260	[p13l823t444r939b509],
28	,	,	O	,	_	0	SENT_260	[p13l823t444r939b509],
29	9	CD	NUMBER	9	dep	105	SENT_260	[p13l963t444r1017b509],
30	,	,	O	,	_	0	SENT_260	[p13l963t444r1017b509],
31	and	CC	NUMBER	and	dep	105	SENT_260	[p13l1041t437r1168b500],
32	18	CD	NUMBER	18	dep	105	SENT_260	[p13l1194t444r1265b500],
33	mg/kg	NN	O	mg/kg	dep	105	SENT_260	[p13l1279t437r1500b521],
34	reduced	VBD	O	reduce	dep	105	SENT_260	[p13l1519t437r1794b500],
35	food	NN	O	food	dep	105	SENT_260	[p13l1813t437r1971b500],
36	consumption	NN	O	consumption	dep	105	SENT_260	[p13l1991t460r2141b500, p13l8t545r322b622],
37	and	CC	O	and	dep	105	SENT_260	[p13l341t539r463b602],
38	prevented	VBD	O	prevent	dep	105	SENT_260	[p13l478t539r806b622],
39	diet-induced	JJ	O	diet-induced	dep	105	SENT_260	[p13l823t539r1244b602],
40	obesity	NN	O	obesity	dep	105	SENT_260	[p13l1261t539r1495b623],
41	in	IN	O	in	dep	105	SENT_260	[p13l1509t545r1574b601],
42	mice	NNS	O	mouse	dep	105	SENT_260	[p13l1591t531r1827b602],
43	.25	CD	NUMBER	.25	dep	105	SENT_260	[p13l1591t531r1827b602],
44	In	IN	O	in	dep	105	SENT_260	[p13l1847t544r1916b601],
45	a	DT	O	a	dep	105	SENT_260	[p13l1934t562r1968b602],
46	multicenter	NN	O	multicenter	dep	105	SENT_260	[p13l1985t539r2141b602, p13l7t648r270b714],
47	,	,	O	,	_	0	SENT_260	[p13l1985t539r2141b602, p13l7t648r270b714],
48	randomized	VBN	O	randomize	dep	105	SENT_260	[p13l292t642r711b714],
49	,	,	O	,	_	0	SENT_260	[p13l292t642r711b714],
50	52-week	JJ	DURATION	52-week	dep	105	SENT_260	[p13l734t642r1027b714],
51	,	,	O	,	_	0	SENT_260	[p13l734t642r1027b714],
52	placebo-controlled	JJ	O	placebo-controlled	dep	105	SENT_260	[p13l1047t642r1691b725],
53	,	,	O	,	_	0	SENT_260	[p13l1047t642r1691b725],
54	double-blind	JJ	O	double-blind	dep	105	SENT_260	[p13l1713t642r2144b705],
55	trial	NN	O	trial	dep	105	SENT_260	[p13l7t745r154b817],
56	,	,	O	,	_	0	SENT_260	[p13l7t745r154b817],
57	lorcaserin	NN	O	lorcaserin	dep	105	SENT_260	[p13l171t745r491b808],
58	at	IN	O	at	dep	105	SENT_260	[p13l509t757r566b808],
59	a	DT	O	a	dep	105	SENT_260	[p13l582t768r617b808],
60	dose	NN	O	dose	dep	105	SENT_260	[p13l633t745r780b808],
61	of	IN	O	of	dep	105	SENT_260	[p13l798t745r869b808],
62	10	CD	NUMBER	10	dep	105	SENT_260	[p13l883t752r951b808],
63	mg	NN	O	mg	dep	105	SENT_260	[p13l964t768r1070b829],
64	b.i.d.	NN	O	b.i.d.	dep	105	SENT_260	[p13l1083t745r1236b808],
65	mediated	VBD	O	mediate	dep	105	SENT_260	[p13l1256t745r1559b808],
66	an	DT	O	a	dep	105	SENT_260	[p13l1576t768r1653b808],
67	average	JJ	O	average	dep	105	SENT_260	[p13l1670t768r1911b829],
68	weight	NN	O	weight	dep	105	SENT_260	[p13l1926t745r2144b829],
69	loss	NN	O	loss	dep	105	SENT_260	[p13l6t848r126b911],
70	of	IN	O	of	dep	105	SENT_260	[p13l145t848r217b911],
71	5.8	CD	NUMBER	5.8	dep	105	SENT_260	[p13l226t855r318b911],
72	i	FW	O	i	dep	105	SENT_260	[p13l333t862r374b910],
73	0.2	CD	NUMBER	0.2	dep	105	SENT_260	[p13l389t855r482b911],
74	kg	NN	O	kg	dep	105	SENT_260	[p13l494t848r574b932],
75	(	NN	O	(	dep	105	SENT_260	[p13l593t849r800b924],
76	5.8	CD	PERCENT	5.8	dep	105	SENT_260	[p13l593t849r800b924],
77	%	NN	PERCENT	%	dep	105	SENT_260	[p13l593t849r800b924],
78	)	CD	NUMBER	)	dep	105	SENT_260	[p13l593t849r800b924],
79	in	IN	O	in	dep	105	SENT_260	[p13l822t854r886b910],
80	883	CD	NUMBER	883	dep	105	SENT_260	[p13l905t855r1017b911],
81	patients	NNS	O	patient	dep	105	SENT_260	[p13l1037t854r1293b931],
82	within	IN	O	within	dep	105	SENT_260	[p13l1309t848r1523b911],
83	1	CD	DURATION	1	dep	105	SENT_260	[p13l1547t855r1571b910],
84	year	NN	NUMBER	year	dep	105	SENT_260	[p13l1592t871r1742b932],
85	,	,	O	,	_	0	SENT_260	[p13l1592t871r1742b932],
86	whereas	IN	O	whereas	dep	105	SENT_260	[p13l1759t848r2025b911],
87	the	DT	O	the	dep	105	SENT_260	[p13l2042t848r2144b911],
88	placebo	NN	O	placebo	dep	105	SENT_260	[p13l6t951r269b1034],
89	induced	VBD	O	induce	dep	105	SENT_260	[p13l291t951r568b1014],
90	an	DT	O	a	dep	105	SENT_260	[p13l589t974r669b1014],
91	average	JJ	O	average	dep	105	SENT_260	[p13l691t974r944b1035],
92	weight	NN	O	weight	dep	105	SENT_260	[p13l964t951r1193b1035],
93	loss	NN	O	loss	dep	105	SENT_260	[p13l1211t951r1337b1014],
94	of	IN	O	of	dep	105	SENT_260	[p13l1359t951r1434b1014],
95	2.2	CD	NUMBER	2.2	dep	105	SENT_260	[p13l1445t958r1542b1014],
96	i	FW	O	i	dep	105	SENT_260	[p13l1560t965r1603b1013],
97	0.1	CD	NUMBER	0.1	dep	105	SENT_260	[p13l1619t958r1711b1014],
98	kg	NN	O	kg	dep	105	SENT_260	[p13l1729t951r1813b1035],
99	(	NN	O	(	dep	105	SENT_260	[p13l1835t951r2051b1028],
100	2.2	CD	PERCENT	2.2	dep	105	SENT_260	[p13l1835t951r2051b1028],
101	%	NN	PERCENT	%	dep	105	SENT_260	[p13l1835t951r2051b1028],
102	)	CD	NUMBER	)	dep	105	SENT_260	[p13l1835t951r2051b1028],
103	in	IN	O	in	dep	105	SENT_260	[p13l2077t957r2144b1013],
104	716	CD	NUMBER	716	dep	105	SENT_260	[p13l9t1060r124b1117],
105	patients	NNS	O	patient	_	0	SENT_260	[p13l142t1060r416b1137],
106	.	.	O	.	_	0	SENT_260	[p13l142t1060r416b1137],

1	There	EX	O	there	expl	2	SENT_261	[p13l437t1054r625b1117],
2	was	VBD	O	be	_	0	SENT_261	[p13l641t1077r764b1117],
3	no	DT	O	no	det	5	SENT_261	[p13l783t1077r867b1117],
4	signiﬁcant	NN	O	signiﬁcant	nn	5	SENT_261	[p13l887t1054r1229b1138],
5	difference	NN	O	difference	nsubj	2	SENT_261	[p13l1246t1054r1571b1117],
6	in	IN	O	in	_	0	SENT_261	[p13l1589t1060r1654b1116],
7	adverse	JJ	O	adverse	amod	8	SENT_261	[p13l1672t1054r1918b1117],
8	events	NNS	O	event	prep_in	5	SENT_261	[p13l1937t1066r2142b1117],
9	between	IN	O	between	_	0	SENT_261	[p13l6t1156r294b1219],
10	the	DT	O	the	det	11	SENT_261	[p13l316t1156r424b1219],
11	lorcaserin	NN	O	lorcaserin	prep_between	8	SENT_261	[p13l446t1156r788b1219],
12	and	CC	O	and	_	0	SENT_261	[p13l812t1156r939b1219],
13	the	DT	O	the	det	15	SENT_261	[p13l960t1156r1068b1219],
14	placebo	NN	O	placebo	nn	15	SENT_261	[p13l1090t1156r1355b1239],
15	groups	NNS	O	group	prep_in	5	SENT_261	[p13l1379t1148r1694b1240],
16	.31	CD	NUMBER	.31	dep	15	SENT_261	[p13l1379t1148r1694b1240],
17	The	DT	O	the	det	18	SENT_261	[p13l1722t1156r1849b1219],
18	effect	NN	O	effect	nsubjpass	27	SENT_261	[p13l1873t1156r2056b1219],
19	of	IN	O	of	_	0	SENT_261	[p13l2078t1156r2153b1219],
20	lorcaserin	NN	O	lorcaserin	prep_of	18	SENT_261	[p13l7t1458r350b1521],
21	on	IN	O	on	_	0	SENT_261	[p13l374t1481r461b1521],
22	body	NN	O	body	nn	24	SENT_261	[p13l483t1458r661b1542],
23	weight	NN	O	weight	nn	24	SENT_261	[p13l679t1458r911b1542],
24	management	NN	O	management	prep_on	20	SENT_261	[p13l933t1470r1384b1542],
25	was	VBD	O	be	auxpass	27	SENT_261	[p13l1404t1481r1532b1521],
26	also	RB	O	also	advmod	27	SENT_261	[p13l1557t1458r1689b1521],
27	examined	VBN	O	examine	rcmod	5	SENT_261	[p13l1714t1458r2053b1521],
28	in	IN	O	in	_	0	SENT_261	[p13l2076t1464r2143b1520],
29	an	DT	O	a	det	30	SENT_261	[p13l9t1584r90b1624],
30	8-week	NN	DURATION	8-week	prep_in	27	SENT_261	[p13l117t1561r382b1633],
31	,	,	O	,	_	0	SENT_261	[p13l117t1561r382b1633],
32	double-blind	JJ	O	double-blind	amod	35	SENT_261	[p13l409t1561r878b1633],
33	,	,	O	,	_	0	SENT_261	[p13l409t1561r878b1633],
34	placebo-controlled	JJ	O	placebo-controlled	amod	35	SENT_261	[p13l904t1561r1565b1644],
35	trial	NN	O	trial	appos	30	SENT_261	[p13l1588t1561r1747b1624],
36	.	.	O	.	_	0	SENT_261	[p13l1588t1561r1747b1624],

1	Lorcaserin	NN	O	lorcaserin	nsubj	2	SENT_262	[p13l1775t1566r2146b1624],
2	induced	VBD	O	induce	_	0	SENT_262	[p13l9t1664r281b1727],
3	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_262	[p13l302t1664r650b1748],
4	reduction	NN	O	reduction	dobj	2	SENT_262	[p13l669t1664r995b1727],
5	of	IN	O	of	_	0	SENT_262	[p13l1016t1664r1090b1727],
6	body	NN	O	body	nn	7	SENT_262	[p13l1098t1664r1273b1748],
7	weight	NN	O	weight	prep_of	4	SENT_262	[p13l1287t1664r1514b1748],
8	and	CC	O	and	_	0	SENT_262	[p13l1533t1664r1658b1727],
9	food	NN	O	food	nn	10	SENT_262	[p13l1678t1664r1833b1727],
10	intake	NN	O	intake	prep_of	4	SENT_262	[p13l1853t1664r2058b1727],
11	in	IN	O	in	_	0	SENT_262	[p13l2079t1670r2145b1726],
12	comparison	NN	O	comparison	prep_in	7	SENT_262	[p13l9t1772r401b1849],
13	with	IN	O	with	_	0	SENT_262	[p13l417t1766r565b1829],
14	placebo	NN	O	placebo	prep_with	2	SENT_262	[p13l581t1766r835b1849],
15	and	CC	O	and	_	0	SENT_262	[p13l855t1766r978b1829],
16	baseline	NN	O	baseline	conj_and	14	SENT_262	[p13l992t1758r1336b1829],
17	.25	CD	NUMBER	.25	num	16	SENT_262	[p13l992t1758r1336b1829],
18	In	IN	O	in	dep	26	SENT_262	[p13l1357t1771r1426b1828],
19	a	DT	O	a	det	20	SENT_262	[p13l1445t1789r1479b1829],
20	number	NN	O	number	pobj	18	SENT_262	[p13l1495t1766r1760b1829],
21	of	IN	O	of	_	0	SENT_262	[p13l1777t1766r1849b1829],
22	phase	NN	O	phase	nn	24	SENT_262	[p13l1856t1766r2045b1849],
23	III	CD	NUMBER	iii	num	24	SENT_262	[p13l2064t1771r2143b1828],
24	trials	NNS	O	trial	prep_of	20	SENT_262	[p13l7t1869r191b1941],
25	,	,	O	,	_	0	SENT_262	[p13l7t1869r191b1941],
26	including	VBG	O	include	rcmod	16	SENT_262	[p13l213t1869r532b1953],
27	the	DT	O	the	det	28	SENT_262	[p13l549t1869r654b1932],
28	BLOOM	NNP	O	BLOOM	pobj	26	SENT_262	[p13l675t1873r1137b1932],
29	.	.	O	.	_	0	SENT_262	[p13l675t1873r1137b1932],

1	—	NN	O	—	_	0	SENT_263	[p13l675t1873r1137b1932],
2	.	.	O	.	_	0	SENT_263	[p13l675t1873r1137b1932],

1	DM	NN	O	dm	nn	4	SENT_264	[p13l675t1873r1137b1932],
2	(	CD	NUMBER	(	num	4	SENT_264	[p13l1161t1869r1545b1946],
3	Behavioral	NNP	O	Behavioral	nn	4	SENT_264	[p13l1161t1869r1545b1946],
4	Modiﬁcation	NNP	O	Modiﬁcation	nsubj	36	SENT_264	[p13l1564t1869r1999b1932],
5	and	CC	O	and	_	0	SENT_264	[p13l2020t1869r2145b1932],
6	Lorcaserin	NNP	O	Lorcaserin	nsubj	36	SENT_264	[p13l9t1977r361b2035],
7	for	IN	O	for	_	0	SENT_264	[p13l379t1972r474b2035],
8	Overweight	NNP	O	Overweight	nn	11	SENT_264	[p13l493t1972r885b2056],
9	and	CC	O	and	_	0	SENT_264	[p13l903t1972r1026b2035],
10	Obesity	NNP	ORGANIZATION	Obesity	nn	11	SENT_264	[p13l1045t1972r1302b2056],
11	Management	NNP	ORGANIZATION	Management	prep_for	4	SENT_264	[p13l1317t1977r1756b2056],
12	in	IN	O	in	_	0	SENT_264	[p13l1774t1978r1839b2034],
13	Diabetes	NNP	O	Diabetes	nn	15	SENT_264	[p13l1858t1972r2144b2035],
14	Mellitus	NNP	O	Mellitus	nn	15	SENT_264	[p13l8t2075r293b2152],
15	)	NN	O	)	prep_in	11	SENT_264	[p13l8t2075r293b2152],
16	and	CC	O	and	_	0	SENT_264	[p13l315t2075r436b2138],
17	BLOSSOM	NN	O	blossom	nn	20	SENT_264	[p13l452t2079r815b2139],
18	(	CD	NUMBER	(	num	20	SENT_264	[p13l836t2075r1207b2151],
19	Behavioral	NNP	O	Behavioral	nn	20	SENT_264	[p13l836t2075r1207b2151],
20	Modiﬁcation	NNP	O	Modiﬁcation	prep_in	11	SENT_264	[p13l1223t2075r1644b2138],
21	and	CC	O	and	_	0	SENT_264	[p13l1663t2075r1783b2138],
22	Lorcaserin	NNP	O	Lorcaserin	nn	24	SENT_264	[p13l1800t2080r2143b2138],
23	Second	NNP	DURATION	Second	nn	24	SENT_264	[p13l9t2178r256b2241],
24	Study	NNP	O	Study	prep_for	4	SENT_264	[p13l278t2178r472b2262],
25	for	IN	O	for	_	0	SENT_264	[p13l489t2178r586b2241],
26	Obesity	NNP	O	Obesity	nn	29	SENT_264	[p13l607t2178r871b2262],
27	Management	NNP	O	Management	nn	29	SENT_264	[p13l888t2179r1362b2262],
28	)	NN	O	)	nn	29	SENT_264	[p13l888t2179r1362b2262],
29	studies	NNS	O	study	prep_for	24	SENT_264	[p13l1388t2178r1639b2250],
30	,	,	O	,	_	0	SENT_264	[p13l1388t2178r1639b2250],
31	subjects	NNS	O	subject	nsubj	36	SENT_264	[p13l1663t2178r1930b2262],
32	in	IN	O	in	_	0	SENT_264	[p13l1952t2184r2018b2240],
33	the	DT	O	the	det	35	SENT_264	[p13l2039t2178r2145b2241],
34	lorcaserin	NN	O	lorcaserin	nn	35	SENT_264	[p13l7t2281r340b2344],
35	groups	NNS	O	group	prep_in	31	SENT_264	[p13l361t2303r590b2365],
36	achieved	VBD	O	achieve	_	0	SENT_264	[p13l612t2281r906b2344],
37	signiﬁcantly	RB	O	signiﬁcantly	advmod	38	SENT_264	[p13l927t2281r1337b2365],
38	greater	JJR	O	greater	amod	40	SENT_264	[p13l1354t2293r1587b2365],
39	weight	NN	O	weight	nn	40	SENT_264	[p13l1604t2281r1830b2365],
40	loss	NN	O	loss	dobj	36	SENT_264	[p13l1848t2281r1972b2344],
41	than	IN	O	than	_	0	SENT_264	[p13l1992t2281r2145b2344],
42	those	DT	O	those	prep_than	36	SENT_264	[p13l7t2383r185b2446],
43	in	IN	O	in	_	0	SENT_264	[p13l204t2389r270b2445],
44	the	DT	O	the	det	46	SENT_264	[p13l287t2383r391b2446],
45	placebo	NN	O	placebo	nn	46	SENT_264	[p13l409t2383r664b2466],
46	groups	NNS	O	group	prep_in	42	SENT_264	[p13l685t2375r1062b2467],
47	.32	CD	NUMBER	.32	number	48	SENT_264	[p13l685t2375r1062b2467],
48	’33	CD	NUMBER	’33	num	46	SENT_264	[p13l685t2375r1062b2467],

1	Lorcaserin	NNP	O	Lorcaserin	nsubj	2	SENT_265	[p13l82t2492r443b2550],
2	has	VBZ	O	have	_	0	SENT_265	[p13l463t2487r574b2550],
3	safety	NN	O	safety	nn	4	SENT_265	[p13l596t2487r791b2571],
4	concerns	NNS	O	concern	dobj	2	SENT_265	[p13l808t2510r1112b2550],
5	regarding	VBG	O	regard	_	0	SENT_265	[p13l1133t2487r1461b2571],
6	psychiatric	JJ	O	psychiatric	amod	9	SENT_265	[p13l1478t2487r1850b2571],
7	and	CC	O	and	_	0	SENT_265	[p13l1871t2487r1996b2550],
8	cardiovascular	JJ	O	cardiovascular	amod	9	SENT_265	[p13l2016t2510r2142b2550, p13l9t2590r392b2653],
9	risks	NNS	O	risk	prep_regarding	4	SENT_265	[p13l411t2590r564b2653],
10	that	WDT	O	that	nsubj	12	SENT_265	[p13l584t2590r714b2653],
11	are	VBP	O	be	cop	12	SENT_265	[p13l734t2613r831b2653],
12	similar	JJ	O	similar	rcmod	9	SENT_265	[p13l852t2590r1084b2653],
13	to	TO	O	to	_	0	SENT_265	[p13l1101t2602r1165b2653],
14	those	DT	O	those	prep_to	12	SENT_265	[p13l1185t2590r1364b2653],
15	of	IN	O	of	_	0	SENT_265	[p13l1384t2590r1457b2653],
16	other	JJ	O	other	amod	19	SENT_265	[p13l1467t2590r1645b2653],
17	5-HT	NN	O	5-ht	nn	19	SENT_265	[p13l1665t2593r1847b2653],
18	receptor	NN	O	receptor	nn	19	SENT_265	[p13l1867t2602r2144b2673],
19	agonists	NNS	O	agonist	prep_of	14	SENT_265	[p13l9t2699r278b2777],
20	but	CC	O	but	_	0	SENT_265	[p13l297t2693r409b2756],
21	to	TO	O	to	_	0	SENT_265	[p13l426t2705r491b2756],
22	a	DT	O	a	det	24	SENT_265	[p13l513t2716r547b2756],
23	lesser	JJR	O	lesser	amod	24	SENT_265	[p13l564t2693r751b2756],
24	extent	NN	O	extent	conj_but	14	SENT_265	[p13l770t2705r990b2756],
25	.	.	O	.	_	0	SENT_265	[p13l770t2705r990b2756],

1	The	DT	O	the	det	5	SENT_266	[p13l1013t2693r1136b2756],
2	most	RBS	O	most	advmod	3	SENT_266	[p13l1155t2705r1323b2756],
3	common	JJ	O	common	amod	5	SENT_266	[p13l1342t2716r1644b2756],
4	adverse	JJ	O	adverse	amod	5	SENT_266	[p13l1664t2693r1914b2756],
5	events	NNS	O	event	nsubj	9	SENT_266	[p13l1935t2705r2144b2756],
6	in	IN	O	in	_	0	SENT_266	[p13l9t2802r77b2858],
7	nondiabetic	JJ	O	nondiabetic	amod	8	SENT_266	[p13l102t2796r525b2859],
8	patients	NNS	O	patient	prep_in	5	SENT_266	[p13l549t2802r829b2879],
9	include	VBP	O	include	_	0	SENT_266	[p13l855t2796r1115b2859],
10	headache	NN	O	headache	nn	19	SENT_266	[p13l1140t2796r1491b2868],
11	,	,	O	,	_	0	SENT_266	[p13l1140t2796r1491b2868],
12	dizziness	NN	O	dizziness	dep	19	SENT_266	[p13l1518t2796r1856b2868],
13	,	,	O	,	_	0	SENT_266	[p13l1518t2796r1856b2868],
14	fatigue	NN	O	fatigue	dep	19	SENT_266	[p13l1883t2796r2142b2880],
15	,	,	O	,	_	0	SENT_266	[p13l1883t2796r2142b2880],
16	nausea	NN	O	nausea	dep	19	SENT_266	[p13l8t2922r254b2971],
17	,	,	O	,	_	0	SENT_266	[p13l8t2922r254b2971],
18	dry	JJ	O	dry	amod	19	SENT_266	[p13l277t2899r393b2983],
19	mouth	NN	O	mouth	dobj	9	SENT_266	[p13l409t2899r651b2971],
20	,	,	O	,	_	0	SENT_266	[p13l409t2899r651b2971],
21	and	CC	O	and	_	0	SENT_266	[p13l673t2899r797b2962],
22	constipation	NN	O	constipation	conj_and	19	SENT_266	[p13l816t2905r1248b2982],
23	.	.	O	.	_	0	SENT_266	[p13l816t2905r1248b2982],

1	In	IN	O	in	_	0	SENT_267	[p13l1272t2904r1341b2961],
2	diabetic	JJ	O	diabetic	amod	3	SENT_267	[p13l1362t2899r1627b2962],
3	patients	NNS	O	patient	prep_in	19	SENT_267	[p13l1645t2905r1927b2982],
4	,	,	O	,	_	0	SENT_267	[p13l1645t2905r1927b2982],
5	hypoglycemia	NN	O	hypoglycemia	nsubj	19	SENT_267	[p13l1947t2899r2143b2983, p13l8t3002r325b3086],
6	,	,	O	,	_	0	SENT_267	[p13l1947t2899r2143b2983, p13l8t3002r325b3086],
7	headache	NN	O	headache	nsubj	19	SENT_267	[p13l346t3002r680b3074],
8	,	,	O	,	_	0	SENT_267	[p13l346t3002r680b3074],
9	back	RB	O	back	advmod	10	SENT_267	[p13l699t3002r860b3065],
10	pain	NN	O	pain	nsubj	19	SENT_267	[p13l876t3008r1042b3085],
11	,	,	O	,	_	0	SENT_267	[p13l876t3008r1042b3085],
12	cough	NN	O	cough	nsubj	19	SENT_267	[p13l1065t3002r1288b3086],
13	,	,	O	,	_	0	SENT_267	[p13l1065t3002r1288b3086],
14	and	CC	O	and	_	0	SENT_267	[p13l1311t3002r1436b3065],
15	fatigue	NN	O	fatigue	nsubj	19	SENT_267	[p13l1454t3002r1683b3086],
16	are	VBP	O	be	aux	19	SENT_267	[p13l1703t3025r1802b3065],
17	the	DT	O	the	det	19	SENT_267	[p13l1822t3002r1927b3065],
18	major	JJ	O	major	amod	19	SENT_267	[p13l1947t3008r2147b3086],
19	complaints	NNS	O	complaint	_	0	SENT_267	[p13l9t3096r560b3187],
20	.31	CD	NUMBER	.31	dobj	19	SENT_267	[p13l9t3096r560b3187],
21	"	``	O	"	punct	20	SENT_267	[p13l9t3096r560b3187],
22	33	CD	NUMBER	33	num	25	SENT_267	[p13l9t3096r560b3187],
23	Potential	JJ	O	potential	amod	25	SENT_267	[p13l583t3104r886b3167],
24	life	NN	O	life	nn	25	SENT_267	[p13l905t3104r1439b3188],
25	—	NN	O	—	dep	20	SENT_267	[p13l905t3104r1439b3188],
26	threatening	VBG	O	threaten	xcomp	19	SENT_267	[p13l905t3104r1439b3188],
27	serotonin	NN	O	serotonin	nn	28	SENT_267	[p13l1459t3110r1784b3167],
28	syndrome	NN	O	syndrome	dobj	26	SENT_267	[p13l1805t3104r2146b3188],
29	or	CC	O	or	_	0	SENT_267	[p13l9t3230r82b3270],
30	neuroleptic	JJ	O	neuroleptic	amod	32	SENT_267	[p13l103t3207r498b3290],
31	malignant	JJ	O	malignant	amod	32	SENT_267	[p13l521t3207r874b3291],
32	syndrome	NN	O	syndrome	dobj	26	SENT_267	[p13l897t3207r1414b3291],
33	—	CD	NUMBER	—	nsubj	37	SENT_267	[p13l897t3207r1414b3291],
34	like	IN	O	like	_	0	SENT_267	[p13l897t3207r1414b3291],
35	reactions	NNS	O	reaction	prep_like	33	SENT_267	[p13l1437t3213r1751b3270],
36	might	MD	O	might	aux	37	SENT_267	[p13l1775t3207r1981b3291],
37	take	VB	O	take	rcmod	28	SENT_267	[p13l2002t3207r2145b3270],
38	place	NN	O	place	dobj	37	SENT_267	[p13l7t3310r179b3393],
39	if	IN	O	if	mark	42	SENT_267	[p13l199t3310r253b3372],
40	lorcaserin	NN	O	lorcaserin	nsubjpass	42	SENT_267	[p13l262t3310r596b3373],
41	is	VBZ	O	be	auxpass	42	SENT_267	[p13l616t3316r665b3373],
42	used	VBN	O	use	advcl	37	SENT_267	[p13l686t3310r841b3373],
43	in	IN	O	in	_	0	SENT_267	[p13l860t3316r926b3372],
44	combination	NN	O	combination	prep_in	42	SENT_267	[p13l946t3310r1373b3373],
45	with	IN	O	with	_	0	SENT_267	[p13l1392t3310r1542b3373],
46	drugs	NNS	O	drug	prep_with	42	SENT_267	[p13l1562t3310r1750b3394],
47	that	WDT	O	that	nsubj	48	SENT_267	[p13l1770t3310r1902b3373],
48	impair	VBP	O	impair	rcmod	46	SENT_267	[p13l1920t3316r2144b3393],
49	metabolism	NN	O	metabolism	nsubj	54	SENT_267	[p13l8t3414r407b3477],
50	of	IN	O	of	_	0	SENT_267	[p13l427t3414r500b3477],
51	serotonin	NN	O	serotonin	prep_of	49	SENT_267	[p13l512t3420r834b3477],
52	or	CC	O	or	_	0	SENT_267	[p13l854t3437r925b3477],
53	increase	NN	O	increase	conj_or	51	SENT_267	[p13l944t3420r1219b3477],
54	presynaptic	JJ	O	presynaptic	xcomp	48	SENT_267	[p13l1238t3420r1629b3498],
55	serotonin	NN	O	serotonin	nn	56	SENT_267	[p13l1650t3420r1971b3477],
56	concentration	NN	O	concentration	dep	54	SENT_267	[p13l1992t3437r2141b3477, p13l9t3508r448b3579],
57	.25	CD	NUMBER	.25	npadvmod	58	SENT_267	[p13l1992t3437r2141b3477, p13l9t3508r448b3579],
58	In	IN	O	in	dep	54	SENT_267	[p13l474t3521r546b3578],
59	very	RB	O	very	advmod	60	SENT_267	[p13l566t3539r722b3600],
60	rare	JJ	O	rare	amod	61	SENT_267	[p13l742t3539r877b3579],
61	cases	NNS	O	case	pobj	58	SENT_267	[p13l901t3539r1094b3588],
62	,	,	O	,	_	0	SENT_267	[p13l901t3539r1094b3588],
63	lorcaserin	NN	O	lorcaserin	nsubj	64	SENT_267	[p13l1118t3516r1465b3579],
64	induces	VBZ	O	induce	parataxis	48	SENT_267	[p13l1488t3516r1754b3579],
65	changes	NNS	O	change	dobj	64	SENT_267	[p13l1779t3516r2053b3600],
66	in	IN	O	in	_	0	SENT_267	[p13l2077t3522r2145b3578],
67	the	DT	O	the	det	68	SENT_267	[p13l7t3619r111b3682],
68	heart	NN	O	heart	prep_in	65	SENT_267	[p13l129t3619r318b3691],
69	,	,	O	,	_	0	SENT_267	[p13l129t3619r318b3691],
70	as	IN	O	as	mark	71	SENT_267	[p13l340t3642r403b3682],
71	evidenced	VBN	O	evidence	advcl	64	SENT_267	[p13l423t3619r759b3682],
72	by	IN	O	by	_	0	SENT_267	[p13l775t3619r858b3703],
73	echocardiography	NN	O	echocardiography	prep_by	71	SENT_267	[p13l874t3619r1482b3703],
74	,	,	O	,	_	0	SENT_267	[p13l874t3619r1482b3703],
75	and	CC	O	and	_	0	SENT_267	[p13l1504t3619r1627b3682],
76	possibly	RB	O	possibly	advmod	77	SENT_267	[p13l1644t3619r1917b3703],
77	causes	VBZ	O	cause	conj_and	42	SENT_267	[p13l1934t3642r2142b3682],
78	valvular	JJ	O	valvular	amod	80	SENT_267	[p13l6t3722r280b3785],
79	heart	NN	O	heart	nn	80	SENT_267	[p13l298t3722r474b3785],
80	diseases	NNS	O	disease	dobj	77	SENT_267	[p13l494t3722r779b3785],
81	.	.	O	.	_	0	SENT_267	[p13l494t3722r779b3785],

1	Other	JJ	O	other	amod	4	SENT_268	[p13l804t3722r1004b3785],
2	potential	JJ	O	potential	amod	4	SENT_268	[p13l1022t3722r1325b3805],
3	side	NN	O	side	nn	4	SENT_268	[p13l1345t3722r1476b3785],
4	effects	NNS	O	effect	nsubj	5	SENT_268	[p13l1497t3722r1706b3785],
5	include	VBP	O	include	_	0	SENT_268	[p13l1727t3722r1976b3785],
6	cognitive	JJ	O	cognitive	acomp	5	SENT_268	[p13l1997t3745r2140b3806, p14l8t23r203b80],

1	impairment	NN	O	impairment	nsubj	29	SENT_269	[p14l227t23r660b100],
2	,	,	O	,	_	0	SENT_269	[p14l227t23r660b100],
3	psychiatric	JJ	O	psychiatric	amod	4	SENT_269	[p14l684t17r1067b101],
4	disorders	NNS	O	disorder	dep	21	SENT_269	[p14l1091t17r1432b89],
5	,	,	O	,	_	0	SENT_269	[p14l1091t17r1432b89],
6	priapism	NN	O	priapism	dep	21	SENT_269	[p14l1456t23r1784b100],
7	,	,	O	,	_	0	SENT_269	[p14l1456t23r1784b100],
8	bradycardia	NN	O	bradycardium	dep	21	SENT_269	[p14l1807t17r2142b101, p14l9t120r128b192],
9	,	,	O	,	_	0	SENT_269	[p14l1807t17r2142b101, p14l9t120r128b192],
10	hematological	JJ	O	hematological	amod	11	SENT_269	[p14l149t120r627b204],
11	changes	NNS	O	change	conj_and	4	SENT_269	[p14l647t120r931b204],
12	,	,	O	,	_	0	SENT_269	[p14l647t120r931b204],
13	prolactin	NN	O	prolactin	nn	14	SENT_269	[p14l952t120r1258b203],
14	elevation	NN	O	elevation	conj_and	4	SENT_269	[p14l1279t120r1601b192],
15	,	,	O	,	_	0	SENT_269	[p14l1279t120r1601b192],
16	and	CC	O	and	_	0	SENT_269	[p14l1623t120r1748b183],
17	pulmonary	JJ	O	pulmonary	amod	18	SENT_269	[p14l1767t120r2148b204],
18	hypertension	NN	O	hypertension	conj_and	4	SENT_269	[p14l7t214r557b306],
19	.25	CD	NUMBER	.25	dep	21	SENT_269	[p14l7t214r557b306],
20	The	DT	O	the	det	21	SENT_269	[p14l583t222r711b285],
21	effect	NN	O	effect	dep	1	SENT_269	[p14l736t222r924b285],
22	of	IN	O	of	_	0	SENT_269	[p14l948t222r1024b285],
23	lorcaserin	NN	O	lorcaserin	prep_of	21	SENT_269	[p14l1037t222r1389b285],
24	on	IN	O	on	_	0	SENT_269	[p14l1414t245r1502b285],
25	breast	NN	O	breast	nn	27	SENT_269	[p14l1525t222r1737b285],
26	cancer	NN	O	cancer	nn	27	SENT_269	[p14l1761t245r1991b285],
27	risk	NN	O	risk	prep_on	23	SENT_269	[p14l2015t222r2148b285],
28	is	VBZ	O	be	cop	29	SENT_269	[p14l8t330r59b387],
29	unclear	JJ	O	unclear	_	0	SENT_269	[p14l82t324r349b387],
30	.	.	O	.	_	0	SENT_269	[p14l82t324r349b387],

1	Given	VBN	O	give	dep	18	SENT_270	[p14l375t328r579b387],
2	that	IN	O	that	complm	4	SENT_270	[p14l601t324r735b387],
3	lorcaserin	NN	O	lorcaserin	nsubj	4	SENT_270	[p14l755t324r1098b387],
4	increases	VBZ	O	increase	pcomp	1	SENT_270	[p14l1121t330r1432b387],
5	breast	NN	O	breast	nn	7	SENT_270	[p14l1453t324r1660b387],
6	cancer	NN	O	cancer	nn	7	SENT_270	[p14l1683t347r1907b387],
7	risk	NN	O	risk	dobj	4	SENT_270	[p14l1929t324r2059b387],
8	in	IN	O	in	_	0	SENT_270	[p14l2078t330r2145b386],
9	rats	NNS	O	rat	prep_in	7	SENT_270	[p14l9t439r149b499],
10	,	,	O	,	_	0	SENT_270	[p14l9t439r149b499],
11	long	RB	O	long	advmod	12	SENT_270	[p14l172t427r518b511],
12	—	RB	O	—	amod	13	SENT_270	[p14l172t427r518b511],
13	term	NN	O	term	nsubjpass	18	SENT_270	[p14l172t427r518b511],
14	postmarketing	VBG	O	postmarket	partmod	13	SENT_270	[p14l539t427r1042b511],
15	safety	NN	O	safety	nn	16	SENT_270	[p14l1064t427r1260b511],
16	monitoring	NN	O	monitoring	dobj	14	SENT_270	[p14l1279t433r1672b511],
17	is	VBZ	O	be	auxpass	18	SENT_270	[p14l1693t433r1742b490],
18	required	VBN	O	require	_	0	SENT_270	[p14l1766t427r2057b510],
19	to	TO	O	to	aux	20	SENT_270	[p14l2078t439r2144b490],
20	evaluate	VB	O	evaluate	xcomp	18	SENT_270	[p14l9t530r288b593],
21	the	DT	O	the	det	23	SENT_270	[p14l310t530r418b593],
22	potential	JJ	O	potential	amod	23	SENT_270	[p14l440t530r748b613],
23	risks	NNS	O	risk	dobj	20	SENT_270	[p14l771t530r929b593],
24	and	CC	O	and	_	0	SENT_270	[p14l954t530r1081b593],
25	safety	NN	O	safety	nn	26	SENT_270	[p14l1103t530r1301b614],
26	concerns	NNS	O	concern	conj_and	23	SENT_270	[p14l1321t553r1648b602],
27	,	,	O	,	_	0	SENT_270	[p14l1321t553r1648b602],
28	in	IN	O	in	_	0	SENT_270	[p14l1673t536r1740b592],
29	addition	NN	O	addition	_	0	SENT_270	[p14l1764t530r2053b593],
30	to	TO	O	to	_	0	SENT_270	[p14l2075t542r2142b593],
31	unexpected	JJ	O	unexpected	amod	33	SENT_270	[p14l8t634r405b717],
32	adverse	JJ	O	adverse	amod	33	SENT_270	[p14l426t634r681b697],
33	events	NNS	O	event	conj_in	23	SENT_270	[p14l704t646r933b697],
34	.	.	O	.	_	0	SENT_270	[p14l704t646r933b697],

1	PHENTERMINE/TOPIRAMATE	NNP	O	PHENTERMINE/TOPIRAMATE	nn	5	SENT_271	[p14l12t848r1036b906],
2	EXTENDED-RELEASE	NNP	O	EXTENDED-RELEASE	nn	5	SENT_271	[p14l1059t849r1789b904],
3	FORMULATION	NNP	O	FORMULATION	nn	5	SENT_271	[p14l12t950r545b1006],
4	(	CD	NUMBER	(	num	5	SENT_271	[p14l568t947r905b1013],
5	QSYMIA	NNP	O	QSYMIA	nsubj	9	SENT_271	[p14l568t947r905b1013],
6	)	CD	NUMBER	)	num	8	SENT_271	[p14l568t947r905b1013],
7	Many	JJ	O	many	amod	8	SENT_271	[p14l8t1051r204b1130],
8	etiologies	NNS	O	etiology	dep	5	SENT_271	[p14l221t1046r541b1130],
9	contribute	VBP	O	contribute	_	0	SENT_271	[p14l562t1046r911b1109],
10	to	TO	O	to	_	0	SENT_271	[p14l931t1058r996b1109],
11	obesity	NN	O	obesity	prep_to	9	SENT_271	[p14l1018t1046r1260b1130],
12	in	IN	O	in	_	0	SENT_271	[p14l1277t1052r1342b1108],
13	humans	NNS	O	human	prep_in	11	SENT_271	[p14l1362t1046r1649b1109],
14	.	.	O	.	_	0	SENT_271	[p14l1362t1046r1649b1109],

1	This	DT	O	this	det	2	SENT_272	[p14l1672t1046r1813b1109],
2	disease	NN	O	disease	nsubjpass	4	SENT_272	[p14l1835t1046r2072b1109],
3	is	VBZ	O	be	auxpass	4	SENT_272	[p14l2093t1052r2142b1109],
4	caused	VBN	O	cause	_	0	SENT_272	[p14l9t1149r234b1212],
5	by	IN	O	by	_	0	SENT_272	[p14l251t1149r333b1233],
6	the	DT	O	the	det	7	SENT_272	[p14l348t1149r452b1212],
7	conﬂuence	NN	O	conﬂuence	agent	4	SENT_272	[p14l472t1149r834b1212],
8	of	IN	O	of	_	0	SENT_272	[p14l855t1149r927b1212],
9	a	DT	O	a	det	10	SENT_272	[p14l938t1172r972b1212],
10	variety	NN	O	variety	prep_of	7	SENT_272	[p14l987t1155r1220b1233],
11	of	IN	O	of	_	0	SENT_272	[p14l1237t1149r1309b1212],
12	factors	NNS	O	factor	prep_of	10	SENT_272	[p14l1319t1149r1560b1221],
13	,	,	O	,	_	0	SENT_272	[p14l1319t1149r1560b1221],
14	including	VBG	O	include	_	0	SENT_272	[p14l1582t1149r1900b1233],
15	energy	NN	O	energy	nn	16	SENT_272	[p14l1919t1172r2147b1233],
16	imbalance	NN	O	imbalance	prep_including	7	SENT_272	[p14l8t1252r370b1324],
17	,	,	O	,	_	0	SENT_272	[p14l8t1252r370b1324],
18	disruption	NN	O	disruption	prep_including	7	SENT_272	[p14l393t1252r744b1335],
19	of	IN	O	of	_	0	SENT_272	[p14l765t1252r837b1315],
20	neuroendocrine	JJ	O	neuroendocrine	amod	21	SENT_272	[p14l848t1252r1389b1315],
21	axes	NNS	O	axis	prep_of	18	SENT_272	[p14l1410t1275r1567b1324],
22	,	,	O	,	_	0	SENT_272	[p14l1410t1275r1567b1324],
23	and	CC	O	and	_	0	SENT_272	[p14l1589t1252r1713b1315],
24	adverse	JJ	O	adverse	amod	26	SENT_272	[p14l1733t1252r1983b1315],
25	psychological	JJ	O	psychological	amod	26	SENT_272	[p14l2002t1274r2141b1336, p14l9t1355r370b1439],
26	factors	NNS	O	factor	prep_including	7	SENT_272	[p14l394t1355r649b1418],
27	.	.	O	.	_	0	SENT_272	[p14l394t1355r649b1418],

1	Given	VBN	O	give	prep	8	SENT_273	[p14l679t1359r887b1418],
2	this	DT	O	this	det	4	SENT_273	[p14l911t1355r1039b1418],
3	complex	NN	O	complex	nn	4	SENT_273	[p14l1066t1355r1366b1438],
4	etiology	NN	O	etiology	dep	1	SENT_273	[p14l1390t1355r1686b1439],
5	,	,	O	,	_	0	SENT_273	[p14l1390t1355r1686b1439],
6	it	PRP	O	it	nsubj	8	SENT_273	[p14l1713t1361r1760b1418],
7	is	VBZ	O	be	cop	8	SENT_273	[p14l1783t1361r1835b1418],
8	unlikely	JJ	O	unlikely	_	0	SENT_273	[p14l1860t1355r2149b1439],
9	that	IN	O	that	complm	13	SENT_273	[p14l7t1458r143b1521],
10	monotherapy	NN	O	monotherapy	nsubj	13	SENT_273	[p14l165t1458r636b1542],
11	will	MD	O	will	aux	13	SENT_273	[p14l654t1458r782b1521],
12	be	VB	O	be	cop	13	SENT_273	[p14l802t1458r882b1521],
13	suﬂicient	JJ	O	suﬂicient	ccomp	8	SENT_273	[p14l907t1458r1222b1521],
14	to	TO	O	to	aux	15	SENT_273	[p14l1243t1470r1310b1521],
15	reverse	VB	O	reverse	xcomp	13	SENT_273	[p14l1335t1481r1579b1521],
16	the	DT	O	the	det	17	SENT_273	[p14l1601t1458r1709b1521],
17	disease	NN	O	disease	dobj	15	SENT_273	[p14l1733t1458r1994b1521],
18	.	.	O	.	_	0	SENT_273	[p14l1733t1458r1994b1521],

1	It	PRP	O	it	nsubj	5	SENT_274	[p14l2021t1463r2071b1521],
2	is	VBZ	O	be	cop	5	SENT_274	[p14l2093t1464r2143b1521],
3	therefore	RB	O	therefore	advmod	5	SENT_274	[p14l7t1561r319b1624],
4	not	RB	O	not	neg	5	SENT_274	[p14l342t1573r457b1624],
5	surprising	JJ	O	surprising	_	0	SENT_274	[p14l479t1567r831b1645],
6	that	IN	O	that	complm	11	SENT_274	[p14l851t1561r985b1624],
7	combination	NN	O	combination	nn	8	SENT_274	[p14l1008t1561r1445b1624],
8	therapies	NNS	O	therapy	nsubjpass	11	SENT_274	[p14l1467t1561r1780b1644],
9	have	VBP	O	have	aux	11	SENT_274	[p14l1802t1561r1959b1624],
10	been	VBN	O	be	auxpass	11	SENT_274	[p14l1980t1561r2145b1624],
11	evaluated	VBN	O	evaluate	ccomp	5	SENT_274	[p14l9t1664r336b1727],
12	clinically	RB	O	clinically	advmod	11	SENT_274	[p14l359t1664r678b1748],
13	,	,	O	,	_	0	SENT_274	[p14l359t1664r678b1748],
14	and	CC	O	and	_	0	SENT_274	[p14l704t1664r831b1727],
15	these	DT	O	these	det	16	SENT_274	[p14l852t1664r1028b1727],
16	show	NN	O	show	dep	18	SENT_274	[p14l1053t1664r1231b1727],
17	substantial	JJ	O	substantial	amod	18	SENT_274	[p14l1252t1664r1623b1727],
18	promise	NN	O	promise	conj_and	5	SENT_274	[p14l1644t1670r1925b1747],
19	in	IN	O	in	_	0	SENT_274	[p14l1948t1670r2015b1726],
20	the	DT	O	the	det	21	SENT_274	[p14l2037t1664r2144b1727],
21	treatment	NN	O	treatment	prep_in	18	SENT_274	[p14l7t1779r337b1830],
22	of	IN	O	of	_	0	SENT_274	[p14l357t1767r429b1830],
23	obesity	NN	O	obesity	prep_of	21	SENT_274	[p14l440t1767r687b1851],
24	.	.	O	.	_	0	SENT_274	[p14l440t1767r687b1851],

1	One	CD	NUMBER	one	num	4	SENT_275	[p14l711t1771r851b1830],
2	such	JJ	O	such	amod	4	SENT_275	[p14l873t1767r1025b1830],
3	cocktail	NN	O	cocktail	nn	4	SENT_275	[p14l1045t1767r1306b1830],
4	therapy	NN	O	therapy	nsubj	19	SENT_275	[p14l1324t1767r1581b1851],
5	that	WDT	O	that	nsubjpass	9	SENT_275	[p14l1597t1767r1728b1830],
6	has	VBZ	O	have	aux	9	SENT_275	[p14l1746t1767r1856b1830],
7	recently	RB	DATE	recently	advmod	9	SENT_275	[p14l1877t1767r2147b1851],
8	been	VBN	O	be	auxpass	9	SENT_275	[p14l6t1870r170b1933],
9	approved	VBN	O	approve	rcmod	4	SENT_275	[p14l194t1870r512b1953],
10	for	IN	O	for	_	0	SENT_275	[p14l533t1870r631b1933],
11	treatment	NN	O	treatment	prep_for	9	SENT_275	[p14l651t1882r987b1933],
12	of	IN	O	of	_	0	SENT_275	[p14l1010t1870r1084b1933],
13	obesity	NN	O	obesity	prep_of	11	SENT_275	[p14l1097t1870r1342b1954],
14	is	VBZ	O	be	cop	19	SENT_275	[p14l1361t1876r1411b1933],
15	phentermine/topira	JJ	O	phentermine/topira	amod	19	SENT_275	[p14l1433t1870r2140b1953],
16	—	NN	O	—	nn	19	SENT_275	[p14l1433t1870r2140b1953],
17	mate	NN	O	mate	nn	19	SENT_275	[p14l8t1985r172b2036],
18	extended-release	JJ	O	extended-release	amod	19	SENT_275	[p14l194t1973r765b2036],
19	formulation	NN	O	formulation	_	0	SENT_275	[p14l785t1973r1211b2045],
20	,	,	O	,	_	0	SENT_275	[p14l785t1973r1211b2045],
21	which	WDT	O	which	nsubjpass	24	SENT_275	[p14l1232t1973r1440b2036],
22	is	VBZ	O	be	aux	24	SENT_275	[p14l1460t1979r1510b2036],
23	being	VBG	O	be	auxpass	24	SENT_275	[p14l1529t1973r1719b2057],
24	marketed	VBN	O	market	rcmod	19	SENT_275	[p14l1738t1973r2060b2036],
25	in	IN	O	in	_	0	SENT_275	[p14l2079t1979r2146b2035],
26	the	DT	O	the	det	28	SENT_275	[p14l7t2076r114b2139],
27	United	NNP	LOCATION	United	nn	28	SENT_275	[p14l136t2076r371b2139],
28	States	NNPS	LOCATION	States	prep_in	24	SENT_275	[p14l392t2080r584b2139],
29	as	IN	O	as	_	0	SENT_275	[p14l607t2099r671b2139],
30	Qsymia	NNP	O	Qsymia	prep_as	24	SENT_275	[p14l695t2080r958b2160],
31	by	IN	O	by	_	0	SENT_275	[p14l977t2076r1061b2160],
32	Vivus	NNP	ORGANIZATION	Vivus	agent	24	SENT_275	[p14l1078t2081r1288b2139],
33	.	.	O	.	_	0	SENT_275	[p14l1078t2081r1288b2139],

1	Phentermine	NNP	O	Phentermine	nsubjpass	4	SENT_276	[p14l83t2178r519b2241],
2	has	VBZ	O	have	aux	4	SENT_276	[p14l537t2178r647b2241],
3	been	VBN	O	be	auxpass	4	SENT_276	[p14l665t2178r826b2241],
4	used	VBN	O	use	dep	24	SENT_276	[p14l846t2178r1001b2241],
5	in	IN	O	in	_	0	SENT_276	[p14l1019t2184r1085b2240],
6	the	DT	O	the	det	8	SENT_276	[p14l1103t2178r1207b2241],
7	United	NNP	LOCATION	United	nn	8	SENT_276	[p14l1228t2178r1458b2241],
8	States	NNPS	LOCATION	States	prep_in	4	SENT_276	[p14l1477t2182r1664b2241],
9	since	IN	O	since	_	0	SENT_276	[p14l1686t2184r1852b2241],
10	1959	CD	DATE	1959	prep_since	4	SENT_276	[p14l1879t2185r2030b2241],
11	for	IN	O	for	_	0	SENT_276	[p14l2050t2178r2146b2241],
12	short	JJ	O	short	amod	15	SENT_276	[p14l9t2280r385b2343],
13	—	JJ	O	—	amod	15	SENT_276	[p14l9t2280r385b2343],
14	term	NN	O	term	nn	15	SENT_276	[p14l9t2280r385b2343],
15	management	NN	O	management	prep_for	4	SENT_276	[p14l408t2292r859b2364],
16	of	IN	O	of	_	0	SENT_276	[p14l881t2280r956b2343],
17	obesity	NN	O	obesity	prep_of	15	SENT_276	[p14l970t2272r1289b2364],
18	.25	CD	NUMBER	.25	num	17	SENT_276	[p14l970t2272r1289b2364],
19	Its	PRP$	O	its	poss	20	SENT_276	[p14l1314t2285r1394b2343],
20	mechanism	NN	O	mechanism	nsubjpass	24	SENT_276	[p14l1418t2280r1819b2343],
21	of	IN	O	of	_	0	SENT_276	[p14l1842t2280r1917b2343],
22	action	NN	O	action	prep_of	20	SENT_276	[p14l1931t2286r2144b2343],
23	is	VBZ	O	be	auxpass	24	SENT_276	[p14l9t2389r59b2446],
24	believed	VBN	O	believe	_	0	SENT_276	[p14l81t2383r371b2446],
25	to	TO	O	to	aux	27	SENT_276	[p14l392t2395r459b2446],
26	be	VB	O	be	cop	27	SENT_276	[p14l482t2383r563b2446],
27	dependent	JJ	O	dependent	xcomp	24	SENT_276	[p14l587t2383r956b2466],
28	on	IN	O	on	_	0	SENT_276	[p14l979t2406r1066b2446],
29	modulation	NN	O	modulation	prep_on	27	SENT_276	[p14l1090t2383r1498b2446],
30	of	IN	O	of	_	0	SENT_276	[p14l1522t2383r1597b2446],
31	catecholamines	NNS	O	catecholamine	prep_of	29	SENT_276	[p14l1611t2383r2145b2446],
32	in	IN	O	in	_	0	SENT_276	[p14l9t2491r75b2547],
33	the	DT	O	the	det	35	SENT_276	[p14l96t2485r202b2548],
34	satiety	NN	O	satiety	nn	35	SENT_276	[p14l225t2491r445b2569],
35	centers	NNS	O	center	prep_in	31	SENT_276	[p14l464t2497r704b2548],
36	of	IN	O	of	_	0	SENT_276	[p14l727t2485r801b2548],
37	the	DT	O	the	det	38	SENT_276	[p14l812t2485r919b2548],
38	hypothalamus	NN	O	hypothalamus	prep_of	29	SENT_276	[p14l939t2485r1445b2569],
39	,	,	O	,	_	0	SENT_276	[p14l939t2485r1445b2569],
40	reducing	VBG	O	reduce	partmod	29	SENT_276	[p14l1469t2485r1772b2569],
41	appetite	NN	O	appetite	dobj	40	SENT_276	[p14l1793t2477r2144b2568],
42	.25	CD	NUMBER	.25	num	41	SENT_276	[p14l1793t2477r2144b2568],
43	Topiramate	NNP	O	Topiramate	nsubjpass	47	SENT_276	[p14l8t2591r404b2671],
44	has	VBZ	O	have	aux	47	SENT_276	[p14l426t2588r540b2651],
45	also	RB	O	also	advmod	47	SENT_276	[p14l564t2588r697b2651],
46	been	VBN	O	be	auxpass	47	SENT_276	[p14l719t2588r885b2651],
47	approved	VBN	O	approve	rcmod	41	SENT_276	[p14l909t2588r1231b2671],
48	by	IN	O	by	_	0	SENT_276	[p14l1251t2588r1336b2672],
49	the	DT	O	the	det	50	SENT_276	[p14l1354t2588r1463b2651],
50	FDA	NNP	ORGANIZATION	FDA	agent	47	SENT_276	[p14l1486t2592r1669b2660],
51	,	,	O	,	_	0	SENT_276	[p14l1486t2592r1669b2660],
52	although	IN	O	although	mark	56	SENT_276	[p14l1694t2588r2002b2672],
53	it	PRP	O	it	nsubjpass	56	SENT_276	[p14l2025t2594r2071b2651],
54	is	VBZ	O	be	auxpass	56	SENT_276	[p14l2094t2594r2144b2651],
55	primarily	RB	O	primarily	advmod	56	SENT_276	[p14l7t2691r347b2775],
56	used	VBN	O	use	dep	29	SENT_276	[p14l371t2691r535b2754],
57	to	TO	O	to	aux	58	SENT_276	[p14l561t2703r630b2754],
58	treat	VB	O	treat	xcomp	56	SENT_276	[p14l658t2703r821b2754],
59	convulsive	JJ	O	convulsive	amod	60	SENT_276	[p14l849t2691r1223b2754],
60	disorders	NNS	O	disorder	dobj	58	SENT_276	[p14l1252t2691r1581b2754],
61	and	CC	O	and	_	0	SENT_276	[p14l1611t2691r1741b2754],
62	migraines	NNS	O	migraine	dobj	58	SENT_276	[p14l1768t2697r2139b2775],
63	.	.	O	.	_	0	SENT_276	[p14l1768t2697r2139b2775],

1	Interestingly	RB	O	interestingly	advmod	5	SENT_277	[p14l9t2794r469b2878],
2	,	,	O	,	_	0	SENT_277	[p14l9t2794r469b2878],
3	it	PRP	O	it	nsubjpass	5	SENT_277	[p14l499t2800r546b2857],
4	was	VBD	O	be	auxpass	5	SENT_277	[p14l571t2817r701b2857],
5	observed	VBN	O	observe	dep	30	SENT_277	[p14l730t2794r1052b2857],
6	that	IN	O	that	complm	10	SENT_277	[p14l1078t2794r1217b2857],
7	patients	NNS	O	patient	nsubj	10	SENT_277	[p14l1242t2800r1522b2877],
8	receiving	VBG	O	receive	partmod	7	SENT_277	[p14l1551t2800r1876b2878],
9	topiramate	NN	O	topiramate	dobj	8	SENT_277	[p14l1901t2800r2142b2877, p14l8t2909r176b2960],
10	lost	VBD	O	lose	ccomp	5	SENT_277	[p14l197t2897r321b2960],
11	weight	NN	O	weight	dobj	10	SENT_277	[p14l341t2897r590b2981],
12	,	,	O	,	_	0	SENT_277	[p14l341t2897r590b2981],
13	and	CC	O	and	_	0	SENT_277	[p14l615t2897r743b2960],
14	this	DT	O	this	nsubj	15	SENT_277	[p14l764t2897r890b2960],
15	generated	VBN	O	generate	conj_and	5	SENT_277	[p14l912t2897r1251b2981],
16	interest	NN	O	interest	dobj	15	SENT_277	[p14l1273t2903r1529b2960],
17	in	IN	O	in	_	0	SENT_277	[p14l1551t2903r1618b2959],
18	evaluating	VBG	O	evaluate	prepc_in	15	SENT_277	[p14l1642t2897r1999b2981],
19	this	DT	O	this	det	20	SENT_277	[p14l2019t2897r2145b2960],
20	compound	NN	O	compound	dobj	18	SENT_277	[p14l9t2999r397b3082],
21	as	IN	O	as	_	0	SENT_277	[p14l426t3022r492b3062],
22	a	DT	O	a	det	25	SENT_277	[p14l523t3022r557b3062],
23	potential	JJ	O	potential	amod	25	SENT_277	[p14l584t2999r905b3082],
24	antiobesity	NN	O	antiobesity	nn	25	SENT_277	[p14l934t2999r1329b3083],
25	drug	NN	O	drug	prep_as	18	SENT_277	[p14l1355t2991r1708b3083],
26	.34	CD	NUMBER	.34	number	27	SENT_277	[p14l1355t2991r1708b3083],
27	‘	CD	NUMBER	‘	dep	25	SENT_277	[p14l1355t2991r1708b3083],
28	36	CD	NUMBER	36	num	29	SENT_277	[p14l1355t2991r1708b3083],
29	Topiramate	NNP	O	Topiramate	dep	27	SENT_277	[p14l1737t3002r2145b3082],
30	enacts	VBZ	O	enact	_	0	SENT_277	[p14l9t3114r236b3165],
31	its	PRP$	O	its	poss	32	SENT_277	[p14l270t3108r352b3165],
32	effects	NNS	O	effect	dobj	30	SENT_277	[p14l387t3102r619b3165],
33	at	IN	O	at	advmod	30	SENT_277	[p14l655t3114r717b3165],
34	least	JJS	O	least	pobj	33	SENT_277	[p14l748t3102r913b3165],
35	partially	RB	O	partially	advmod	33	SENT_277	[p14l944t3102r1256b3186],
36	through	IN	O	through	_	0	SENT_277	[p14l1285t3102r1581b3186],
37	antagonism	NN	O	antagonism	prep_through	33	SENT_277	[p14l1616t3108r2041b3186],
38	of	IN	O	of	_	0	SENT_277	[p14l2075t3102r2153b3165],
39	Oc-amino-3-hydroxy	JJ	O	oc-amino-3-hydroxy	amod	43	SENT_277	[p14l9t3205r1469b3289],
40	—	NN	O	—	nn	43	SENT_277	[p14l9t3205r1469b3289],
41	5-methyl-4-isoxazole	JJ	O	5-methyl-4-isoxazole	amod	43	SENT_277	[p14l9t3205r1469b3289],
42	propionate/kainate	NN	O	propionate/kainate	nn	43	SENT_277	[p14l1490t3205r2143b3288],
43	receptors	NNS	O	receptor	prep_of	37	SENT_277	[p14l9t3320r342b3391],
44	,	,	O	,	_	0	SENT_277	[p14l9t3320r342b3391],
45	although	IN	O	although	_	0	SENT_277	[p14l366t3308r672b3392],
46	induction	NN	O	induction	prep_although	33	SENT_277	[p14l693t3308r1030b3371],
47	of	IN	O	of	_	0	SENT_277	[p14l1052t3308r1126b3371],
48	y	NN	O	y	npadvmod	50	SENT_277	[p14l1136t3308r1672b3392],
49	—	CD	NUMBER	—	num	48	SENT_277	[p14l1136t3308r1672b3392],
50	aminobutyric	JJ	O	aminobutyric	amod	51	SENT_277	[p14l1136t3308r1672b3392],
51	acid	NN	O	acid	prep_of	46	SENT_277	[p14l1695t3308r1836b3371],
52	(	CD	NUMBER	(	num	54	SENT_277	[p14l1860t3309r2141b3385],
53	GABA	NN	O	gaba	nn	54	SENT_277	[p14l1860t3309r2141b3385],
54	)	NN	O	)	nsubj	30	SENT_277	[p14l1860t3309r2141b3385],

1	VOLUME	NN	O	volume	dep	6	SENT_278	[p14l542t3526r765b3568],
2	95	CD	NUMBER	95	dep	1	SENT_278	[p14l783t3527r839b3568],
3	NUMBER	NN	O	number	dep	6	SENT_278	[p14l860t3526r1084b3568],
4	1	CD	NUMBER	1	num	3	SENT_278	[p14l1105t3528r1118b3568],
5	|	CD	NUMBER	|	num	6	SENT_278	[p14l1148t3522r1152b3583],
6	JANUARY	NNP	DATE	JANUARY	dep	17	SENT_278	[p14l1171t3526r1416b3568],
7	2014	CD	DATE	2014	num	6	SENT_278	[p14l1432t3527r1553b3568],
8	|	CD	NUMBER	|	num	12	SENT_278	[p14l1571t3522r1576b3583],
9	www.nature.com/cpt	JJ	O	www.nature.com/cpt	amod	12	SENT_278	[p14l1595t3526r2145b3579],
10	receptor-mediated	JJ	O	receptor-mediated	amod	12	SENT_278	[p15l8t133r629b216],
11	inhibitory	JJ	O	inhibitory	amod	12	SENT_278	[p15l649t133r990b217],
12	currents	NNS	O	current	dep	6	SENT_278	[p15l1008t145r1284b196],
13	and	CC	O	and	_	0	SENT_278	[p15l1307t133r1431b196],
14	modiﬁcation	NN	O	modiﬁcation	conj_and	6	SENT_278	[p15l1451t133r1883b196],
15	of	IN	O	of	_	0	SENT_278	[p15l1905t133r1978b196],
16	voltage	NN	O	voltage	prep_of	14	SENT_278	[p15l1986t133r2139b196, p15l8t236r341b320],
17	—	CD	NUMBER	—	_	0	SENT_278	[p15l1986t133r2139b196, p15l8t236r341b320],
18	gated	VBN	O	gate	partmod	17	SENT_278	[p15l1986t133r2139b196, p15l8t236r341b320],
19	calcium	NN	O	calcium	nn	22	SENT_278	[p15l364t236r637b299],
20	and	CC	O	and	_	0	SENT_278	[p15l662t236r790b299],
21	sodium	NN	O	sodium	conj_and	19	SENT_278	[p15l814t236r1076b299],
22	channels	NNS	O	channel	nsubj	25	SENT_278	[p15l1100t236r1404b299],
23	may	MD	O	may	aux	25	SENT_278	[p15l1428t259r1577b320],
24	also	RB	O	also	advmod	25	SENT_278	[p15l1598t236r1731b299],
25	play	VB	O	play	dep	18	SENT_278	[p15l1755t236r1902b320],
26	a	DT	O	a	det	27	SENT_278	[p15l1922t259r1958b299],
27	roles	NNS	O	role	nsubj	28	SENT_278	[p15l1981t236r2143b299],
28	(	VBP	O	(	dep	25	SENT_278	[p15l11t339r272b421],
29	Figure	NN	O	figure	dobj	28	SENT_278	[p15l11t339r272b421],
30	2b	JJ	O	2b	amod	34	SENT_278	[p15l293t330r492b415],
31	)	NN	O	)	nn	34	SENT_278	[p15l293t330r492b415],
32	.37	CD	NUMBER	.37	num	34	SENT_278	[p15l293t330r492b415],
33	Animal	NN	O	animal	nn	34	SENT_278	[p15l513t338r774b401],
34	studies	NNS	O	study	nsubj	35	SENT_278	[p15l797t338r1033b401],
35	suggest	VBP	O	suggest	dep	25	SENT_278	[p15l1056t350r1307b422],
36	that	IN	O	that	complm	38	SENT_278	[p15l1327t338r1462b401],
37	topiramate	NN	O	topiramate	nsubj	38	SENT_278	[p15l1481t344r1856b421],
38	induces	VBZ	O	induce	ccomp	35	SENT_278	[p15l1879t338r2142b401],
39	weight	NN	O	weight	nn	40	SENT_278	[p15l6t441r227b525],
40	loss	NN	O	loss	dobj	38	SENT_278	[p15l242t441r363b504],
41	not	RB	O	not	neg	42	SENT_278	[p15l382t453r492b504],
42	only	RB	O	only	preconj	38	SENT_278	[p15l510t441r655b525],
43	by	IN	O	by	_	0	SENT_278	[p15l668t441r750b525],
44	decreasing	VBG	O	decrease	amod	46	SENT_278	[p15l765t441r1115b525],
45	food	NN	O	food	nn	46	SENT_278	[p15l1131t441r1283b504],
46	intake	NN	O	intake	prep_by	38	SENT_278	[p15l1300t441r1501b504],
47	but	CC	O	but	_	0	SENT_278	[p15l1517t441r1627b504],
48	also	RB	O	also	_	0	SENT_278	[p15l1645t441r1770b504],
49	by	IN	O	by	_	0	SENT_278	[p15l1788t441r1870b525],
50	increasing	VBG	O	increase	amod	52	SENT_278	[p15l1884t447r2141b504, p15l8t551r117b629],
51	energy	NN	O	energy	nn	52	SENT_278	[p15l139t568r375b629],
52	expenditure	NN	O	expenditure	prep_by	38	SENT_278	[p15l394t545r826b628],
53	,	,	O	,	_	0	SENT_278	[p15l394t545r826b628],
54	possibly	RB	O	possibly	advmod	38	SENT_278	[p15l849t545r1134b629],
55	through	IN	O	through	_	0	SENT_278	[p15l1152t545r1433b629],
56	decreased	VBN	O	decrease	amod	57	SENT_278	[p15l1456t545r1797b608],
57	efﬁciency	NN	O	efﬁciency	prep_through	38	SENT_278	[p15l1819t545r2149b629],
58	of	IN	O	of	_	0	SENT_278	[p15l8t647r82b710],
59	nutrient	NN	O	nutrient	nn	60	SENT_278	[p15l94t653r374b710],
60	utilization	NN	O	utilization	prep_of	57	SENT_278	[p15l394t639r920b710],
61	.38	CD	NUMBER	.38	num	62	SENT_278	[p15l394t639r920b710],
62	‘	NN	O	‘	dep	60	SENT_278	[p15l394t639r920b710],
63	4	CD	NUMBER	4	number	64	SENT_278	[p15l394t639r920b710],
64	°	CD	NUMBER	°	dep	62	SENT_278	[p15l394t639r920b710],
65	Although	IN	O	although	mark	82	SENT_278	[p15l941t647r1269b731],
66	the	DT	O	the	det	68	SENT_278	[p15l1290t647r1396b710],
67	exact	JJ	O	exact	amod	68	SENT_278	[p15l1419t659r1595b710],
68	mechanisms	NNS	O	mechanism	nsubj	82	SENT_278	[p15l1615t647r2042b710],
69	by	IN	O	by	_	0	SENT_278	[p15l2062t647r2147b731],
70	which	WDT	O	which	rel	72	SENT_278	[p15l6t750r216b813],
71	topiramate	NN	O	topiramate	nsubj	75	SENT_278	[p15l236t756r608b833],
72	regulates	VBZ	O	regulate	rcmod	68	SENT_278	[p15l631t750r933b834],
73	appetite	NN	O	appetite	dobj	72	SENT_278	[p15l956t756r1226b833],
74	and	CC	O	and	_	0	SENT_278	[p15l1249t750r1376b813],
75	induces	VBZ	O	induce	conj_and	72	SENT_278	[p15l1397t750r1658b813],
76	weight	NN	O	weight	nn	77	SENT_278	[p15l1678t750r1908b834],
77	loss	NN	O	loss	dobj	75	SENT_278	[p15l1927t750r2053b813],
78	in	IN	O	in	_	0	SENT_278	[p15l2076t756r2143b812],
79	humans	NNS	O	human	prep_in	75	SENT_278	[p15l7t853r284b916],
80	is	VBZ	O	be	aux	82	SENT_278	[p15l308t859r358b916],
81	are	VBP	O	be	cop	82	SENT_278	[p15l383t876r484b916],
82	unknown	JJ	O	unknown	advcl	87	SENT_278	[p15l507t853r860b925],
83	,	,	O	,	_	0	SENT_278	[p15l507t853r860b925],
84	signiﬁcant	JJ	O	signiﬁcant	amod	86	SENT_278	[p15l886t853r1246b937],
85	clinical	JJ	O	clinical	amod	86	SENT_278	[p15l1268t853r1516b916],
86	evidence	NN	O	evidence	nsubj	87	SENT_278	[p15l1539t853r1843b916],
87	exists	VBZ	O	exist	dep	25	SENT_278	[p15l1866t859r2054b916],
88	to	TO	O	to	aux	89	SENT_278	[p15l2076t865r2143b916],
89	support	VB	O	support	xcomp	87	SENT_278	[p15l8t967r269b1038],
90	its	PRP$	O	its	poss	91	SENT_278	[p15l287t961r361b1018],
91	use	NN	O	use	dobj	89	SENT_278	[p15l382t978r491b1018],
92	as	IN	O	as	_	0	SENT_278	[p15l512t978r575b1018],
93	an	DT	O	a	det	95	SENT_278	[p15l596t978r675b1018],
94	antiobesity	JJ	O	antiobesity	amod	95	SENT_278	[p15l696t955r1064b1039],
95	drug	NN	O	drug	prep_as	89	SENT_278	[p15l1081t947r1413b1039],
96	.34	CD	NUMBER	.34	number	97	SENT_278	[p15l1081t947r1413b1039],
97	‘	CD	NUMBER	‘	num	98	SENT_278	[p15l1081t947r1413b1039],
98	36	CD	NUMBER	36	dep	89	SENT_278	[p15l1081t947r1413b1039],

1	The	DT	O	the	det	2	SENT_279	[p15l81t1058r206b1121],
2	FDA	NNP	ORGANIZATION	FDA	nsubj	3	SENT_279	[p15l230t1062r392b1120],
3	approved	VBD	O	approve	dep	43	SENT_279	[p15l416t1058r735b1141],
4	the	DT	O	the	det	5	SENT_279	[p15l755t1058r862b1121],
5	combination	NN	O	combination	dobj	3	SENT_279	[p15l886t1058r1323b1121],
6	of	IN	O	of	_	0	SENT_279	[p15l1346t1058r1420b1121],
7	phentermine/topiramate	NN	O	phentermine/topiramate	prep_of	5	SENT_279	[p15l1432t1058r2142b1141, p15l7t1173r178b1224],
8	in	IN	O	in	_	0	SENT_279	[p15l204t1167r272b1223],
9	2012	CD	DATE	2012	prep_in	3	SENT_279	[p15l298t1168r485b1233],
10	,	,	O	,	_	0	SENT_279	[p15l298t1168r485b1233],
11	largely	RB	O	largely	advmod	3	SENT_279	[p15l510t1161r748b1245],
12	on	IN	O	on	_	0	SENT_279	[p15l770t1184r858b1224],
13	the	DT	O	the	det	14	SENT_279	[p15l883t1161r992b1224],
14	strength	NN	O	strength	prep_on	3	SENT_279	[p15l1019t1161r1311b1245],
15	of	IN	O	of	_	0	SENT_279	[p15l1337t1161r1413b1224],
16	evidence	NN	O	evidence	prep_of	14	SENT_279	[p15l1429t1161r1739b1224],
17	from	IN	O	from	_	0	SENT_279	[p15l1764t1161r1937b1224],
18	three	CD	NUMBER	three	num	20	SENT_279	[p15l1962t1161r2143b1224],
19	clinical	JJ	O	clinical	amod	20	SENT_279	[p15l8t1264r253b1327],
20	trials	NNS	O	trial	prep_from	16	SENT_279	[p15l273t1264r462b1336],
21	,	,	O	,	_	0	SENT_279	[p15l273t1264r462b1336],
22	known	VBN	O	know	partmod	20	SENT_279	[p15l484t1264r721b1328],
23	as	IN	O	as	_	0	SENT_279	[p15l743t1287r807b1328],
24	the	DT	O	the	det	27	SENT_279	[p15l827t1264r934b1328],
25	CONQUER	NNP	O	CONQUER	nn	27	SENT_279	[p15l956t1268r1386b1340],
26	,	,	O	,	_	0	SENT_279	[p15l956t1268r1386b1340],
27	EQUIP	NNP	O	EQUIP	prep_as	22	SENT_279	[p15l1409t1268r1665b1340],
28	,	,	O	,	_	0	SENT_279	[p15l1409t1268r1665b1340],
29	and	CC	O	and	_	0	SENT_279	[p15l1689t1264r1816b1327],
30	SEQUEL	NN	O	sequel	nn	31	SENT_279	[p15l1836t1268r2144b1340],
31	trials	NNS	O	trial	prep_as	22	SENT_279	[p15l7t1358r363b1429],
32	.41	CD	NUMBER	.41	num	35	SENT_279	[p15l7t1358r363b1429],
33	‘	CD	NUMBER	‘	num	35	SENT_279	[p15l7t1358r363b1429],
34	43	CD	NUMBER	43	num	35	SENT_279	[p15l7t1358r363b1429],
35	Data	NNS	O	datum	nsubj	40	SENT_279	[p15l389t1371r555b1429],
36	from	IN	O	from	_	0	SENT_279	[p15l577t1366r749b1429],
37	these	DT	O	these	det	39	SENT_279	[p15l771t1366r951b1429],
38	three	CD	NUMBER	three	num	39	SENT_279	[p15l974t1366r1153b1429],
39	trials	NNS	O	trial	prep_from	35	SENT_279	[p15l1176t1366r1352b1429],
40	showed	VBD	O	show	ccomp	22	SENT_279	[p15l1377t1366r1640b1429],
41	phentermine	NN	O	phentermine	dobj	40	SENT_279	[p15l1662t1366r2144b1449],
42	/	:	O	/	punct	43	SENT_279	[p15l1662t1366r2144b1449],
43	topiramate	NN	O	topiramate	_	0	SENT_279	[p15l7t1475r372b1552],
44	to	TO	O	to	aux	46	SENT_279	[p15l391t1481r456b1532],
45	be	VB	O	be	cop	46	SENT_279	[p15l475t1469r553b1532],
46	eﬂicacious	JJ	O	eﬂicacious	dep	43	SENT_279	[p15l574t1469r923b1532],
47	in	IN	O	in	_	0	SENT_279	[p15l943t1475r1009b1531],
48	inducing	VBG	O	induce	prepc_in	46	SENT_279	[p15l1029t1469r1329b1553],
49	and	CC	O	and	_	0	SENT_279	[p15l1348t1469r1472b1532],
50	maintaining	VBG	O	maintain	prepc_in	46	SENT_279	[p15l1490t1475r1902b1553],
51	weight	NN	O	weight	nn	52	SENT_279	[p15l1919t1469r2144b1553],
52	loss	NN	O	loss	dobj	48	SENT_279	[p15l6t1572r149b1635],
53	.	.	O	.	_	0	SENT_279	[p15l6t1572r149b1635],

1	Across	IN	O	across	_	0	SENT_280	[p15l174t1576r404b1635],
2	the	DT	O	the	det	4	SENT_280	[p15l426t1572r532b1635],
3	three	CD	NUMBER	three	num	4	SENT_280	[p15l554t1572r730b1635],
4	trials	NNS	O	trial	prep_across	12	SENT_280	[p15l751t1572r942b1644],
5	,	,	O	,	_	0	SENT_280	[p15l751t1572r942b1644],
6	~	NN	O	~	nsubj	12	SENT_280	[p15l968t1577r1159b1637],
7	75	CD	PERCENT	75	number	8	SENT_280	[p15l968t1577r1159b1637],
8	%	NN	PERCENT	%	amod	6	SENT_280	[p15l968t1577r1159b1637],
9	of	IN	O	of	_	0	SENT_280	[p15l1184t1572r1258b1635],
10	treated	JJ	O	treated	amod	11	SENT_280	[p15l1270t1572r1509b1635],
11	subjects	NNS	O	subject	prep_of	6	SENT_280	[p15l1531t1572r1801b1656],
12	exhibited	VBD	O	exhibit	_	0	SENT_280	[p15l1825t1572r2143b1635],
13	a	DT	O	a	det	17	SENT_280	[p15l8t1698r43b1738],
14	5	CD	PERCENT	5	number	15	SENT_280	[p15l66t1680r165b1740],
15	%	NN	PERCENT	%	amod	17	SENT_280	[p15l66t1680r165b1740],
16	weight	NN	O	weight	nn	17	SENT_280	[p15l187t1675r417b1759],
17	loss	NN	O	loss	dobj	12	SENT_280	[p15l437t1675r581b1747],
18	,	,	O	,	_	0	SENT_280	[p15l437t1675r581b1747],
19	and	CC	O	and	_	0	SENT_280	[p15l606t1675r733b1738],
20	~	NN	O	~	nsubj	23	SENT_280	[p15l756t1680r947b1740],
21	50	CD	PERCENT	50	number	22	SENT_280	[p15l756t1680r947b1740],
22	%	NN	PERCENT	%	amod	20	SENT_280	[p15l756t1680r947b1740],
23	exhibited	VBD	O	exhibit	conj_and	12	SENT_280	[p15l971t1675r1288b1738],
24	a	DT	O	a	det	28	SENT_280	[p15l1311t1698r1345b1738],
25	10	CD	PERCENT	10	number	26	SENT_280	[p15l1373t1680r1508b1739],
26	%	NN	PERCENT	%	amod	28	SENT_280	[p15l1373t1680r1508b1739],
27	weight	NN	O	weight	nn	28	SENT_280	[p15l1531t1675r1761b1759],
28	loss	NN	O	loss	dobj	23	SENT_280	[p15l1781t1675r1924b1738],
29	.	.	O	.	_	0	SENT_280	[p15l1781t1675r1924b1738],

1	These	DT	O	these	det	2	SENT_281	[p15l1949t1675r2144b1738],
2	benchmarks	NNS	O	benchmark	nsubj	3	SENT_281	[p15l6t1778r428b1841],
3	represent	VBP	O	represent	_	0	SENT_281	[p15l450t1790r768b1861],
4	important	JJ	O	important	amod	6	SENT_281	[p15l788t1784r1136b1861],
5	efﬁcacy	NN	O	efﬁcacy	nn	6	SENT_281	[p15l1156t1778r1413b1862],
6	thresholds	NNS	O	threshold	dobj	3	SENT_281	[p15l1430t1778r1787b1841],
7	in	IN	O	in	_	0	SENT_281	[p15l1809t1784r1875b1840],
8	evaluation	NN	O	evaluation	prep_in	3	SENT_281	[p15l1897t1778r2141b1841, p15l7t1887r142b1944],
9	of	IN	O	of	_	0	SENT_281	[p15l163t1881r236b1944],
10	obesity	NN	O	obesity	nn	11	SENT_281	[p15l247t1881r488b1965],
11	pharmacotherapies	NNS	O	pharmacotherapy	prep_of	8	SENT_281	[p15l503t1881r1171b1964],
12	.	.	O	.	_	0	SENT_281	[p15l503t1881r1171b1964],

1	Importantly	RB	O	importantly	advmod	7	SENT_282	[p15l1195t1881r1613b1965],
2	,	,	O	,	_	0	SENT_282	[p15l1195t1881r1613b1965],
3	this	DT	O	this	det	5	SENT_282	[p15l1634t1881r1757b1944],
4	weight	NN	O	weight	nn	5	SENT_282	[p15l1776t1881r2003b1965],
5	loss	NN	O	loss	nsubjpass	7	SENT_282	[p15l2020t1881r2144b1944],
6	was	VBD	O	be	auxpass	7	SENT_282	[p15l6t2008r135b2048],
7	accompanied	VBN	O	accompany	_	0	SENT_282	[p15l161t1985r632b2068],
8	by	IN	O	by	_	0	SENT_282	[p15l653t1985r739b2069],
9	improvement	NN	O	improvement	agent	7	SENT_282	[p15l760t1991r1238b2068],
10	in	IN	O	in	_	0	SENT_282	[p15l1261t1991r1329b2047],
11	weight-related	JJ	O	weight-related	amod	14	SENT_282	[p15l1352t1985r1863b2069],
12	comor	NN	O	comor	nn	14	SENT_282	[p15l1887t2008r2141b2048],
13	—	NN	O	—	nn	14	SENT_282	[p15l1887t2008r2141b2048],
14	bidities	NNS	O	bidity	prep_in	7	SENT_282	[p15l6t2088r289b2160],
15	,	,	O	,	_	0	SENT_282	[p15l6t2088r289b2160],
16	including	VBG	O	include	_	0	SENT_282	[p15l317t2088r660b2172],
17	serum	NN	O	serum	nn	19	SENT_282	[p15l687t2111r909b2151],
18	lipid	NN	O	lipid	nn	19	SENT_282	[p15l935t2088r1098b2171],
19	proﬁle	NN	O	proﬁle	prep_including	7	SENT_282	[p15l1123t2088r1373b2171],
20	,	,	O	,	_	0	SENT_282	[p15l1123t2088r1373b2171],
21	waist	NN	O	waist	nn	22	SENT_282	[p15l1400t2094r1585b2151],
22	circumference	NN	O	circumference	conj_and	19	SENT_282	[p15l1611t2088r2144b2160],
23	,	,	O	,	_	0	SENT_282	[p15l1611t2088r2144b2160],
24	and	CC	O	and	_	0	SENT_282	[p15l8t2191r135b2254],
25	blood	NN	O	blood	nn	26	SENT_282	[p15l154t2191r354b2254],
26	pressure	NN	O	pressure	conj_and	19	SENT_282	[p15l374t2213r676b2274],
27	.	.	O	.	_	0	SENT_282	[p15l374t2213r676b2274],

1	It	PRP	O	it	nsubj	3	SENT_283	[p15l702t2196r752b2254],
2	is	VBZ	O	be	cop	3	SENT_283	[p15l773t2197r823b2254],
3	unclear	JJ	O	unclear	dep	28	SENT_283	[p15l846t2191r1101b2254],
4	whether	IN	O	whether	complm	8	SENT_283	[p15l1121t2191r1404b2254],
5	sustained	JJ	O	sustained	amod	7	SENT_283	[p15l1426t2191r1748b2254],
6	weight	NN	O	weight	nn	7	SENT_283	[p15l1768t2191r1997b2275],
7	loss	NN	O	loss	nsubj	8	SENT_283	[p15l2018t2191r2144b2254],
8	requires	VBZ	O	require	ccomp	3	SENT_283	[p15l8t2300r279b2377],
9	indeﬁnite	JJ	O	indeﬁnite	amod	10	SENT_283	[p15l300t2294r623b2357],
10	treatment	NN	O	treatment	dobj	8	SENT_283	[p15l642t2306r974b2357],
11	with	IN	O	with	_	0	SENT_283	[p15l990t2294r1142b2357],
12	phentermine/topiramate	NN	O	phentermine/topiramate	prep_with	8	SENT_283	[p15l1160t2294r2013b2377],
13	,	,	O	,	_	0	SENT_283	[p15l1160t2294r2013b2377],
14	but	CC	O	but	_	0	SENT_283	[p15l2033t2294r2146b2357],
15	it	PRP	O	it	nsubjpass	18	SENT_283	[p15l8t2403r53b2460],
16	has	VBZ	O	have	aux	18	SENT_283	[p15l70t2397r181b2460],
17	been	VBN	O	be	auxpass	18	SENT_283	[p15l199t2397r361b2460],
18	speculated	VBN	O	speculate	conj_but	3	SENT_283	[p15l382t2397r738b2480],
19	that	IN	O	that	complm	25	SENT_283	[p15l756t2397r889b2460],
20	discontinuation	NN	O	discontinuation	nsubj	25	SENT_283	[p15l908t2397r1440b2460],
21	of	IN	O	of	_	0	SENT_283	[p15l1461t2397r1534b2460],
22	the	DT	O	the	det	23	SENT_283	[p15l1543t2397r1648b2460],
23	drug	NN	O	drug	prep_of	20	SENT_283	[p15l1669t2397r1829b2481],
24	may	MD	O	may	aux	25	SENT_283	[p15l1847t2420r1992b2481],
25	lead	VB	O	lead	ccomp	18	SENT_283	[p15l2007t2397r2146b2460],
26	to	TO	O	to	_	0	SENT_283	[p15l7t2511r72b2562],
27	weight	NN	O	weight	prep_to	25	SENT_283	[p15l93t2499r323b2583],
28	regain	VBP	O	regain	_	0	SENT_283	[p15l344t2491r636b2583],
29	.25	CD	NUMBER	.25	nsubj	28	SENT_283	[p15l344t2491r636b2583],

1	Although	IN	O	although	dep	105	SENT_284	[p15l80t2602r408b2686],
2	drug	NN	O	drug	dep	105	SENT_284	[p15l430t2602r592b2686],
3	interactions	NNS	O	interaction	dep	105	SENT_284	[p15l612t2608r1017b2665],
4	are	VBP	O	be	dep	105	SENT_284	[p15l1041t2625r1141b2665],
5	rare	JJ	O	rare	dep	105	SENT_284	[p15l1163t2625r1296b2665],
6	for	IN	O	for	dep	105	SENT_284	[p15l1318t2602r1415b2665],
7	phentermine/topiramate	NN	O	phentermine/topiramate	dep	105	SENT_284	[p15l1435t2602r2141b2685, p15l7t2717r187b2777],
8	,	,	O	,	_	0	SENT_284	[p15l1435t2602r2141b2685, p15l7t2717r187b2777],
9	adverse	JJ	O	adverse	dep	105	SENT_284	[p15l209t2705r460b2768],
10	events	NNS	O	event	dep	105	SENT_284	[p15l480t2717r688b2768],
11	observed	VBN	O	observe	dep	105	SENT_284	[p15l710t2705r1014b2768],
12	in	IN	O	in	dep	105	SENT_284	[p15l1033t2711r1098b2767],
13	clinical	JJ	O	clinical	dep	105	SENT_284	[p15l1119t2705r1359b2768],
14	trials	NNS	O	trial	dep	105	SENT_284	[p15l1377t2705r1545b2768],
15	include	VBP	O	include	dep	105	SENT_284	[p15l1565t2705r1812b2768],
16	paresthe	NN	O	paresthe	dep	105	SENT_284	[p15l1831t2705r2141b2788],
17	—	CD	NUMBER	—	dep	105	SENT_284	[p15l1831t2705r2141b2788],
18	sias	NNS	O	sia	dep	105	SENT_284	[p15l8t2814r142b2880],
19	,	,	O	,	_	0	SENT_284	[p15l8t2814r142b2880],
20	headaches	NNS	O	headache	dep	105	SENT_284	[p15l163t2808r524b2880],
21	,	,	O	,	_	0	SENT_284	[p15l163t2808r524b2880],
22	constipation	NN	O	constipation	dep	105	SENT_284	[p15l546t2814r977b2891],
23	,	,	O	,	_	0	SENT_284	[p15l546t2814r977b2891],
24	dry	JJ	O	dry	dep	105	SENT_284	[p15l999t2808r1115b2892],
25	mouth	NN	O	mouth	dep	105	SENT_284	[p15l1131t2808r1371b2880],
26	,	,	O	,	_	0	SENT_284	[p15l1131t2808r1371b2880],
27	upper	JJ	O	upper	dep	105	SENT_284	[p15l1392t2830r1589b2891],
28	respiratory	JJ	O	respiratory	dep	105	SENT_284	[p15l1608t2814r1975b2892],
29	tract	NN	O	tract	dep	105	SENT_284	[p15l1991t2820r2145b2871],
30	infection	NN	O	infection	dep	105	SENT_284	[p15l8t2912r322b2984],
31	,	,	O	,	_	0	SENT_284	[p15l8t2912r322b2984],
32	nasopharyngitis	NN	O	nasopharyngitis	dep	105	SENT_284	[p15l342t2912r893b2996],
33	,	,	O	,	_	0	SENT_284	[p15l342t2912r893b2996],
34	dizziness	NN	O	dizziness	dep	105	SENT_284	[p15l915t2912r1229b2984],
35	,	,	O	,	_	0	SENT_284	[p15l915t2912r1229b2984],
36	insomnia	NN	O	insomnia	dep	105	SENT_284	[p15l1251t2918r1579b2984],
37	,	,	O	,	_	0	SENT_284	[p15l1251t2918r1579b2984],
38	depression	NN	O	depression	dep	105	SENT_284	[p15l1601t2912r1974b2995],
39	,	,	O	,	_	0	SENT_284	[p15l1601t2912r1974b2995],
40	anxiety	NN	O	anxiety	dep	105	SENT_284	[p15l1995t2935r2139b2975, p15l8t3020r141b3098],
41	,	,	O	,	_	0	SENT_284	[p15l1995t2935r2139b2975, p15l8t3020r141b3098],
42	blurry	JJ	O	blurry	dep	105	SENT_284	[p15l161t3014r379b3098],
43	vision	NN	O	vision	dep	105	SENT_284	[p15l392t3020r617b3086],
44	,	,	O	,	_	0	SENT_284	[p15l392t3020r617b3086],
45	and	CC	O	and	dep	105	SENT_284	[p15l640t3014r765b3077],
46	irritability	NN	O	irritability	dep	105	SENT_284	[p15l785t3006r1300b3098],
47	.41	CD	NUMBER	.41	dep	105	SENT_284	[p15l785t3006r1300b3098],
48	‘	CD	NUMBER	‘	dep	105	SENT_284	[p15l785t3006r1300b3098],
49	43	CD	NUMBER	43	dep	105	SENT_284	[p15l785t3006r1300b3098],
50	Given	VBN	O	give	dep	105	SENT_284	[p15l1323t3018r1525b3077],
51	this	DT	O	this	dep	105	SENT_284	[p15l1544t3014r1667b3077],
52	lengthy	JJ	O	lengthy	dep	105	SENT_284	[p15l1688t3014r1944b3098],
53	list	NN	O	list	dep	105	SENT_284	[p15l1959t3014r2060b3077],
54	of	IN	O	of	dep	105	SENT_284	[p15l2079t3014r2153b3077],
55	events	NNS	O	event	dep	105	SENT_284	[p15l8t3129r236b3189],
56	,	,	O	,	_	0	SENT_284	[p15l8t3129r236b3189],
57	it	PRP	O	it	dep	105	SENT_284	[p15l258t3123r303b3180],
58	is	VBZ	O	be	dep	105	SENT_284	[p15l322t3123r371b3180],
59	not	RB	O	not	dep	105	SENT_284	[p15l392t3129r504b3180],
60	surprising	JJ	O	surprising	dep	105	SENT_284	[p15l524t3123r868b3201],
61	that	IN	O	that	dep	105	SENT_284	[p15l885t3117r1017b3180],
62	one	CD	NUMBER	one	dep	105	SENT_284	[p15l1037t3140r1158b3180],
63	clinical	JJ	O	clinical	dep	105	SENT_284	[p15l1178t3117r1420b3180],
64	trial	NN	O	trial	dep	105	SENT_284	[p15l1438t3117r1577b3180],
65	of	IN	O	of	dep	105	SENT_284	[p15l1597t3117r1670b3180],
66	phentermine	NN	O	phentermine	dep	105	SENT_284	[p15l1680t3117r2144b3200],
67	/	:	O	/	dep	105	SENT_284	[p15l1680t3117r2144b3200],
68	topiramate	NN	O	topiramate	dep	105	SENT_284	[p15l7t3226r379b3303],
69	reported	VBD	O	report	dep	105	SENT_284	[p15l401t3220r697b3303],
70	a	DT	O	a	dep	105	SENT_284	[p15l718t3243r752b3283],
71	dropout	NN	O	dropout	dep	105	SENT_284	[p15l773t3220r1051b3303],
72	rate	NN	O	rate	dep	105	SENT_284	[p15l1071t3232r1198b3283],
73	of	IN	O	of	dep	105	SENT_284	[p15l1220t3220r1294b3283],
74	~	NN	O	~	dep	105	SENT_284	[p15l1309t3255r1349b3267],
75	19	CD	PERCENT	19	dep	105	SENT_284	[p15l1363t3226r1499b3284],
76	%	NN	PERCENT	%	dep	105	SENT_284	[p15l1363t3226r1499b3284],
77	(	CD	NUMBER	(	dep	105	SENT_284	[p15l1526t3220r1857b3304],
78	although	IN	O	although	dep	105	SENT_284	[p15l1526t3220r1857b3304],
79	another	DT	O	another	dep	105	SENT_284	[p15l1879t3220r2145b3283],
80	trial	NN	O	trial	dep	105	SENT_284	[p15l7t3322r146b3385],
81	reported	VBD	O	report	dep	105	SENT_284	[p15l167t3322r460b3405],
82	this	DT	O	this	dep	105	SENT_284	[p15l479t3322r602b3385],
83	number	NN	O	number	dep	105	SENT_284	[p15l623t3322r895b3385],
84	to	TO	O	to	dep	105	SENT_284	[p15l913t3334r978b3385],
85	be	VB	O	be	dep	105	SENT_284	[p15l998t3322r1077b3385],
86	as	RB	O	as	dep	105	SENT_284	[p15l1098t3345r1162b3385],
87	low	JJ	O	low	dep	105	SENT_284	[p15l1182t3322r1305b3385],
88	as	IN	O	as	dep	105	SENT_284	[p15l1323t3345r1387b3385],
89	4	CD	PERCENT	4	dep	105	SENT_284	[p15l1407t3314r1698b3399],
90	%	NN	PERCENT	%	dep	105	SENT_284	[p15l1407t3314r1698b3399],
91	)	CD	NUMBER	)	dep	105	SENT_284	[p15l1407t3314r1698b3399],
92	.42	CD	NUMBER	.42	dep	105	SENT_284	[p15l1407t3314r1698b3399],
93	’43	CD	NUMBER	’43	dep	105	SENT_284	[p15l1407t3314r1698b3399],
94	A	DT	O	a	dep	105	SENT_284	[p15l1719t3326r1776b3384],
95	more	RBR	O	more	dep	105	SENT_284	[p15l1796t3345r1972b3385],
96	serious	JJ	O	serious	dep	105	SENT_284	[p15l1994t3328r2141b3385, p15l8t3448r125b3488],
97	potential	JJ	O	potential	dep	105	SENT_284	[p15l147t3425r457b3508],
98	adverse	JJ	O	adverse	dep	105	SENT_284	[p15l480t3425r738b3488],
99	event	NN	O	event	dep	105	SENT_284	[p15l763t3437r947b3488],
100	involves	VBZ	O	involve	dep	105	SENT_284	[p15l969t3425r1248b3488],
101	the	DT	O	the	dep	105	SENT_284	[p15l1271t3425r1379b3488],
102	risk	NN	O	risk	dep	105	SENT_284	[p15l1402t3425r1532b3488],
103	of	IN	O	of	dep	105	SENT_284	[p15l1553t3425r1627b3488],
104	cardiovascular	JJ	O	cardiovascular	dep	105	SENT_284	[p15l1641t3425r2146b3488],
105	events	NNS	O	event	_	0	SENT_284	[p15l8t3540r235b3591],
106	.	.	O	.	_	0	SENT_284	[p15l8t3540r235b3591],

1	Although	IN	O	although	mark	9	SENT_285	[p15l257t3528r580b3612],
2	patients	NNS	O	patient	nsubj	9	SENT_285	[p15l599t3534r865b3611],
3	treated	VBN	O	treat	partmod	2	SENT_285	[p15l884t3528r1120b3591],
4	with	IN	O	with	_	0	SENT_285	[p15l1137t3528r1288b3591],
5	phentermine/topiramate	NN	O	phentermine/topiramate	prep_with	3	SENT_285	[p15l1307t3528r2143b3611],
6	in	IN	O	in	_	0	SENT_285	[p15l8t3637r74b3693],
7	clinical	JJ	O	clinical	amod	8	SENT_285	[p15l95t3631r339b3694],
8	trials	NNS	O	trial	prep_in	5	SENT_285	[p15l359t3631r529b3694],
9	exhibited	VBD	O	exhibit	advcl	23	SENT_285	[p15l551t3631r867b3694],
10	a	DT	O	a	det	12	SENT_285	[p15l887t3654r922b3694],
11	slight	JJ	O	slight	amod	12	SENT_285	[p15l942t3631r1127b3715],
12	increase	NN	O	increase	dobj	9	SENT_285	[p15l1146t3637r1423b3694],
13	in	IN	O	in	_	0	SENT_285	[p15l1445t3637r1511b3693],
14	heart	NN	O	heart	nn	15	SENT_285	[p15l1530t3631r1708b3694],
15	rate	NN	O	rate	prep_in	9	SENT_285	[p15l1727t3643r1872b3703],
16	,	,	O	,	_	0	SENT_285	[p15l1727t3643r1872b3703],
17	the	DT	O	the	det	18	SENT_285	[p15l1893t3631r1999b3694],
18	risk	NN	O	risk	nsubjpass	30	SENT_285	[p15l2020t3631r2149b3694],
19	of	IN	O	of	_	0	SENT_285	[p15l8t3734r84b3797],
20	cardiovascular	JJ	O	cardiovascular	amod	21	SENT_285	[p15l103t3734r626b3797],
21	events	NNS	O	event	prep_of	18	SENT_285	[p15l653t3746r875b3797],
22	is	VBZ	O	be	cop	23	SENT_285	[p15l903t3740r955b3797],
23	unclear	JJ	O	unclear	_	0	SENT_285	[p15l983t3734r1250b3797],
24	at	IN	O	at	_	0	SENT_285	[p15l1277t3746r1338b3797],
25	this	DT	O	this	det	26	SENT_285	[p15l1364t3734r1494b3797],
26	time	NN	O	time	prep_at	23	SENT_285	[p15l1520t3740r1681b3797],
27	and	CC	O	and	_	0	SENT_285	[p15l1710t3734r1840b3797],
28	is	VBZ	O	be	aux	30	SENT_285	[p15l1867t3740r1919b3797],
29	being	VBG	O	be	auxpass	30	SENT_285	[p15l1945t3734r2145b3818],
30	monitored	VBN	O	monitor	conj_and	23	SENT_285	[p16l7t20r370b83],
31	by	IN	O	by	_	0	SENT_285	[p16l389t20r473b104],
32	Vivus	NNP	ORGANIZATION	Vivus	agent	30	SENT_285	[p16l490t25r683b83],
33	in	IN	O	in	_	0	SENT_285	[p16l706t26r772b82],
34	postmarketing	JJ	O	postmarketing	amod	35	SENT_285	[p16l793t20r1296b104],
35	studies	NNS	O	study	prep_in	30	SENT_285	[p16l1316t12r1730b83],
36	.	.	O	.	_	0	SENT_285	[p16l1316t12r1730b83],

1	‘“	NN	O	‘“	_	0	SENT_286	[p16l1316t12r1730b83],
2	‘	CD	NUMBER	‘	num	3	SENT_286	[p16l1316t12r1730b83],
3	44	CD	NUMBER	44	dep	1	SENT_286	[p16l1316t12r1730b83],

1	In	IN	O	in	_	0	SENT_287	[p16l82t127r151b185],
2	addition	NN	O	addition	_	0	SENT_287	[p16l171t122r450b186],
3	to	TO	O	to	_	0	SENT_287	[p16l469t134r533b186],
4	adverse	JJ	O	adverse	amod	5	SENT_287	[p16l555t122r803b186],
5	events	NNS	O	event	prep_in_addition_to	15	SENT_287	[p16l823t134r1030b186],
6	observed	VBN	O	observe	partmod	5	SENT_287	[p16l1050t122r1353b186],
7	in	IN	O	in	_	0	SENT_287	[p16l1371t128r1436b185],
8	clinical	JJ	O	clinical	amod	9	SENT_287	[p16l1456t122r1694b186],
9	trials	NNS	O	trial	prep_in	6	SENT_287	[p16l1712t122r1896b194],
10	,	,	O	,	_	0	SENT_287	[p16l1712t122r1896b194],
11	several	JJ	O	several	amod	14	SENT_287	[p16l1918t122r2146b186],
12	other	JJ	O	other	amod	14	SENT_287	[p16l8t226r195b289],
13	safety	NN	O	safety	nn	14	SENT_287	[p16l220t226r422b310],
14	issues	NNS	O	issue	nsubj	15	SENT_287	[p16l443t232r645b289],
15	cloud	VBP	O	cloud	_	0	SENT_287	[p16l670t226r866b289],
16	the	DT	O	the	det	17	SENT_287	[p16l888t226r997b289],
17	use	NN	O	use	dobj	15	SENT_287	[p16l1022t249r1136b289],
18	of	IN	O	of	_	0	SENT_287	[p16l1161t226r1237b289],
19	phentermine/topiramate	NN	O	phentermine/topiramate	prep_of	17	SENT_287	[p16l1250t226r2143b309],
20	.	.	O	.	_	0	SENT_287	[p16l1250t226r2143b309],

1	Given	VBN	O	give	prep	9	SENT_288	[p16l9t333r209b392],
2	the	DT	O	the	det	4	SENT_288	[p16l229t329r334b392],
3	addictive	JJ	O	addictive	amod	4	SENT_288	[p16l356t329r663b392],
4	potential	NN	O	potential	dep	1	SENT_288	[p16l683t329r987b412],
5	of	IN	O	of	_	0	SENT_288	[p16l1007t329r1080b392],
6	amphetamines	NNS	O	amphetamine	prep_of	4	SENT_288	[p16l1092t329r1609b412],
7	,	,	O	,	_	0	SENT_288	[p16l1092t329r1609b412],
8	there	EX	O	there	expl	9	SENT_288	[p16l1630t329r1803b392],
9	was	VBD	O	be	_	0	SENT_288	[p16l1822t352r1947b392],
10	some	DT	O	some	det	11	SENT_288	[p16l1968t352r2145b392],
11	concern	NN	O	concern	nsubj	9	SENT_288	[p16l8t455r289b495],
12	regarding	VBG	O	regard	_	0	SENT_288	[p16l313t432r650b516],
13	widespread	JJ	O	widespread	amod	14	SENT_288	[p16l670t432r1070b515],
14	use	NN	O	use	prep_regarding	11	SENT_288	[p16l1093t455r1206b495],
15	of	IN	O	of	_	0	SENT_288	[p16l1230t432r1305b495],
16	phentermine	NN	O	phentermine	prep_of	14	SENT_288	[p16l1318t432r1787b515],
17	.	.	O	.	_	0	SENT_288	[p16l1318t432r1787b515],

1	However	RB	O	however	advmod	11	SENT_289	[p16l1814t437r2140b504],
2	,	,	O	,	_	0	SENT_289	[p16l1814t437r2140b504],
3	a	DT	O	a	det	4	SENT_289	[p16l8t558r43b598],
4	study	NN	O	study	nsubj	11	SENT_289	[p16l69t535r262b619],
5	investigating	VBG	O	investigate	partmod	4	SENT_289	[p16l284t541r740b619],
6	the	DT	O	the	det	8	SENT_289	[p16l763t535r873b598],
7	addictive	JJ	O	addictive	amod	8	SENT_289	[p16l900t535r1223b598],
8	potential	NN	O	potential	dobj	5	SENT_289	[p16l1248t535r1566b618],
9	of	IN	O	of	_	0	SENT_289	[p16l1592t535r1668b598],
10	phentermine	NN	O	phentermine	prep_of	8	SENT_289	[p16l1683t535r2143b618],
11	showed	VBD	O	show	_	0	SENT_289	[p16l8t637r266b700],
12	only	RB	O	only	advmod	14	SENT_289	[p16l287t637r438b721],
13	minimal	JJ	O	minimal	amod	14	SENT_289	[p16l457t637r749b700],
14	addictiveness	NN	O	addictiveness	dobj	11	SENT_289	[p16l771t637r1247b709],
15	,	,	O	,	_	0	SENT_289	[p16l771t637r1247b709],
16	allaying	VBG	O	allay	partmod	11	SENT_289	[p16l1271t637r1538b721],
17	these	DT	O	these	det	18	SENT_289	[p16l1557t637r1733b700],
18	concerns	NNS	O	concern	dobj	16	SENT_289	[p16l1755t629r2143b700],
19	.45	CD	NUMBER	.45	nsubj	26	SENT_289	[p16l1755t629r2143b700],
20	Importantly	RB	O	importantly	advmod	26	SENT_289	[p16l8t740r427b824],
21	,	,	O	,	_	0	SENT_289	[p16l8t740r427b824],
22	phentermine/topiramate	NN	O	phentermine/topiramate	nsubj	26	SENT_289	[p16l448t740r1284b823],
23	is	VBZ	O	be	cop	26	SENT_289	[p16l1305t746r1354b803],
24	also	RB	O	also	advmod	26	SENT_289	[p16l1376t740r1505b803],
25	a	DT	O	a	det	26	SENT_289	[p16l1527t763r1561b803],
26	teratogen	NN	O	teratogen	rcmod	18	SENT_289	[p16l1579t752r1915b824],
27	,	,	O	,	_	0	SENT_289	[p16l1579t752r1915b824],
28	classiﬁed	VBN	O	classiﬁed	partmod	26	SENT_289	[p16l1937t740r2140b803, p16l7t842r132b905],
29	as	IN	O	as	_	0	SENT_289	[p16l151t865r215b905],
30	a	DT	O	a	det	33	SENT_289	[p16l236t865r270b905],
31	pregnancy	NN	O	pregnancy	nn	33	SENT_289	[p16l287t864r644b926],
32	category	NN	O	category	nn	33	SENT_289	[p16l661t854r947b926],
33	X	NN	O	x	prep_as	28	SENT_289	[p16l962t847r1018b904],
34	drug	NN	O	drug	tmod	28	SENT_289	[p16l1037t834r1274b926],
35	.25	CD	NUMBER	.25	num	34	SENT_289	[p16l1037t834r1274b926],
36	Amid	IN	O	amid	_	0	SENT_289	[p16l1294t842r1489b905],
37	these	DT	O	these	det	38	SENT_289	[p16l1506t842r1679b905],
38	concerns	NNS	O	concern	prep_amid	42	SENT_289	[p16l1699t865r2018b914],
39	,	,	O	,	_	0	SENT_289	[p16l1699t865r2018b914],
40	the	DT	O	the	det	41	SENT_289	[p16l2039t842r2143b905],
41	FDA	NNP	ORGANIZATION	FDA	nsubj	42	SENT_289	[p16l8t949r167b1007],
42	approved	VBD	O	approve	rcmod	34	SENT_289	[p16l187t945r498b1028],
43	the	DT	O	the	det	45	SENT_289	[p16l516t945r620b1008],
44	combinatorial	JJ	O	combinatorial	amod	45	SENT_289	[p16l640t945r1111b1008],
45	therapy	NN	O	therapy	dobj	42	SENT_289	[p16l1129t945r1386b1029],
46	with	IN	O	with	_	0	SENT_289	[p16l1400t945r1550b1008],
47	a	DT	O	a	det	49	SENT_289	[p16l1571t968r1605b1008],
48	Risk	NN	O	risk	nn	49	SENT_289	[p16l1624t945r1771b1008],
49	Evaluation	NN	O	evaluation	prep_with	42	SENT_289	[p16l1787t945r2146b1008],
50	and	CC	O	and	_	0	SENT_289	[p16l8t1047r135b1110],
51	Mitigation	NNP	O	Mitigation	nn	54	SENT_289	[p16l157t1052r521b1131],
52	Strategy	NNP	O	Strategy	nn	54	SENT_289	[p16l546t1051r826b1131],
53	(	CD	NUMBER	(	num	54	SENT_289	[p16l849t1039r1205b1124],
54	REMS	NNP	O	REMS	prep_with	42	SENT_289	[p16l849t1039r1205b1124],
55	)	CD	NUMBER	)	number	56	SENT_289	[p16l849t1039r1205b1124],
56	.25	CD	NUMBER	.25	dep	54	SENT_289	[p16l849t1039r1205b1124],
57	As	IN	O	as	mark	65	SENT_289	[p16l1228t1051r1315b1110],
58	with	IN	O	with	_	0	SENT_289	[p16l1337t1047r1491b1110],
59	the	DT	O	the	det	61	SENT_289	[p16l1512t1047r1620b1110],
60	cardiovascular	JJ	O	cardiovascular	amod	61	SENT_289	[p16l1643t1047r2145b1110],
61	risks	NNS	O	risk	prep_with	65	SENT_289	[p16l8t1150r181b1222],
62	,	,	O	,	_	0	SENT_289	[p16l8t1150r181b1222],
63	Vivus	NNP	ORGANIZATION	Vivus	nsubjpass	65	SENT_289	[p16l202t1155r393b1213],
64	is	VBZ	O	be	auxpass	65	SENT_289	[p16l414t1156r463b1213],
65	engaged	VBN	O	engage	advcl	42	SENT_289	[p16l485t1150r762b1234],
66	in	IN	O	in	prt	65	SENT_289	[p16l781t1156r847b1212],
67	a	DT	O	a	det	71	SENT_289	[p16l868t1173r902b1213],
68	rigorous	JJ	O	rigorous	amod	71	SENT_289	[p16l921t1156r1203b1234],
69	postmarketing	VBG	O	postmarket	amod	71	SENT_289	[p16l1223t1150r1720b1234],
70	surveillance	NN	O	surveillance	nn	71	SENT_289	[p16l1739t1150r2143b1213],
71	program	NN	O	program	dobj	65	SENT_289	[p16l6t1274r304b1336],
72	to	TO	O	to	aux	73	SENT_289	[p16l325t1264r390b1315],
73	evaluate	VB	O	evaluate	xcomp	65	SENT_289	[p16l414t1252r691b1315],
74	these	DT	O	these	det	76	SENT_289	[p16l712t1252r888b1315],
75	teratogenic	JJ	O	teratogenic	amod	76	SENT_289	[p16l908t1258r1290b1336],
76	risks	NNS	O	risk	nsubj	78	SENT_289	[p16l1312t1244r1629b1315],
77	.25	CD	NUMBER	.25	npadvmod	78	SENT_289	[p16l1312t1244r1629b1315],
78	>	JJR	O	>	xcomp	73	SENT_289	[p16l1312t1244r1629b1315],
79	44	CD	NUMBER	44	dep	34	SENT_289	[p16l1312t1244r1629b1315],

1	Weight	NNP	O	Weight	nsubj	2	SENT_290	[p16l80t1356r322b1440],
2	regain	VB	O	regain	_	0	SENT_290	[p16l340t1362r548b1440],
3	remains	VBZ	O	remain	cop	6	SENT_290	[p16l569t1362r836b1419],
4	a	DT	O	a	det	6	SENT_290	[p16l857t1379r891b1419],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_290	[p16l911t1356r1259b1440],
6	limitation	NN	O	limitation	dep	2	SENT_290	[p16l1277t1356r1609b1419],
7	among	IN	O	among	_	0	SENT_290	[p16l1630t1379r1861b1440],
8	patients	NNS	O	patient	prep_among	6	SENT_290	[p16l1878t1362r2143b1439],
9	attempting	VBG	O	attempt	partmod	8	SENT_290	[p16l8t1465r381b1543],
10	to	TO	O	to	aux	11	SENT_290	[p16l401t1471r467b1522],
11	lose	VB	O	lose	xcomp	9	SENT_290	[p16l489t1459r622b1522],
12	weight	NN	O	weight	dobj	11	SENT_290	[p16l643t1459r889b1543],
13	.	.	O	.	_	0	SENT_290	[p16l643t1459r889b1543],

1	Although	IN	O	although	mark	14	SENT_291	[p16l913t1459r1241b1543],
2	interventions	NNS	O	intervention	nsubj	14	SENT_291	[p16l1264t1465r1719b1522],
3	such	JJ	O	such	_	0	SENT_291	[p16l1743t1459r1898b1522],
4	as	IN	O	as	_	0	SENT_291	[p16l1921t1482r1986b1522],
5	lifestyle	NN	O	lifestyle	nn	6	SENT_291	[p16l2008t1459r2139b1522, p16l9t1562r164b1646],
6	modiﬁcation	NN	O	modiﬁcation	prep_such_as	2	SENT_291	[p16l187t1562r656b1634],
7	,	,	O	,	_	0	SENT_291	[p16l187t1562r656b1634],
8	pharmacotherapy	NN	O	pharmacotherapy	prep_such_as	2	SENT_291	[p16l680t1562r1313b1646],
9	,	,	O	,	_	0	SENT_291	[p16l680t1562r1313b1646],
10	or	CC	O	or	_	0	SENT_291	[p16l1339t1585r1413b1625],
11	bariatric	JJ	O	bariatric	amod	12	SENT_291	[p16l1433t1562r1731b1625],
12	surgery	NN	O	surgery	prep_such_as	2	SENT_291	[p16l1755t1585r2019b1646],
13	are	VBP	O	be	cop	14	SENT_291	[p16l2040t1585r2142b1625],
14	effective	JJ	O	effective	advcl	25	SENT_291	[p16l8t1665r301b1728],
15	in	IN	O	in	_	0	SENT_291	[p16l328t1671r397b1727],
16	inducing	VBG	O	induce	prepc_in	14	SENT_291	[p16l423t1665r742b1749],
17	weight	NN	O	weight	nn	18	SENT_291	[p16l766t1665r1005b1749],
18	loss	NN	O	loss	dobj	16	SENT_291	[p16l1029t1665r1161b1728],
19	initially	RB	O	initially	advmod	16	SENT_291	[p16l1188t1665r1475b1749],
20	,	,	O	,	_	0	SENT_291	[p16l1188t1665r1475b1749],
21	most	RBS	O	most	advmod	22	SENT_291	[p16l1503t1677r1680b1728],
22	subjects	NNS	O	subject	nsubj	25	SENT_291	[p16l1706t1665r1989b1749],
23	will	MD	O	will	aux	25	SENT_291	[p16l2014t1665r2146b1728],
24	eventually	RB	O	eventually	advmod	25	SENT_291	[p16l8t1768r374b1852],
25	regain	VB	O	regain	_	0	SENT_291	[p16l397t1774r617b1852],
26	their	PRP$	O	they	poss	28	SENT_291	[p16l642t1768r811b1831],
27	lost	VBN	O	lose	amod	28	SENT_291	[p16l834t1768r962b1831],
28	weight	NN	O	weight	dobj	25	SENT_291	[p16l985t1768r1239b1852],
29	.	.	O	.	_	0	SENT_291	[p16l985t1768r1239b1852],

1	Given	VBN	O	give	prep	22	SENT_292	[p16l1269t1772r1479b1831],
2	the	DT	O	the	det	3	SENT_292	[p16l1504t1768r1614b1831],
3	importance	NN	O	importance	dep	1	SENT_292	[p16l1640t1774r2050b1851],
4	of	IN	O	of	_	0	SENT_292	[p16l2077t1768r2153b1831],
5	weight	NN	O	weight	nn	6	SENT_292	[p16l6t1872r246b1956],
6	maintenance	NN	O	maintenance	prep_of	3	SENT_292	[p16l272t1878r733b1935],
7	in	IN	O	in	_	0	SENT_292	[p16l762t1878r830b1934],
8	the	DT	O	the	det	11	SENT_292	[p16l857t1872r968b1935],
9	long-term	JJ	O	long-term	amod	11	SENT_292	[p16l994t1872r1358b1956],
10	disease	NN	O	disease	nn	11	SENT_292	[p16l1386t1872r1638b1935],
11	prognosis	NN	O	prognosis	prep_in	6	SENT_292	[p16l1665t1878r2016b1956],
12	for	IN	O	for	_	0	SENT_292	[p16l2044t1872r2146b1935],
13	obese	JJ	O	obese	amod	14	SENT_292	[p16l8t1975r210b2038],
14	patients	NNS	O	patient	prep_for	11	SENT_292	[p16l240t1981r550b2058],
15	,	,	O	,	_	0	SENT_292	[p16l240t1981r550b2058],
16	the	DT	O	the	det	17	SENT_292	[p16l582t1975r695b2038],
17	mechanisms	NNS	O	mechanism	nsubj	25	SENT_292	[p16l726t1975r1179b2038],
18	underlying	VBG	O	underlie	amod	19	SENT_292	[p16l1211t1975r1613b2059],
19	weight	NN	O	weight	nsubj	20	SENT_292	[p16l1641t1975r1885b2059],
20	regain	VBP	O	regain	rcmod	17	SENT_292	[p16l1916t1981r2142b2059],
21	remain	VBP	O	remain	cop	22	SENT_292	[p16l9t2084r261b2141],
22	important	JJ	O	important	_	0	SENT_292	[p16l288t2084r651b2161],
23	and	CC	O	and	_	0	SENT_292	[p16l678t2078r809b2141],
24	actively	RB	O	actively	advmod	25	SENT_292	[p16l835t2078r1109b2162],
25	researched	VBD	O	research	conj_and	22	SENT_292	[p16l1133t2078r1517b2141],
26	questions	NNS	O	question	dobj	25	SENT_292	[p16l1543t2084r1901b2161],
27	.	.	O	.	_	0	SENT_292	[p16l1543t2084r1901b2161],

1	In	IN	O	in	mark	10	SENT_293	[p16l1932t2083r2005b2140],
2	the	DT	O	the	det	3	SENT_293	[p16l2031t2078r2142b2141],
3	context	NN	O	context	nsubj	10	SENT_293	[p16l9t2193r259b2244],
4	of	IN	O	of	_	0	SENT_293	[p16l279t2181r352b2244],
5	the	DT	O	the	det	7	SENT_293	[p16l362t2181r468b2244],
6	substantial	JJ	O	substantial	amod	7	SENT_293	[p16l489t2181r855b2244],
7	problem	NN	O	problem	prep_of	3	SENT_293	[p16l874t2181r1161b2264],
8	of	IN	O	of	_	0	SENT_293	[p16l1182t2181r1255b2244],
9	weight	NN	O	weight	prep_of	7	SENT_293	[p16l1264t2181r1493b2265],
10	regain	VBP	O	regain	advcl	18	SENT_293	[p16l1512t2187r1741b2265],
11	,	,	O	,	_	0	SENT_293	[p16l1512t2187r1741b2265],
12	persistence	NN	O	persistence	nsubj	18	SENT_293	[p16l1761t2187r2140b2264],
13	of	IN	O	of	_	0	SENT_293	[p16l9t2284r83b2347],
14	the	DT	O	the	det	16	SENT_293	[p16l93t2284r200b2347],
15	weight-loss	JJ	O	weight-loss	amod	16	SENT_293	[p16l219t2284r606b2368],
16	response	NN	O	response	prep_of	12	SENT_293	[p16l629t2306r928b2367],
17	is	VBZ	O	be	cop	18	SENT_293	[p16l950t2290r1000b2347],
18	desirable	JJ	O	desirable	_	0	SENT_293	[p16l1023t2284r1326b2347],
19	in	IN	O	in	_	0	SENT_293	[p16l1348t2290r1414b2346],
20	any	DT	O	any	det	23	SENT_293	[p16l1437t2307r1558b2368],
21	potential	JJ	O	potential	amod	23	SENT_293	[p16l1574t2284r1880b2367],
22	obesity	NN	O	obesity	nn	23	SENT_293	[p16l1901t2284r2146b2368],
23	therapy	NN	O	therapy	prep_in	18	SENT_293	[p16l7t2387r274b2471],
24	.	.	O	.	_	0	SENT_293	[p16l7t2387r274b2471],

1	Importantly	RB	O	importantly	advmod	4	SENT_294	[p16l298t2387r719b2471],
2	,	,	O	,	_	0	SENT_294	[p16l298t2387r719b2471],
3	topiramate	NN	O	topiramate	nsubj	4	SENT_294	[p16l740t2393r1109b2470],
4	appears	VBZ	O	appear	_	0	SENT_294	[p16l1130t2409r1387b2470],
5	to	TO	O	to	aux	6	SENT_294	[p16l1407t2399r1473b2450],
6	possess	VB	O	possess	xcomp	4	SENT_294	[p16l1493t2409r1742b2470],
7	this	DT	O	this	det	9	SENT_294	[p16l1761t2387r1885b2450],
8	important	JJ	O	important	amod	9	SENT_294	[p16l1906t2393r2139b2470, p16l7t2502r142b2553],
9	characteristic	NN	O	characteristic	dobj	6	SENT_294	[p16l165t2490r642b2553],
10	.	.	O	.	_	0	SENT_294	[p16l165t2490r642b2553],

1	In	IN	O	in	_	0	SENT_295	[p16l668t2495r739b2552],
2	several	JJ	O	several	amod	4	SENT_295	[p16l763t2490r998b2553],
3	clinical	JJ	O	clinical	amod	4	SENT_295	[p16l1021t2490r1267b2553],
4	trials	NNS	O	trial	prep_in	45	SENT_295	[p16l1288t2490r1479b2562],
5	,	,	O	,	_	0	SENT_295	[p16l1288t2490r1479b2562],
6	cohorts	NNS	O	cohort	nsubj	12	SENT_295	[p16l1504t2490r1760b2553],
7	of	IN	O	of	_	0	SENT_295	[p16l1785t2490r1859b2553],
8	patients	NNS	O	patient	prep_of	6	SENT_295	[p16l1871t2496r2141b2573],
9	treated	VBN	O	treat	partmod	8	SENT_295	[p16l7t2593r256b2656],
10	with	IN	O	with	_	0	SENT_295	[p16l280t2593r439b2656],
11	topiramate	NN	O	topiramate	prep_with	9	SENT_295	[p16l464t2599r853b2676],
12	maintained	VBD	O	maintain	parataxis	45	SENT_295	[p16l880t2593r1288b2656],
13	weight	NN	O	weight	nn	14	SENT_295	[p16l1312t2593r1551b2677],
14	loss	NN	O	loss	dobj	12	SENT_295	[p16l1575t2593r1706b2656],
15	as	RB	O	as	advmod	16	SENT_295	[p16l1735t2616r1801b2656],
16	long	RB	O	long	advmod	12	SENT_295	[p16l1827t2593r1984b2677],
17	as	IN	O	as	_	0	SENT_295	[p16l2010t2616r2076b2656],
18	1	CD	DURATION	1	prep_as	12	SENT_295	[p16l2110t2600r2136b2655],
19	year	NN	NUMBER	year	tmod	12	SENT_295	[p16l6t2719r161b2780],
20	,	,	O	,	_	0	SENT_295	[p16l6t2719r161b2780],
21	even	RB	O	even	advmod	27	SENT_295	[p16l184t2719r339b2759],
22	after	IN	O	after	dep	27	SENT_295	[p16l360t2696r512b2759],
23	the	DT	O	the	det	25	SENT_295	[p16l530t2696r635b2759],
24	placebo	NN	O	placebo	nn	25	SENT_295	[p16l655t2696r916b2779],
25	group	NN	O	group	nsubj	27	SENT_295	[p16l937t2718r1136b2780],
26	had	VBD	O	have	aux	27	SENT_295	[p16l1157t2696r1283b2759],
27	exhibited	VBN	O	exhibit	dep	45	SENT_295	[p16l1303t2696r1618b2759],
28	marked	JJ	O	marked	amod	29	SENT_295	[p16l1637t2696r1897b2759],
29	weight	NN	O	weight	nsubj	30	SENT_295	[p16l1914t2696r2143b2780],
30	regain	VB	O	regain	ccomp	27	SENT_295	[p16l9t2790r377b2882],
31	.34	CD	NUMBER	.34	num	32	SENT_295	[p16l9t2790r377b2882],
32	’35	CD	NUMBER	’35	dobj	30	SENT_295	[p16l9t2790r377b2882],
33	Importantly	RB	O	importantly	advmod	30	SENT_295	[p16l401t2798r824b2882],
34	,	,	O	,	_	0	SENT_295	[p16l401t2798r824b2882],
35	one	CD	NUMBER	one	nsubj	45	SENT_295	[p16l849t2821r970b2861],
36	of	IN	O	of	_	0	SENT_295	[p16l993t2798r1066b2861],
37	the	DT	O	the	det	39	SENT_295	[p16l1077t2798r1183b2861],
38	clinical	JJ	O	clinical	amod	39	SENT_295	[p16l1206t2798r1450b2861],
39	trials	NNS	O	trial	prep_of	35	SENT_295	[p16l1470t2798r1641b2861],
40	evaluating	VBG	O	evaluate	partmod	39	SENT_295	[p16l1664t2798r2017b2882],
41	the	DT	O	the	det	42	SENT_295	[p16l2036t2798r2142b2861],
42	combination	NN	O	combination	dobj	40	SENT_295	[p16l9t2901r456b2964],
43	of	IN	O	of	_	0	SENT_295	[p16l481t2901r556b2964],
44	phentermine/topiramate	NN	O	phentermine/topiramate	prep_of	42	SENT_295	[p16l569t2901r1440b2984],
45	showed	VBD	O	show	_	0	SENT_295	[p16l1465t2901r1730b2964],
46	a	DT	O	a	det	49	SENT_295	[p16l1754t2924r1788b2964],
47	sustained	JJ	O	sustained	amod	49	SENT_295	[p16l1812t2901r2143b2964],
48	weight	NN	O	weight	nn	49	SENT_295	[p16l7t3003r236b3087],
49	loss	NN	O	loss	dobj	45	SENT_295	[p16l255t3003r380b3066],
50	at	IN	O	at	_	0	SENT_295	[p16l403t3015r462b3066],
51	2	CD	DURATION	2	num	52	SENT_295	[p16l483t3010r519b3065],
52	years	NNS	NUMBER	year	prep_at	45	SENT_295	[p16l540t3026r714b3087],
53	of	IN	O	of	_	0	SENT_295	[p16l737t3003r811b3066],
54	follow-up	NN	O	follow-up	prep_of	52	SENT_295	[p16l822t2995r1231b3086],
55	.43	CD	NUMBER	.43	num	54	SENT_295	[p16l822t2995r1231b3086],

1	The	DT	O	the	det	2	SENT_296	[p16l82t3106r203b3169],
2	persistent	JJ	O	persistent	dep	6	SENT_296	[p16l220t3112r537b3189],
3	and	CC	O	and	_	0	SENT_296	[p16l554t3106r676b3169],
4	robust	JJ	O	robust	conj_and	2	SENT_296	[p16l692t3106r901b3169],
5	clinical	JJ	O	clinical	amod	6	SENT_296	[p16l918t3106r1150b3169],
6	effects	NNS	O	effect	dep	10	SENT_296	[p16l1168t3106r1370b3169],
7	of	IN	O	of	_	0	SENT_296	[p16l1389t3106r1460b3169],
8	phentermine	NN	O	phentermine	prep_of	6	SENT_296	[p16l1467t3106r1916b3189],
9	/	:	O	/	punct	10	SENT_296	[p16l1467t3106r1916b3189],
10	topiramate	NN	O	topiramate	_	0	SENT_296	[p16l1919t3112r2139b3189, p16l8t3221r173b3272],
11	may	MD	O	may	aux	13	SENT_296	[p16l195t3232r342b3293],
12	be	VB	O	be	cop	13	SENT_296	[p16l358t3209r438b3272],
13	attributable	JJ	O	attributable	rcmod	10	SENT_296	[p16l460t3209r851b3272],
14	to	TO	O	to	_	0	SENT_296	[p16l872t3221r938b3272],
15	the	DT	O	the	det	17	SENT_296	[p16l960t3209r1066b3272],
16	complementary	JJ	O	complementary	amod	17	SENT_296	[p16l1088t3209r1630b3293],
17	effects	NNS	O	effect	prep_to	13	SENT_296	[p16l1648t3209r1859b3272],
18	of	IN	O	of	_	0	SENT_296	[p16l1882t3209r1956b3272],
19	these	DT	O	these	det	21	SENT_296	[p16l1967t3209r2142b3272],
20	two	CD	NUMBER	two	num	21	SENT_296	[p16l7t3324r131b3375],
21	compounds	NNS	O	compound	prep_of	17	SENT_296	[p16l152t3312r564b3395],
22	.	.	O	.	_	0	SENT_296	[p16l152t3312r564b3395],

1	The	DT	O	the	det	2	SENT_297	[p16l587t3312r710b3375],
2	chronology	NN	O	chronology	nsubj	13	SENT_297	[p16l731t3312r1117b3396],
3	of	IN	O	of	_	0	SENT_297	[p16l1134t3312r1207b3375],
4	weight	NN	O	weight	nn	5	SENT_297	[p16l1215t3312r1440b3396],
5	loss	NN	O	loss	prep_of	2	SENT_297	[p16l1457t3312r1580b3375],
6	induced	VBN	O	induce	partmod	5	SENT_297	[p16l1600t3312r1872b3375],
7	by	IN	O	by	_	0	SENT_297	[p16l1888t3312r1972b3396],
8	both	CC	O	both	dep	11	SENT_297	[p16l1986t3312r2142b3375],
9	the	DT	O	the	det	11	SENT_297	[p16l7t3415r115b3478],
10	two	CD	NUMBER	two	num	11	SENT_297	[p16l138t3427r265b3478],
11	compounds	NNS	O	compound	agent	6	SENT_297	[p16l291t3415r700b3498],
12	may	MD	O	may	aux	13	SENT_297	[p16l724t3438r874b3499],
13	represent	VB	O	represent	_	0	SENT_297	[p16l893t3427r1217b3498],
14	the	DT	O	the	det	15	SENT_297	[p16l1238t3415r1346b3478],
15	source	NN	O	source	dobj	13	SENT_297	[p16l1371t3438r1595b3478],
16	of	IN	O	of	_	0	SENT_297	[p16l1619t3415r1694b3478],
17	this	DT	O	this	det	18	SENT_297	[p16l1707t3415r1833b3478],
18	complementarity	NN	O	complementarity	prep_of	15	SENT_297	[p16l1858t3415r2138b3498, p16l8t3524r355b3602],
19	.	.	O	.	_	0	SENT_297	[p16l1858t3415r2138b3498, p16l8t3524r355b3602],

1	Phentermine	NN	O	phentermine	nsubj	2	SENT_298	[p16l381t3518r830b3581],
2	induces	VBZ	O	induce	_	0	SENT_298	[p16l853t3518r1116b3581],
3	weight	NN	O	weight	nn	4	SENT_298	[p16l1137t3518r1369b3602],
4	loss	NN	O	loss	dobj	2	SENT_298	[p16l1389t3518r1516b3581],
5	in	IN	O	in	_	0	SENT_298	[p16l1539t3524r1606b3580],
6	the	DT	O	the	det	8	SENT_298	[p16l1627t3518r1734b3581],
7	short	JJ	O	short	amod	8	SENT_298	[p16l1758t3518r1936b3581],
8	term	NN	O	term	prep_in	4	SENT_298	[p16l1956t3530r2139b3590],
9	,	,	O	,	_	0	SENT_298	[p16l1956t3530r2139b3590],
10	whereas	IN	O	whereas	mark	14	SENT_298	[p16l7t3621r284b3684],
11	topiramate	NN	O	topiramate	nsubjpass	14	SENT_298	[p16l305t3627r677b3704],
12	has	VBZ	O	have	aux	14	SENT_298	[p16l698t3621r810b3684],
13	been	VBN	O	be	auxpass	14	SENT_298	[p16l830t3621r995b3684],
14	shown	VBN	O	show	advcl	2	SENT_298	[p16l1018t3621r1240b3684],
15	to	TO	O	to	aux	19	SENT_298	[p16l1261t3633r1327b3684],
16	be	VB	O	be	cop	19	SENT_298	[p16l1348t3621r1428b3684],
17	a	DT	O	a	det	19	SENT_298	[p16l1451t3644r1485b3684],
18	longer-term	JJ	O	longer-term	amod	19	SENT_298	[p16l1505t3621r1917b3705],
19	agent	NN	O	agent	xcomp	14	SENT_298	[p16l1939t3633r2137b3705],
20	.	.	O	.	_	0	SENT_298	[p16l1939t3633r2137b3705],

1	In	IN	O	in	_	0	SENT_299	[p16l9t3729r81b3786],
2	addition	NN	O	addition	_	0	SENT_299	[p16l103t3724r392b3787],
3	to	TO	O	to	_	0	SENT_299	[p16l412t3736r479b3787],
4	chronology	NN	O	chronology	prep_in_addition_to	9	SENT_299	[p16l503t3724r907b3808],
5	,	,	O	,	_	0	SENT_299	[p16l503t3724r907b3808],
6	complementary	JJ	O	complementary	amod	7	SENT_299	[p16l931t3724r1476b3808],
7	effects	NNS	O	effect	nsubj	9	SENT_299	[p16l1495t3724r1708b3787],
8	may	MD	O	may	aux	9	SENT_299	[p16l1731t3747r1879b3808],
9	exist	VB	O	exist	_	0	SENT_299	[p16l1898t3730r2053b3787],
10	in	IN	O	in	_	0	SENT_299	[p16l2074t3730r2141b3786],
11	the	DT	O	the	det	12	SENT_299	[p17l7t16r115b79],
12	mechanisms	NNS	O	mechanism	prep_in	9	SENT_299	[p17l138t16r569b79],
13	by	IN	O	by	_	0	SENT_299	[p17l590t16r675b100],
14	which	WDT	O	which	rel	17	SENT_299	[p17l692t16r905b79],
15	the	DT	O	the	det	16	SENT_299	[p17l926t16r1034b79],
16	compounds	NNS	O	compound	nsubj	17	SENT_299	[p17l1057t16r1465b99],
17	induce	VBP	O	induce	rcmod	12	SENT_299	[p17l1488t16r1721b79],
18	weight	NN	O	weight	nn	19	SENT_299	[p17l1742t16r1974b100],
19	loss	NN	O	loss	dobj	17	SENT_299	[p17l1994t16r2139b79],
20	.	.	O	.	_	0	SENT_299	[p17l1994t16r2139b79],

1	Interestingly	RB	O	interestingly	advmod	6	SENT_300	[p17l9t119r466b203],
2	,	,	O	,	_	0	SENT_300	[p17l9t119r466b203],
3	several	JJ	O	several	amod	4	SENT_300	[p17l496t119r738b182],
4	studies	NNS	O	study	nsubj	6	SENT_300	[p17l766t119r1009b182],
5	have	VBP	O	have	aux	6	SENT_300	[p17l1035t119r1195b182],
6	documented	VBN	O	document	_	0	SENT_300	[p17l1223t119r1669b182],
7	the	DT	O	the	det	8	SENT_300	[p17l1693t119r1803b182],
8	ability	NN	O	ability	dobj	6	SENT_300	[p17l1831t119r2052b203],
9	of	IN	O	of	_	0	SENT_300	[p17l2076t119r2151b182],
10	topiramate	NN	O	topiramate	prep_of	8	SENT_300	[p17l7t227r374b304],
11	to	TO	O	to	aux	12	SENT_300	[p17l394t233r459b284],
12	reduce	VB	O	reduce	xcomp	6	SENT_300	[p17l482t221r707b284],
13	calorie	NN	O	calorie	nn	14	SENT_300	[p17l729t221r953b284],
14	intake	NN	O	intake	nsubj	21	SENT_300	[p17l974t213r1336b284],
15	.46	CD	NUMBER	.46	npadvmod	16	SENT_300	[p17l974t213r1336b284],
16	>	JJR	O	>	dep	21	SENT_300	[p17l974t213r1336b284],
17	47	CD	NUMBER	47	nsubj	21	SENT_300	[p17l974t213r1336b284],
18	These	DT	O	these	det	19	SENT_300	[p17l1357t221r1550b284],
19	studies	NNS	O	study	dep	17	SENT_300	[p17l1572t221r1803b284],
20	have	VBP	O	have	aux	21	SENT_300	[p17l1824t221r1977b284],
21	suggested	VBN	O	suggest	xcomp	12	SENT_300	[p17l1999t244r2138b305, p17l8t324r217b408],
22	that	IN	O	that	complm	27	SENT_300	[p17l234t324r365b387],
23	this	DT	O	this	det	24	SENT_300	[p17l381t324r503b387],
24	effect	NN	O	effect	nsubj	27	SENT_300	[p17l523t324r701b387],
25	may	MD	O	may	aux	27	SENT_300	[p17l718t347r863b408],
26	be	VB	O	be	cop	27	SENT_300	[p17l876t324r954b387],
27	due	JJ	O	due	ccomp	21	SENT_300	[p17l974t324r1094b387],
28	to	TO	O	to	_	0	SENT_300	[p17l1112t336r1177b387],
29	topiramate	NN	O	topiramate	poss	31	SENT_300	[p17l1196t324r1595b407],
30	’s	POS	O	’s	_	0	SENT_300	[p17l1196t324r1595b407],
31	ability	NN	O	ability	prep_to	27	SENT_300	[p17l1616t324r1823b408],
32	to	TO	O	to	aux	33	SENT_300	[p17l1837t336r1902b387],
33	inhibit	VB	O	inhibit	infmod	31	SENT_300	[p17l1922t324r2145b387],
34	compulsive	JJ	O	compulsive	amod	36	SENT_300	[p17l9t427r402b510],
35	food	NN	O	food	nn	36	SENT_300	[p17l426t427r587b490],
36	cravings	NNS	O	craving	dobj	33	SENT_300	[p17l610t433r897b511],
37	and	CC	O	and	_	0	SENT_300	[p17l922t427r1050b490],
38	addictive	JJ	O	addictive	amod	39	SENT_300	[p17l1074t427r1389b490],
39	behavior	NN	O	behavior	dobj	33	SENT_300	[p17l1411t427r1728b490],
40	.	.	O	.	_	0	SENT_300	[p17l1411t427r1728b490],

1	This	DT	O	this	det	2	SENT_301	[p17l1755t427r1900b490],
2	observation	NN	O	observation	nsubjpass	4	SENT_301	[p17l1925t427r2138b490, p17l6t536r224b593],
3	is	VBZ	O	be	auxpass	4	SENT_301	[p17l247t536r298b593],
4	based	VBN	O	base	_	0	SENT_301	[p17l320t530r519b593],
5	largely	RB	O	largely	advmod	4	SENT_301	[p17l540t530r771b614],
6	on	IN	O	on	_	0	SENT_301	[p17l792t553r879b593],
7	the	DT	O	the	det	9	SENT_301	[p17l901t530r1009b593],
8	clinical	JJ	O	clinical	amod	9	SENT_301	[p17l1033t530r1281b593],
9	eﬂicacy	NN	O	eﬂicacy	prep_on	4	SENT_301	[p17l1304t530r1565b614],
10	of	IN	O	of	_	0	SENT_301	[p17l1586t530r1660b593],
11	topiramate	NN	O	topiramate	prep_of	9	SENT_301	[p17l1673t536r2050b613],
12	in	IN	O	in	_	0	SENT_301	[p17l2073t536r2141b592],
13	treating	VBG	O	treat	prepc_in	4	SENT_301	[p17l7t639r263b717],
14	binge	NN	O	binge	dobj	13	SENT_301	[p17l277t633r457b717],
15	eating	VBG	O	eat	partmod	14	SENT_301	[p17l476t639r676b717],
16	disorder	NN	O	disorder	dobj	15	SENT_301	[p17l693t633r967b696],
17	through	IN	O	through	_	0	SENT_301	[p17l983t633r1250b717],
18	antagonism	NN	O	antagonism	prep_through	15	SENT_301	[p17l1269t639r1652b717],
19	of	IN	O	of	_	0	SENT_301	[p17l1670t633r1742b696],
20	0camino3hydroxy	NN	O	0camino3hydroxy	prep_of	18	SENT_301	[p17l1752t639r2139b697, p17l7t735r1010b819],
21	—	CD	NUMBER	—	num	24	SENT_301	[p17l1752t639r2139b697, p17l7t735r1010b819],
22	5-methyl-4-isoxazole	JJ	O	5-methyl-4-isoxazole	amod	24	SENT_301	[p17l1752t639r2139b697, p17l7t735r1010b819],
23	propionate/kainate	NN	O	propionate/kainate	nn	24	SENT_301	[p17l1027t735r1652b818],
24	receptors	NNS	O	receptor	nsubj	33	SENT_301	[p17l1671t727r2141b818],
25	.46	CD	NUMBER	.46	dep	24	SENT_301	[p17l1671t727r2141b818],
26	‘	CD	NUMBER	‘	number	27	SENT_301	[p17l1671t727r2141b818],
27	48	CD	NUMBER	48	dep	24	SENT_301	[p17l1671t727r2141b818],
28	These	DT	O	these	det	31	SENT_301	[p17l8t838r199b901],
29	beneﬁcial	JJ	O	beneﬁcial	amod	31	SENT_301	[p17l216t838r540b901],
30	psychological	JJ	O	psychological	amod	31	SENT_301	[p17l557t838r1013b922],
31	effects	NNS	O	effect	dep	27	SENT_301	[p17l1031t838r1239b901],
32	may	MD	O	may	aux	33	SENT_301	[p17l1258t861r1403b922],
33	behave	VB	O	behave	dep	15	SENT_301	[p17l1416t838r1649b901],
34	synergistically	RB	O	synergistically	advmod	33	SENT_301	[p17l1669t838r2145b922],
35	with	IN	O	with	_	0	SENT_301	[p17l7t941r157b1004],
36	neuroendocrine	JJ	O	neuroendocrine	amod	37	SENT_301	[p17l178t941r722b1004],
37	mechanisms	NNS	O	mechanism	prep_with	33	SENT_301	[p17l743t941r1164b1004],
38	of	IN	O	of	_	0	SENT_301	[p17l1186t941r1260b1004],
39	inducing	VBG	O	induce	prepc_of	37	SENT_301	[p17l1271t941r1572b1025],
40	weight	NN	O	weight	nn	41	SENT_301	[p17l1590t941r1816b1025],
41	loss	NN	O	loss	dobj	39	SENT_301	[p17l1835t941r1975b1004],
42	.	.	O	.	_	0	SENT_301	[p17l1835t941r1975b1004],

1	This	DT	O	this	nsubj	2	SENT_302	[p17l1999t941r2141b1004],
2	makes	VBZ	O	make	_	0	SENT_302	[p17l8t1045r224b1108],
3	phentermine/topiramate	NN	O	phentermine/topiramate	nsubj	4	SENT_302	[p17l245t1045r1089b1128],
4	unique	JJ	O	unique	xcomp	2	SENT_302	[p17l1111t1051r1350b1128],
5	in	IN	O	in	_	0	SENT_302	[p17l1372t1051r1438b1107],
6	obesity	NN	O	obesity	nn	7	SENT_302	[p17l1461t1045r1704b1129],
7	therapeutics	NNS	O	therapeutics	prep_in	4	SENT_302	[p17l1722t1045r2141b1128],
8	in	IN	O	in	_	0	SENT_302	[p17l9t1154r75b1210],
9	that	IN	O	that	complm	11	SENT_302	[p17l96t1148r230b1211],
10	it	PRP	O	it	nsubj	11	SENT_302	[p17l251t1154r297b1211],
11	targets	VBZ	O	target	prepc_in	7	SENT_302	[p17l316t1160r543b1232],
12	not	RB	O	not	neg	16	SENT_302	[p17l565t1160r680b1211],
13	only	RB	O	only	advmod	16	SENT_302	[p17l701t1148r852b1232],
14	the	DT	O	the	det	16	SENT_302	[p17l869t1148r976b1211],
15	neuroendocrine	JJ	O	neuroendocrine	amod	16	SENT_302	[p17l998t1148r1551b1211],
16	milieu	NN	O	milieu	dobj	11	SENT_302	[p17l1573t1148r1793b1211],
17	of	IN	O	of	_	0	SENT_302	[p17l1814t1148r1889b1211],
18	obesity	NN	O	obesity	prep_of	16	SENT_302	[p17l1901t1148r2146b1232],
19	but	CC	O	but	_	0	SENT_302	[p17l6t1251r118b1314],
20	also	RB	O	also	advmod	16	SENT_302	[p17l139t1251r267b1314],
21	the	DT	O	the	det	23	SENT_302	[p17l289t1251r393b1314],
22	psychological	JJ	O	psychological	amod	23	SENT_302	[p17l413t1251r871b1335],
23	factors	NNS	O	factor	conj_but	16	SENT_302	[p17l891t1251r1115b1314],
24	of	IN	O	of	_	0	SENT_302	[p17l1137t1251r1211b1314],
25	binge	NN	O	binge	nn	26	SENT_302	[p17l1220t1251r1404b1335],
26	eating	NN	O	eating	prep_of	23	SENT_302	[p17l1426t1257r1630b1335],
27	underlying	VBG	O	underlie	xcomp	11	SENT_302	[p17l1649t1251r2019b1335],
28	the	DT	O	the	det	29	SENT_302	[p17l2037t1251r2142b1314],
29	disease	NN	O	disease	dobj	27	SENT_302	[p17l9t1354r259b1417],
30	.	.	O	.	_	0	SENT_302	[p17l9t1354r259b1417],

1	These	DT	O	these	det	4	SENT_303	[p17l281t1354r472b1417],
2	various	JJ	O	various	amod	4	SENT_303	[p17l488t1360r734b1417],
3	complementary	JJ	O	complementary	amod	4	SENT_303	[p17l754t1354r1285b1438],
4	effects	NNS	O	effect	nsubj	14	SENT_303	[p17l1301t1354r1508b1417],
5	make	VBP	O	make	_	0	SENT_303	[p17l1527t1354r1708b1417],
6	this	DT	O	this	det	7	SENT_303	[p17l1726t1354r1847b1417],
7	regimen	NN	O	regimen	nsubj	8	SENT_303	[p17l1867t1360r2143b1438],
8	unique	JJ	O	unique	xcomp	5	SENT_303	[p17l8t1463r235b1540],
9	among	IN	O	among	_	0	SENT_303	[p17l254t1480r479b1541],
10	its	PRP$	O	its	poss	11	SENT_303	[p17l495t1463r566b1520],
11	peers	NNS	O	peer	prep_among	8	SENT_303	[p17l583t1479r754b1540],
12	and	CC	O	and	_	0	SENT_303	[p17l773t1457r895b1520],
13	may	MD	O	may	aux	14	SENT_303	[p17l911t1480r1052b1541],
14	represent	VB	O	represent	conj_and	5	SENT_303	[p17l1066t1469r1367b1540],
15	an	DT	O	a	det	17	SENT_303	[p17l1385t1480r1462b1520],
16	important	JJ	O	important	amod	17	SENT_303	[p17l1479t1463r1810b1540],
17	paradigm	NN	O	paradigm	dobj	14	SENT_303	[p17l1825t1457r2140b1541],
18	in	IN	O	in	_	0	SENT_303	[p17l8t1566r74b1622],
19	the	DT	DATE	the	det	21	SENT_303	[p17l93t1560r197b1623],
20	future	JJ	DATE	future	amod	21	SENT_303	[p17l217t1560r419b1623],
21	development	NN	O	development	prep_in	14	SENT_303	[p17l439t1560r874b1643],
22	of	IN	O	of	_	0	SENT_303	[p17l893t1560r966b1623],
23	combinatorial	JJ	O	combinatorial	amod	24	SENT_303	[p17l977t1560r1447b1623],
24	therapies	NNS	O	therapy	prep_of	21	SENT_303	[p17l1465t1560r1784b1643],
25	.	.	O	.	_	0	SENT_303	[p17l1465t1560r1784b1643],

1	ANTIOBESITY	JJ	O	antiobesity	amod	2	SENT_304	[p17l8t1774r495b1830],
2	DRUGS	NNS	O	drug	_	0	SENT_304	[p17l515t1775r764b1830],
3	IN	IN	O	in	_	0	SENT_304	[p17l786t1775r854b1829],
4	THE	DT	O	the	det	5	SENT_304	[p17l871t1775r1010b1829],
5	PIPELINE	NNP	O	PIPELINE	prep_in	2	SENT_304	[p17l1032t1775r1350b1829],

1	A	DT	O	a	det	3	SENT_305	[p17l7t1874r65b1932],
2	fundamental	JJ	O	fundamental	amod	3	SENT_305	[p17l89t1870r539b1933],
3	trait	NN	O	trait	nsubj	13	SENT_305	[p17l561t1876r707b1933],
4	shared	VBN	O	share	partmod	3	SENT_305	[p17l731t1870r961b1933],
5	by	IN	O	by	_	0	SENT_305	[p17l981t1870r1067b1954],
6	many	JJ	O	many	amod	8	SENT_305	[p17l1087t1893r1284b1954],
7	antiobesity	JJ	O	antiobesity	amod	8	SENT_305	[p17l1305t1870r1692b1954],
8	drugs	NNS	O	drug	agent	4	SENT_305	[p17l1712t1870r1908b1954],
9	under	IN	O	under	_	0	SENT_305	[p17l1932t1870r2142b1933],
10	development	NN	O	development	prep_under	4	SENT_305	[p17l9t1973r453b2056],
11	is	VBZ	O	be	cop	13	SENT_305	[p17l474t1979r523b2036],
12	the	DT	O	the	det	13	SENT_305	[p17l546t1973r652b2036],
13	targeting	NN	O	targeting	_	0	SENT_305	[p17l673t1979r981b2057],
14	of	IN	O	of	_	0	SENT_305	[p17l1002t1973r1075b2036],
15	endogenous	JJ	O	endogenous	amod	17	SENT_305	[p17l1089t1973r1501b2057],
16	endocrine	JJ	O	endocrine	amod	17	SENT_305	[p17l1524t1973r1869b2036],
17	circuits	NNS	O	circuit	prep_of	13	SENT_305	[p17l1893t1979r2141b2036],
18	regulating	VBG	O	regulate	partmod	17	SENT_305	[p17l9t2076r351b2160],
19	energy	NN	O	energy	nn	20	SENT_305	[p17l370t2099r599b2160],
20	homeostasis	NN	O	homeostasis	dobj	18	SENT_305	[p17l615t2076r1045b2139],
21	.	.	O	.	_	0	SENT_305	[p17l615t2076r1045b2139],

1	Most	JJS	O	most	nsubj	7	SENT_306	[p17l1068t2081r1240b2139],
2	of	IN	O	of	_	0	SENT_306	[p17l1259t2076r1332b2139],
3	these	DT	O	these	det	5	SENT_306	[p17l1342t2076r1515b2139],
4	endocrine	JJ	O	endocrine	amod	5	SENT_306	[p17l1536t2076r1876b2139],
5	circuits	NNS	O	circuit	prep_of	1	SENT_306	[p17l1897t2082r2142b2139],
6	are	VBP	O	be	cop	7	SENT_306	[p17l9t2202r113b2242],
7	anorexigenic	JJ	O	anorexigenic	_	0	SENT_306	[p17l141t2185r617b2263],
8	.	.	O	.	_	0	SENT_306	[p17l141t2185r617b2263],

1	Peripheral	JJ	O	peripheral	amod	3	SENT_307	[p17l647t2179r1016b2262],
2	peptide	NN	O	peptide	nn	3	SENT_307	[p17l1041t2179r1309b2262],
3	hormones	NNS	O	hormone	nsubj	8	SENT_307	[p17l1335t2179r1696b2242],
4	are	VBP	O	be	auxpass	5	SENT_307	[p17l1724t2202r1828b2242],
5	released	VBN	O	release	_	0	SENT_307	[p17l1855t2179r2144b2242],
6	postprandially	RB	O	postprandially	advmod	5	SENT_307	[p17l7t2282r529b2366],
7	and	CC	O	and	_	0	SENT_307	[p17l552t2282r683b2345],
8	travel	VB	O	travel	conj_and	5	SENT_307	[p17l708t2282r907b2345],
9	in	IN	O	in	_	0	SENT_307	[p17l933t2288r1001b2344],
10	the	DT	O	the	det	11	SENT_307	[p17l1027t2282r1137b2345],
11	circulation	NN	O	circulation	prep_in	8	SENT_307	[p17l1165t2282r1551b2345],
12	to	TO	O	to	_	0	SENT_307	[p17l1576t2294r1644b2345],
13	their	PRP$	O	they	poss	15	SENT_307	[p17l1671t2282r1841b2345],
14	cognate	JJ	O	cognate	amod	15	SENT_307	[p17l1867t2294r2141b2366],
15	receptors	NNS	O	receptor	prep_to	8	SENT_307	[p17l9t2397r349b2468],
16	,	,	O	,	_	0	SENT_307	[p17l9t2397r349b2468],
17	which	WDT	O	which	nsubjpass	19	SENT_307	[p17l373t2385r588b2448],
18	are	VBP	O	be	auxpass	19	SENT_307	[p17l612t2408r714b2448],
19	expressed	VBN	O	express	rcmod	15	SENT_307	[p17l739t2385r1080b2468],
20	in	IN	O	in	_	0	SENT_307	[p17l1103t2391r1171b2447],
21	the	DT	O	the	det	24	SENT_307	[p17l1194t2385r1303b2448],
22	homeostatic	JJ	O	homeostatic	amod	24	SENT_307	[p17l1326t2385r1756b2448],
23	regulatory	JJ	O	regulatory	amod	24	SENT_307	[p17l1780t2385r2145b2469],
24	centers	NNS	O	center	prep_in	19	SENT_307	[p17l9t2500r253b2551],
25	in	IN	O	in	_	0	SENT_307	[p17l277t2494r344b2550],
26	the	DT	O	the	det	29	SENT_307	[p17l367t2488r475b2551],
27	central	JJ	O	central	amod	29	SENT_307	[p17l499t2488r737b2551],
28	nervous	JJ	O	nervous	amod	29	SENT_307	[p17l760t2511r1038b2551],
29	system	NN	O	system	prep_in	24	SENT_307	[p17l1063t2500r1317b2572],
30	,	,	O	,	_	0	SENT_307	[p17l1063t2500r1317b2572],
31	notably	RB	O	notably	advmod	33	SENT_307	[p17l1342t2488r1604b2572],
32	the	DT	O	the	det	33	SENT_307	[p17l1623t2488r1731b2551],
33	ARC	NN	O	arc	prep_in	19	SENT_307	[p17l1754t2492r1923b2551],
34	of	IN	O	of	_	0	SENT_307	[p17l1947t2488r2022b2551],
35	the	DT	O	the	det	36	SENT_307	[p17l2035t2488r2143b2551],
36	hypothalamus	NN	O	hypothalamus	prep_of	33	SENT_307	[p17l7t2591r512b2675],
37	and	CC	O	and	_	0	SENT_307	[p17l539t2591r669b2654],
38	the	DT	O	the	det	41	SENT_307	[p17l693t2591r803b2654],
39	dorsal	NN	O	dorsal	nn	41	SENT_307	[p17l829t2591r1046b2654],
40	vagal	NN	O	vagal	nn	41	SENT_307	[p17l1068t2591r1253b2675],
41	complex	NN	O	complex	conj_and	24	SENT_307	[p17l1278t2591r1579b2674],
42	in	IN	O	in	_	0	SENT_307	[p17l1603t2597r1671b2653],
43	the	DT	O	the	det	44	SENT_307	[p17l1696t2591r1806b2654],
44	medulla	NN	O	medullum	prep_in	41	SENT_307	[p17l1831t2591r2137b2654],
45	.	.	O	.	_	0	SENT_307	[p17l1831t2591r2137b2654],

1	The	DT	O	the	det	2	SENT_308	[p17l8t2694r134b2757],
2	ARC	NNP	O	ARC	nsubj	7	SENT_308	[p17l156t2698r324b2757],
3	is	VBZ	O	be	aux	7	SENT_308	[p17l347t2700r397b2757],
4	home	NN	O	home	advmod	7	SENT_308	[p17l420t2694r614b2757],
5	to	TO	O	to	_	0	SENT_308	[p17l636t2706r702b2757],
6	neurons	NNS	O	neuron	prep_to	4	SENT_308	[p17l726t2717r1006b2757],
7	expressing	VBG	O	express	dep	38	SENT_308	[p17l1030t2700r1392b2778],
8	the	DT	O	the	det	10	SENT_308	[p17l1413t2694r1520b2757],
9	key	JJ	O	key	amod	10	SENT_308	[p17l1541t2694r1662b2778],
10	(	NN	O	(	nsubj	15	SENT_308	[p17l1685t2694r1757b2771],
11	i	FW	O	i	nn	14	SENT_308	[p17l1685t2694r1757b2771],
12	)	FW	O	)	nn	14	SENT_308	[p17l1685t2694r1757b2771],
13	orexigenic	JJ	O	orexigenic	amod	14	SENT_308	[p17l1785t2700r2141b2778],
14	(	NN	O	(	dep	10	SENT_308	[p17l12t2797r425b2881],
15	stimulating	VBG	O	stimulate	dep	7	SENT_308	[p17l12t2797r425b2881],
16	appetite	NN	O	appetite	nn	18	SENT_308	[p17l444t2798r738b2880],
17	)	NN	O	)	nn	18	SENT_308	[p17l444t2798r738b2880],
18	neurotransmitters	NNS	O	neurotransmitter	nsubj	19	SENT_308	[p17l762t2803r1375b2860],
19	agouti-related	JJ	O	agouti-related	ccomp	15	SENT_308	[p17l1397t2797r1870b2881],
20	peptide	NN	O	peptide	nn	23	SENT_308	[p17l1888t2797r2143b2880],
21	(	CD	NUMBER	(	num	23	SENT_308	[p17l12t2901r258b2984],
22	AgRP	NN	O	agrp	nn	23	SENT_308	[p17l12t2901r258b2984],
23	)	NN	O	)	dobj	19	SENT_308	[p17l12t2901r258b2984],
24	and	CC	O	and	_	0	SENT_308	[p17l283t2900r407b2963],
25	neuropeptide	NN	O	neuropeptide	nn	26	SENT_308	[p17l426t2900r878b2983],
26	Y	NN	O	y	dobj	19	SENT_308	[p17l897t2905r950b2962],
27	(	CD	NUMBER	(	num	28	SENT_308	[p17l972t2900r1185b2977],
28	NPY	NN	O	npy	tmod	15	SENT_308	[p17l972t2900r1185b2977],
29	)	CD	NUMBER	)	advmod	28	SENT_308	[p17l972t2900r1185b2977],
30	and	CC	O	and	_	0	SENT_308	[p17l1210t2900r1334b2963],
31	(	CD	NUMBER	(	advmod	28	SENT_308	[p17l1357t2901r1450b2976],
32	ii	LS	O	ii	dep	38	SENT_308	[p17l1357t2901r1450b2976],
33	)	CD	NUMBER	)	num	38	SENT_308	[p17l1357t2901r1450b2976],
34	anorexigenic	JJ	O	anorexigenic	amod	38	SENT_308	[p17l1475t2906r1906b2984],
35	(	CD	NUMBER	(	num	38	SENT_308	[p17l1929t2901r2140b2983, p17l7t3003r560b3087],
36	appetite-suppressing	JJ	O	appetite-suppressing	amod	38	SENT_308	[p17l1929t2901r2140b2983, p17l7t3003r560b3087],
37	)	NN	O	)	nn	38	SENT_308	[p17l1929t2901r2140b2983, p17l7t3003r560b3087],
38	neurotransmitters	NNS	O	neurotransmitter	_	0	SENT_308	[p17l583t3009r1181b3066],
39	POMC	JJ	ORGANIZATION	pomc	dobj	38	SENT_308	[p17l1202t3007r1436b3066],
40	and	CC	O	and	_	0	SENT_308	[p17l1456t3003r1579b3066],
41	the	DT	O	the	det	46	SENT_308	[p17l1596t3003r1700b3066],
42	cocaine	NN	O	cocaine	amod	46	SENT_308	[p17l1720t3009r1996b3066],
43	-	:	O	-	_	0	SENT_308	[p17l1720t3009r1996b3066],
44	and	CC	O	and	_	0	SENT_308	[p17l2019t3003r2142b3066],
45	amphetamine-regulated	JJ	O	amphetamine-regulated	amod	46	SENT_308	[p17l9t3106r832b3190],
46	transcript	NN	O	transcript	conj_and	39	SENT_308	[p17l852t3112r1187b3189],
47	(	CD	NUMBER	(	num	50	SENT_308	[p17l1211t3107r1469b3189],
48	Figure	NN	O	figure	nn	50	SENT_308	[p17l1211t3107r1469b3189],
49	2	CD	NUMBER	2	num	50	SENT_308	[p17l1490t3107r1576b3182],
50	)	NN	O	)	nsubj	38	SENT_308	[p17l1490t3107r1576b3182],
51	.	.	O	.	_	0	SENT_308	[p17l1490t3107r1576b3182],

1	POMC	JJ	ORGANIZATION	pomc	nsubj	23	SENT_309	[p17l83t3213r325b3272],
2	itself	PRP	O	itself	nsubjpass	4	SENT_309	[p17l349t3209r521b3272],
3	is	VBZ	O	be	auxpass	4	SENT_309	[p17l535t3215r585b3272],
4	cleaved	VBN	O	cleave	rcmod	1	SENT_309	[p17l609t3209r862b3272],
5	to	TO	O	to	aux	6	SENT_309	[p17l883t3221r950b3272],
6	yield	VB	O	yield	xcomp	4	SENT_309	[p17l971t3209r1139b3293],
7	several	JJ	O	several	amod	8	SENT_309	[p17l1163t3209r1399b3272],
8	hormones	NNS	O	hormone	dobj	6	SENT_309	[p17l1421t3209r1790b3281],
9	,	,	O	,	_	0	SENT_309	[p17l1421t3209r1790b3281],
10	including	VBG	O	include	_	0	SENT_309	[p17l1815t3209r2145b3293],
11	oc-melanocyte-stimulating	JJ	O	oc-melanocyte-stimulating	amod	12	SENT_309	[p17l9t3312r963b3396],
12	hormone	NN	O	hormone	prep_including	4	SENT_309	[p17l989t3312r1338b3384],
13	,	,	O	,	_	0	SENT_309	[p17l989t3312r1338b3384],
14	which	WDT	O	which	nsubj	15	SENT_309	[p17l1367t3312r1586b3375],
15	binds	VBZ	O	bind	rcmod	12	SENT_309	[p17l1612t3312r1809b3375],
16	the	DT	O	the	det	17	SENT_309	[p17l1838t3312r1949b3375],
17	melanocortin	NN	O	melanocortin	dobj	15	SENT_309	[p17l1977t3312r2138b3375, p17l9t3421r345b3478],
18	3	CD	NUMBER	3	dep	17	SENT_309	[p17l369t3422r402b3478],
19	and	CC	O	and	_	0	SENT_309	[p17l429t3415r556b3478],
20	melanocortin	NN	O	melanocortin	conj_and	17	SENT_309	[p17l578t3415r1044b3478],
21	4	CD	NUMBER	4	num	22	SENT_309	[p17l1066t3422r1105b3477],
22	receptors	NNS	O	receptor	dep	20	SENT_309	[p17l1128t3427r1443b3498],
23	(	VBP	O	(	_	0	SENT_309	[p17l1470t3416r1725b3491],
24	MC3R	NN	O	mc3r	dobj	23	SENT_309	[p17l1470t3416r1725b3491],
25	and	CC	O	and	_	0	SENT_309	[p17l1746t3415r1873b3478],
26	MC4R	NN	O	mc4r	dobj	23	SENT_309	[p17l1895t3419r2140b3487],
27	,	,	O	,	_	0	SENT_309	[p17l1895t3419r2140b3487],
28	respectively	RB	O	respectively	advmod	29	SENT_309	[p17l9t3518r443b3602],
29	)	CD	NUMBER	)	rcmod	24	SENT_309	[p17l9t3518r443b3602],
30	to	TO	O	to	aux	31	SENT_309	[p17l469t3530r536b3581],
31	transmit	VB	O	transmit	xcomp	23	SENT_309	[p17l559t3524r856b3581],
32	the	DT	O	the	det	34	SENT_309	[p17l877t3518r985b3581],
33	anorexigenic	JJ	O	anorexigenic	amod	34	SENT_309	[p17l1009t3524r1454b3602],
34	signal	NN	O	signal	dobj	31	SENT_309	[p17l1478t3518r1696b3602],
35	.	.	O	.	_	0	SENT_309	[p17l1478t3518r1696b3602],

1	Rhythm	NN	O	rhythm	nsubj	3	SENT_310	[p17l1723t3518r2005b3602],
2	has	VBZ	O	have	aux	3	SENT_310	[p17l2027t3518r2141b3581],
3	developed	VBN	O	develop	_	0	SENT_310	[p17l9t3621r360b3704],
4	the	DT	O	the	det	6	SENT_310	[p17l380t3621r487b3684],
5	MC4R	NN	O	mc4r	nn	6	SENT_310	[p17l510t3625r739b3684],
6	agonist	NN	O	agonist	dobj	3	SENT_310	[p17l759t3627r1005b3705],
7	RM-493	NN	O	rm-493	nn	9	SENT_310	[p17l1027t3626r1307b3684],
8	(	CD	NUMBER	(	num	9	SENT_310	[p17l1336t3622r1556b3697],
9	Table	NNP	O	Table	dep	6	SENT_310	[p17l1336t3622r1556b3697],
10	2	CD	NUMBER	2	number	11	SENT_310	[p17l1577t3622r1663b3697],
11	)	CD	NUMBER	)	dep	9	SENT_310	[p17l1577t3622r1663b3697],
12	.	.	O	.	_	0	SENT_310	[p17l1577t3622r1663b3697],

1	In	IN	O	in	_	0	SENT_311	[p17l1689t3626r1760b3683],
2	preclinical	JJ	O	preclinical	amod	3	SENT_311	[p17l1782t3621r2143b3704],
3	studies	NNS	O	study	prep_in	11	SENT_311	[p17l9t3724r271b3796],
4	,	,	O	,	_	0	SENT_311	[p17l9t3724r271b3796],
5	obese	JJ	O	obese	amod	6	SENT_311	[p17l297t3724r493b3787],
6	primates	NNS	O	primate	nsubj	11	SENT_311	[p17l516t3730r823b3807],
7	treated	VBN	O	treat	partmod	6	SENT_311	[p17l847t3724r1093b3787],
8	for	IN	O	for	_	0	SENT_311	[p17l1116t3724r1216b3787],
9	8	CD	DURATION	8	num	10	SENT_311	[p17l1241t3731r1275b3787],
10	weeks	NNS	NUMBER	week	prep_for	7	SENT_311	[p17l1300t3724r1510b3787],
11	lost	VBD	O	lose	_	0	SENT_311	[p17l1534t3724r1660b3787],
12	an	DT	O	a	det	13	SENT_311	[p17l1683t3747r1765b3787],
13	average	NN	O	average	dobj	11	SENT_311	[p17l1791t3747r2052b3808],
14	of	IN	O	of	prep	11	SENT_311	[p17l2077t3724r2153b3787],

1	13.5	CD	PERCENT	13.5	num	2	SENT_312	[p18l15t21r216b81],
2	%	NN	PERCENT	%	_	0	SENT_312	[p18l15t21r216b81],
3	of	IN	O	of	_	0	SENT_312	[p18l241t16r316b79],
4	their	PRP$	O	they	poss	6	SENT_312	[p18l329t16r495b79],
5	body	NN	O	body	nn	6	SENT_312	[p18l515t16r694b100],
6	weight	NN	O	weight	prep_of	2	SENT_312	[p18l712t16r962b100],
7	,	,	O	,	_	0	SENT_312	[p18l712t16r962b100],
8	with	IN	O	with	_	0	SENT_312	[p18l986t16r1141b79],
9	signiﬁcant	JJ	O	signiﬁcant	amod	10	SENT_312	[p18l1165t16r1527b100],
10	improvements	NNS	O	improvement	prep_with	2	SENT_312	[p18l1549t22r2050b99],
11	in	IN	O	in	_	0	SENT_312	[p18l2074t22r2142b78],
12	both	DT	O	both	det	14	SENT_312	[p18l6t119r166b182],
13	insulin	NN	O	insulin	nn	14	SENT_312	[p18l188t119r424b182],
14	sensitivity	NN	O	sensitivity	prep_in	10	SENT_312	[p18l447t125r794b203],
15	and	CC	O	and	_	0	SENT_312	[p18l814t119r940b182],
16	cardiovascular	JJ	O	cardiovascular	amod	17	SENT_312	[p18l963t119r1462b182],
17	function	NN	O	function	conj_and	14	SENT_312	[p18l1483t119r1792b182],
18	.	.	O	.	_	0	SENT_312	[p18l1483t119r1792b182],

1	However	RB	O	however	_	0	SENT_313	[p18l1819t124r2138b191],
2	,	,	O	,	_	0	SENT_313	[p18l1819t124r2138b191],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_314	[p18l20t268r139b289],
2	PHARMACOLOGY	NNP	O	PHARMACOLOGY	dep	12	SENT_314	[p18l148t268r373b289],
3	&	CC	O	&	_	0	SENT_314	[p18l380t268r600b289],
4	THERAPEUT	NNP	O	THERAPEUT	nn	6	SENT_314	[p18l380t268r600b289],
5	|	CD	NUMBER	|	num	6	SENT_314	[p18l380t268r600b289],
6	CS	NNP	O	CS	conj_and	2	SENT_314	[p18l380t268r600b289],
7	|	NNP	O	|	nn	8	SENT_314	[p18l610t266r612b296],
8	VOLUME	NNP	O	VOLUME	dep	2	SENT_314	[p18l620t268r728b289],
9	95	CD	NUMBER	95	num	10	SENT_314	[p18l736t268r763b289],
10	NUMBER	NN	O	number	dep	12	SENT_314	[p18l773t268r881b289],
11	1	CD	NUMBER	1	num	12	SENT_314	[p18l891t269r898b289],
12	|	CD	NUMBER	|	dep	15	SENT_314	[p18l912t266r914b296],
13	JANUARY	NNP	DATE	JANUARY	dep	12	SENT_314	[p18l923t268r1041b289],
14	2014	CD	DATE	2014	num	15	SENT_314	[p18l1049t268r1107b289],
15	59	CD	DATE	59	_	0	SENT_314	[p18l2109t268r2139b289],

1	in	IN	O	in	_	0	SENT_315	[p18l8t650r76b706],
2	a	DT	O	a	det	3	SENT_315	[p18l103t667r138b707],
3	trial	NN	O	trial	prep_in	72	SENT_315	[p18l161t644r309b707],
4	with	IN	O	with	_	0	SENT_315	[p18l332t644r491b707],
5	obese	JJ	O	obese	amod	7	SENT_315	[p18l517t644r714b707],
6	human	JJ	O	human	amod	7	SENT_315	[p18l739t644r991b707],
7	subjects	NNS	O	subject	prep_with	3	SENT_315	[p18l1017t644r1319b728],
8	,	,	O	,	_	0	SENT_315	[p18l1017t644r1319b728],
9	Merck	NNP	PERSON	Merck	poss	13	SENT_315	[p18l1345t644r1613b707],
10	’s	POS	O	’s	_	0	SENT_315	[p18l1345t644r1613b707],
11	MC4R	NN	O	mc4r	nn	13	SENT_315	[p18l1639t648r1875b707],
12	agonist	NN	O	agonist	nn	13	SENT_315	[p18l1899t650r2154b728],
13	MK	NN	O	mk	nsubj	72	SENT_315	[p18l7t752r330b810],
14	—	CD	NUMBER	—	number	15	SENT_315	[p18l7t752r330b810],
15	0493	CD	DATE	0493	num	13	SENT_315	[p18l7t752r330b810],
16	induced	VBN	O	induce	dep	13	SENT_315	[p18l354t747r629b810],
17	only	RB	O	only	advmod	16	SENT_315	[p18l648t747r798b831],
18	a	DT	O	a	det	24	SENT_315	[p18l815t770r850b810],
19	small	JJ	O	small	amod	22	SENT_315	[p18l870t747r1066b819],
20	,	,	O	,	_	0	SENT_315	[p18l870t747r1066b819],
21	statistically	RB	O	statistically	advmod	22	SENT_315	[p18l1088t747r1468b831],
22	insigniﬁcant	JJ	O	insigniﬁcant	amod	24	SENT_315	[p18l1484t747r1906b831],
23	weight	NN	O	weight	nn	24	SENT_315	[p18l1924t747r2151b831],
24	reduction	NN	O	reduction	dobj	16	SENT_315	[p18l8t850r345b913],
25	as	IN	O	as	prep	16	SENT_315	[p18l369t873r434b913],
26	compared	VBN	O	compare	_	0	SENT_315	[p18l459t850r806b933],
27	with	IN	O	with	prepc_compared_with	25	SENT_315	[p18l826t850r981b913],
28	placebo	NN	O	placebo	pobj	25	SENT_315	[p18l1003t850r1270b933],
29	after	IN	O	after	_	0	SENT_315	[p18l1295t850r1450b913],
30	12	CD	DURATION	12	num	31	SENT_315	[p18l1479t857r1550b912],
31	weeks	NNS	NUMBER	week	prep_after	28	SENT_315	[p18l1573t850r1780b913],
32	in	IN	O	in	_	0	SENT_315	[p18l1804t856r1872b912],
33	a	DT	O	a	det	35	SENT_315	[p18l1896t873r1930b913],
34	ﬁxeddose	NN	O	ﬁxeddose	nn	35	SENT_315	[p18l1952t850r2148b913, p18l8t952r166b1016],
35	study	NN	O	study	prep_in	31	SENT_315	[p18l191t952r381b1037],
36	or	CC	O	or	_	0	SENT_315	[p18l402t975r475b1016],
37	after	IN	O	after	mark	49	SENT_315	[p18l499t952r655b1016],
38	18	CD	DURATION	18	num	39	SENT_315	[p18l684t959r756b1016],
39	weeks	NNS	NUMBER	week	nsubj	49	SENT_315	[p18l780t952r988b1016],
40	of	IN	O	of	_	0	SENT_315	[p18l1013t952r1089b1016],
41	stepped-titration	NN	O	stepped-titration	nn	42	SENT_315	[p18l1104t952r1696b1036],
42	dosing	NN	O	dosing	prep_of	39	SENT_315	[p18l1721t944r2039b1037],
43	.49	CD	NUMBER	.49	num	42	SENT_315	[p18l1721t944r2039b1037],
44	As	IN	O	as	_	0	SENT_315	[p18l2062t957r2150b1016],
45	Merck	NNP	PERSON	Merck	poss	47	SENT_315	[p18l7t1056r258b1119],
46	’s	POS	O	’s	_	0	SENT_315	[p18l7t1056r258b1119],
47	MK-0493	NN	O	mk-0493	prep_as	49	SENT_315	[p18l278t1061r598b1119],
48	was	VBD	O	be	aux	49	SENT_315	[p18l618t1079r742b1119],
49	promising	VBG	O	promise	conj_or	25	SENT_315	[p18l761t1062r1106b1140],
50	at	IN	O	at	_	0	SENT_315	[p18l1125t1068r1183b1119],
51	the	DT	O	the	det	53	SENT_315	[p18l1201t1056r1305b1119],
52	preclinical	JJ	O	preclinical	amod	53	SENT_315	[p18l1324t1056r1675b1139],
53	stage	NN	O	stage	prep_at	49	SENT_315	[p18l1695t1068r1858b1140],
54	but	CC	O	but	_	0	SENT_315	[p18l1876t1056r1988b1119],
55	only	RB	O	only	_	0	SENT_315	[p18l2007t1056r2154b1140],
56	tested	VBN	O	test	dep	13	SENT_315	[p18l7t1159r205b1222],
57	in	IN	O	in	_	0	SENT_315	[p18l225t1165r291b1221],
58	rodents	NNS	O	rodent	prep_in	56	SENT_315	[p18l311t1159r584b1231],
59	,	,	O	,	_	0	SENT_315	[p18l311t1159r584b1231],
60	that	IN	O	that	dep	66	SENT_315	[p18l605t1159r738b1222],
61	Rhythm	NNP	MISC	Rhythm	poss	65	SENT_315	[p18l758t1159r1068b1243],
62	’s	POS	MISC	’s	_	0	SENT_315	[p18l758t1159r1068b1243],
63	RM-493	NN	MISC	rm-493	nn	65	SENT_315	[p18l1089t1164r1366b1222],
64	preclinical	JJ	O	preclinical	amod	65	SENT_315	[p18l1388t1159r1743b1242],
65	success	NN	O	success	nsubj	66	SENT_315	[p18l1764t1182r2006b1222],
66	was	VBD	O	be	ccomp	16	SENT_315	[p18l2025t1182r2150b1222],
67	in	IN	O	in	_	0	SENT_315	[p18l8t1268r76b1324],
68	primates	NNS	O	primate	prep_in	66	SENT_315	[p18l98t1268r405b1345],
69	may	MD	O	may	aux	72	SENT_315	[p18l430t1285r580b1346],
70	be	VB	O	be	cop	72	SENT_315	[p18l598t1262r679b1325],
71	more	RBR	O	more	advmod	72	SENT_315	[p18l703t1285r885b1325],
72	predictive	JJ	O	predictive	_	0	SENT_315	[p18l908t1262r1260b1345],
73	of	IN	O	of	_	0	SENT_315	[p18l1284t1262r1360b1325],
74	the	DT	O	the	det	75	SENT_315	[p18l1373t1262r1482b1325],
75	results	NNS	O	result	prep_of	72	SENT_315	[p18l1507t1262r1733b1325],
76	in	IN	O	in	_	0	SENT_315	[p18l1758t1268r1826b1324],
77	humans	NNS	O	human	prep_in	75	SENT_315	[p18l1849t1262r2147b1325],
78	.	.	O	.	_	0	SENT_315	[p18l1849t1262r2147b1325],

1	Rhythm	NN	O	rhythm	nsubj	2	SENT_316	[p18l8t1365r287b1449],
2	initiated	VBD	O	initiate	ccomp	66	SENT_316	[p18l310t1365r596b1428],
3	phase	NN	O	phase	nsubj	46	SENT_316	[p18l616t1365r812b1448],
4	II	CD	NUMBER	ii	num	5	SENT_316	[p18l835t1370r889b1427],
5	trials	NNS	O	trial	dep	3	SENT_316	[p18l912t1365r1083b1428],
6	of	IN	O	of	dep	8	SENT_316	[p18l1108t1365r1181b1428],
7	RM	NN	O	rm	pobj	6	SENT_316	[p18l1195t1370r1475b1428],
8	—	NN	O	—	rcmod	5	SENT_316	[p18l1195t1370r1475b1428],
9	493	CD	NUMBER	493	num	8	SENT_316	[p18l1195t1370r1475b1428],
10	in	IN	O	in	dep	8	SENT_316	[p18l1501t1371r1568b1427],
11	December	NNP	DATE	December	pobj	10	SENT_316	[p18l1590t1365r1947b1428],
12	2012	CD	DATE	2012	num	11	SENT_316	[p18l1969t1372r2149b1437],
13	,	,	O	,	_	0	SENT_316	[p18l1969t1372r2149b1437],
14	with	IN	O	with	dep	8	SENT_316	[p18l6t1468r160b1532],
15	completion	NN	O	completion	pobj	14	SENT_316	[p18l184t1468r576b1552],
16	scheduled	VBN	O	schedule	partmod	3	SENT_316	[p18l600t1468r947b1532],
17	for	IN	O	for	_	0	SENT_316	[p18l968t1468r1067b1532],
18	October	NNP	DATE	October	prep_for	16	SENT_316	[p18l1090t1468r1374b1532],
19	2013.5	CD	NUMBER	2013.5	num	18	SENT_316	[p18l1396t1461r1610b1532],
20	Due	JJ	O	due	_	0	SENT_316	[p18l1634t1474r1778b1532],
21	to	TO	O	to	_	0	SENT_316	[p18l1801t1480r1867b1532],
22	the	DT	O	the	det	23	SENT_316	[p18l1890t1468r1998b1532],
23	role	NN	O	role	prep_due_to	16	SENT_316	[p18l2021t1468r2151b1532],
24	of	IN	O	of	_	0	SENT_316	[p18l8t1572r84b1635],
25	MCs	NNS	O	mc	prep_of	23	SENT_316	[p18l101t1576r268b1635],
26	in	IN	O	in	_	0	SENT_316	[p18l294t1578r363b1634],
27	cardiovascular	JJ	O	cardiovascular	amod	30	SENT_316	[p18l390t1572r912b1635],
28	and	CC	O	and	_	0	SENT_316	[p18l938t1572r1069b1635],
29	sexual	JJ	O	sexual	conj_and	27	SENT_316	[p18l1095t1572r1317b1635],
30	function	NN	O	function	prep_in	25	SENT_316	[p18l1342t1572r1667b1644],
31	,	,	O	,	_	0	SENT_316	[p18l1342t1572r1667b1644],
32	the	DT	O	the	det	36	SENT_316	[p18l1694t1572r1805b1635],
33	potential	JJ	O	potential	amod	36	SENT_316	[p18l1830t1572r2150b1655],
34	off-target	JJ	O	off-target	amod	36	SENT_316	[p18l8t1675r352b1759],
35	adverse	JJ	O	adverse	amod	36	SENT_316	[p18l381t1675r652b1738],
36	effects	NNS	O	effect	dobj	16	SENT_316	[p18l683t1675r913b1738],
37	of	IN	O	of	_	0	SENT_316	[p18l945t1675r1022b1738],
38	MC	NNP	O	MC	nn	39	SENT_316	[p18l1041t1679r1176b1738],
39	signaling	NN	O	signaling	prep_of	36	SENT_316	[p18l1207t1675r1538b1759],
40	in	IN	O	in	_	0	SENT_316	[p18l1566t1681r1636b1737],
41	obesity	NN	O	obesity	nn	44	SENT_316	[p18l1666t1675r1926b1759],
42	treatment	NN	O	treatment	nn	44	SENT_316	[p18l1952t1687r2147b1738, p18l7t1789r192b1841],
43	warrant	NN	O	warrant	nn	44	SENT_316	[p18l215t1789r497b1841],
44	scrutiny	NN	O	scrutiny	prep_in	16	SENT_316	[p18l524t1769r894b1862],
45	.5	CD	NUMBER	.5	num	46	SENT_316	[p18l524t1769r894b1862],
46	°	NN	O	°	xcomp	2	SENT_316	[p18l524t1769r894b1862],
47	For	IN	O	for	dep	46	SENT_316	[p18l922t1783r1043b1841],
48	example	NN	O	example	pobj	47	SENT_316	[p18l1069t1777r1384b1861],
49	,	,	O	,	_	0	SENT_316	[p18l1069t1777r1384b1861],
50	phase	NN	O	phase	dep	2	SENT_316	[p18l1411t1777r1615b1861],
51	I	PRP	O	I	dep	50	SENT_316	[p18l1642t1781r1697b1844],
52	/	:	O	/	punct	50	SENT_316	[p18l1642t1781r1697b1844],
53	II	CD	NUMBER	ii	num	54	SENT_316	[p18l1704t1783r1759b1840],
54	trials	NNS	O	trial	dep	50	SENT_316	[p18l1786t1777r1967b1841],
55	with	IN	O	with	_	0	SENT_316	[p18l1992t1777r2152b1841],
56	the	DT	O	the	det	61	SENT_316	[p18l7t1881r114b1944],
57	oc	NN	O	oc	nn	61	SENT_316	[p18l138t1881r1050b1965],
58	—	NN	O	—	nn	61	SENT_316	[p18l138t1881r1050b1965],
59	melanocyte-stimulating	JJ	O	melanocyte-stimulating	amod	61	SENT_316	[p18l138t1881r1050b1965],
60	hormone	NN	O	hormone	nn	61	SENT_316	[p18l1070t1881r1389b1944],
61	analog	NN	O	analog	prep_with	54	SENT_316	[p18l1412t1881r1657b1965],
62	,	,	O	,	_	0	SENT_316	[p18l1412t1881r1657b1965],
63	Melanotan	NNP	O	Melanotan	nn	64	SENT_316	[p18l1682t1881r2053b1944],
64	II	NNP	O	II	dep	2	SENT_316	[p18l2077t1886r2150b1953],
65	,	,	O	,	_	0	SENT_316	[p18l2077t1886r2150b1953],
66	caused	VBD	O	cause	_	0	SENT_316	[p18l8t1984r240b2048],
67	dose	NN	O	dose	nn	68	SENT_316	[p18l261t1984r816b2068],
68	—	NN	O	—	nsubj	69	SENT_316	[p18l261t1984r816b2068],
69	dependent	JJ	O	dependent	xcomp	66	SENT_316	[p18l261t1984r816b2068],
70	penile	JJ	O	penile	amod	71	SENT_316	[p18l835t1984r1046b2068],
71	erections	NNS	O	erection	nsubj	66	SENT_316	[p18l1068t1976r1456b2048],
72	.	.	O	.	_	0	SENT_316	[p18l1068t1976r1456b2048],

1	“	NN	O	“	_	0	SENT_317	[p18l1068t1976r1456b2048],

1	NPY	NN	O	npy	nsubj	2	SENT_318	[p18l80t2093r251b2151],
2	activates	VBZ	O	activate	_	0	SENT_318	[p18l278t2094r585b2151],
3	G	NN	O	g	nn	4	SENT_318	[p18l614t2092r671b2151],
4	protein	NN	O	protein	dobj	2	SENT_318	[p18l696t2088r1296b2171],
5	—	CD	NUMBER	—	num	4	SENT_318	[p18l696t2088r1296b2171],
6	coupled	VBN	O	couple	prep	2	SENT_318	[p18l696t2088r1296b2171],
7	receptors	NNS	O	receptor	nn	8	SENT_318	[p18l1322t2100r1653b2171],
8	Y1	NN	O	y1	dep	6	SENT_318	[p18l1679t2093r1769b2150],
9	and	CC	O	and	_	0	SENT_318	[p18l1803t2088r1934b2151],
10	Y5	NN	O	y5	dep	6	SENT_318	[p18l1958t2093r2052b2151],
11	to	TO	O	to	aux	12	SENT_318	[p18l2080t2100r2148b2151],
12	stimulate	VB	O	stimulate	infmod	8	SENT_318	[p18l8t2190r330b2254],
13	appetite	NN	O	appetite	nn	21	SENT_318	[p18l355t2182r717b2274],
14	.52	CD	NUMBER	.52	num	13	SENT_318	[p18l355t2182r717b2274],
15	Shionogi	NNP	PERSON	Shionogi	poss	20	SENT_318	[p18l742t2190r1095b2275],
16	’s	POS	O	’s	_	0	SENT_318	[p18l742t2190r1095b2275],
17	S	NN	O	s	nn	20	SENT_318	[p18l1120t2194r1357b2254],
18	—	CD	NUMBER	—	number	19	SENT_318	[p18l1120t2194r1357b2254],
19	2367	CD	DATE	2367	num	20	SENT_318	[p18l1120t2194r1357b2254],
20	(	NN	O	(	dep	13	SENT_318	[p18l1385t2190r1796b2274],
21	Velneperit	NN	O	velneperit	dobj	12	SENT_318	[p18l1385t2190r1796b2274],
22	;	:	O	;	_	0	SENT_318	[p18l1385t2190r1796b2274],
23	Figure	NN	O	figure	nsubj	55	SENT_318	[p18l1822t2195r2059b2274],
24	2	CD	NUMBER	2	num	25	SENT_318	[p18l2081t2191r2147b2268],
25	)	NN	O	)	nsubj	30	SENT_318	[p18l2081t2191r2147b2268],
26	is	VBZ	O	be	cop	30	SENT_318	[p18l8t2300r58b2357],
27	a	DT	O	a	det	30	SENT_318	[p18l83t2317r117b2357],
28	Y5	NN	O	y5	nn	30	SENT_318	[p18l138t2299r230b2357],
29	receptor	NN	O	receptor	nn	30	SENT_318	[p18l256t2306r547b2377],
30	inhibitor	NN	O	inhibitor	rcmod	23	SENT_318	[p18l569t2294r881b2357],
31	that	WDT	O	that	nsubj	33	SENT_318	[p18l902t2294r1039b2357],
32	has	VBZ	O	have	aux	33	SENT_318	[p18l1060t2294r1173b2357],
33	completed	VBN	O	complete	rcmod	30	SENT_318	[p18l1198t2294r1563b2377],
34	phase	NN	O	phase	nsubj	36	SENT_318	[p18l1584t2294r1782b2377],
35	II	CD	NUMBER	ii	num	36	SENT_318	[p18l1807t2299r1861b2356],
36	trials	NNS	O	trial	xcomp	33	SENT_318	[p18l1884t2294r2061b2357],
37	in	IN	O	in	_	0	SENT_318	[p18l2085t2300r2152b2356],
38	the	DT	O	the	det	40	SENT_318	[p18l7t2397r117b2460],
39	United	NNP	LOCATION	United	nn	40	SENT_318	[p18l142t2397r387b2460],
40	States	NNPS	LOCATION	States	prep_in	36	SENT_318	[p18l412t2401r613b2460],
41	and	CC	O	and	_	0	SENT_318	[p18l640t2397r770b2460],
42	is	VBZ	O	be	cop	47	SENT_318	[p18l794t2403r846b2460],
43	in	IN	O	in	_	0	SENT_318	[p18l872t2403r941b2459],
44	a	DT	O	a	det	45	SENT_318	[p18l966t2420r1001b2460],
45	phase	NN	O	phase	prep_in	47	SENT_318	[p18l1024t2397r1226b2480],
46	III	CD	NUMBER	iii	num	47	SENT_318	[p18l1252t2402r1339b2459],
47	trial	NN	O	trial	rcmod	30	SENT_318	[p18l1364t2397r1512b2460],
48	in	IN	O	in	_	0	SENT_318	[p18l1537t2403r1605b2459],
49	Japan	NNP	LOCATION	Japan	prep_in	47	SENT_318	[p18l1631t2402r1827b2480],
50	initiated	VBD	O	initiate	parataxis	2	SENT_318	[p18l1853t2397r2152b2460],
51	in	IN	O	in	_	0	SENT_318	[p18l8t2506r75b2562],
52	August	NNP	DATE	August	prep_in	50	SENT_318	[p18l97t2504r347b2584],
53	2013	CD	DATE	2013	num	52	SENT_318	[p18l369t2507r530b2563],
54	and	CC	O	and	_	0	SENT_318	[p18l558t2500r685b2563],
55	scheduled	VBN	O	schedule	conj_and	50	SENT_318	[p18l709t2500r1060b2563],
56	for	IN	O	for	_	0	SENT_318	[p18l1083t2500r1182b2563],
57	completion	NN	O	completion	prep_for	55	SENT_318	[p18l1205t2500r1602b2583],
58	in	IN	O	in	_	0	SENT_318	[p18l1626t2506r1693b2562],
59	March	NNP	DATE	March	prep_in	57	SENT_318	[p18l1716t2500r1943b2563],
60	2014	CD	DATE	2014	num	59	SENT_318	[p18l1965t2507r2148b2563],
61	.	.	O	.	_	0	SENT_318	[p18l1965t2507r2148b2563],

1	In	IN	O	in	dep	2	SENT_319	[p18l8t2608r80b2665],
2	combination	NN	O	combination	_	0	SENT_319	[p18l104t2603r550b2666],
3	with	IN	O	with	_	0	SENT_319	[p18l572t2603r728b2666],
4	a	DT	O	a	det	6	SENT_319	[p18l752t2626r786b2666],
5	reduced-calorie	JJ	O	reduced-calorie	amod	6	SENT_319	[p18l809t2603r1362b2666],
6	diet	NN	O	diet	prep_with	2	SENT_319	[p18l1386t2603r1537b2675],
7	,	,	O	,	_	0	SENT_319	[p18l1386t2603r1537b2675],
8	800	CD	NUMBER	800	num	9	SENT_319	[p18l1563t2610r1683b2666],
9	mg	NN	O	mg	appos	6	SENT_319	[p18l1704t2607r1840b2687],
10	/	:	O	/	punct	2	SENT_319	[p18l1704t2607r1840b2687],
11	d	NN	O	d	nn	12	SENT_319	[p18l1847t2603r1889b2666],
12	S	NN	O	s	dep	2	SENT_319	[p18l1912t2607r2150b2666],
13	—	CD	NUMBER	—	num	14	SENT_319	[p18l1912t2607r2150b2666],
14	2367	CD	DATE	2367	dep	12	SENT_319	[p18l1912t2607r2150b2666],

1	Table	NNP	O	Table	_	0	SENT_320	[p18l6t2844r186b2899],
2	2	CD	NUMBER	2	num	4	SENT_320	[p18l203t2847r238b2899],
3	Antiobesity	NN	O	antiobesity	nn	4	SENT_320	[p18l292t2843r683b2915],
4	medications	NNS	O	medication	nsubj	22	SENT_320	[p18l699t2844r1107b2899],
5	under	IN	O	under	_	0	SENT_320	[p18l1125t2844r1322b2899],
6	development	NN	O	development	prep_under	4	SENT_320	[p18l1337t2843r1783b2914],
7	vs.	CC	O	vs.	prep	6	SENT_320	[p18l6t2962r100b3002],
8	placebo	NN	O	placebo	dep	7	SENT_320	[p18l130t2939r412b3022],
9	induced	VBD	O	induce	rcmod	1	SENT_320	[p18l442t2939r739b3002],
10	at	IN	O	at	quantmod	12	SENT_320	[p18l767t2951r830b3002],
11	least	JJS	O	least	mwe	10	SENT_320	[p18l856t2939r1022b3002],
12	5	CD	PERCENT	5	dep	13	SENT_320	[p18l1050t2945r1154b3004],
13	%	NN	PERCENT	%	dep	15	SENT_320	[p18l1050t2945r1154b3004],
14	weight	NN	O	weight	nn	15	SENT_320	[p18l1182t2939r1429b3023],
15	loss	NN	O	loss	dobj	9	SENT_320	[p18l1455t2939r1611b3011],
16	,	,	O	,	_	0	SENT_320	[p18l1455t2939r1611b3011],
17	reduced	VBD	O	reduce	rcmod	1	SENT_320	[p18l1641t2939r1937b3002],
18	waist	NN	O	waist	nn	19	SENT_320	[p18l1962t2945r2152b3002],
19	circumference	NN	O	circumference	dobj	17	SENT_320	[p18l9t3043r545b3115],
20	,	,	O	,	_	0	SENT_320	[p18l9t3043r545b3115],
21	and	CC	O	and	_	0	SENT_320	[p18l574t3043r705b3106],
22	improved	VBD	O	improve	rcmod	1	SENT_320	[p18l731t3043r1076b3126],
23	lipid	NN	O	lipid	nn	24	SENT_320	[p18l1101t3043r1265b3126],
24	panels	NNS	O	panel	dobj	22	SENT_320	[p18l1289t3043r1517b3126],
25	in	IN	O	in	_	0	SENT_320	[p18l1544t3049r1613b3105],
26	obese	JJ	O	obese	amod	27	SENT_320	[p18l1640t3043r1839b3106],
27	patients	NNS	O	patient	prep_in	22	SENT_320	[p18l1865t3049r2149b3126],
28	over	IN	O	over	_	0	SENT_320	[p18l9t3168r160b3209],
29	the	DT	O	the	det	30	SENT_320	[p18l182t3145r290b3209],
30	course	NN	O	course	prep_over	22	SENT_320	[p18l315t3168r543b3209],
31	of	IN	O	of	dep	33	SENT_320	[p18l567t3145r642b3209],
32	1	CD	DURATION	1	num	33	SENT_320	[p18l663t3152r687b3208],
33	year	NN	NUMBER	year	dep	34	SENT_320	[p18l715t3137r941b3230],
34	.53	CD	NUMBER	.53	dep	1	SENT_320	[p18l715t3137r941b3230],
35	It	PRP	O	it	nsubjpass	38	SENT_320	[p18l966t3151r1016b3209],
36	should	MD	O	should	aux	38	SENT_320	[p18l1040t3145r1276b3209],
37	be	VB	O	be	auxpass	38	SENT_320	[p18l1297t3146r1377b3209],
38	noted	VBN	O	note	rcmod	34	SENT_320	[p18l1401t3145r1602b3209],
39	that	IN	O	that	complm	48	SENT_320	[p18l1624t3145r1761b3209],
40	neuropeptide	NN	O	neuropeptide	nn	43	SENT_320	[p18l1783t3167r2149b3229, p18l7t3249r146b3312],
41	Y5	NN	O	y5	nn	43	SENT_320	[p18l172t3254r268b3312],
42	receptor	NN	O	receptor	nn	43	SENT_320	[p18l298t3261r602b3332],
43	antagonism	NN	O	antagonism	nsubj	48	SENT_320	[p18l630t3255r1056b3333],
44	with	IN	O	with	_	0	SENT_320	[p18l1081t3249r1244b3312],
45	Merck	NNP	PERSON	Merck	poss	47	SENT_320	[p18l1271t3249r1546b3312],
46	’s	POS	O	’s	_	0	SENT_320	[p18l1271t3249r1546b3312],
47	MK-0557	NN	O	mk-0557	prep_with	43	SENT_320	[p18l1574t3254r1922b3312],
48	failed	VBD	O	fail	ccomp	38	SENT_320	[p18l1949t3249r2152b3312],
49	to	TO	O	to	aux	50	SENT_320	[p18l7t3364r77b3415],
50	induce	VB	O	induce	xcomp	48	SENT_320	[p18l107t3352r355b3415],
51	clinically	RB	O	clinically	advmod	52	SENT_320	[p18l385t3352r724b3436],
52	meaningful	JJ	O	meaningful	amod	54	SENT_320	[p18l749t3352r1175b3436],
53	weight	NN	O	weight	nn	54	SENT_320	[p18l1201t3352r1448b3436],
54	loss	NN	O	loss	dobj	50	SENT_320	[p18l1475t3352r1611b3415],
55	in	IN	O	in	_	0	SENT_320	[p18l1641t3358r1711b3414],
56	overweight	JJ	O	overweight	amod	59	SENT_320	[p18l1741t3352r2153b3436],
57	and	CC	O	and	_	0	SENT_320	[p18l9t3455r141b3518],
58	obese	JJ	O	obese	conj_and	56	SENT_320	[p18l167t3455r366b3518],
59	adults	NNS	O	adult	prep_in	50	SENT_320	[p18l394t3455r608b3518],
60	in	IN	O	in	_	0	SENT_320	[p18l636t3461r705b3517],
61	a	DT	O	a	det	64	SENT_320	[p18l733t3478r767b3518],
62	52-week	JJ	DURATION	52-week	amod	64	SENT_320	[p18l794t3455r1096b3518],
63	weight-loss	NN	O	weight-loss	nn	64	SENT_320	[p18l1117t3455r1529b3539],
64	study	NN	O	study	prep_in	59	SENT_320	[p18l1557t3455r1763b3539],
65	,	,	O	,	_	0	SENT_320	[p18l1557t3455r1763b3539],
66	despite	IN	O	despite	_	0	SENT_320	[p18l1792t3455r2045b3538],
67	its	PRP$	O	its	poss	68	SENT_320	[p18l2072t3461r2152b3518],
68	success	NN	O	success	nsubj	74	SENT_320	[p18l9t3581r275b3621],
69	in	IN	O	in	_	0	SENT_320	[p18l304t3564r375b3620],
70	preclinical	JJ	O	preclinical	amod	73	SENT_320	[p18l403t3558r795b3641],
71	and	CC	O	and	_	0	SENT_320	[p18l824t3558r958b3621],
72	proof-of-concept/dose	JJ	O	proof-of-concept/dose	amod	73	SENT_320	[p18l984t3558r2153b3642],
73	—	NN	O	—	prep_in	68	SENT_320	[p18l984t3558r2153b3642],
74	ranging	VBG	O	range	prepc_despite	50	SENT_320	[p18l984t3558r2153b3642],
75	studies	NNS	O	study	dobj	74	SENT_320	[p18l9t3652r342b3724],
76	.54	CD	NUMBER	.54	num	75	SENT_320	[p18l9t3652r342b3724],
77	The	DT	O	the	det	78	SENT_320	[p18l365t3660r501b3724],
78	investigators	NNS	O	investigator	nsubj	79	SENT_320	[p18l525t3667r977b3745],
79	concluded	VBD	O	conclude	rcmod	75	SENT_320	[p18l1002t3660r1371b3724],
80	that	IN	O	that	_	0	SENT_320	[p18l1393t3660r1532b3724],
81	neuropeptide	NN	O	neuropeptide	nn	82	SENT_320	[p18l1555t3660r2033b3744],
82	Y5	NN	O	y5	prep_that	79	SENT_320	[p18l2056t3666r2150b3724],

1	receptor	NN	O	receptor	nn	2	SENT_321	[p19l9t29r317b100],
2	antagonism	NN	O	antagonism	nsubj	12	SENT_321	[p19l346t23r777b101],
3	was	VBD	O	be	cop	4	SENT_321	[p19l804t40r938b80],
4	insufficient	JJ	O	insufficient	_	0	SENT_321	[p19l968t17r1395b80],
5	as	IN	O	as	_	0	SENT_321	[p19l1424t40r1492b80],
6	monotherapy	NN	O	monotherapy	prep_as	4	SENT_321	[p19l1521t17r2023b101],
7	for	IN	O	for	_	0	SENT_321	[p19l2049t17r2153b80],
8	antiobesity	JJ	O	antiobesity	amod	10	SENT_321	[p19l9t120r405b204],
9	drug	NN	O	drug	nn	10	SENT_321	[p19l428t120r596b204],
10	therapy	NN	O	therapy	prep_for	4	SENT_321	[p19l619t120r893b204],
11	but	CC	O	but	_	0	SENT_321	[p19l913t120r1030b183],
12	discussed	VBD	O	discuss	conj_but	4	SENT_321	[p19l1056t120r1398b183],
13	its	PRP$	O	its	poss	14	SENT_321	[p19l1423t126r1502b183],
14	potential	NN	O	potential	dobj	12	SENT_321	[p19l1528t120r1849b203],
15	in	IN	O	in	_	0	SENT_321	[p19l1875t126r1943b182],
16	combination	NN	O	combination	nn	17	SENT_321	[p19l1969t143r2149b183, p19l6t223r307b286],
17	therapy	NN	O	therapy	prep_in	12	SENT_321	[p19l332t223r614b307],
18	.	.	O	.	_	0	SENT_321	[p19l332t223r614b307],

1	Modulation	NN	O	modulation	nsubj	18	SENT_322	[p19l82t326r487b389],
2	of	IN	O	of	_	0	SENT_322	[p19l509t326r582b389],
3	monoamine	NN	O	monoamine	nn	4	SENT_322	[p19l593t332r1009b389],
4	neurotransmitters	NNS	O	neurotransmitter	prep_of	1	SENT_322	[p19l1030t332r1666b398],
5	,	,	O	,	_	0	SENT_322	[p19l1030t332r1666b398],
6	such	JJ	O	such	_	0	SENT_322	[p19l1689t326r1844b389],
7	as	IN	O	as	_	0	SENT_322	[p19l1865t349r1929b389],
8	dopamine	NN	O	dopamine	prep_such_as	1	SENT_322	[p19l1951t326r2149b409, p19l8t435r200b501],
9	,	,	O	,	_	0	SENT_322	[p19l1951t326r2149b409, p19l8t435r200b501],
10	norepinephrine	NN	O	norepinephrine	prep_such_as	1	SENT_322	[p19l222t429r777b512],
11	,	,	O	,	_	0	SENT_322	[p19l222t429r777b512],
12	and	CC	O	and	_	0	SENT_322	[p19l800t429r926b492],
13	serotonin	NN	O	serotonin	prep_such_as	1	SENT_322	[p19l947t435r1291b501],
14	,	,	O	,	_	0	SENT_322	[p19l947t435r1291b501],
15	can	MD	O	can	aux	18	SENT_322	[p19l1314t452r1431b492],
16	be	VB	O	be	cop	18	SENT_322	[p19l1450t429r1529b492],
17	highly	RB	O	highly	advmod	18	SENT_322	[p19l1549t429r1768b513],
18	effective	JJ	O	effective	_	0	SENT_322	[p19l1786t429r2066b492],
19	in	IN	O	in	_	0	SENT_322	[p19l2087t435r2154b491],
20	suppressing	VBG	O	suppress	prepc_in	18	SENT_322	[p19l9t538r422b616],
21	appetite	NN	O	appetite	dobj	20	SENT_322	[p19l445t538r740b615],
22	,	,	O	,	_	0	SENT_322	[p19l445t538r740b615],
23	but	CC	O	but	_	0	SENT_322	[p19l763t532r879b595],
24	adverse	JJ	O	adverse	amod	25	SENT_322	[p19l903t532r1164b595],
25	effects	NNS	O	effect	nsubj	34	SENT_322	[p19l1188t532r1405b595],
26	such	JJ	O	such	_	0	SENT_322	[p19l1431t532r1589b595],
27	as	IN	O	as	_	0	SENT_322	[p19l1613t555r1679b595],
28	cardiovascular	JJ	O	cardiovascular	amod	29	SENT_322	[p19l1704t532r2147b595, p19l7t635r100b698],
29	events	NNS	O	event	prep_such_as	25	SENT_322	[p19l123t647r341b698],
30	and	CC	O	and	_	0	SENT_322	[p19l367t635r496b698],
31	addiction	NN	O	addiction	conj_and	29	SENT_322	[p19l519t635r855b698],
32	are	VBP	O	be	cop	34	SENT_322	[p19l880t658r982b698],
33	major	JJ	O	major	amod	34	SENT_322	[p19l1006t641r1214b719],
34	concerns	NNS	O	concern	conj_but	18	SENT_322	[p19l1237t658r1552b698],
35	with	IN	O	with	_	0	SENT_322	[p19l1575t635r1732b698],
36	their	PRP$	O	they	poss	37	SENT_322	[p19l1755t635r1923b698],
37	use	NN	O	use	prep_with	34	SENT_322	[p19l1945t658r2059b698],
38	in	IN	O	in	_	0	SENT_322	[p19l2083t641r2151b697],
39	weight	NN	O	weight	nn	40	SENT_322	[p19l7t738r243b823],
40	management	NN	O	management	prep_in	37	SENT_322	[p19l265t731r805b823],
41	.55	CD	NUMBER	.55	num	43	SENT_322	[p19l265t731r805b823],
42	Orexigen	NNP	O	Orexigen	nn	43	SENT_322	[p19l831t742r1155b823],
43	Therapeutics	NNPS	O	Therapeutics	nsubj	45	SENT_322	[p19l1179t738r1630b822],
44	has	VBZ	O	have	aux	45	SENT_322	[p19l1654t738r1769b802],
45	developed	VBN	O	develop	rcmod	34	SENT_322	[p19l1794t738r2153b822],
46	the	DT	O	the	det	52	SENT_322	[p19l7t842r113b905],
47	combination	NN	O	combination	nn	52	SENT_322	[p19l134t842r565b905],
48	drug	NN	O	drug	nn	52	SENT_322	[p19l586t842r747b926],
49	bupropion/naltrexone	NN	O	bupropion/naltrexone	nn	52	SENT_322	[p19l763t842r1514b925],
50	(	CD	NUMBER	(	num	52	SENT_322	[p19l1538t842r1924b919],
51	Contrave	NNP	O	Contrave	nn	52	SENT_322	[p19l1538t842r1924b919],
52	)	NN	O	)	dobj	45	SENT_322	[p19l1538t842r1924b919],
53	,	,	O	,	_	0	SENT_322	[p19l1538t842r1924b919],
54	which	WDT	O	which	nsubj	55	SENT_322	[p19l1944t842r2152b905],
55	combines	VBZ	O	combine	rcmod	52	SENT_322	[p19l9t946r346b1009],
56	bupropion	NN	O	bupropion	dobj	55	SENT_322	[p19l368t946r762b1029],
57	,	,	O	,	_	0	SENT_322	[p19l368t946r762b1029],
58	a	DT	O	a	det	59	SENT_322	[p19l788t969r824b1009],
59	dopamine	NN	O	dopamine	conj_and	56	SENT_322	[p19l848t946r1203b1029],
60	and	CC	O	and	_	0	SENT_322	[p19l1229t946r1358b1009],
61	norepinephrine	NN	O	norepinephrine	nn	63	SENT_322	[p19l1382t946r1935b1029],
62	reuptake	NN	O	reuptake	nn	63	SENT_322	[p19l1960t968r2148b1029, p19l7t1049r152b1112],
63	inhibitor	NN	O	inhibitor	conj_and	59	SENT_322	[p19l177t1049r501b1121],
64	,	,	O	,	_	0	SENT_322	[p19l177t1049r501b1121],
65	and	CC	O	and	_	0	SENT_322	[p19l527t1049r656b1112],
66	naltrexone	NN	O	naltrexone	conj_and	56	SENT_322	[p19l679t1049r1072b1121],
67	,	,	O	,	_	0	SENT_322	[p19l679t1049r1072b1121],
68	an	DT	O	a	det	71	SENT_322	[p19l1098t1072r1180b1112],
69	opioid	JJ	O	opioid	amod	71	SENT_322	[p19l1204t1049r1429b1132],
70	receptor	NN	O	receptor	nn	71	SENT_322	[p19l1453t1061r1745b1132],
71	antagonist	NN	O	antagonist	appos	66	SENT_322	[p19l1768t1055r2149b1133],
72	.	.	O	.	_	0	SENT_322	[p19l1768t1055r2149b1133],

1	Bupropion	NNP	O	Bupropion	nsubj	2	SENT_323	[p19l9t1157r386b1235],
2	increases	VBZ	O	increase	_	0	SENT_323	[p19l410t1158r728b1215],
3	dopamine	NN	O	dopamine	nn	4	SENT_323	[p19l753t1152r1107b1235],
4	activity	NN	O	activity	dobj	2	SENT_323	[p19l1132t1158r1392b1236],
5	and	CC	O	and	_	0	SENT_323	[p19l1413t1152r1543b1215],
6	POMC	JJ	O	pomc	amod	7	SENT_323	[p19l1566t1156r1813b1215],
7	neuronal	JJ	O	neuronal	dobj	2	SENT_323	[p19l1837t1152r2153b1215],

1	Target	NN	O	target	nn	2	SENT_324	[p19l19t1331r110b1361],
2	Drug	NN	O	drug	_	0	SENT_324	[p19l691t1330r760b1361],
3	Company	NN	O	company	nn	4	SENT_324	[p19l994t1330r1131b1361],
4	Mechanism	NN	O	mechanism	dep	2	SENT_324	[p19l1320t1329r1483b1354],
5	of	IN	O	of	_	0	SENT_324	[p19l1491t1329r1520b1354],
6	action	NN	O	action	prep_of	4	SENT_324	[p19l1526t1330r1614b1354],
7	Status	NNP	O	Status	nn	8	SENT_324	[p19l1946t1330r2034b1354],
8	Central	NNP	O	Central	dep	2	SENT_324	[p19l20t1388r117b1413],
9	neuropeptide	NN	O	neuropeptide	nn	13	SENT_324	[p19l127t1388r315b1419],
10	signaling	NN	O	signaling	nn	13	SENT_324	[p19l323t1388r446b1419],
11	Melanocortin	NN	O	melanocortin	nn	13	SENT_324	[p19l54t1453r237b1478],
12	receptor	NN	O	receptor	nn	13	SENT_324	[p19l247t1457r362b1484],
13	MK	NN	O	mk	dep	8	SENT_324	[p19l602t1453r721b1477],
14	.	.	O	.	_	0	SENT_324	[p19l602t1453r721b1477],

1	—	NN	O	—	_	0	SENT_325	[p19l602t1453r721b1477],
2	.	.	O	.	_	0	SENT_325	[p19l602t1453r721b1477],

1	O493	NN	O	o493	nn	2	SENT_326	[p19l602t1453r721b1477],
2	Merck	NNP	O	Merck	nsubj	7	SENT_326	[p19l940t1452r1023b1477],
3	Selective	JJ	O	selective	amod	5	SENT_326	[p19l1221t1452r1343b1477],
4	MC4R	NN	O	mc4r	nn	5	SENT_326	[p19l1352t1453r1430b1477],
5	agonist	NN	O	agonist	dep	2	SENT_326	[p19l1438t1453r1546b1484],
6	,	,	O	,	_	0	SENT_326	[p19l1438t1453r1546b1484],
7	increases	VBZ	O	increase	_	0	SENT_326	[p19l1555t1453r1679b1477],
8	Phase	NN	O	phase	dobj	7	SENT_326	[p19l1854t1452r1933b1477],
9	II	CD	NUMBER	ii	num	8	SENT_326	[p19l1942t1453r1953b1477],
10	completed	VBN	O	complete	partmod	8	SENT_326	[p19l1962t1452r2110b1483],

1	MC3R/4R	NN	O	mc3r/4r	nn	2	SENT_327	[p19l1222t1501r1347b1526],
2	signaling	NN	O	signaling	_	0	SENT_327	[p19l1355t1500r1478b1531],

1	RM	NN	O	rm	nn	2	SENT_328	[p19l603t1565r705b1589],
2	—	NN	O	—	_	0	SENT_328	[p19l603t1565r705b1589],
3	493	CD	NUMBER	493	num	7	SENT_328	[p19l603t1565r705b1589],
4	Rhythm	NNP	O	Rhythm	nn	7	SENT_328	[p19l940t1564r1045b1596],
5	Selective	JJ	O	selective	amod	7	SENT_328	[p19l1221t1564r1343b1589],
6	MC4R	NN	O	mc4r	nn	7	SENT_328	[p19l1352t1565r1430b1589],
7	agonist	NN	O	agonist	nsubj	9	SENT_328	[p19l1438t1565r1546b1596],
8	,	,	O	,	_	0	SENT_328	[p19l1438t1565r1546b1596],
9	increases	VBZ	O	increase	rcmod	2	SENT_328	[p19l1555t1565r1679b1589],
10	Phase	NN	O	phase	dobj	9	SENT_328	[p19l1854t1564r1933b1589],
11	II	CD	NUMBER	ii	num	10	SENT_328	[p19l1942t1565r1953b1589],

1	MC3/4R	NN	O	mc3/4r	nn	2	SENT_329	[p19l1222t1613r1329b1637],
2	signaling	NN	O	signaling	_	0	SENT_329	[p19l1337t1612r1460b1643],

1	NPY	NN	O	npy	nn	2	SENT_330	[p19l55t1672r110b1695],
2	MK-0557	NN	O	mk-0557	dep	10	SENT_330	[p19l602t1671r722b1694],
3	Merck	NNP	O	Merck	dep	2	SENT_330	[p19l940t1670r1023b1694],
4	Y5	NN	O	y5	nn	5	SENT_330	[p19l1220t1671r1253b1694],
5	receptor	NN	O	receptor	dep	10	SENT_330	[p19l1263t1674r1378b1701],
6	antagonist	NN	O	antagonist	nn	10	SENT_330	[p19l1385t1671r1539b1701],
7	,	,	O	,	_	0	SENT_330	[p19l1385t1671r1539b1701],
8	NPY	NN	O	npy	dep	10	SENT_330	[p19l1548t1671r1603b1694],
9	blocker	NN	O	blocker	nn	10	SENT_330	[p19l1611t1670r1712b1694],
10	Phase	NN	O	phase	dep	12	SENT_330	[p19l1854t1670r1933b1694],
11	II	CD	NUMBER	ii	dep	10	SENT_330	[p19l1942t1671r1953b1694],
12	completed	VBN	O	complete	_	0	SENT_330	[p19l1962t1670r2110b1701],

1	Velneperit	NNP	PERSON	Velneperit	nn	3	SENT_331	[p19l600t1728r742b1759],
2	Shionogi	NNP	PERSON	Shionogi	nn	3	SENT_331	[p19l939t1728r1060b1759],
3	USA	NNP	LOCATION	USA	_	0	SENT_331	[p19l1070t1729r1125b1753],
4	Y5	NN	O	y5	nn	6	SENT_331	[p19l1220t1729r1253b1753],
5	receptor	NN	O	receptor	nn	6	SENT_331	[p19l1263t1732r1378b1759],
6	antagonist	NN	O	antagonist	dep	3	SENT_331	[p19l1385t1729r1539b1759],
7	,	,	O	,	_	0	SENT_331	[p19l1385t1729r1539b1759],
8	NPY	NN	O	npy	nn	10	SENT_331	[p19l1548t1729r1603b1752],
9	blocker	NN	O	blocker	nn	10	SENT_331	[p19l1611t1728r1712b1753],
10	Phase	NN	O	phase	appos	6	SENT_331	[p19l1854t1728r1933b1753],
11	III	CD	NUMBER	iii	number	12	SENT_331	[p19l1942t1729r1961b1752],
12	(	CD	NUMBER	(	num	14	SENT_331	[p19l602t1778r713b1806],
13	S-2367	NN	O	s-2367	nn	14	SENT_331	[p19l602t1778r713b1806],
14	)	NN	O	)	dep	10	SENT_331	[p19l602t1778r713b1806],

1	Monoamine	NN	O	monoamine	nn	2	SENT_332	[p19l21t1837r187b1860],
2	neurotransmission	NN	O	neurotransmission	_	0	SENT_332	[p19l196t1837r450b1860],

1	Dopamine/norepinephrine/serotonin	NN	O	dopamine/norepinephrine/serotonin	nn	4	SENT_333	[p19l54t1921r548b1952],
2	Contrave	NNP	O	Contrave	nn	4	SENT_333	[p19l601t1921r725b1945],
3	Orexigen	NNP	O	Orexigen	nn	4	SENT_333	[p19l939t1921r1063b1952],
4	Norepinephrine/dopamine	NNP	O	Norepinephrine/dopamine	_	0	SENT_333	[p19l1222t1920r1594b1951],
5	Phase	NN	O	phase	dobj	7	SENT_333	[p19l1854t1920r1933b1945],
6	III	CD	NUMBER	iii	num	5	SENT_333	[p19l1942t1921r1961b1945],
7	completed	VBN	O	complete	partmod	4	SENT_333	[p19l1970t1920r2126b1951],
8	;	:	O	;	_	0	SENT_333	[p19l1970t1920r2126b1951],
9	(	CD	NUMBER	(	num	10	SENT_333	[p19l602t1964r770b1995],
10	bupropion	NN	O	bupropion	dep	4	SENT_333	[p19l602t1964r770b1995],
11	/	:	O	/	punct	13	SENT_333	[p19l602t1964r770b1995],
12	reuptake	NN	O	reuptake	nn	13	SENT_333	[p19l1222t1964r1343b1995],
13	inhibitor	NN	O	inhibitor	dep	10	SENT_333	[p19l1352t1964r1469b1989],
14	NDA	NN	ORGANIZATION	nda	nn	17	SENT_333	[p19l1854t1965r1915b1989],
15	submission	NN	O	submission	nn	17	SENT_333	[p19l1923t1964r2077b1989],
16	naltrexone	NN	O	naltrexone	nn	17	SENT_333	[p19l602t2008r757b2036],
17	)	NN	O	)	dep	13	SENT_333	[p19l602t2008r757b2036],

1	Intestinal	JJ	O	intestinal	amod	12	SENT_334	[p19l22t2072r146b2096],
2	peptide	NN	O	peptide	nn	12	SENT_334	[p19l156t2072r261b2103],
3	hormone	NN	O	hormone	nn	12	SENT_334	[p19l270t2072r396b2096],
4	signaling	NN	O	signaling	nn	12	SENT_334	[p19l404t2072r528b2103],
5	GLP	NN	O	glp	nn	12	SENT_334	[p19l54t2132r128b2155],
6	—	NN	O	—	nn	12	SENT_334	[p19l54t2132r128b2155],
7	1	CD	NUMBER	1	num	12	SENT_334	[p19l54t2132r128b2155],
8	Liraglutide	NNP	O	Liraglutide	nn	12	SENT_334	[p19l603t2130r749b2161],
9	Novo	NNP	ORGANIZATION	Novo	nn	12	SENT_334	[p19l940t2131r1011b2154],
10	Nordisk	NNP	ORGANIZATION	Nordisk	nn	12	SENT_334	[p19l1020t2130r1124b2154],
11	GLP-1R	NN	O	glp-1r	nn	12	SENT_334	[p19l1221t2131r1319b2154],
12	agonist	NN	O	agonist	nsubj	17	SENT_334	[p19l1326t2131r1435b2161],
13	,	,	O	,	_	0	SENT_334	[p19l1326t2131r1435b2161],
14	GLP	NN	O	glp	nn	15	SENT_334	[p19l1442t2131r1517b2154],
15	—	NN	O	—	appos	12	SENT_334	[p19l1442t2131r1517b2154],
16	1	CD	NUMBER	1	dep	15	SENT_334	[p19l1442t2131r1517b2154],
17	mimicking	VBG	O	mimic	_	0	SENT_334	[p19l1531t2130r1674b2161],
18	Phase	NN	O	phase	dobj	17	SENT_334	[p19l1854t2130r1933b2154],
19	III	CD	NUMBER	iii	num	18	SENT_334	[p19l1942t2131r1961b2154],
20	completed	VBN	O	complete	partmod	18	SENT_334	[p19l1970t2130r2126b2161],
21	;	:	O	;	_	0	SENT_334	[p19l1970t2130r2126b2161],
22	(	CD	NUMBER	(	num	23	SENT_334	[p19l602t2173r719b2201],
23	Victoza	NNP	O	Victoza	nsubj	37	SENT_334	[p19l602t2173r719b2201],
24	)	CD	NUMBER	)	num	23	SENT_334	[p19l602t2173r719b2201],
25	NDA	NNP	ORGANIZATION	NDA	nn	28	SENT_334	[p19l1854t2174r1916b2197],
26	submission	NN	O	submission	nn	28	SENT_334	[p19l1923t2173r2077b2197],
27	Byetta	NNP	LOCATION	Byetta	nn	28	SENT_334	[p19l603t2232r687b2262],
28	(	NNP	O	(	dep	23	SENT_334	[p19l696t2231r848b2259],
29	Exenatide	NNP	O	Exenatide	nn	32	SENT_334	[p19l696t2231r848b2259],
30	)	NNP	O	)	nn	32	SENT_334	[p19l696t2231r848b2259],
31	Amylin	NNP	O	Amylin	nn	32	SENT_334	[p19l939t2231r1033b2262],
32	GLP-1Ragonist	NNP	O	GLP-1Ragonist	dep	23	SENT_334	[p19l1221t2232r1435b2262],
33	,	,	O	,	_	0	SENT_334	[p19l1221t2232r1435b2262],
34	GLP	NNP	O	GLP	appos	32	SENT_334	[p19l1443t2232r1517b2255],
35	—	CD	NUMBER	—	number	36	SENT_334	[p19l1443t2232r1517b2255],
36	1	CD	NUMBER	1	dep	34	SENT_334	[p19l1443t2232r1517b2255],
37	mimicking	VBG	O	mimic	parataxis	17	SENT_334	[p19l1531t2231r1674b2262],
38	Phase	NN	O	phase	dobj	37	SENT_334	[p19l1854t2231r1933b2255],
39	III	CD	NUMBER	iii	num	38	SENT_334	[p19l1942t2232r1961b2255],

1	OXM	NNP	O	OXM	nn	4	SENT_335	[p19l54t2317r119b2341],
2	Oxyntomodulin	NNP	O	Oxyntomodulin	nn	4	SENT_335	[p19l602t2315r818b2347],
3	Prolor	NNP	O	Prolor	nn	4	SENT_335	[p19l940t2315r1021b2340],
4	GLP	NNP	O	GLP	_	0	SENT_335	[p19l1221t2316r1296b2340],
5	—	NN	O	—	nn	8	SENT_335	[p19l1221t2316r1296b2340],
6	1	CD	NUMBER	1	num	8	SENT_335	[p19l1221t2316r1296b2340],
7	R	NN	O	r	nn	8	SENT_335	[p19l1304t2316r1319b2340],
8	agonist	NN	O	agonist	dep	4	SENT_335	[p19l1326t2316r1435b2347],
9	,	,	O	,	_	0	SENT_335	[p19l1326t2316r1435b2347],
10	OXM	NN	O	oxm	appos	4	SENT_335	[p19l1443t2316r1508b2340],
11	mimicking	VBG	O	mimic	partmod	10	SENT_335	[p19l1517t2315r1660b2347],
12	Phase	NN	O	phase	nsubj	14	SENT_335	[p19l1854t2315r1933b2340],
13	I	PRP	O	I	dep	14	SENT_335	[p19l1942t2316r1946b2340],
14	recruiting	VBG	O	recruit	xcomp	11	SENT_335	[p19l1956t2316r2087b2347],

1	(	NN	O	(	nn	2	SENT_336	[p19l602t2365r758b2393],
2	OXY-RPEG	NN	O	oxy-rpeg	nsubj	14	SENT_336	[p19l602t2365r758b2393],
3	)	CD	NUMBER	)	num	5	SENT_336	[p19l602t2365r758b2393],
4	TKS1225	NN	O	tks1225	nn	5	SENT_336	[p19l600t2430r718b2453],
5	Thiakis/Wyeth	NN	O	thiakis/wyeth	dep	2	SENT_336	[p19l938t2429r1147b2460],
6	/	:	O	/	punct	8	SENT_336	[p19l938t2429r1147b2460],
7	GLP	NN	O	glp	nn	8	SENT_336	[p19l1221t2430r1296b2453],
8	—	NN	O	—	dep	2	SENT_336	[p19l1221t2430r1296b2453],
9	1	CD	NUMBER	1	num	11	SENT_336	[p19l1221t2430r1296b2453],
10	R	NN	O	r	nn	11	SENT_336	[p19l1304t2430r1319b2453],
11	agonist	NN	O	agonist	dep	8	SENT_336	[p19l1326t2430r1435b2460],
12	,	,	O	,	_	0	SENT_336	[p19l1326t2430r1435b2460],
13	OXM	NN	O	oxm	appos	8	SENT_336	[p19l1443t2430r1508b2453],
14	mimicking	VBG	O	mimic	_	0	SENT_336	[p19l1517t2429r1660b2460],
15	Phase	NN	O	phase	nsubj	16	SENT_336	[p19l1854t2429r1933b2453],
16	I	PRP	O	I	xcomp	14	SENT_336	[p19l1942t2430r1946b2453],

1	Pﬁzer	NN	O	pﬁzer	_	0	SENT_337	[p19l940t2474r1015b2499],

1	Pancreatic	JJ	O	pancreatic	amod	3	SENT_338	[p19l22t2534r162b2557],
2	hormone	NN	O	hormone	nn	3	SENT_338	[p19l171t2533r296b2557],
3	signaling	NN	O	signaling	dep	8	SENT_338	[p19l304t2533r428b2564],
4	PP	NN	O	pp	nn	5	SENT_338	[p19l55t2593r87b2616],
5	PP1420	NN	O	pp1420	dep	3	SENT_338	[p19l603t2592r703b2615],
6	Wel	NN	O	wel	dep	8	SENT_338	[p19l938t2591r1147b2615],
7	|	CD	NUMBER	|	num	6	SENT_338	[p19l938t2591r1147b2615],
8	comeTrust	NN	O	cometrust	dep	12	SENT_338	[p19l938t2591r1147b2615],
9	Pancreatic	JJ	O	pancreatic	amod	10	SENT_338	[p19l1222t2592r1363b2615],
10	polypeptide	NN	O	polypeptide	dep	8	SENT_338	[p19l1371t2591r1538b2622],
11	analog	NN	O	analog	nn	12	SENT_338	[p19l1546t2591r1638b2622],
12	Phase	NN	O	phase	_	0	SENT_338	[p19l1854t2591r1933b2615],
13	I	PRP	O	I	nsubj	14	SENT_338	[p19l1942t2592r1946b2615],
14	completed	VBD	O	complete	rcmod	12	SENT_338	[p19l1955t2591r2102b2621],
15	Amylin	NNP	O	Amylin	nn	18	SENT_338	[p19l54t2650r148b2681],
16	Davalintide	NNP	O	Davalintide	nn	18	SENT_338	[p19l603t2649r758b2674],
17	Amylin	NNP	O	Amylin	nn	18	SENT_338	[p19l939t2649r1033b2680],
18	Amylin	NNP	O	Amylin	dobj	14	SENT_338	[p19l1221t2649r1316b2680],
19	mimicking	VBG	O	mimic	partmod	18	SENT_338	[p19l1325t2649r1469b2680],
20	Phase	NN	O	phase	dobj	19	SENT_338	[p19l1855t2649r1933b2674],
21	II	CD	NUMBER	ii	num	20	SENT_338	[p19l1942t2650r1954b2673],

1	(	NN	O	(	nn	2	SENT_339	[p19l603t2689r725b2717],
2	AC2307	NN	O	ac2307	_	0	SENT_339	[p19l603t2689r725b2717],
3	)	CD	NUMBER	)	dep	2	SENT_339	[p19l603t2689r725b2717],

1	Adipose	NN	O	adipose	nn	4	SENT_340	[p19l20t2747r132b2778],
2	tissue	NN	O	tissue	nn	4	SENT_340	[p19l139t2748r218b2771],
3	hormone	NN	O	hormone	nn	4	SENT_340	[p19l227t2747r353b2771],
4	signaling	NN	O	signaling	_	0	SENT_340	[p19l361t2747r484b2778],
5	Leptin	NNP	MISC	Leptin	nn	7	SENT_340	[p19l55t2807r139b2836],
6	Metreleptin	NNP	MISC	Metreleptin	nn	7	SENT_340	[p19l602t2805r761b2835],
7	Amylin/Takeda	NNP	MISC	Amylin/Takeda	dep	15	SENT_340	[p19l939t2805r1143b2836],
8	Leptin	NN	MISC	leptin	nn	10	SENT_340	[p19l1223t2806r1306b2835],
9	receptor	NN	O	receptor	nn	10	SENT_340	[p19l1316t2808r1432b2835],
10	agonist	NN	O	agonist	dep	7	SENT_340	[p19l1439t2806r1540b2836],
11	Phase	NN	O	phase	dep	15	SENT_340	[p19l1855t2805r1933b2829],
12	III	CD	NUMBER	iii	num	11	SENT_340	[p19l1942t2806r1962b2829],
13	recruiting	NN	O	recruiting	nn	15	SENT_340	[p19l1972t2806r2103b2836],
14	Inhibition	NN	O	inhibition	nn	15	SENT_340	[p19l22t2863r153b2888],
15	oflipase	NN	O	oflipase	dep	30	SENT_340	[p19l162t2863r274b2894],
16	Pancreatic	JJ	O	pancreatic	amod	18	SENT_340	[p19l55t2923r195b2946],
17	lipase	NN	O	lipase	nn	18	SENT_340	[p19l204t2921r281b2952],
18	Cetilistat	NN	O	cetilistat	dep	15	SENT_340	[p19l602t2921r721b2945],
19	(	CD	NUMBER	(	num	20	SENT_340	[p19l730t2921r795b2949],
20	ATL	NN	O	atl	nsubj	30	SENT_340	[p19l730t2921r795b2949],
21	-	:	O	-	_	0	SENT_340	[p19l730t2921r795b2949],
22	A	DT	O	a	det	24	SENT_340	[p19l939t2921r1170b2952],
23	|	NN	O	|	nn	24	SENT_340	[p19l939t2921r1170b2952],
24	izyme/Takeda	NN	O	izyme/takeda	dep	20	SENT_340	[p19l939t2921r1170b2952],
25	/	:	O	/	punct	24	SENT_340	[p19l939t2921r1170b2952],
26	Pancreatic	JJ	O	pancreatic	amod	28	SENT_340	[p19l1235t2922r1375b2945],
27	lipase	NN	O	lipase	nn	28	SENT_340	[p19l1384t2921r1462b2951],
28	inhibitor	NN	O	inhibitor	dep	20	SENT_340	[p19l1470t2921r1592b2949],
29	,	,	O	,	_	0	SENT_340	[p19l1470t2921r1592b2949],
30	inhibits	VBZ	O	inhibit	dep	4	SENT_340	[p19l1600t2921r1701b2945],
31	Phase	NN	O	phase	dobj	30	SENT_340	[p19l1858t2921r1937b2945],
32	III	CD	NUMBER	iii	num	31	SENT_340	[p19l1946t2922r1965b2945],
33	completed	VBN	O	complete	partmod	31	SENT_340	[p19l1974t2921r2122b2951],

1	962	CD	NUMBER	962	_	0	SENT_341	[p19l602t2964r660b2992],
2	)	CD	NUMBER	)	num	3	SENT_341	[p19l602t2964r660b2992],
3	Norgine	NN	O	norgine	dep	1	SENT_341	[p19l940t2965r1049b2995],
4	intestinal	JJ	O	intestinal	amod	6	SENT_341	[p19l1293t2964r1417b2989],
5	lipid	NN	O	lipid	nn	6	SENT_341	[p19l1427t2964r1484b2995],
6	absorption	NN	O	absorption	dep	1	SENT_341	[p19l1493t2964r1642b2995],

1	GLP	NN	O	glp	nn	2	SENT_342	[p19l20t3020r85b3040],
2	—	NN	O	—	_	0	SENT_342	[p19l20t3020r85b3040],
3	1	CD	NUMBER	1	dep	2	SENT_342	[p19l20t3020r85b3040],
4	,	,	O	,	_	0	SENT_342	[p19l91t3036r96b3044],
5	glu	NN	O	glu	appos	3	SENT_342	[p19l103t3019r139b3046],
6	on	IN	O	on	_	0	SENT_342	[p19l185t3019r267b3040],
7	—	CD	NUMBER	—	num	8	SENT_342	[p19l185t3019r267b3040],
8	|	CD	NUMBER	|	prep_on	5	SENT_342	[p19l185t3019r267b3040],
9	ike	NN	O	ike	nn	10	SENT_342	[p19l185t3019r267b3040],
10	peptide	NN	O	peptide	dep	2	SENT_342	[p19l274t3019r367b3046],
11	1	CD	NUMBER	1	dep	10	SENT_342	[p19l376t3021r393b3044],
12	;	:	O	;	_	0	SENT_342	[p19l376t3021r393b3044],
13	MC3R/4R	NN	O	mc3r/4r	dep	10	SENT_342	[p19l400t3020r516b3044],
14	,	,	O	,	_	0	SENT_342	[p19l400t3020r516b3044],
15	melanocortin	NN	O	melanocortin	dep	10	SENT_342	[p19l523t3019r683b3040],
16	3	CD	NUMBER	3	num	15	SENT_342	[p19l691t3020r703b3040],
17	and	CC	O	and	_	0	SENT_342	[p19l711t3019r755b3040],
18	melanocortin	NN	O	melanocortin	dep	10	SENT_342	[p19l764t3019r924b3040],
19	4	CD	NUMBER	4	num	20	SENT_342	[p19l931t3021r945b3040],
20	receptors	NNS	O	receptor	dep	13	SENT_342	[p19l952t3022r1070b3046],
21	;	:	O	;	_	0	SENT_342	[p19l952t3022r1070b3046],
22	NDA	NNP	ORGANIZATION	NDA	dep	10	SENT_342	[p19l1078t3020r1137b3044],
23	,	,	O	,	_	0	SENT_342	[p19l1078t3020r1137b3044],
24	New	NNP	MISC	New	nn	26	SENT_342	[p19l1145t3020r1198b3040],
25	Drug	NNP	MISC	Drug	nn	26	SENT_342	[p19l1205t3020r1263b3046],
26	Application	NN	MISC	application	appos	22	SENT_342	[p19l1270t3019r1415b3046],
27	;	:	MISC	;	_	0	SENT_342	[p19l1270t3019r1415b3046],
28	NPY	NNP	MISC	NPY	dep	10	SENT_342	[p19l1423t3020r1473b3044],
29	,	,	O	,	_	0	SENT_342	[p19l1423t3020r1473b3044],
30	neuropeptideY	NN	O	neuropeptidey	appos	28	SENT_342	[p19l1481t3019r1671b3046],
31	;	:	O	;	_	0	SENT_342	[p19l1481t3019r1671b3046],
32	OXM	NNP	O	OXM	dep	10	SENT_342	[p19l1677t3020r1741b3044],
33	,	,	O	,	_	0	SENT_342	[p19l1677t3020r1741b3044],
34	oxyntomodulin	NN	O	oxyntomodulin	appos	32	SENT_342	[p19l1748t3019r1940b3046],
35	;	:	O	;	_	0	SENT_342	[p19l1748t3019r1940b3046],
36	PP	NN	O	pp	dep	10	SENT_342	[p19l1947t3020r1977b3044],
37	,	,	O	,	_	0	SENT_342	[p19l1947t3020r1977b3044],
38	pancreatic	JJ	O	pancreatic	amod	39	SENT_342	[p19l1985t3020r2110b3046],
39	polypepti	NN	O	polypeptus	appos	36	SENT_342	[p19l21t3053r135b3080],
40	.	.	O	.	_	0	SENT_342	[p19l169t3070r172b3074],

1	VOLUME	NN	O	volume	nn	3	SENT_343	[p19l1367t3157r1475b3178],
2	95	CD	NUMBER	95	num	3	SENT_343	[p19l1483t3157r1510b3178],
3	NUMBER	NN	O	number	_	0	SENT_343	[p19l1520t3157r1628b3178],
4	1	CD	NUMBER	1	number	5	SENT_343	[p19l1638t3158r1645b3178],
5	|	CD	NUMBER	|	dep	3	SENT_343	[p19l1659t3155r1661b3185],
6	JANUARY	NNP	DATE	JANUARY	dep	5	SENT_343	[p19l1670t3157r1788b3178],
7	2014	CD	DATE	2014	num	6	SENT_343	[p19l1796t3157r1854b3178],
8	|	CD	NUMBER	|	num	9	SENT_343	[p19l1863t3155r1865b3185],
9	www.nature.com/cpt	NN	O	www.nature.com/cpt	dep	3	SENT_343	[p19l1874t3157r2139b3183],

1	STATE	NN	O	state	_	0	SENT_344	[p19l1761t3300r1902b3337],

1	ART	NN	O	art	_	0	SENT_345	[p19l2045t3300r2139b3337],

1	activation	NN	O	activation	_	0	SENT_346	[p20l9t91r380b157],
2	,	,	O	,	_	0	SENT_346	[p20l9t91r380b157],
3	thereby	RB	O	thereby	advmod	1	SENT_346	[p20l407t85r678b169],
4	reducing	VBG	O	reduce	dep	1	SENT_346	[p20l701t85r1017b169],
5	appetite	NN	O	appetite	dobj	4	SENT_346	[p20l1042t91r1324b168],
6	and	CC	O	and	_	0	SENT_346	[p20l1352t85r1482b148],
7	increasing	VBG	O	increase	conj_and	4	SENT_346	[p20l1508t91r1875b169],
8	energy	NN	O	energy	nn	9	SENT_346	[p20l1901t108r2144b169],
9	expenditure	NN	O	expenditure	iobj	7	SENT_346	[p20l9t188r419b271],
10	(	CD	NUMBER	(	num	9	SENT_346	[p20l445t189r704b271],
11	Figure	NN	O	figure	nn	13	SENT_346	[p20l445t189r704b271],
12	2	CD	NUMBER	2	num	13	SENT_346	[p20l725t188r811b265],
13	)	NN	O	)	dobj	7	SENT_346	[p20l725t188r811b265],
14	.	.	O	.	_	0	SENT_346	[p20l725t188r811b265],

1	Naltrexone	NN	O	naltrexone	nsubj	2	SENT_347	[p20l836t188r1215b251],
2	blocks	VBZ	O	block	_	0	SENT_347	[p20l1236t188r1454b251],
3	opioid	JJ	O	opioid	amod	4	SENT_347	[p20l1478t188r1697b271],
4	receptors	NNS	O	receptor	dobj	2	SENT_347	[p20l1719t200r2032b271],
5	on	IN	O	on	_	0	SENT_347	[p20l2055t211r2142b251],
6	the	DT	O	the	det	8	SENT_347	[p20l8t291r117b354],
7	POMC	JJ	O	pomc	amod	8	SENT_347	[p20l142t295r389b354],
8	neurons	NNS	O	neuron	prep_on	2	SENT_347	[p20l413t314r717b363],
9	,	,	O	,	_	0	SENT_347	[p20l413t314r717b363],
10	preventing	VBG	O	prevent	partmod	2	SENT_347	[p20l742t297r1124b375],
11	feedback	NN	O	feedback	nn	12	SENT_347	[p20l1146t291r1460b354],
12	inhibition	NN	O	inhibition	nsubj	15	SENT_347	[p20l1481t291r1832b354],
13	and	CC	O	and	_	0	SENT_347	[p20l1857t291r1986b354],
14	further	JJ	O	further	conj_and	12	SENT_347	[p20l2010t291r2139b354, p20l8t394r150b457],
15	increasing	VBG	O	increase	dep	10	SENT_347	[p20l172t400r532b478],
16	POMC	JJ	O	pomc	amod	17	SENT_347	[p20l554t398r798b457],
17	activity	NN	O	activity	dobj	15	SENT_347	[p20l823t400r1087b478],
18	.	.	O	.	_	0	SENT_347	[p20l823t400r1087b478],

1	In	IN	O	in	dep	191	SENT_348	[p20l1114t399r1186b456],
2	a	DT	O	a	dep	191	SENT_348	[p20l1211t417r1246b457],
3	comparison	NN	O	comparison	dep	191	SENT_348	[p20l1268t400r1681b477],
4	of	IN	O	of	dep	191	SENT_348	[p20l1705t394r1780b457],
5	combined	JJ	O	combined	dep	191	SENT_348	[p20l1794t394r2143b457],
6	bupropion	NN	O	bupropion	dep	191	SENT_348	[p20l7t497r370b580],
7	(	NN	O	(	dep	191	SENT_348	[p20l397t498r543b573],
8	400	CD	NUMBER	400	dep	191	SENT_348	[p20l397t498r543b573],
9	mg	NN	O	mg	dep	191	SENT_348	[p20l558t501r693b581],
10	/	:	O	/	dep	191	SENT_348	[p20l558t501r693b581],
11	d	NN	O	d	dep	191	SENT_348	[p20l699t497r758b569],
12	,	,	O	,	_	0	SENT_348	[p20l699t497r758b569],
13	sustained-release	JJ	O	sustained-release	dep	191	SENT_348	[p20l783t497r1370b560],
14	formulation	NN	O	formulation	dep	191	SENT_348	[p20l1393t497r1832b574],
15	)	NN	O	)	dep	191	SENT_348	[p20l1393t497r1832b574],
16	and	CC	O	and	dep	191	SENT_348	[p20l1860t497r1986b560],
17	nal	JJ	O	nal	dep	191	SENT_348	[p20l2008t497r2140b560],
18	—	NN	O	—	dep	191	SENT_348	[p20l2008t497r2140b560],
19	trexone	NN	O	trexone	dep	191	SENT_348	[p20l8t612r267b663],
20	(	CD	NUMBER	(	dep	191	SENT_348	[p20l294t601r398b677],
21	48	CD	NUMBER	48	dep	191	SENT_348	[p20l294t601r398b677],
22	mg	NN	O	mg	dep	191	SENT_348	[p20l415t604r550b684],
23	/	:	O	/	dep	191	SENT_348	[p20l415t604r550b684],
24	d	NN	O	d	dep	191	SENT_348	[p20l556t600r623b677],
25	)	NN	O	)	dep	191	SENT_348	[p20l556t600r623b677],
26	therapy	NN	O	therapy	dep	191	SENT_348	[p20l649t600r912b684],
27	for	IN	O	for	dep	191	SENT_348	[p20l932t600r1029b663],
28	obesity	NN	O	obesity	dep	191	SENT_348	[p20l1052t600r1298b684],
29	vs.	CC	O	vs.	dep	191	SENT_348	[p20l1314t623r1402b663],
30	monotherapy	NN	O	monotherapy	dep	191	SENT_348	[p20l1428t600r1896b684],
31	or	CC	O	or	dep	191	SENT_348	[p20l1915t623r1987b663],
32	placebo	NN	O	placebo	dep	191	SENT_348	[p20l2008t600r2139b683, p20l9t703r179b775],
33	,	,	O	,	_	0	SENT_348	[p20l2008t600r2139b683, p20l9t703r179b775],
34	weight	NN	O	weight	dep	191	SENT_348	[p20l200t703r426b787],
35	loss	NN	O	loss	dep	191	SENT_348	[p20l444t703r568b766],
36	was	VBD	O	be	dep	191	SENT_348	[p20l587t726r711b766],
37	1.2	CD	NUMBER	1.2	dep	191	SENT_348	[p20l739t710r828b766],
38	kg	NN	O	kg	dep	191	SENT_348	[p20l842t703r924b787],
39	(	NN	O	(	dep	191	SENT_348	[p20l946t703r1160b780],
40	1.1	CD	PERCENT	1.1	dep	191	SENT_348	[p20l946t703r1160b780],
41	%	NN	PERCENT	%	dep	191	SENT_348	[p20l946t703r1160b780],
42	)	CD	NUMBER	)	dep	191	SENT_348	[p20l946t703r1160b780],
43	for	IN	O	for	dep	191	SENT_348	[p20l1184t703r1280b766],
44	placebo	NN	O	placebo	dep	191	SENT_348	[p20l1298t703r1573b786],
45	,	,	O	,	_	0	SENT_348	[p20l1298t703r1573b786],
46	1.6	CD	NUMBER	1.6	dep	191	SENT_348	[p20l1602t709r1692b766],
47	kg	NN	O	kg	dep	191	SENT_348	[p20l1706t703r1787b787],
48	(	NN	O	(	dep	191	SENT_348	[p20l1809t704r2023b780],
49	1.7	CD	PERCENT	1.7	dep	191	SENT_348	[p20l1809t704r2023b780],
50	%	NN	PERCENT	%	dep	191	SENT_348	[p20l1809t704r2023b780],
51	)	CD	NUMBER	)	dep	191	SENT_348	[p20l1809t704r2023b780],
52	for	IN	O	for	dep	191	SENT_348	[p20l2047t703r2143b766],
53	naltrexone	NN	O	naltrexone	dep	191	SENT_348	[p20l8t806r381b869],
54	monotherapy	NN	O	monotherapy	dep	191	SENT_348	[p20l405t806r890b890],
55	,	,	O	,	_	0	SENT_348	[p20l405t806r890b890],
56	3.1	CD	NUMBER	3.1	dep	191	SENT_348	[p20l917t813r1010b869],
57	kg	NN	O	kg	dep	191	SENT_348	[p20l1031t806r1115b890],
58	(	NN	O	(	dep	191	SENT_348	[p20l1141t806r1362b883],
59	3.1	CD	PERCENT	3.1	dep	191	SENT_348	[p20l1141t806r1362b883],
60	%	NN	PERCENT	%	dep	191	SENT_348	[p20l1141t806r1362b883],
61	)	CD	NUMBER	)	dep	191	SENT_348	[p20l1141t806r1362b883],
62	for	IN	O	for	dep	191	SENT_348	[p20l1390t806r1490b869],
63	bupropion	NN	O	bupropion	dep	191	SENT_348	[p20l1510t806r1881b889],
64	monotherapy	NN	O	monotherapy	dep	191	SENT_348	[p20l1905t829r2139b869, p20l8t909r278b993],
65	,	,	O	,	_	0	SENT_348	[p20l1905t829r2139b869, p20l8t909r278b993],
66	and	CC	O	and	dep	191	SENT_348	[p20l303t909r429b972],
67	6.9	CD	NUMBER	6.9	dep	191	SENT_348	[p20l452t915r548b972],
68	kg	NN	O	kg	dep	191	SENT_348	[p20l564t909r647b993],
69	(	NN	O	(	dep	191	SENT_348	[p20l671t910r887b985],
70	7.5	CD	PERCENT	7.5	dep	191	SENT_348	[p20l671t910r887b985],
71	%	NN	PERCENT	%	dep	191	SENT_348	[p20l671t910r887b985],
72	)	CD	NUMBER	)	dep	191	SENT_348	[p20l671t910r887b985],
73	for	IN	O	for	dep	191	SENT_348	[p20l914t909r1012b972],
74	naltrexone/bupropion	NN	O	naltrexone/bupropion	dep	191	SENT_348	[p20l1033t909r1790b992],
75	combination	NN	O	combination	dep	191	SENT_348	[p20l1813t909r2137b972, p20l8t1017r145b1074],
76	therapy	NN	O	therapy	dep	191	SENT_348	[p20l167t1011r438b1095],
77	,	,	O	,	_	0	SENT_348	[p20l167t1011r438b1095],
78	which	WDT	O	which	dep	191	SENT_348	[p20l460t1011r670b1074],
79	demonstrated	VBD	O	demonstrate	dep	191	SENT_348	[p20l693t1011r1168b1074],
80	their	PRP$	O	they	dep	191	SENT_348	[p20l1189t1011r1353b1074],
81	synergy	NN	O	synergy	dep	191	SENT_348	[p20l1375t1003r1716b1095],
82	.56	CD	NUMBER	.56	dep	191	SENT_348	[p20l1375t1003r1716b1095],
83	In	IN	O	in	dep	191	SENT_348	[p20l1740t1016r1811b1073],
84	addition	NN	O	addition	dep	191	SENT_348	[p20l1834t1011r2140b1083],
85	,	,	O	,	_	0	SENT_348	[p20l1834t1011r2140b1083],
86	bupropion/naltrexone	NN	O	bupropion/naltrexone	dep	191	SENT_348	[p20l7t1114r786b1197],
87	may	MD	O	may	dep	191	SENT_348	[p20l809t1137r959b1198],
88	regulate	VB	O	regulate	dep	191	SENT_348	[p20l979t1114r1258b1198],
89	activity	NN	O	activity	dep	191	SENT_348	[p20l1283t1120r1542b1198],
90	in	IN	O	in	dep	191	SENT_348	[p20l1563t1120r1630b1176],
91	the	DT	O	the	dep	191	SENT_348	[p20l1653t1114r1762b1177],
92	dopamine	NN	O	dopamine	dep	191	SENT_348	[p20l1787t1114r2140b1197],
93	reward	NN	O	reward	dep	191	SENT_348	[p20l9t1217r246b1280],
94	system	NN	O	system	dep	191	SENT_348	[p20l266t1229r497b1301],
95	of	IN	O	of	dep	191	SENT_348	[p20l517t1217r591b1280],
96	the	DT	O	the	dep	191	SENT_348	[p20l601t1217r706b1280],
97	brain	NN	O	brain	dep	191	SENT_348	[p20l725t1217r905b1280],
98	that	WDT	O	that	dep	191	SENT_348	[p20l924t1217r1057b1280],
99	helps	VBZ	O	help	dep	191	SENT_348	[p20l1076t1217r1251b1300],
100	control	NN	O	control	dep	191	SENT_348	[p20l1273t1217r1516b1280],
101	food	NN	O	food	dep	191	SENT_348	[p20l1536t1217r1693b1280],
102	cravings	NNS	O	craving	dep	191	SENT_348	[p20l1712t1223r1993b1301],
103	and	CC	O	and	dep	191	SENT_348	[p20l2015t1217r2141b1280],
104	overeating	VBG	O	overeat	dep	191	SENT_348	[p20l9t1325r377b1403],
105	behaviors	NNS	O	behavior	dep	191	SENT_348	[p20l398t1319r738b1382],
106	(	CD	NUMBER	(	dep	191	SENT_348	[p20l767t1320r1033b1402],
107	Figure	NN	O	figure	dep	191	SENT_348	[p20l767t1320r1033b1402],
108	2	CD	NUMBER	2	dep	191	SENT_348	[p20l1056t1311r1212b1396],
109	)	CD	NUMBER	)	dep	191	SENT_348	[p20l1056t1311r1212b1396],
110	.56	CD	NUMBER	.56	dep	191	SENT_348	[p20l1056t1311r1212b1396],
111	In	IN	O	in	dep	191	SENT_348	[p20l1237t1324r1309b1381],
112	phase	NN	O	phase	dep	191	SENT_348	[p20l1333t1319r1532b1402],
113	III	CD	NUMBER	iii	dep	191	SENT_348	[p20l1558t1324r1642b1381],
114	clinical	JJ	O	clinical	dep	191	SENT_348	[p20l1669t1319r1921b1382],
115	trials	NNS	O	trial	dep	191	SENT_348	[p20l1943t1319r2140b1391],
116	,	,	O	,	_	0	SENT_348	[p20l1943t1319r2140b1391],
117	bupropion/naltrexone	NN	O	bupropion/naltrexone	dep	191	SENT_348	[p20l7t1422r774b1505],
118	vs.	CC	O	vs.	dep	191	SENT_348	[p20l795t1445r883b1485],
119	placebo	NN	O	placebo	dep	191	SENT_348	[p20l908t1422r1174b1505],
120	induced	VBD	O	induce	dep	191	SENT_348	[p20l1198t1422r1479b1485],
121	greater	JJR	O	greater	dep	191	SENT_348	[p20l1501t1434r1741b1506],
122	weight	NN	O	weight	dep	191	SENT_348	[p20l1761t1422r1993b1506],
123	loss	NN	O	loss	dep	191	SENT_348	[p20l2014t1422r2141b1485],
124	on	IN	O	on	dep	191	SENT_348	[p20l9t1547r97b1587],
125	a	DT	O	a	dep	191	SENT_348	[p20l124t1547r160b1587],
126	diet	NN	O	diet	dep	191	SENT_348	[p20l185t1524r319b1587],
127	and	CC	O	and	dep	191	SENT_348	[p20l345t1524r475b1587],
128	exercise	NN	O	exercise	dep	191	SENT_348	[p20l500t1530r780b1587],
129	program	NN	O	program	dep	191	SENT_348	[p20l805t1546r1114b1608],
130	over	IN	O	over	dep	191	SENT_348	[p20l1141t1547r1294b1587],
131	56	CD	DURATION	56	dep	191	SENT_348	[p20l1320t1530r1399b1587],
132	weeks	NNS	NUMBER	week	dep	191	SENT_348	[p20l1424t1517r1690b1587],
133	.5	CD	NUMBER	.5	dep	191	SENT_348	[p20l1424t1517r1690b1587],
134	In	IN	O	in	dep	191	SENT_348	[p20l1718t1529r1791b1586],
135	2011	CD	DATE	2011	dep	191	SENT_348	[p20l1817t1531r2004b1596],
136	,	,	O	,	_	0	SENT_348	[p20l1817t1531r2004b1596],
137	the	DT	O	the	dep	191	SENT_348	[p20l2031t1524r2141b1587],
138	FDA	NNP	ORGANIZATION	FDA	dep	191	SENT_348	[p20l9t1631r171b1689],
139	rejected	VBD	O	reject	dep	191	SENT_348	[p20l193t1627r464b1711],
140	bupropion/naltrexone	NN	O	bupropion/naltrexone	dep	191	SENT_348	[p20l483t1627r1242b1710],
141	and	CC	O	and	dep	191	SENT_348	[p20l1266t1627r1392b1690],
142	requested	VBD	O	request	dep	191	SENT_348	[p20l1414t1627r1745b1710],
143	a	DT	O	a	dep	191	SENT_348	[p20l1767t1650r1802b1690],
144	large	JJ	O	large	dep	191	SENT_348	[p20l1822t1627r1986b1711],
145	cardiovascular	JJ	O	cardiovascular	dep	191	SENT_348	[p20l2010t1650r2139b1690, p20l9t1730r396b1793],
146	risk	NN	O	risk	dep	191	SENT_348	[p20l415t1730r542b1793],
147	trial	NN	O	trial	dep	191	SENT_348	[p20l557t1730r696b1793],
148	to	TO	O	to	dep	191	SENT_348	[p20l714t1742r779b1793],
149	address	VB	O	address	dep	191	SENT_348	[p20l801t1730r1051b1793],
150	long-term	JJ	O	long-term	dep	191	SENT_348	[p20l1071t1730r1411b1814],
151	adverse	JJ	O	adverse	dep	191	SENT_348	[p20l1432t1730r1683b1793],
152	effects	NNS	O	effect	dep	191	SENT_348	[p20l1703t1730r1912b1793],
153	before	IN	O	before	dep	191	SENT_348	[p20l1930t1730r2142b1793],
154	it	PRP	O	it	dep	191	SENT_348	[p20l9t1838r55b1895],
155	could	MD	O	could	dep	191	SENT_348	[p20l77t1832r270b1895],
156	approve	VB	O	approve	dep	191	SENT_348	[p20l293t1854r567b1915],
157	the	DT	O	the	dep	191	SENT_348	[p20l589t1832r697b1895],
158	drug	NN	O	drug	dep	191	SENT_348	[p20l721t1825r935b1916],
159	.5	CD	NUMBER	.5	dep	191	SENT_348	[p20l721t1825r935b1916],
160	Orexigen	NNP	O	Orexigen	dep	191	SENT_348	[p20l961t1836r1279b1916],
161	has	VBZ	O	have	dep	191	SENT_348	[p20l1302t1832r1415b1895],
162	begun	VBN	O	begin	dep	191	SENT_348	[p20l1437t1832r1653b1916],
163	the	DT	O	the	dep	191	SENT_348	[p20l1675t1832r1783b1895],
164	requested	VBN	O	request	dep	191	SENT_348	[p20l1807t1832r2142b1915],
165	long-term	JJ	O	long-term	dep	191	SENT_348	[p20l7t1935r351b2019],
166	clinical	JJ	O	clinical	dep	191	SENT_348	[p20l373t1935r616b1998],
167	trial	NN	O	trial	dep	191	SENT_348	[p20l635t1935r792b2007],
168	,	,	O	,	_	0	SENT_348	[p20l635t1935r792b2007],
169	and	CC	O	and	dep	191	SENT_348	[p20l814t1935r940b1998],
170	its	PRP$	O	its	dep	191	SENT_348	[p20l960t1941r1035b1998],
171	New	NNP	MISC	New	dep	191	SENT_348	[p20l1055t1940r1213b1998],
172	Drug	NNP	MISC	Drug	dep	191	SENT_348	[p20l1230t1940r1410b2019],
173	Application	NN	MISC	application	dep	191	SENT_348	[p20l1428t1935r1826b2018],
174	has	VBZ	O	have	dep	191	SENT_348	[p20l1846t1935r1957b1998],
175	been	VBN	O	be	dep	191	SENT_348	[p20l1976t1935r2140b1998],
176	submitted	VBN	O	submit	dep	191	SENT_348	[p20l9t2038r350b2101],
177	and	CC	O	and	dep	191	SENT_348	[p20l371t2038r496b2101],
178	reviewed	VBN	O	review	dep	191	SENT_348	[p20l516t2038r822b2101],
179	by	IN	O	by	dep	191	SENT_348	[p20l839t2038r923b2122],
180	the	DT	O	the	dep	191	SENT_348	[p20l939t2038r1045b2101],
181	FDA	NNP	ORGANIZATION	FDA	dep	191	SENT_348	[p20l1066t2042r1244b2110],
182	,	,	O	,	_	0	SENT_348	[p20l1066t2042r1244b2110],
183	with	IN	O	with	dep	191	SENT_348	[p20l1264t2038r1416b2101],
184	potential	JJ	O	potential	dep	191	SENT_348	[p20l1435t2038r1740b2121],
185	approval	NN	O	approval	dep	191	SENT_348	[p20l1760t2038r2054b2121],
186	in	IN	O	in	dep	191	SENT_348	[p20l2073t2044r2140b2100],
187	late	JJ	DATE	late	dep	191	SENT_348	[p20l7t2141r125b2204],
188	2013	CD	DATE	2013	dep	191	SENT_348	[p20l147t2148r306b2204],
189	or	CC	O	or	dep	191	SENT_348	[p20l331t2164r403b2204],
190	early	JJ	DATE	early	dep	191	SENT_348	[p20l424t2141r590b2225],
191	2014	CD	DATE	2014	_	0	SENT_348	[p20l608t2148r787b2204],
192	.	.	O	.	_	0	SENT_348	[p20l608t2148r787b2204],

1	Amylin	NNP	O	Amylin	nsubjpass	18	SENT_349	[p20l81t2244r358b2328],
2	,	,	O	,	_	0	SENT_349	[p20l81t2244r358b2328],
3	also	RB	O	also	advmod	4	SENT_349	[p20l383t2244r515b2307],
4	called	VBN	O	call	partmod	1	SENT_349	[p20l539t2244r739b2307],
5	islet	NN	O	islet	nn	7	SENT_349	[p20l761t2244r898b2307],
6	amyloid	NN	O	amyloid	nn	7	SENT_349	[p20l920t2244r1198b2328],
7	polypeptide	NN	O	polypeptide	dobj	4	SENT_349	[p20l1219t2244r1645b2328],
8	,	,	O	,	_	0	SENT_349	[p20l1219t2244r1645b2328],
9	is	VBZ	O	be	auxpass	10	SENT_349	[p20l1670t2250r1720b2307],
10	synthesized	VBN	O	synthesize	_	0	SENT_349	[p20l1745t2244r2144b2328],
11	by	IN	O	by	_	0	SENT_349	[p20l7t2347r93b2431],
12	pancreatic	JJ	O	pancreatic	amod	15	SENT_349	[p20l116t2353r487b2430],
13	B	NN	O	b	nn	15	SENT_349	[p20l517t2345r748b2428],
14	—	NN	O	—	nn	15	SENT_349	[p20l517t2345r748b2428],
15	cells	NNS	O	cell	agent	10	SENT_349	[p20l517t2345r748b2428],
16	and	CC	O	and	_	0	SENT_349	[p20l777t2347r908b2410],
17	is	VBZ	O	be	auxpass	18	SENT_349	[p20l934t2353r986b2410],
18	secreted	VBN	O	secrete	conj_and	10	SENT_349	[p20l1015t2347r1307b2410],
19	with	IN	O	with	_	0	SENT_349	[p20l1331t2347r1490b2410],
20	insulin	NN	O	insulin	prep_with	18	SENT_349	[p20l1517t2347r1764b2410],
21	postprandially	RB	O	postprandially	amod	20	SENT_349	[p20l1790t2359r2139b2430, p20l9t2442r285b2533],
22	.57	CD	NUMBER	.57	tmod	21	SENT_349	[p20l1790t2359r2139b2430, p20l9t2442r285b2533],
23	Amylin	NNP	O	Amylin	nsubj	24	SENT_349	[p20l310t2449r578b2533],
24	acts	VBZ	O	act	rcmod	20	SENT_349	[p20l606t2461r739b2512],
25	synergistically	RB	O	synergistically	advmod	24	SENT_349	[p20l768t2449r1281b2533],
26	with	IN	O	with	_	0	SENT_349	[p20l1302t2449r1461b2512],
27	insulin	NN	O	insulin	prep_with	24	SENT_349	[p20l1488t2449r1734b2512],
28	to	TO	O	to	aux	29	SENT_349	[p20l1760t2461r1829b2512],
29	regulate	VB	O	regulate	xcomp	24	SENT_349	[p20l1857t2449r2141b2533],
30	plasma	NN	O	plasma	nn	32	SENT_349	[p20l7t2552r250b2635],
31	glucose	NN	O	glucose	nn	32	SENT_349	[p20l270t2552r523b2636],
32	levels	NNS	O	level	dobj	29	SENT_349	[p20l543t2552r745b2615],
33	.	.	O	.	_	0	SENT_349	[p20l543t2552r745b2615],

1	Amylin	NNP	O	Amylin	poss	5	SENT_350	[p20l769t2552r1062b2636],
2	’s	POS	O	’s	_	0	SENT_350	[p20l769t2552r1062b2636],
3	fasting	NN	O	fasting	nn	5	SENT_350	[p20l1083t2552r1312b2636],
4	plasma	NN	O	plasma	nn	5	SENT_350	[p20l1331t2552r1574b2635],
5	concentration	NN	O	concentration	_	0	SENT_350	[p20l1594t2558r2070b2615],
6	is	VBZ	O	be	cop	7	SENT_350	[p20l2092t2558r2141b2615],
7	low	JJ	O	low	dep	5	SENT_350	[p20l7t2654r131b2717],
8	and	CC	O	and	_	0	SENT_350	[p20l150t2654r276b2717],
9	rises	VBZ	O	rise	conj_and	7	SENT_350	[p20l296t2660r448b2717],
10	following	VBG	O	follow	amod	12	SENT_350	[p20l470t2654r792b2738],
11	food	NN	O	food	nn	12	SENT_350	[p20l811t2654r969b2717],
12	intake	NN	O	intake	dobj	9	SENT_350	[p20l989t2646r1278b2717],
13	.58	CD	NUMBER	.58	dobj	7	SENT_350	[p20l989t2646r1278b2717],
14	Amylin	NNP	O	Amylin	nsubj	16	SENT_350	[p20l1300t2654r1557b2738],
15	also	RB	O	also	advmod	16	SENT_350	[p20l1579t2654r1710b2717],
16	functions	VBZ	O	function	rcmod	13	SENT_350	[p20l1732t2654r2055b2717],
17	as	IN	O	as	_	0	SENT_350	[p20l2077t2677r2141b2717],
18	an	DT	O	a	det	19	SENT_350	[p20l9t2781r90b2821],
19	anorectic	NN	O	anorectic	prep_as	16	SENT_350	[p20l115t2764r453b2830],
20	,	,	O	,	_	0	SENT_350	[p20l115t2764r453b2830],
21	mediating	VBG	O	mediate	amod	23	SENT_350	[p20l477t2758r832b2842],
22	appetite	NN	O	appetite	nn	23	SENT_350	[p20l854t2764r1129b2841],
23	suppression	NN	O	suppression	appos	19	SENT_350	[p20l1153t2764r1565b2841],
24	via	IN	O	via	_	0	SENT_350	[p20l1585t2764r1689b2821],
25	activation	NN	O	activation	prep_via	23	SENT_350	[p20l1711t2764r2054b2821],
26	of	IN	O	of	_	0	SENT_350	[p20l2078t2758r2153b2821],
27	amylin	NN	O	amylin	nn	28	SENT_350	[p20l9t2861r243b2945],
28	receptors	NNS	O	receptor	prep_of	23	SENT_350	[p20l266t2873r578b2944],
29	in	IN	O	in	_	0	SENT_350	[p20l602t2867r668b2923],
30	the	DT	O	the	det	32	SENT_350	[p20l689t2861r795b2924],
31	area	NN	O	area	nn	32	SENT_350	[p20l819t2884r959b2924],
32	postrema	NN	O	postrema	prep_in	23	SENT_350	[p20l978t2873r1301b2944],
33	of	IN	O	of	_	0	SENT_350	[p20l1323t2861r1396b2924],
34	the	DT	O	the	det	37	SENT_350	[p20l1408t2861r1515b2924],
35	dorsal	NN	O	dorsal	nn	37	SENT_350	[p20l1538t2861r1747b2924],
36	vagal	NN	O	vagal	nn	37	SENT_350	[p20l1765t2861r1943b2945],
37	compleX57	NN	O	complex57	prep_of	32	SENT_350	[p20l1965t2884r2139b2924, p20l7t2956r212b3046],
38	and	CC	O	and	_	0	SENT_350	[p20l236t2963r363b3026],
39	vagal	NN	O	vagal	nn	40	SENT_350	[p20l382t2963r561b3047],
40	signaling	NN	O	signaling	conj_and	37	SENT_350	[p20l584t2955r1054b3047],
41	.59	CD	NUMBER	.59	number	42	SENT_350	[p20l584t2955r1054b3047],
42	’60	CD	NUMBER	’60	dep	5	SENT_350	[p20l584t2955r1054b3047],
43	The	DT	O	the	det	49	SENT_350	[p20l1078t2963r1203b3026],
44	amylin	NN	O	amylin	nn	49	SENT_350	[p20l1227t2963r1463b3047],
45	analog	NN	O	analog	nn	49	SENT_350	[p20l1486t2963r1714b3047],
46	pramlintide	NN	O	pramlintide	nn	49	SENT_350	[p20l1734t2963r2141b3046],
47	(	CD	NUMBER	(	num	49	SENT_350	[p20l12t3066r321b3150],
48	Symlin	NNP	LOCATION	Symlin	nn	49	SENT_350	[p20l12t3066r321b3150],
49	)	NN	O	)	dep	42	SENT_350	[p20l12t3066r321b3150],
50	,	,	O	,	_	0	SENT_350	[p20l12t3066r321b3150],
51	from	IN	O	from	_	0	SENT_350	[p20l343t3066r509b3129],
52	Amylin	NNP	O	Amylin	nn	53	SENT_350	[p20l528t3066r784b3150],
53	Pharmaceuticals/Bristol	NNP	O	Pharmaceuticals/Bristol	prep_from	5	SENT_350	[p20l804t3066r1856b3150],
54	.	.	O	.	_	0	SENT_350	[p20l804t3066r1856b3150],

1	—	NN	O	—	_	0	SENT_351	[p20l804t3066r1856b3150],
2	.	.	O	.	_	0	SENT_351	[p20l804t3066r1856b3150],

1	Myers	NNP	ORGANIZATION	Myers	nn	2	SENT_352	[p20l804t3066r1856b3150],
2	Squibb	NNP	ORGANIZATION	Squibb	nsubj	25	SENT_352	[p20l1878t3066r2139b3149],
3	/	:	ORGANIZATION	/	punct	8	SENT_352	[p20l1878t3066r2139b3149],
4	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	nsubjpass	8	SENT_352	[p20l8t3172r458b3241],
5	,	,	O	,	_	0	SENT_352	[p20l8t3172r458b3241],
6	is	VBZ	O	be	auxpass	8	SENT_352	[p20l483t3175r533b3232],
7	already	RB	O	already	advmod	8	SENT_352	[p20l557t3169r807b3253],
8	approved	VBN	O	approve	dep	2	SENT_352	[p20l827t3169r1144b3252],
9	for	IN	O	for	_	0	SENT_352	[p20l1166t3169r1263b3232],
10	diabetic	JJ	O	diabetic	amod	12	SENT_352	[p20l1285t3169r1555b3232],
11	adjunctive	JJ	O	adjunctive	amod	12	SENT_352	[p20l1578t3169r1933b3253],
12	treatment	NN	O	treatment	prep_for	8	SENT_352	[p20l1955t3181r2137b3232, p20l8t3264r242b3334],
13	.5	CD	NUMBER	.5	tmod	8	SENT_352	[p20l1955t3181r2137b3232, p20l8t3264r242b3334],
14	Notably	RB	O	notably	advmod	13	SENT_352	[p20l268t3271r561b3355],
15	,	,	O	,	_	0	SENT_352	[p20l268t3271r561b3355],
16	120	CD	NUMBER	120	num	18	SENT_352	[p20l596t3278r712b3334],
17	pg	NN	O	pg	nn	18	SENT_352	[p20l742t3294r824b3355],
18	b.i.d.	NN	O	b.i.d.	dep	8	SENT_352	[p20l845t3271r1016b3334],
19	or	CC	O	or	_	0	SENT_352	[p20l1045t3294r1119b3334],
20	150	CD	NUMBER	150	num	23	SENT_352	[p20l1150t3278r1267b3334],
21	pg	NN	O	pg	nn	23	SENT_352	[p20l1297t3294r1379b3355],
22	q.d.	NN	O	q.d.	nn	23	SENT_352	[p20l1403t3271r1528b3354],
23	pramlintide	NN	O	pramlintide	dep	8	SENT_352	[p20l1556t3271r1977b3354],
24	also	RB	O	also	advmod	25	SENT_352	[p20l2003t3271r2139b3334],
25	induced	VBD	O	induce	_	0	SENT_352	[p20l9t3374r279b3437],
26	an	DT	O	a	det	29	SENT_352	[p20l298t3397r376b3437],
27	average	JJ	O	average	amod	29	SENT_352	[p20l396t3397r643b3458],
28	weight	NN	O	weight	nn	29	SENT_352	[p20l661t3374r884b3458],
29	loss	NN	O	loss	dobj	25	SENT_352	[p20l901t3374r1024b3437],
30	of	IN	O	of	_	0	SENT_352	[p20l1045t3374r1117b3437],
31	2.6	CD	NUMBER	2.6	num	32	SENT_352	[p20l1127t3380r1222b3437],
32	kg	NN	O	kg	prep_of	29	SENT_352	[p20l1235t3374r1316b3458],
33	over	IN	O	over	_	0	SENT_352	[p20l1334t3397r1478b3437],
34	1	CD	DURATION	1	num	35	SENT_352	[p20l1503t3381r1527b3436],
35	year	NN	NUMBER	year	prep_over	25	SENT_352	[p20l1550t3397r1692b3458],
36	in	IN	O	in	_	0	SENT_352	[p20l1710t3380r1775b3436],
37	type	NN	O	type	amod	39	SENT_352	[p20l1793t3386r1936b3458],
38	2	CD	NUMBER	2	number	37	SENT_352	[p20l1956t3381r1991b3436],
39	diabetics	NNS	O	diabetic	prep_in	35	SENT_352	[p20l2013t3374r2139b3437, p20l7t3476r219b3548],
40	,	,	O	,	_	0	SENT_352	[p20l2013t3374r2139b3437, p20l7t3476r219b3548],
41	with	IN	O	with	_	0	SENT_352	[p20l239t3476r389b3539],
42	minimal	JJ	O	minimal	amod	44	SENT_352	[p20l409t3476r697b3539],
43	adverse	JJ	O	adverse	amod	44	SENT_352	[p20l717t3476r968b3539],
44	effects	NNS	O	effect	prep_with	25	SENT_352	[p20l989t3468r1273b3539],
45	.	.	O	.	_	0	SENT_352	[p20l989t3468r1273b3539],

1	“	NN	O	“	nn	3	SENT_353	[p20l989t3468r1273b3539],
2	Amylin	NNP	ORGANIZATION	Amylin	nn	3	SENT_353	[p20l1296t3476r1551b3560],
3	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nsubj	18	SENT_353	[p20l1571t3476r2141b3539],
4	’	CD	NUMBER	’	num	7	SENT_353	[p20l1571t3476r2141b3539],
5	second-generation	JJ	O	second-generation	amod	7	SENT_353	[p20l9t3579r654b3663],
6	amylin	NN	O	amylin	nn	7	SENT_353	[p20l678t3579r914b3663],
7	analog	NN	O	analog	dep	3	SENT_353	[p20l938t3579r1184b3663],
8	,	,	O	,	_	0	SENT_353	[p20l938t3579r1184b3663],
9	davalintide	NN	O	davalintide	nn	12	SENT_353	[p20l1209t3579r1593b3642],
10	(	CD	NUMBER	(	num	12	SENT_353	[p20l1620t3580r1976b3655],
11	AC2307	NN	O	ac2307	nn	12	SENT_353	[p20l1620t3580r1976b3655],
12	)	NN	O	)	appos	3	SENT_353	[p20l1620t3580r1976b3655],
13	,	,	O	,	_	0	SENT_353	[p20l1620t3580r1976b3655],
14	is	VBZ	O	be	cop	18	SENT_353	[p20l2000t3585r2051b3642],
15	in	IN	O	in	_	0	SENT_353	[p20l2075t3585r2142b3641],
16	phase	NN	O	phase	prep_in	18	SENT_353	[p20l7t3682r202b3765],
17	II	CD	NUMBER	ii	num	18	SENT_353	[p20l224t3687r277b3744],
18	trials	NNS	O	trial	_	0	SENT_353	[p20l299t3682r470b3745],
19	for	IN	O	for	_	0	SENT_353	[p20l492t3682r589b3745],
20	an	DT	O	a	det	22	SENT_353	[p20l610t3705r690b3745],
21	obesity	NN	O	obesity	nn	22	SENT_353	[p20l712t3682r957b3766],
22	indication	NN	O	indication	prep_for	18	SENT_353	[p20l974t3682r1339b3745],
23	.	.	O	.	_	0	SENT_353	[p20l974t3682r1339b3745],

1	Leptin	NNP	O	Leptin	nsubj	4	SENT_354	[p21l82t21r315b99],
2	is	VBZ	O	be	cop	4	SENT_354	[p21l341t22r393b79],
3	a	DT	O	a	det	4	SENT_354	[p21l421t39r456b79],
4	hormone	NN	O	hormone	_	0	SENT_354	[p21l479t16r809b79],
5	made	VBN	O	make	dep	4	SENT_354	[p21l835t16r1029b79],
6	by	IN	O	by	_	0	SENT_354	[p21l1054t16r1140b100],
7	adipose	NN	O	adipose	nn	8	SENT_354	[p21l1163t16r1437b99],
8	tissue	NN	O	tissue	prep_by	5	SENT_354	[p21l1462t22r1664b79],
9	and	CC	O	and	_	0	SENT_354	[p21l1691t16r1822b79],
10	secreted	VBN	O	secrete	conj_and	5	SENT_354	[p21l1848t16r2142b79],
11	into	IN	O	into	_	0	SENT_354	[p21l9t125r144b182],
12	the	DT	O	the	det	13	SENT_354	[p21l167t119r275b182],
13	circulation	NN	O	circulation	prep_into	10	SENT_354	[p21l298t119r675b182],
14	in	IN	O	in	_	0	SENT_354	[p21l697t125r764b181],
15	proportion	NN	O	proportion	prep_in	13	SENT_354	[p21l786t125r1170b202],
16	to	TO	O	to	_	0	SENT_354	[p21l1192t131r1258b182],
17	its	PRP$	O	its	poss	18	SENT_354	[p21l1282t125r1360b182],
18	mass	NN	O	mass	prep_to	10	SENT_354	[p21l1383t142r1570b182],
19	.	.	O	.	_	0	SENT_354	[p21l1383t142r1570b182],

1	Leptin	NN	O	leptin	nsubj	2	SENT_355	[p21l1596t124r1821b202],
2	activates	VBZ	O	activate	_	0	SENT_355	[p21l1844t125r2141b182],
3	leptin	NN	O	leptin	nn	4	SENT_355	[p21l7t222r216b305],
4	receptors	NNS	O	receptor	dobj	2	SENT_355	[p21l243t234r595b305],
5	,	,	O	,	_	0	SENT_355	[p21l243t234r595b305],
6	which	WDT	O	which	nsubjpass	8	SENT_355	[p21l621t222r840b285],
7	are	VBP	O	be	auxpass	8	SENT_355	[p21l867t245r972b285],
8	expressed	VBN	O	express	rcmod	4	SENT_355	[p21l999t222r1350b305],
9	throughout	IN	O	throughout	_	0	SENT_355	[p21l1374t222r1788b306],
10	the	DT	O	the	det	11	SENT_355	[p21l1812t222r1923b285],
11	body	NN	O	body	prep_throughout	8	SENT_355	[p21l1948t222r2142b306],
12	,	,	O	,	_	0	SENT_355	[p21l1948t222r2142b306],
13	with	IN	O	with	_	0	SENT_355	[p21l7t325r159b388],
14	high	JJ	O	high	amod	15	SENT_355	[p21l180t325r333b409],
15	expression	NN	O	expression	prep_with	8	SENT_355	[p21l355t331r716b408],
16	in	IN	O	in	_	0	SENT_355	[p21l739t331r804b387],
17	the	DT	O	the	det	19	SENT_355	[p21l826t325r931b388],
18	hypothalamic	JJ	O	hypothalamic	amod	19	SENT_355	[p21l952t325r1423b409],
19	ARC	NN	O	arc	prep_in	15	SENT_355	[p21l1444t329r1627b388],
20	.	.	O	.	_	0	SENT_355	[p21l1444t329r1627b388],

1	Hypothalamic	JJ	O	hypothalamic	amod	5	SENT_356	[p21l1652t325r2141b409],
2	leptin	NN	O	leptin	nn	5	SENT_356	[p21l7t428r210b511],
3	receptor	NN	O	receptor	nn	5	SENT_356	[p21l233t440r524b511],
4	activation	NN	O	activation	nn	5	SENT_356	[p21l546t434r892b491],
5	drives	NNS	O	drive	nsubj	12	SENT_356	[p21l916t428r1124b491],
6	increased	VBD	O	increase	ccomp	28	SENT_356	[p21l1148t428r1481b491],
7	POMC	JJ	O	pomc	amod	8	SENT_356	[p21l1504t432r1747b491],
8	expression	NN	O	expression	dobj	6	SENT_356	[p21l1771t434r2142b511],
9	and	CC	O	and	_	0	SENT_356	[p21l9t531r137b594],
10	signaling	NN	O	signaling	dobj	6	SENT_356	[p21l160t531r478b615],
11	and	CC	O	and	_	0	SENT_356	[p21l500t531r628b594],
12	inhibits	VBZ	O	inhibit	conj_and	6	SENT_356	[p21l650t531r915b594],
13	NPY/AgRP	NN	O	npy/agrp	nn	14	SENT_356	[p21l938t535r1337b615],
14	expression	NN	O	expression	dobj	12	SENT_356	[p21l1362t537r1733b614],
15	and	CC	O	and	_	0	SENT_356	[p21l1757t531r1885b594],
16	signaling	NN	O	signaling	dobj	12	SENT_356	[p21l1907t531r2139b615, p21l9t639r140b717],
17	,	,	O	,	_	0	SENT_356	[p21l1907t531r2139b615, p21l9t639r140b717],
18	thereby	RB	O	thereby	advmod	19	SENT_356	[p21l167t633r441b717],
19	suppressing	VBG	O	suppress	partmod	14	SENT_356	[p21l465t639r891b717],
20	appetite	NN	O	appetite	dobj	19	SENT_356	[p21l916t626r1255b716],
21	.5	CD	NUMBER	.5	num	20	SENT_356	[p21l916t626r1255b716],
22	Conversely	RB	O	conversely	advmod	19	SENT_356	[p21l1283t633r1698b717],
23	,	,	O	,	_	0	SENT_356	[p21l1283t633r1698b717],
24	a	DT	O	a	det	27	SENT_356	[p21l1727t656r1761b696],
25	decreased	VBN	O	decrease	amod	27	SENT_356	[p21l1787t633r2143b696],
26	fat	NN	O	fat	nn	27	SENT_356	[p21l8t736r97b799],
27	mass	NN	O	mass	nsubj	28	SENT_356	[p21l121t759r293b799],
28	results	VBZ	O	result	_	0	SENT_356	[p21l319t736r548b799],
29	in	IN	O	in	_	0	SENT_356	[p21l574t742r642b798],
30	lower	JJR	O	lower	amod	33	SENT_356	[p21l666t736r863b799],
31	plasma	NN	O	plasma	nn	33	SENT_356	[p21l886t736r1137b819],
32	leptin	NN	O	leptin	nn	33	SENT_356	[p21l1161t736r1366b819],
33	concentrations	NNS	O	concentration	prep_in	28	SENT_356	[p21l1392t742r1939b808],
34	,	,	O	,	_	0	SENT_356	[p21l1392t742r1939b808],
35	leading	VBG	O	lead	xcomp	28	SENT_356	[p21l1965t736r2139b799, p21l9t845r123b923],
36	to	TO	O	to	_	0	SENT_356	[p21l148t851r217b902],
37	increased	VBN	O	increase	amod	38	SENT_356	[p21l246t839r593b902],
38	appetite	NN	O	appetite	prep_to	35	SENT_356	[p21l621t845r929b922],
39	.	.	O	.	_	0	SENT_356	[p21l621t845r929b922],

1	Thus	RB	O	thus	advmod	7	SENT_357	[p21l960t839r1152b911],
2	,	,	O	,	_	0	SENT_357	[p21l960t839r1152b911],
3	leptin	NN	O	leptin	nsubj	7	SENT_357	[p21l1180t839r1391b922],
4	is	VBZ	O	be	cop	7	SENT_357	[p21l1419t845r1472b902],
5	a	DT	O	a	det	7	SENT_357	[p21l1501t862r1536b902],
6	key	JJ	O	key	amod	7	SENT_357	[p21l1561t839r1688b923],
7	hormone	NN	O	hormone	_	0	SENT_357	[p21l1711t839r2044b902],
8	in	IN	O	in	_	0	SENT_357	[p21l2073t845r2143b901],
9	the	DT	O	the	det	10	SENT_357	[p21l8t942r121b1005],
10	regulation	NN	O	regulation	prep_in	7	SENT_357	[p21l153t942r535b1026],
11	of	IN	O	of	_	0	SENT_357	[p21l567t942r645b1005],
12	energy	NN	O	energy	nn	13	SENT_357	[p21l667t965r919b1026],
13	homeostasis	NN	O	homeostasis	prep_of	10	SENT_357	[p21l945t942r1421b1005],
14	.	.	O	.	_	0	SENT_357	[p21l945t942r1421b1005],

1	Patients	NNS	O	patient	nsubj	13	SENT_358	[p21l1457t947r1750b1005],
2	with	IN	O	with	_	0	SENT_358	[p21l1781t942r1945b1005],
3	congenital	JJ	O	congenital	amod	5	SENT_358	[p21l1977t965r2138b1005, p21l8t1045r248b1129],
4	leptin	NN	O	leptin	nn	5	SENT_358	[p21l271t1045r477b1128],
5	deﬁciency	NN	O	deﬁciency	prep_with	1	SENT_358	[p21l503t1045r864b1129],
6	develop	VBP	O	develop	ccomp	27	SENT_358	[p21l887t1045r1159b1128],
7	early	JJ	O	early	amod	10	SENT_358	[p21l1187t1045r1582b1129],
8	—	NN	O	—	nn	10	SENT_358	[p21l1187t1045r1582b1129],
9	onset	NN	O	onset	nn	10	SENT_358	[p21l1187t1045r1582b1129],
10	obesity	NN	O	obesity	dobj	6	SENT_358	[p21l1607t1045r1861b1129],
11	and	CC	O	and	_	0	SENT_358	[p21l1883t1045r2013b1108],
12	are	VBP	O	be	cop	13	SENT_358	[p21l2038t1068r2141b1108],
13	responsive	JJ	O	responsive	ccomp	27	SENT_358	[p21l9t1153r381b1230],
14	to	TO	O	to	_	0	SENT_358	[p21l404t1159r471b1210],
15	leptin	NN	O	leptin	nn	17	SENT_358	[p21l496t1147r700b1230],
16	replacement	NN	O	replacement	nn	17	SENT_358	[p21l724t1147r1159b1230],
17	therapy	NN	O	therapy	prep_to	13	SENT_358	[p21l1181t1139r1604b1231],
18	.62	CD	NUMBER	.62	num	19	SENT_358	[p21l1181t1139r1604b1231],
19	*	CD	NUMBER	*	dobj	6	SENT_358	[p21l1181t1139r1604b1231],
20	63	CD	NUMBER	63	npadvmod	21	SENT_358	[p21l1181t1139r1604b1231],
21	Unfortunately	RB	O	unfortunately	advmod	6	SENT_358	[p21l1630t1147r2140b1231],
22	,	,	O	,	_	0	SENT_358	[p21l1630t1147r2140b1231],
23	patients	NNS	O	patient	nsubj	27	SENT_358	[p21l7t1256r295b1333],
24	with	IN	O	with	_	0	SENT_358	[p21l322t1250r483b1313],
25	diet-induced	JJ	O	diet-induced	amod	26	SENT_358	[p21l511t1250r980b1313],
26	obesity	NN	O	obesity	prep_with	23	SENT_358	[p21l1007t1250r1268b1334],
27	develop	VB	O	develop	_	0	SENT_358	[p21l1292t1250r1572b1333],
28	leptin	NN	O	leptin	nn	30	SENT_358	[p21l1600t1250r1811b1333],
29	receptor	NN	O	receptor	nn	30	SENT_358	[p21l1839t1262r2142b1333],
30	resistance	NN	O	resistance	dobj	27	SENT_358	[p21l9t1344r441b1415],
31	.	.	O	.	_	0	SENT_358	[p21l9t1344r441b1415],

1	“	NN	O	“	nsubj	4	SENT_359	[p21l9t1344r441b1415],
2	These	DT	O	these	det	3	SENT_359	[p21l465t1352r663b1415],
3	patients	NNS	O	patient	dep	1	SENT_359	[p21l687t1358r966b1435],
4	have	VBP	O	have	_	0	SENT_359	[p21l991t1352r1150b1415],
5	high	JJ	O	high	amod	8	SENT_359	[p21l1174t1352r1332b1436],
6	plasma	NN	O	plasma	nn	8	SENT_359	[p21l1356t1352r1606b1435],
7	leptin	NN	O	leptin	nn	8	SENT_359	[p21l1629t1352r1833b1435],
8	concentrations	NNS	O	concentration	dobj	4	SENT_359	[p21l1859t1375r2137b1415, p21l8t1461r306b1527],
9	,	,	O	,	_	0	SENT_359	[p21l1859t1375r2137b1415, p21l8t1461r306b1527],
10	reﬂecting	VBG	O	reﬂecting	partmod	4	SENT_359	[p21l334t1455r674b1539],
11	their	PRP$	O	they	poss	13	SENT_359	[p21l697t1455r869b1518],
12	high	JJ	O	high	amod	13	SENT_359	[p21l892t1455r1053b1539],
13	adiposity	NN	O	adiposity	dobj	10	SENT_359	[p21l1080t1455r1422b1539],
14	,	,	O	,	_	0	SENT_359	[p21l1080t1455r1422b1539],
15	but	CC	O	but	_	0	SENT_359	[p21l1448t1455r1566b1518],
16	this	DT	O	this	det	19	SENT_359	[p21l1590t1455r1721b1518],
17	high	JJ	O	high	amod	19	SENT_359	[p21l1746t1455r1907b1539],
18	leptin	NN	O	leptin	nn	19	SENT_359	[p21l1932t1455r2140b1538],
19	level	NN	O	level	nsubj	21	SENT_359	[p21l7t1558r163b1621],
20	is	VBZ	O	be	cop	21	SENT_359	[p21l185t1564r234b1621],
21	ineffective	JJ	O	ineffective	conj_but	4	SENT_359	[p21l258t1558r610b1621],
22	in	IN	O	in	_	0	SENT_359	[p21l632t1564r698b1620],
23	driving	VBG	O	drive	prepc_in	21	SENT_359	[p21l721t1558r971b1642],
24	appetite	NN	O	appetite	nn	25	SENT_359	[p21l992t1564r1264b1641],
25	reduction	NN	O	reduction	dobj	23	SENT_359	[p21l1286t1558r1637b1621],
26	.	.	O	.	_	0	SENT_359	[p21l1286t1558r1637b1621],

1	Although	IN	O	although	mark	5	SENT_360	[p21l1661t1558r1989b1642],
2	leptin	NN	O	leptin	nn	3	SENT_360	[p21l2010t1558r2139b1641, p21l8t1667r104b1724],
3	monotherapy	NN	O	monotherapy	nsubj	5	SENT_360	[p21l128t1661r605b1745],
4	appears	VBZ	O	appear	cop	5	SENT_360	[p21l626t1683r893b1744],
5	intractable	JJ	O	intractable	advcl	24	SENT_360	[p21l917t1661r1295b1724],
6	as	IN	O	as	_	0	SENT_360	[p21l1319t1684r1385b1724],
7	a	DT	O	a	det	9	SENT_360	[p21l1409t1684r1444b1724],
8	therapeutic	JJ	O	therapeutic	amod	9	SENT_360	[p21l1465t1661r1867b1744],
9	option	NN	O	option	prep_as	5	SENT_360	[p21l1891t1667r2140b1744],
10	,	,	O	,	_	0	SENT_360	[p21l1891t1667r2140b1744],
11	the	DT	O	the	det	12	SENT_360	[p21l8t1764r118b1827],
12	resensitization	NN	O	resensitization	nsubj	24	SENT_360	[p21l145t1770r670b1827],
13	of	IN	O	of	_	0	SENT_360	[p21l697t1764r773b1827],
14	the	DT	O	the	det	16	SENT_360	[p21l789t1764r900b1827],
15	leptin	NN	O	leptin	nn	16	SENT_360	[p21l925t1764r1133b1847],
16	receptor	NN	O	receptor	prep_of	12	SENT_360	[p21l1160t1776r1459b1847],
17	to	TO	O	to	_	0	SENT_360	[p21l1482t1776r1551b1827],
18	its	PRP$	O	its	poss	20	SENT_360	[p21l1578t1770r1658b1827],
19	cognate	JJ	O	cognate	amod	20	SENT_360	[p21l1685t1776r1961b1848],
20	hormone	NN	O	hormone	prep_to	16	SENT_360	[p21l1987t1764r2139b1827, p21l8t1890r207b1930],
21	is	VBZ	O	be	cop	24	SENT_360	[p21l233t1873r285b1930],
22	an	DT	O	a	det	24	SENT_360	[p21l312t1890r394b1930],
23	active	JJ	O	active	amod	24	SENT_360	[p21l420t1873r625b1930],
24	strategy	NN	O	strategy	_	0	SENT_360	[p21l652t1879r934b1951],
25	in	IN	O	in	_	0	SENT_360	[p21l956t1873r1024b1929],
26	antiobesity	JJ	O	antiobesity	amod	28	SENT_360	[p21l1051t1867r1446b1951],
27	drug	NN	O	drug	nn	28	SENT_360	[p21l1468t1867r1636b1951],
28	development	NN	O	development	prep_in	24	SENT_360	[p21l1660t1867r2140b1950],
29	.	.	O	.	_	0	SENT_360	[p21l1660t1867r2140b1950],

1	Intriguingly	RB	O	intriguingly	advmod	7	SENT_361	[p21l9t1970r453b2054],
2	,	,	O	,	_	0	SENT_361	[p21l9t1970r453b2054],
3	the	DT	O	the	det	6	SENT_361	[p21l479t1970r589b2033],
4	pancreatic	JJ	O	pancreatic	amod	6	SENT_361	[p21l614t1976r986b2053],
5	hormone	NN	O	hormone	nn	6	SENT_361	[p21l1010t1970r1337b2033],
6	amylin	NN	O	amylin	nsubj	7	SENT_361	[p21l1364t1970r1608b2054],
7	restores	VBZ	O	restore	ccomp	39	SENT_361	[p21l1634t1982r1909b2033],
8	leptin	NN	O	leptin	nn	10	SENT_361	[p21l1934t1970r2141b2053],
9	receptor	NN	O	receptor	nn	10	SENT_361	[p21l10t2113r308b2184],
10	responsiveness	NN	O	responsiveness	dobj	7	SENT_361	[p21l332t2107r866b2184],
11	to	TO	O	to	_	0	SENT_361	[p21l892t2113r960b2164],
12	leptin	NN	O	leptin	prep_to	10	SENT_361	[p21l986t2101r1193b2184],
13	in	IN	O	in	_	0	SENT_361	[p21l1220t2107r1288b2163],
14	the	DT	O	the	det	15	SENT_361	[p21l1313t2101r1424b2164],
15	setting	NN	O	setting	nsubj	21	SENT_361	[p21l1451t2107r1692b2185],
16	of	IN	O	of	_	0	SENT_361	[p21l1716t2101r1792b2164],
17	obesity	NN	O	obesity	nn	20	SENT_361	[p21l1810t2093r2141b2185],
18	.65	CD	NUMBER	.65	num	20	SENT_361	[p21l1810t2093r2141b2185],
19	Combination	NN	O	combination	nn	20	SENT_361	[p21l11t2204r487b2267],
20	therapy	NN	O	therapy	prep_of	15	SENT_361	[p21l512t2204r787b2288],
21	comprising	VBG	O	comprise	prepc_in	7	SENT_361	[p21l809t2210r1215b2288],
22	Amylin	NNP	ORGANIZATION	Amylin	nn	23	SENT_361	[p21l1239t2204r1507b2288],
23	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	dobj	21	SENT_361	[p21l1534t2204r2142b2267],
24	’	CD	NUMBER	’	num	26	SENT_361	[p21l1534t2204r2142b2267],
25	leptin	NN	O	leptin	nn	26	SENT_361	[p21l8t2307r217b2390],
26	analog	NN	O	analog	dep	23	SENT_361	[p21l244t2307r501b2391],
27	,	,	O	,	_	0	SENT_361	[p21l244t2307r501b2391],
28	metreleptin	NN	O	metreleptin	appos	26	SENT_361	[p21l529t2307r970b2390],
29	,	,	O	,	_	0	SENT_361	[p21l529t2307r970b2390],
30	and	CC	O	and	_	0	SENT_361	[p21l999t2307r1131b2370],
31	its	PRP$	O	its	poss	33	SENT_361	[p21l1156t2313r1236b2370],
32	amylin	NN	O	amylin	nn	33	SENT_361	[p21l1264t2307r1510b2391],
33	analog	NN	O	analog	dobj	21	SENT_361	[p21l1537t2307r1794b2391],
34	,	,	O	,	_	0	SENT_361	[p21l1537t2307r1794b2391],
35	pramlin	NN	O	pramlin	nn	37	SENT_361	[p21l1820t2307r2139b2390],
36	—	CD	NUMBER	—	num	37	SENT_361	[p21l1820t2307r2139b2390],
37	tide	NN	O	tide	appos	33	SENT_361	[p21l8t2410r165b2482],
38	,	,	O	,	_	0	SENT_361	[p21l8t2410r165b2482],
39	induced	VBD	O	induce	_	0	SENT_361	[p21l193t2410r486b2473],
40	a	DT	O	a	det	46	SENT_361	[p21l513t2433r548b2473],
41	greater	JJR	O	greater	amod	46	SENT_361	[p21l574t2422r826b2494],
42	and	CC	O	and	_	0	SENT_361	[p21l852t2410r984b2473],
43	more	JJR	O	more	conj_and	41	SENT_361	[p21l1009t2433r1195b2473],
44	durable	JJ	O	durable	amod	46	SENT_361	[p21l1223t2410r1496b2473],
45	weight	NN	O	weight	nn	46	SENT_361	[p21l1521t2410r1763b2494],
46	reduction	NN	O	reduction	dobj	39	SENT_361	[p21l1789t2410r2142b2473],
47	vs.	CC	O	vs.	prep	46	SENT_361	[p21l7t2536r98b2576],
48	monotherapy	NN	O	monotherapy	dep	47	SENT_361	[p21l128t2513r618b2597],
49	in	IN	O	in	_	0	SENT_361	[p21l641t2519r710b2575],
50	phase	NN	O	phase	prep_in	39	SENT_361	[p21l736t2513r940b2596],
51	II	CD	NUMBER	ii	num	52	SENT_361	[p21l968t2518r1023b2575],
52	trials	NNS	O	trial	nsubj	39	SENT_361	[p21l1050t2513r1232b2576],
53	in	IN	O	in	_	0	SENT_361	[p21l1259t2519r1329b2575],
54	overweight	JJ	O	overweight	amod	57	SENT_361	[p21l1356t2513r1758b2597],
55	and	CC	O	and	_	0	SENT_361	[p21l1784t2513r1916b2576],
56	obese	JJ	O	obese	amod	57	SENT_361	[p21l1942t2513r2142b2576],
57	patients	NNS	O	patient	prep_in	52	SENT_361	[p21l8t2607r403b2698],
58	.	.	O	.	_	0	SENT_361	[p21l8t2607r403b2698],

1	“	NN	O	“	nsubjpass	11	SENT_362	[p21l8t2607r403b2698],
2	Unfortunately	RB	O	unfortunately	advmod	1	SENT_362	[p21l438t2615r989b2699],
3	,	,	O	,	_	0	SENT_362	[p21l438t2615r989b2699],
4	Amylin	NNP	ORGANIZATION	Amylin	nn	5	SENT_362	[p21l1025t2615r1306b2699],
5	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nsubjpass	11	SENT_362	[p21l1343t2615r1969b2678],
6	and	CC	O	and	_	0	SENT_362	[p21l2006t2615r2142b2678],
7	Takeda	NNP	ORGANIZATION	Takeda	nn	9	SENT_362	[p21l9t2718r258b2781],
8	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	nn	9	SENT_362	[p21l281t2718r826b2781],
9	Company	NNP	ORGANIZATION	Company	nsubjpass	11	SENT_362	[p21l850t2722r1192b2802],
10	were	VBD	O	be	auxpass	11	SENT_362	[p21l1210t2741r1374b2781],
11	forced	VBN	O	force	_	0	SENT_362	[p21l1396t2718r1616b2781],
12	to	TO	O	to	aux	13	SENT_362	[p21l1637t2730r1704b2781],
13	suspend	VB	O	suspend	xcomp	11	SENT_362	[p21l1729t2718r2014b2801],
14	the	DT	O	the	det	15	SENT_362	[p21l2035t2718r2144b2781],
15	trials	NNS	O	trial	nsubj	21	SENT_362	[p21l8t2821r181b2884],
16	due	JJ	O	due	_	0	SENT_362	[p21l205t2821r327b2884],
17	to	TO	O	to	_	0	SENT_362	[p21l348t2833r414b2884],
18	a	DT	O	a	det	20	SENT_362	[p21l437t2844r472b2884],
19	laboratory	NN	O	laboratory	nn	20	SENT_362	[p21l491t2821r853b2905],
20	ﬁnding	NN	O	ﬁnding	prep_due_to	21	SENT_362	[p21l871t2821r1119b2905],
21	involving	VBG	O	involve	xcomp	13	SENT_362	[p21l1140t2821r1463b2905],
22	antibody-mediated	JJ	O	antibody-mediated	amod	24	SENT_362	[p21l1484t2821r2143b2905],
23	metreleptin	NN	O	metreleptin	nn	24	SENT_362	[p21l9t2923r431b3006],
24	neutralization	NN	O	neutralization	dobj	21	SENT_362	[p21l458t2915r1058b2986],
25	.67	CD	NUMBER	.67	nsubj	31	SENT_362	[p21l458t2915r1058b2986],
26	Fortunately	RB	O	fortunately	advmod	31	SENT_362	[p21l1084t2923r1516b3007],
27	,	,	O	,	_	0	SENT_362	[p21l1084t2923r1516b3007],
28	other	JJ	O	other	amod	30	SENT_362	[p21l1544t2923r1735b2986],
29	preclinical	JJ	O	preclinical	amod	30	SENT_362	[p21l1760t2923r2142b3006],
30	studies	NNS	O	study	nsubj	31	SENT_362	[p21l10t3026r256b3089],
31	suggest	VBP	O	suggest	rcmod	24	SENT_362	[p21l283t3038r543b3110],
32	that	IN	O	that	complm	36	SENT_362	[p21l567t3026r706b3089],
33	leptin	NN	O	leptin	nn	34	SENT_362	[p21l729t3026r936b3109],
34	resensitization	NN	O	resensitization	nsubj	36	SENT_362	[p21l962t3032r1483b3089],
35	is	VBZ	O	be	cop	36	SENT_362	[p21l1509t3032r1560b3089],
36	achievable	JJ	O	achievable	ccomp	31	SENT_362	[p21l1588t3026r1959b3089],
37	with	IN	O	with	_	0	SENT_362	[p21l1984t3026r2142b3089],
38	combination	NN	O	combination	nn	39	SENT_362	[p21l10t3129r474b3192],
39	therapy	NN	O	therapy	prep_with	36	SENT_362	[p21l501t3129r781b3213],
40	comprising	VBG	O	comprise	xcomp	36	SENT_362	[p21l806t3135r1221b3213],
41	leptin	NN	O	leptin	nn	42	SENT_362	[p21l1246t3129r1458b3212],
42	analogs	NNS	O	analog	dobj	40	SENT_362	[p21l1487t3129r1760b3213],
43	and	CC	O	and	_	0	SENT_362	[p21l1790t3129r1922b3192],
44	other	JJ	O	other	amod	46	SENT_362	[p21l1950t3129r2143b3192],
45	pharmacotherapeutic	JJ	O	pharmacotherapeutic	amod	46	SENT_362	[p21l8t3232r765b3315],
46	agents	NNS	O	agent	dobj	40	SENT_362	[p21l789t3244r1026b3316],
47	,	,	O	,	_	0	SENT_362	[p21l789t3244r1026b3316],
48	namely	RB	O	namely	advmod	36	SENT_362	[p21l1051t3232r1317b3316],
49	,	,	O	,	_	0	SENT_362	[p21l1051t3232r1317b3316],
50	exendin-4	NN	O	exendin-4	nn	54	SENT_362	[p21l1342t3232r1695b3295],
51	or	CC	O	or	_	0	SENT_362	[p21l1718t3255r1791b3295],
52	ﬁbroblast	NN	O	ﬁbroblast	nn	54	SENT_362	[p21l1812t3232r2143b3295],
53	growth	NN	O	growth	nn	54	SENT_362	[p21l9t3334r259b3418],
54	factor	NN	O	factor	attr	36	SENT_362	[p21l283t3334r488b3397],
55	21.68	CD	NUMBER	21.68	num	54	SENT_362	[p21l511t3326r676b3397],

1	Glucagon	NNP	O	Glucagon	nsubjpass	52	SENT_363	[p21l84t3437r585b3521],
2	—	CD	NUMBER	—	num	1	SENT_363	[p21l84t3437r585b3521],
3	like	IN	O	like	_	0	SENT_363	[p21l84t3437r585b3521],
4	peptide	NN	O	peptide	prep_like	1	SENT_363	[p21l610t3437r876b3520],
5	1	CD	NUMBER	1	num	4	SENT_363	[p21l909t3444r934b3499],
6	(	CD	NUMBER	(	num	8	SENT_363	[p21l969t3437r1253b3514],
7	GLP-1	NN	O	glp-1	nn	8	SENT_363	[p21l969t3437r1253b3514],
8	)	NN	O	)	nsubjpass	10	SENT_363	[p21l969t3437r1253b3514],
9	is	VBZ	O	be	auxpass	10	SENT_363	[p21l1283t3443r1334b3500],
10	derived	VBN	O	derive	rcmod	4	SENT_363	[p21l1361t3437r1627b3500],
11	from	IN	O	from	_	0	SENT_363	[p21l1651t3437r1825b3500],
12	cleavage	NN	O	cleavage	prep_from	10	SENT_363	[p21l1851t3437r2143b3521],
13	of	IN	O	of	_	0	SENT_363	[p21l10t3541r85b3604],
14	the	DT	O	the	det	17	SENT_363	[p21l98t3541r207b3604],
15	preproglucagon	NN	O	preproglucagon	nn	17	SENT_363	[p21l231t3541r787b3625],
16	gene	NN	O	gene	nn	17	SENT_363	[p21l811t3564r971b3625],
17	product	NN	O	product	prep_of	12	SENT_363	[p21l994t3541r1292b3624],
18	,	,	O	,	_	0	SENT_363	[p21l994t3541r1292b3624],
19	which	WDT	O	which	nsubjpass	21	SENT_363	[p21l1315t3541r1530b3604],
20	is	VBZ	O	be	auxpass	21	SENT_363	[p21l1555t3547r1606b3604],
21	synthesized	VBN	O	synthesize	rcmod	17	SENT_363	[p21l1631t3541r2040b3625],
22	by	IN	O	by	_	0	SENT_363	[p21l2061t3541r2147b3625],
23	enteroendocrine	NN	O	enteroendocrine	nn	25	SENT_363	[p21l10t3643r604b3706],
24	L	NN	O	l	nn	25	SENT_363	[p21l633t3648r676b3705],
25	cells	NNS	O	cell	agent	21	SENT_363	[p21l704t3643r855b3706],
26	in	IN	O	in	_	0	SENT_363	[p21l884t3649r952b3705],
27	the	DT	O	the	det	28	SENT_363	[p21l979t3643r1090b3706],
28	ileum	NN	O	ileum	prep_in	25	SENT_363	[p21l1118t3643r1322b3706],
29	and	CC	O	and	_	0	SENT_363	[p21l1349t3643r1480b3706],
30	proximal	JJ	O	proximal	amod	34	SENT_363	[p21l1506t3643r1831b3726],
31	colon	NN	O	colon	nn	34	SENT_363	[p21l1859t3635r2142b3706],
32	.69	CD	NUMBER	.69	num	34	SENT_363	[p21l1859t3635r2142b3706],
33	GLP	NN	O	glp	nn	34	SENT_363	[p21l11t3750r224b3809],
34	—	NN	O	—	dep	35	SENT_363	[p21l11t3750r224b3809],
35	1	CD	NUMBER	1	conj_and	10	SENT_363	[p21l11t3750r224b3809],
36	is	VBZ	O	be	auxpass	37	SENT_363	[p21l253t3752r303b3809],
37	secreted	VBN	O	secrete	_	0	SENT_363	[p21l327t3746r605b3809],
38	following	VBG	O	follow	_	0	SENT_363	[p21l627t3746r949b3830],
39	food	NN	O	food	nn	40	SENT_363	[p21l970t3746r1127b3809],
40	intake	NN	O	intake	prep_following	37	SENT_363	[p21l1149t3746r1357b3809],
41	and	CC	O	and	_	0	SENT_363	[p21l1381t3746r1507b3809],
42	mediates	VBZ	O	mediate	conj_and	37	SENT_363	[p21l1528t3746r1831b3809],
43	a	DT	O	a	det	44	SENT_363	[p21l1855t3769r1889b3809],
44	Variety	NNP	O	Variety	dobj	42	SENT_363	[p21l1908t3752r2146b3830],
45	of	IN	O	of	_	0	SENT_363	[p22l10t24r85b87],
46	functions	NNS	O	function	prep_of	44	SENT_363	[p22l99t24r448b87],
47	:	:	O	:	_	0	SENT_363	[p22l99t24r448b87],
48	increased	VBN	O	increase	conj_and	37	SENT_363	[p22l475t24r808b87],
49	insulin	NN	O	insulin	nn	50	SENT_363	[p22l831t24r1073b87],
50	secretion	NN	O	secretion	dobj	48	SENT_363	[p22l1097t30r1433b96],
51	,	,	O	,	_	0	SENT_363	[p22l1097t30r1433b96],
52	decreased	VBD	O	decrease	conj_and	37	SENT_363	[p22l1459t24r1805b87],
53	glucagon	NN	O	glucagon	nn	54	SENT_363	[p22l1827t24r2143b108],
54	secretion	NN	O	secretion	dobj	52	SENT_363	[p22l10t133r347b199],
55	,	,	O	,	_	0	SENT_363	[p22l10t133r347b199],
56	decreased	VBD	O	decrease	conj_and	37	SENT_363	[p22l373t127r719b190],
57	gastric	JJ	O	gastric	amod	58	SENT_363	[p22l742t133r973b211],
58	secretion	NN	O	secretion	dobj	56	SENT_363	[p22l998t133r1316b190],
59	and	CC	O	and	_	0	SENT_363	[p22l1340t127r1469b190],
60	motility	NN	O	motility	dobj	56	SENT_363	[p22l1492t127r1782b211],
61	,	,	O	,	_	0	SENT_363	[p22l1492t127r1782b211],
62	increased	VBD	O	increase	conj_and	37	SENT_363	[p22l1808t127r2142b190],
63	satiety	NN	O	satiety	dobj	62	SENT_363	[p22l10t236r240b314],
64	,	,	O	,	_	0	SENT_363	[p22l10t236r240b314],
65	and	CC	O	and	_	0	SENT_363	[p22l266t230r393b293],
66	decreased	VBD	O	decrease	conj_and	37	SENT_363	[p22l415t230r755b293],
67	food	NN	O	food	nn	68	SENT_363	[p22l776t230r935b293],
68	intake	NN	O	intake	dobj	66	SENT_363	[p22l957t230r1183b293],
69	.	.	O	.	_	0	SENT_363	[p22l957t230r1183b293],

1	Indeed	RB	O	indeed	advmod	27	SENT_364	[p22l1210t230r1466b302],
2	,	,	O	,	_	0	SENT_364	[p22l1210t230r1466b302],
3	GLP	NN	O	glp	nn	4	SENT_364	[p22l1491t234r1706b293],
4	—	NN	O	—	nsubj	27	SENT_364	[p22l1491t234r1706b293],
5	1	CD	NUMBER	1	num	6	SENT_364	[p22l1491t234r1706b293],
6	administration	NN	O	administration	nsubj	12	SENT_364	[p22l1736t230r2138b293, p22l8t339r145b396],
7	in	IN	O	in	_	0	SENT_364	[p22l167t339r233b395],
8	preclinical	JJ	O	preclinical	amod	11	SENT_364	[p22l253t333r611b416],
9	and	CC	O	and	_	0	SENT_364	[p22l632t333r758b396],
10	clinical	JJ	O	clinical	amod	11	SENT_364	[p22l779t333r1023b396],
11	trials	NNS	O	trial	prep_in	6	SENT_364	[p22l1042t333r1213b396],
12	induced	VBD	O	induce	rcmod	4	SENT_364	[p22l1235t333r1512b396],
13	satiety	NN	O	satiety	nn	16	SENT_364	[p22l1533t339r1753b417],
14	and	CC	O	and	_	0	SENT_364	[p22l1770t333r1897b396],
15	weight	NN	O	weight	nn	16	SENT_364	[p22l1915t333r2144b417],
16	loss	NN	O	loss	iobj	12	SENT_364	[p22l8t427r303b498],
17	.7	CD	NUMBER	.7	number	18	SENT_364	[p22l8t427r303b498],
18	°	CD	NUMBER	°	num	19	SENT_364	[p22l8t427r303b498],
19	‘	NN	O	‘	dobj	12	SENT_364	[p22l8t427r303b498],
20	73	CD	NUMBER	73	dobj	12	SENT_364	[p22l8t427r303b498],
21	However	RB	O	however	advmod	20	SENT_364	[p22l325t440r635b507],
22	,	,	O	,	_	0	SENT_364	[p22l325t440r635b507],
23	dipeptidyl	NN	O	dipeptidyl	nn	25	SENT_364	[p22l658t435r997b519],
24	peptidase	NN	O	peptidase	nn	25	SENT_364	[p22l1015t435r1404b518],
25	—	NN	O	—	dobj	12	SENT_364	[p22l1015t435r1404b518],
26	4	CD	NUMBER	4	dep	25	SENT_364	[p22l1015t435r1404b518],
27	degrades	VBZ	O	degrade	_	0	SENT_364	[p22l1424t435r1719b519],
28	endogenous	JJ	O	endogenous	amod	29	SENT_364	[p22l1739t435r2141b519],
29	GLP-1	NN	O	glp-1	dobj	27	SENT_364	[p22l11t542r230b601],
30	in	IN	O	in	_	0	SENT_364	[p22l261t544r330b600],
31	<	JJR	O	<	prep_in	27	SENT_364	[p22l356t545r440b600],
32	2	CD	DURATION	2	num	33	SENT_364	[p22l356t545r440b600],
33	minutes	NNS	NUMBER	minute	tmod	31	SENT_364	[p22l465t530r835b601],
34	.	.	O	.	_	0	SENT_364	[p22l465t530r835b601],

1	”	NN	O	”	ccomp	9	SENT_365	[p22l465t530r835b601],
2	Consequently	RB	O	consequently	advmod	1	SENT_365	[p22l860t538r1359b622],
3	,	,	O	,	_	0	SENT_365	[p22l860t538r1359b622],
4	degradation-resistant	JJ	O	degradation-resistant	amod	6	SENT_365	[p22l1386t538r2144b622],
5	GLP-1	NN	O	glp-1	nn	6	SENT_365	[p22l11t645r224b704],
6	analogs	NNS	O	analog	nsubjpass	9	SENT_365	[p22l251t641r506b725],
7	have	VBP	O	have	aux	9	SENT_365	[p22l526t641r681b704],
8	been	VBN	O	be	auxpass	9	SENT_365	[p22l699t641r863b704],
9	developed	VBN	O	develop	_	0	SENT_365	[p22l884t641r1233b724],
10	to	TO	O	to	aux	11	SENT_365	[p22l1251t653r1317b704],
11	increase	VB	O	increase	xcomp	9	SENT_365	[p22l1338t647r1615b704],
12	the	DT	O	the	det	13	SENT_365	[p22l1635t641r1741b704],
13	practicality	NN	O	practicality	dobj	11	SENT_365	[p22l1761t641r2148b725],
14	of	IN	O	of	_	0	SENT_365	[p22l10t744r85b807],
15	GLP-1	NN	O	glp-1	nn	16	SENT_365	[p22l100t748r318b807],
16	pharmacotherapy	NN	O	pharmacotherapy	prep_of	13	SENT_365	[p22l347t744r979b828],
17	.	.	O	.	_	0	SENT_365	[p22l347t744r979b828],

1	Liraglutide	NNP	O	Liraglutide	nsubj	13	SENT_366	[p22l1006t744r1389b828],
2	(	CD	NUMBER	(	num	1	SENT_366	[p22l1416t745r1733b820],
3	Victoza	NNP	O	Victoza	dep	1	SENT_366	[p22l1416t745r1733b820],
4	)	CD	NUMBER	)	num	3	SENT_366	[p22l1416t745r1733b820],
5	from	IN	O	from	_	0	SENT_366	[p22l1760t744r1931b807],
6	Novo	NNP	ORGANIZATION	Novo	nn	7	SENT_366	[p22l1954t749r2142b807],
7	Nordisk	NNP	ORGANIZATION	Nordisk	prep_from	1	SENT_366	[p22l8t847r284b910],
8	is	VBZ	O	be	cop	13	SENT_366	[p22l300t853r349b910],
9	a	DT	O	a	det	13	SENT_366	[p22l371t870r405b910],
10	GLP	NN	O	glp	nn	13	SENT_366	[p22l425t851r636b910],
11	—	NN	O	—	nn	13	SENT_366	[p22l425t851r636b910],
12	1	CD	NUMBER	1	num	13	SENT_366	[p22l425t851r636b910],
13	analog	NN	O	analog	_	0	SENT_366	[p22l663t847r886b931],
14	that	WDT	O	that	nsubj	15	SENT_366	[p22l903t847r1035b910],
15	contains	VBZ	O	contain	rcmod	13	SENT_366	[p22l1055t853r1336b910],
16	an	DT	O	a	det	19	SENT_366	[p22l1358t870r1436b910],
17	amino	NN	O	amino	nn	19	SENT_366	[p22l1457t853r1670b910],
18	acid	NN	O	acid	nn	19	SENT_366	[p22l1692t847r1830b910],
19	substitution	NN	O	substitution	dobj	15	SENT_366	[p22l1850t847r2141b910, p22l8t956r143b1013],
20	and	CC	O	and	_	0	SENT_366	[p22l163t950r287b1013],
21	a	DT	O	a	det	24	SENT_366	[p22l307t973r341b1013],
22	fatty	JJ	O	fatty	amod	24	SENT_366	[p22l359t950r510b1034],
23	acid	NN	O	acid	nn	24	SENT_366	[p22l526t950r663b1013],
24	attachment	NN	O	attachment	conj_and	19	SENT_366	[p22l683t950r1076b1022],
25	,	,	O	,	_	0	SENT_366	[p22l683t950r1076b1022],
26	which	WDT	O	which	nsubj	27	SENT_366	[p22l1096t950r1301b1013],
27	stabilize	VBP	O	stabilize	rcmod	13	SENT_366	[p22l1322t950r1591b1013],
28	it	PRP	O	it	dobj	27	SENT_366	[p22l1611t956r1656b1013],
29	against	IN	O	against	_	0	SENT_366	[p22l1675t956r1909b1034],
30	degradation	NN	O	degradation	prep_against	27	SENT_366	[p22l1929t950r2141b1034, p22l10t1053r229b1116],
31	by	IN	O	by	_	0	SENT_366	[p22l249t1053r334b1137],
32	dipeptidyl	NN	O	dipeptidyl	nn	33	SENT_366	[p22l353t1053r703b1137],
33	peptidase-4	NN	O	peptidase-4	prep_by	27	SENT_366	[p22l724t1053r1141b1136],
34	.	.	O	.	_	0	SENT_366	[p22l724t1053r1141b1136],

1	Its	PRP$	O	its	poss	3	SENT_367	[p22l1168t1058r1247b1116],
2	13-hour	JJ	DURATION	13-hour	amod	3	SENT_367	[p22l1277t1053r1549b1116],
3	half	NN	O	half	nsubj	6	SENT_367	[p22l1570t1053r1837b1116],
4	—	JJ	O	—	amod	5	SENT_367	[p22l1570t1053r1837b1116],
5	life	NN	O	life	tmod	6	SENT_367	[p22l1570t1053r1837b1116],
6	makes	VBZ	O	make	_	0	SENT_367	[p22l1859t1053r2075b1116],
7	it	PRP	O	it	nsubj	8	SENT_367	[p22l2099t1059r2145b1116],
8	suitable	JJ	O	suitable	xcomp	6	SENT_367	[p22l10t1156r269b1219],
9	for	IN	O	for	_	0	SENT_367	[p22l289t1156r386b1219],
10	once	RB	DATE	once	advmod	13	SENT_367	[p22l406t1156r764b1240],
11	—	CD	NUMBER	—	pobj	10	SENT_367	[p22l406t1156r764b1240],
12	daily	JJ	SET	daily	amod	13	SENT_367	[p22l406t1156r764b1240],
13	administration	NN	O	administration	prep_for	8	SENT_367	[p22l782t1156r1305b1219],
14	.	.	O	.	_	0	SENT_367	[p22l782t1156r1305b1219],

1	Exenatide	NNP	O	Exenatide	nn	3	SENT_368	[p22l1328t1156r1664b1219],
2	(	NNP	O	(	nn	3	SENT_368	[p22l1688t1157r1951b1240],
3	Byetta	NNP	LOCATION	Byetta	nsubj	11	SENT_368	[p22l1688t1157r1951b1240],
4	)	CD	NUMBER	)	num	3	SENT_368	[p22l1688t1157r1951b1240],
5	from	IN	O	from	_	0	SENT_368	[p22l1975t1156r2142b1219],
6	Amylin	NNP	ORGANIZATION	Amylin	nn	8	SENT_368	[p22l8t1259r266b1343],
7	Pharmaceuticals/Bristol-Myers	NNP	O	Pharmaceuticals/Bristol-Myers	nn	8	SENT_368	[p22l287t1259r1350b1343],
8	Squibb/AstraZeneca	NNP	O	Squibb/AstraZeneca	prep_from	3	SENT_368	[p22l1372t1259r2073b1342],
9	is	VBZ	O	be	cop	11	SENT_368	[p22l2093t1265r2143b1322],
10	an	DT	O	a	det	11	SENT_368	[p22l10t1385r90b1425],
11	analog	NN	O	analog	_	0	SENT_368	[p22l114t1362r341b1446],
12	of	IN	O	of	_	0	SENT_368	[p22l362t1362r436b1425],
13	eXendin	NN	O	exendin	prep_of	11	SENT_368	[p22l450t1362r814b1434],
14	—	CD	NUMBER	—	number	15	SENT_368	[p22l450t1362r814b1434],
15	4	CD	NUMBER	4	num	13	SENT_368	[p22l450t1362r814b1434],
16	,	,	O	,	_	0	SENT_368	[p22l450t1362r814b1434],
17	a	DT	O	a	det	21	SENT_368	[p22l840t1385r874b1425],
18	Gila	NNP	O	Gila	nn	21	SENT_368	[p22l897t1362r1038b1425],
19	monster	NN	O	monster	nn	21	SENT_368	[p22l1059t1374r1345b1425],
20	salivary	JJ	O	salivary	amod	21	SENT_368	[p22l1367t1362r1634b1446],
21	hormone	NN	O	hormone	dep	24	SENT_368	[p22l1652t1362r1969b1425],
22	with	IN	O	with	_	0	SENT_368	[p22l1990t1362r2143b1425],
23	functions	NNS	O	function	prep_with	21	SENT_368	[p22l9t1465r332b1528],
24	similar	JJ	O	similar	ccomp	11	SENT_368	[p22l355t1465r592b1528],
25	to	TO	O	to	_	0	SENT_368	[p22l612t1477r678b1528],
26	those	DT	O	those	prep_to	24	SENT_368	[p22l700t1465r882b1528],
27	of	IN	O	of	_	0	SENT_368	[p22l905t1465r979b1528],
28	GLP-1	NN	O	glp-1	prep_of	26	SENT_368	[p22l993t1469r1229b1528],
29	.	.	O	.	_	0	SENT_368	[p22l993t1469r1229b1528],

1	As	IN	O	as	prep	12	SENT_369	[p22l1253t1469r1339b1528],
2	with	IN	O	with	pcomp	1	SENT_369	[p22l1360t1465r1513b1528],
3	the	DT	O	the	det	6	SENT_369	[p22l1533t1465r1639b1528],
4	amylin	NN	O	amylin	nn	6	SENT_369	[p22l1662t1465r1896b1549],
5	analog	NN	O	analog	nn	6	SENT_369	[p22l1919t1465r2145b1549],
6	pramlintide	NN	O	pramlintide	pobj	2	SENT_369	[p22l8t1568r427b1651],
7	,	,	O	,	_	0	SENT_369	[p22l8t1568r427b1651],
8	liraglutide	NN	O	liraglutide	nsubjpass	12	SENT_369	[p22l448t1568r796b1652],
9	and	CC	O	and	_	0	SENT_369	[p22l817t1568r942b1631],
10	exenatide	NN	O	exenatide	conj_and	8	SENT_369	[p22l962t1568r1284b1631],
11	are	VBP	O	be	auxpass	12	SENT_369	[p22l1306t1591r1405b1631],
12	approved	VBN	O	approve	_	0	SENT_369	[p22l1426t1568r1741b1651],
13	by	IN	O	by	_	0	SENT_369	[p22l1758t1568r1841b1652],
14	the	DT	O	the	det	15	SENT_369	[p22l1857t1568r1962b1631],
15	FDA	NNP	ORGANIZATION	FDA	agent	12	SENT_369	[p22l1984t1572r2144b1630],
16	for	IN	O	for	prep	15	SENT_369	[p22l9t1670r108b1733],
17	adjunctive	JJ	O	adjunctive	amod	18	SENT_369	[p22l130t1670r488b1754],
18	therapy	NN	O	therapy	dep	27	SENT_369	[p22l511t1670r775b1754],
19	in	IN	O	in	_	0	SENT_369	[p22l795t1676r862b1732],
20	type	NN	O	type	nn	22	SENT_369	[p22l884t1682r1031b1754],
21	2	CD	NUMBER	2	num	22	SENT_369	[p22l1055t1677r1091b1732],
22	diabetes	NN	O	diabetes	prep_in	18	SENT_369	[p22l1116t1662r1574b1733],
23	.75	CD	NUMBER	.75	num	22	SENT_369	[p22l1116t1662r1574b1733],
24	‘	NN	O	‘	dep	27	SENT_369	[p22l1116t1662r1574b1733],
25	78	CD	NUMBER	78	num	24	SENT_369	[p22l1116t1662r1574b1733],
26	The	DT	O	the	det	27	SENT_369	[p22l1598t1670r1724b1733],
27	potential	NN	O	potential	dep	16	SENT_369	[p22l1746t1670r2055b1753],
28	of	IN	O	of	_	0	SENT_369	[p22l2078t1670r2152b1733],
29	these	DT	O	these	det	30	SENT_369	[p22l8t1773r183b1836],
30	drugs	NNS	O	drug	prep_of	27	SENT_369	[p22l205t1773r396b1857],
31	to	TO	O	to	aux	32	SENT_369	[p22l416t1785r481b1836],
32	treat	VB	O	treat	xcomp	12	SENT_369	[p22l502t1785r658b1836],
33	both	CC	O	both	preconj	34	SENT_369	[p22l675t1773r834b1836],
34	diabetes	NNS	O	diabetes	nsubj	42	SENT_369	[p22l855t1773r1131b1836],
35	and	CC	O	and	_	0	SENT_369	[p22l1153t1773r1279b1836],
36	obesity	NN	O	obesity	nsubj	42	SENT_369	[p22l1299t1773r1543b1857],
37	would	MD	O	would	aux	42	SENT_369	[p22l1559t1773r1772b1836],
38	be	VB	O	be	cop	42	SENT_369	[p22l1790t1773r1869b1836],
39	a	DT	O	a	det	42	SENT_369	[p22l1891t1796r1925b1836],
40	major	JJ	O	major	amod	42	SENT_369	[p22l1944t1779r2146b1857],
41	synergistic	JJ	O	synergistic	amod	42	SENT_369	[p22l10t1882r367b1960],
42	beneﬁt	NN	O	beneﬁt	ccomp	32	SENT_369	[p22l384t1876r616b1939],
43	considering	VBG	O	consider	partmod	42	SENT_369	[p22l635t1876r1031b1960],
44	the	DT	O	the	nsubj	45	SENT_369	[p22l1048t1876r1152b1939],
45	overlap	VBP	O	overlap	ccomp	43	SENT_369	[p22l1173t1876r1416b1959],
46	in	IN	O	in	_	0	SENT_369	[p22l1438t1882r1503b1938],
47	patient	NN	O	patient	nn	48	SENT_369	[p22l1521t1882r1756b1959],
48	population	NN	O	population	prep_in	45	SENT_369	[p22l1774t1876r2142b1959],
49	and	CC	O	and	_	0	SENT_369	[p22l10t1979r140b2042],
50	the	DT	O	the	det	52	SENT_369	[p22l162t1979r271b2042],
51	close	JJ	O	close	amod	52	SENT_369	[p22l296t1979r468b2042],
52	association	NN	O	association	conj_and	48	SENT_369	[p22l493t1985r884b2042],
53	between	IN	O	between	_	0	SENT_369	[p22l906t1979r1201b2042],
54	these	DT	O	these	det	55	SENT_369	[p22l1224t1979r1405b2042],
55	diseases	NNS	O	disease	prep_between	52	SENT_369	[p22l1430t1979r1729b2042],
56	.	.	O	.	_	0	SENT_369	[p22l1430t1979r1729b2042],

1	Liraglutide	NNP	O	Liraglutide	nsubj	4	SENT_370	[p22l1757t1979r2144b2063],
2	and	CC	O	and	_	0	SENT_370	[p22l10t2082r136b2145],
3	exenatide	NN	O	exenatide	conj_and	1	SENT_370	[p22l157t2082r481b2145],
4	induced	VBD	O	induce	_	0	SENT_370	[p22l503t2082r780b2145],
5	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_370	[p22l801t2082r1155b2166],
6	weight	NN	O	weight	nn	7	SENT_370	[p22l1173t2082r1403b2166],
7	loss	NN	O	loss	dobj	4	SENT_370	[p22l1421t2082r1547b2145],
8	in	IN	O	in	_	0	SENT_370	[p22l1569t2088r1636b2144],
9	diabetics	NNS	O	diabetic	prep_in	4	SENT_370	[p22l1657t2082r1975b2145],
10	.	.	O	.	_	0	SENT_370	[p22l1657t2082r1975b2145],

1	This	DT	O	this	det	3	SENT_371	[p22l1999t2082r2142b2145],
2	weight	NN	O	weight	nn	3	SENT_371	[p22l8t2185r237b2269],
3	loss	NN	O	loss	nsubj	11	SENT_371	[p22l257t2185r383b2248],
4	was	VBD	O	be	cop	6	SENT_371	[p22l405t2208r531b2248],
5	dose	NN	O	dose	dep	6	SENT_371	[p22l554t2185r709b2248],
6	dependent	JJ	O	dependent	_	0	SENT_371	[p22l732t2185r1112b2268],
7	,	,	O	,	_	0	SENT_371	[p22l732t2185r1112b2268],
8	progressive	JJ	O	progressive	conj_and	6	SENT_371	[p22l1136t2191r1540b2269],
9	,	,	O	,	_	0	SENT_371	[p22l1136t2191r1540b2269],
10	and	CC	O	and	_	0	SENT_371	[p22l1565t2185r1692b2248],
11	durable	JJ	O	durable	conj_and	6	SENT_371	[p22l1714t2185r1971b2248],
12	over	IN	O	over	_	0	SENT_371	[p22l1994t2208r2142b2248],
13	30	CD	DURATION	30	num	14	SENT_371	[p22l11t2295r89b2351],
14	weeks	NNS	NUMBER	week	prep_over	11	SENT_371	[p22l112t2288r339b2351],
15	.	.	O	.	_	0	SENT_371	[p22l112t2288r339b2351],

1	In	IN	O	in	_	0	SENT_372	[p22l366t2293r438b2350],
2	studies	NNS	O	study	prep_in	9	SENT_372	[p22l463t2288r704b2351],
3	with	IN	O	with	_	0	SENT_372	[p22l726t2288r883b2351],
4	nondiabetic	JJ	O	nondiabetic	amod	6	SENT_372	[p22l906t2288r1324b2351],
5	obese	JJ	O	obese	amod	6	SENT_372	[p22l1348t2288r1542b2351],
6	patients	NNS	O	patient	prep_with	2	SENT_372	[p22l1565t2294r1861b2371],
7	,	,	O	,	_	0	SENT_372	[p22l1565t2294r1861b2371],
8	liraglutide	NN	O	liraglutide	nsubj	9	SENT_372	[p22l1884t2288r2139b2372, p22l8t2391r138b2454],
9	drove	VBD	O	drive	_	0	SENT_372	[p22l159t2391r349b2454],
10	a	DT	O	a	det	12	SENT_372	[p22l372t2414r406b2454],
11	6-kg	JJ	O	6-kg	amod	12	SENT_372	[p22l427t2391r579b2475],
12	(	NN	O	(	nsubj	30	SENT_372	[p22l602t2391r757b2468],
13	8	CD	PERCENT	8	num	14	SENT_372	[p22l602t2391r757b2468],
14	%	NN	PERCENT	%	amod	12	SENT_372	[p22l602t2391r757b2468],
15	)	CD	NUMBER	)	num	17	SENT_372	[p22l602t2391r757b2468],
16	weight	NN	O	weight	nn	17	SENT_372	[p22l780t2391r1010b2475],
17	loss	NN	O	loss	dep	14	SENT_372	[p22l1028t2391r1172b2463],
18	,	,	O	,	_	0	SENT_372	[p22l1028t2391r1172b2463],
19	and	CC	O	and	_	0	SENT_372	[p22l1196t2391r1322b2454],
20	>	JJR	O	>	amod	12	SENT_372	[p22l1344t2397r1532b2455],
21	35	CD	PERCENT	35	num	22	SENT_372	[p22l1344t2397r1532b2455],
22	%	NN	PERCENT	%	dep	14	SENT_372	[p22l1344t2397r1532b2455],
23	of	IN	O	of	_	0	SENT_372	[p22l1556t2391r1629b2454],
24	the	DT	O	the	det	25	SENT_372	[p22l1640t2391r1746b2454],
25	patients	NNS	O	patient	prep_of	12	SENT_372	[p22l1766t2397r2035b2474],
26	on	IN	O	on	_	0	SENT_372	[p22l2057t2414r2143b2454],
27	the	DT	O	the	det	29	SENT_372	[p22l8t2494r116b2557],
28	highest	JJS	O	highest	amod	29	SENT_372	[p22l139t2494r392b2578],
29	dose	NN	O	dose	prep_on	25	SENT_372	[p22l415t2494r571b2557],
30	achieved	VBD	O	achieve	ccomp	9	SENT_372	[p22l596t2494r900b2557],
31	weight	NN	O	weight	nn	32	SENT_372	[p22l920t2494r1154b2578],
32	loss	NN	O	loss	dobj	30	SENT_372	[p22l1174t2494r1302b2557],
33	of	IN	O	of	_	0	SENT_372	[p22l1327t2494r1402b2557],
34	>	JJR	O	>	prep_of	32	SENT_372	[p22l1418t2500r1628b2559],
35	10	CD	PERCENT	10	number	36	SENT_372	[p22l1418t2500r1628b2559],
36	%	NN	PERCENT	%	amod	34	SENT_372	[p22l1418t2500r1628b2559],
37	.	.	O	.	_	0	SENT_372	[p22l1418t2500r1628b2559],

1	Novo	NNP	ORGANIZATION	Novo	nn	2	SENT_373	[p22l1653t2499r1840b2557],
2	Nordisk	NNP	ORGANIZATION	Nordisk	nsubj	3	SENT_373	[p22l1864t2494r2147b2557],
3	completed	VBD	O	complete	_	0	SENT_373	[p22l10t2597r379b2680],
4	these	DT	O	these	det	7	SENT_373	[p22l402t2597r583b2660],
5	phase	NN	O	phase	nn	7	SENT_373	[p22l607t2597r808b2680],
6	III	CD	NUMBER	iii	num	7	SENT_373	[p22l834t2602r919b2659],
7	trials	NNS	O	trial	dobj	3	SENT_373	[p22l944t2597r1122b2660],
8	for	IN	O	for	_	0	SENT_373	[p22l1147t2597r1247b2660],
9	liraglutide	NN	O	liraglutide	prep_for	3	SENT_373	[p22l1270t2597r1634b2681],
10	for	IN	O	for	_	0	SENT_373	[p22l1658t2597r1759b2660],
11	an	DT	O	a	det	13	SENT_373	[p22l1784t2620r1865b2660],
12	obesity	NN	O	obesity	nn	13	SENT_373	[p22l1891t2597r2144b2681],
13	indication	NN	O	indication	prep_for	9	SENT_373	[p22l9t2700r352b2763],
14	in	IN	O	in	_	0	SENT_373	[p22l373t2706r438b2762],
15	nondiabetic	JJ	O	nondiabetic	amod	17	SENT_373	[p22l459t2700r860b2763],
16	obese	JJ	O	obese	amod	17	SENT_373	[p22l881t2700r1068b2763],
17	patients	NNS	O	patient	prep_in	3	SENT_373	[p22l1087t2706r1352b2783],
18	in	IN	O	in	_	0	SENT_373	[p22l1373t2706r1439b2762],
19	September	NNP	DATE	September	prep_in	17	SENT_373	[p22l1459t2700r1820b2783],
20	2010	CD	DATE	2010	num	19	SENT_373	[p22l1839t2707r1998b2763],
21	and	CC	O	and	_	0	SENT_373	[p22l2020t2700r2144b2763],
22	in	IN	O	in	_	0	SENT_373	[p22l9t2809r74b2865],
23	diabetic	JJ	O	diabetic	amod	25	SENT_373	[p22l94t2803r355b2866],
24	obese	JJ	O	obese	amod	25	SENT_373	[p22l375t2803r559b2866],
25	patients	NNS	O	patient	prep_in	3	SENT_373	[p22l577t2809r838b2886],
26	in	IN	O	in	_	0	SENT_373	[p22l858t2809r923b2865],
27	January	NNP	DATE	January	prep_in	25	SENT_373	[p22l942t2808r1200b2887],
28	2013	CD	DATE	2013	num	27	SENT_373	[p22l1216t2810r1389b2866],
29	.	.	O	.	_	0	SENT_373	[p22l1216t2810r1389b2866],

1	Novo	NNP	ORGANIZATION	Novo	nn	2	SENT_374	[p22l1411t2808r1590b2866],
2	Nordisk	NNP	ORGANIZATION	Nordisk	nsubj	3	SENT_374	[p22l1610t2803r1880b2866],
3	expects	VBZ	O	expect	_	0	SENT_374	[p22l1897t2815r2140b2886],
4	regulatory	JJ	O	regulatory	amod	5	SENT_374	[p22l10t2906r365b2990],
5	ﬁlings	NNS	O	ﬁlings	dobj	3	SENT_374	[p22l383t2906r589b2990],
6	in	IN	O	in	_	0	SENT_374	[p22l611t2912r678b2968],
7	the	DT	O	the	det	9	SENT_374	[p22l699t2906r805b2969],
8	European	NNP	ORGANIZATION	European	nn	9	SENT_374	[p22l827t2911r1158b2989],
9	Union	NNP	ORGANIZATION	Union	prep_in	3	SENT_374	[p22l1180t2911r1396b2969],
10	and	CC	O	and	_	0	SENT_374	[p22l1419t2906r1545b2969],
11	the	DT	O	the	det	13	SENT_374	[p22l1565t2906r1671b2969],
12	United	NNP	LOCATION	United	nn	13	SENT_374	[p22l1694t2906r1928b2969],
13	States	NNPS	LOCATION	States	prep_in	3	SENT_374	[p22l1950t2910r2142b2969],
14	to	TO	O	to	aux	15	SENT_374	[p22l8t3021r76b3072],
15	begin	VB	O	begin	xcomp	3	SENT_374	[p22l100t3009r298b3093],
16	by	IN	O	by	_	0	SENT_374	[p22l321t3009r407b3093],
17	the	DT	DATE	the	det	18	SENT_374	[p22l428t3009r537b3072],
18	start	NN	DATE	start	prep_by	15	SENT_374	[p22l564t3021r721b3072],
19	of	IN	DATE	of	_	0	SENT_374	[p22l745t3009r821b3072],
20	2014	CD	DATE	2014	prep_of	18	SENT_374	[p22l837t3016r1022b3072],
21	.	.	O	.	_	0	SENT_374	[p22l837t3016r1022b3072],

1	Bristol-Myers	NNP	O	Bristol-Myers	nn	2	SENT_375	[p22l1051t3009r1535b3093],
2	Squibb	NNP	O	Squibb	nsubjpass	4	SENT_375	[p22l1562t3009r1806b3092],
3	is	VBZ	O	be	auxpass	4	SENT_375	[p22l1832t3015r1884b3072],
4	scheduled	VBN	O	schedule	_	0	SENT_375	[p22l1910t3009r2138b3072, p22l9t3112r164b3175],
5	to	TO	O	to	aux	6	SENT_375	[p22l190t3124r258b3175],
6	complete	VB	O	complete	xcomp	4	SENT_375	[p22l288t3112r613b3195],
7	its	PRP$	O	its	poss	8	SENT_375	[p22l642t3118r721b3175],
8	phase	NN	O	phase	nsubj	11	SENT_375	[p22l748t3112r952b3195],
9	III	CD	NUMBER	iii	num	11	SENT_375	[p22l981t3117r1068b3174],
10	obesity	NN	O	obesity	nn	11	SENT_375	[p22l1097t3112r1355b3196],
11	trials	NNS	O	trial	xcomp	6	SENT_375	[p22l1377t3112r1558b3175],
12	on	IN	O	on	_	0	SENT_375	[p22l1588t3135r1676b3175],
13	exenatide	NN	O	exenatide	prep_on	11	SENT_375	[p22l1705t3112r2046b3175],
14	in	IN	O	in	_	0	SENT_375	[p22l2075t3118r2144b3174],
15	February	NNP	DATE	February	prep_in	13	SENT_375	[p22l10t3215r331b3299],
16	2014	CD	DATE	2014	num	15	SENT_375	[p22l351t3222r534b3278],
17	.	.	O	.	_	0	SENT_375	[p22l351t3222r534b3278],

1	Furthermore	RB	O	furthermore	advmod	5	SENT_376	[p22l561t3215r1032b3287],
2	,	,	O	,	_	0	SENT_376	[p22l561t3215r1032b3287],
3	Novo	NNP	O	Novo	nn	4	SENT_376	[p22l1056t3220r1244b3278],
4	Nordisk/Emisphere	NNP	O	Nordisk/Emisphere	nsubj	5	SENT_376	[p22l1268t3215r1958b3298],
5	used	VBD	O	use	_	0	SENT_376	[p22l1982t3215r2144b3278],
6	Emisphere	NNP	ORGANIZATION	Emisphere	poss	11	SENT_376	[p22l9t3318r409b3401],
7	’s	POS	O	’s	_	0	SENT_376	[p22l9t3318r409b3401],
8	proprietary	NN	O	proprietary	nn	11	SENT_376	[p22l429t3324r821b3402],
9	oral	JJ	O	oral	amod	11	SENT_376	[p22l838t3318r969b3381],
10	sodium	NN	O	sodium	nn	11	SENT_376	[p22l990t3318r1246b3381],
11	N	NN	O	n	dobj	5	SENT_376	[p22l1265t3323r1354b3381],
12	-	:	O	-	_	0	SENT_376	[p22l1265t3323r1354b3381],
13	[	NN	O	[	dep	11	SENT_376	[p22l1368t3318r2136b3402],
14	8	CD	NUMBER	8	num	13	SENT_376	[p22l1368t3318r2136b3402],
15	-	:	O	-	_	0	SENT_376	[p22l1368t3318r2136b3402],
16	(	CD	NUMBER	(	num	19	SENT_376	[p22l1368t3318r2136b3402],
17	2-hydroxybenzoyl	JJ	O	2-hydroxybenzoyl	amod	19	SENT_376	[p22l1368t3318r2136b3402],
18	)	CD	NUMBER	)	tmod	17	SENT_376	[p22l1368t3318r2136b3402],
19	amino	NN	O	amino	dep	13	SENT_376	[p22l10t3422r257b3497],
20	]	NN	O	]	nn	22	SENT_376	[p22l10t3422r257b3497],
21	caprylate	NN	O	caprylate	nn	22	SENT_376	[p22l291t3421r610b3505],
22	technology	NN	O	technology	dep	19	SENT_376	[p22l634t3421r1031b3505],
23	to	TO	O	to	aux	24	SENT_376	[p22l1052t3433r1119b3484],
24	develop	VB	O	develop	xcomp	5	SENT_376	[p22l1146t3421r1418b3504],
25	the	DT	O	the	det	30	SENT_376	[p22l1443t3421r1553b3484],
26	long-acting	JJ	O	long-acting	amod	30	SENT_376	[p22l1576t3421r1984b3505],
27	oral	JJ	O	oral	amod	30	SENT_376	[p22l2008t3421r2144b3484],
28	GLP-1	NN	MISC	glp-1	nn	30	SENT_376	[p22l11t3528r225b3587],
29	analog	NN	O	analog	nn	30	SENT_376	[p22l255t3524r482b3608],
30	NN9924	NN	O	nn9924	dobj	24	SENT_376	[p22l502t3529r812b3596],
31	,	,	O	,	_	0	SENT_376	[p22l502t3529r812b3596],
32	which	WDT	O	which	nsubj	37	SENT_376	[p22l835t3524r1045b3587],
33	is	VBZ	O	be	cop	37	SENT_376	[p22l1068t3530r1118b3587],
34	in	IN	O	in	_	0	SENT_376	[p22l1142t3530r1208b3586],
35	phase	NN	O	phase	prep_in	37	SENT_376	[p22l1230t3524r1425b3607],
36	I	PRP	O	I	dep	37	SENT_376	[p22l1449t3529r1472b3586],
37	trials	NNS	O	trial	rcmod	30	SENT_376	[p22l1495t3524r1667b3587],
38	in	IN	O	in	_	0	SENT_376	[p22l1691t3530r1757b3586],
39	the	DT	O	the	det	41	SENT_376	[p22l1779t3524r1886b3587],
40	United	NNP	LOCATION	United	nn	41	SENT_376	[p22l1909t3524r2145b3587],
41	Kingdom	NNP	LOCATION	Kingdom	prep_in	37	SENT_376	[p22l10t3619r381b3710],
42	.5	CD	NUMBER	.5	num	41	SENT_376	[p22l10t3619r381b3710],

1	Like	IN	O	like	_	0	SENT_377	[p22l83t3729r229b3792],
2	GLP-1	NN	O	glp-1	nn	6	SENT_377	[p22l253t3733r491b3801],
3	,	,	O	,	_	0	SENT_377	[p22l253t3733r491b3801],
4	oxyntomodulin	NN	O	oxyntomodulin	dep	6	SENT_377	[p22l517t3729r1050b3813],
5	(	CD	NUMBER	(	num	6	SENT_377	[p22l1077t3729r1321b3806],
6	OXM	NN	O	oxm	prep_like	11	SENT_377	[p22l1077t3729r1321b3806],
7	)	NN	O	)	nsubj	11	SENT_377	[p22l1077t3729r1321b3806],
8	is	VBZ	O	be	cop	11	SENT_377	[p22l1348t3735r1398b3792],
9	an	DT	O	a	det	11	SENT_377	[p22l1422t3752r1502b3792],
10	anorexigenic	JJ	O	anorexigenic	amod	11	SENT_377	[p22l1526t3735r1965b3813],
11	peptide	NN	O	peptide	_	0	SENT_377	[p22l1987t3751r2140b3812, p23l8t17r141b80],

1	hormone	NN	O	hormone	nsubj	9	SENT_378	[p23l164t17r489b80],
2	produced	VBD	O	produce	_	0	SENT_378	[p23l512t17r850b100],
3	from	IN	O	from	_	0	SENT_378	[p23l872t17r1044b80],
4	the	DT	O	the	det	5	SENT_378	[p23l1067t17r1177b80],
5	processing	NN	O	processing	prep_from	2	SENT_378	[p23l1199t23r1576b101],
6	of	IN	O	of	_	0	SENT_378	[p23l1599t17r1675b80],
7	preproglucagon	NN	O	preproglucagon	prep_of	5	SENT_378	[p23l1687t17r2140b101, p23l9t143r139b204],
8	and	CC	O	and	_	0	SENT_378	[p23l164t120r293b183],
9	secreted	VBN	O	secrete	conj_and	2	SENT_378	[p23l318t120r606b183],
10	postprandially	RB	O	postprandially	advmod	9	SENT_378	[p23l628t120r1143b204],
11	with	IN	O	with	_	0	SENT_378	[p23l1162t120r1320b183],
12	GLP	NN	O	glp	nn	13	SENT_378	[p23l1345t124r1565b183],
13	—	NN	O	—	prep_with	9	SENT_378	[p23l1345t124r1565b183],
14	1	CD	NUMBER	1	num	13	SENT_378	[p23l1345t124r1565b183],
15	by	IN	O	by	_	0	SENT_378	[p23l1593t120r1679b204],
16	the	DT	O	the	det	18	SENT_378	[p23l1699t120r1808b183],
17	L	NN	O	l	nn	18	SENT_378	[p23l1834t125r1877b182],
18	cells	NNS	O	cell	prep_by	9	SENT_378	[p23l1902t120r2050b183],
19	in	IN	O	in	prep	9	SENT_378	[p23l2075t126r2143b182],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_379	[p23l22t269r141b290],
2	PHARMACOLOGY	NNP	O	PHARMACOLOGY	dep	12	SENT_379	[p23l150t269r375b290],
3	&	CC	O	&	_	0	SENT_379	[p23l382t269r602b290],
4	THERAPEUT	NNP	O	THERAPEUT	nn	6	SENT_379	[p23l382t269r602b290],
5	|	CD	NUMBER	|	num	6	SENT_379	[p23l382t269r602b290],
6	CS	NNP	O	CS	conj_and	2	SENT_379	[p23l382t269r602b290],
7	|	NNP	O	|	nn	8	SENT_379	[p23l612t267r614b297],
8	VOLUME	NNP	O	VOLUME	dep	2	SENT_379	[p23l622t269r730b290],
9	95	CD	NUMBER	95	num	10	SENT_379	[p23l738t269r765b290],
10	NUMBER	NN	O	number	dep	12	SENT_379	[p23l775t269r883b290],
11	1	CD	NUMBER	1	num	12	SENT_379	[p23l893t270r900b290],
12	|	CD	NUMBER	|	dep	15	SENT_379	[p23l914t267r916b297],
13	JANUARY	NNP	DATE	JANUARY	dep	12	SENT_379	[p23l925t269r1043b290],
14	2014	CD	DATE	2014	num	15	SENT_379	[p23l1051t269r1109b290],
15	61	CD	DATE	61	_	0	SENT_379	[p23l2110t269r2137b290],

1	the	DT	O	the	det	2	SENT_380	[p23l8t645r117b708],
2	colon	NN	O	colon	_	0	SENT_380	[p23l142t645r353b708],
3	.	.	O	.	_	0	SENT_380	[p23l142t645r353b708],

1	Injections	NNS	O	injection	nsubj	6	SENT_381	[p23l381t650r729b729],
2	of	IN	O	of	_	0	SENT_381	[p23l755t645r831b708],
3	OXM	NNP	O	OXM	prep_of	1	SENT_381	[p23l846t649r1041b708],
4	in	IN	O	in	_	0	SENT_381	[p23l1066t651r1134b707],
5	humans	NNS	O	human	prep_in	3	SENT_381	[p23l1157t645r1439b708],
6	caused	VBD	O	cause	_	0	SENT_381	[p23l1464t645r1702b708],
7	a	DT	O	a	det	9	SENT_381	[p23l1725t668r1761b708],
8	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_381	[p23l1785t645r2151b729],
9	reduction	NN	O	reduction	dobj	6	SENT_381	[p23l9t748r345b811],
10	in	IN	O	in	_	0	SENT_381	[p23l368t754r435b810],
11	weight	NN	O	weight	prep_in	9	SENT_381	[p23l456t748r689b832],
12	and	CC	O	and	_	0	SENT_381	[p23l711t748r838b811],
13	appetite	NN	O	appetite	conj_and	11	SENT_381	[p23l861t754r1153b831],
14	,	,	O	,	_	0	SENT_381	[p23l861t754r1153b831],
15	in	IN	O	in	_	0	SENT_381	[p23l1178t754r1245b810],
16	addition	NN	O	addition	_	0	SENT_381	[p23l1269t748r1559b811],
17	to	TO	O	to	_	0	SENT_381	[p23l1581t760r1648b811],
18	an	DT	O	a	det	19	SENT_381	[p23l1673t771r1754b811],
19	increase	NN	O	increase	conj_in	9	SENT_381	[p23l1777t754r2058b811],
20	in	IN	O	in	_	0	SENT_381	[p23l2081t754r2148b810],
21	energy	NN	O	energy	nn	22	SENT_381	[p23l9t874r244b935],
22	expenditure	NN	O	expenditure	prep_in	19	SENT_381	[p23l264t851r693b934],
23	.	.	O	.	_	0	SENT_381	[p23l264t851r693b934],

1	OXM	NNP	O	OXM	nsubj	5	SENT_382	[p23l720t855r911b914],
2	is	VBZ	O	be	cop	5	SENT_382	[p23l935t857r985b914],
3	a	DT	O	a	det	5	SENT_382	[p23l1010t874r1044b914],
4	dual	JJ	O	dual	amod	5	SENT_382	[p23l1067t851r1215b914],
5	agonist	NN	O	agonist	_	0	SENT_382	[p23l1238t857r1484b935],
6	of	IN	O	of	_	0	SENT_382	[p23l1507t851r1581b914],
7	the	DT	O	the	det	8	SENT_382	[p23l1593t851r1700b914],
8	GLP-1R	NN	O	glp-1r	prep_of	5	SENT_382	[p23l1724t855r2003b914],
9	and	CC	O	and	_	0	SENT_382	[p23l2024t851r2151b914],
10	the	DT	O	the	det	12	SENT_382	[p23l8t954r115b1017],
11	glucagon	NN	O	glucagon	nn	12	SENT_382	[p23l138t954r449b1038],
12	receptor	NN	O	receptor	prep_of	5	SENT_382	[p23l472t966r770b1037],
13	,	,	O	,	_	0	SENT_382	[p23l472t966r770b1037],
14	and	CC	O	and	_	0	SENT_382	[p23l795t954r923b1017],
15	it	PRP	O	it	nsubj	17	SENT_382	[p23l944t960r990b1017],
16	may	MD	O	may	aux	17	SENT_382	[p23l1012t977r1160b1038],
17	exert	VB	O	exert	conj_and	5	SENT_382	[p23l1179t966r1350b1017],
18	its	PRP$	O	its	poss	20	SENT_382	[p23l1373t960r1448b1017],
19	anorectic	JJ	O	anorectic	amod	20	SENT_382	[p23l1473t960r1790b1017],
20	effects	NNS	O	effect	dobj	17	SENT_382	[p23l1814t954r2027b1017],
21	via	IN	O	via	_	0	SENT_382	[p23l2048t960r2150b1017],
22	activation	NN	O	activation	prep_via	20	SENT_382	[p23l9t1062r352b1119],
23	of	IN	O	of	_	0	SENT_382	[p23l375t1056r450b1119],
24	central	JJ	O	central	amod	25	SENT_382	[p23l464t1056r702b1119],
25	GLP	NN	O	glp	prep_of	22	SENT_382	[p23l726t1060r904b1119],
26	-	:	O	-	_	0	SENT_382	[p23l726t1060r904b1119],
27	IRS	NNP	ORGANIZATION	IRS	dobj	17	SENT_382	[p23l918t1061r1036b1119],
28	and	CC	O	and	_	0	SENT_382	[p23l1061t1056r1189b1119],
29	stimulation	NN	O	stimulation	dobj	17	SENT_382	[p23l1211t1056r1609b1119],
30	of	IN	O	of	_	0	SENT_382	[p23l1633t1056r1708b1119],
31	POMC	JJ	O	pomc	amod	32	SENT_382	[p23l1722t1060r1966b1119],
32	neurons	NNS	O	neuron	prep_of	29	SENT_382	[p23l1989t1079r2146b1119, p23l9t1181r157b1222],
33	in	IN	O	in	_	0	SENT_382	[p23l181t1165r248b1221],
34	the	DT	O	the	det	37	SENT_382	[p23l270t1158r377b1222],
35	ARC	NNP	O	ARC	nn	37	SENT_382	[p23l399t1162r567b1222],
36	(	CD	NUMBER	(	num	37	SENT_382	[p23l594t1159r854b1242],
37	Figure	NNP	O	Figure	prep_in	17	SENT_382	[p23l594t1159r854b1242],
38	2	CD	NUMBER	2	number	39	SENT_382	[p23l876t1150r1074b1235],
39	)	CD	NUMBER	)	num	41	SENT_382	[p23l876t1150r1074b1235],
40	.5	CD	NUMBER	.5	number	41	SENT_382	[p23l876t1150r1074b1235],
41	’79	CD	NUMBER	’79	nsubj	62	SENT_382	[p23l876t1150r1074b1235],
42	Like	IN	O	like	_	0	SENT_382	[p23l1098t1158r1244b1222],
43	GLP	NN	O	glp	nn	44	SENT_382	[p23l1268t1162r1508b1231],
44	—	NN	O	—	prep_like	49	SENT_382	[p23l1268t1162r1508b1231],
45	1	CD	NUMBER	1	num	44	SENT_382	[p23l1268t1162r1508b1231],
46	,	,	O	,	_	0	SENT_382	[p23l1268t1162r1508b1231],
47	rapid	JJ	O	rapid	amod	48	SENT_382	[p23l1533t1158r1712b1242],
48	degradation	NN	O	degradation	nsubj	49	SENT_382	[p23l1735t1158r2149b1243],
49	makes	VBZ	O	make	rcmod	41	SENT_382	[p23l8t1262r222b1325],
50	endogenous	JJ	O	endogenous	amod	51	SENT_382	[p23l243t1262r652b1346],
51	OXM	NN	O	oxm	dobj	49	SENT_382	[p23l675t1266r863b1325],
52	impractical	JJ	O	impractical	amod	51	SENT_382	[p23l884t1262r1268b1345],
53	for	IN	O	for	_	0	SENT_382	[p23l1287t1262r1384b1325],
54	pharmacotherapy	NN	O	pharmacotherapy	prep_for	52	SENT_382	[p23l1402t1262r2016b1346],
55	,	,	O	,	_	0	SENT_382	[p23l1402t1262r2016b1346],
56	but	CC	O	but	_	0	SENT_382	[p23l2035t1262r2148b1325],
57	long	RB	O	long	advmod	58	SENT_382	[p23l7t1365r407b1449],
58	—	RB	O	—	amod	51	SENT_382	[p23l7t1365r407b1449],
59	acting	VBG	O	act	dep	58	SENT_382	[p23l7t1365r407b1449],
60	OXM	NN	O	oxm	nn	61	SENT_382	[p23l430t1369r622b1428],
61	analogs	NNS	O	analog	dobj	59	SENT_382	[p23l647t1365r906b1449],
62	are	VBP	O	be	rcmod	37	SENT_382	[p23l930t1388r1032b1428],
63	in	IN	O	in	_	0	SENT_382	[p23l1055t1371r1122b1427],
64	development	NN	O	development	prep_in	62	SENT_382	[p23l1146t1365r1612b1448],
65	.	.	O	.	_	0	SENT_382	[p23l1146t1365r1612b1448],

1	TKS1225	CD	NUMBER	tks1225	_	0	SENT_383	[p23l1638t1368r1955b1428],
2	from	IN	O	from	_	0	SENT_383	[p23l1980t1365r2150b1428],
3	Thiakis/Wyeth	NN	O	thiakis/wyeth	prep_from	1	SENT_383	[p23l8t1468r577b1552],
4	/	:	O	/	punct	1	SENT_383	[p23l8t1468r577b1552],
5	Pfizer	NNP	ORGANIZATION	Pfizer	nsubj	6	SENT_383	[p23l584t1468r795b1531],
6	is	VBZ	O	be	dep	1	SENT_383	[p23l822t1474r875b1531],
7	in	IN	O	in	_	0	SENT_383	[p23l904t1474r974b1530],
8	phase	NN	O	phase	prep_in	6	SENT_383	[p23l1001t1468r1205b1551],
9	I	PRP	O	I	dep	10	SENT_383	[p23l1235t1473r1259b1530],
10	trials	NNS	O	trial	dep	8	SENT_383	[p23l1288t1468r1489b1531],
11	.	.	O	.	_	0	SENT_383	[p23l1288t1468r1489b1531],

1	OXY-RPEG	NN	O	oxy-rpeg	nsubjpass	7	SENT_384	[p23l1521t1472r1944b1531],
2	from	IN	O	from	_	0	SENT_384	[p23l1973t1468r2148b1531],
3	PROLOR	NNP	O	PROLOR	nn	4	SENT_384	[p23l9t1575r350b1634],
4	Biotech	NNP	O	Biotech	prep_from	1	SENT_384	[p23l375t1571r647b1634],
5	has	VBZ	O	have	aux	7	SENT_384	[p23l674t1571r790b1634],
6	been	VBN	O	be	auxpass	7	SENT_384	[p23l817t1571r989b1634],
7	engineered	VBN	O	engineer	_	0	SENT_384	[p23l1017t1571r1417b1655],
8	with	IN	O	with	_	0	SENT_384	[p23l1441t1571r1602b1634],
9	its	PRP$	O	its	poss	13	SENT_384	[p23l1630t1577r1709b1634],
10	proprietary	JJ	O	proprietary	amod	13	SENT_384	[p23l1737t1577r2153b1655],
11	reversible	JJ	O	reversible	amod	13	SENT_384	[p23l9t1674r345b1737],
12	pegylation	NN	O	pegylation	nn	13	SENT_384	[p23l368t1674r739b1758],
13	technology	NN	O	technology	prep_with	7	SENT_384	[p23l762t1674r1157b1758],
14	to	TO	O	to	aux	15	SENT_384	[p23l1175t1686r1243b1737],
15	increase	VB	O	increase	xcomp	7	SENT_384	[p23l1268t1680r1552b1737],
16	its	PRP$	O	its	poss	19	SENT_384	[p23l1576t1680r1654b1737],
17	half	NN	O	half	nn	19	SENT_384	[p23l1677t1674r1969b1746],
18	—	CD	NUMBER	—	num	19	SENT_384	[p23l1677t1674r1969b1746],
19	life	NN	O	life	dobj	15	SENT_384	[p23l1677t1674r1969b1746],
20	,	,	O	,	_	0	SENT_384	[p23l1677t1674r1969b1746],
21	with	IN	O	with	_	0	SENT_384	[p23l1992t1674r2149b1737],
22	an	DT	O	a	det	24	SENT_384	[p23l9t1800r91b1840],
23	added	VBN	O	add	amod	24	SENT_384	[p23l117t1777r333b1840],
24	beneﬁt	NN	O	beneﬁt	prep_with	7	SENT_384	[p23l354t1777r599b1840],
25	of	IN	O	of	_	0	SENT_384	[p23l623t1777r699b1840],
26	increased	VBN	O	increase	amod	27	SENT_384	[p23l714t1777r1052b1840],
27	potency	NN	O	potency	prep_of	24	SENT_384	[p23l1074t1789r1369b1861],
28	.	.	O	.	_	0	SENT_384	[p23l1074t1789r1369b1861],

1	In	IN	O	in	_	0	SENT_385	[p23l1398t1782r1471b1839],
2	preclinical	JJ	O	preclinical	amod	3	SENT_385	[p23l1494t1777r1868b1860],
3	testing	NN	O	testing	prep_in	8	SENT_385	[p23l1891t1783r2147b1861],
4	,	,	O	,	_	0	SENT_385	[p23l1891t1783r2147b1861],
5	OXY-RPEG	NN	O	oxy-rpeg	nsubj	8	SENT_385	[p23l10t1884r415b1943],
6	was	VBD	O	be	cop	8	SENT_385	[p23l434t1903r560b1943],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_385	[p23l583t1880r1003b1964],
8	superior	JJ	O	superior	_	0	SENT_385	[p23l1021t1886r1308b1963],
9	to	TO	O	to	_	0	SENT_385	[p23l1327t1892r1393b1943],
10	twice-daily	JJ	O	twice-daily	amod	11	SENT_385	[p23l1414t1880r1797b1964],
11	injections	NNS	O	injection	prep_to	8	SENT_385	[p23l1815t1886r2148b1964],
12	of	IN	O	of	_	0	SENT_385	[p23l9t1983r84b2046],
13	OXM	NNP	O	OXM	prep_of	11	SENT_385	[p23l98t1987r290b2046],
14	in	IN	O	in	_	0	SENT_385	[p23l315t1989r382b2045],
15	the	DT	O	the	det	16	SENT_385	[p23l404t1983r512b2046],
16	reduction	NN	O	reduction	prep_in	8	SENT_385	[p23l535t1983r872b2046],
17	of	IN	O	of	_	0	SENT_385	[p23l896t1983r970b2046],
18	food	NN	O	food	nn	19	SENT_385	[p23l984t1983r1143b2046],
19	intake	NN	O	intake	prep_of	16	SENT_385	[p23l1166t1983r1377b2046],
20	and	CC	O	and	_	0	SENT_385	[p23l1401t1983r1529b2046],
21	in	IN	O	in	_	0	SENT_385	[p23l1551t1989r1618b2045],
22	the	DT	O	the	det	23	SENT_385	[p23l1641t1983r1748b2046],
23	degree	NN	O	degree	prep_in	8	SENT_385	[p23l1772t1983r1999b2067],
24	and	CC	O	and	_	0	SENT_385	[p23l2023t1983r2151b2046],
25	durability	NN	O	durability	conj_and	23	SENT_385	[p23l9t2086r345b2171],
26	of	IN	O	of	_	0	SENT_385	[p23l365t2086r438b2150],
27	weight	NN	O	weight	nn	28	SENT_385	[p23l448t2086r678b2171],
28	loss	NN	O	loss	prep_of	23	SENT_385	[p23l698t2079r874b2150],
29	.5	CD	NUMBER	.5	num	28	SENT_385	[p23l698t2079r874b2150],

1	THE	DT	O	the	det	3	SENT_386	[p23l8t2303r147b2357],
2	EMERGING	VBG	O	emerge	amod	3	SENT_386	[p23l169t2303r553b2357],
3	ROLE	NN	O	role	nsubj	42	SENT_386	[p23l577t2302r759b2358],
4	OF	IN	O	of	_	0	SENT_386	[p23l779t2302r872b2358],
5	CYCLIC	NNP	O	CYCLIC	nn	8	SENT_386	[p23l893t2303r1144b2358],
6	GUANOSINE	NNP	O	GUANOSINE	nn	8	SENT_386	[p23l1163t2302r1600b2358],
7	MONOPHOSPHATE	NNP	O	MONOPHOSPHATE	nn	8	SENT_386	[p23l11t2405r688b2461],
8	SIGNALING	NNP	O	SIGNALING	prep_of	3	SENT_386	[p23l708t2406r1110b2461],
9	IN	IN	O	in	_	0	SENT_386	[p23l1133t2406r1201b2460],
10	ANTIOBESITY	NNP	O	ANTIOBESITY	nn	11	SENT_386	[p23l1222t2405r1710b2461],
11	PHARMACOTHERAPY	NNP	O	PHARMACOTHERAPY	prep_in	8	SENT_386	[p23l12t2508r773b2564],
12	Cyclic	JJ	O	cyclic	amod	13	SENT_386	[p23l10t2604r216b2688],
13	nucleotides	NNS	O	nucleotide	dep	11	SENT_386	[p23l237t2604r639b2676],
14	,	,	O	,	_	0	SENT_386	[p23l237t2604r639b2676],
15	including	VBG	O	include	partmod	11	SENT_386	[p23l662t2604r985b2688],
16	3	CD	NUMBER	3	dobj	15	SENT_386	[p23l1006t2602r1367b2688],
17	'	''	O	'	_	0	SENT_386	[p23l1006t2602r1367b2688],
18	,5	CD	NUMBER	,5	dep	16	SENT_386	[p23l1006t2602r1367b2688],
19	'	''	O	'	_	0	SENT_386	[p23l1006t2602r1367b2688],
20	-	:	O	-	_	0	SENT_386	[p23l1006t2602r1367b2688],
21	cyclic	JJ	O	cyclic	amod	26	SENT_386	[p23l1006t2602r1367b2688],
22	guanosine	NN	O	guanosine	nn	26	SENT_386	[p23l1388t2610r1734b2688],
23	monophosphate	NN	O	monophosphate	nn	26	SENT_386	[p23l1755t2604r2146b2687, p23l7t2707r205b2790],
24	(	CD	NUMBER	(	num	26	SENT_386	[p23l241t2708r528b2784],
25	CGMP	NN	O	cgmp	nn	26	SENT_386	[p23l241t2708r528b2784],
26	)	NN	O	)	conj_and	16	SENT_386	[p23l241t2708r528b2784],
27	and	CC	O	and	_	0	SENT_386	[p23l566t2707r699b2770],
28	3	CD	NUMBER	3	conj_and	16	SENT_386	[p23l732t2705r1126b2791],
29	'	''	O	'	_	0	SENT_386	[p23l732t2705r1126b2791],
30	,5	CD	NUMBER	,5	dobj	15	SENT_386	[p23l732t2705r1126b2791],
31	'	''	O	'	_	0	SENT_386	[p23l732t2705r1126b2791],
32	-	:	O	-	_	0	SENT_386	[p23l732t2705r1126b2791],
33	cyclic	JJ	O	cyclic	amod	35	SENT_386	[p23l732t2705r1126b2791],
34	adenosine	NN	O	adenosine	nn	35	SENT_386	[p23l1159t2707r1526b2770],
35	monophosphate	NN	O	monophosphate	dep	3	SENT_386	[p23l1559t2707r2148b2790],
36	(	CD	NUMBER	(	num	38	SENT_386	[p23l12t2810r309b2887],
37	cAMP	NN	O	camp	nn	38	SENT_386	[p23l12t2810r309b2887],
38	)	NN	O	)	dep	35	SENT_386	[p23l12t2810r309b2887],
39	,	,	O	,	_	0	SENT_386	[p23l12t2810r309b2887],
40	are	VBP	O	be	cop	42	SENT_386	[p23l333t2833r435b2873],
41	second	JJ	ORDINAL	second	amod	42	SENT_386	[p23l458t2810r699b2873],
42	messengers	NNS	O	messenger	_	0	SENT_386	[p23l720t2833r1115b2894],
43	important	JJ	O	important	amod	42	SENT_386	[p23l1138t2816r1490b2893],
44	in	IN	O	in	_	0	SENT_386	[p23l1511t2816r1578b2872],
45	many	JJ	O	many	amod	47	SENT_386	[p23l1600t2833r1796b2894],
46	biological	JJ	O	biological	amod	47	SENT_386	[p23l1812t2810r2151b2894],
47	processes	NNS	O	process	prep_in	43	SENT_386	[p23l7t2935r317b2996],
48	(	CD	NUMBER	(	num	49	SENT_386	[p23l339t2914r588b2996],
49	Figure	NN	O	figure	dep	42	SENT_386	[p23l339t2914r588b2996],
50	3	CD	NUMBER	3	num	51	SENT_386	[p23l605t2914r686b2990],
51	)	NN	O	)	dep	49	SENT_386	[p23l605t2914r686b2990],
52	.	.	O	.	_	0	SENT_386	[p23l605t2914r686b2990],

1	The	DT	O	the	det	3	SENT_387	[p23l708t2913r830b2976],
2	canonical	JJ	O	canonical	amod	3	SENT_387	[p23l849t2913r1164b2976],
3	role	NN	O	role	nsubjpass	13	SENT_387	[p23l1181t2913r1305b2976],
4	of	IN	O	of	_	0	SENT_387	[p23l1324t2913r1396b2976],
5	cAMP	NN	O	camp	prep_of	3	SENT_387	[p23l1405t2917r1615b2976],
6	in	IN	O	in	_	0	SENT_387	[p23l1635t2919r1700b2975],
7	carbohydrate	NN	O	carbohydrate	nn	10	SENT_387	[p23l1718t2913r2150b2997],
8	and	CC	O	and	_	0	SENT_387	[p23l9t3016r134b3079],
9	lipid	NN	O	lipid	nn	10	SENT_387	[p23l152t3016r305b3099],
10	metabolism	NN	O	metabolism	prep_in	5	SENT_387	[p23l324t3016r721b3079],
11	is	VBZ	O	be	auxpass	13	SENT_387	[p23l741t3022r791b3079],
12	well	RB	O	well	advmod	13	SENT_387	[p23l810t3016r946b3079],
13	established	VBN	O	establish	_	0	SENT_387	[p23l967t3016r1351b3088],
14	,	,	O	,	_	0	SENT_387	[p23l967t3016r1351b3088],
15	reﬂecting	VBG	O	reﬂecting	xcomp	13	SENT_387	[p23l1374t3016r1690b3100],
16	sophisticated	JJ	O	sophisticated	amod	17	SENT_387	[p23l1711t3016r2150b3099],
17	studies	NNS	O	study	dobj	15	SENT_387	[p23l10t3118r241b3182],
18	of	IN	O	of	_	0	SENT_387	[p23l264t3118r337b3182],
19	insulin	NN	O	insulin	prep_of	17	SENT_387	[p23l349t3118r582b3182],
20	and	CC	O	and	_	0	SENT_387	[p23l604t3118r730b3182],
21	glucagon	NN	O	glucagon	conj_and	17	SENT_387	[p23l750t3110r1137b3203],
22	.8	CD	NUMBER	.8	number	23	SENT_387	[p23l750t3110r1137b3203],
23	°	CD	NUMBER	°	num	24	SENT_387	[p23l750t3110r1137b3203],
24	Speciﬁcally	NNP	O	Speciﬁcally	dep	21	SENT_387	[p23l1159t3118r1549b3203],
25	,	,	O	,	_	0	SENT_387	[p23l1159t3118r1549b3203],
26	binding	NN	O	binding	nsubj	33	SENT_387	[p23l1569t3118r1836b3203],
27	of	IN	O	of	_	0	SENT_387	[p23l1856t3118r1930b3182],
28	glucagon	NN	O	glucagon	prep_of	26	SENT_387	[p23l1941t3118r2145b3203, p23l9t3245r135b3306],
29	to	TO	O	to	_	0	SENT_387	[p23l157t3234r223b3285],
30	an	DT	O	a	det	32	SENT_387	[p23l246t3245r327b3285],
31	adrenergic	JJ	O	adrenergic	amod	32	SENT_387	[p23l350t3222r713b3306],
32	receptor	NN	O	receptor	prep_to	28	SENT_387	[p23l735t3234r1019b3305],
33	activates	VBZ	O	activate	conj_and	13	SENT_387	[p23l1041t3228r1330b3285],
34	adenylyl	JJ	O	adenylyl	amod	35	SENT_387	[p23l1354t3222r1639b3306],
35	cyclase	NN	O	cyclase	dobj	33	SENT_387	[p23l1661t3222r1916b3306],
36	,	,	O	,	_	0	SENT_387	[p23l1661t3222r1916b3306],
37	which	WDT	O	which	nsubj	38	SENT_387	[p23l1938t3222r2148b3285],
38	results	VBZ	O	result	rcmod	35	SENT_387	[p23l9t3325r223b3388],
39	in	IN	O	in	_	0	SENT_387	[p23l242t3331r308b3387],
40	an	DT	O	a	det	41	SENT_387	[p23l327t3348r406b3388],
41	increase	NN	O	increase	prep_in	38	SENT_387	[p23l425t3331r697b3388],
42	in	IN	O	in	_	0	SENT_387	[p23l716t3331r781b3387],
43	intracellular	JJ	O	intracellular	amod	44	SENT_387	[p23l800t3325r1206b3388],
44	cAMP	NN	O	camp	prep_in	41	SENT_387	[p23l1224t3329r1438b3388],
45	and	CC	O	and	_	0	SENT_387	[p23l1459t3325r1583b3388],
46	elicits	VBZ	O	elicit	conj_and	38	SENT_387	[p23l1601t3325r1789b3388],
47	sequential	JJ	O	sequential	amod	49	SENT_387	[p23l1809t3325r2149b3408],
48	downstream	JJ	O	downstream	amod	49	SENT_387	[p23l10t3428r422b3491],
49	signaling	NN	O	signaling	dobj	46	SENT_387	[p23l442t3428r742b3512],
50	that	WDT	O	that	nsubj	51	SENT_387	[p23l757t3428r887b3491],
51	promotes	VBZ	O	promote	rcmod	49	SENT_387	[p23l903t3440r1217b3511],
52	gluconeogenesis	NN	O	gluconeogenesis	dobj	51	SENT_387	[p23l1236t3428r1776b3512],
53	and	CC	O	and	_	0	SENT_387	[p23l1795t3428r1919b3491],
54	lipoly	JJ	O	lipoly	amod	56	SENT_387	[p23l1935t3428r2147b3512],
55	—	NN	O	—	nn	56	SENT_387	[p23l1935t3428r2147b3512],
56	sis	NN	O	si	nsubj	77	SENT_387	[p23l10t3537r89b3594],
57	in	IN	O	in	dep	60	SENT_387	[p23l109t3537r174b3593],
58	the	DT	O	the	det	59	SENT_387	[p23l192t3530r296b3594],
59	liver	NN	O	liver	pobj	57	SENT_387	[p23l314t3522r530b3594],
60	.81	CD	NUMBER	.81	rcmod	56	SENT_387	[p23l314t3522r530b3594],
61	On	IN	O	on	dep	60	SENT_387	[p23l555t3534r660b3594],
62	the	DT	O	the	det	63	SENT_387	[p23l678t3530r782b3594],
63	contrary	NN	O	contrary	pobj	61	SENT_387	[p23l802t3542r1097b3615],
64	,	,	O	,	_	0	SENT_387	[p23l802t3542r1097b3615],
65	insulin	NN	O	insulin	appos	63	SENT_387	[p23l1118t3530r1365b3603],
66	,	,	O	,	_	0	SENT_387	[p23l1118t3530r1365b3603],
67	through	IN	O	through	dep	60	SENT_387	[p23l1384t3530r1656b3615],
68	its	PRP$	O	its	poss	69	SENT_387	[p23l1675t3537r1748b3594],
69	receptor	NN	O	receptor	pobj	67	SENT_387	[p23l1768t3543r2045b3614],
70	on	IN	O	on	_	0	SENT_387	[p23l2063t3553r2148b3594],
71	the	DT	O	the	det	73	SENT_387	[p23l8t3634r113b3697],
72	plasma	NN	O	plasma	nn	73	SENT_387	[p23l131t3634r370b3717],
73	membrane	NN	O	membrane	prep_on	69	SENT_387	[p23l388t3634r752b3697],
74	of	IN	O	of	_	0	SENT_387	[p23l772t3634r845b3697],
75	hepatocytes	NNS	O	hepatocyte	prep_of	73	SENT_387	[p23l854t3634r1268b3718],
76	,	,	O	,	_	0	SENT_387	[p23l854t3634r1268b3718],
77	activates	VBZ	O	activate	conj_and	13	SENT_387	[p23l1289t3640r1573b3697],
78	cyclic	JJ	O	cyclic	amod	80	SENT_387	[p23l1593t3634r1780b3718],
79	nucleotide	NN	O	nucleotide	nn	80	SENT_387	[p23l1798t3634r2149b3697],
80	phosphodiesterases	NNS	O	phosphodiesterase	nsubj	81	SENT_387	[p23l8t3737r654b3820],
81	(	VBP	O	(	ccomp	77	SENT_387	[p23l677t3738r911b3814],
82	PDES	NN	O	pde	nn	83	SENT_387	[p23l677t3738r911b3814],
83	)	NN	O	)	dobj	81	SENT_387	[p23l677t3738r911b3814],
84	that	WDT	O	that	nsubj	85	SENT_387	[p23l933t3737r1062b3800],
85	convert	VBP	O	convert	rcmod	83	SENT_387	[p23l1080t3749r1329b3800],
86	cAMP	NN	O	camp	dobj	85	SENT_387	[p23l1348t3741r1559b3800],
87	to	TO	O	to	_	0	SENT_387	[p23l1578t3749r1642b3800],
88	AMP	NN	O	amp	prep_to	85	SENT_387	[p23l1661t3741r1839b3799],
89	and	CC	O	and	cc	83	SENT_387	[p23l1859t3737r1983b3800],
90	consequently	RB	O	consequently	advmod	83	SENT_387	[p23l2001t3760r2147b3800, p24l10t20r339b105],

1	terminates	VBZ	O	terminate	_	0	SENT_388	[p24l356t27r720b84],
2	CAMP	NN	O	camp	nn	3	SENT_388	[p24l743t24r961b84],
3	signaling	NN	O	signaling	dobj	1	SENT_388	[p24l985t12r1375b105],
4	.82	CD	NUMBER	.82	num	3	SENT_388	[p24l985t12r1375b105],
5	Reciprocally	RB	O	reciprocally	advmod	1	SENT_388	[p24l1399t20r1834b105],
6	,	,	O	,	_	0	SENT_388	[p24l1399t20r1834b105],
7	hydrolysis	NN	O	hydrolysis	dep	1	SENT_388	[p24l1857t20r2147b105, p24l10t130r90b187],
8	of	IN	O	of	_	0	SENT_388	[p24l113t124r186b187],
9	CAMP	NN	O	camp	prep_of	7	SENT_388	[p24l198t128r414b187],
10	by	IN	O	by	_	0	SENT_388	[p24l434t124r518b208],
11	PDEs	NNS	O	pde	prep_by	7	SENT_388	[p24l537t129r723b187],
12	in	IN	O	in	mark	17	SENT_388	[p24l745t130r811b186],
13	pancreatic	JJ	O	pancreatic	amod	16	SENT_388	[p24l831t130r1182b207],
14	B	NN	O	b	nn	16	SENT_388	[p24l1206t122r1423b205],
15	—	NN	O	—	nn	16	SENT_388	[p24l1206t122r1423b205],
16	cells	NNS	O	cell	nsubj	22	SENT_388	[p24l1206t122r1423b205],
17	depletes	VBZ	O	deplete	advcl	1	SENT_388	[p24l1446t124r1717b207],
18	intracellular	JJ	O	intracellular	amod	20	SENT_388	[p24l1740t124r2150b187],
19	CAMP	NN	O	camp	nn	20	SENT_388	[p24l10t231r224b290],
20	levels	NNS	O	level	dobj	17	SENT_388	[p24l244t226r425b290],
21	and	CC	O	and	_	0	SENT_388	[p24l447t226r571b290],
22	inhibits	VBZ	O	inhibit	advcl	1	SENT_388	[p24l590t226r843b290],
23	insulin	NN	O	insulin	nn	24	SENT_388	[p24l864t226r1095b290],
24	secretion	NN	O	secretion	dobj	22	SENT_388	[p24l1116t218r1497b290],
25	.83	CD	NUMBER	.83	nsubj	1	SENT_388	[p24l1116t218r1497b290],

1	The	DT	O	the	det	2	SENT_389	[p24l83t330r207b393],
2	role	NN	O	role	nsubjpass	13	SENT_389	[p24l227t330r355b393],
3	of	IN	O	of	_	0	SENT_389	[p24l376t330r449b393],
4	CAMP	NN	O	camp	prep_of	2	SENT_389	[p24l460t334r675b393],
5	in	IN	O	in	_	0	SENT_389	[p24l696t336r762b392],
6	the	DT	O	the	det	7	SENT_389	[p24l781t330r886b393],
7	regulation	NN	O	regulation	prep_in	4	SENT_389	[p24l907t330r1252b414],
8	of	IN	O	of	_	0	SENT_389	[p24l1273t330r1346b393],
9	energy	NN	O	energy	nn	10	SENT_389	[p24l1357t353r1588b414],
10	homeostasis	NN	O	homeostasis	prep_of	7	SENT_389	[p24l1604t330r2019b393],
11	has	VBZ	O	have	aux	13	SENT_389	[p24l2038t330r2149b393],
12	been	VBN	O	be	auxpass	13	SENT_389	[p24l7t433r171b496],
13	extended	VBN	O	extend	_	0	SENT_389	[p24l192t433r502b496],
14	via	IN	O	via	_	0	SENT_389	[p24l519t439r620b496],
15	its	PRP$	O	its	poss	17	SENT_389	[p24l639t439r715b496],
16	intimate	JJ	O	intimate	amod	17	SENT_389	[p24l736t439r1019b496],
17	relationship	NN	O	relationship	prep_via	13	SENT_389	[p24l1040t433r1443b516],
18	with	IN	O	with	_	0	SENT_389	[p24l1463t433r1615b496],
19	AMP-activated	JJ	MISC	amp-activated	amod	21	SENT_389	[p24l1634t433r2151b496],
20	protein	NN	O	protein	nn	21	SENT_389	[p24l8t542r256b619],
21	kinase	NN	O	kinase	prep_with	13	SENT_389	[p24l275t536r492b599],
22	(	CD	NUMBER	(	num	25	SENT_389	[p24l516t537r807b613],
23	AMPK	NNP	O	AMPK	nn	25	SENT_389	[p24l516t537r807b613],
24	)	NN	O	)	nn	25	SENT_389	[p24l516t537r807b613],
25	signaling	NN	O	signaling	dep	21	SENT_389	[p24l833t536r1157b620],
26	.	.	O	.	_	0	SENT_389	[p24l833t536r1157b620],

1	Intracellular	JJ	O	intracellular	amod	2	SENT_390	[p24l1181t536r1601b599],
2	CAMP	NN	O	camp	_	0	SENT_390	[p24l1621t540r1837b599],
3	activates	VBZ	O	activate	rcmod	2	SENT_390	[p24l1859t542r2148b599],
4	the	DT	O	the	det	7	SENT_390	[p24l8t639r115b702],
5	AMPK	NN	ORGANIZATION	ampk	nn	7	SENT_390	[p24l136t643r378b701],
6	signaling	NN	O	signaling	nn	7	SENT_390	[p24l399t639r710b723],
7	pathway	NN	O	pathway	conj_and	7	SENT_390	[p24l730t639r1019b723],
8	through	IN	O	through	_	0	SENT_390	[p24l1037t639r1315b723],
9	its	PRP$	O	its	poss	11	SENT_390	[p24l1336t645r1412b702],
10	metabolite	NN	O	metabolite	nn	11	SENT_390	[p24l1434t639r1797b702],
11	AMP	NN	O	amp	prep_through	7	SENT_390	[p24l1819t643r2000b701],
12	and	CC	O	and	_	0	SENT_390	[p24l2024t639r2151b702],
13	by	IN	O	by	_	0	SENT_390	[p24l7t742r93b827],
14	elevating	VBG	O	elevate	prepc_by	7	SENT_390	[p24l114t742r429b827],
15	Cytosolic	JJ	O	cytosolic	amod	16	SENT_390	[p24l451t742r761b827],
16	Ca2	NN	O	ca2	dobj	14	SENT_390	[p24l786t743r948b834],
17	+	CC	O	+	_	0	SENT_390	[p24l786t743r948b834],
18	Concentrations	NNS	O	concentration	dobj	14	SENT_390	[p24l973t748r1495b806],
19	through	IN	O	through	_	0	SENT_390	[p24l1518t742r1803b827],
20	exchange	NN	O	exchange	nn	21	SENT_390	[p24l1827t742r2150b827],
21	protein	NN	O	protein	prep_through	14	SENT_390	[p24l8t852r259b929],
22	activated	VBN	O	activate	partmod	21	SENT_390	[p24l282t846r591b909],
23	by	IN	O	by	_	0	SENT_390	[p24l610t846r695b930],
24	CAMP	NN	O	camp	nn	27	SENT_390	[p24l715t850r933b909],
25	(	NN	O	(	nn	27	SENT_390	[p24l960t847r1220b929],
26	Epacl	NN	O	epacl	nn	27	SENT_390	[p24l960t847r1220b929],
27	)	NN	O	)	agent	22	SENT_390	[p24l960t847r1220b929],
28	signaling	NN	O	signaling	ccomp	3	SENT_390	[p24l1248t846r1560b930],
29	and	CC	O	and	dep	34	SENT_390	[p24l1582t846r1726b918],
30	,	,	O	,	_	0	SENT_390	[p24l1582t846r1726b918],
31	thereby	RB	O	thereby	dep	34	SENT_390	[p24l1749t846r2020b930],
32	,	,	O	,	_	0	SENT_390	[p24l1749t846r2020b930],
33	the	DT	O	the	det	34	SENT_390	[p24l2043t846r2150b909],
34	activation	NN	O	activation	dep	28	SENT_390	[p24l10t956r347b1013],
35	of	IN	O	of	_	0	SENT_390	[p24l369t949r443b1013],
36	calmodulin	NN	O	calmodulin	nn	37	SENT_390	[p24l454t949r1246b1033],
37	—	NN	O	—	prep_of	34	SENT_390	[p24l454t949r1246b1033],
38	dependent	JJ	O	dependent	amod	39	SENT_390	[p24l454t949r1246b1033],
39	protein	NN	O	protein	dobj	28	SENT_390	[p24l1264t956r1514b1033],
40	kinase	NN	O	kinase	nn	41	SENT_390	[p24l1533t950r1751b1013],
41	kinase	NN	O	kinase	dep	2	SENT_390	[p24l1771t941r2150b1031],
42	-	:	O	-	_	0	SENT_390	[p24l1771t941r2150b1031],
43	[	CD	NUMBER	[	dep	41	SENT_390	[p24l1771t941r2150b1031],
44	$	$	MONEY	$	nsubj	57	SENT_390	[p24l1771t941r2150b1031],
45	.84	CD	MONEY	.84	num	44	SENT_390	[p24l1771t941r2150b1031],
46	AMPK	NN	ORGANIZATION	ampk	nsubj	47	SENT_390	[p24l8t1057r250b1115],
47	regulates	VBZ	O	regulate	rcmod	44	SENT_390	[p24l269t1053r570b1137],
48	energy	NN	O	energy	nn	49	SENT_390	[p24l592t1076r824b1137],
49	balance	NN	O	balance	dobj	47	SENT_390	[p24l839t1053r1098b1116],
50	at	IN	O	at	_	0	SENT_390	[p24l1120t1065r1179b1116],
51	both	CC	O	both	preconj	53	SENT_390	[p24l1196t1053r1354b1116],
52	the	DT	O	the	dep	53	SENT_390	[p24l1374t1053r1480b1116],
53	cellular	JJ	O	cellular	prep_at	47	SENT_390	[p24l1501t1053r1750b1116],
54	and	CC	O	and	_	0	SENT_390	[p24l1771t1053r1896b1116],
55	wholebody	JJ	O	wholebody	amod	56	SENT_390	[p24l1914t1053r2146b1116, p24l7t1155r185b1240],
56	levels	NNS	O	level	prep_at	47	SENT_390	[p24l203t1147r473b1219],
57	.85	VBP	NUMBER	.85	rcmod	43	SENT_390	[p24l203t1147r473b1219],
58	AMPK	NN	O	ampk	nsubj	59	SENT_390	[p24l496t1159r740b1218],
59	inhibits	VBZ	O	inhibit	ccomp	57	SENT_390	[p24l762t1155r1023b1219],
60	synthesis	NN	O	synthesis	dobj	59	SENT_390	[p24l1047t1155r1358b1240],
61	of	IN	O	of	_	0	SENT_390	[p24l1382t1155r1457b1219],
62	both	CC	O	both	preconj	64	SENT_390	[p24l1468t1155r1629b1219],
63	fatty	JJ	O	fatty	amod	64	SENT_390	[p24l1651t1155r1807b1240],
64	acids	NNS	O	acid	prep_of	60	SENT_390	[p24l1827t1155r1998b1219],
65	and	CC	O	and	_	0	SENT_390	[p24l2023t1155r2150b1219],
66	cholesterol	NN	O	cholesterol	conj_and	64	SENT_390	[p24l10t1259r407b1322],
67	by	IN	O	by	_	0	SENT_390	[p24l435t1259r522b1343],
68	inactivation	NN	O	inactivation	prep_by	59	SENT_390	[p24l550t1265r986b1322],
69	of	IN	O	of	_	0	SENT_390	[p24l1017t1259r1094b1322],
70	acetyl	NN	O	acetyl	prep_of	68	SENT_390	[p24l1116t1259r1531b1343],
71	.	.	O	.	_	0	SENT_390	[p24l1116t1259r1531b1343],

1	—	NN	O	—	_	0	SENT_391	[p24l1116t1259r1531b1343],
2	.	.	O	.	_	0	SENT_391	[p24l1116t1259r1531b1343],

1	CoA	NN	O	coa	nn	2	SENT_392	[p24l1116t1259r1531b1343],
2	carboxylase	NN	O	carboxylase	_	0	SENT_392	[p24l1561t1259r1988b1343],
3	and	CC	O	and	cc	4	SENT_392	[p24l2019t1259r2152b1322],
4	3	CD	NUMBER	3	num	2	SENT_392	[p24l11t1361r1370b1446],
5	.	.	O	.	_	0	SENT_392	[p24l11t1361r1370b1446],

1	—	NN	O	—	_	0	SENT_393	[p24l11t1361r1370b1446],
2	.	.	O	.	_	0	SENT_393	[p24l11t1361r1370b1446],

1	hydroxy	NN	O	hydroxy	_	0	SENT_394	[p24l11t1361r1370b1446],
2	.	.	O	.	_	0	SENT_394	[p24l11t1361r1370b1446],

1	—	NN	O	—	_	0	SENT_395	[p24l11t1361r1370b1446],
2	.	.	O	.	_	0	SENT_395	[p24l11t1361r1370b1446],

1	3	LS	NUMBER	3	_	0	SENT_396	[p24l11t1361r1370b1446],
2	.	.	O	.	_	0	SENT_396	[p24l11t1361r1370b1446],

1	—	NN	O	—	_	0	SENT_397	[p24l11t1361r1370b1446],
2	.	.	O	.	_	0	SENT_397	[p24l11t1361r1370b1446],

1	methylglutaryl	NN	O	methylglutaryl	_	0	SENT_398	[p24l11t1361r1370b1446],
2	.	.	O	.	_	0	SENT_398	[p24l11t1361r1370b1446],

1	—	NN	O	—	_	0	SENT_399	[p24l11t1361r1370b1446],
2	.	.	O	.	_	0	SENT_399	[p24l11t1361r1370b1446],

1	Coenzyme	NNP	MISC	Coenzyme	nn	5	SENT_400	[p24l11t1361r1370b1446],
2	A	NNP	MISC	A	nn	5	SENT_400	[p24l1393t1365r1450b1424],
3	reduCtase	NNP	O	reduCtase	nn	5	SENT_400	[p24l1473t1353r1884b1425],
4	.85	CD	NUMBER	.85	num	5	SENT_400	[p24l1473t1353r1884b1425],
5	AMPK	NNP	O	AMPK	nsubj	6	SENT_400	[p24l1907t1366r2151b1424],
6	opposes	VBZ	O	oppose	_	0	SENT_400	[p24l10t1487r284b1548],
7	gluconeogenesis	NN	O	gluconeogenesis	dobj	6	SENT_400	[p24l307t1465r867b1549],
8	by	IN	O	by	_	0	SENT_400	[p24l889t1465r973b1549],
9	inhibiting	VBG	O	inhibit	prepc_by	6	SENT_400	[p24l992t1465r1333b1549],
10	transcription	NN	O	transcription	dobj	9	SENT_400	[p24l1353t1471r1803b1548],
11	of	IN	O	of	_	0	SENT_400	[p24l1826t1465r1900b1528],
12	critical	JJ	O	critical	amod	14	SENT_400	[p24l1914t1465r2149b1528],
13	gluconeogenic	JJ	O	gluconeogenic	amod	14	SENT_400	[p24l9t1568r519b1652],
14	enzymes	NNS	O	enzyme	prep_of	10	SENT_400	[p24l544t1590r863b1652],
15	.	.	O	.	_	0	SENT_400	[p24l544t1590r863b1652],

1	Activation	NN	O	activation	nsubj	4	SENT_401	[p24l889t1572r1258b1631],
2	of	IN	O	of	_	0	SENT_401	[p24l1282t1568r1357b1631],
3	AMPK	NNP	O	AMPK	prep_of	1	SENT_401	[p24l1371t1572r1618b1630],
4	facilitates	VBZ	O	facilitate	_	0	SENT_401	[p24l1640t1568r1971b1631],
5	fatty	JJ	O	fatty	amod	7	SENT_401	[p24l1995t1568r2153b1652],
6	acid	NN	O	acid	nn	7	SENT_401	[p24l10t1671r151b1734],
7	oxidation	NN	O	oxidation	dobj	4	SENT_401	[p24l173t1671r501b1734],
8	and	CC	O	and	_	0	SENT_401	[p24l525t1671r652b1734],
9	mitochondrial	JJ	O	mitochondrial	amod	10	SENT_401	[p24l673t1671r1172b1734],
10	biogenesis	NN	O	biogenesis	dobj	4	SENT_401	[p24l1192t1671r1568b1755],
11	,	,	O	,	_	0	SENT_401	[p24l1192t1671r1568b1755],
12	which	WDT	O	which	nsubj	13	SENT_401	[p24l1591t1671r1802b1734],
13	promotes	VBZ	O	promote	rcmod	7	SENT_401	[p24l1824t1683r2149b1754],
14	energy	NN	O	energy	nn	15	SENT_401	[p24l10t1796r255b1858],
15	expenditure	NN	O	expenditure	dobj	13	SENT_401	[p24l280t1765r798b1857],
16	.	.	O	.	_	0	SENT_401	[p24l280t1765r798b1857],

1	“	NN	O	“	ccomp	10	SENT_402	[p24l280t1765r798b1857],
2	Interestingly	RB	O	interestingly	advmod	1	SENT_402	[p24l827t1773r1295b1858],
3	,	,	O	,	_	0	SENT_402	[p24l827t1773r1295b1858],
4	activation	NN	O	activation	nsubj	10	SENT_402	[p24l1326t1780r1681b1837],
5	of	IN	O	of	_	0	SENT_402	[p24l1710t1773r1787b1837],
6	AMPK	NNP	ORGANIZATION	AMPK	prep_of	4	SENT_402	[p24l1804t1778r2055b1836],
7	in	IN	O	in	_	0	SENT_402	[p24l2082t1780r2151b1836],
8	the	DT	O	the	det	9	SENT_402	[p24l9t1876r118b1940],
9	hypothalamus	NN	O	hypothalamus	prep_in	6	SENT_402	[p24l142t1876r645b1961],
10	promotes	VBZ	O	promote	ccomp	46	SENT_402	[p24l669t1888r1003b1960],
11	food	NN	O	food	nn	13	SENT_402	[p24l1028t1876r1190b1940],
12	intake	NN	O	intake	nn	13	SENT_402	[p24l1214t1876r1430b1940],
13	behavior	NN	O	behavior	dobj	10	SENT_402	[p24l1453t1868r1843b1940],
14	.87	CD	NUMBER	.87	nsubj	25	SENT_402	[p24l1453t1868r1843b1940],
15	In	IN	O	in	_	0	SENT_402	[p24l1868t1882r1941b1939],
16	some	DT	O	some	det	17	SENT_402	[p24l1967t1899r2150b1940],
17	Cells	NNS	O	cell	prep_in	14	SENT_402	[p24l10t1979r171b2051],
18	,	,	O	,	_	0	SENT_402	[p24l10t1979r171b2051],
19	an	DT	O	a	det	20	SENT_402	[p24l194t2002r273b2043],
20	increase	NN	O	increase	appos	17	SENT_402	[p24l294t1985r569b2043],
21	in	IN	O	in	_	0	SENT_402	[p24l590t1985r656b2042],
22	intracellular	JJ	O	intracellular	amod	24	SENT_402	[p24l676t1979r1090b2043],
23	CGMP	NN	O	cgmp	nn	24	SENT_402	[p24l1110t1983r1327b2043],
24	Concentration	NN	O	concentration	prep_in	20	SENT_402	[p24l1350t1985r1823b2043],
25	increases	VBZ	O	increase	rcmod	13	SENT_402	[p24l1843t1985r2150b2043],
26	CAMP	NN	O	camp	nn	27	SENT_402	[p24l10t2087r227b2146],
27	levels	NNS	O	level	dobj	25	SENT_402	[p24l249t2082r435b2146],
28	by	IN	O	by	_	0	SENT_402	[p24l456t2082r540b2167],
29	inhibiting	VBG	O	inhibit	prepc_by	25	SENT_402	[p24l559t2082r900b2167],
30	PDEs	NNS	O	pde	dobj	29	SENT_402	[p24l922t2088r1109b2146],
31	that	WDT	O	that	nsubj	32	SENT_402	[p24l1131t2082r1266b2146],
32	degrade	VBP	O	degrade	rcmod	30	SENT_402	[p24l1287t2082r1559b2167],
33	CAIVIR88	NN	O	caivir88	dobj	32	SENT_402	[p24l1583t2074r1870b2146],
34	Indeed	RB	O	indeed	advmod	32	SENT_402	[p24l1894t2082r2148b2155],
35	,	,	O	,	_	0	SENT_402	[p24l1894t2082r2148b2155],
36	inhibition	NN	O	inhibition	nsubj	46	SENT_402	[p24l10t2185r367b2249],
37	of	IN	O	of	_	0	SENT_402	[p24l394t2185r470b2249],
38	PDE4	NN	O	pde4	prep_of	36	SENT_402	[p24l488t2190r711b2257],
39	,	,	O	,	_	0	SENT_402	[p24l488t2190r711b2257],
40	PDE5	NN	O	pde5	appos	38	SENT_402	[p24l740t2190r964b2257],
41	,	,	O	,	_	0	SENT_402	[p24l740t2190r964b2257],
42	PDE9	NN	O	pde9	appos	38	SENT_402	[p24l993t2190r1217b2257],
43	,	,	O	,	_	0	SENT_402	[p24l993t2190r1217b2257],
44	and	CC	O	and	_	0	SENT_402	[p24l1246t2185r1377b2249],
45	PDE1O	NN	O	pde1o	appos	38	SENT_402	[p24l1403t2190r1649b2249],
46	decreases	VBZ	O	decrease	_	0	SENT_402	[p24l1677t2185r2014b2249],
47	the	DT	O	the	det	48	SENT_402	[p24l2039t2185r2150b2249],
48	adiposity	NN	O	adiposity	dobj	46	SENT_402	[p24l10t2289r326b2373],
49	in	IN	O	in	_	0	SENT_402	[p24l344t2295r411b2351],
50	mice	NNS	O	mouse	prep_in	46	SENT_402	[p24l432t2295r596b2352],
51	fed	VBN	O	feed	partmod	50	SENT_402	[p24l618t2289r724b2352],
52	a	DT	O	a	det	54	SENT_402	[p24l745t2312r780b2352],
53	high-fat	JJ	O	high-fat	amod	54	SENT_402	[p24l800t2289r1074b2373],
54	diet	NN	O	diet	dobj	51	SENT_402	[p24l1096t2289r1225b2352],
55	or	CC	O	or	_	0	SENT_402	[p24l1246t2312r1318b2352],
56	in	IN	O	in	_	0	SENT_402	[p24l1339t2295r1405b2351],
57	ob/ob	JJ	O	ob/ob	amod	58	SENT_402	[p24l1429t2289r1615b2355],
58	mice	NNS	O	mouse	conj_or	50	SENT_402	[p24l1636t2295r1816b2352],
59	.	.	O	.	_	0	SENT_402	[p24l1636t2295r1816b2352],

1	Recently	RB	DATE	recently	_	0	SENT_403	[p24l1843t2289r2148b2373],
2	,	,	O	,	_	0	SENT_403	[p24l1843t2289r2148b2373],

1	Pancreas	NN	O	pancreas	nn	2	SENT_404	[p24l324t2508r426b2527],
2	Insulin	NN	O	insulin	_	0	SENT_404	[p24l641t2493r719b2527],
3	I	PRP	O	I	dep	2	SENT_404	[p24l1524t2520r1525b2523],
4	'	''	O	'	_	0	SENT_404	[p24l1560t2506r1563b2507],
5	’	CD	NUMBER	’	num	6	SENT_404	[p24l1943t2508r1947b2509],
6	V	NN	O	v	dep	3	SENT_404	[p24l355t2546r369b2550],
7	_	CD	NUMBER	_	number	8	SENT_404	[p24l355t2546r369b2550],
8	_	CD	NUMBER	_	dep	2	SENT_404	[p24l383t2544r389b2546],
9	_	NN	O	_	dep	8	SENT_404	[p24l440t2546r444b2548],
10	.	.	O	.	_	0	SENT_404	[p24l457t2542r459b2544],

1	__	NN	O	__	_	0	SENT_405	[p24l512t2544r518b2548],
2	secretion	NN	O	secretion	nn	3	SENT_405	[p24l625t2524r734b2542],
3	_	NN	O	_	dep	1	SENT_405	[p24l1786t2548r1796b2552],
4	>	JJR	O	>	amod	5	SENT_405	[p24l1786t2548r1796b2552],
5	.3	NN	NUMBER	.3	dep	3	SENT_405	[p24l1813t2536r1823b2552],
6	V	NN	O	v	dep	5	SENT_405	[p24l1872t2547r1875b2548],
7	,	,	O	,	_	0	SENT_405	[p24l1887t2545r1890b2546],

1	-	:	O	-	_	0	SENT_406	[p24l256t2562r261b2564],
2	.	.	O	.	_	0	SENT_406	[p24l301t2560r316b2571],

1	i	LS	O	i	dep	7	SENT_407	[p24l301t2560r316b2571],
2	,	,	O	,	_	0	SENT_407	[p24l353t2572r356b2576],
3	_	NN	O	_	dep	7	SENT_407	[p24l478t2578r480b2580],
4	,	,	O	,	_	0	SENT_407	[p24l1553t2570r1556b2571],
5	‘	CD	NUMBER	‘	num	7	SENT_407	[p24l1598t2578r1599b2582],
6	__	CD	NUMBER	__	num	7	SENT_407	[p24l1768t2552r1881b2580],
7	Sal_li	NNS	O	sal_li	_	0	SENT_407	[p24l1768t2552r1881b2580],
8	‘	CD	MONEY	‘	number	9	SENT_407	[p24l1768t2552r1881b2580],
9	£	CD	MONEY	£	dep	7	SENT_407	[p24l1768t2552r1881b2580],
10	tln	NN	O	tln	nn	13	SENT_407	[p24l1768t2552r1881b2580],
11	_	CD	NUMBER	_	num	13	SENT_407	[p24l1768t2552r1881b2580],
12	|	NN	O	|	nn	13	SENT_407	[p24l1768t2552r1881b2580],
13	j	NN	O	j	dep	9	SENT_407	[p24l1768t2552r1881b2580],
14	.	.	O	.	_	0	SENT_407	[p24l1943t2565r1946b2566],

1	_	NN	O	_	_	0	SENT_408	[p24l333t2606r348b2609],
2	‘	CD	NUMBER	‘	number	3	SENT_408	[p24l418t2586r438b2600],
3	_	CD	NUMBER	_	dep	1	SENT_408	[p24l1492t2605r1508b2610],
4	j'	NN	O	j'	dep	3	SENT_408	[p24l1525t2580r1560b2611],
5	.	.	O	.	_	0	SENT_408	[p24l1525t2580r1560b2611],

1	-	:	O	-	_	0	SENT_409	[p24l1525t2580r1560b2611],
2	.	.	O	.	_	0	SENT_409	[p24l1525t2580r1560b2611],

1	;	:	O	;	_	0	SENT_410	[p24l1525t2580r1560b2611],
2	'	''	O	'	_	0	SENT_410	[p24l1525t2580r1560b2611],
3	‘	CD	NUMBER	‘	num	4	SENT_410	[p24l1705t2580r1714b2584],
4	Pﬁﬁppetile	NN	O	pﬁﬁppetile	nsubj	1	SENT_410	[p24l1736t2574r1889b2611],

1	,	,	O	,	_	0	SENT_411	[p24l243t2628r250b2639],
2	,	,	O	,	_	0	SENT_411	[p24l243t2628r250b2639],
3	3	CD	NUMBER	3	num	4	SENT_411	[p24l302t2626r308b2642],
4	3	CD	NUMBER	3	nsubj	5	SENT_411	[p24l321t2612r332b2638],
5	"	``	O	"	_	0	SENT_411	[p24l364t2620r369b2623],
6	'	''	O	'	_	0	SENT_411	[p24l380t2622r383b2624],
7	‘	RB	O	‘	advmod	5	SENT_411	[p24l431t2614r438b2617],
8	,	,	O	,	_	0	SENT_411	[p24l512t2636r514b2639],
9	‘	NN	O	‘	prep	5	SENT_411	[p24l1423t2620r1426b2622],
10	m	NN	O	m	nn	12	SENT_411	[p24l1445t2636r1482b2643],
11	*	CD	NUMBER	*	num	12	SENT_411	[p24l1445t2636r1482b2643],
12	W	NN	O	w	dep	9	SENT_411	[p24l1501t2636r1508b2639],
13	.	.	O	.	_	0	SENT_411	[p24l1545t2631r1548b2632],

1	.	.	O	.	_	0	SENT_412	[p24l1605t2634r1612b2639],

1	_	RB	O	_	dep	2	SENT_413	[p24l1605t2634r1612b2639],
2	wk	NN	DURATION	wk	dep	5	SENT_413	[p24l1634t2616r1664b2644],
3	‘	CD	NUMBER	‘	num	2	SENT_413	[p24l1634t2616r1664b2644],
4	‘	CD	NUMBER	‘	num	5	SENT_413	[p24l1728t2618r1755b2652],
5	V3	NN	O	v3	dep	7	SENT_413	[p24l1728t2618r1755b2652],
6	’	CD	NUMBER	’	num	7	SENT_413	[p24l1728t2618r1755b2652],
7	F	NN	O	f	dep	9	SENT_413	[p24l1767t2612r1957b2671],
8	;	:	O	;	_	0	SENT_413	[p24l1767t2612r1957b2671],
9	‘	CD	NUMBER	‘	_	0	SENT_413	[p24l1767t2612r1957b2671],
10	I	PRP	O	I	nsubj	11	SENT_413	[p24l1767t2612r1957b2671],
11	‘	VBP	O	‘	rcmod	9	SENT_413	[p24l1767t2612r1957b2671],
12	l'	NN	O	l'	dobj	11	SENT_413	[p24l1767t2612r1957b2671],
13	.	.	O	.	_	0	SENT_413	[p24l1767t2612r1957b2671],

1	l	NN	O	l	dep	2	SENT_414	[p24l1767t2612r1957b2671],
2	>	JJR	O	>	_	0	SENT_414	[p24l1767t2612r1957b2671],
3	[	CD	NUMBER	[	num	4	SENT_414	[p24l1767t2612r1957b2671],
4	‘	NN	O	‘	dep	2	SENT_414	[p24l1767t2612r1957b2671],
5	lf	NN	O	lf	nn	8	SENT_414	[p24l1767t2612r1957b2671],
6	‘	CD	NUMBER	‘	num	8	SENT_414	[p24l1767t2612r1957b2671],
7	llE‘S	NN	O	lle‘s	nn	8	SENT_414	[p24l1767t2612r1957b2671],
8	5l	NN	O	5l	dep	2	SENT_414	[p24l1767t2612r1957b2671],
9	‘	CD	NUMBER	‘	num	10	SENT_414	[p24l1767t2612r1957b2671],
10	lllflV5	NN	O	lllflv5	dep	8	SENT_414	[p24l1767t2612r1957b2671],
11	:	:	O	:	_	0	SENT_414	[p24l1767t2612r1957b2671],
12	__	IN	O	__	amod	10	SENT_414	[p24l1767t2612r1957b2671],

1	sGMP	NN	O	sgmp	_	0	SENT_415	[p24l1486t2815r1554b2834],

1	PGC	NNP	O	PGC	_	0	SENT_416	[p24l638t2943r687b2967],
2	,9	CD	NUMBER	,9	num	1	SENT_416	[p24l940t2931r960b2960],
3	’	CD	NUMBER	’	num	6	SENT_416	[p24l940t2931r960b2960],
4	\	NN	O	\	nn	6	SENT_416	[p24l1128t2906r1248b2980],
5	'	''	O	'	_	0	SENT_416	[p24l1128t2906r1248b2980],
6	Angiogenesis	NNP	O	Angiogenesis	dep	1	SENT_416	[p24l1455t2935r1604b2965],
7	i	FW	O	i	nn	9	SENT_416	[p24l1632t2928r1638b2948],
8	’	FW	O	’	nn	9	SENT_416	[p24l1632t2928r1638b2948],
9	V	NN	O	v	dep	1	SENT_416	[p24l1768t2924r1779b2943],

1	CGMP	NN	O	cgmp	nn	2	SENT_417	[p24l868t2982r936b3001],
2	F	NN	O	f	_	0	SENT_417	[p24l1560t2968r1584b3000],
3	i	FW	O	i	dep	2	SENT_417	[p24l1564t3008r1568b3020],
4	:	:	O	:	_	0	SENT_417	[p24l1564t3008r1568b3020],
5	sG	NN	O	sg	dep	2	SENT_417	[p24l638t3052r668b3071],
6	.	.	O	.	_	0	SENT_417	[p24l1427t3036r1536b3069],

1	~	NN	O	~	_	0	SENT_418	[p24l1427t3036r1536b3069],
2	"	''	O	"	punct	1	SENT_418	[p24l1427t3036r1536b3069],
3	”‘	CD	NUMBER	”‘	num	4	SENT_418	[p24l1427t3036r1536b3069],
4	V	NN	O	v	dep	1	SENT_418	[p24l1427t3036r1536b3069],
5	‘	CD	NUMBER	‘	number	6	SENT_418	[p24l1427t3036r1536b3069],
6	}	CD	NUMBER	}	num	7	SENT_418	[p24l664t2972r856b3046],
7	_	NN	O	_	dep	4	SENT_418	[p24l664t2972r856b3046],
8	.	.	O	.	_	0	SENT_418	[p24l664t2972r856b3046],

1	°	NN	O	°	dep	3	SENT_419	[p24l670t3052r687b3071],
2	K.	NNP	O	K.	dep	1	SENT_419	[p24l926t3014r1244b3135],
3	....	NNP	O	....	_	0	SENT_419	[p24l926t3014r1244b3135],
4	/	:	O	/	punct	3	SENT_419	[p24l926t3014r1244b3135],

1	Oxidative	JJ	O	oxidative	_	0	SENT_420	[p24l288t3186r407b3208],
2	+	CC	O	+	cc	1	SENT_420	[p24l1452t3149r1476b3216],

1	Skeletal	JJ	O	skeletal	amod	2	SENT_421	[p24l211t3016r297b3035],
2	muscle	NN	O	muscle	_	0	SENT_421	[p24l211t3046r288b3065],

1	V	NN	O	v	_	0	SENT_422	[p24l1356t3152r1360b3164],

1	thermogenesi	NNS	O	thermogenesus	_	0	SENT_423	[p24l1586t3168r1761b3196],

1	,	,	O	,	_	0	SENT_424	[p24l379t3221r382b3225],
2	M	NN	O	m	_	0	SENT_424	[p24l429t3204r644b3231],
3	PGC	NN	ORGANIZATION	pgc	dep	2	SENT_424	[p24l657t3203r726b3222],
4	—	CD	NUMBER	—	number	5	SENT_424	[p24l657t3203r726b3222],
5	1	CD	NUMBER	1	num	6	SENT_424	[p24l657t3203r726b3222],
6	_	NN	O	_	dobj	2	SENT_424	[p24l1356t3216r1360b3223],

1	metabolism	NN	O	metabolism	nn	2	SENT_425	[p24l275t3221r421b3243],
2	o	NN	O	o	_	0	SENT_425	[p24l732t3209r747b3222],
3	‘	CD	NUMBER	‘	num	4	SENT_425	[p24l732t3209r747b3222],
4	PKG	NN	O	pkg	dep	2	SENT_425	[p24l1264t3218r1313b3237],
5	.	.	O	.	_	0	SENT_425	[p24l1320t3221r1384b3251],

1	—	NN	O	—	_	0	SENT_426	[p24l1320t3221r1384b3251],
2	.	.	O	.	_	0	SENT_426	[p24l1320t3221r1384b3251],

1	.	.	O	.	_	0	SENT_427	[p24l1320t3221r1384b3251],

1	—	NN	O	—	_	0	SENT_428	[p24l1320t3221r1384b3251],
2	.	.	O	.	_	0	SENT_428	[p24l1320t3221r1384b3251],

1	g	NN	O	g	dep	2	SENT_429	[p24l1320t3221r1384b3251],
2	RhoA	NN	O	rhoa	_	0	SENT_429	[p24l1389t3221r1457b3241],
3	/	:	O	/	punct	2	SENT_429	[p24l1389t3221r1457b3241],

1	[	NN	O	[	_	0	SENT_430	[p24l185t3295r233b3336],
2	El	NNP	O	El	dep	1	SENT_430	[p24l185t3295r233b3336],
3	---	CD	NUMBER	---	num	2	SENT_430	[p24l1424t3276r1523b3334],
4	.	.	O	.	_	0	SENT_430	[p24l1424t3276r1523b3334],

1	‘	NN	O	‘	nn	3	SENT_431	[p24l1424t3276r1523b3334],
2	cGMP	NN	O	cgmp	nn	3	SENT_431	[p24l1424t3276r1523b3334],
3	c	NN	O	c	_	0	SENT_431	[p24l1704t3278r1753b3339],
4	*	CD	NUMBER	*	dep	3	SENT_431	[p24l1704t3278r1753b3339],

1	Figure	NNP	O	Figure	_	0	SENT_432	[p24l21t3405r111b3435],
2	3	CD	NUMBER	3	num	1	SENT_432	[p24l119t3406r134b3428],
3	Adenosine	NNP	ORGANIZATION	Adenosine	dep	1	SENT_432	[p24l158t3405r300b3428],
4	3	CD	NUMBER	3	num	3	SENT_432	[p24l308t3404r446b3435],
5	’	CD	NUMBER	’	number	6	SENT_432	[p24l308t3404r446b3435],
6	,5	CD	NUMBER	,5	num	7	SENT_432	[p24l308t3404r446b3435],
7	’	NN	O	’	dep	3	SENT_432	[p24l308t3404r446b3435],
8	.	.	O	.	_	0	SENT_432	[p24l308t3404r446b3435],

1	—	NN	O	—	_	0	SENT_433	[p24l308t3404r446b3435],
2	.	.	O	.	_	0	SENT_433	[p24l308t3404r446b3435],

1	cyc	NN	O	cyc	_	0	SENT_434	[p24l308t3404r446b3435],
2	|	CD	NUMBER	|	num	1	SENT_434	[p24l308t3404r446b3435],
3	ic	JJ	O	ic	amod	7	SENT_434	[p24l308t3404r446b3435],
4	monophosphate	NN	O	monophosphate	nn	7	SENT_434	[p24l454t3405r676b3435],
5	(	NN	O	(	nn	7	SENT_434	[p24l685t3405r788b3432],
6	cAMP	NN	O	camp	nn	7	SENT_434	[p24l685t3405r788b3432],
7	)	NN	O	)	dep	1	SENT_434	[p24l685t3405r788b3432],
8	and	CC	O	and	_	0	SENT_434	[p24l795t3405r844b3428],
9	guanosine	NN	O	guanosine	dep	1	SENT_434	[p24l853t3406r992b3435],
10	3	CD	NUMBER	3	num	11	SENT_434	[p24l1000t3404r1138b3435],
11	’	NN	O	’	dep	1	SENT_434	[p24l1000t3404r1138b3435],
12	,5	CD	NUMBER	,5	num	13	SENT_434	[p24l1000t3404r1138b3435],
13	’	NN	O	’	dep	11	SENT_434	[p24l1000t3404r1138b3435],
14	.	.	O	.	_	0	SENT_434	[p24l1000t3404r1138b3435],

1	—	NN	O	—	_	0	SENT_435	[p24l1000t3404r1138b3435],
2	.	.	O	.	_	0	SENT_435	[p24l1000t3404r1138b3435],

1	cyclic	JJ	O	cyclic	amod	2	SENT_436	[p24l1000t3404r1138b3435],
2	monophosphate	NN	O	monophosphate	_	0	SENT_436	[p24l1146t3405r1369b3435],
3	(	CD	NUMBER	(	num	5	SENT_436	[p24l1377t3405r1609b3432],
4	cGMP	NN	O	cgmp	nn	5	SENT_436	[p24l1377t3405r1609b3432],
5	)	NN	O	)	dep	2	SENT_436	[p24l1377t3405r1609b3432],
6	.	.	O	.	_	0	SENT_436	[p24l1377t3405r1609b3432],

1	—	NN	O	—	_	0	SENT_437	[p24l1377t3405r1609b3432],
2	.	.	O	.	_	0	SENT_437	[p24l1377t3405r1609b3432],

1	mediated	JJ	O	mediated	amod	2	SENT_438	[p24l1377t3405r1609b3432],
2	signaling	NN	O	signaling	nsubj	3	SENT_438	[p24l1618t3405r1737b3435],
3	regulates	VBZ	O	regulate	_	0	SENT_438	[p24l1747t3405r1868b3435],
4	metabolism	NN	O	metabolism	nn	7	SENT_438	[p24l1877t3405r2033b3428],
5	and	CC	O	and	_	0	SENT_438	[p24l2042t3405r2091b3428],
6	energy	NN	O	energy	conj_and	4	SENT_438	[p24l21t3452r113b3476],
7	homeostasis	NN	O	homeostasis	dobj	3	SENT_438	[p24l121t3445r293b3469],
8	.	.	O	.	_	0	SENT_438	[p24l121t3445r293b3469],

1	Increased	VBN	O	increase	amod	3	SENT_439	[p24l302t3445r427b3469],
2	cGMP	NN	O	cgmp	nn	3	SENT_439	[p24l435t3446r512b3469],
3	levels	NNS	O	level	nsubj	21	SENT_439	[p24l521t3445r599b3473],
4	,	,	O	,	_	0	SENT_439	[p24l521t3445r599b3473],
5	via	IN	O	via	_	0	SENT_439	[p24l607t3446r643b3469],
6	activation	NN	O	activation	prep_via	3	SENT_439	[p24l652t3446r782b3469],
7	of	IN	O	of	_	0	SENT_439	[p24l791t3445r818b3469],
8	particulate	JJ	O	particulate	amod	14	SENT_439	[p24l824t3445r966b3475],
9	or	CC	O	or	_	0	SENT_439	[p24l974t3452r1001b3469],
10	soluble	JJ	O	soluble	amod	14	SENT_439	[p24l1009t3445r1104b3469],
11	guanylyl	NN	O	guanylyl	nn	14	SENT_439	[p24l1112t3445r1223b3476],
12	cyclase	NN	O	cyclase	nn	14	SENT_439	[p24l1232t3445r1326b3476],
13	(	CD	NUMBER	(	num	14	SENT_439	[p24l1335t3446r1400b3475],
14	pGC	NN	O	pgc	prep_of	6	SENT_439	[p24l1335t3446r1400b3475],
15	or	CC	O	or	_	0	SENT_439	[p24l1407t3452r1434b3469],
16	sGC	NN	O	sgc	conj_or	6	SENT_439	[p24l1442t3446r1498b3473],
17	,	,	O	,	_	0	SENT_439	[p24l1442t3446r1498b3473],
18	respectively	RB	O	respectively	advmod	19	SENT_439	[p24l1507t3445r1680b3476],
19	)	CD	NUMBER	)	rcmod	16	SENT_439	[p24l1507t3445r1680b3476],
20	,	,	O	,	_	0	SENT_439	[p24l1507t3445r1680b3476],
21	activate	VBP	O	activate	_	0	SENT_439	[p24l1688t3447r1792b3469],
22	peroxisome	NN	O	peroxisome	dobj	21	SENT_439	[p24l1801t3446r1956b3475],
23	pro	JJ	O	pro	amod	26	SENT_439	[p24l1965t3445r2122b3475],
24	|	NN	O	|	nn	26	SENT_439	[p24l1965t3445r2122b3475],
25	iferator	NN	O	iferator	nn	26	SENT_439	[p24l1965t3445r2122b3475],
26	—	NN	O	—	dep	22	SENT_439	[p24l1965t3445r2122b3475],

1	Illustrated	NNP	O	Illustrated	dep	4	SENT_440	[p24l1976t3246r1995b3351],
2	by	IN	O	by	_	0	SENT_440	[p24l1976t3212r2000b3236],
3	Zina	NNP	PERSON	Zina	prep_by	1	SENT_440	[p24l1976t3156r1995b3204],
4	Deretsky	NNP	PERSON	Deretsky	nsubj	5	SENT_440	[p24l1976t3051r2000b3147],
5	activated	VBD	O	activate	_	0	SENT_440	[p24l21t3486r142b3510],
6	receptor-y	JJ	O	receptor-y	amod	7	SENT_440	[p24l152t3490r288b3517],
7	coactivator	NN	O	coactivator	dobj	5	SENT_440	[p24l293t3487r441b3510],
8	10	CD	NUMBER	10	number	9	SENT_440	[p24l451t3488r484b3510],
9	¢	CD	NUMBER	¢	num	11	SENT_440	[p24l451t3488r484b3510],
10	(	NN	O	(	nn	11	SENT_440	[p24l492t3486r576b3514],
11	PGC-1	NN	O	pgc-1	dep	7	SENT_440	[p24l492t3486r576b3514],
12	or	CC	O	or	_	0	SENT_440	[p24l584t3486r617b3514],
13	)	NN	O	)	conj_or	7	SENT_440	[p24l584t3486r617b3514],
14	,	,	O	,	_	0	SENT_440	[p24l584t3486r617b3514],
15	a	DT	O	a	det	17	SENT_440	[p24l625t3493r638b3510],
16	master	NN	O	master	nn	17	SENT_440	[p24l648t3490r738b3510],
17	regulator	NN	O	regulator	appos	13	SENT_440	[p24l746t3486r868b3517],
18	of	IN	O	of	_	0	SENT_440	[p24l875t3486r902b3510],
19	mitochondrial	JJ	O	mitochondrial	amod	20	SENT_440	[p24l909t3486r1094b3510],
20	biogenesis	NN	O	biogenesis	prep_of	17	SENT_440	[p24l1104t3486r1246b3517],
21	and	CC	O	and	_	0	SENT_440	[p24l1254t3486r1302b3510],
22	function	NN	O	function	prep_of	17	SENT_440	[p24l1311t3486r1430b3510],
23	.	.	O	.	_	0	SENT_440	[p24l1311t3486r1430b3510],

1	cGMP	NN	O	cgmp	nn	2	SENT_441	[p24l1437t3487r1514b3510],
2	signaling	NN	O	signaling	nsubj	4	SENT_441	[p24l1522t3486r1641b3517],
3	also	RB	O	also	advmod	4	SENT_441	[p24l1650t3486r1702b3510],
4	regulates	VBZ	O	regulate	_	0	SENT_441	[p24l1711t3486r1832b3517],
5	the	DT	O	the	det	8	SENT_441	[p24l1839t3486r1883b3510],
6	metabolic	JJ	O	metabolic	amod	8	SENT_441	[p24l1891t3486r2023b3510],
7	sensors	NNS	O	sensor	nn	8	SENT_441	[p24l2031t3493r2129b3510],
8	sirtuin	NN	O	sirtuin	dobj	4	SENT_441	[p24l21t3528r103b3551],
9	1	CD	NUMBER	1	number	10	SENT_441	[p24l114t3529r121b3551],
10	(	CD	NUMBER	(	num	12	SENT_441	[p24l135t3528r223b3555],
11	SIRT1	NN	O	sirt1	nn	12	SENT_441	[p24l135t3528r223b3555],
12	)	NN	O	)	dep	8	SENT_441	[p24l135t3528r223b3555],
13	and	CC	O	and	_	0	SENT_441	[p24l232t3527r281b3551],
14	AMP	NN	O	amp	nn	15	SENT_441	[p24l289t3527r483b3551],
15	—	NN	O	—	conj_and	12	SENT_441	[p24l289t3527r483b3551],
16	activated	VBN	O	activate	partmod	8	SENT_441	[p24l289t3527r483b3551],
17	protein	NN	O	protein	nn	18	SENT_441	[p24l492t3528r587b3558],
18	kinase	NN	O	kinase	dobj	16	SENT_441	[p24l597t3527r679b3551],
19	(	CD	NUMBER	(	num	20	SENT_441	[p24l688t3528r790b3555],
20	AMPK	NNP	O	AMPK	advmod	16	SENT_441	[p24l688t3528r790b3555],
21	)	CD	NUMBER	)	num	20	SENT_441	[p24l688t3528r790b3555],
22	,	,	O	,	_	0	SENT_441	[p24l688t3528r790b3555],
23	which	WDT	O	which	nsubj	25	SENT_441	[p24l798t3527r877b3551],
24	directly	RB	O	directly	advmod	25	SENT_441	[p24l886t3527r984b3558],
25	activate	VBP	O	activate	rcmod	20	SENT_441	[p24l992t3528r1095b3551],
26	PGC	NN	O	pgc	nsubj	28	SENT_441	[p24l1105t3528r1206b3552],
27	—	CD	NUMBER	—	num	26	SENT_441	[p24l1105t3528r1206b3552],
28	1oc	JJ	O	1oc	xcomp	25	SENT_441	[p24l1105t3528r1206b3552],
29	by	IN	O	by	_	0	SENT_441	[p24l1214t3527r1245b3558],
30	deacetylation	NN	O	deacetylation	prep_by	20	SENT_441	[p24l1252t3527r1432b3558],
31	and	CC	O	and	_	0	SENT_441	[p24l1441t3527r1489b3551],
32	phosphorylation	NN	O	phosphorylation	conj_and	30	SENT_441	[p24l1499t3527r1726b3558],
33	,	,	O	,	_	0	SENT_441	[p24l1499t3527r1726b3558],
34	respectively	RB	O	respectively	advmod	20	SENT_441	[p24l1735t3527r1898b3558],
35	.	.	O	.	_	0	SENT_441	[p24l1735t3527r1898b3558],

1	Resveratrol	NNP	O	Resveratrol	nsubj	2	SENT_442	[p24l1907t3527r2052b3551],
2	stimulates	VBZ	O	stimulate	_	0	SENT_442	[p24l21t3568r156b3592],
3	mitochondrial	JJ	O	mitochondrial	amod	4	SENT_442	[p24l165t3568r351b3592],
4	function	NN	O	function	dobj	2	SENT_442	[p24l359t3568r470b3592],
5	by	IN	O	by	_	0	SENT_442	[p24l480t3568r512b3599],
6	activating	VBG	O	activate	prepc_by	2	SENT_442	[p24l519t3569r649b3599],
7	SIRT1	NN	O	sirt1	dobj	6	SENT_442	[p24l658t3569r724b3592],
8	and	CC	O	and	_	0	SENT_442	[p24l737t3568r786b3592],
9	stimulating	VBG	O	stimulate	prepc_by	2	SENT_442	[p24l795t3568r944b3599],
10	cGMP	NN	O	cgmp	nn	11	SENT_442	[p24l953t3569r1030b3592],
11	production	NN	O	production	dobj	9	SENT_442	[p24l1039t3568r1193b3598],
12	.	.	O	.	_	0	SENT_442	[p24l1039t3568r1193b3598],

1	Phosphodiesterases	NNS	O	phosphodiesterase	nsubj	2	SENT_443	[p24l1202t3568r1466b3598],
2	(	VBP	O	(	_	0	SENT_443	[p24l1475t3569r1564b3596],
3	PDEs	NNS	O	pde	nsubj	19	SENT_443	[p24l1475t3569r1564b3596],
4	)	CD	NUMBER	)	num	3	SENT_443	[p24l1475t3569r1564b3596],
5	,	,	O	,	_	0	SENT_443	[p24l1475t3569r1564b3596],
6	which	WDT	O	which	nsubj	13	SENT_443	[p24l1572t3568r1651b3592],
7	hydrolyze	VBP	O	hydrolyze	rcmod	3	SENT_443	[p24l1661t3568r1788b3599],
8	cAMP	NN	O	camp	dobj	7	SENT_443	[p24l1796t3569r1871b3592],
9	and	CC	O	and	_	0	SENT_443	[p24l1879t3568r1928b3592],
10	CGMP	NN	O	cgmp	dobj	7	SENT_443	[p24l1937t3569r2013b3592],
11	and	CC	O	and	_	0	SENT_443	[p24l2021t3568r2070b3592],
12	thereby	RB	O	thereby	advmod	13	SENT_443	[p24l20t3609r124b3640],
13	terminate	VBP	O	terminate	rcmod	3	SENT_443	[p24l130t3610r260b3633],
14	their	PRP$	O	they	poss	15	SENT_443	[p24l267t3609r330b3633],
15	signal	NN	O	signal	dobj	13	SENT_443	[p24l337t3609r420b3640],
16	,	,	O	,	_	0	SENT_443	[p24l337t3609r420b3640],
17	are	VBP	O	be	cop	19	SENT_443	[p24l428t3616r468b3633],
18	the	DT	O	the	det	19	SENT_443	[p24l475t3609r519b3633],
19	target	NN	O	target	ccomp	2	SENT_443	[p24l526t3613r606b3640],
20	for	IN	O	for	_	0	SENT_443	[p24l613t3609r649b3633],
21	sildenaﬁl	NN	O	sildenaﬁl	prep_for	19	SENT_443	[p24l657t3609r780b3637],
22	,	,	O	,	_	0	SENT_443	[p24l657t3609r780b3637],
23	a	DT	O	a	det	25	SENT_443	[p24l788t3616r801b3633],
24	PDE	NN	O	pde	nn	25	SENT_443	[p24l811t3610r863b3633],
25	inhibitor	NN	O	inhibitor	dep	26	SENT_443	[p24l871t3609r984b3633],
26	specific	JJ	O	specific	ccomp	2	SENT_443	[p24l992t3609r1090b3639],
27	for	IN	O	for	_	0	SENT_443	[p24l1097t3609r1134b3633],
28	PDE5	NN	O	pde5	prep_for	26	SENT_443	[p24l1142t3610r1216b3633],
29	.	.	O	.	_	0	SENT_443	[p24l1142t3610r1216b3633],

1	Furthermore	RB	O	furthermore	advmod	5	SENT_444	[p24l1226t3609r1398b3637],
2	,	,	O	,	_	0	SENT_444	[p24l1226t3609r1398b3637],
3	cAMP	NN	O	camp	nsubjpass	5	SENT_444	[p24l1406t3610r1481b3633],
4	is	VBZ	O	be	auxpass	5	SENT_444	[p24l1490t3610r1508b3633],
5	required	VBN	O	require	_	0	SENT_444	[p24l1517t3609r1627b3639],
6	for	IN	O	for	_	0	SENT_444	[p24l1635t3609r1672b3633],
7	glucose-induced	JJ	O	glucose-induced	amod	9	SENT_444	[p24l1679t3609r1900b3640],
8	insulin	NN	O	insulin	nn	9	SENT_444	[p24l1910t3609r1995b3633],
9	release	NN	O	release	prep_for	5	SENT_444	[p24l2005t3609r2096b3633],
10	by	IN	O	by	_	0	SENT_444	[p24l2105t3609r2136b3640],
11	pancreatic	JJ	O	pancreatic	amod	13	SENT_444	[p24l22t3651r159b3680],
12	[	NN	O	[	nn	13	SENT_444	[p24l168t3649r257b3681],
13	3-cells	NNS	O	3-cell	agent	5	SENT_444	[p24l168t3649r257b3681],
14	.	.	O	.	_	0	SENT_444	[p24l168t3649r257b3681],

1	Furthermore	RB	O	furthermore	advmod	10	SENT_445	[p24l266t3650r439b3678],
2	,	,	O	,	_	0	SENT_445	[p24l266t3650r439b3678],
3	postprandial	JJ	O	postprandial	amod	4	SENT_445	[p24l448t3650r614b3680],
4	release	NN	O	release	nsubj	10	SENT_445	[p24l624t3650r716b3674],
5	of	IN	O	of	_	0	SENT_445	[p24l723t3650r751b3674],
6	the	DT	O	the	det	9	SENT_445	[p24l756t3650r799b3674],
7	intestinal	JJ	O	intestinal	amod	9	SENT_445	[p24l808t3650r927b3674],
8	hormone	NN	O	hormone	nn	9	SENT_445	[p24l938t3650r1060b3674],
9	uroguanylin	NN	O	uroguanylin	prep_of	4	SENT_445	[p24l1069t3650r1227b3681],
10	results	VBZ	O	result	_	0	SENT_445	[p24l1237t3650r1321b3674],
11	in	IN	O	in	_	0	SENT_445	[p24l1330t3651r1352b3674],
12	the	DT	O	the	det	14	SENT_445	[p24l1360t3650r1404b3674],
13	endocrine	JJ	O	endocrine	amod	14	SENT_445	[p24l1411t3650r1546b3674],
14	activation	NN	O	activation	prep_in	10	SENT_445	[p24l1554t3651r1684b3674],
15	of	IN	O	of	_	0	SENT_445	[p24l1693t3650r1720b3674],
16	hypothalamic	JJ	O	hypothalamic	amod	19	SENT_445	[p24l1727t3650r1908b3681],
17	guanylyl	NN	O	guanylyl	nn	19	SENT_445	[p24l1916t3650r2027b3681],
18	cyclase	NN	O	cyclase	nn	19	SENT_445	[p24l2036t3650r2130b3681],
19	C	NN	O	c	prep_of	14	SENT_445	[p24l21t3692r37b3715],
20	(	JJ	O	(	amod	22	SENT_445	[p24l46t3691r174b3719],
21	GUCYZC	NN	O	gucyzc	nn	22	SENT_445	[p24l46t3691r174b3719],
22	)	NN	O	)	dobj	10	SENT_445	[p24l46t3691r174b3719],
23	to	TO	O	to	aux	24	SENT_445	[p24l182t3695r209b3715],
24	produce	VB	O	produce	infmod	22	SENT_445	[p24l218t3691r328b3721],
25	CGMP	NN	O	cgmp	dobj	24	SENT_445	[p24l335t3692r414b3719],
26	,	,	O	,	_	0	SENT_445	[p24l335t3692r414b3719],
27	which	WDT	O	which	nsubj	28	SENT_445	[p24l422t3691r500b3715],
28	stimulates	VBZ	O	stimulate	rcmod	25	SENT_445	[p24l509t3691r645b3715],
29	satiety	NN	O	satiety	dobj	28	SENT_445	[p24l653t3692r740b3722],
30	and	CC	O	and	_	0	SENT_445	[p24l747t3691r796b3715],
31	suppresses	VBZ	O	suppress	conj_and	10	SENT_445	[p24l805t3698r951b3721],
32	appetite	NN	O	appetite	dobj	31	SENT_445	[p24l959t3692r1076b3721],
33	.	.	O	.	_	0	SENT_445	[p24l959t3692r1076b3721],

1	Moreover	RB	O	moreover	advmod	9	SENT_446	[p24l1084t3692r1216b3719],
2	,	,	O	,	_	0	SENT_446	[p24l1084t3692r1216b3719],
3	in	IN	O	in	_	0	SENT_446	[p24l1225t3692r1246b3715],
4	adipose	NN	O	adipose	nn	5	SENT_446	[p24l1255t3691r1359b3721],
5	tissue	NN	O	tissue	prep_in	9	SENT_446	[p24l1367t3692r1449b3719],
6	,	,	O	,	_	0	SENT_446	[p24l1367t3692r1449b3719],
7	CGMP	NN	O	cgmp	nn	8	SENT_446	[p24l1457t3692r1533b3715],
8	signaling	NN	O	signaling	nsubj	9	SENT_446	[p24l1541t3691r1661b3722],
9	promotes	VBZ	O	promote	_	0	SENT_446	[p24l1670t3695r1797b3721],
10	lipolysis	NN	O	lipolysis	dobj	9	SENT_446	[p24l1807t3691r1910b3722],
11	and	CC	O	and	_	0	SENT_446	[p24l1918t3691r1967b3715],
12	induces	VBZ	O	induce	conj_and	9	SENT_446	[p24l1976t3691r2078b3715],
13	adipogenic	JJ	O	adipogenic	amod	16	SENT_446	[p24l21t3732r170b3762],
14	and	CC	O	and	_	0	SENT_446	[p24l178t3732r226b3756],
15	thermogenic	JJ	O	thermogenic	conj_and	13	SENT_446	[p24l235t3732r407b3762],
16	programs	NNS	O	program	dobj	12	SENT_446	[p24l416t3739r542b3762],
17	during	IN	O	during	_	0	SENT_446	[p24l551t3732r637b3762],
18	brown	JJ	O	brown	amod	21	SENT_446	[p24l647t3732r731b3756],
19	fat	JJ	O	fat	amod	21	SENT_446	[p24l739t3732r774b3756],
20	cell	NN	O	cell	nn	21	SENT_446	[p24l781t3732r824b3756],
21	differentiation	NN	O	differentiation	prep_during	12	SENT_446	[p24l833t3732r1021b3756],
22	through	IN	O	through	_	0	SENT_446	[p24l1029t3732r1137b3762],
23	protein	NN	O	protein	nn	25	SENT_446	[p24l1147t3733r1241b3762],
24	kinase	NN	O	kinase	nn	25	SENT_446	[p24l1251t3732r1333b3756],
25	G	NN	O	g	prep_through	21	SENT_446	[p24l1341t3733r1360b3756],
26	(	CD	NUMBER	(	num	28	SENT_446	[p24l1369t3732r1583b3759],
27	PKG	NN	O	pkg	nn	28	SENT_446	[p24l1369t3732r1583b3759],
28	)	NN	O	)	dobj	9	SENT_446	[p24l1369t3732r1583b3759],
29	.	.	O	.	_	0	SENT_446	[p24l1369t3732r1583b3759],

1	—	NN	O	—	_	0	SENT_447	[p24l1369t3732r1583b3759],
2	.	.	O	.	_	0	SENT_447	[p24l1369t3732r1583b3759],

1	mediated	JJ	O	mediated	amod	2	SENT_448	[p24l1369t3732r1583b3759],
2	inhibition	NN	O	inhibition	_	0	SENT_448	[p24l1593t3732r1719b3756],
3	of	IN	O	of	_	0	SENT_448	[p24l1728t3732r1756b3756],
4	RhoA	NN	O	rhoa	nn	7	SENT_448	[p24l1762t3732r1832b3756],
5	and	CC	O	and	_	0	SENT_448	[p24l1840t3732r1889b3756],
6	Rho-associated	JJ	MISC	rho-associated	nn	7	SENT_448	[p24l1899t3732r2099b3756],
7	kinase	NN	O	kinase	prep_of	2	SENT_448	[p24l22t3773r104b3797],
8	(	CD	NUMBER	(	num	10	SENT_448	[p24l113t3774r204b3801],
9	ROCK	NN	O	rock	nn	10	SENT_448	[p24l113t3774r204b3801],
10	)	NN	O	)	dep	2	SENT_448	[p24l113t3774r204b3801],
11	and	CC	O	and	_	0	SENT_448	[p24l213t3773r269b3801],
12	,	,	O	,	_	0	SENT_448	[p24l213t3773r269b3801],
13	thereby	RB	O	thereby	dep	10	SENT_448	[p24l276t3773r384b3804],
14	,	,	O	,	_	0	SENT_448	[p24l276t3773r384b3804],
15	the	DT	O	the	det	16	SENT_448	[p24l391t3773r435b3797],
16	activation	NN	O	activation	conj_and	10	SENT_448	[p24l443t3774r573b3797],
17	of	IN	O	of	_	0	SENT_448	[p24l581t3773r609b3797],
18	phosphoinositide	JJ	O	phosphoinositide	amod	23	SENT_448	[p24l616t3773r849b3804],
19	3	CD	NUMBER	3	tmod	18	SENT_448	[p24l857t3773r966b3797],
20	—	NN	O	—	nn	23	SENT_448	[p24l857t3773r966b3797],
21	kinase	NN	O	kinase	nn	23	SENT_448	[p24l857t3773r966b3797],
22	(	CD	NUMBER	(	num	23	SENT_448	[p24l975t3773r1133b3801],
23	P	NN	O	p	prep_of	16	SENT_448	[p24l975t3773r1133b3801],
24	|	CD	NUMBER	|	num	26	SENT_448	[p24l975t3773r1133b3801],
25	3K	NN	O	3k	nn	26	SENT_448	[p24l975t3773r1133b3801],
26	)	NN	O	)	dep	16	SENT_448	[p24l975t3773r1133b3801],
27	.	.	O	.	_	0	SENT_448	[p24l975t3773r1133b3801],

1	—	NN	O	—	_	0	SENT_449	[p24l975t3773r1133b3801],
2	.	.	O	.	_	0	SENT_449	[p24l975t3773r1133b3801],

1	v	LS	O	v	_	0	SENT_450	[p24l975t3773r1133b3801],
2	.	.	O	.	_	0	SENT_450	[p24l975t3773r1133b3801],

1	—	NN	O	—	_	0	SENT_451	[p24l975t3773r1133b3801],
2	.	.	O	.	_	0	SENT_451	[p24l975t3773r1133b3801],

1	akt	NN	O	akt	nn	3	SENT_452	[p24l975t3773r1133b3801],
2	murine	JJ	O	murine	amod	3	SENT_452	[p24l1141t3774r1235b3797],
3	thymoma	NN	O	thymoma	_	0	SENT_452	[p24l1242t3773r1371b3804],
4	viral	JJ	O	viral	amod	7	SENT_452	[p24l1379t3773r1433b3797],
5	oncogene	NN	O	oncogene	nn	7	SENT_452	[p24l1442t3780r1575b3804],
6	homolog	NN	O	homolog	nn	7	SENT_452	[p24l1584t3773r1704b3804],
7	signaling	NN	O	signaling	dep	3	SENT_452	[p24l1713t3773r1839b3804],
8	.	.	O	.	_	0	SENT_452	[p24l1713t3773r1839b3804],

1	62	CD	NUMBER	62	num	4	SENT_453	[p25l20t60r51b81],
2	VOLUME	NN	O	volume	nn	4	SENT_453	[p25l1368t60r1476b81],
3	95	CD	NUMBER	95	num	4	SENT_453	[p25l1484t60r1511b81],
4	NUMBER	NN	O	number	nsubj	10	SENT_453	[p25l1521t60r1629b81],
5	1	CD	NUMBER	1	number	6	SENT_453	[p25l1639t61r1646b81],
6	|	CD	NUMBER	|	num	7	SENT_453	[p25l1660t58r1662b88],
7	JANUARY	NNP	DATE	JANUARY	tmod	10	SENT_453	[p25l1671t60r1789b81],
8	2014	CD	DATE	2014	num	7	SENT_453	[p25l1796t60r1855b81],
9	|	CD	NUMBER	|	npadvmod	10	SENT_453	[p25l1864t58r1866b88],
10	www.nature.com/cpt	JJ	O	www.nature.com/cpt	_	0	SENT_453	[p25l1875t60r2140b86],
11	emerging	VBG	O	emerge	amod	12	SENT_453	[p25l10t442r344b520],
12	evidence	NN	O	evidence	nsubj	13	SENT_453	[p25l368t436r677b499],
13	suggests	VBZ	O	suggest	ccomp	10	SENT_453	[p25l703t448r991b520],
14	that	IN	O	that	complm	17	SENT_453	[p25l1016t436r1154b499],
15	cGMP	NN	O	cgmp	nsubj	17	SENT_453	[p25l1178t440r1402b499],
16	may	MD	O	may	aux	17	SENT_453	[p25l1428t459r1579b520],
17	regulate	VB	O	regulate	ccomp	13	SENT_453	[p25l1600t436r1881b520],
18	energy	NN	O	energy	nn	19	SENT_453	[p25l1906t459r2147b520],
19	balance	NN	O	balance	dobj	17	SENT_453	[p25l8t538r267b601],
20	directly	RB	O	directly	advmod	17	SENT_453	[p25l290t530r622b622],
21	.89	CD	NUMBER	.89	pobj	20	SENT_453	[p25l290t530r622b622],

1	cGMP	NN	O	cgmp	nsubj	6	SENT_454	[p25l84t645r308b704],
2	is	VBZ	O	be	cop	6	SENT_454	[p25l333t647r385b704],
3	an	DT	O	a	det	6	SENT_454	[p25l410t664r492b704],
4	important	JJ	O	important	amod	6	SENT_454	[p25l517t647r875b724],
5	second	JJ	ORDINAL	second	amod	6	SENT_454	[p25l899t641r1144b704],
6	messenger	NN	O	messenger	dep	14	SENT_454	[p25l1167t664r1539b725],
7	generated	VBN	O	generate	partmod	6	SENT_454	[p25l1562t641r1907b725],
8	by	IN	O	by	_	0	SENT_454	[p25l1928t641r2014b725],
9	the	DT	O	the	det	10	SENT_454	[p25l2034t641r2143b704],
10	family	NN	O	family	agent	7	SENT_454	[p25l9t743r237b827],
11	of	IN	O	of	_	0	SENT_454	[p25l262t743r338b806],
12	guanylyl	NN	O	guanylyl	nn	13	SENT_454	[p25l355t743r658b827],
13	cyclases	NNS	O	cyclase	prep_of	10	SENT_454	[p25l685t743r967b827],
14	(	VBP	O	(	_	0	SENT_454	[p25l998t735r1297b820],
15	GCs	NNS	O	gc	dobj	14	SENT_454	[p25l998t735r1297b820],
16	)	CD	NUMBER	)	number	17	SENT_454	[p25l998t735r1297b820],
17	.88	CD	NUMBER	.88	nsubj	14	SENT_454	[p25l998t735r1297b820],
18	There	EX	O	there	expl	19	SENT_454	[p25l1325t743r1524b806],
19	are	VBP	O	be	rcmod	17	SENT_454	[p25l1553t766r1657b806],
20	two	CD	NUMBER	two	num	21	SENT_454	[p25l1683t755r1813b806],
21	forms	NNS	O	form	nsubj	19	SENT_454	[p25l1841t743r2047b806],
22	of	IN	O	of	_	0	SENT_454	[p25l2076t743r2152b806],
23	GCs	NNS	O	gc	prep_of	21	SENT_454	[p25l11t850r177b909],
24	:	:	O	:	_	0	SENT_454	[p25l11t850r177b909],
25	cytosolic	JJ	O	cytosolic	amod	28	SENT_454	[p25l205t846r513b930],
26	(	NN	O	(	nn	28	SENT_454	[p25l540t846r840b923],
27	soluble	JJ	O	soluble	amod	28	SENT_454	[p25l540t846r840b923],
28	)	NN	O	)	dep	21	SENT_454	[p25l540t846r840b923],
29	and	CC	O	and	_	0	SENT_454	[p25l869t846r997b909],
30	membrane-bound	JJ	O	membrane-bound	amod	33	SENT_454	[p25l1020t846r1663b909],
31	(	NN	O	(	nn	33	SENT_454	[p25l1688t846r2140b929],
32	particulate	JJ	O	particulate	amod	33	SENT_454	[p25l1688t846r2140b929],
33	)	NN	O	)	conj_and	28	SENT_454	[p25l1688t846r2140b929],
34	.	.	O	.	_	0	SENT_454	[p25l1688t846r2140b929],

1	Soluble	JJ	O	soluble	amod	2	SENT_455	[p25l11t949r264b1012],
2	GCS	NNS	O	gc	nsubjpass	4	SENT_455	[p25l289t953r436b1012],
3	are	VBP	O	be	auxpass	4	SENT_455	[p25l461t972r563b1012],
4	activated	VBN	O	activate	_	0	SENT_455	[p25l587t949r898b1012],
5	by	IN	O	by	_	0	SENT_455	[p25l918t949r1004b1033],
6	nitric	JJ	O	nitric	amod	7	SENT_455	[p25l1023t955r1212b1012],
7	oxide	NN	O	oxide	agent	4	SENT_455	[p25l1235t949r1441b1021],
8	,	,	O	,	_	0	SENT_455	[p25l1235t949r1441b1021],
9	whereas	IN	O	whereas	mark	13	SENT_455	[p25l1464t949r1746b1012],
10	particulate	JJ	O	particulate	amod	11	SENT_455	[p25l1769t949r2144b1032],
11	GCs	NNS	O	gc	nsubjpass	13	SENT_455	[p25l11t1056r157b1115],
12	are	VBP	O	be	auxpass	13	SENT_455	[p25l181t1075r282b1115],
13	activated	VBN	O	activate	advcl	4	SENT_455	[p25l305t1052r613b1115],
14	upon	IN	O	upon	_	0	SENT_455	[p25l635t1074r813b1135],
15	binding	NN	O	binding	prep_upon	13	SENT_455	[p25l834t1052r1104b1136],
16	by	IN	O	by	_	0	SENT_455	[p25l1123t1052r1208b1136],
17	their	PRP$	O	they	poss	19	SENT_455	[p25l1226t1052r1390b1115],
18	cognate	JJ	O	cognate	amod	19	SENT_455	[p25l1412t1064r1676b1136],
19	ligands	NNS	O	ligand	agent	13	SENT_455	[p25l1698t1052r1962b1136],
20	,	,	O	,	_	0	SENT_455	[p25l1698t1052r1962b1136],
21	such	JJ	O	such	_	0	SENT_455	[p25l1988t1052r2143b1115],
22	as	IN	O	as	_	0	SENT_455	[p25l10t1178r75b1218],
23	the	DT	O	the	det	25	SENT_455	[p25l97t1155r203b1218],
24	natriuretic	JJ	O	natriuretic	amod	25	SENT_455	[p25l226t1161r589b1218],
25	peptides	NNS	O	peptide	prep_such_as	13	SENT_455	[p25l610t1155r899b1238],
26	(	VBP	O	(	rcmod	25	SENT_455	[p25l925t1155r1129b1232],
27	atrial	JJ	O	atrial	amod	29	SENT_455	[p25l925t1155r1129b1232],
28	natriuretic	JJ	O	natriuretic	amod	29	SENT_455	[p25l1150t1161r1513b1218],
29	peptide	NN	O	peptide	dobj	26	SENT_455	[p25l1534t1155r1791b1238],
30	and	CC	O	and	_	0	SENT_455	[p25l1815t1155r1942b1218],
31	brain	NN	O	brain	nn	33	SENT_455	[p25l1961t1155r2142b1218],
32	natriuretic	JJ	O	natriuretic	amod	33	SENT_455	[p25l9t1264r378b1321],
33	peptide	NN	O	peptide	dobj	26	SENT_455	[p25l400t1258r661b1341],
34	for	IN	O	for	_	0	SENT_455	[p25l685t1258r784b1321],
35	GC-A	NN	O	gc-a	prep_for	33	SENT_455	[p25l807t1262r1033b1330],
36	,	,	O	,	_	0	SENT_455	[p25l807t1262r1033b1330],
37	and	CC	O	and	_	0	SENT_455	[p25l1059t1258r1187b1321],
38	C	NN	O	c	conj_and	13	SENT_455	[p25l1211t1262r1447b1342],
39	—	CD	NUMBER	—	num	40	SENT_455	[p25l1211t1262r1447b1342],
40	type	NN	O	type	nn	42	SENT_455	[p25l1211t1262r1447b1342],
41	natriuretic	JJ	O	natriuretic	amod	42	SENT_455	[p25l1471t1264r1839b1321],
42	peptide	NN	O	peptide	dobj	38	SENT_455	[p25l1881t1258r2143b1341],
43	for	IN	O	for	_	0	SENT_455	[p25l9t1361r106b1424],
44	GC-B	NN	O	gc-b	prep_for	42	SENT_455	[p25l126t1365r317b1424],
45	and	CC	O	and	_	0	SENT_455	[p25l340t1361r464b1424],
46	the	DT	O	the	det	48	SENT_455	[p25l482t1361r587b1424],
47	intestinal	JJ	O	intestinal	amod	48	SENT_455	[p25l608t1361r920b1424],
48	peptides	NNS	O	peptide	nsubj	49	SENT_455	[p25l938t1361r1222b1444],
49	(	VBP	O	(	conj_and	4	SENT_455	[p25l1246t1361r1566b1445],
50	guanylin	NN	O	guanylin	dobj	49	SENT_455	[p25l1246t1361r1566b1445],
51	and	CC	O	and	_	0	SENT_455	[p25l1587t1361r1711b1424],
52	uroguanylin	NN	O	uroguanylin	conj_and	50	SENT_455	[p25l1730t1361r2143b1445],
53	for	IN	O	for	_	0	SENT_455	[p25l9t1463r106b1526],
54	GC	NN	O	gc	prep_for	50	SENT_455	[p25l126t1467r327b1526],
55	.	.	O	.	_	0	SENT_455	[p25l126t1467r327b1526],

1	—	NN	O	—	_	0	SENT_456	[p25l126t1467r327b1526],
2	.	.	O	.	_	0	SENT_456	[p25l126t1467r327b1526],

1	C	NN	O	c	nn	3	SENT_457	[p25l126t1467r327b1526],
2	(	CD	NUMBER	(	num	3	SENT_457	[p25l351t1455r846b1540],
3	GUCY2C	NN	O	gucy2c	nsubj	14	SENT_457	[p25l351t1455r846b1540],
4	)	CD	NUMBER	)	number	5	SENT_457	[p25l351t1455r846b1540],
5	)	CD	NUMBER	)	amod	3	SENT_457	[p25l351t1455r846b1540],
6	.88	CD	NUMBER	.88	dep	5	SENT_457	[p25l351t1455r846b1540],
7	As	IN	O	as	dep	6	SENT_457	[p25l866t1467r952b1526],
8	a	DT	O	a	det	11	SENT_457	[p25l973t1486r1008b1526],
9	critical	JJ	O	critical	amod	11	SENT_457	[p25l1027t1463r1260b1526],
10	second	JJ	ORDINAL	second	amod	11	SENT_457	[p25l1280t1463r1516b1526],
11	messenger	NN	O	messenger	pobj	7	SENT_457	[p25l1535t1486r1903b1547],
12	,	,	O	,	_	0	SENT_457	[p25l1535t1486r1903b1547],
13	cGMP	NN	O	cgmp	appos	11	SENT_457	[p25l1926t1467r2143b1526],
14	regulates	VBZ	O	regulate	dep	53	SENT_457	[p25l10t1566r318b1650],
15	a	DT	O	a	det	16	SENT_457	[p25l343t1589r377b1629],
16	variety	NN	O	variety	dobj	14	SENT_457	[p25l397t1572r639b1650],
17	of	IN	O	of	_	0	SENT_457	[p25l659t1566r734b1629],
18	physiological	JJ	O	physiological	amod	19	SENT_457	[p25l747t1566r1207b1650],
19	processes	NNS	O	process	prep_of	16	SENT_457	[p25l1228t1588r1575b1649],
20	,	,	O	,	_	0	SENT_457	[p25l1228t1588r1575b1649],
21	and	CC	O	and	_	0	SENT_457	[p25l1601t1566r1729b1629],
22	its	PRP$	O	its	poss	24	SENT_457	[p25l1751t1572r1828b1629],
23	intracellular	JJ	O	intracellular	amod	24	SENT_457	[p25l1852t1566r2142b1629, p25l8t1669r168b1732],
24	concentration	NN	O	concentration	nsubjpass	27	SENT_457	[p25l190t1675r672b1732],
25	is	VBZ	O	be	auxpass	27	SENT_457	[p25l696t1675r746b1732],
26	meticulously	RB	O	meticulously	advmod	27	SENT_457	[p25l770t1669r1219b1753],
27	balanced	VBN	O	balance	conj_and	14	SENT_457	[p25l1236t1669r1548b1732],
28	by	IN	O	by	_	0	SENT_457	[p25l1568t1669r1652b1753],
29	the	DT	O	the	det	30	SENT_457	[p25l1671t1669r1779b1732],
30	activity	NN	O	activity	agent	27	SENT_457	[p25l1802t1675r2058b1753],
31	of	IN	O	of	_	0	SENT_457	[p25l2078t1669r2153b1732],
32	GCs	NNS	O	gc	prep_of	30	SENT_457	[p25l11t1775r154b1834],
33	that	WDT	O	that	nsubj	34	SENT_457	[p25l174t1771r307b1834],
34	produce	VBP	O	produce	rcmod	32	SENT_457	[p25l324t1771r602b1854],
35	cGMP	NN	O	cgmp	dobj	34	SENT_457	[p25l623t1775r839b1834],
36	and	CC	O	and	_	0	SENT_457	[p25l861t1771r986b1834],
37	PDEs	NNS	O	pde	dobj	34	SENT_457	[p25l1005t1776r1190b1834],
38	that	WDT	O	that	nsubj	39	SENT_457	[p25l1210t1771r1342b1834],
39	hydrolyze	VBP	O	hydrolyze	rcmod	35	SENT_457	[p25l1360t1771r1690b1855],
40	cGMP	NN	O	cgmp	nsubj	43	SENT_457	[p25l1711t1763r1998b1834],
41	.88	CD	NUMBER	.88	num	40	SENT_457	[p25l1711t1763r1998b1834],
42	The	DT	O	the	det	43	SENT_457	[p25l2019t1771r2143b1834],
43	role	NN	O	role	xcomp	39	SENT_457	[p25l10t1874r138b1937],
44	of	IN	O	of	_	0	SENT_457	[p25l159t1874r233b1937],
45	cGMP	NN	O	cgmp	prep_of	43	SENT_457	[p25l245t1878r463b1937],
46	in	IN	O	in	_	0	SENT_457	[p25l485t1880r551b1936],
47	the	DT	O	the	det	48	SENT_457	[p25l571t1874r677b1937],
48	regulation	NN	O	regulation	prep_in	39	SENT_457	[p25l698t1874r1046b1958],
49	of	IN	O	of	_	0	SENT_457	[p25l1067t1874r1141b1937],
50	energy	NN	O	energy	nn	51	SENT_457	[p25l1153t1897r1386b1958],
51	balance	NN	O	balance	prep_of	48	SENT_457	[p25l1400t1874r1660b1937],
52	is	VBZ	O	be	auxpass	53	SENT_457	[p25l1681t1880r1731b1937],
53	highlighted	VBN	O	highlight	_	0	SENT_457	[p25l1751t1874r2145b1958],
54	by	IN	O	by	_	0	SENT_457	[p25l8t1976r90b2060],
55	its	PRP$	O	its	poss	56	SENT_457	[p25l106t1982r180b2039],
56	role	NN	O	role	agent	53	SENT_457	[p25l201t1976r327b2039],
57	in	IN	O	in	_	0	SENT_457	[p25l347t1982r413b2038],
58	mitochondrial	JJ	O	mitochondrial	amod	59	SENT_457	[p25l432t1976r917b2039],
59	biogenesis90	NN	O	biogenesis90	prep_in	56	SENT_457	[p25l934t1968r1342b2060],
60	and	CC	O	and	_	0	SENT_457	[p25l1363t1976r1487b2039],
61	protection	NN	O	protection	conj_and	59	SENT_457	[p25l1505t1982r1854b2059],
62	of	IN	O	of	_	0	SENT_457	[p25l1874t1976r1947b2039],
63	mitochondrial	JJ	O	mitochondrial	amod	64	SENT_457	[p25l1957t1982r2140b2039, p25l10t2078r340b2141],
64	function	NN	O	function	prep_of	56	SENT_457	[p25l361t2078r653b2141],
65	from	IN	O	from	_	0	SENT_457	[p25l675t2078r842b2141],
66	oxidative	JJ	O	oxidative	amod	67	SENT_457	[p25l864t2078r1173b2141],
67	damage	NN	O	damage	prep_from	53	SENT_457	[p25l1196t2070r1536b2162],
68	.91	CD	NUMBER	.91	nsubjpass	53	SENT_457	[p25l1196t2070r1536b2162],

1	Mammalian	JJ	MISC	mammalian	amod	3	SENT_458	[p25l83t2181r501b2244],
2	adipose	NN	O	adipose	nn	3	SENT_458	[p25l523t2181r783b2264],
3	tissue	NN	O	tissue	nsubjpass	6	SENT_458	[p25l803t2187r995b2244],
4	is	VBZ	O	be	auxpass	6	SENT_458	[p25l1016t2187r1066b2244],
5	mainly	RB	O	mainly	advmod	6	SENT_458	[p25l1087t2181r1327b2265],
6	composed	VBN	O	compose	_	0	SENT_458	[p25l1344t2181r1695b2264],
7	of	IN	O	of	_	0	SENT_458	[p25l1715t2181r1789b2244],
8	two	CD	NUMBER	two	num	9	SENT_458	[p25l1799t2193r1924b2244],
9	types	NNS	O	type	prep_of	6	SENT_458	[p25l1945t2193r2140b2265],
10	:	:	O	:	_	0	SENT_458	[p25l1945t2193r2140b2265],
11	white	JJ	O	white	amod	16	SENT_458	[p25l8t2283r196b2346],
12	adipose	NN	O	adipose	nn	16	SENT_458	[p25l218t2283r478b2366],
13	tissue	NN	O	tissue	nn	16	SENT_458	[p25l498t2289r690b2346],
14	(	CD	NUMBER	(	num	16	SENT_458	[p25l714t2284r943b2359],
15	WAT	NN	O	wat	nn	16	SENT_458	[p25l714t2284r943b2359],
16	)	NN	O	)	dep	9	SENT_458	[p25l714t2284r943b2359],
17	and	CC	O	and	_	0	SENT_458	[p25l969t2283r1095b2346],
18	brown	JJ	O	brown	amod	20	SENT_458	[p25l1113t2283r1334b2346],
19	adipose	NN	O	adipose	nn	20	SENT_458	[p25l1356t2283r1616b2366],
20	tissue	NN	O	tissue	dep	9	SENT_458	[p25l1636t2289r1828b2346],
21	(	CD	NUMBER	(	num	22	SENT_458	[p25l1852t2275r2142b2360],
22	BAT	NN	O	bat	dep	9	SENT_458	[p25l1852t2275r2142b2360],
23	)	CD	NUMBER	)	number	24	SENT_458	[p25l1852t2275r2142b2360],
24	.92	CD	NUMBER	.92	num	26	SENT_458	[p25l1852t2275r2142b2360],
25	WAT	NN	O	wat	nn	26	SENT_458	[p25l8t2388r192b2448],
26	extracts	NNS	O	extract	dep	22	SENT_458	[p25l220t2397r497b2448],
27	fat	JJ	O	fat	amod	26	SENT_458	[p25l525t2385r615b2448],
28	from	IN	O	from	_	0	SENT_458	[p25l641t2385r815b2448],
29	the	DT	O	the	det	30	SENT_458	[p25l841t2385r952b2448],
30	circulation	NN	O	circulation	prep_from	27	SENT_458	[p25l980t2385r1367b2448],
31	and	CC	O	and	_	0	SENT_458	[p25l1395t2385r1526b2448],
32	stores	NNS	O	store	prep_of	6	SENT_458	[p25l1553t2397r1756b2448],
33	the	DT	O	the	det	35	SENT_458	[p25l1784t2385r1894b2448],
34	excess	JJ	O	excess	amod	35	SENT_458	[p25l1922t2408r2140b2448],
35	energy	NN	O	energy	dep	32	SENT_458	[p25l10t2511r243b2572],
36	in	IN	O	in	_	0	SENT_458	[p25l261t2494r327b2550],
37	the	DT	O	the	det	38	SENT_458	[p25l348t2488r454b2551],
38	form	NN	O	form	prep_in	6	SENT_458	[p25l475t2488r643b2551],
39	of	IN	O	of	_	0	SENT_458	[p25l665t2488r739b2551],
40	triglycerides	NNS	O	triglyceride	prep_of	38	SENT_458	[p25l749t2488r1190b2572],
41	.	.	O	.	_	0	SENT_458	[p25l749t2488r1190b2572],

1	WAT	NNP	O	WAT	nsubj	4	SENT_459	[p25l1213t2491r1391b2551],
2	is	VBZ	O	be	cop	4	SENT_459	[p25l1413t2494r1463b2551],
3	also	RB	O	also	advmod	4	SENT_459	[p25l1486t2488r1616b2551],
4	responsible	JJ	O	responsible	ccomp	28	SENT_459	[p25l1639t2488r2026b2571],
5	for	IN	O	for	_	0	SENT_459	[p25l2047t2488r2144b2551],
6	the	DT	O	the	det	7	SENT_459	[p25l9t2591r114b2654],
7	production	NN	O	production	prep_for	4	SENT_459	[p25l133t2591r514b2674],
8	of	IN	O	of	_	0	SENT_459	[p25l534t2591r607b2654],
9	hormones	NNS	O	hormone	prep_of	7	SENT_459	[p25l617t2591r978b2663],
10	,	,	O	,	_	0	SENT_459	[p25l617t2591r978b2663],
11	such	JJ	O	such	_	0	SENT_459	[p25l1001t2591r1154b2654],
12	as	IN	O	as	_	0	SENT_459	[p25l1174t2614r1238b2654],
13	leptin	NN	O	leptin	nn	15	SENT_459	[p25l1257t2591r1470b2674],
14	,	,	O	,	_	0	SENT_459	[p25l1257t2591r1470b2674],
15	estrogen	NN	O	estrogen	prep_such_as	28	SENT_459	[p25l1493t2603r1796b2675],
16	,	,	O	,	_	0	SENT_459	[p25l1493t2603r1796b2675],
17	and	CC	O	and	_	0	SENT_459	[p25l1819t2591r1943b2654],
18	resistin	NN	O	resistin	conj_and	15	SENT_459	[p25l1963t2597r2138b2654, p25l9t2699r121b2765],
19	,	,	O	,	_	0	SENT_459	[p25l1963t2597r2138b2654, p25l9t2699r121b2765],
20	and	CC	O	and	_	0	SENT_459	[p25l144t2693r270b2756],
21	inﬂammatory	JJ	O	inﬂammatory	amod	22	SENT_459	[p25l290t2693r764b2777],
22	cytokines	NNS	O	cytokine	prep_such_as	28	SENT_459	[p25l781t2685r1186b2777],
23	.93	CD	NUMBER	.93	num	24	SENT_459	[p25l781t2685r1186b2777],
24	BAT	NN	O	bat	dep	22	SENT_459	[p25l1208t2696r1360b2755],
25	is	VBZ	O	be	cop	28	SENT_459	[p25l1381t2699r1431b2756],
26	the	DT	O	the	det	28	SENT_459	[p25l1451t2693r1557b2756],
27	major	JJ	O	major	amod	28	SENT_459	[p25l1578t2699r1780b2777],
28	tissue	NN	O	tissue	_	0	SENT_459	[p25l1799t2699r1990b2756],
29	that	WDT	O	that	nsubj	30	SENT_459	[p25l2010t2693r2144b2756],
30	dissipates	VBZ	O	dissipate	rcmod	28	SENT_459	[p25l10t2796r336b2879],
31	energy	NN	O	energy	dobj	30	SENT_459	[p25l360t2819r594b2880],
32	in	IN	O	in	_	0	SENT_459	[p25l613t2802r680b2858],
33	the	DT	O	the	det	34	SENT_459	[p25l701t2796r808b2859],
34	form	NN	O	form	prep_in	31	SENT_459	[p25l831t2796r999b2859],
35	of	IN	O	of	_	0	SENT_459	[p25l1022t2796r1096b2859],
36	heat	NN	O	heat	prep_of	34	SENT_459	[p25l1108t2796r1252b2859],
37	through	IN	O	through	_	0	SENT_459	[p25l1273t2796r1551b2880],
38	a	DT	O	a	det	39	SENT_459	[p25l1575t2819r1609b2859],
39	process	NN	O	process	prep_through	30	SENT_459	[p25l1629t2818r1883b2879],
40	known	VBN	O	know	partmod	39	SENT_459	[p25l1905t2796r2143b2859],
41	as	IN	O	as	_	0	SENT_459	[p25l10t2922r74b2962],
42	nonshivering	JJ	O	nonshivering	amod	43	SENT_459	[p25l97t2899r550b2983],
43	thermogenesis	NN	O	thermogenesis	prep_as	40	SENT_459	[p25l570t2899r1069b2983],
44	(	CD	NUMBER	(	num	47	SENT_459	[p25l1095t2900r1354b2982],
45	Figure	NNP	O	Figure	dep	46	SENT_459	[p25l1095t2900r1354b2982],
46	3	CD	NUMBER	3	amod	47	SENT_459	[p25l1375t2900r1461b2976],
47	)	NN	O	)	nsubj	28	SENT_459	[p25l1375t2900r1461b2976],
48	.	.	O	.	_	0	SENT_459	[p25l1375t2900r1461b2976],

1	BAT	NN	O	bat	nsubj	5	SENT_460	[p25l1486t2902r1638b2961],
2	generates	VBZ	O	generate	_	0	SENT_460	[p25l1660t2911r1978b2983],
3	heat	NN	O	heat	dobj	2	SENT_460	[p25l2000t2899r2144b2962],
4	and	CC	O	and	_	0	SENT_460	[p25l10t3002r139b3065],
5	increases	VBZ	O	increase	conj_and	2	SENT_460	[p25l161t3008r477b3065],
6	energy	NN	O	energy	nn	7	SENT_460	[p25l501t3025r739b3086],
7	expenditure	NN	O	expenditure	dobj	5	SENT_460	[p25l759t3002r1178b3085],
8	through	IN	O	through	_	0	SENT_460	[p25l1200t3002r1483b3086],
9	the	DT	O	the	det	12	SENT_460	[p25l1506t3002r1614b3065],
10	mitochondrial	JJ	O	mitochondrial	amod	12	SENT_460	[p25l1637t3002r2142b3065],
11	transmembrane	NN	O	transmembrane	nn	12	SENT_460	[p25l9t3105r552b3168],
12	protein	NN	O	protein	prep_through	5	SENT_460	[p25l574t3111r840b3188],
13	,	,	O	,	_	0	SENT_460	[p25l574t3111r840b3188],
14	uncoupling	NN	O	uncoupling	nn	15	SENT_460	[p25l864t3105r1256b3189],
15	protein	NN	O	protein	appos	12	SENT_460	[p25l1296t3111r1544b3188],
16	1	CD	NUMBER	1	number	17	SENT_460	[p25l1573t3112r1598b3167],
17	(	CD	NUMBER	(	num	19	SENT_460	[p25l1630t3105r1912b3182],
18	UCP1	NN	O	ucp1	nn	19	SENT_460	[p25l1630t3105r1912b3182],
19	)	NN	O	)	dobj	2	SENT_460	[p25l1630t3105r1912b3182],
20	,	,	O	,	_	0	SENT_460	[p25l1630t3105r1912b3182],
21	which	WDT	O	which	nsubj	22	SENT_460	[p25l1934t3105r2143b3168],
22	dissipates	VBZ	O	dissipate	rcmod	19	SENT_460	[p25l10t3208r335b3291],
23	the	DT	O	the	det	24	SENT_460	[p25l357t3208r463b3271],
24	energy	NN	O	energy	nsubj	68	SENT_460	[p25l487t3231r720b3292],
25	generated	VBN	O	generate	partmod	24	SENT_460	[p25l739t3208r1074b3292],
26	during	IN	O	during	_	0	SENT_460	[p25l1096t3208r1327b3292],
27	oxidative	JJ	O	oxidative	amod	30	SENT_460	[p25l1348t3208r1658b3271],
28	phosphoryla	NN	O	phosphorylum	nn	30	SENT_460	[p25l1679t3208r2139b3292],
29	—	NN	O	—	nn	30	SENT_460	[p25l1679t3208r2139b3292],
30	tion	NN	O	tion	prep_during	25	SENT_460	[p25l9t3317r143b3374],
31	in	IN	O	in	_	0	SENT_460	[p25l163t3317r228b3373],
32	the	DT	O	the	det	33	SENT_460	[p25l247t3311r351b3374],
33	mitochondria	NN	O	mitochondrium	prep_in	30	SENT_460	[p25l372t3311r835b3374],
34	into	IN	O	into	_	0	SENT_460	[p25l854t3317r985b3374],
35	heat	NN	O	heat	prep_into	25	SENT_460	[p25l1004t3311r1146b3374],
36	by	IN	O	by	_	0	SENT_460	[p25l1162t3311r1245b3395],
37	allowing	VBG	O	allow	agent	25	SENT_460	[p25l1262t3311r1548b3395],
38	protons	NNS	O	proton	dobj	37	SENT_460	[p25l1565t3323r1822b3394],
39	that	WDT	O	that	nsubjpass	42	SENT_460	[p25l1842t3311r1973b3374],
40	have	VBP	O	have	aux	42	SENT_460	[p25l1990t3311r2143b3374],
41	been	VBN	O	be	auxpass	42	SENT_460	[p25l8t3414r173b3477],
42	pumped	VBN	O	pump	rcmod	38	SENT_460	[p25l196t3414r486b3497],
43	into	IN	O	into	_	0	SENT_460	[p25l508t3420r643b3477],
44	the	DT	O	the	det	46	SENT_460	[p25l667t3414r774b3477],
45	intermembrane	NN	O	intermembrane	nn	46	SENT_460	[p25l798t3414r1338b3477],
46	space	NN	O	space	prep_into	42	SENT_460	[p25l1362t3436r1548b3497],
47	to	TO	O	to	_	0	SENT_460	[p25l1570t3426r1637b3477],
48	leak	NN	O	leak	prep_to	42	SENT_460	[p25l1660t3414r1803b3477],
49	back	RB	O	back	advmod	37	SENT_460	[p25l1820t3414r1985b3477],
50	into	IN	O	into	_	0	SENT_460	[p25l2005t3420r2141b3477],
51	the	DT	O	the	det	53	SENT_460	[p25l9t3516r115b3579],
52	mitochondrial	JJ	O	mitochondrial	amod	53	SENT_460	[p25l136t3516r630b3579],
53	matrix	NN	O	matrix	prep_into	37	SENT_460	[p25l650t3508r959b3579],
54	.94	CD	NUMBER	.94	dep	37	SENT_460	[p25l650t3508r959b3579],
55	As	IN	O	as	dep	54	SENT_460	[p25l978t3520r1065b3579],
56	a	DT	O	a	det	57	SENT_460	[p25l1087t3539r1122b3579],
57	consequence	NN	O	consequence	pobj	55	SENT_460	[p25l1142t3539r1597b3599],
58	,	,	O	,	_	0	SENT_460	[p25l1142t3539r1597b3599],
59	increasing	VBG	O	increase	conj_or	37	SENT_460	[p25l1620t3522r1972b3600],
60	BAT	NN	O	bat	nn	61	SENT_460	[p25l1991t3519r2143b3578],
61	function	NN	O	function	dobj	59	SENT_460	[p25l9t3619r301b3682],
62	or	CC	O	or	_	0	SENT_460	[p25l322t3642r393b3682],
63	differentiating	VBG	O	differentiate	agent	25	SENT_460	[p25l413t3619r898b3703],
64	WAT	NNP	O	WAT	dobj	63	SENT_460	[p25l915t3622r1092b3682],
65	into	IN	O	into	_	0	SENT_460	[p25l1113t3625r1246b3682],
66	BAT	NN	O	bat	prep_into	63	SENT_460	[p25l1268t3622r1419b3681],
67	may	MD	O	may	aux	68	SENT_460	[p25l1439t3642r1585b3703],
68	promote	VB	O	promote	ccomp	22	SENT_460	[p25l1601t3631r1891b3702],
69	energy	NN	O	energy	nn	70	SENT_460	[p25l1912t3642r2144b3703],
70	expenditure	NN	O	expenditure	dobj	68	SENT_460	[p25l10t3722r428b3805],
71	and	CC	O	and	_	0	SENT_460	[p25l453t3722r581b3785],
72	offset	VBP	O	offset	conj_and	2	SENT_460	[p25l604t3722r792b3785],
73	the	DT	O	the	det	76	SENT_460	[p25l813t3722r922b3785],
74	positive	JJ	O	positive	amod	76	SENT_460	[p25l944t3728r1217b3805],
75	energy	NN	O	energy	nn	76	SENT_460	[p25l1241t3745r1479b3806],
76	balance	NN	O	balance	dobj	72	SENT_460	[p25l1497t3722r1762b3785],
77	associated	VBN	O	associate	partmod	76	SENT_460	[p25l1787t3722r2142b3785],
78	with	IN	O	with	_	0	SENT_460	[p26l8t20r160b83],
79	overnutrition	NN	O	overnutrition	prep_with	77	SENT_460	[p26l182t26r641b83],
80	to	TO	O	to	aux	81	SENT_460	[p26l662t32r728b83],
81	reduce	VB	O	reduce	xcomp	77	SENT_460	[p26l750t20r978b83],
82	obesity	NN	O	obesity	dobj	81	SENT_460	[p26l1000t12r1315b104],
83	.95	CD	NUMBER	.95	num	82	SENT_460	[p26l1000t12r1315b104],

1	In	IN	O	in	dep	149	SENT_461	[p26l84t128r153b185],
2	BAT	NN	O	bat	dep	149	SENT_461	[p26l174t126r331b195],
3	,	,	O	,	_	0	SENT_461	[p26l174t126r331b195],
4	cGMP	NN	O	cgmp	dep	149	SENT_461	[p26l353t127r567b186],
5	signaling	NN	O	signaling	dep	149	SENT_461	[p26l589t123r889b207],
6	has	VBZ	O	have	dep	149	SENT_461	[p26l906t123r1016b186],
7	been	VBN	O	be	dep	149	SENT_461	[p26l1034t123r1194b186],
8	shown	VBN	O	show	dep	149	SENT_461	[p26l1215t123r1432b186],
9	to	TO	O	to	dep	149	SENT_461	[p26l1451t135r1515b186],
10	induce	VB	O	induce	dep	149	SENT_461	[p26l1536t123r1759b186],
11	adipogenic	JJ	O	adipogenic	dep	149	SENT_461	[p26l1781t123r2143b207],
12	and	CC	O	and	dep	149	SENT_461	[p26l10t226r135b289],
13	thermogenic	JJ	O	thermogenic	dep	149	SENT_461	[p26l154t226r584b310],
14	programs	NNS	O	program	dep	149	SENT_461	[p26l602t248r925b310],
15	during	IN	O	during	dep	149	SENT_461	[p26l947t226r1174b310],
16	brown	JJ	O	brown	dep	149	SENT_461	[p26l1191t226r1409b289],
17	fat	JJ	O	fat	dep	149	SENT_461	[p26l1429t226r1514b289],
18	cell	NN	O	cell	dep	149	SENT_461	[p26l1534t226r1644b289],
19	differentiation	NN	O	differentiation	dep	149	SENT_461	[p26l1665t226r2143b289],
20	through	IN	O	through	dep	149	SENT_461	[p26l9t329r276b413],
21	protein	NN	O	protein	dep	149	SENT_461	[p26l292t335r531b412],
22	kinase	NN	O	kinase	dep	149	SENT_461	[p26l547t329r756b392],
23	G	NN	O	g	dep	149	SENT_461	[p26l775t329r1184b392],
24	—	CD	NUMBER	—	dep	149	SENT_461	[p26l775t329r1184b392],
25	mediated	JJ	O	mediated	dep	149	SENT_461	[p26l775t329r1184b392],
26	inhibition	NN	O	inhibition	dep	149	SENT_461	[p26l1201t329r1527b392],
27	of	IN	O	of	dep	149	SENT_461	[p26l1545t329r1617b392],
28	RhoA	NN	O	rhoa	dep	149	SENT_461	[p26l1626t329r1821b392],
29	and	CC	O	and	dep	149	SENT_461	[p26l1839t329r1961b392],
30	Rhoassociated	JJ	MISC	rhoassociated	dep	149	SENT_461	[p26l1978t329r2141b392, p26l10t432r345b495],
31	kinase	NN	O	kinase	dep	149	SENT_461	[p26l361t432r571b495],
32	and	CC	O	and	dep	149	SENT_461	[p26l590t432r729b504],
33	,	,	O	,	_	0	SENT_461	[p26l590t432r729b504],
34	thereby	RB	O	thereby	dep	149	SENT_461	[p26l747t432r1005b516],
35	,	,	O	,	_	0	SENT_461	[p26l747t432r1005b516],
36	the	DT	O	the	dep	149	SENT_461	[p26l1024t432r1128b495],
37	activation	NN	O	activation	dep	149	SENT_461	[p26l1146t438r1470b495],
38	of	IN	O	of	dep	149	SENT_461	[p26l1489t432r1561b495],
39	phosphoinositide	NN	O	phosphoinositide	dep	149	SENT_461	[p26l1568t432r2144b515],
40	3-kinase	NN	O	3-kinase	dep	149	SENT_461	[p26l11t535r511b598],
41	—	CD	NUMBER	—	dep	149	SENT_461	[p26l11t535r511b598],
42	v-akt	NN	O	v-akt	dep	149	SENT_461	[p26l11t535r511b598],
43	murine	JJ	O	murine	dep	149	SENT_461	[p26l530t541r777b598],
44	thymoma	NN	O	thymoma	dep	149	SENT_461	[p26l797t535r1124b619],
45	viral	JJ	O	viral	dep	149	SENT_461	[p26l1140t535r1293b598],
46	oncogene	NN	O	oncogene	dep	149	SENT_461	[p26l1313t558r1634b619],
47	homolog	NN	O	homolog	dep	149	SENT_461	[p26l1653t535r1957b619],
48	signaling	NN	O	signaling	dep	149	SENT_461	[p26l1977t541r2140b619, p26l10t637r176b721],
49	(	CD	NUMBER	(	dep	149	SENT_461	[p26l198t638r454b720],
50	Figure	NNP	O	Figure	dep	149	SENT_461	[p26l198t638r454b720],
51	3	CD	NUMBER	3	dep	149	SENT_461	[p26l474t629r622b714],
52	)	CD	NUMBER	)	dep	149	SENT_461	[p26l474t629r622b714],
53	.96	CD	NUMBER	.96	dep	149	SENT_461	[p26l474t629r622b714],
54	In	IN	O	in	dep	149	SENT_461	[p26l644t642r715b699],
55	addition	NN	O	addition	dep	149	SENT_461	[p26l737t637r1037b709],
56	,	,	O	,	_	0	SENT_461	[p26l737t637r1037b709],
57	increasing	VBG	O	increase	dep	149	SENT_461	[p26l1060t643r1407b721],
58	cGMP	NN	O	cgmp	dep	149	SENT_461	[p26l1426t641r1644b700],
59	levels	NNS	O	level	dep	149	SENT_461	[p26l1665t637r1847b700],
60	through	IN	O	through	dep	149	SENT_461	[p26l1868t637r2143b721],
61	cell-permeable	JJ	O	cell-permeable	dep	149	SENT_461	[p26l10t740r519b823],
62	cGMP	NN	O	cgmp	dep	149	SENT_461	[p26l544t744r765b803],
63	or	CC	O	or	dep	149	SENT_461	[p26l791t763r863b803],
64	sildenaﬁl-mediated	JJ	O	sildenaﬁl-mediated	dep	149	SENT_461	[p26l886t740r1553b803],
65	PDE5	NN	O	pde5	dep	149	SENT_461	[p26l1575t745r1773b803],
66	inhibition	NN	O	inhibition	dep	149	SENT_461	[p26l1799t740r2142b803],
67	enhanced	VBD	O	enhance	dep	149	SENT_461	[p26l10t842r323b905],
68	BAT	NN	O	bat	dep	149	SENT_461	[p26l340t845r485b904],
69	differentiation	NN	O	differentiation	dep	149	SENT_461	[p26l503t834r1040b905],
70	.97	CD	NUMBER	.97	dep	149	SENT_461	[p26l503t834r1040b905],
71	Conversely	RB	O	conversely	dep	149	SENT_461	[p26l1058t842r1426b926],
72	,	,	O	,	_	0	SENT_461	[p26l1058t842r1426b926],
73	cGMP	NN	O	cgmp	dep	149	SENT_461	[p26l1446t846r1655b905],
74	signaling	NN	O	signaling	dep	149	SENT_461	[p26l1675t842r1981b926],
75	,	,	O	,	_	0	SENT_461	[p26l1675t842r1981b926],
76	activated	VBN	O	activate	dep	149	SENT_461	[p26l2000t848r2140b905, p26l7t945r186b1008],
77	by	IN	O	by	dep	149	SENT_461	[p26l201t945r284b1029],
78	binding	NN	O	binding	dep	149	SENT_461	[p26l296t945r557b1029],
79	of	IN	O	of	dep	149	SENT_461	[p26l573t945r646b1008],
80	natriuretic	JJ	O	natriuretic	dep	149	SENT_461	[p26l654t951r1002b1008],
81	peptides	NNS	O	peptide	dep	149	SENT_461	[p26l1019t945r1297b1028],
82	(	VBP	O	(	dep	149	SENT_461	[p26l1319t945r1514b1022],
83	atrial	JJ	O	atrial	dep	149	SENT_461	[p26l1319t945r1514b1022],
84	natriuretic	JJ	O	natriuretic	dep	149	SENT_461	[p26l1531t951r1879b1008],
85	peptide	NN	O	peptide	dep	149	SENT_461	[p26l1895t945r2144b1028],
86	and	CC	O	and	dep	149	SENT_461	[p26l10t1048r137b1111],
87	brain	NN	O	brain	dep	149	SENT_461	[p26l156t1048r337b1111],
88	natriuretic	JJ	O	natriuretic	dep	149	SENT_461	[p26l358t1054r719b1111],
89	peptide	NN	O	peptide	dep	149	SENT_461	[p26l739t1048r1021b1131],
90	)	NN	O	)	dep	149	SENT_461	[p26l739t1048r1021b1131],
91	to	TO	O	to	dep	149	SENT_461	[p26l1046t1060r1112b1111],
92	GC-A	NN	O	gc-a	dep	149	SENT_461	[p26l1137t1052r1360b1120],
93	,	,	O	,	_	0	SENT_461	[p26l1137t1052r1360b1120],
94	triggers	VBZ	O	trigger	dep	149	SENT_461	[p26l1383t1054r1642b1132],
95	lipolytic	JJ	O	lipolytic	dep	149	SENT_461	[p26l1663t1048r1941b1132],
96	pathways	NNS	O	pathway	dep	149	SENT_461	[p26l1961t1048r2141b1131, p26l8t1173r167b1234],
97	and	CC	O	and	dep	149	SENT_461	[p26l186t1150r309b1213],
98	mobilizes	VBZ	O	mobilize	dep	149	SENT_461	[p26l325t1150r639b1213],
99	the	DT	O	the	dep	149	SENT_461	[p26l657t1150r759b1213],
100	fat	JJ	O	fat	dep	149	SENT_461	[p26l777t1150r860b1213],
101	stored	VBN	O	store	dep	149	SENT_461	[p26l877t1150r1079b1213],
102	in	IN	O	in	dep	149	SENT_461	[p26l1096t1156r1161b1212],
103	WAT98	NNP	O	WAT98	dep	149	SENT_461	[p26l1177t1142r1420b1213],
104	Notably	RB	O	notably	dep	149	SENT_461	[p26l1439t1150r1710b1234],
105	,	,	O	,	_	0	SENT_461	[p26l1439t1150r1710b1234],
106	atrial	JJ	O	atrial	dep	149	SENT_461	[p26l1730t1150r1898b1213],
107	natriuretic	JJ	O	natriuretic	dep	149	SENT_461	[p26l1915t1156r2140b1213, p26l10t1259r157b1316],
108	peptide	NN	O	peptide	dep	149	SENT_461	[p26l176t1253r788b1336],
109	—	NN	O	—	dep	149	SENT_461	[p26l176t1253r788b1336],
110	mediated	VBD	O	mediate	dep	149	SENT_461	[p26l176t1253r788b1336],
111	lipolysis	NN	O	lipolysis	dep	149	SENT_461	[p26l806t1253r1076b1337],
112	is	VBZ	O	be	dep	149	SENT_461	[p26l1098t1259r1147b1316],
113	resistant	JJ	O	resistant	dep	149	SENT_461	[p26l1168t1259r1448b1316],
114	to	TO	O	to	dep	149	SENT_461	[p26l1466t1265r1531b1316],
115	hyperinsulinemia	NN	O	hyperinsulinemia	dep	149	SENT_461	[p26l1552t1253r2145b1337],
116	and	CC	O	and	dep	149	SENT_461	[p26l10t1355r135b1418],
117	independent	JJ	O	independent	dep	149	SENT_461	[p26l155t1355r581b1438],
118	of	IN	O	of	dep	149	SENT_461	[p26l601t1355r674b1418],
119	impaired	JJ	O	impaired	dep	149	SENT_461	[p26l685t1355r989b1438],
120	B-adrenergic	JJ	MISC	b-adrenergic	dep	149	SENT_461	[p26l1011t1353r1442b1439],
121	receptor	NN	O	receptor	dep	149	SENT_461	[p26l1462t1367r1741b1438],
122	signaling	NN	O	signaling	dep	149	SENT_461	[p26l1761t1347r2142b1439],
123	.98	CD	NUMBER	.98	dep	149	SENT_461	[p26l1761t1347r2142b1439],
124	Therefore	RB	O	therefore	dep	149	SENT_461	[p26l9t1458r353b1530],
125	,	,	O	,	_	0	SENT_461	[p26l9t1458r353b1530],
126	“	NN	O	“	dep	149	SENT_461	[p26l377t1458r770b1542],
127	browning	NN	O	browning	dep	149	SENT_461	[p26l377t1458r770b1542],
128	”	NN	O	”	dep	149	SENT_461	[p26l377t1458r770b1542],
129	of	IN	O	of	dep	149	SENT_461	[p26l794t1458r868b1521],
130	the	DT	O	the	dep	149	SENT_461	[p26l878t1458r984b1521],
131	WAT	NNP	O	WAT	dep	149	SENT_461	[p26l1004t1461r1183b1521],
132	via	IN	O	via	dep	149	SENT_461	[p26l1201t1464r1303b1521],
133	cGMP	NN	O	cgmp	dep	149	SENT_461	[p26l1323t1462r1542b1521],
134	pathways	NNS	O	pathway	dep	149	SENT_461	[p26l1563t1458r1879b1542],
135	may	MD	O	may	dep	149	SENT_461	[p26l1900t1481r2047b1542],
136	be	VB	O	be	dep	149	SENT_461	[p26l2063t1458r2142b1521],
137	a	DT	O	a	dep	149	SENT_461	[p26l10t1585r45b1625],
138	promising	JJ	O	promising	dep	149	SENT_461	[p26l63t1568r409b1646],
139	strategy	NN	O	strategy	dep	149	SENT_461	[p26l429t1574r693b1646],
140	to	TO	O	to	dep	149	SENT_461	[p26l709t1574r774b1625],
141	increase	VB	O	increase	dep	149	SENT_461	[p26l796t1568r1068b1625],
142	BAT-mediated	JJ	MISC	bat-mediated	dep	149	SENT_461	[p26l1089t1562r1580b1625],
143	energy	NN	O	energy	dep	149	SENT_461	[p26l1600t1585r1830b1646],
144	expenditure	NN	O	expenditure	dep	149	SENT_461	[p26l1847t1562r2141b1645, p26l9t1677r140b1728],
145	and	CC	O	and	dep	149	SENT_461	[p26l158t1665r281b1728],
146	decrease	VB	O	decrease	dep	149	SENT_461	[p26l299t1665r578b1728],
147	WAT-mediated	JJ	O	wat-mediated	dep	149	SENT_461	[p26l595t1665r1104b1728],
148	fat	JJ	O	fat	dep	149	SENT_461	[p26l1120t1665r1203b1728],
149	storage	NN	O	storage	_	0	SENT_461	[p26l1221t1677r1468b1749],
150	.	.	O	.	_	0	SENT_461	[p26l1221t1677r1468b1749],

1	Moreover	RB	O	moreover	advmod	17	SENT_462	[p26l1488t1670r1821b1737],
2	,	,	O	,	_	0	SENT_462	[p26l1488t1670r1821b1737],
3	the	DT	O	the	det	5	SENT_462	[p26l1840t1665r1943b1728],
4	ready	JJ	O	ready	amod	5	SENT_462	[p26l1961t1665r2145b1749],
5	availability	NN	O	availability	nsubj	17	SENT_462	[p26l10t1768r376b1852],
6	of	IN	O	of	_	0	SENT_462	[p26l393t1768r467b1831],
7	approved	VBN	O	approve	amod	9	SENT_462	[p26l479t1768r792b1851],
8	PDE5	NN	O	pde5	nn	9	SENT_462	[p26l813t1773r1006b1831],
9	inhibitors	NNS	O	inhibitor	prep_of	5	SENT_462	[p26l1030t1768r1375b1840],
10	,	,	O	,	_	0	SENT_462	[p26l1030t1768r1375b1840],
11	such	JJ	O	such	_	0	SENT_462	[p26l1398t1768r1551b1831],
12	as	IN	O	as	_	0	SENT_462	[p26l1573t1791r1636b1831],
13	sildenaﬁl	NN	O	sildenaﬁl	prep_such_as	5	SENT_462	[p26l1659t1768r1978b1840],
14	,	,	O	,	_	0	SENT_462	[p26l1659t1768r1978b1840],
15	may	MD	O	may	aux	17	SENT_462	[p26l2000t1791r2147b1852],
16	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_462	[p26l11t1871r423b1955],
17	facilitate	VB	O	facilitate	_	0	SENT_462	[p26l440t1871r723b1934],
18	implementing	VBG	O	implement	xcomp	17	SENT_462	[p26l745t1871r1222b1955],
19	this	DT	O	this	det	20	SENT_462	[p26l1240t1871r1362b1934],
20	strategy	NN	O	strategy	dobj	18	SENT_462	[p26l1385t1883r1657b1955],
21	.	.	O	.	_	0	SENT_462	[p26l1385t1883r1657b1955],

1	In	IN	O	in	_	0	SENT_463	[p26l1681t1876r1752b1933],
2	addition	NN	O	addition	_	0	SENT_463	[p26l1773t1871r2056b1934],
3	to	TO	O	to	_	0	SENT_463	[p26l2076t1883r2142b1934],
4	BAT	NN	O	bat	prep_in_addition_to	10	SENT_463	[p26l10t1977r167b2046],
5	,	,	O	,	_	0	SENT_463	[p26l10t1977r167b2046],
6	skeletal	JJ	O	skeletal	amod	7	SENT_463	[p26l188t1974r430b2037],
7	muscle	NN	O	muscle	nsubj	10	SENT_463	[p26l447t1974r678b2037],
8	is	VBZ	O	be	cop	10	SENT_463	[p26l697t1980r745b2037],
9	another	DT	O	another	det	10	SENT_463	[p26l765t1974r1022b2037],
10	site	NN	O	site	_	0	SENT_463	[p26l1040t1980r1147b2037],
11	for	IN	O	for	_	0	SENT_463	[p26l1166t1974r1260b2037],
12	thermogenesis	NN	O	thermogenesis	nn	15	SENT_463	[p26l1276t1974r1759b2058],
13	and	CC	O	and	_	0	SENT_463	[p26l1779t1974r1902b2037],
14	energy	NN	O	energy	nn	15	SENT_463	[p26l1920t1997r2147b2058],
15	expenditure	NN	O	expenditure	prep_for	10	SENT_463	[p26l10t2077r413b2160],
16	.	.	O	.	_	0	SENT_463	[p26l10t2077r413b2160],

1	Activation	NN	O	activation	nsubj	10	SENT_464	[p26l432t2081r771b2140],
2	of	IN	O	of	_	0	SENT_464	[p26l789t2077r860b2140],
3	GC-A	NN	O	gc-a	prep_of	1	SENT_464	[p26l869t2081r1067b2140],
4	by	IN	O	by	_	0	SENT_464	[p26l1082t2077r1163b2161],
5	natriuretic	JJ	O	natriuretic	amod	6	SENT_464	[p26l1177t2083r1518b2140],
6	peptides	NNS	O	peptide	prep_by	3	SENT_464	[p26l1534t2077r1807b2160],
7	in	IN	O	in	_	0	SENT_464	[p26l1825t2083r1889b2139],
8	skeletal	JJ	O	skeletal	amod	9	SENT_464	[p26l1907t2077r2144b2140],
9	muscle	NN	O	muscle	prep_in	6	SENT_464	[p26l9t2180r244b2243],
10	increases	VBZ	O	increase	_	0	SENT_464	[p26l264t2186r566b2243],
11	cGMP	NN	O	cgmp	nn	12	SENT_464	[p26l588t2184r804b2243],
12	accumulation	NN	O	accumulation	dobj	10	SENT_464	[p26l827t2180r1285b2243],
13	and	CC	O	and	_	0	SENT_464	[p26l1306t2180r1431b2243],
14	promotes	VBZ	O	promote	conj_and	10	SENT_464	[p26l1449t2192r1766b2263],
15	energy	NN	O	energy	nn	16	SENT_464	[p26l1788t2203r2017b2264],
16	use	NN	O	use	dobj	14	SENT_464	[p26l2034t2203r2143b2243],
17	through	IN	O	through	_	0	SENT_464	[p26l9t2282r278b2366],
18	protein	NN	O	protein	nn	21	SENT_464	[p26l295t2288r536b2365],
19	kinase	NN	O	kinase	nn	21	SENT_464	[p26l553t2282r764b2345],
20	G	NN	O	g	nn	21	SENT_464	[p26l784t2282r1240b2365],
21	—	NN	O	—	prep_through	14	SENT_464	[p26l784t2282r1240b2365],
22	dependent	JJ	O	dependent	amod	23	SENT_464	[p26l784t2282r1240b2365],
23	mitochondrial	JJ	O	mitochondrial	amod	26	SENT_464	[p26l1257t2282r1736b2345],
24	biogenesis	NN	O	biogenesis	nn	26	SENT_464	[p26l1752t2275r2142b2366],
25	.5	CD	NUMBER	.5	num	26	SENT_464	[p26l1752t2275r2142b2366],
26	GC	NN	O	gc	dep	14	SENT_464	[p26l84t2389r288b2448],
27	.	.	O	.	_	0	SENT_464	[p26l84t2389r288b2448],

1	—	NN	O	—	_	0	SENT_465	[p26l84t2389r288b2448],
2	.	.	O	.	_	0	SENT_465	[p26l84t2389r288b2448],

1	C	NN	O	c	nsubj	7	SENT_466	[p26l84t2389r288b2448],
2	(	JJ	O	(	amod	4	SENT_466	[p26l316t2385r705b2462],
3	GUCYZC	NN	O	gucyzc	nn	4	SENT_466	[p26l316t2385r705b2462],
4	)	NN	O	)	dep	1	SENT_466	[p26l316t2385r705b2462],
5	is	VBZ	O	be	cop	7	SENT_466	[p26l733t2391r783b2448],
6	another	DT	O	another	det	7	SENT_466	[p26l808t2385r1077b2448],
7	member	NN	O	member	_	0	SENT_466	[p26l1098t2385r1390b2448],
8	of	IN	O	of	_	0	SENT_466	[p26l1413t2385r1487b2448],
9	the	DT	O	the	det	12	SENT_466	[p26l1500t2385r1607b2448],
10	particulate	JJ	O	particulate	amod	12	SENT_466	[p26l1629t2385r2002b2468],
11	GC	NN	O	gc	nn	12	SENT_466	[p26l2026t2389r2142b2448],
12	family	NN	O	family	prep_of	7	SENT_466	[p26l9t2488r256b2572],
13	;	:	O	;	_	0	SENT_466	[p26l9t2488r256b2572],
14	its	PRP$	O	its	poss	15	SENT_466	[p26l286t2494r365b2551],
15	expression	NN	O	expression	nsubj	19	SENT_466	[p26l394t2494r773b2571],
16	has	VBZ	O	have	aux	19	SENT_466	[p26l800t2488r916b2551],
17	been	VBN	O	be	cop	19	SENT_466	[p26l942t2488r1113b2551],
18	historically	RB	O	historically	advmod	19	SENT_466	[p26l1140t2488r1545b2572],
19	restricted	JJ	O	restricted	parataxis	7	SENT_466	[p26l1569t2488r1911b2551],
20	to	TO	O	to	_	0	SENT_466	[p26l1936t2500r2004b2551],
21	the	DT	O	the	det	23	SENT_466	[p26l2032t2488r2143b2551],
22	intestinal	JJ	O	intestinal	amod	23	SENT_466	[p26l10t2590r340b2653],
23	epithelium	NN	O	epithelium	prep_to	19	SENT_466	[p26l366t2582r833b2673],
24	.88	CD	NUMBER	.88	num	25	SENT_466	[p26l366t2582r833b2673],
25	GUCYZC	NN	O	gucyzc	nsubjpass	27	SENT_466	[p26l861t2594r1203b2653],
26	is	VBZ	O	be	auxpass	27	SENT_466	[p26l1229t2596r1281b2653],
27	activated	VBN	O	activate	ccomp	19	SENT_466	[p26l1308t2590r1627b2653],
28	by	IN	O	by	_	0	SENT_466	[p26l1649t2590r1736b2674],
29	the	DT	O	the	det	32	SENT_466	[p26l1757t2590r1867b2653],
30	endogenous	JJ	O	endogenous	amod	32	SENT_466	[p26l1894t2590r2140b2674, p26l10t2717r207b2757],
31	hormones	NNS	O	hormone	nn	32	SENT_466	[p26l228t2694r572b2757],
32	guanylin	NN	O	guanylin	agent	27	SENT_466	[p26l593t2694r889b2778],
33	and	CC	O	and	_	0	SENT_466	[p26l910t2694r1036b2757],
34	uroguanylin	NN	O	uroguanylin	agent	27	SENT_466	[p26l1055t2694r1471b2778],
35	in	IN	O	in	_	0	SENT_466	[p26l1491t2700r1558b2756],
36	a	DT	O	a	det	38	SENT_466	[p26l1579t2717r1613b2757],
37	paracrine	NN	O	paracrine	nn	38	SENT_466	[p26l1631t2700r1955b2777],
38	fashion	NN	O	fashion	prep_in	32	SENT_466	[p26l1975t2694r2139b2757, p26l10t2803r123b2860],
39	in	IN	O	in	_	0	SENT_466	[p26l149t2803r217b2859],
40	the	DT	O	the	det	41	SENT_466	[p26l242t2797r352b2860],
41	intestine	NN	O	intestine	prep_in	38	SENT_466	[p26l379t2803r701b2860],
42	.	.	O	.	_	0	SENT_466	[p26l379t2803r701b2860],

1	GUCYZC	NN	O	gucyzc	nn	2	SENT_467	[p26l731t2801r1073b2860],
2	signaling	NN	O	signaling	nsubj	3	SENT_467	[p26l1101t2797r1424b2881],
3	defends	VBZ	O	defend	_	0	SENT_467	[p26l1449t2797r1722b2860],
4	a	DT	O	a	det	5	SENT_467	[p26l1749t2820r1784b2860],
5	variety	NN	O	variety	dobj	3	SENT_467	[p26l1806t2803r2055b2881],
6	of	IN	O	of	_	0	SENT_467	[p26l2077t2797r2153b2860],
7	homeostatic	JJ	O	homeostatic	amod	8	SENT_467	[p26l8t2900r427b2963],
8	mechanisms	NNS	O	mechanism	prep_of	5	SENT_467	[p26l447t2900r872b2963],
9	that	WDT	O	that	nsubj	11	SENT_467	[p26l892t2900r1026b2963],
10	are	VBP	O	be	cop	11	SENT_467	[p26l1046t2923r1146b2963],
11	crucial	JJ	O	crucial	rcmod	5	SENT_467	[p26l1167t2900r1399b2963],
12	to	TO	O	to	_	0	SENT_467	[p26l1418t2912r1483b2963],
13	intestinal	JJ	O	intestinal	amod	14	SENT_467	[p26l1505t2900r1821b2963],
14	integrity	NN	O	integrity	prep_to	11	SENT_467	[p26l1842t2906r2142b2984],
15	,	,	O	,	_	0	SENT_467	[p26l1842t2906r2142b2984],
16	including	VBG	O	include	_	0	SENT_467	[p26l10t3003r345b3087],
17	electrolyte	NN	O	electrolyte	prep_including	30	SENT_467	[p26l367t3003r730b3087],
18	and	CC	O	and	_	0	SENT_467	[p26l755t3003r884b3066],
19	ﬂuid	JJ	O	ﬂuid	amod	20	SENT_467	[p26l906t3003r1067b3066],
20	balance	NN	O	balance	prep_including	30	SENT_467	[p26l1088t3003r1373b3075],
21	,	,	O	,	_	0	SENT_467	[p26l1088t3003r1373b3075],
22	proliferation	NN	O	proliferation	conj_and	20	SENT_467	[p26l1397t3003r1841b3086],
23	and	CC	O	and	_	0	SENT_467	[p26l1866t3003r1995b3066],
24	differentiation	NN	O	differentiation	conj_and	20	SENT_467	[p26l2018t3003r2139b3066, p26l9t3106r404b3169],
25	along	IN	O	along	_	0	SENT_467	[p26l425t3106r611b3190],
26	the	DT	O	the	det	29	SENT_467	[p26l629t3106r735b3169],
27	intestinal	JJ	O	intestinal	amod	29	SENT_467	[p26l755t3106r1070b3169],
28	crypt	NN	O	crypt	nn	29	SENT_467	[p26l1090t3106r1493b3190],
29	—	NN	O	—	prep_along	20	SENT_467	[p26l1090t3106r1493b3190],
30	villus	VBZ	O	villus	dep	3	SENT_467	[p26l1090t3106r1493b3190],
31	axis	NN	O	axis	nsubj	30	SENT_467	[p26l1514t3112r1660b3178],
32	,	,	O	,	_	0	SENT_467	[p26l1514t3112r1660b3178],
33	DNA	NN	O	dna	nn	34	SENT_467	[p26l1682t3110r1861b3169],
34	damage	NN	O	damage	nsubj	30	SENT_467	[p26l1881t3106r2143b3190],
35	sensing	VBG	O	sense	partmod	34	SENT_467	[p26l10t3215r274b3293],
36	and	CC	O	and	_	0	SENT_467	[p26l298t3209r428b3272],
37	repair	NN	O	repair	nsubj	30	SENT_467	[p26l453t3215r675b3292],
38	,	,	O	,	_	0	SENT_467	[p26l453t3215r675b3292],
39	and	CC	O	and	_	0	SENT_467	[p26l703t3209r833b3272],
40	the	DT	O	the	det	42	SENT_467	[p26l856t3209r965b3272],
41	barrier	NN	O	barrier	nn	42	SENT_467	[p26l989t3209r1236b3272],
42	function	NN	O	function	nsubj	63	SENT_467	[p26l1259t3209r1562b3272],
43	of	IN	O	of	_	0	SENT_467	[p26l1589t3209r1664b3272],
44	the	DT	O	the	det	50	SENT_467	[p26l1679t3209r1788b3272],
45	intestinal	JJ	O	intestinal	amod	46	SENT_467	[p26l1814t3209r2143b3272],
46	lining	JJ	O	lining	amod	50	SENT_467	[p26l8t3303r421b3395],
47	.99	NN	NUMBER	.99	nn	50	SENT_467	[p26l8t3303r421b3395],
48	‘	NN	O	‘	nn	50	SENT_467	[p26l8t3303r421b3395],
49	1	CD	NUMBER	1	num	50	SENT_467	[p26l8t3303r421b3395],
50	°	NN	O	°	prep_of	42	SENT_467	[p26l8t3303r421b3395],
51	2	CD	NUMBER	2	dep	50	SENT_467	[p26l8t3303r421b3395],
52	The	DT	O	the	det	54	SENT_467	[p26l444t3311r570b3374],
53	recent	JJ	O	recent	amod	54	SENT_467	[p26l594t3323r806b3374],
54	discovery	NN	O	discovery	dep	50	SENT_467	[p26l828t3311r1161b3395],
55	of	IN	O	of	_	0	SENT_467	[p26l1181t3311r1255b3374],
56	GUCYZC	NN	O	gucyzc	nn	57	SENT_467	[p26l1270t3315r1604b3374],
57	expression	NN	O	expression	prep_of	54	SENT_467	[p26l1628t3317r1993b3394],
58	and	CC	O	and	_	0	SENT_467	[p26l2017t3311r2144b3374],
59	function	NN	O	function	conj_and	50	SENT_467	[p26l9t3414r302b3477],
60	in	IN	O	in	_	0	SENT_467	[p26l325t3420r391b3476],
61	the	DT	O	the	det	62	SENT_467	[p26l413t3414r519b3477],
62	hypothalamus	NN	O	hypothalamus	prep_in	59	SENT_467	[p26l541t3414r1028b3498],
63	expands	VBZ	O	expand	conj_and	3	SENT_467	[p26l1052t3414r1332b3497],
64	the	DT	O	the	det	66	SENT_467	[p26l1354t3414r1461b3477],
65	homeostatic	JJ	O	homeostatic	amod	66	SENT_467	[p26l1482t3414r1902b3477],
66	role	NN	O	role	dobj	63	SENT_467	[p26l1924t3414r2053b3477],
67	of	IN	O	of	_	0	SENT_467	[p26l2077t3414r2150b3477],
68	GUCYZC	NN	O	gucyzc	prep_of	66	SENT_467	[p26l11t3521r366b3580],
69	.	.	O	.	_	0	SENT_467	[p26l11t3521r366b3580],

1	Explicitly	RB	O	explicitly	advmod	5	SENT_468	[p26l393t3517r736b3601],
2	,	,	O	,	_	0	SENT_468	[p26l393t3517r736b3601],
3	hypothalamic	JJ	O	hypothalamic	amod	4	SENT_468	[p26l760t3517r1243b3601],
4	GUCYZC	NN	O	gucyzc	nsubj	5	SENT_468	[p26l1267t3521r1606b3580],
5	induces	VBZ	O	induce	_	0	SENT_468	[p26l1629t3517r1897b3580],
6	satiety	JJ	O	satiety	amod	7	SENT_468	[p26l1922t3523r2148b3601],
7	responses	NNS	O	response	dobj	5	SENT_468	[p26l10t3643r345b3704],
8	upon	IN	O	upon	_	0	SENT_468	[p26l369t3643r548b3704],
9	activation	NN	O	activation	prep_upon	5	SENT_468	[p26l572t3627r914b3684],
10	by	IN	O	by	_	0	SENT_468	[p26l935t3621r1020b3705],
11	endocrine	JJ	O	endocrine	amod	12	SENT_468	[p26l1040t3621r1390b3684],
12	uroguanylin	NN	O	uroguanylin	prep_by	5	SENT_468	[p26l1414t3621r1838b3705],
13	released	VBN	O	release	partmod	12	SENT_468	[p26l1862t3621r2142b3684],
14	from	IN	O	from	_	0	SENT_468	[p26l9t3723r180b3786],
15	the	DT	O	the	det	16	SENT_468	[p26l203t3723r312b3786],
16	intestine	NN	O	intestine	prep_from	13	SENT_468	[p26l335t3729r635b3786],
17	postprandially	RB	O	postprandially	amod	16	SENT_468	[p26l658t3715r1272b3807],
18	.103	CD	NUMBER	.103	tmod	17	SENT_468	[p26l658t3715r1272b3807],
19	Furthermore	RB	O	furthermore	advmod	16	SENT_468	[p26l1299t3723r1768b3795],
20	,	,	O	,	_	0	SENT_468	[p26l1299t3723r1768b3795],
21	mice	NNS	O	mouse	appos	16	SENT_468	[p26l1793t3729r1960b3786],
22	deﬁcient	JJ	O	deﬁcient	amod	21	SENT_468	[p26l1985t3723r2140b3786, p27l10t28r177b84],

1	in	IN	O	in	_	0	SENT_469	[p27l199t27r266b83],
2	GUCYZC	NN	O	gucyzc	nn	3	SENT_469	[p27l290t25r625b85],
3	signaling	NN	O	signaling	pobj	1	SENT_469	[p27l649t21r963b105],
4	(	CD	NUMBER	(	num	5	SENT_469	[p27l988t11r1386b105],
5	Gucy2c	NN	O	gucy2c	dep	3	SENT_469	[p27l988t11r1386b105],
6	‘	CD	NUMBER	‘	dep	5	SENT_469	[p27l988t11r1386b105],
7	/	:	O	/	punct	6	SENT_469	[p27l988t11r1386b105],
8	‘	CD	NUMBER	‘	num	9	SENT_469	[p27l988t11r1386b105],
9	)	CD	NUMBER	)	nsubj	10	SENT_469	[p27l988t11r1386b105],
10	have	VBP	O	have	dep	6	SENT_469	[p27l1413t21r1569b84],
11	defective	JJ	O	defective	amod	13	SENT_469	[p27l1593t21r1899b84],
12	satiety	JJ	O	satiety	amod	13	SENT_469	[p27l1924t28r2146b105],
13	responses	NNS	O	response	dobj	10	SENT_469	[p27l10t147r336b208],
14	after	IN	O	after	_	0	SENT_469	[p27l358t125r508b188],
15	food	NN	O	food	nn	16	SENT_469	[p27l527t125r683b188],
16	intake	NN	O	intake	prep_after	10	SENT_469	[p27l702t125r926b197],
17	,	,	O	,	_	0	SENT_469	[p27l702t125r926b197],
18	resulting	VBG	O	result	partmod	10	SENT_469	[p27l947t125r1244b209],
19	in	IN	O	in	_	0	SENT_469	[p27l1263t131r1329b187],
20	hyperphagia	NN	O	hyperphagium	nn	24	SENT_469	[p27l1348t125r1771b209],
21	and	CC	O	and	_	0	SENT_469	[p27l1790t125r1915b188],
22	excess	JJ	O	excess	conj_and	20	SENT_469	[p27l1935t148r2141b188],
23	weight	NN	O	weight	nn	24	SENT_469	[p27l8t227r234b311],
24	gain	NN	O	gain	prep_in	18	SENT_469	[p27l253t219r505b311],
25	.1	CD	NUMBER	.1	num	26	SENT_469	[p27l253t219r505b311],
26	°	NN	O	°	dep	24	SENT_469	[p27l253t219r505b311],
27	3	CD	NUMBER	3	dobj	18	SENT_469	[p27l253t219r505b311],
28	These	DT	O	these	det	29	SENT_469	[p27l526t227r718b290],
29	mice	NNS	O	mouse	nsubj	30	SENT_469	[p27l739t233r900b290],
30	display	VBP	O	display	rcmod	27	SENT_469	[p27l921t227r1159b311],
31	obesity-associated	JJ	O	obesity-associated	amod	32	SENT_469	[p27l1176t227r1791b311],
32	disorders	NNS	O	disorder	dobj	30	SENT_469	[p27l1812t227r2141b299],
33	,	,	O	,	_	0	SENT_469	[p27l1812t227r2141b299],
34	including	VBG	O	include	_	0	SENT_469	[p27l9t330r342b414],
35	elevated	JJ	O	elevated	amod	36	SENT_469	[p27l365t330r647b393],
36	adiposity	NN	O	adiposity	prep_including	3	SENT_469	[p27l670t330r1000b414],
37	,	,	O	,	_	0	SENT_469	[p27l670t330r1000b414],
38	hypertriglyceridemia	NN	O	hypertriglyceridemia	prep_including	3	SENT_469	[p27l1024t330r1781b414],
39	,	,	O	,	_	0	SENT_469	[p27l1024t330r1781b414],
40	hyperleptinemia	NN	O	hyperleptinemia	prep_including	3	SENT_469	[p27l1806t330r2139b414, p27l8t439r287b505],
41	,	,	O	,	_	0	SENT_469	[p27l1806t330r2139b414, p27l8t439r287b505],
42	hyperinsulinemia	NN	O	hyperinsulinemia	prep_including	3	SENT_469	[p27l308t433r925b517],
43	,	,	O	,	_	0	SENT_469	[p27l308t433r925b517],
44	and	CC	O	and	_	0	SENT_469	[p27l948t433r1073b496],
45	impaired	JJ	O	impaired	amod	46	SENT_469	[p27l1092t433r1399b516],
46	glycemic	JJ	O	glycemic	amod	47	SENT_469	[p27l1418t433r1718b517],
47	control	NN	O	control	conj_and	36	SENT_469	[p27l1738t433r1997b505],
48	,	,	O	,	_	0	SENT_469	[p27l1738t433r1997b505],
49	and	CC	O	and	_	0	SENT_469	[p27l2020t433r2145b496],
50	develop	VB	O	develop	conj_and	1	SENT_469	[p27l10t536r273b619],
51	metabolic	JJ	O	metabolic	amod	52	SENT_469	[p27l297t536r635b599],
52	diseases	NNS	O	disease	dobj	50	SENT_469	[p27l658t536r949b608],
53	,	,	O	,	_	0	SENT_469	[p27l658t536r949b608],
54	including	VBG	O	include	_	0	SENT_469	[p27l973t536r1300b620],
55	fulminant	JJ	O	fulminant	amod	56	SENT_469	[p27l1320t536r1663b599],
56	diabetes	NN	O	diabetes	prep_including	52	SENT_469	[p27l1685t536r1981b608],
57	,	,	O	,	_	0	SENT_469	[p27l1685t536r1981b608],
58	leftventricular	JJ	O	leftventricular	amod	59	SENT_469	[p27l2004t536r2138b599, p27l7t638r385b701],
59	hypertrophy	NN	O	hypertrophy	conj_and	56	SENT_469	[p27l405t638r842b722],
60	,	,	O	,	_	0	SENT_469	[p27l405t638r842b722],
61	and	CC	O	and	_	0	SENT_469	[p27l866t638r992b701],
62	hepatic	JJ	O	hepatic	amod	64	SENT_469	[p27l1012t638r1260b721],
63	steatosis	NN	O	steatosis	nn	64	SENT_469	[p27l1282t630r1676b701],
64	.1	NN	NUMBER	.1	conj_and	56	SENT_469	[p27l1282t630r1676b701],
65	°	CD	NUMBER	°	number	66	SENT_469	[p27l1282t630r1676b701],
66	3	CD	NUMBER	3	dep	64	SENT_469	[p27l1282t630r1676b701],

1	This	DT	O	this	det	5	SENT_470	[p27l83t741r230b804],
2	gut	NN	O	gut	nn	5	SENT_470	[p27l258t741r609b825],
3	—	CD	NUMBER	—	num	5	SENT_470	[p27l258t741r609b825],
4	brain	NN	O	brain	nn	5	SENT_470	[p27l258t741r609b825],
5	axis	NN	O	axis	nsubj	17	SENT_470	[p27l637t747r771b804],
6	regulating	VBG	O	regulate	partmod	5	SENT_470	[p27l800t741r1164b825],
7	appetite	NN	O	appetite	dobj	6	SENT_470	[p27l1190t747r1493b824],
8	,	,	O	,	_	0	SENT_470	[p27l1190t747r1493b824],
9	body	NN	O	body	nn	10	SENT_470	[p27l1520t741r1702b825],
10	weight	NN	O	weight	dobj	6	SENT_470	[p27l1724t741r1982b825],
11	,	,	O	,	_	0	SENT_470	[p27l1724t741r1982b825],
12	and	CC	O	and	_	0	SENT_470	[p27l2012t741r2143b804],
13	metabolism	NN	O	metabolism	dobj	6	SENT_470	[p27l9t843r401b906],
14	through	IN	O	through	_	0	SENT_470	[p27l420t843r690b927],
15	GUCYZC	NNP	O	GUCYZC	nn	16	SENT_470	[p27l711t847r1034b906],
16	signaling103	NN	O	signaling103	prep_through	6	SENT_470	[p27l1055t835r1443b927],
17	offers	VBZ	O	offer	_	0	SENT_470	[p27l1465t843r1645b906],
18	a	DT	O	a	det	19	SENT_470	[p27l1667t866r1700b906],
19	target	NN	O	target	nsubj	27	SENT_470	[p27l1718t855r1909b927],
20	for	IN	O	for	_	0	SENT_470	[p27l1927t843r2022b906],
21	the	DT	O	the	det	22	SENT_470	[p27l2039t843r2143b906],
22	development	NN	O	development	prep_for	19	SENT_470	[p27l10t946r454b1029],
23	of	IN	O	of	_	0	SENT_470	[p27l476t946r550b1009],
24	pharmacotherapeutic	JJ	O	pharmacotherapeutic	amod	25	SENT_470	[p27l561t946r1300b1029],
25	interventions	NNS	O	intervention	prep_of	22	SENT_470	[p27l1322t952r1777b1009],
26	to	TO	O	to	aux	27	SENT_470	[p27l1799t958r1865b1009],
27	combat	VB	O	combat	xcomp	17	SENT_470	[p27l1889t946r2143b1009],
28	obesity	NN	O	obesity	dobj	27	SENT_470	[p27l10t1049r256b1133],
29	.	.	O	.	_	0	SENT_470	[p27l10t1049r256b1133],

1	Targeting	NN	O	targeting	nn	3	SENT_471	[p27l279t1052r598b1133],
2	GUCYZC	NN	O	gucyzc	nn	3	SENT_471	[p27l617t1053r943b1112],
3	signaling	NN	O	signaling	nsubj	4	SENT_471	[p27l964t1049r1268b1133],
4	would	MD	O	would	_	0	SENT_471	[p27l1284t1049r1495b1112],
5	leverage	NN	O	leverage	dobj	4	SENT_471	[p27l1513t1049r1786b1133],
6	an	DT	O	a	det	9	SENT_471	[p27l1807t1072r1886b1112],
7	endogenous	JJ	O	endogenous	amod	9	SENT_471	[p27l1906t1049r2139b1133, p27l10t1175r206b1215],
8	endocrine	JJ	O	endocrine	amod	9	SENT_471	[p27l228t1152r568b1215],
9	mechanism	NN	O	mechanism	dep	4	SENT_471	[p27l588t1152r980b1215],
10	that	WDT	O	that	nsubj	11	SENT_471	[p27l998t1152r1130b1215],
11	sentinels	VBZ	O	sentinel	rcmod	9	SENT_471	[p27l1150t1152r1442b1215],
12	energy	NN	O	energy	nn	13	SENT_471	[p27l1463t1175r1694b1236],
13	homeostasis	NN	O	homeostasis	dobj	11	SENT_471	[p27l1709t1152r2140b1215],
14	.	.	O	.	_	0	SENT_471	[p27l1709t1152r2140b1215],

1	Moreover	RB	O	moreover	advmod	7	SENT_472	[p27l9t1260r345b1327],
2	,	,	O	,	_	0	SENT_472	[p27l9t1260r345b1327],
3	GUCYZC	NN	O	gucyzc	nn	4	SENT_472	[p27l368t1259r690b1318],
4	activation	NN	O	activation	nsubj	7	SENT_472	[p27l711t1261r1038b1318],
5	may	MD	O	may	aux	7	SENT_472	[p27l1057t1278r1200b1339],
6	be	VB	O	be	cop	7	SENT_472	[p27l1214t1255r1291b1318],
7	achievable	JJ	O	achievable	_	0	SENT_472	[p27l1312t1255r1657b1318],
8	with	IN	O	with	_	0	SENT_472	[p27l1675t1255r1823b1318],
9	reformulations	NNS	O	reformulation	prep_with	7	SENT_472	[p27l1843t1255r2141b1318, p27l8t1358r229b1421],
10	of	IN	O	of	_	0	SENT_472	[p27l250t1358r322b1421],
11	existing	VBG	O	exist	amod	14	SENT_472	[p27l333t1364r594b1442],
12	GUCYZC	NNP	O	GUCYZC	nn	14	SENT_472	[p27l613t1362r938b1421],
13	peptide	NN	O	peptide	nn	14	SENT_472	[p27l957t1358r1208b1441],
14	agonists	NNS	O	agonist	prep_of	9	SENT_472	[p27l1229t1364r1515b1442],
15	,	,	O	,	_	0	SENT_472	[p27l1229t1364r1515b1442],
16	such	JJ	O	such	_	0	SENT_472	[p27l1537t1358r1689b1421],
17	as	IN	O	as	_	0	SENT_472	[p27l1709t1381r1772b1421],
18	linaclotide	NN	O	linaclotide	nn	20	SENT_472	[p27l1791t1358r2144b1421],
19	(	CD	NUMBER	(	num	20	SENT_472	[p27l13t1461r307b1538],
20	Linzess	NNP	O	Linzess	prep_such_as	14	SENT_472	[p27l13t1461r307b1538],
21	,	,	O	,	_	0	SENT_472	[p27l13t1461r307b1538],
22	Ironwood	NNP	ORGANIZATION	Ironwood	nn	23	SENT_472	[p27l332t1461r670b1525],
23	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	prep_such_as	14	SENT_472	[p27l693t1461r1275b1533],
24	,	,	O	,	_	0	SENT_472	[p27l693t1461r1275b1533],
25	Forest	NNP	ORGANIZATION	Forest	nn	27	SENT_472	[p27l1301t1466r1510b1525],
26	Laboratories	NNP	ORGANIZATION	Laboratories	nn	27	SENT_472	[p27l1532t1461r1988b1538],
27	)	NN	O	)	conj_and	20	SENT_472	[p27l1532t1461r1988b1538],
28	and	CC	O	and	_	0	SENT_472	[p27l2016t1461r2142b1524],
29	plecanatide	NN	O	plecanatide	conj_and	20	SENT_472	[p27l8t1564r394b1647],
30	(	CD	NUMBER	(	num	32	SENT_472	[p27l417t1564r716b1648],
31	Synergy	NN	O	synergy	nn	32	SENT_472	[p27l417t1564r716b1648],
32	Pharmaceuticals	NNS	O	pharmaceutical	dep	29	SENT_472	[p27l734t1564r1337b1641],
33	)	CD	NUMBER	)	dep	29	SENT_472	[p27l734t1564r1337b1641],
34	.	.	O	.	_	0	SENT_472	[p27l734t1564r1337b1641],

1	Particularly	RB	O	particularly	dep	108	SENT_473	[p27l1361t1564r1765b1648],
2	,	,	O	,	_	0	SENT_473	[p27l1361t1564r1765b1648],
3	linaclotide	NN	O	linaclotide	dep	108	SENT_473	[p27l1785t1564r2141b1627],
4	was	VBD	O	be	dep	108	SENT_473	[p27l8t1690r137b1730],
5	approved	VBN	O	approve	dep	108	SENT_473	[p27l164t1667r492b1750],
6	in	IN	O	in	dep	108	SENT_473	[p27l516t1673r584b1729],
7	2012	CD	DATE	2012	dep	108	SENT_473	[p27l609t1674r775b1730],
8	by	IN	O	by	dep	108	SENT_473	[p27l800t1667r886b1751],
9	the	DT	O	the	dep	108	SENT_473	[p27l906t1667r1016b1730],
10	FDA	NNP	ORGANIZATION	FDA	dep	108	SENT_473	[p27l1042t1671r1208b1729],
11	and	CC	O	and	dep	108	SENT_473	[p27l1234t1667r1364b1730],
12	the	DT	O	the	dep	108	SENT_473	[p27l1387t1667r1496b1730],
13	EMA	NN	O	ema	dep	108	SENT_473	[p27l1522t1671r1709b1729],
14	to	TO	O	to	dep	108	SENT_473	[p27l1733t1679r1801b1730],
15	treat	VB	O	treat	dep	108	SENT_473	[p27l1826t1679r1987b1730],
16	disorders	NNS	O	disorder	dep	108	SENT_473	[p27l2012t1667r2140b1730, p27l10t1770r229b1833],
17	of	IN	O	of	dep	108	SENT_473	[p27l254t1770r329b1833],
18	gastrointestinal	JJ	O	gastrointestinal	dep	108	SENT_473	[p27l343t1770r883b1854],
19	motility	NN	O	motility	dep	108	SENT_473	[p27l906t1770r1186b1854],
20	(	CD	NUMBER	(	dep	108	SENT_473	[p27l1210t1770r1502b1846],
21	chronic	JJ	O	chronic	dep	108	SENT_473	[p27l1210t1770r1502b1846],
22	idiopathic	JJ	O	idiopathic	dep	108	SENT_473	[p27l1526t1770r1880b1853],
23	constipation	NN	O	constipation	dep	108	SENT_473	[p27l1904t1776r2139b1833, p27l8t1878r247b1955],
24	,	,	O	,	_	0	SENT_473	[p27l1904t1776r2139b1833, p27l8t1878r247b1955],
25	and	CC	O	and	dep	108	SENT_473	[p27l271t1872r398b1935],
26	irritable	JJ	O	irritable	dep	108	SENT_473	[p27l420t1872r693b1935],
27	bowel	NN	O	bowel	dep	108	SENT_473	[p27l714t1872r917b1935],
28	syndrome	NN	O	syndrome	dep	108	SENT_473	[p27l940t1872r1282b1956],
29	with	IN	O	with	dep	108	SENT_473	[p27l1303t1872r1456b1935],
30	constipation	NN	O	constipation	dep	108	SENT_473	[p27l1479t1864r2049b1955],
31	)	CD	NUMBER	)	dep	108	SENT_473	[p27l1479t1864r2049b1955],
32	.1	CD	NUMBER	.1	dep	108	SENT_473	[p27l1479t1864r2049b1955],
33	°	NN	O	°	dep	108	SENT_473	[p27l1479t1864r2049b1955],
34	4	CD	NUMBER	4	dep	108	SENT_473	[p27l1479t1864r2049b1955],
35	In	IN	O	in	dep	108	SENT_473	[p27l2072t1877r2143b1934],
36	clinical	JJ	O	clinical	dep	108	SENT_473	[p27l10t1975r251b2038],
37	trials	NNS	O	trial	dep	108	SENT_473	[p27l270t1975r457b2047],
38	,	,	O	,	_	0	SENT_473	[p27l270t1975r457b2047],
39	patients	NNS	O	patient	dep	108	SENT_473	[p27l477t1981r742b2058],
40	with	IN	O	with	dep	108	SENT_473	[p27l762t1975r912b2038],
41	chronic	JJ	O	chronic	dep	108	SENT_473	[p27l933t1975r1188b2038],
42	constipation	NN	O	constipation	dep	108	SENT_473	[p27l1209t1981r1628b2058],
43	improved	VBN	O	improve	dep	108	SENT_473	[p27l1648t1975r1973b2058],
44	after	IN	O	after	dep	108	SENT_473	[p27l1993t1975r2143b2038],
45	12	CD	NUMBER	12	dep	108	SENT_473	[p27l16t2085r87b2140],
46	or	CC	O	or	dep	108	SENT_473	[p27l110t2101r182b2141],
47	26	CD	DURATION	26	dep	108	SENT_473	[p27l202t2084r280b2141],
48	weeks	NNS	NUMBER	week	dep	108	SENT_473	[p27l300t2078r505b2141],
49	of	IN	O	of	dep	108	SENT_473	[p27l527t2078r601b2141],
50	treatment	NN	O	treatment	dep	108	SENT_473	[p27l611t2090r947b2141],
51	with	IN	O	with	dep	108	SENT_473	[p27l966t2078r1118b2141],
52	290	CD	NUMBER	290	dep	108	SENT_473	[p27l1139t2085r1258b2141],
53	pg	NN	O	pg	dep	108	SENT_473	[p27l1284t2101r1363b2162],
54	oral	JJ	O	oral	dep	108	SENT_473	[p27l1384t2078r1515b2141],
55	linaclotide	NN	O	linaclotide	dep	108	SENT_473	[p27l1534t2078r1913b2150],
56	,	,	O	,	_	0	SENT_473	[p27l1534t2078r1913b2150],
57	which	WDT	O	which	dep	108	SENT_473	[p27l1934t2078r2143b2141],
58	had	VBD	O	have	dep	108	SENT_473	[p27l8t2181r136b2244],
59	no	DT	O	no	dep	108	SENT_473	[p27l155t2204r241b2244],
60	systemic	JJ	O	systemic	dep	108	SENT_473	[p27l263t2187r554b2265],
61	exposure	NN	O	exposure	dep	108	SENT_473	[p27l575t2203r899b2264],
62	,	,	O	,	_	0	SENT_473	[p27l575t2203r899b2264],
63	was	VBD	O	be	dep	108	SENT_473	[p27l919t2204r1045b2244],
64	well	RB	O	well	dep	108	SENT_473	[p27l1064t2181r1202b2244],
65	tolerated	VBN	O	tolerate	dep	108	SENT_473	[p27l1221t2181r1539b2253],
66	,	,	O	,	_	0	SENT_473	[p27l1221t2181r1539b2253],
67	and	CC	O	and	dep	108	SENT_473	[p27l1562t2181r1688b2244],
68	had	VBD	O	have	dep	108	SENT_473	[p27l1706t2181r1834b2244],
69	minimal	JJ	O	minimal	dep	108	SENT_473	[p27l1853t2181r2144b2244],
70	adverse	JJ	O	adverse	dep	108	SENT_473	[p27l10t2283r265b2346],
71	effects	NNS	O	effect	dep	108	SENT_473	[p27l288t2283r519b2355],
72	,	,	O	,	_	0	SENT_473	[p27l288t2283r519b2355],
73	diarrhea	NN	O	diarrhea	dep	108	SENT_473	[p27l544t2283r832b2346],
74	being	VBG	O	be	dep	108	SENT_473	[p27l851t2283r1043b2367],
75	the	DT	O	the	dep	108	SENT_473	[p27l1063t2283r1169b2346],
76	most	RBS	O	most	dep	108	SENT_473	[p27l1191t2295r1361b2346],
77	common	JJ	O	common	dep	108	SENT_473	[p27l1383t2276r1740b2346],
78	.5	NN	NUMBER	.5	dep	108	SENT_473	[p27l1383t2276r1740b2346],
79	A	DT	O	a	dep	108	SENT_473	[p27l1763t2287r1820b2345],
80	phase	NN	O	phase	dep	108	SENT_473	[p27l1841t2283r2035b2366],
81	III	CD	NUMBER	iii	dep	108	SENT_473	[p27l2059t2288r2141b2345],
82	trial	NN	O	trial	dep	108	SENT_473	[p27l8t2386r146b2449],
83	will	MD	O	will	dep	108	SENT_473	[p27l163t2386r286b2449],
84	be	VB	O	be	dep	108	SENT_473	[p27l303t2386r381b2449],
85	initiated	VBN	O	initiate	dep	108	SENT_473	[p27l401t2386r680b2449],
86	in	IN	O	in	dep	108	SENT_473	[p27l698t2392r764b2448],
87	the	DT	DATE	the	dep	108	SENT_473	[p27l782t2386r886b2449],
88	fourth	JJ	DATE	fourth	dep	108	SENT_473	[p27l907t2386r1118b2449],
89	quarter	NN	DATE	quarter	dep	108	SENT_473	[p27l1138t2398r1384b2469],
90	of	IN	DATE	of	dep	108	SENT_473	[p27l1403t2386r1475b2449],
91	2013	CD	DATE	2013	dep	108	SENT_473	[p27l1486t2393r1642b2449],
92	to	TO	O	to	dep	108	SENT_473	[p27l1663t2398r1728b2449],
93	evaluate	VB	O	evaluate	dep	108	SENT_473	[p27l1749t2386r2020b2449],
94	the	DT	O	the	dep	108	SENT_473	[p27l2039t2386r2143b2449],
95	safety	NN	O	safety	dep	108	SENT_473	[p27l10t2489r210b2573],
96	and	CC	O	and	dep	108	SENT_473	[p27l231t2489r359b2552],
97	efficacy	NN	O	efficacy	dep	108	SENT_473	[p27l382t2489r644b2573],
98	of	IN	O	of	dep	108	SENT_473	[p27l664t2489r739b2552],
99	plecanatide	NN	O	plecanatide	dep	108	SENT_473	[p27l752t2489r1150b2572],
100	for	IN	O	for	dep	108	SENT_473	[p27l1173t2489r1272b2552],
101	the	DT	O	the	dep	108	SENT_473	[p27l1294t2489r1402b2552],
102	treatment	NN	O	treatment	dep	108	SENT_473	[p27l1425t2501r1767b2552],
103	of	IN	O	of	dep	108	SENT_473	[p27l1790t2489r1864b2552],
104	chronic	JJ	O	chronic	dep	108	SENT_473	[p27l1879t2489r2143b2552],
105	idiopathic	JJ	O	idiopathic	dep	108	SENT_473	[p27l9t2593r355b2676],
106	constipation	NN	O	constipation	dep	108	SENT_473	[p27l377t2599r801b2676],
107	in	IN	O	in	dep	108	SENT_473	[p27l823t2599r889b2655],
108	patients	NNS	O	patient	_	0	SENT_473	[p27l910t2599r1196b2676],
109	.	.	O	.	_	0	SENT_473	[p27l910t2599r1196b2676],

1	These	DT	O	these	det	2	SENT_474	[p27l83t2696r279b2759],
2	developments	NNS	O	development	nsubj	3	SENT_474	[p27l303t2696r783b2779],
3	offer	VBP	O	offer	_	0	SENT_474	[p27l807t2696r965b2759],
4	new	JJ	O	new	amod	6	SENT_474	[p27l988t2719r1132b2759],
5	signaling	NN	O	signaling	nn	6	SENT_474	[p27l1153t2696r1468b2780],
6	circuits	NNS	O	circuit	dobj	3	SENT_474	[p27l1489t2702r1742b2759],
7	that	WDT	O	that	nsubjpass	10	SENT_474	[p27l1764t2696r1900b2759],
8	can	MD	O	can	aux	10	SENT_474	[p27l1923t2719r2040b2759],
9	be	VB	O	be	auxpass	10	SENT_474	[p27l2062t2696r2142b2759],
10	leveraged	VBN	O	leverage	rcmod	6	SENT_474	[p27l8t2799r340b2883],
11	for	IN	O	for	_	0	SENT_474	[p27l362t2799r461b2862],
12	weight	NN	O	weight	nn	13	SENT_474	[p27l482t2799r715b2883],
13	management	NN	O	management	prep_for	10	SENT_474	[p27l737t2811r1207b2883],
14	.	.	O	.	_	0	SENT_474	[p27l737t2811r1207b2883],

1	Intriguingly	RB	O	intriguingly	advmod	24	SENT_475	[p27l1234t2799r1664b2883],
2	,	,	O	,	_	0	SENT_475	[p27l1234t2799r1664b2883],
3	because	IN	O	because	mark	9	SENT_475	[p27l1686t2799r1959b2862],
4	both	DT	O	both	preconj	5	SENT_475	[p27l1981t2799r2143b2862],
5	thermogenesis	NN	O	thermogenesis	nsubjpass	9	SENT_475	[p27l8t2902r514b2986],
6	and	CC	O	and	_	0	SENT_475	[p27l539t2902r667b2965],
7	satiety	NN	O	satiety	conj_and	5	SENT_475	[p27l690t2908r913b2986],
8	are	VBP	O	be	auxpass	9	SENT_475	[p27l933t2925r1035b2965],
9	increased	VBN	O	increase	csubj	35	SENT_475	[p27l1058t2902r1387b2965],
10	by	IN	O	by	_	0	SENT_475	[p27l1407t2902r1492b2986],
11	activation	NN	O	activation	agent	9	SENT_475	[p27l1512t2908r1854b2965],
12	of	IN	O	of	_	0	SENT_475	[p27l1877t2902r1952b2965],
13	these	DT	O	these	det	15	SENT_475	[p27l1964t2902r2142b2965],
14	cGMP	NN	O	cgmp	nn	15	SENT_475	[p27l10t3009r231b3068],
15	pathways	NNS	O	pathway	prep_of	11	SENT_475	[p27l255t3005r596b3089],
16	,	,	O	,	_	0	SENT_475	[p27l255t3005r596b3089],
17	stimulating	VBG	O	stimulate	xcomp	9	SENT_475	[p27l622t3005r1018b3089],
18	them	PRP	O	they	dobj	17	SENT_475	[p27l1039t3005r1219b3068],
19	through	IN	O	through	_	0	SENT_475	[p27l1241t3005r1524b3089],
20	drug	NN	O	drug	nn	21	SENT_475	[p27l1547t3005r1712b3089],
21	administration	NN	O	administration	prep_through	17	SENT_475	[p27l1734t3005r2141b3068, p27l8t3114r143b3171],
22	could	MD	O	could	aux	24	SENT_475	[p27l164t3108r351b3171],
23	conceivably	RB	O	conceivably	advmod	24	SENT_475	[p27l370t3108r767b3192],
24	drive	VB	O	drive	_	0	SENT_475	[p27l783t3108r953b3171],
25	both	DT	O	both	dobj	24	SENT_475	[p27l971t3108r1128b3171],
26	of	IN	O	of	_	0	SENT_475	[p27l1148t3108r1220b3171],
27	these	DT	O	these	det	29	SENT_475	[p27l1230t3108r1402b3171],
28	physiologic	JJ	O	physiologic	amod	29	SENT_475	[p27l1421t3108r1806b3192],
29	processes	NNS	O	process	prep_of	25	SENT_475	[p27l1824t3130r2141b3191],
30	in	IN	O	in	_	0	SENT_475	[p27l10t3217r77b3273],
31	the	DT	O	the	det	33	SENT_475	[p27l100t3211r209b3274],
32	same	JJ	O	same	amod	33	SENT_475	[p27l234t3234r410b3274],
33	direction	NN	O	direction	prep_in	29	SENT_475	[p27l434t3211r753b3274],
34	and	CC	O	and	_	0	SENT_475	[p27l777t3211r906b3274],
35	induce	VB	O	induce	conj_and	24	SENT_475	[p27l929t3211r1165b3274],
36	weight	NN	O	weight	nn	37	SENT_475	[p27l1187t3211r1422b3295],
37	loss	NN	O	loss	dobj	35	SENT_475	[p27l1443t3211r1572b3274],
38	by	IN	O	by	_	0	SENT_475	[p27l1595t3211r1680b3295],
39	mutual	JJ	O	mutual	amod	40	SENT_475	[p27l1700t3211r1950b3274],
40	reinforcement	NN	O	reinforcement	prep_by	35	SENT_475	[p27l1973t3217r2139b3274, p27l9t3314r374b3377],
41	.	.	O	.	_	0	SENT_475	[p27l1973t3217r2139b3274, p27l9t3314r374b3377],

1	Moreover	RB	O	moreover	advmod	8	SENT_476	[p27l399t3319r745b3386],
2	,	,	O	,	_	0	SENT_476	[p27l399t3319r745b3386],
3	practical	JJ	O	practical	amod	5	SENT_476	[p27l769t3314r1066b3397],
4	off-the-shelf	JJ	O	off-the-shelf	amod	5	SENT_476	[p27l1088t3314r1517b3377],
5	approaches	NNS	O	approach	nsubj	8	SENT_476	[p27l1531t3314r1915b3397],
6	might	MD	O	might	aux	8	SENT_476	[p27l1938t3314r2142b3398],
7	be	VB	O	be	cop	8	SENT_476	[p27l7t3417r89b3480],
8	possible	JJ	O	possible	_	0	SENT_476	[p27l114t3417r419b3500],
9	,	,	O	,	_	0	SENT_476	[p27l114t3417r419b3500],
10	given	VBN	O	give	prep	8	SENT_476	[p27l447t3423r637b3501],
11	the	DT	O	the	det	12	SENT_476	[p27l662t3417r772b3480],
12	existence	NN	O	existence	dep	10	SENT_476	[p27l799t3423r1122b3480],
13	of	IN	O	of	_	0	SENT_476	[p27l1148t3417r1224b3480],
14	an	DT	O	a	det	16	SENT_476	[p27l1241t3440r1324b3480],
15	established	JJ	O	established	amod	16	SENT_476	[p27l1350t3417r1743b3480],
16	market	NN	O	market	prep_of	12	SENT_476	[p27l1767t3417r2019b3480],
17	for	IN	O	for	_	0	SENT_476	[p27l2043t3417r2144b3480],
18	medications	NNS	O	medication	prep_for	16	SENT_476	[p27l9t3520r430b3583],
19	targeting	VBG	O	target	partmod	18	SENT_476	[p27l453t3526r764b3604],
20	cGMP	NN	O	cgmp	nn	21	SENT_476	[p27l786t3524r1007b3583],
21	pathways	NNS	O	pathway	dobj	19	SENT_476	[p27l1029t3520r1369b3604],
22	,	,	O	,	_	0	SENT_476	[p27l1029t3520r1369b3604],
23	with	IN	O	with	_	0	SENT_476	[p27l1392t3520r1546b3583],
24	FDA	NNP	ORGANIZATION	FDA	prep_with	19	SENT_476	[p27l1569t3524r1756b3582],
25	-	:	O	-	_	0	SENT_476	[p27l1569t3524r1756b3582],
26	and	CC	O	and	_	0	SENT_476	[p27l1783t3520r1911b3583],
27	EMAapproved	JJ	O	emaapproved	amod	28	SENT_476	[p27l1932t3524r2140b3582, p27l10t3623r327b3706],
28	drugs	NNS	O	drug	conj_and	16	SENT_476	[p27l348t3623r539b3707],
29	such	JJ	O	such	_	0	SENT_476	[p27l563t3623r717b3686],
30	as	IN	O	as	_	0	SENT_476	[p27l739t3646r803b3686],
31	sildenaﬁl	NN	O	sildenaﬁl	prep_such_as	28	SENT_476	[p27l826t3623r1134b3686],
32	and	CC	O	and	_	0	SENT_476	[p27l1156t3623r1282b3686],
33	linaclotide	NN	O	linaclotide	prep_such_as	28	SENT_476	[p27l1301t3623r1678b3686],
34	.	.	O	.	_	0	SENT_476	[p27l1301t3623r1678b3686],

1	CONCLUSION	NN	O	conclusion	nn	2	SENT_477	[p28l10t73r486b129],
2	Obesity	NN	O	obesity	nsubj	8	SENT_477	[p28l11t169r276b253],
3	is	VBZ	O	be	cop	8	SENT_477	[p28l295t175r345b232],
4	a	DT	O	a	det	8	SENT_477	[p28l369t192r403b232],
5	global	JJ	O	global	amod	8	SENT_477	[p28l425t169r633b253],
6	public	JJ	O	public	amod	8	SENT_477	[p28l654t169r867b252],
7	health	NN	O	health	nn	8	SENT_477	[p28l888t169r1101b232],
8	crisis	NN	O	crisis	_	0	SENT_477	[p28l1123t175r1314b232],
9	.	.	O	.	_	0	SENT_477	[p28l1123t175r1314b232],

1	Obesity-related	JJ	O	obesity-related	amod	2	SENT_478	[p28l1341t169r1870b253],
2	comorbidities	NNS	O	comorbidity	nsubjpass	4	SENT_478	[p28l1892t192r2140b232, p28l7t272r268b335],
3	are	VBP	O	be	auxpass	4	SENT_478	[p28l297t295r400b335],
4	highlighted	VBN	O	highlight	_	0	SENT_478	[p28l427t272r838b356],
5	by	IN	O	by	_	0	SENT_478	[p28l862t272r948b356],
6	three	CD	NUMBER	three	num	8	SENT_478	[p28l971t272r1153b335],
7	major	JJ	O	major	amod	8	SENT_478	[p28l1180t278r1389b356],
8	causes	NNS	O	cause	agent	4	SENT_478	[p28l1416t295r1639b335],
9	of	IN	O	of	_	0	SENT_478	[p28l1668t272r1744b335],
10	death	NN	O	death	prep_of	8	SENT_478	[p28l1762t272r1975b335],
11	:	:	O	:	_	0	SENT_478	[p28l1762t272r1975b335],
12	cardiovascular	JJ	O	cardiovascular	amod	8	SENT_478	[p28l2006t295r2139b335, p28l10t375r422b439],
13	disease	NN	O	disease	dep	8	SENT_478	[p28l450t375r721b447],
14	,	,	O	,	_	0	SENT_478	[p28l450t375r721b447],
15	cancer	NN	O	cancer	conj_and	13	SENT_478	[p28l751t398r997b447],
16	,	,	O	,	_	0	SENT_478	[p28l751t398r997b447],
17	and	CC	O	and	_	0	SENT_478	[p28l1028t375r1159b438],
18	diabetes	NN	O	diabetes	conj_and	13	SENT_478	[p28l1187t375r1496b439],
19	.	.	O	.	_	0	SENT_478	[p28l1187t375r1496b439],

1	In	IN	O	in	_	0	SENT_479	[p28l1528t380r1601b438],
2	Iune	JJ	O	iune	amod	3	SENT_479	[p28l1629t380r1787b451],
3	2013	CD	DATE	2013	prep_in	10	SENT_479	[p28l1815t382r2003b447],
4	,	,	O	,	_	0	SENT_479	[p28l1815t382r2003b447],
5	the	DT	O	the	det	8	SENT_479	[p28l2032t375r2143b439],
6	American	NNP	ORGANIZATION	American	nn	8	SENT_479	[p28l9t482r362b541],
7	Medical	NNP	ORGANIZATION	Medical	nn	8	SENT_479	[p28l388t478r674b541],
8	Association	NNP	ORGANIZATION	Association	nsubj	10	SENT_479	[p28l700t482r1117b541],
9	officially	RB	O	officially	advmod	10	SENT_479	[p28l1144t478r1449b562],
10	recognized	VBD	O	recognize	_	0	SENT_479	[p28l1473t478r1864b562],
11	obesity	NN	O	obesity	dobj	10	SENT_479	[p28l1891t478r2145b562],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_480	[p28l21t627r140b648],
2	PHARMACOLOGY&THERAPEUT	NN	O	pharmacology&therapeut	dep	10	SENT_480	[p28l149t627r601b648],
3	|	CD	NUMBER	|	num	2	SENT_480	[p28l149t627r601b648],
4	CS	NNP	O	CS	nn	6	SENT_480	[p28l149t627r601b648],
5	|	NNP	O	|	nn	6	SENT_480	[p28l611t625r729b655],
6	VOLUME	NNP	O	VOLUME	dep	2	SENT_480	[p28l611t625r729b655],
7	95	CD	NUMBER	95	num	8	SENT_480	[p28l737t627r764b648],
8	NUMBER	NN	O	number	dep	10	SENT_480	[p28l774t627r882b648],
9	1	CD	NUMBER	1	num	10	SENT_480	[p28l892t628r899b648],
10	]	CD	NUMBER	]	dep	13	SENT_480	[p28l912t625r915b655],
11	JANUARY	NNP	DATE	JANUARY	dep	10	SENT_480	[p28l924t627r1042b648],
12	2014	CD	DATE	2014	num	13	SENT_480	[p28l1049t627r1108b648],
13	63	CD	DATE	63	_	0	SENT_480	[p28l2109t627r2139b648],

1	itself	PRP	O	itself	nsubj	2	SENT_481	[p28l10t1003r178b1066],
2	as	IN	O	as	_	0	SENT_481	[p28l189t1026r253b1066],
3	a	DT	O	a	det	4	SENT_481	[p28l274t1026r309b1066],
4	disease	NN	O	disease	pobj	2	SENT_481	[p28l328t1003r582b1066],
5	.	.	O	.	_	0	SENT_481	[p28l328t1003r582b1066],

1	Obesity	NN	O	obesity	nsubj	3	SENT_482	[p28l606t1003r868b1087],
2	profoundly	RB	O	profoundly	advmod	3	SENT_482	[p28l884t1003r1267b1087],
3	affects	VBZ	O	affect	_	0	SENT_482	[p28l1284t1003r1493b1066],
4	morbidity	NN	O	morbidity	dobj	3	SENT_482	[p28l1514t1003r1864b1087],
5	,	,	O	,	_	0	SENT_482	[p28l1514t1003r1864b1087],
6	mortality	NN	O	mortality	dobj	3	SENT_482	[p28l1885t1003r2140b1066, p28l10t1112r107b1190],
7	,	,	O	,	_	0	SENT_482	[p28l1885t1003r2140b1066, p28l10t1112r107b1190],
8	health-care	NN	O	health-care	nn	9	SENT_482	[p28l131t1106r521b1169],
9	costs	NNS	O	cost	conj_and	4	SENT_482	[p28l544t1118r731b1178],
10	,	,	O	,	_	0	SENT_482	[p28l544t1118r731b1178],
11	and	CC	O	and	_	0	SENT_482	[p28l756t1106r884b1169],
12	professional	JJ	O	professional	amod	15	SENT_482	[p28l904t1106r1324b1189],
13	and	CC	O	and	_	0	SENT_482	[p28l1347t1106r1475b1169],
14	personal	JJ	O	personal	conj_and	12	SENT_482	[p28l1496t1106r1795b1189],
15	quality	NN	O	quality	conj_and	4	SENT_482	[p28l1818t1106r2059b1190],
16	of	IN	O	of	_	0	SENT_482	[p28l2078t1106r2153b1169],
17	life	NN	O	life	prep_of	15	SENT_482	[p28l8t1209r127b1272],
18	.	.	O	.	_	0	SENT_482	[p28l8t1209r127b1272],

1	Awareness	NN	O	awareness	nsubj	7	SENT_483	[p28l152t1213r512b1272],
2	of	IN	O	of	_	0	SENT_483	[p28l535t1209r608b1272],
3	the	DT	O	the	det	5	SENT_483	[p28l620t1209r726b1272],
4	obesity	NN	O	obesity	nn	5	SENT_483	[p28l749t1209r992b1293],
5	problem	NN	O	problem	prep_of	1	SENT_483	[p28l1009t1209r1297b1292],
6	has	VBZ	O	have	aux	7	SENT_483	[p28l1318t1209r1430b1272],
7	done	VBN	O	do	_	0	SENT_483	[p28l1453t1209r1620b1272],
8	little	JJ	O	little	acomp	7	SENT_483	[p28l1641t1209r1792b1272],
9	to	TO	O	to	aux	10	SENT_483	[p28l1814t1221r1879b1272],
10	reverse	VB	O	reverse	xcomp	8	SENT_483	[p28l1903t1232r2143b1272],
11	the	DT	O	the	det	13	SENT_483	[p28l9t1312r118b1375],
12	obesity	NN	O	obesity	nn	13	SENT_483	[p28l144t1312r395b1396],
13	trends	NNS	O	trend	dobj	10	SENT_483	[p28l416t1312r637b1375],
14	among	IN	O	among	_	0	SENT_483	[p28l664t1335r905b1396],
15	the	DT	O	the	det	17	SENT_483	[p28l927t1312r1036b1375],
16	global	JJ	O	global	amod	17	SENT_483	[p28l1061t1312r1276b1396],
17	population	NN	O	population	prep_among	10	SENT_483	[p28l1299t1312r1703b1395],
18	.	.	O	.	_	0	SENT_483	[p28l1299t1312r1703b1395],

1	Recent	JJ	O	recent	amod	2	SENT_484	[p28l1732t1317r1972b1375],
2	data	NNS	O	datum	nsubj	3	SENT_484	[p28l1996t1312r2144b1375],
3	suggest	VBP	O	suggest	_	0	SENT_484	[p28l10t1427r256b1499],
4	that	IN	O	that	complm	18	SENT_484	[p28l275t1415r408b1478],
5	growth	NN	O	growth	nsubj	18	SENT_484	[p28l428t1415r669b1499],
6	of	IN	O	of	_	0	SENT_484	[p28l690t1415r764b1478],
7	the	DT	O	the	det	11	SENT_484	[p28l774t1415r880b1478],
8	overweight	JJ	O	overweight	amod	11	SENT_484	[p28l902t1415r1278b1499],
9	and	CC	O	and	_	0	SENT_484	[p28l1299t1415r1424b1478],
10	obese	JJ	O	obese	amod	11	SENT_484	[p28l1445t1415r1633b1478],
11	populations	NNS	O	population	prep_of	5	SENT_484	[p28l1653t1415r2055b1498],
12	in	IN	O	in	_	0	SENT_484	[p28l2077t1421r2143b1477],
13	both	DT	O	both	preconj	14	SENT_484	[p28l8t1518r168b1581],
14	children	NNS	O	child	prep_in	11	SENT_484	[p28l191t1518r477b1581],
15	and	CC	O	and	_	0	SENT_484	[p28l500t1518r627b1581],
16	adults	NNS	O	adult	conj_and	14	SENT_484	[p28l649t1518r853b1581],
17	have	VBP	O	have	aux	18	SENT_484	[p28l875t1518r1031b1581],
18	slowed	VBN	O	slow	ccomp	3	SENT_484	[p28l1055t1518r1305b1581],
19	.	.	O	.	_	0	SENT_484	[p28l1055t1518r1305b1581],

1	However	RB	O	however	advmod	6	SENT_485	[p28l1332t1523r1653b1590],
2	,	,	O	,	_	0	SENT_485	[p28l1332t1523r1653b1590],
3	these	DT	O	these	det	4	SENT_485	[p28l1676t1518r1853b1581],
4	populations	NNS	O	population	nsubj	6	SENT_485	[p28l1874t1518r2141b1601, p28l9t1627r173b1684],
5	remain	VBP	O	remain	cop	6	SENT_485	[p28l194t1627r431b1684],
6	substantial	JJ	O	substantial	_	0	SENT_485	[p28l452t1621r813b1684],
7	and	CC	O	and	_	0	SENT_485	[p28l832t1621r957b1684],
8	growing	VBG	O	grow	conj_and	6	SENT_485	[p28l975t1627r1267b1705],
9	.	.	O	.	_	0	SENT_485	[p28l975t1627r1267b1705],

1	Given	VBN	O	give	dep	19	SENT_486	[p28l1291t1625r1490b1684],
2	that	IN	O	that	complm	9	SENT_486	[p28l1508t1621r1640b1684],
3	the	DT	O	the	det	4	SENT_486	[p28l1657t1621r1761b1684],
4	promotion	NN	O	promotion	nsubj	9	SENT_486	[p28l1780t1627r2144b1704],
5	of	IN	O	of	_	0	SENT_486	[p28l10t1724r84b1787],
6	lifestyle	NN	O	lifestyle	nn	7	SENT_486	[p28l94t1724r351b1808],
7	modiﬁcations	NNS	O	modiﬁcations	prep_of	4	SENT_486	[p28l373t1724r839b1787],
8	has	VBZ	O	have	aux	9	SENT_486	[p28l861t1724r972b1787],
9	proven	VBN	O	prove	pcomp	1	SENT_486	[p28l993t1746r1229b1807],
10	inadequate	JJ	O	inadequate	acomp	9	SENT_486	[p28l1251t1724r1640b1807],
11	,	,	O	,	_	0	SENT_486	[p28l1251t1724r1640b1807],
12	the	DT	O	the	det	14	SENT_486	[p28l1662t1724r1768b1787],
13	adjunctive	JJ	O	adjunctive	amod	14	SENT_486	[p28l1791t1724r2142b1808],
14	role	NN	O	role	nsubj	19	SENT_486	[p28l10t1827r137b1890],
15	of	IN	O	of	_	0	SENT_486	[p28l158t1827r232b1890],
16	medical	JJ	O	medical	amod	17	SENT_486	[p28l243t1827r510b1890],
17	therapy	NN	O	therapy	prep_of	14	SENT_486	[p28l529t1827r789b1911],
18	is	VBZ	O	be	cop	19	SENT_486	[p28l806t1833r855b1890],
19	vital	JJ	O	vital	_	0	SENT_486	[p28l874t1827r1036b1890],
20	.	.	O	.	_	0	SENT_486	[p28l874t1827r1036b1890],

1	The	DT	O	the	det	2	SENT_487	[p28l1060t1827r1184b1890],
2	goal	NN	O	goal	nsubj	3	SENT_487	[p28l1205t1827r1345b1911],
3	is	VBZ	O	be	_	0	SENT_487	[p28l1365t1833r1415b1890],
4	to	TO	O	to	aux	5	SENT_487	[p28l1435t1839r1500b1890],
5	use	VB	O	use	xcomp	3	SENT_487	[p28l1522t1850r1632b1890],
6	drug	NN	O	drug	nn	7	SENT_487	[p28l1654t1827r1814b1911],
7	regimens	NNS	O	regimen	dobj	5	SENT_487	[p28l1834t1833r2143b1911],
8	in	IN	O	in	_	0	SENT_487	[p28l10t1936r74b1992],
9	combination	NN	O	combination	prep_in	5	SENT_487	[p28l94t1930r516b1993],
10	with	IN	O	with	_	0	SENT_487	[p28l533t1930r682b1993],
11	improved	VBN	O	improve	amod	13	SENT_487	[p28l701t1930r1021b2013],
12	eating	NN	O	eating	nn	13	SENT_487	[p28l1039t1936r1241b2014],
13	habits	NNS	O	habit	prep_with	5	SENT_487	[p28l1257t1930r1453b1993],
14	and	CC	O	and	_	0	SENT_487	[p28l1474t1930r1597b1993],
15	physical	JJ	O	physical	amod	16	SENT_487	[p28l1614t1930r1884b2014],
16	activity	NN	O	activity	prep_with	5	SENT_487	[p28l1903t1936r2147b2014],
17	to	TO	O	to	aux	18	SENT_487	[p28l9t2045r74b2096],
18	achieve	VB	O	achieve	infmod	16	SENT_487	[p28l98t2033r350b2096],
19	a	DT	O	a	det	23	SENT_487	[p28l373t2056r407b2096],
20	meaningful	JJ	O	meaningful	amod	22	SENT_487	[p28l428t2033r838b2117],
21	,	,	O	,	_	0	SENT_487	[p28l428t2033r838b2117],
22	sustainable	JJ	O	sustainable	amod	23	SENT_487	[p28l863t2033r1239b2096],
23	reduction	NN	O	reduction	dobj	18	SENT_487	[p28l1261t2033r1592b2096],
24	in	IN	O	in	_	0	SENT_487	[p28l1615t2039r1681b2095],
25	body	NN	O	body	nn	26	SENT_487	[p28l1701t2033r1877b2117],
26	weight	NN	O	weight	prep_in	23	SENT_487	[p28l1894t2033r2138b2117],
27	.	.	O	.	_	0	SENT_487	[p28l1894t2033r2138b2117],

1	However	RB	O	however	advmod	13	SENT_488	[p28l10t2141r335b2208],
2	,	,	O	,	_	0	SENT_488	[p28l10t2141r335b2208],
3	safety	NN	O	safety	nn	4	SENT_488	[p28l360t2136r560b2220],
4	issues	NNS	O	issue	nsubj	13	SENT_488	[p28l579t2142r777b2199],
5	throughout	IN	O	throughout	_	0	SENT_488	[p28l800t2136r1199b2220],
6	the	DT	O	the	det	8	SENT_488	[p28l1220t2136r1328b2199],
7	long	JJ	O	long	amod	8	SENT_488	[p28l1349t2136r1503b2220],
8	history	NN	O	history	prep_throughout	4	SENT_488	[p28l1523t2136r1772b2220],
9	of	IN	O	of	_	0	SENT_488	[p28l1791t2136r1866b2199],
10	weightloss	NN	O	weightloss	nn	11	SENT_488	[p28l1878t2136r2138b2220, p28l8t2239r135b2302],
11	drugs	NNS	O	drug	prep_of	8	SENT_488	[p28l159t2239r352b2323],
12	had	VBD	O	have	aux	13	SENT_488	[p28l375t2239r504b2302],
13	decimated	VBN	O	decimate	_	0	SENT_488	[p28l526t2239r884b2302],
14	the	DT	O	the	det	15	SENT_488	[p28l905t2239r1012b2302],
15	ﬁeld	NN	O	ﬁeld	dobj	13	SENT_488	[p28l1034t2239r1200b2311],
16	,	,	O	,	_	0	SENT_488	[p28l1034t2239r1200b2311],
17	leaving	VBG	O	leave	partmod	13	SENT_488	[p28l1223t2239r1470b2323],
18	the	DT	O	the	det	21	SENT_488	[p28l1490t2239r1597b2302],
19	lipase	NN	O	lipase	nn	21	SENT_488	[p28l1619t2239r1814b2322],
20	inhibitor	NN	O	inhibitor	nn	21	SENT_488	[p28l1838t2239r2143b2302],
21	orlistat	NN	O	orlistat	dobj	17	SENT_488	[p28l10t2342r237b2405],
22	as	IN	O	as	_	0	SENT_488	[p28l255t2365r317b2405],
23	the	DT	O	the	det	25	SENT_488	[p28l335t2342r438b2405],
24	sole	JJ	O	sole	amod	25	SENT_488	[p28l458t2342r583b2405],
25	drug	NN	O	drug	prep_as	17	SENT_488	[p28l602t2342r759b2426],
26	approved	VBN	O	approve	partmod	25	SENT_488	[p28l776t2342r1082b2425],
27	for	IN	O	for	_	0	SENT_488	[p28l1099t2342r1193b2405],
28	chronic	JJ	O	chronic	amod	30	SENT_488	[p28l1211t2342r1461b2405],
29	weight	NN	O	weight	nn	30	SENT_488	[p28l1477t2342r1698b2426],
30	management	NN	O	management	prep_for	26	SENT_488	[p28l1715t2354r2146b2426],
31	until	IN	O	until	_	0	SENT_488	[p28l9t2445r171b2508],
32	2012	CD	DATE	2012	prep_until	26	SENT_488	[p28l193t2452r375b2517],
33	,	,	O	,	_	0	SENT_488	[p28l193t2452r375b2517],
34	when	WRB	O	when	advmod	40	SENT_488	[p28l397t2445r587b2508],
35	two	CD	NUMBER	two	num	38	SENT_488	[p28l608t2457r735b2508],
36	new	JJ	O	new	amod	38	SENT_488	[p28l758t2468r902b2508],
37	antiobesity	JJ	O	antiobesity	amod	38	SENT_488	[p28l922t2445r1303b2529],
38	drugs	NNS	O	drug	nsubjpass	40	SENT_488	[p28l1322t2445r1515b2529],
39	were	VBD	O	be	auxpass	40	SENT_488	[p28l1537t2468r1699b2508],
40	approved	VBN	O	approve	advcl	26	SENT_488	[p28l1722t2445r2042b2528],
41	by	IN	O	by	_	0	SENT_488	[p28l2062t2445r2146b2529],
42	the	DT	O	the	det	43	SENT_488	[p28l9t2548r117b2611],
43	FDA	NNP	ORGANIZATION	FDA	agent	40	SENT_488	[p28l142t2552r324b2611],
44	:	:	O	:	_	0	SENT_488	[p28l142t2552r324b2611],
45	lorcaserin	NN	O	lorcaserin	dep	25	SENT_488	[p28l349t2548r698b2611],
46	and	CC	O	and	_	0	SENT_488	[p28l722t2548r851b2611],
47	phentermine/topiramate	NN	O	phentermine/topiramate	nn	51	SENT_488	[p28l873t2548r1739b2631],
48	(	NN	O	(	nn	51	SENT_488	[p28l1767t2548r2141b2625, p28l10t2651r244b2714],
49	extendedrelease	NN	O	extendedrelease	nn	51	SENT_488	[p28l1767t2548r2141b2625, p28l10t2651r244b2714],
50	formulation	NN	O	formulation	nn	51	SENT_488	[p28l268t2651r737b2728],
51	)	NN	O	)	conj_and	45	SENT_488	[p28l268t2651r737b2728],
52	.	.	O	.	_	0	SENT_488	[p28l268t2651r737b2728],

1	Concerns	NNS	O	concern	nsubj	2	SENT_489	[p28l765t2655r1100b2715],
2	remain	VBP	O	remain	_	0	SENT_489	[p28l1124t2657r1372b2715],
3	for	IN	O	for	_	0	SENT_489	[p28l1395t2651r1495b2714],
4	these	DT	O	these	det	6	SENT_489	[p28l1517t2651r1696b2714],
5	new	JJ	O	new	amod	6	SENT_489	[p28l1721t2674r1866b2715],
6	entries	NNS	O	entry	prep_for	2	SENT_489	[p28l1888t2657r2141b2723],
7	,	,	O	,	_	0	SENT_489	[p28l1888t2657r2141b2723],
8	including	VBG	O	include	_	0	SENT_489	[p28l10t2754r340b2838],
9	limited	JJ	O	limited	amod	10	SENT_489	[p28l360t2754r608b2817],
10	efﬁcacy	NN	O	efﬁcacy	prep_including	6	SENT_489	[p28l630t2754r899b2838],
11	,	,	O	,	_	0	SENT_489	[p28l630t2754r899b2838],
12	carcinogenicity	NN	O	carcinogenicity	conj_and	10	SENT_489	[p28l924t2760r1466b2838],
13	,	,	O	,	_	0	SENT_489	[p28l924t2760r1466b2838],
14	and	CC	O	and	_	0	SENT_489	[p28l1490t2754r1618b2817],
15	cardiovascular	JJ	O	cardiovascular	amod	16	SENT_489	[p28l1641t2754r2145b2817],
16	risk	NN	O	risk	prep_including	6	SENT_489	[p28l10t2857r150b2920],
17	.	.	O	.	_	0	SENT_489	[p28l10t2857r150b2920],

1	Nonetheless	RB	O	nonetheless	advmod	4	SENT_490	[p28l172t2857r602b2929],
2	,	,	O	,	_	0	SENT_490	[p28l172t2857r602b2929],
3	they	PRP	O	they	nsubj	4	SENT_490	[p28l622t2857r771b2941],
4	represent	VBP	O	represent	_	0	SENT_490	[p28l787t2869r1102b2940],
5	the	DT	O	the	det	7	SENT_490	[p28l1119t2857r1224b2920],
6	ﬁrst	JJ	O	ﬁrst	amod	7	SENT_490	[p28l1244t2857r1376b2920],
7	new	JJ	O	new	dobj	4	SENT_490	[p28l1394t2880r1536b2920],
8	approved	VBN	O	approve	partmod	7	SENT_490	[p28l1554t2857r1867b2940],
9	chronic	JJ	O	chronic	amod	12	SENT_490	[p28l1887t2857r2143b2920],
10	weight	NN	O	weight	nn	12	SENT_490	[p28l8t2960r235b3044],
11	management	NN	O	management	nn	12	SENT_490	[p28l255t2972r697b3044],
12	drugs	NNS	O	drug	dobj	8	SENT_490	[p28l718t2960r908b3044],
13	in	IN	O	in	_	0	SENT_490	[p28l931t2966r997b3022],
14	13	CD	DURATION	13	num	15	SENT_490	[p28l1025t2967r1094b3023],
15	years	NNS	NUMBER	year	prep_in	12	SENT_490	[p28l1116t2983r1306b3044],
16	.	.	O	.	_	0	SENT_490	[p28l1116t2983r1306b3044],

1	Moreover	RB	O	moreover	advmod	9	SENT_491	[p28l1331t2965r1673b3032],
2	,	,	O	,	_	0	SENT_491	[p28l1331t2965r1673b3032],
3	a	DT	O	a	det	4	SENT_491	[p28l1698t2983r1732b3023],
4	host	NN	O	host	nsubj	9	SENT_491	[p28l1752t2960r1896b3023],
5	of	IN	O	of	_	0	SENT_491	[p28l1917t2960r1991b3023],
6	new	JJ	O	new	amod	8	SENT_491	[p28l2003t2983r2145b3023],
7	antiobesity	JJ	O	antiobesity	amod	8	SENT_491	[p28l10t3064r380b3148],
8	drugs	NNS	O	drug	prep_of	4	SENT_491	[p28l397t3064r585b3148],
9	are	VBP	O	be	_	0	SENT_491	[p28l606t3087r705b3127],
10	in	IN	O	in	_	0	SENT_491	[p28l724t3070r790b3126],
11	the	DT	O	the	det	12	SENT_491	[p28l808t3064r913b3127],
12	pipeline	NN	O	pipeline	prep_in	9	SENT_491	[p28l932t3064r1219b3147],
13	,	,	O	,	_	0	SENT_491	[p28l932t3064r1219b3147],
14	and	CC	O	and	_	0	SENT_491	[p28l1241t3064r1365b3127],
15	many	JJ	O	many	nsubj	16	SENT_491	[p28l1383t3087r1573b3148],
16	epitomize	VBP	O	epitomize	conj_and	9	SENT_491	[p28l1590t3070r1918b3147],
17	newer	JJR	O	newer	amod	18	SENT_491	[p28l1938t3087r2144b3127],
18	strategies	NNS	O	strategy	dobj	16	SENT_491	[p28l10t3173r316b3251],
19	in	IN	O	in	_	0	SENT_491	[p28l336t3173r401b3229],
20	antiobesity	JJ	O	antiobesity	amod	22	SENT_491	[p28l421t3167r786b3251],
21	drug	NN	O	drug	nn	22	SENT_491	[p28l802t3167r960b3251],
22	development	NN	O	development	prep_in	18	SENT_491	[p28l978t3167r1409b3250],
23	designed	VBN	O	design	partmod	22	SENT_491	[p28l1427t3167r1723b3251],
24	to	TO	O	to	aux	25	SENT_491	[p28l1740t3179r1804b3230],
25	minimize	VB	O	minimize	xcomp	23	SENT_491	[p28l1824t3173r2142b3230],
26	risk	NN	O	risk	dobj	25	SENT_491	[p28l10t3270r136b3333],
27	and	CC	O	and	_	0	SENT_491	[p28l152t3270r276b3333],
28	maximize	VB	O	maximize	conj_and	25	SENT_491	[p28l294t3276r622b3333],
29	efﬁcacy	NN	O	efﬁcacy	dobj	28	SENT_491	[p28l642t3270r909b3354],
30	:	:	O	:	_	0	SENT_491	[p28l642t3270r909b3354],
31	targeting	VBG	O	target	amod	34	SENT_491	[p28l931t3276r1231b3354],
32	endogenous	JJ	O	endogenous	amod	34	SENT_491	[p28l1249t3270r1652b3354],
33	endocrine	JJ	O	endocrine	amod	34	SENT_491	[p28l1672t3270r2010b3333],
34	circuits	NNS	O	circuit	conj_and	18	SENT_491	[p28l2030t3276r2140b3333, p28l10t3379r166b3436],
35	regulating	VBG	O	regulate	partmod	34	SENT_491	[p28l188t3373r532b3457],
36	energy	NN	O	energy	nn	37	SENT_491	[p28l552t3396r783b3457],
37	homeostasis	NN	O	homeostasis	dobj	35	SENT_491	[p28l799t3373r1214b3436],
38	and	CC	O	and	_	0	SENT_491	[p28l1237t3373r1362b3436],
39	metabolism	NN	O	metabolism	dobj	35	SENT_491	[p28l1382t3373r1798b3445],
40	;	:	O	;	_	0	SENT_491	[p28l1382t3373r1798b3445],
41	and	CC	O	and	_	0	SENT_491	[p28l1822t3373r1947b3436],
42	combination	NN	O	combination	nn	43	SENT_491	[p28l1968t3396r2140b3436, p28l8t3476r287b3539],
43	therapy	NN	O	therapy	conj_and	18	SENT_491	[p28l305t3476r560b3560],
44	with	IN	O	with	_	0	SENT_491	[p28l574t3476r722b3539],
45	monotherapeutic	JJ	O	monotherapeutic	amod	46	SENT_491	[p28l741t3476r1316b3559],
46	agents	NNS	O	agent	prep_with	43	SENT_491	[p28l1336t3488r1542b3560],
47	to	TO	O	to	aux	48	SENT_491	[p28l1561t3488r1625b3539],
48	elicit	VB	O	elicit	infmod	43	SENT_491	[p28l1646t3476r1804b3539],
49	improved	JJ	O	improved	amod	50	SENT_491	[p28l1821t3476r2142b3559],
50	safety	NN	O	safety	dobj	48	SENT_491	[p28l11t3579r210b3663],
51	and	CC	O	and	_	0	SENT_491	[p28l231t3579r359b3642],
52	eﬂicacy	NN	O	eﬂicacy	dobj	48	SENT_491	[p28l382t3579r652b3663],
53	,	,	O	,	_	0	SENT_491	[p28l382t3579r652b3663],
54	with	IN	O	with	_	0	SENT_491	[p28l675t3579r831b3642],
55	potential	JJ	O	potential	amod	56	SENT_491	[p28l852t3579r1164b3662],
56	synergy	NN	O	synergy	prep_with	48	SENT_491	[p28l1188t3602r1467b3663],
57	.	.	O	.	_	0	SENT_491	[p28l1188t3602r1467b3663],

1	These	DT	O	these	det	3	SENT_492	[p28l1493t3579r1691b3642],
2	future	JJ	DATE	future	amod	3	SENT_492	[p28l1714t3579r1924b3642],
3	drugs	NNS	O	drug	nsubj	4	SENT_492	[p28l1948t3579r2143b3663],
4	offer	VBP	O	offer	_	0	SENT_492	[p28l10t3682r169b3745],
5	the	DT	O	the	det	6	SENT_492	[p28l190t3682r299b3745],
6	potential	NN	O	potential	dobj	4	SENT_492	[p28l321t3682r633b3765],
7	of	IN	O	of	_	0	SENT_492	[p28l656t3682r731b3745],
8	supplanting	VBG	O	supplant	prepc_of	6	SENT_492	[p28l746t3682r1158b3766],
9	or	CC	O	or	_	0	SENT_492	[p28l1179t3705r1252b3745],
10	even	RB	O	even	advmod	8	SENT_492	[p28l1275t3705r1435b3745],
11	combining	VBG	O	combine	conj_or	8	SENT_492	[p28l1458t3682r1836b3766],
12	with	IN	O	with	_	0	SENT_492	[p28l1855t3682r2011b3745],
13	the	DT	O	the	det	16	SENT_492	[p28l2033t3682r2142b3745],
14	newly	RB	O	newly	advmod	15	SENT_492	[p29l9t16r212b100],
15	approved	VBN	O	approve	amod	16	SENT_492	[p29l229t16r543b99],
16	drugs	NNS	O	drug	prep_with	11	SENT_492	[p29l562t16r768b100],
17	.	.	O	.	_	0	SENT_492	[p29l562t16r768b100],

1	Finally	RB	O	finally	advmod	13	SENT_493	[p29l792t16r1033b100],
2	,	,	O	,	_	0	SENT_493	[p29l792t16r1033b100],
3	the	DT	O	the	det	4	SENT_493	[p29l1054t16r1159b79],
4	modulation	NN	O	modulation	nsubj	13	SENT_493	[p29l1178t16r1575b79],
5	of	IN	O	of	_	0	SENT_493	[p29l1596t16r1669b79],
6	cGMP	NN	O	cgmp	nn	7	SENT_493	[p29l1679t20r1896b79],
7	signaling	NN	O	signaling	prep_of	4	SENT_493	[p29l1918t16r2141b100, p29l10t126r115b204],
8	in	IN	O	in	_	0	SENT_493	[p29l133t126r198b182],
9	medical	JJ	O	medical	amod	11	SENT_493	[p29l217t120r481b183],
10	weight	NN	O	weight	nn	11	SENT_493	[p29l497t120r722b204],
11	management	NN	O	management	prep_in	7	SENT_493	[p29l739t132r1175b204],
12	has	VBZ	O	have	aux	13	SENT_493	[p29l1192t120r1301b183],
13	emerged	VBN	O	emerge	_	0	SENT_493	[p29l1321t120r1609b204],
14	as	IN	O	as	_	0	SENT_493	[p29l1628t143r1691b183],
15	an	DT	O	a	det	18	SENT_493	[p29l1712t143r1790b183],
16	intriguing	JJ	O	intriguing	amod	18	SENT_493	[p29l1809t126r2146b204],
17	new	JJ	O	new	amod	18	SENT_493	[p29l9t246r154b286],
18	paradigm	NN	O	paradigm	prep_as	13	SENT_493	[p29l172t223r506b307],
19	for	IN	O	for	_	0	SENT_493	[p29l528t223r626b286],
20	a	DT	O	a	det	23	SENT_493	[p29l648t246r683b286],
21	well-characterized	JJ	O	well-characterized	amod	23	SENT_493	[p29l702t223r1340b286],
22	drug	NN	O	drug	nn	23	SENT_493	[p29l1362t223r1526b307],
23	class	NN	O	class	prep_for	18	SENT_493	[p29l1547t223r1719b286],
24	.	.	O	.	_	0	SENT_493	[p29l1547t223r1719b286],

1	Discoveries	NNS	O	discovery	nsubj	13	SENT_494	[p29l1745t228r2142b286],
2	in	IN	O	in	_	0	SENT_494	[p29l10t332r78b388],
3	the	DT	O	the	det	5	SENT_494	[p29l100t326r208b389],
4	molecular	JJ	O	molecular	amod	5	SENT_494	[p29l232t326r585b389],
5	mechanisms	NNS	O	mechanism	prep_in	1	SENT_494	[p29l606t326r1042b389],
6	regulating	VBG	O	regulate	partmod	5	SENT_494	[p29l1066t326r1421b410],
7	adipose	JJ	O	adipose	amod	8	SENT_494	[p29l1444t326r1709b409],
8	metabolism	NN	O	metabolism	dobj	6	SENT_494	[p29l1733t326r2144b389],
9	and	CC	O	and	_	0	SENT_494	[p29l10t429r136b492],
10	satiety	NN	O	satiety	nn	11	SENT_494	[p29l158t435r376b513],
11	signaling	NN	O	signaling	conj_and	8	SENT_494	[p29l396t429r704b513],
12	have	VBP	O	have	aux	13	SENT_494	[p29l723t429r878b492],
13	opened	VBN	O	open	_	0	SENT_494	[p29l900t429r1152b512],
14	the	DT	O	the	det	15	SENT_494	[p29l1171t429r1277b492],
15	door	NN	O	door	dobj	13	SENT_494	[p29l1300t429r1462b492],
16	for	IN	O	for	_	0	SENT_494	[p29l1482t429r1579b492],
17	targeting	VBG	O	target	prepc_for	13	SENT_494	[p29l1598t435r1904b513],
18	CGMP	NN	ORGANIZATION	cgmp	nn	19	SENT_494	[p29l1925t433r2143b492],
19	signaling	NN	O	signaling	dobj	17	SENT_494	[p29l10t532r319b616],
20	as	IN	O	as	_	0	SENT_494	[p29l340t555r404b595],
21	a	DT	O	a	det	24	SENT_494	[p29l428t555r462b595],
22	future	JJ	DATE	future	amod	24	SENT_494	[p29l483t532r688b595],
23	antiobesity	NN	O	antiobesity	nn	24	SENT_494	[p29l711t532r1085b616],
24	strategy	NN	O	strategy	prep_as	17	SENT_494	[p29l1105t544r1380b616],
25	.	.	O	.	_	0	SENT_494	[p29l1105t544r1380b616],

1	These	DT	O	these	det	2	SENT_495	[p29l1404t532r1598b595],
2	advances	NNS	O	advance	nsubj	9	SENT_495	[p29l1621t532r1927b595],
3	in	IN	O	in	_	0	SENT_495	[p29l1950t538r2016b594],
4	the	DT	O	the	det	5	SENT_495	[p29l2037t532r2143b595],
5	development	NN	O	development	prep_in	2	SENT_495	[p29l10t635r456b718],
6	of	IN	O	of	_	0	SENT_495	[p29l478t635r552b698],
7	antiobesity	JJ	O	antiobesity	amod	8	SENT_495	[p29l566t635r943b719],
8	pharmacotherapy	NN	O	pharmacotherapy	prep_of	5	SENT_495	[p29l961t635r1575b719],
9	offer	VBP	O	offer	_	0	SENT_495	[p29l1594t635r1751b698],
10	new	JJ	O	new	amod	11	SENT_495	[p29l1772t658r1915b698],
11	armaments	NNS	O	armament	dobj	9	SENT_495	[p29l1935t658r2138b698, p29l9t750r214b801],
12	in	IN	O	in	_	0	SENT_495	[p29l235t744r302b800],
13	the	DT	O	the	det	14	SENT_495	[p29l321t738r426b801],
14	ﬁght	NN	O	ﬁght	prep_in	9	SENT_495	[p29l447t738r601b822],
15	to	TO	O	to	aux	16	SENT_495	[p29l620t750r685b801],
16	reverse	VB	O	reverse	infmod	14	SENT_495	[p29l708t761r945b801],
17	the	DT	DURATION	the	det	18	SENT_495	[p29l966t738r1071b801],
18	decades	NNS	DURATION	decade	dobj	16	SENT_495	[p29l1092t738r1539b822],
19	—	RB	O	—	advmod	16	SENT_495	[p29l1092t738r1539b822],
20	long	RB	O	long	advmod	16	SENT_495	[p29l1092t738r1539b822],
21	rise	NN	O	rise	pobj	20	SENT_495	[p29l1558t744r1677b801],
22	of	IN	O	of	_	0	SENT_495	[p29l1699t738r1772b801],
23	obesity	NN	O	obesity	prep_of	21	SENT_495	[p29l1783t738r2031b822],
24	.	.	O	.	_	0	SENT_495	[p29l1783t738r2031b822],

1	ACKNOWLEDGMENTS	NNP	O	ACKNOWLEDGMENTS	nn	2	SENT_496	[p29l9t902r690b951],
2	Support	NN	O	support	nsubjpass	4	SENT_496	[p29l10t989r244b1050],
3	was	VBD	O	be	auxpass	4	SENT_496	[p29l259t1002r367b1037],
4	provided	VBN	O	provide	_	0	SENT_496	[p29l386t987r641b1050],
5	by	IN	O	by	_	0	SENT_496	[p29l662t987r729b1051],
6	grants	NNS	O	grant	agent	4	SENT_496	[p29l744t995r923b1051],
7	from	IN	O	from	_	0	SENT_496	[p29l939t987r1072b1037],
8	the	DT	O	the	det	14	SENT_496	[p29l1090t987r1184b1038],
9	National	NNP	ORGANIZATION	National	dep	14	SENT_496	[p29l1203t987r1439b1038],
10	Institutes	NNPS	ORGANIZATION	Institutes	dep	9	SENT_496	[p29l1461t990r1724b1038],
11	of	IN	ORGANIZATION	of	_	0	SENT_496	[p29l1742t987r1801b1037],
12	Health	NNP	ORGANIZATION	Health	prep_of	9	SENT_496	[p29l1815t987r1998b1038],
13	(	CD	NUMBER	(	num	12	SENT_496	[p29l11t1074r148b1130],
14	NIH	NNP	ORGANIZATION	NIH	prep_from	6	SENT_496	[p29l11t1074r148b1130],
15	;	:	O	;	_	0	SENT_496	[p29l11t1074r148b1130],
16	P30	NN	O	p30	nn	17	SENT_496	[p29l167t1075r268b1123],
17	CA56036	NN	O	ca56036	dep	6	SENT_496	[p29l285t1074r557b1130],
18	,	,	O	,	_	0	SENT_496	[p29l285t1074r557b1130],
19	R01	NN	O	r01	nn	20	SENT_496	[p29l577t1075r668b1123],
20	CA1	NN	O	ca1	appos	17	SENT_496	[p29l695t1074r799b1123],
21	70533	CD	NUMBER	70533	num	22	SENT_496	[p29l816t1074r1023b1130],
22	)	NN	O	)	tmod	4	SENT_496	[p29l816t1074r1023b1130],
23	,	,	O	,	_	0	SENT_496	[p29l816t1074r1023b1130],
24	the	DT	O	the	det	26	SENT_496	[p29l1039t1073r1132b1123],
25	Pennsylvania	NNP	ORGANIZATION	Pennsylvania	nn	26	SENT_496	[p29l1152t1073r1524b1137],
26	Department	NNP	ORGANIZATION	Department	appos	22	SENT_496	[p29l1545t1075r1896b1136],
27	of	IN	ORGANIZATION	of	_	0	SENT_496	[p29l1912t1072r1971b1123],
28	Health	NNP	ORGANIZATION	Health	prep_of	26	SENT_496	[p29l12t1156r195b1206],
29	(	CD	NUMBER	(	num	28	SENT_496	[p29l216t1157r343b1214],
30	SAP	NN	O	sap	dep	26	SENT_496	[p29l216t1157r343b1214],
31	4100059197	CD	NUMBER	4100059197	num	30	SENT_496	[p29l359t1159r728b1214],
32	,	,	O	,	_	0	SENT_496	[p29l359t1159r728b1214],
33	SAP	NN	O	sap	dep	30	SENT_496	[p29l746t1158r854b1206],
34	4100051723	CD	NUMBER	4100051723	num	35	SENT_496	[p29l870t1157r1259b1214],
35	)	NN	O	)	dep	33	SENT_496	[p29l870t1157r1259b1214],
36	,	,	O	,	_	0	SENT_496	[p29l870t1157r1259b1214],
37	and	CC	O	and	_	0	SENT_496	[p29l1276t1156r1381b1206],
38	Targeted	VBN	ORGANIZATION	target	conj_and	30	SENT_496	[p29l1395t1156r1647b1220],
39	Diagnostics	NNPS	ORGANIZATION	Diagnostics	dep	22	SENT_496	[p29l1669t1158r2000b1220],
40	&	CC	ORGANIZATION	&	_	0	SENT_496	[p29l9t1242r563b1305],
41	Therapeutics	NNPS	ORGANIZATION	Therapeutics	dep	22	SENT_496	[p29l9t1242r563b1305],
42	.	.	O	.	_	0	SENT_496	[p29l9t1242r563b1305],

1	The	DT	O	the	det	3	SENT_497	[p29l9t1242r563b1305],
2	Pennsylvania	NNP	O	Pennsylvania	nn	3	SENT_497	[p29l582t1242r954b1306],
3	Department	NNP	O	Department	nsubj	7	SENT_497	[p29l976t1244r1326b1305],
4	of	IN	O	of	_	0	SENT_497	[p29l1342t1242r1402b1292],
5	Health	NNP	O	Health	prep_of	3	SENT_497	[p29l1416t1242r1599b1293],
6	specifically	RB	O	specifically	advmod	7	SENT_497	[p29l1618t1242r1933b1307],
7	disclaims	VBZ	O	disclaim	_	0	SENT_497	[p29l10t1328r272b1378],
8	responsibility	NN	O	responsibility	dobj	7	SENT_497	[p29l291t1328r678b1392],
9	for	IN	O	for	_	0	SENT_497	[p29l691t1327r770b1378],
10	any	DT	O	any	det	11	SENT_497	[p29l786t1342r887b1392],
11	analyses	NNS	O	analysis	prep_for	8	SENT_497	[p29l902t1328r1157b1392],
12	,	,	O	,	_	0	SENT_497	[p29l902t1328r1157b1392],
13	interpretations	NNS	O	interpretation	prep_for	8	SENT_497	[p29l1176t1330r1617b1391],
14	,	,	O	,	_	0	SENT_497	[p29l1176t1330r1617b1391],
15	or	CC	O	or	_	0	SENT_497	[p29l1634t1342r1692b1378],
16	conclusions	NNS	O	conclusion	prep_for	8	SENT_497	[p29l1707t1328r2060b1378],
17	.	.	O	.	_	0	SENT_497	[p29l1707t1328r2060b1378],

1	G.W.K.	NNP	O	G.W.K.	nsubj	7	SENT_498	[p29l9t1413r188b1461],
2	is	VBZ	O	be	cop	7	SENT_498	[p29l206t1413r244b1461],
3	the	DT	O	the	det	7	SENT_498	[p29l260t1411r353b1461],
4	recipient	JJ	O	recipient	amod	7	SENT_498	[p29l372t1413r624b1474],
5	ofthe	NN	O	ofthe	nn	7	SENT_498	[p29l640t1410r803b1461],
6	Graduate	NN	O	graduate	nn	7	SENT_498	[p29l820t1411r1085b1461],
7	Award	NN	O	award	_	0	SENT_498	[p29l1102t1411r1282b1461],
8	for	IN	O	for	_	0	SENT_498	[p29l1300t1410r1379b1461],
9	Integrative	NNP	ORGANIZATION	Integrative	nn	10	SENT_498	[p29l1397t1413r1705b1474],
10	Research	NNP	ORGANIZATION	Research	prep_for	7	SENT_498	[p29l1725t1411r1977b1461],
11	in	IN	O	in	_	0	SENT_498	[p29l11t1500r58b1547],
12	Pharmacology	NNP	O	Pharmacology	prep_in	10	SENT_498	[p29l79t1497r494b1561],
13	from	IN	O	from	_	0	SENT_498	[p29l507t1497r641b1547],
14	the	DT	O	the	det	16	SENT_498	[p29l659t1497r752b1547],
15	American	NNP	ORGANIZATION	American	nn	16	SENT_498	[p29l769t1500r1041b1548],
16	Society	NNP	ORGANIZATION	Society	prep_from	12	SENT_498	[p29l1060t1499r1269b1561],
17	for	IN	ORGANIZATION	for	_	0	SENT_498	[p29l1283t1497r1362b1547],
18	Pharmacology	NNP	ORGANIZATION	Pharmacology	prep_for	16	SENT_498	[p29l1380t1497r1795b1562],
19	and	CC	ORGANIZATION	and	_	0	SENT_498	[p29l1810t1497r1915b1547],
20	Experimental	JJ	ORGANIZATION	experimental	amod	21	SENT_498	[p29l12t1583r388b1646],
21	Therapeutics	NNS	ORGANIZATION	therapeutics	conj_and	16	SENT_498	[p29l402t1583r775b1646],
22	and	CC	O	and	_	0	SENT_498	[p29l793t1583r898b1633],
23	a	DT	O	a	det	25	SENT_498	[p29l916t1597r943b1633],
24	Predoctoral	NNP	O	Predoctoral	nn	25	SENT_498	[p29l965t1583r1292b1633],
25	Fellowship	NNP	O	Fellowship	conj_and	21	SENT_498	[p29l1314t1583r1618b1646],
26	in	IN	O	in	prep	12	SENT_498	[p29l1637t1585r1683b1632],
27	Pharmaco	NNP	ORGANIZATION	Pharmaco	nn	28	SENT_498	[p29l1705t1583r2144b1647],
28	|	NNP	O	|	dep	26	SENT_498	[p29l1705t1583r2144b1647],
29	ogy	NN	O	ogy	dep	28	SENT_498	[p29l1705t1583r2144b1647],
30	/	:	O	/	punct	28	SENT_498	[p29l1705t1583r2144b1647],
31	Toxicology	NNP	O	Toxicology	dep	28	SENT_498	[p29l7t1666r318b1730],
32	from	IN	O	from	_	0	SENT_498	[p29l332t1665r465b1716],
33	the	DT	O	the	det	35	SENT_498	[p29l483t1666r577b1716],
34	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	nn	35	SENT_498	[p29l597t1666r1036b1716],
35	Research	NNP	ORGANIZATION	Research	prep_from	31	SENT_498	[p29l1058t1666r1310b1716],
36	and	CC	ORGANIZATION	and	_	0	SENT_498	[p29l1329t1666r1434b1716],
37	Manufacturers	NNP	ORGANIZATION	Manufacturers	dep	28	SENT_498	[p29l1454t1665r1871b1716],
38	of	IN	ORGANIZATION	of	_	0	SENT_498	[p29l1888t1665r1947b1716],
39	America	NNP	ORGANIZATION	America	nn	40	SENT_498	[p29l9t1755r243b1803],
40	Foundation	NNP	ORGANIZATION	Foundation	prep_of	37	SENT_498	[p29l264t1752r608b1803],
41	.	.	O	.	_	0	SENT_498	[p29l264t1752r608b1803],

1	J.E.L.	NNP	O	J.E.L.	nsubjpass	3	SENT_499	[p29l623t1755r757b1803],
2	was	VBD	O	be	auxpass	3	SENT_499	[p29l772t1767r880b1803],
3	supported	VBN	O	support	_	0	SENT_499	[p29l898t1752r1196b1815],
4	by	IN	O	by	_	0	SENT_499	[p29l1218t1752r1284b1816],
5	NIH	NNP	ORGANIZATION	NIH	agent	3	SENT_499	[p29l1302t1755r1400b1802],
6	institutional	JJ	O	institutional	amod	9	SENT_499	[p29l1421t1752r1763b1803],
7	award	NN	O	award	nn	9	SENT_499	[p29l1783t1752r1955b1803],
8	T32	NN	O	t32	nn	9	SENT_499	[p29l1969t1755r2072b1802],
9	GM08562	NN	O	gm08562	dobj	3	SENT_499	[p29l9t1840r283b1888],
10	for	IN	O	for	_	0	SENT_499	[p29l300t1837r379b1888],
11	Postdoctoral	NNP	O	Postdoctoral	nn	12	SENT_499	[p29l397t1838r755b1888],
12	Training	NNP	O	Training	prep_for	9	SENT_499	[p29l769t1840r1002b1901],
13	in	IN	O	in	_	0	SENT_499	[p29l1023t1840r1069b1887],
14	Clinical	JJ	O	clinical	amod	15	SENT_499	[p29l1088t1838r1292b1888],
15	Pharmacology	NN	O	pharmacology	prep_in	12	SENT_499	[p29l1314t1838r1728b1902],
16	and	CC	O	and	_	0	SENT_499	[p29l1743t1838r1848b1888],
17	is	VBZ	O	be	cop	23	SENT_499	[p29l1869t1840r1906b1888],
18	the	DT	O	the	det	23	SENT_499	[p29l1922t1838r2015b1888],
19	recipient	JJ	O	recipient	amod	23	SENT_499	[p29l12t1923r263b1984],
20	ofthe	NN	O	ofthe	nn	23	SENT_499	[p29l279t1920r443b1971],
21	Young	NN	O	young	nn	23	SENT_499	[p29l455t1923r636b1985],
22	Investigator	NN	O	investigator	nn	23	SENT_499	[p29l658t1923r999b1985],
23	Award	NN	O	award	conj_and	3	SENT_499	[p29l1014t1921r1194b1971],
24	from	IN	O	from	_	0	SENT_499	[p29l1212t1920r1346b1971],
25	the	DT	O	the	det	27	SENT_499	[p29l1364t1921r1457b1971],
26	American	NNP	ORGANIZATION	American	nn	27	SENT_499	[p29l1474t1923r1746b1971],
27	Society	NNP	ORGANIZATION	Society	prep_from	23	SENT_499	[p29l1765t1923r1974b1985],
28	for	IN	ORGANIZATION	for	_	0	SENT_499	[p29l1988t1920r2067b1971],
29	Clinical	JJ	ORGANIZATION	clinical	amod	30	SENT_499	[p29l9t2007r212b2058],
30	Pharmacology	NN	ORGANIZATION	pharmacology	prep_for	23	SENT_499	[p29l235t2007r649b2072],
31	and	CC	ORGANIZATION	and	_	0	SENT_499	[p29l664t2007r769b2057],
32	Therapeutics	NNS	ORGANIZATION	therapeutics	prep_for	23	SENT_499	[p29l782t2007r1170b2070],
33	.	.	O	.	_	0	SENT_499	[p29l782t2007r1170b2070],

1	E.S.B.	NNP	O	E.S.B.	nsubj	12	SENT_500	[p29l1190t2009r1332b2058],
2	is	VBZ	O	be	cop	12	SENT_500	[p29l1350t2010r1388b2057],
3	the	DT	O	the	det	12	SENT_500	[p29l1403t2007r1497b2057],
4	recipient	JJ	O	recipient	amod	12	SENT_500	[p29l1516t2010r1768b2070],
5	ofthe	NNP	O	ofthe	nn	12	SENT_500	[p29l1784t2007r1947b2057],
6	Ruth	NNP	PERSON	Ruth	nn	12	SENT_500	[p29l1966t2007r2094b2058],
7	L.	NNP	PERSON	L.	nn	12	SENT_500	[p29l12t2094r52b2142],
8	Kirschstein	NNP	PERSON	Kirschstein	nn	12	SENT_500	[p29l72t2092r378b2142],
9	National	NNP	ORGANIZATION	National	nn	12	SENT_500	[p29l400t2092r636b2142],
10	Research	NNP	ORGANIZATION	Research	nn	12	SENT_500	[p29l659t2092r910b2142],
11	Service	NNP	ORGANIZATION	Service	nn	12	SENT_500	[p29l930t2093r1135b2142],
12	Award	NN	O	award	_	0	SENT_500	[p29l1151t2092r1332b2142],
13	for	IN	O	for	mark	18	SENT_500	[p29l1350t2091r1429b2142],
14	Individual	JJ	O	individual	amod	17	SENT_500	[p29l1447t2092r1727b2142],
15	Predoctoral	JJ	O	predoctoral	amod	17	SENT_500	[p29l1749t2092r2076b2142],
16	MD/PhD	NN	O	md/phd	nn	17	SENT_500	[p29l11t2176r253b2228],
17	Fellows	NNS	O	fellow	nsubj	18	SENT_500	[p29l272t2176r481b2226],
18	(	VBP	O	(	advcl	12	SENT_500	[p29l500t2177r539b2234],
19	1	CD	NUMBER	1	num	20	SENT_500	[p29l500t2177r539b2234],
20	F30	NN	O	f30	dobj	18	SENT_500	[p29l569t2178r667b2226],
21	CA180500	CD	NUMBER	ca180500	number	22	SENT_500	[p29l684t2177r995b2234],
22	)	CD	NUMBER	)	npadvmod	18	SENT_500	[p29l684t2177r995b2234],
23	from	IN	O	from	_	0	SENT_500	[p29l1012t2175r1146b2226],
24	the	DT	O	the	det	25	SENT_500	[p29l1164t2176r1257b2226],
25	NIH	NNP	ORGANIZATION	NIH	prep_from	18	SENT_500	[p29l1277t2178r1392b2226],
26	.	.	O	.	_	0	SENT_500	[p29l1277t2178r1392b2226],

1	S.A.W.	NNP	O	S.A.W.	nsubj	10	SENT_501	[p29l1410t2178r1580b2226],
2	is	VBZ	O	be	cop	10	SENT_501	[p29l1599t2178r1636b2226],
3	the	DT	O	the	det	10	SENT_501	[p29l1652t2176r1746b2226],
4	Samuel	NNP	ORGANIZATION	Samuel	nn	10	SENT_501	[p29l1763t2176r1972b2226],
5	MV	NNP	ORGANIZATION	MV	nn	10	SENT_501	[p29l1992t2178r2083b2226],
6	Hamilton	NNP	ORGANIZATION	Hamilton	nn	10	SENT_501	[p29l12t2262r273b2312],
7	Professor	NNP	O	Professor	nn	10	SENT_501	[p29l294t2262r556b2312],
8	ofThomas	NNP	O	ofThomas	nn	10	SENT_501	[p29l572t2262r865b2313],
9	Jefferson	NNP	ORGANIZATION	Jefferson	nn	10	SENT_501	[p29l880t2262r1139b2313],
10	University	NNP	ORGANIZATION	University	_	0	SENT_501	[p29l1161t2265r1457b2327],
11	.	.	O	.	_	0	SENT_501	[p29l1161t2265r1457b2327],

1	CONFLICT	NN	O	conflict	nsubj	7	SENT_502	[p29l10t2415r322b2464],
2	OF	IN	O	of	_	0	SENT_502	[p29l337t2415r419b2464],
3	INTEREST	NN	O	interest	nn	4	SENT_502	[p29l438t2415r736b2463],
4	S.A.W.	NN	O	s.a.w.	prep_of	1	SENT_502	[p29l10t2501r179b2550],
5	is	VBZ	O	be	cop	7	SENT_502	[p29l197t2502r234b2550],
6	the	DT	O	the	det	7	SENT_502	[p29l249t2499r342b2550],
7	chair	NN	O	chair	_	0	SENT_502	[p29l358t2499r496b2550],
8	of	IN	O	of	_	0	SENT_502	[p29l511t2499r570b2550],
9	the	DT	O	the	det	11	SENT_502	[p29l580t2499r673b2550],
10	Data	NNP	ORGANIZATION	Data	nn	11	SENT_502	[p29l691t2502r818b2550],
11	Safety	NNP	ORGANIZATION	Safety	prep_of	7	SENT_502	[p29l836t2499r1010b2564],
12	Monitoring	VBG	ORGANIZATION	monitor	partmod	11	SENT_502	[p29l1026t2502r1343b2563],
13	Board	NNP	ORGANIZATION	Board	dobj	12	SENT_502	[p29l1364t2499r1525b2550],
14	for	IN	O	for	_	0	SENT_502	[p29l1541t2499r1620b2550],
15	the	DT	O	the	det	17	SENT_502	[p29l1633t2499r1726b2550],
16	CHARTTria	NN	O	charttrium	nn	17	SENT_502	[p29l1742t2499r2064b2550],
17	|	NN	O	|	prep_for	13	SENT_502	[p29l1742t2499r2064b2550],
18	sponsored	VBN	O	sponsor	partmod	17	SENT_502	[p29l10t2583r307b2646],
19	by	IN	O	by	_	0	SENT_502	[p29l327t2583r394b2647],
20	Cardio3	NNP	ORGANIZATION	Cardio3	nn	21	SENT_502	[p29l408t2583r625b2633],
21	Biosciences	NNPS	ORGANIZATION	Biosciences	agent	18	SENT_502	[p29l646t2585r970b2633],
22	and	CC	O	and	_	0	SENT_502	[p29l987t2583r1091b2633],
23	the	DT	O	the	det	25	SENT_502	[p29l1108t2583r1200b2633],
24	chair	NN	O	chair	nn	25	SENT_502	[p29l1217t2583r1355b2633],
25	(	NN	O	(	agent	18	SENT_502	[p29l1372t2583r1874b2646],
26	uncompensated	JJ	O	uncompensated	amod	27	SENT_502	[p29l1372t2583r1874b2646],
27	)	NN	O	)	nsubj	28	SENT_502	[p29l1372t2583r1874b2646],
28	ofthe	VBZ	O	ofthe	rcmod	25	SENT_502	[p29l1892t2582r2054b2633],
29	Scientific	NNP	ORGANIZATION	Scientific	nn	32	SENT_502	[p29l10t2667r266b2718],
30	Advisory	NNP	ORGANIZATION	Advisory	nn	32	SENT_502	[p29l281t2668r531b2732],
31	Board	NNP	ORGANIZATION	Board	nn	32	SENT_502	[p29l548t2668r709b2718],
32	ofTargeted	NNP	ORGANIZATION	ofTargeted	dobj	28	SENT_502	[p29l727t2667r1042b2732],
33	Diagnostics	NNPS	ORGANIZATION	Diagnostics	tmod	28	SENT_502	[p29l1063t2670r1391b2732],
34	&	CC	ORGANIZATION	&	_	0	SENT_502	[p29l1407t2668r1839b2731],
35	Therapeutics	NNPS	ORGANIZATION	Therapeutics	conj_and	33	SENT_502	[p29l1407t2668r1839b2731],
36	,	,	O	,	_	0	SENT_502	[p29l1407t2668r1839b2731],
37	which	WDT	O	which	nsubj	38	SENT_502	[p29l1854t2668r2023b2718],
38	provided	VBD	O	provide	rcmod	33	SENT_502	[p29l12t2753r263b2816],
39	research	NN	O	research	nn	40	SENT_502	[p29l284t2753r518b2804],
40	funding	NN	O	funding	dobj	38	SENT_502	[p29l535t2753r759b2817],
41	that	IN	O	that	nsubj	46	SENT_502	[p29l776t2753r904b2811],
42	,	,	O	,	_	0	SENT_502	[p29l776t2753r904b2811],
43	in	IN	O	in	_	0	SENT_502	[p29l922t2756r968b2803],
44	part	NN	O	part	prep_in	46	SENT_502	[p29l989t2761r1116b2816],
45	,	,	O	,	_	0	SENT_502	[p29l989t2761r1116b2816],
46	supported	VBD	O	support	rcmod	40	SENT_502	[p29l1133t2753r1428b2816],
47	this	DT	O	this	det	48	SENT_502	[p29l1445t2753r1546b2804],
48	work	NN	O	work	dobj	46	SENT_502	[p29l1562t2753r1717b2811],
49	;	:	O	;	_	0	SENT_502	[p29l1562t2753r1717b2811],
50	he	PRP	O	he	nsubj	51	SENT_502	[p29l1735t2753r1802b2804],
51	has	VBZ	O	have	parataxis	7	SENT_502	[p29l1820t2753r1912b2804],
52	a	DT	O	a	det	53	SENT_502	[p29l1928t2768r1955b2804],
53	license	NN	O	license	dobj	51	SENT_502	[p29l12t2838r203b2888],
54	to	TO	O	to	aux	55	SENT_502	[p29l218t2846r275b2888],
55	commercialize	VB	O	commercialize	infmod	53	SENT_502	[p29l291t2838r704b2888],
56	inventions	NNS	O	invention	dobj	55	SENT_502	[p29l722t2840r1017b2888],
57	related	VBN	O	relate	advmod	55	SENT_502	[p29l1035t2838r1228b2888],
58	to	TO	O	to	_	0	SENT_502	[p29l1246t2845r1303b2888],
59	this	DT	O	this	det	60	SENT_502	[p29l1318t2838r1419b2888],
60	work	NN	O	work	prep_to	57	SENT_502	[p29l1435t2838r1590b2888],
61	.	.	O	.	_	0	SENT_502	[p29l1435t2838r1590b2888],

1	S.A.W.	NNP	O	S.A.W.	nsubjpass	16	SENT_503	[p29l1607t2840r1776b2888],
2	is	VBZ	O	be	cop	4	SENT_503	[p29l1794t2840r1831b2888],
3	Editor	NNP	O	Editor	nn	4	SENT_503	[p29l1850t2838r2112b2888],
4	—	NNP	O	—	_	0	SENT_503	[p29l1850t2838r2112b2888],
5	in	IN	O	in	_	0	SENT_503	[p29l1850t2838r2112b2888],
6	—	NNP	O	—	nn	7	SENT_503	[p29l1850t2838r2112b2888],
7	Chief	NNP	O	Chief	prep_in	4	SENT_503	[p29l9t2922r160b2973],
8	of	IN	O	of	_	0	SENT_503	[p29l171t2922r229b2973],
9	Clinical	JJ	O	clinical	prep_of	7	SENT_503	[p29l241t2923r443b2973],
10	Pharmacology	NNP	O	Pharmacology	dep	9	SENT_503	[p29l453t2923r907b2987],
11	&	CC	O	&	_	0	SENT_503	[p29l453t2923r907b2987],
12	Therapeutics	NNPS	O	Therapeutics	dep	9	SENT_503	[p29l921t2923r1270b2986],
13	but	CC	O	but	_	0	SENT_503	[p29l1288t2923r1382b2973],
14	was	VBD	O	be	auxpass	16	SENT_503	[p29l1397t2938r1504b2973],
15	not	RB	O	not	neg	16	SENT_503	[p29l1523t2931r1616b2973],
16	involved	VBN	O	involve	conj_but	4	SENT_503	[p29l1633t2923r1871b2973],
17	in	IN	O	in	_	0	SENT_503	[p29l1892t2925r1938b2973],
18	the	DT	O	the	prep_in	16	SENT_503	[p29l1955t2923r2047b2973],

1	64	CD	NUMBER	64	num	2	SENT_504	[p29l9t3104r73b3145],
2	review	NN	O	review	nsubj	14	SENT_504	[p29l10t3182r198b3231],
3	or	CC	O	or	_	0	SENT_504	[p29l212t3195r270b3231],
4	decision	NN	O	decision	nn	5	SENT_504	[p29l285t3180r520b3231],
5	process	NN	O	process	conj_or	2	SENT_504	[p29l541t3195r754b3244],
6	for	IN	O	for	_	0	SENT_504	[p29l769t3179r848b3231],
7	this	DT	O	this	det	10	SENT_504	[p29l861t3180r963b3231],
8	artic	JJ	O	artic	amod	10	SENT_504	[p29l980t3180r1284b3231],
9	|	NN	O	|	nn	10	SENT_504	[p29l980t3180r1284b3231],
10	e.	NN	O	e.	prep_for	5	SENT_504	[p29l980t3180r1284b3231],
11	The	DT	O	the	det	13	SENT_504	[p29l980t3180r1284b3231],
12	other	JJ	O	other	amod	13	SENT_504	[p29l1301t3180r1455b3231],
13	authors	NNS	O	author	dep	5	SENT_504	[p29l1469t3180r1686b3231],
14	declared	VBD	O	declare	_	0	SENT_504	[p29l1703t3180r1947b3231],
15	no	DT	O	no	det	16	SENT_504	[p29l1968t3195r2038b3231],
16	conflict	NN	O	conflict	dobj	14	SENT_504	[p29l8t3264r220b3316],
17	of	IN	O	of	_	0	SENT_504	[p29l235t3264r294b3315],
18	interest	NN	O	interest	prep_of	16	SENT_504	[p29l307t3268r534b3316],
19	.	.	O	.	_	0	SENT_504	[p29l307t3268r534b3316],

1	©	RB	O	©	dep	2	SENT_505	[p29l8t3454r48b3495],
2	2014	CD	DATE	2014	dep	4	SENT_505	[p29l63t3453r194b3497],
3	American	NNP	ORGANIZATION	American	nn	4	SENT_505	[p29l207t3452r462b3497],
4	Society	NNP	ORGANIZATION	Society	_	0	SENT_505	[p29l480t3452r675b3510],
5	for	IN	ORGANIZATION	for	_	0	SENT_505	[p29l687t3449r760b3497],
6	Clinical	JJ	ORGANIZATION	clinical	amod	7	SENT_505	[p29l774t3450r963b3497],
7	Pharmacology	NN	ORGANIZATION	pharmacology	prep_for	4	SENT_505	[p29l984t3450r1370b3510],
8	and	CC	ORGANIZATION	and	_	0	SENT_505	[p29l1384t3450r1482b3497],
9	Therapeutics	NNS	ORGANIZATION	therapeutics	prep_for	4	SENT_505	[p29l1494t3450r1843b3509],

1	P	NN	O	p	_	0	SENT_506	[p30l9t458r50b505],
2	”	SYM	O	”	dep	1	SENT_506	[p30l9t458r50b505],

1	Ma	NNP	O	Ma	nn	3	SENT_507	[p30l131t66r706b124],
2	|	CD	NUMBER	|	num	3	SENT_507	[p30l131t66r706b124],
3	ik	NN	O	ik	_	0	SENT_507	[p30l131t66r706b124],
4	,	,	O	,	_	0	SENT_507	[p30l131t66r706b124],
5	V.S.	NNP	LOCATION	V.S.	appos	3	SENT_507	[p30l131t66r706b124],
6	,	,	O	,	_	0	SENT_507	[p30l131t66r706b124],
7	Wi	NNP	O	Wi	nsubj	8	SENT_507	[p30l131t66r706b124],
8	|	VBD	O	|	dep	3	SENT_507	[p30l131t66r706b124],
9	|	CD	NUMBER	|	num	10	SENT_507	[p30l131t66r706b124],
10	ett	NN	O	ett	dobj	8	SENT_507	[p30l131t66r706b124],
11	,	,	O	,	_	0	SENT_507	[p30l131t66r706b124],
12	W.C.	NNP	O	W.C.	appos	3	SENT_507	[p30l131t66r706b124],
13	&	CC	O	&	_	0	SENT_507	[p30l721t68r757b116],
14	Hu	NNP	O	Hu	conj_and	12	SENT_507	[p30l773t69r856b124],
15	,	,	O	,	_	0	SENT_507	[p30l773t69r856b124],
16	F.B.	NNP	O	F.B.	nn	18	SENT_507	[p30l873t68r951b116],
17	Global	NNP	O	Global	nn	18	SENT_507	[p30l965t66r1132b116],
18	obesity	NN	O	obesity	appos	3	SENT_507	[p30l1149t66r1354b130],
19	:	:	O	:	_	0	SENT_507	[p30l1149t66r1354b130],
20	trends	NNS	O	trend	dep	3	SENT_507	[p30l1367t66r1546b124],
21	,	,	O	,	_	0	SENT_507	[p30l1367t66r1546b124],
22	riskfactors	NNS	O	riskfactor	conj_and	20	SENT_507	[p30l1563t66r1838b116],
23	and	CC	O	and	_	0	SENT_507	[p30l1853t66r1949b116],
24	policy	NN	O	policy	nn	25	SENT_507	[p30l1967t66r2124b130],
25	implications	NNS	O	implication	conj_and	20	SENT_507	[p30l133t144r463b207],
26	.	.	O	.	_	0	SENT_507	[p30l133t144r463b207],

1	Nat	NN	PERSON	nat	_	0	SENT_508	[p30l478t147r579b194],
2	.	.	O	.	_	0	SENT_508	[p30l478t147r579b194],

1	Rev.	NNP	O	Rev.	nn	2	SENT_509	[p30l593t146r689b194],
2	Endocrinol	NNP	PERSON	Endocrinol	_	0	SENT_509	[p30l704t144r988b194],
3	.	.	O	.	_	0	SENT_509	[p30l704t144r988b194],

1	9	CD	NUMBER	9	_	0	SENT_510	[p30l1002t148r1047b202],
2	,	,	O	,	_	0	SENT_510	[p30l1002t148r1047b202],
3	13-27	CD	NUMBER	13-27	number	4	SENT_510	[p30l1065t147r1219b194],
4	(	CD	NUMBER	(	appos	1	SENT_510	[p30l1236t145r1410b202],
5	2013	CD	DATE	2013	num	6	SENT_510	[p30l1236t145r1410b202],
6	)	NN	O	)	dep	4	SENT_510	[p30l1236t145r1410b202],
7	.	.	O	.	_	0	SENT_510	[p30l1236t145r1410b202],

1	Wang	NNP	PERSON	Wang	_	0	SENT_511	[p30l128t225r291b285],
2	,	,	O	,	_	0	SENT_511	[p30l128t225r291b285],
3	Y.C.	NNP	O	Y.C.	conj_and	1	SENT_511	[p30l302t224r404b280],
4	,	,	O	,	_	0	SENT_511	[p30l302t224r404b280],
5	McPherson	NNP	PERSON	McPherson	conj_and	1	SENT_511	[p30l419t222r724b280],
6	,	,	O	,	_	0	SENT_511	[p30l419t222r724b280],
7	K.	NNP	O	K.	conj_and	1	SENT_511	[p30l741t225r797b280],
8	,	,	O	,	_	0	SENT_511	[p30l741t225r797b280],
9	Marsh	NNP	PERSON	Marsh	conj_and	1	SENT_511	[p30l812t222r1046b280],
10	,	,	O	,	_	0	SENT_511	[p30l812t222r1046b280],
11	T.	NNP	O	T.	conj_and	1	SENT_511	[p30l812t222r1046b280],
12	,	,	O	,	_	0	SENT_511	[p30l812t222r1046b280],
13	Gortmaker	NNP	PERSON	Gortmaker	conj_and	1	SENT_511	[p30l1060t222r1352b280],
14	,	,	O	,	_	0	SENT_511	[p30l1060t222r1352b280],
15	S.L.	NNP	PERSON	S.L.	conj_and	1	SENT_511	[p30l1367t224r1450b272],
16	&	CC	PERSON	&	_	0	SENT_511	[p30l1464t224r1501b272],
17	Brown	NNP	PERSON	Brown	conj_and	1	SENT_511	[p30l1516t224r1695b280],
18	,	,	O	,	_	0	SENT_511	[p30l1516t224r1695b280],
19	M.	NNP	PERSON	M.	nn	20	SENT_511	[p30l1710t225r1770b272],
20	Health	NNP	PERSON	Health	appos	1	SENT_511	[p30l1786t222r1953b272],
21	and	CC	O	and	_	0	SENT_511	[p30l1970t222r2066b272],
22	economic	JJ	O	economic	amod	23	SENT_511	[p30l131t303r390b350],
23	burden	NN	O	burden	appos	1	SENT_511	[p30l406t300r592b350],
24	of	IN	O	of	_	0	SENT_511	[p30l609t300r663b350],
25	the	DT	O	the	det	28	SENT_511	[p30l672t300r757b350],
26	projected	VBN	O	project	amod	28	SENT_511	[p30l774t300r1022b363],
27	obesity	NN	O	obesity	nn	28	SENT_511	[p30l1039t300r1231b364],
28	trends	NNS	O	trend	prep_of	23	SENT_511	[p30l1243t300r1409b350],
29	in	IN	O	in	_	0	SENT_511	[p30l1426t303r1468b349],
30	the	DT	O	the	det	31	SENT_511	[p30l1484t300r1570b350],
31	USA	NNP	LOCATION	USA	prep_in	28	SENT_511	[p30l1586t302r1692b350],
32	and	CC	O	and	_	0	SENT_511	[p30l1706t300r1802b350],
33	the	DT	O	the	det	34	SENT_511	[p30l1817t300r1903b350],
34	UK	NNP	LOCATION	UK	conj_and	31	SENT_511	[p30l1920t303r2004b350],
35	.	.	O	.	_	0	SENT_511	[p30l1920t303r2004b350],

1	Lancet	NNP	O	Lancet	_	0	SENT_512	[p30l131t380r301b426],
2	378	CD	NUMBER	378	num	1	SENT_512	[p30l312t380r427b434],
3	,	,	O	,	_	0	SENT_512	[p30l312t380r427b434],
4	81	CD	NUMBER	81	num	1	SENT_512	[p30l441t380r493b426],
5	5-825	CD	NUMBER	5-825	num	6	SENT_512	[p30l507t380r664b426],
6	(	NN	O	(	dep	1	SENT_512	[p30l682t378r782b434],
7	201	CD	NUMBER	201	number	8	SENT_512	[p30l682t378r782b434],
8	1	CD	NUMBER	1	num	9	SENT_512	[p30l801t378r856b434],
9	)	NN	O	)	dep	6	SENT_512	[p30l801t378r856b434],
10	.	.	O	.	_	0	SENT_512	[p30l801t378r856b434],

1	Kopelman	NNP	PERSON	Kopelman	_	0	SENT_513	[p30l132t455r411b518],
2	,	,	O	,	_	0	SENT_513	[p30l132t455r411b518],
3	PG	NNP	O	PG	appos	1	SENT_513	[p30l428t457r513b505],
4	.	.	O	.	_	0	SENT_513	[p30l428t457r513b505],

1	Obesity	NN	O	obesity	_	0	SENT_514	[p30l528t455r729b519],
2	as	IN	O	as	_	0	SENT_514	[p30l742t470r794b505],
3	a	DT	O	a	det	5	SENT_514	[p30l808t470r834b505],
4	medical	JJ	O	medical	amod	5	SENT_514	[p30l852t455r1054b505],
5	problem	NN	O	problem	prep_as	1	SENT_514	[p30l1073t455r1307b518],
6	.	.	O	.	_	0	SENT_514	[p30l1073t455r1307b518],

1	Nature	NNP	O	Nature	_	0	SENT_515	[p30l1321t458r1495b505],
2	404	CD	NUMBER	404	num	1	SENT_515	[p30l1507t458r1623b513],
3	,	,	O	,	_	0	SENT_515	[p30l1507t458r1623b513],
4	635-643	CD	NUMBER	635-643	num	1	SENT_515	[p30l1637t458r1859b505],
5	(	CD	NUMBER	(	num	7	SENT_515	[p30l1878t456r2052b513],
6	2000	CD	DATE	2000	num	7	SENT_515	[p30l1878t456r2052b513],
7	)	NN	O	)	dep	1	SENT_515	[p30l1878t456r2052b513],
8	.	.	O	.	_	0	SENT_515	[p30l1878t456r2052b513],

1	AMA	NNP	ORGANIZATION	AMA	nsubj	2	SENT_516	[p30l129t536r255b582],
2	Adopts	VBZ	O	adopt	_	0	SENT_516	[p30l268t533r456b596],
3	New	NNP	O	New	nn	4	SENT_516	[p30l474t536r589b583],
4	Policies	NNS	O	policy	dobj	2	SENT_516	[p30l605t533r796b583],
5	on	IN	O	on	_	0	SENT_516	[p30l810t548r875b583],
6	Second	JJ	ORDINAL	second	amod	8	SENT_516	[p30l892t533r1083b583],
7	Day	NN	DURATION	day	nn	8	SENT_516	[p30l1103t535r1201b597],
8	ofVoting	NN	O	ofvoting	prep_on	2	SENT_516	[p30l1213t533r1444b596],
9	at	IN	O	at	_	0	SENT_516	[p30l1461t541r1509b583],
10	Annual	JJ	SET	annual	prep_at	8	SENT_516	[p30l1523t533r1707b583],
11	Meeting	VBG	O	meet	partmod	10	SENT_516	[p30l1725t536r1954b596],
12	.	.	O	.	_	0	SENT_516	[p30l1725t536r1954b596],

1	(	RB	O	(	dep	3	SENT_517	[p30l1108t690r1282b747],
2	2013	CD	DATE	2013	num	3	SENT_517	[p30l1108t690r1282b747],
3	)	CD	NUMBER	)	_	0	SENT_517	[p30l1108t690r1282b747],
4	.	.	O	.	_	0	SENT_517	[p30l1108t690r1282b747],

1	Kim	NNP	PERSON	Kim	_	0	SENT_518	[p30l132t769r245b823],
2	,	,	O	,	_	0	SENT_518	[p30l132t769r245b823],
3	G.W.	NNP	O	G.W.	conj_and	1	SENT_518	[p30l261t768r392b823],
4	,	,	O	,	_	0	SENT_518	[p30l261t768r392b823],
5	Lin	NNP	PERSON	Lin	conj_and	1	SENT_518	[p30l411t769r501b823],
6	,	,	O	,	_	0	SENT_518	[p30l411t769r501b823],
7	J.E.	NNP	PERSON	J.E.	conj_and	1	SENT_518	[p30l515t769r609b823],
8	,	,	O	,	_	0	SENT_518	[p30l515t769r609b823],
9	Blomain	NNP	LOCATION	Blomain	conj_and	1	SENT_518	[p30l629t766r860b823],
10	,	,	O	,	_	0	SENT_518	[p30l629t766r860b823],
11	E.S.	NNP	ORGANIZATION	E.S.	conj_and	1	SENT_518	[p30l879t768r964b815],
12	&	CC	ORGANIZATION	&	_	0	SENT_518	[p30l980t766r1298b823],
13	Wa	NNP	ORGANIZATION	Wa	conj_and	1	SENT_518	[p30l980t766r1298b823],
14	|	CD	NUMBER	|	num	15	SENT_518	[p30l980t766r1298b823],
15	dman	NN	O	dman	dep	1	SENT_518	[p30l980t766r1298b823],
16	,	,	O	,	_	0	SENT_518	[p30l980t766r1298b823],
17	S.A.	NNP	O	S.A.	nn	19	SENT_518	[p30l1315t768r1410b815],
18	New	NNP	O	New	nn	19	SENT_518	[p30l1429t769r1547b815],
19	advances	NNS	O	advance	appos	1	SENT_518	[p30l1562t766r1813b815],
20	in	IN	O	in	_	0	SENT_518	[p30l1831t769r1875b815],
21	models	NNS	O	model	prep_in	19	SENT_518	[p30l1895t766r2090b815],
22	and	CC	O	and	_	0	SENT_518	[p30l131t844r229b894],
23	strategies	NNS	O	strategy	conj_and	21	SENT_518	[p30l248t847r508b907],
24	for	IN	O	for	_	0	SENT_518	[p30l524t844r598b894],
25	developing	VBG	O	develop	amod	29	SENT_518	[p30l613t844r918b907],
26	anti	JJ	O	anti	amod	29	SENT_518	[p30l936t844r1261b908],
27	—	NN	O	—	nn	29	SENT_518	[p30l936t844r1261b908],
28	obesity	NN	O	obesity	nn	29	SENT_518	[p30l936t844r1261b908],
29	drugs	NNS	O	drug	prep_for	21	SENT_518	[p30l1276t844r1442b907],
30	.	.	O	.	_	0	SENT_518	[p30l1276t844r1442b907],

1	Expert	NN	O	expert	_	0	SENT_519	[p30l1458t847r1625b907],
2	Opin	NN	PERSON	opin	dep	1	SENT_519	[p30l1636t846r1772b907],
3	.	.	O	.	_	0	SENT_519	[p30l1636t846r1772b907],

1	Drug	NN	O	drug	_	0	SENT_520	[p30l1788t846r1917b907],
2	Discov	NNP	O	Discov	dep	1	SENT_520	[p30l1931t846r2114b894],
3	.	.	O	.	_	0	SENT_520	[p30l1931t846r2114b894],

1	8	CD	NUMBER	8	_	0	SENT_521	[p30l131t924r176b978],
2	,	,	O	,	_	0	SENT_521	[p30l131t924r176b978],
3	655-671	CD	NUMBER	655-671	number	4	SENT_521	[p30l193t925r413b970],
4	(	CD	NUMBER	(	appos	1	SENT_521	[p30l441t922r621b978],
5	2013	CD	DATE	2013	num	6	SENT_521	[p30l441t922r621b978],
6	)	NN	O	)	dep	4	SENT_521	[p30l441t922r621b978],
7	.	.	O	.	_	0	SENT_521	[p30l441t922r621b978],

1	Obesity	NNP	ORGANIZATION	Obesity	nn	2	SENT_522	[p30l129t999r331b1063],
2	Society	NNP	ORGANIZATION	Society	nsubj	3	SENT_522	[p30l344t1001r535b1063],
3	supports	VBZ	O	support	_	0	SENT_522	[p30l548t1007r780b1062],
4	efforts	NNS	O	effort	nsubj	6	SENT_522	[p30l795t999r962b1049],
5	to	TO	O	to	aux	6	SENT_522	[p30l976t1007r1028b1049],
6	reduce	VB	O	reduce	xcomp	3	SENT_522	[p30l1045t999r1222b1049],
7	consumption	NN	O	consumption	dobj	6	SENT_522	[p30l1237t1002r1585b1062],
8	of	IN	O	of	_	0	SENT_522	[p30l1602t999r1656b1049],
9	sugar	NN	O	sugar	prep_of	7	SENT_522	[p30l1666t999r2117b1063],
10	—	CD	NUMBER	—	num	9	SENT_522	[p30l1666t999r2117b1063],
11	sweetened	VBN	O	sweeten	partmod	9	SENT_522	[p30l1666t999r2117b1063],
12	beverages	NNS	O	beverage	dobj	11	SENT_522	[p30l133t1077r413b1141],
13	.	.	O	.	_	0	SENT_522	[p30l133t1077r413b1141],

1	(	RB	O	(	dep	3	SENT_523	[p30l1707t1156r1881b1213],
2	2012	CD	DATE	2012	num	3	SENT_523	[p30l1707t1156r1881b1213],
3	)	CD	NUMBER	)	_	0	SENT_523	[p30l1707t1156r1881b1213],
4	.	.	O	.	_	0	SENT_523	[p30l1707t1156r1881b1213],

1	Robert	NNP	ORGANIZATION	Robert	nn	4	SENT_524	[p30l132t1233r307b1283],
2	Wood	NNP	ORGANIZATION	Wood	nn	4	SENT_524	[p30l317t1233r471b1283],
3	Johnson	NNP	ORGANIZATION	Johnson	nn	4	SENT_524	[p30l485t1233r706b1283],
4	Foundation	NNP	ORGANIZATION	Foundation	_	0	SENT_524	[p30l725t1233r1039b1283],
5	.	.	O	.	_	0	SENT_524	[p30l725t1233r1039b1283],

1	New	NNP	O	New	nn	2	SENT_525	[p30l1056t1236r1171b1283],
2	Report	NNP	O	Report	_	0	SENT_525	[p30l1187t1235r1375b1296],
3	:	:	O	:	_	0	SENT_525	[p30l1187t1235r1375b1296],
4	Adult	NN	O	adult	nn	6	SENT_525	[p30l1388t1233r1531b1283],
5	Obesity	NNP	O	Obesity	nn	6	SENT_525	[p30l1545t1233r1746b1297],
6	Rates	NNP	O	Rates	nsubj	7	SENT_525	[p30l1762t1235r1898b1283],
7	Hold	VB	O	hold	dep	2	SENT_525	[p30l1915t1233r2034b1283],
8	Steady	NNP	O	Steady	dep	11	SENT_525	[p30l131t1311r309b1375],
9	But	CC	O	but	advmod	11	SENT_525	[p30l324t1313r409b1361],
10	Remain	NNP	O	Remain	nn	11	SENT_525	[p30l426t1313r618b1361],
11	High	NNP	O	High	dep	7	SENT_525	[p30l637t1311r772b1375],
12	.	.	O	.	_	0	SENT_525	[p30l637t1311r772b1375],

1	(	RB	O	(	dep	3	SENT_526	[p30l757t1468r931b1525],
2	2013	CD	DATE	2013	num	3	SENT_526	[p30l757t1468r931b1525],
3	)	CD	NUMBER	)	_	0	SENT_526	[p30l757t1468r931b1525],
4	.	.	O	.	_	0	SENT_526	[p30l757t1468r931b1525],

1	DeMaria	NNP	PERSON	DeMaria	_	0	SENT_527	[p30l132t1548r362b1603],
2	,	,	O	,	_	0	SENT_527	[p30l132t1548r362b1603],
3	E.J.	NNP	O	E.J.	nn	5	SENT_527	[p30l379t1548r452b1595],
4	Bariatric	JJ	O	bariatric	amod	5	SENT_527	[p30l469t1547r680b1595],
5	surgery	NN	O	surgery	appos	1	SENT_527	[p30l694t1560r892b1609],
6	for	IN	O	for	_	0	SENT_527	[p30l903t1545r976b1595],
7	morbid	JJ	O	morbid	amod	8	SENT_527	[p30l991t1545r1179b1595],
8	obesity	NN	O	obesity	prep_for	5	SENT_527	[p30l1196t1545r1397b1609],
9	.	.	O	.	_	0	SENT_527	[p30l1196t1545r1397b1609],

1	N.	NNP	O	N.	nn	2	SENT_528	[p30l1411t1548r1459b1595],
2	Engl	NNP	O	Engl	_	0	SENT_528	[p30l1474t1545r1592b1609],
3	.	.	O	.	_	0	SENT_528	[p30l1474t1545r1592b1609],

1	J.	NNP	O	J.	nn	2	SENT_529	[p30l1603t1548r1637b1595],
2	Med	NNP	O	Med	_	0	SENT_529	[p30l1651t1545r1774b1595],
3	.	.	O	.	_	0	SENT_529	[p30l1651t1545r1774b1595],

1	356	CD	NUMBER	356	_	0	SENT_530	[p30l1788t1549r1903b1603],
2	,	,	O	,	_	0	SENT_530	[p30l1788t1549r1903b1603],
3	2176-2183	CD	DATE	2176-2183	number	4	SENT_530	[p30l131t1626r419b1672],
4	(	CD	NUMBER	(	appos	1	SENT_530	[p30l436t1623r610b1679],
5	2007	CD	DATE	2007	num	6	SENT_530	[p30l436t1623r610b1679],
6	)	NN	O	)	dep	4	SENT_530	[p30l436t1623r610b1679],
7	.	.	O	.	_	0	SENT_530	[p30l436t1623r610b1679],

1	Zimmet	NNP	PERSON	Zimmet	_	0	SENT_531	[p30l129t1703r348b1758],
2	,	,	O	,	_	0	SENT_531	[p30l129t1703r348b1758],
3	P.	NNP	O	P.	conj_and	1	SENT_531	[p30l364t1702r396b1750],
4	&	CC	O	&	_	0	SENT_531	[p30l410t1702r447b1750],
5	Alberti	NNP	PERSON	Alberti	conj_and	1	SENT_531	[p30l459t1700r649b1758],
6	,	,	O	,	_	0	SENT_531	[p30l459t1700r649b1758],
7	K.G.	NNP	O	K.G.	nn	8	SENT_531	[p30l666t1702r762b1750],
8	Surgery	NNP	O	Surgery	appos	1	SENT_531	[p30l777t1702r981b1764],
9	or	CC	O	or	_	0	SENT_531	[p30l994t1715r1047b1750],
10	medical	JJ	O	medical	amod	11	SENT_531	[p30l1062t1700r1264b1750],
11	therapy	NN	O	therapy	appos	1	SENT_531	[p30l1280t1700r1484b1764],
12	for	IN	O	for	_	0	SENT_531	[p30l1495t1700r1568b1750],
13	obese	JJ	O	obese	amod	14	SENT_531	[p30l1581t1700r1737b1750],
14	patients	NNS	O	patient	prep_for	11	SENT_531	[p30l1754t1703r1963b1763],
15	with	IN	O	with	_	0	SENT_531	[p30l1977t1700r2090b1750],
16	type	NN	O	type	nn	18	SENT_531	[p30l130t1786r247b1842],
17	2	CD	NUMBER	2	num	18	SENT_531	[p30l261t1782r289b1827],
18	diabetes	NN	O	diabetes	prep_with	14	SENT_531	[p30l305t1778r553b1828],
19	?	.	O	?	_	0	SENT_531	[p30l305t1778r553b1828],

1	N.	NNP	O	N.	nn	2	SENT_532	[p30l567t1781r616b1828],
2	Engl	NNP	O	Engl	_	0	SENT_532	[p30l630t1778r749b1842],
3	.	.	O	.	_	0	SENT_532	[p30l630t1778r749b1842],

1	J.	NNP	O	J.	nn	2	SENT_533	[p30l760t1781r794b1828],
2	Med	NNP	O	Med	_	0	SENT_533	[p30l808t1778r930b1828],
3	.	.	O	.	_	0	SENT_533	[p30l808t1778r930b1828],

1	366	CD	NUMBER	366	_	0	SENT_534	[p30l945t1782r1060b1836],
2	,	,	O	,	_	0	SENT_534	[p30l945t1782r1060b1836],
3	1635-1636	CD	DATE	1635-1636	number	4	SENT_534	[p30l1079t1782r1364b1828],
4	(	CD	NUMBER	(	appos	1	SENT_534	[p30l1380t1779r1554b1836],
5	2012	CD	DATE	2012	num	6	SENT_534	[p30l1380t1779r1554b1836],
6	)	NN	O	)	dep	4	SENT_534	[p30l1380t1779r1554b1836],
7	.	.	O	.	_	0	SENT_534	[p30l1380t1779r1554b1836],

1	Connolly	NNP	PERSON	Connolly	_	0	SENT_535	[p30l129t1856r373b1920],
2	,	,	O	,	_	0	SENT_535	[p30l129t1856r373b1920],
3	H.M.	NNP	PERSON	H.M.	nn	4	SENT_535	[p30l389t1859r502b1906],
4	etal	NNP	O	etal	appos	1	SENT_535	[p30l516t1856r631b1906],
5	.	.	O	.	_	0	SENT_535	[p30l516t1856r631b1906],

1	Valvular	JJ	O	valvular	amod	3	SENT_536	[p30l641t1856r852b1906],
2	heart	NN	O	heart	nn	3	SENT_536	[p30l867t1856r1003b1906],
3	disease	NN	O	disease	nsubj	4	SENT_536	[p30l1017t1856r1208b1906],
4	associated	VBN	O	associate	_	0	SENT_536	[p30l1223t1856r1495b1906],
5	with	IN	O	with	_	0	SENT_536	[p30l1510t1856r1624b1906],
6	fenﬂuramine	NN	O	fenﬂuramine	nn	8	SENT_536	[p30l1639t1856r1998b1906],
7	—	CD	NUMBER	—	num	8	SENT_536	[p30l1639t1856r1998b1906],
8	phentermine	NN	O	phentermine	prep_with	4	SENT_536	[p30l133t1934r486b1997],
9	.	.	O	.	_	0	SENT_536	[p30l133t1934r486b1997],

1	N.	NNP	O	N.	nn	2	SENT_537	[p30l501t1937r548b1984],
2	Engl	NNP	O	Engl	_	0	SENT_537	[p30l563t1934r863b1998],
3	.	.	O	.	_	0	SENT_537	[p30l563t1934r863b1998],

1	J.	NNP	O	J.	nn	2	SENT_538	[p30l563t1934r863b1998],
2	Med	NNP	O	Med	_	0	SENT_538	[p30l563t1934r863b1998],
3	.	.	O	.	_	0	SENT_538	[p30l563t1934r863b1998],

1	337	CD	NUMBER	337	_	0	SENT_539	[p30l878t1938r993b1992],
2	,	,	O	,	_	0	SENT_539	[p30l878t1938r993b1992],
3	581-588	CD	NUMBER	581-588	number	4	SENT_539	[p30l1008t1938r1231b1984],
4	(	CD	NUMBER	(	appos	1	SENT_539	[p30l1248t1935r1422b1992],
5	1997	CD	DATE	1997	num	6	SENT_539	[p30l1248t1935r1422b1992],
6	)	NN	O	)	dep	4	SENT_539	[p30l1248t1935r1422b1992],
7	.	.	O	.	_	0	SENT_539	[p30l1248t1935r1422b1992],

1	Asher	NNP	PERSON	Asher	_	0	SENT_540	[p30l129t2012r287b2070],
2	,	,	O	,	_	0	SENT_540	[p30l129t2012r287b2070],
3	W.L.	NNP	O	W.L.	nn	5	SENT_540	[p30l297t2015r402b2062],
4	Mortality	NNP	O	Mortality	nn	5	SENT_540	[p30l417t2012r656b2076],
5	rate	NN	O	rate	appos	1	SENT_540	[p30l670t2020r768b2062],
6	in	IN	O	in	_	0	SENT_540	[p30l784t2015r827b2061],
7	patients	NNS	O	patient	prep_in	5	SENT_540	[p30l845t2015r1055b2075],
8	receiving	VBG	O	receive	partmod	7	SENT_540	[p30l1071t2012r1436b2076],
9	"	''	O	"	punct	8	SENT_540	[p30l1071t2012r1436b2076],
10	diet	NN	O	diet	dobj	8	SENT_540	[p30l1071t2012r1436b2076],
11	pi	NN	O	pi	prep	8	SENT_540	[p30l1452t2012r1580b2075],
12	|	NN	O	|	nn	16	SENT_540	[p30l1452t2012r1580b2075],
13	|	CD	NUMBER	|	num	16	SENT_540	[p30l1452t2012r1580b2075],
14	s.	NN	O	s.	nn	16	SENT_540	[p30l1452t2012r1580b2075],
15	”	NN	O	”	nn	16	SENT_540	[p30l1452t2012r1580b2075],
16	Curr	NN	O	curr	dep	11	SENT_540	[p30l1589t2014r1702b2062],
17	.	.	O	.	_	0	SENT_540	[p30l1589t2014r1702b2062],

1	Ther	NNP	O	Ther	_	0	SENT_541	[p30l1719t2012r1835b2062],
2	.	.	O	.	_	0	SENT_541	[p30l1719t2012r1835b2062],

1	Res	NNP	O	Res	_	0	SENT_542	[p30l1850t2014r1943b2062],
2	.	.	O	.	_	0	SENT_542	[p30l1850t2014r1943b2062],

1	Clin	NNP	O	Clin	_	0	SENT_543	[p30l1958t2012r2063b2062],
2	.	.	O	.	_	0	SENT_543	[p30l1958t2012r2063b2062],

1	Exp	NN	O	exp	_	0	SENT_544	[p30l130t2092r231b2151],
2	.	.	O	.	_	0	SENT_544	[p30l130t2092r231b2151],

1	14	CD	NUMBER	14	_	0	SENT_545	[p30l249t2093r326b2146],
2	,	,	O	,	_	0	SENT_545	[p30l249t2093r326b2146],
3	525-539	CD	NUMBER	525-539	num	6	SENT_545	[p30l340t2093r564b2139],
4	(	CD	NUMBER	(	num	6	SENT_545	[p30l580t2090r754b2146],
5	1972	CD	NUMBER	1972	num	6	SENT_545	[p30l580t2090r754b2146],
6	)	NNS	O	)	appos	1	SENT_545	[p30l580t2090r754b2146],
7	.	.	O	.	_	0	SENT_545	[p30l580t2090r754b2146],

1	Kernan	NNP	PERSON	Kernan	nn	3	SENT_546	[p30l132t2170r327b2225],
2	,	,	O	,	_	0	SENT_546	[p30l132t2170r327b2225],
3	W.N.	NNP	O	W.N.	dep	4	SENT_546	[p30l338t2170r454b2217],
4	etal	JJ	O	etal	_	0	SENT_546	[p30l468t2167r583b2217],
5	.	.	O	.	_	0	SENT_546	[p30l468t2167r583b2217],

1	Phenylpropanolamine	NN	O	phenylpropanolamine	_	0	SENT_547	[p30l600t2167r1183b2231],
2	and	CC	O	and	_	0	SENT_547	[p30l1198t2167r1294b2217],
3	the	DT	O	the	det	4	SENT_547	[p30l1309t2167r1395b2217],
4	risk	NN	O	risk	conj_and	1	SENT_547	[p30l1411t2167r1499b2217],
5	of	IN	O	of	_	0	SENT_547	[p30l1511t2167r1565b2217],
6	hemorrhagic	JJ	O	hemorrhagic	amod	7	SENT_547	[p30l1577t2167r1913b2231],
7	stroke	NN	O	stroke	prep_of	1	SENT_547	[p30l1928t2167r2099b2217],
8	.	.	O	.	_	0	SENT_547	[p30l1928t2167r2099b2217],

1	N.	NNP	O	N.	nn	2	SENT_548	[p30l130t2248r178b2295],
2	Engl	NNP	O	Engl	_	0	SENT_548	[p30l193t2245r311b2309],
3	.	.	O	.	_	0	SENT_548	[p30l193t2245r311b2309],

1	J.	NNP	O	J.	nn	2	SENT_549	[p30l322t2248r356b2295],
2	Med	NNP	O	Med	_	0	SENT_549	[p30l370t2245r493b2295],
3	.	.	O	.	_	0	SENT_549	[p30l370t2245r493b2295],

1	343	CD	NUMBER	343	_	0	SENT_550	[p30l507t2249r623b2303],
2	,	,	O	,	_	0	SENT_550	[p30l507t2249r623b2303],
3	1826-1832	CD	DATE	1826-1832	number	4	SENT_550	[p30l641t2249r926b2295],
4	(	CD	NUMBER	(	appos	1	SENT_550	[p30l943t2246r1117b2303],
5	2000	CD	DATE	2000	num	6	SENT_550	[p30l943t2246r1117b2303],
6	)	NN	O	)	dep	4	SENT_550	[p30l943t2246r1117b2303],
7	.	.	O	.	_	0	SENT_550	[p30l943t2246r1117b2303],

1	Haller	NNP	PERSON	Haller	nsubj	15	SENT_551	[p30l132t2322r289b2379],
2	,	,	O	,	_	0	SENT_551	[p30l132t2322r289b2379],
3	C.A.	NNP	ORGANIZATION	C.A.	nsubj	15	SENT_551	[p30l304t2324r402b2372],
4	&	CC	ORGANIZATION	&	_	0	SENT_551	[p30l416t2324r453b2372],
5	Benowitz	NNP	ORGANIZATION	Benowitz	conj_and	1	SENT_551	[p30l468t2324r722b2379],
6	,	,	O	,	_	0	SENT_551	[p30l468t2324r722b2379],
7	N.L.	NNP	O	N.L.	appos	1	SENT_551	[p30l738t2325r830b2372],
8	Adverse	JJ	O	adverse	amod	9	SENT_551	[p30l844t2322r1054b2372],
9	cardiovascular	JJ	O	cardiovascular	dep	7	SENT_551	[p30l1069t2322r1447b2372],
10	and	CC	O	and	_	0	SENT_551	[p30l1460t2322r1556b2372],
11	central	JJ	O	central	amod	14	SENT_551	[p30l1573t2322r1749b2372],
12	nervous	JJ	O	nervous	amod	14	SENT_551	[p30l1767t2337r1976b2372],
13	system	NN	O	system	nn	14	SENT_551	[p30l131t2408r310b2464],
14	events	NNS	O	event	conj_and	9	SENT_551	[p30l327t2408r498b2450],
15	associated	VBN	O	associate	_	0	SENT_551	[p30l512t2400r784b2450],
16	with	IN	O	with	_	0	SENT_551	[p30l800t2400r913b2450],
17	dietary	JJ	O	dietary	amod	18	SENT_551	[p30l930t2400r1114b2464],
18	supplements	NNS	O	supplement	prep_with	15	SENT_551	[p30l1127t2400r1469b2463],
19	containing	VBG	O	contain	partmod	18	SENT_551	[p30l1484t2403r1764b2464],
20	ephedra	NN	O	ephedron	nn	21	SENT_551	[p30l1780t2400r1997b2463],
21	alkaloids	NNS	O	alkaloid	dobj	19	SENT_551	[p30l131t2478r372b2528],
22	.	.	O	.	_	0	SENT_551	[p30l131t2478r372b2528],

1	N.	NNP	O	N.	nn	2	SENT_552	[p30l386t2481r434b2528],
2	Engl	NNP	O	Engl	_	0	SENT_552	[p30l449t2478r567b2542],
3	.	.	O	.	_	0	SENT_552	[p30l449t2478r567b2542],

1	J.	NNP	O	J.	nn	2	SENT_553	[p30l578t2481r612b2528],
2	Med	NNP	O	Med	_	0	SENT_553	[p30l626t2478r749b2528],
3	.	.	O	.	_	0	SENT_553	[p30l626t2478r749b2528],

1	343	CD	NUMBER	343	_	0	SENT_554	[p30l763t2482r878b2536],
2	,	,	O	,	_	0	SENT_554	[p30l763t2482r878b2536],
3	1833-1838	CD	DATE	1833-1838	number	4	SENT_554	[p30l897t2482r1182b2528],
4	(	CD	NUMBER	(	appos	1	SENT_554	[p30l1199t2479r1373b2536],
5	2000	CD	DATE	2000	num	6	SENT_554	[p30l1199t2479r1373b2536],
6	)	NN	O	)	dep	4	SENT_554	[p30l1199t2479r1373b2536],
7	.	.	O	.	_	0	SENT_554	[p30l1199t2479r1373b2536],

1	US	NNP	ORGANIZATION	US	nn	2	SENT_555	[p30l132t2558r198b2606],
2	Food	NNP	ORGANIZATION	Food	_	0	SENT_555	[p30l215t2557r342b2606],
3	and	CC	ORGANIZATION	and	_	0	SENT_555	[p30l358t2557r454b2606],
4	Drug	NNP	ORGANIZATION	Drug	nn	5	SENT_555	[p30l473t2559r599b2620],
5	Administration	NNP	ORGANIZATION	Administration	conj_and	2	SENT_555	[p30l614t2557r1020b2606],
6	.	.	O	.	_	0	SENT_555	[p30l614t2557r1020b2606],

1	FDA	NNP	ORGANIZATION	FDA	nn	4	SENT_556	[p30l1037t2559r1143b2606],
2	Drug	NNP	O	Drug	nn	4	SENT_556	[p30l1159t2559r1284b2620],
3	Safety	NNP	O	Safety	nn	4	SENT_556	[p30l1302t2556r1462b2620],
4	Communication	NNP	O	Communication	_	0	SENT_556	[p30l1475t2558r1912b2606],
5	:	:	O	:	_	0	SENT_556	[p30l1475t2558r1912b2606],
6	FDA	NNP	ORGANIZATION	FDA	nn	7	SENT_556	[p30l1929t2559r2035b2606],
7	Recommends	NNPS	O	Recommends	dep	4	SENT_556	[p30l133t2635r491b2684],
8	Against	IN	O	against	_	0	SENT_556	[p30l505t2637r703b2698],
9	the	DT	O	the	det	12	SENT_556	[p30l716t2635r802b2684],
10	Continued	JJ	O	continued	amod	12	SENT_556	[p30l816t2635r1091b2684],
11	Use	NN	O	use	nn	12	SENT_556	[p30l1109t2637r1201b2684],
12	ofMeridia	NN	O	ofmeridium	prep_against	7	SENT_556	[p30l1216t2634r1475b2684],
13	(	CD	NUMBER	(	num	15	SENT_556	[p30l1493t2635r1855b2692],
14	sibutramine	NN	O	sibutramine	nn	15	SENT_556	[p30l1493t2635r1855b2692],
15	)	NN	O	)	dep	7	SENT_556	[p30l1493t2635r1855b2692],
16	.	.	O	.	_	0	SENT_556	[p30l1493t2635r1855b2692],

1	(	RB	O	(	dep	3	SENT_557	[p30l1871t2636r2045b2692],
2	2010	CD	DATE	2010	num	3	SENT_557	[p30l1871t2636r2045b2692],
3	)	CD	NUMBER	)	_	0	SENT_557	[p30l1871t2636r2045b2692],
4	.	.	O	.	_	0	SENT_557	[p30l1871t2636r2045b2692],

1	Topol	NNP	PERSON	Topol	nn	4	SENT_558	[p30l127t2791r286b2853],
2	,	,	O	,	_	0	SENT_558	[p30l127t2791r286b2853],
3	E.J.	NNP	O	E.J.	appos	4	SENT_558	[p30l303t2793r376b2840],
4	etal.	NNP	O	etal.	_	0	SENT_558	[p30l390t2791r519b2848],
5	;	:	O	;	_	0	SENT_558	[p30l390t2791r519b2848],
6	CRESCENDO	NNP	O	CRESCENDO	nn	7	SENT_558	[p30l532t2792r859b2840],
7	Investigators	NNS	O	investigator	dep	4	SENT_558	[p30l877t2793r1223b2854],
8	.	.	O	.	_	0	SENT_558	[p30l877t2793r1223b2854],

1	Rimonabant	NNP	O	Rimonabant	_	0	SENT_559	[p30l1240t2791r1561b2840],
2	for	IN	O	for	_	0	SENT_559	[p30l1574t2790r1646b2840],
3	prevention	NN	O	prevention	prep_for	1	SENT_559	[p30l1661t2793r1944b2853],
4	of	IN	O	of	_	0	SENT_559	[p30l1961t2790r2015b2840],
5	cardiovascular	JJ	O	cardiovascular	amod	6	SENT_559	[p30l131t2868r508b2917],
6	events	NNS	O	event	nn	9	SENT_559	[p30l522t2875r693b2917],
7	(	JJ	O	(	amod	9	SENT_559	[p30l709t2869r1082b2924],
8	CRESCENDO	NN	O	crescendo	nn	9	SENT_559	[p30l709t2869r1082b2924],
9	)	NN	O	)	prep_of	3	SENT_559	[p30l709t2869r1082b2924],
10	:	:	O	:	_	0	SENT_559	[p30l709t2869r1082b2924],
11	a	DT	O	a	dep	1	SENT_559	[p30l1096t2882r1122b2917],
12	randomised	VBN	O	randomise	partmod	11	SENT_559	[p30l1140t2868r1465b2924],
13	,	,	O	,	_	0	SENT_559	[p30l1140t2868r1465b2924],
14	multicentre	NN	O	multicentre	appos	11	SENT_559	[p30l1481t2868r1795b2924],
15	,	,	O	,	_	0	SENT_559	[p30l1481t2868r1795b2924],
16	placebocontrolled	JJ	O	placebocontrolled	amod	17	SENT_559	[p30l1811t2868r2039b2929, p30l131t2945r397b2994],
17	trial	NN	O	trial	appos	14	SENT_559	[p30l412t2945r524b2994],
18	.	.	O	.	_	0	SENT_559	[p30l412t2945r524b2994],

1	Lancet	NNP	O	Lancet	_	0	SENT_560	[p30l538t2947r708b2994],
2	376	CD	NUMBER	376	num	1	SENT_560	[p30l719t2948r834b3001],
3	,	,	O	,	_	0	SENT_560	[p30l719t2948r834b3001],
4	51	CD	NUMBER	51	num	1	SENT_560	[p30l849t2949r900b2994],
5	7-523	CD	NUMBER	7-523	number	6	SENT_560	[p30l915t2948r1071b2994],
6	(	CD	NUMBER	(	dep	1	SENT_560	[p30l1089t2946r1263b3001],
7	2010	CD	DATE	2010	num	8	SENT_560	[p30l1089t2946r1263b3001],
8	)	NN	O	)	dep	6	SENT_560	[p30l1089t2946r1263b3001],
9	.	.	O	.	_	0	SENT_560	[p30l1089t2946r1263b3001],

1	European	JJ	ORGANIZATION	european	_	0	SENT_561	[p30l131t3025r378b3085],
2	Medicines	NNP	ORGANIZATION	Medicines	nn	3	SENT_561	[p30l396t3023r661b3072],
3	Agency	NNP	ORGANIZATION	Agency	dep	1	SENT_561	[p30l675t3025r883b3086],
4	.	.	O	.	_	0	SENT_561	[p30l675t3025r883b3086],

1	Withdrawal	NN	O	withdrawal	_	0	SENT_562	[p30l894t3023r1192b3072],
2	of	IN	O	of	_	0	SENT_562	[p30l1209t3022r1263b3072],
3	the	DT	O	the	det	6	SENT_562	[p30l1271t3023r1357b3072],
4	marketing	NN	O	marketing	nn	6	SENT_562	[p30l1374t3023r1639b3086],
5	authorisation	NN	O	authorisation	nn	6	SENT_562	[p30l1656t3023r2004b3072],
6	application	NN	O	application	prep_of	1	SENT_562	[p30l130t3101r422b3163],
7	for	IN	O	for	_	0	SENT_562	[p30l437t3100r510b3150],
8	Belviq	NNP	O	Belviq	prep_for	1	SENT_562	[p30l525t3101r680b3163],
9	(	CD	NUMBER	(	num	11	SENT_562	[p30l698t3101r999b3158],
10	lorcaserin	NN	O	lorcaserin	nn	11	SENT_562	[p30l698t3101r999b3158],
11	)	NN	O	)	dep	8	SENT_562	[p30l698t3101r999b3158],
12	.	.	O	.	_	0	SENT_562	[p30l698t3101r999b3158],

1	(	RB	O	(	dep	3	SENT_563	[p30l1015t3102r1189b3158],
2	2013	CD	DATE	2013	num	3	SENT_563	[p30l1015t3102r1189b3158],
3	)	CD	NUMBER	)	_	0	SENT_563	[p30l1015t3102r1189b3158],
4	.	.	O	.	_	0	SENT_563	[p30l1015t3102r1189b3158],

1	European	JJ	ORGANIZATION	european	_	0	SENT_564	[p30l131t3259r378b3319],
2	Medicines	NNP	ORGANIZATION	Medicines	nn	3	SENT_564	[p30l396t3257r661b3306],
3	Agency	NNP	ORGANIZATION	Agency	dep	1	SENT_564	[p30l675t3259r883b3320],
4	.	.	O	.	_	0	SENT_564	[p30l675t3259r883b3320],

1	Refusal	NN	O	refusal	_	0	SENT_565	[p30l900t3256r1082b3306],
2	of	IN	O	of	_	0	SENT_565	[p30l1099t3256r1153b3306],
3	the	DT	O	the	det	5	SENT_565	[p30l1161t3257r1247b3306],
4	marketing	NN	O	marketing	nn	5	SENT_565	[p30l1264t3257r1529b3320],
5	authorisation	NN	O	authorisation	prep_of	1	SENT_565	[p30l1545t3257r1894b3306],
6	for	IN	O	for	_	0	SENT_565	[p30l1909t3256r1982b3306],
7	Qsiva	NNP	O	Qsiva	dep	9	SENT_565	[p30l130t3335r270b3388],
8	(	CD	NUMBER	(	num	7	SENT_565	[p30l288t3334r994b3395],
9	phentermine/topiramate	JJ	O	phentermine/topiramate	amod	10	SENT_565	[p30l288t3334r994b3395],
10	)	NN	O	)	prep_for	1	SENT_565	[p30l288t3334r994b3395],
11	.	.	O	.	_	0	SENT_565	[p30l288t3334r994b3395],

1	(	RB	O	(	dep	3	SENT_566	[p30l1010t3335r1184b3390],
2	2013	CD	DATE	2013	num	3	SENT_566	[p30l1010t3335r1184b3390],
3	)	CD	NUMBER	)	_	0	SENT_566	[p30l1010t3335r1184b3390],
4	.	.	O	.	_	0	SENT_566	[p30l1010t3335r1184b3390],

1	Davidson	NNP	PERSON	Davidson	_	0	SENT_567	[p30l131t3568r388b3625],
2	,	,	O	,	_	0	SENT_567	[p30l131t3568r388b3625],
3	M.H.	NNP	O	M.H.	nn	4	SENT_567	[p30l404t3570r517b3617],
4	etal	NNP	O	etal	appos	1	SENT_567	[p30l531t3568r646b3617],
5	.	.	O	.	_	0	SENT_567	[p30l531t3568r646b3617],

1	Weight	NNP	O	Weight	nn	2	SENT_568	[p30l657t3568r846b3631],
2	control	NN	O	control	_	0	SENT_568	[p30l859t3568r1042b3617],
3	and	CC	O	and	_	0	SENT_568	[p30l1059t3568r1155b3617],
4	risk	NN	O	risk	nn	6	SENT_568	[p30l1174t3568r1261b3617],
5	factor	NN	O	factor	nn	6	SENT_568	[p30l1271t3567r1425b3617],
6	reduction	NN	O	reduction	conj_and	2	SENT_568	[p30l1440t3568r1691b3617],
7	in	IN	O	in	_	0	SENT_568	[p30l1709t3570r1751b3617],
8	obese	JJ	O	obese	amod	9	SENT_568	[p30l1768t3568r1924b3617],
9	subjects	NNS	O	subject	prep_in	2	SENT_568	[p30l131t3646r346b3709],
10	treated	VBN	O	treat	partmod	9	SENT_568	[p30l359t3646r546b3695],
11	for	IN	O	for	_	0	SENT_568	[p30l561t3645r633b3695],
12	2	CD	DURATION	2	num	13	SENT_568	[p30l647t3649r674b3695],
13	years	NNS	NUMBER	year	prep_for	10	SENT_568	[p30l688t3660r824b3709],
14	with	IN	O	with	_	0	SENT_568	[p30l837t3646r951b3695],
15	orlistatz	NN	O	orlistatz	prep_with	2	SENT_568	[p30l967t3646r1159b3695],
16	a	DT	O	a	dep	15	SENT_568	[p30l1174t3660r1199b3695],
17	randomized	VBN	O	randomize	partmod	2	SENT_568	[p30l1217t3646r1529b3695],
18	controlled	JJ	O	controlled	amod	19	SENT_568	[p30l1546t3646r1812b3695],
19	trial	NN	O	trial	dobj	17	SENT_568	[p30l1827t3646r2093b3695],
20	.	.	O	.	_	0	SENT_568	[p30l1827t3646r2093b3695],

1	JAMA	NN	O	jama	_	0	SENT_569	[p30l1827t3646r2093b3695],
2	281	CD	NUMBER	281	num	1	SENT_569	[p30l131t3726r246b3779],
3	,	,	O	,	_	0	SENT_569	[p30l131t3726r246b3779],
4	235-242	CD	NUMBER	235-242	number	5	SENT_569	[p30l260t3726r483b3772],
5	(	CD	NUMBER	(	appos	1	SENT_569	[p30l500t3724r674b3779],
6	1999	CD	DATE	1999	num	7	SENT_569	[p30l500t3724r674b3779],
7	)	NN	O	)	dep	5	SENT_569	[p30l500t3724r674b3779],
8	.	.	O	.	_	0	SENT_569	[p30l500t3724r674b3779],

1	Public	NNP	O	Public	nn	2	SENT_570	[p31l131t17r288b66],
2	Citizen	NNP	O	Citizen	_	0	SENT_570	[p31l302t18r492b66],
3	.	.	O	.	_	0	SENT_570	[p31l302t18r492b66],

1	Petition	NN	O	petition	nsubj	5	SENT_571	[p31l509t19r707b66],
2	to	TO	O	to	_	0	SENT_571	[p31l722t24r775b66],
3	Ban	NNP	O	Ban	nn	4	SENT_571	[p31l792t19r884b66],
4	Orlistat	NNP	O	Orlistat	prep_to	1	SENT_571	[p31l901t17r1090b66],
5	(	VBD	O	(	_	0	SENT_571	[p31l1105t17r1213b73],
6	Alli	NNP	PERSON	Alli	dobj	5	SENT_571	[p31l1105t17r1213b73],
7	,	,	O	,	_	0	SENT_571	[p31l1105t17r1213b73],
8	Xenical	NNP	O	Xenical	appos	6	SENT_571	[p31l1227t17r1447b73],
9	)	CD	NUMBER	)	num	8	SENT_571	[p31l1227t17r1447b73],
10	.	.	O	.	_	0	SENT_571	[p31l1227t17r1447b73],

1	(	NN	O	(	_	0	SENT_572	[p31l1462t18r1563b73],
2	201	CD	NUMBER	201	number	3	SENT_572	[p31l1462t18r1563b73],
3	1	CD	NUMBER	1	dep	1	SENT_572	[p31l1581t18r1637b73],
4	)	NN	O	)	dep	3	SENT_572	[p31l1581t18r1637b73],
5	.	.	O	.	_	0	SENT_572	[p31l1581t18r1637b73],

1	Song	NN	O	song	nsubj	9	SENT_573	[p31l129t174r275b236],
2	,	,	O	,	_	0	SENT_573	[p31l129t174r275b236],
3	B.M.	NNP	ORGANIZATION	B.M.	appos	1	SENT_573	[p31l291t175r397b222],
4	&	CC	ORGANIZATION	&	_	0	SENT_573	[p31l410t174r447b222],
5	Avery	NNP	ORGANIZATION	Avery	conj_and	3	SENT_573	[p31l459t175r619b236],
6	,	,	O	,	_	0	SENT_573	[p31l459t175r619b236],
7	L.	NNP	O	L.	nn	8	SENT_573	[p31l635t175r672b222],
8	Serotonin	NNP	O	Serotonin	appos	3	SENT_573	[p31l687t174r941b222],
9	activates	VBZ	O	activate	_	0	SENT_573	[p31l957t175r1187b222],
10	overall	JJ	O	overall	amod	11	SENT_573	[p31l1202t173r1373b222],
11	feeding	NN	O	feeding	dobj	9	SENT_573	[p31l1388t172r1587b236],
12	by	IN	O	by	_	0	SENT_573	[p31l1605t173r1667b236],
13	activating	VBG	O	activate	prepc_by	9	SENT_573	[p31l1680t175r1937b236],
14	two	CD	NUMBER	two	num	17	SENT_573	[p31l129t258r229b300],
15	separate	JJ	O	separate	amod	17	SENT_573	[p31l244t258r467b313],
16	neural	JJ	O	neural	amod	17	SENT_573	[p31l484t251r644b300],
17	pathways	NNS	O	pathway	dobj	13	SENT_573	[p31l663t251r910b314],
18	in	IN	O	in	_	0	SENT_573	[p31l927t253r969b300],
19	Caenorhabditis	NN	O	caenorhabditis	nn	20	SENT_573	[p31l987t251r1374b300],
20	eIegans	NNS	O	eiegan	prep_in	13	SENT_573	[p31l1386t251r1636b314],
21	.	.	O	.	_	0	SENT_573	[p31l1386t251r1636b314],

1	J.	NNP	PERSON	J.	nn	2	SENT_574	[p31l1386t251r1636b314],
2	Neurosci	NNP	PERSON	Neurosci	_	0	SENT_574	[p31l1651t253r1881b300],
3	.	.	O	.	_	0	SENT_574	[p31l1651t253r1881b300],

1	32	CD	NUMBER	32	_	0	SENT_575	[p31l1895t254r1975b308],
2	,	,	O	,	_	0	SENT_575	[p31l1895t254r1975b308],
3	1920-1931	CD	DATE	1920-1931	number	4	SENT_575	[p31l135t331r410b377],
4	(	CD	NUMBER	(	appos	1	SENT_575	[p31l436t329r610b384],
5	2012	CD	DATE	2012	num	6	SENT_575	[p31l436t329r610b384],
6	)	NN	O	)	dep	4	SENT_575	[p31l436t329r610b384],
7	.	.	O	.	_	0	SENT_575	[p31l436t329r610b384],

1	Fink	NNP	PERSON	Fink	_	0	SENT_576	[p31l131t406r248b463],
2	,	,	O	,	_	0	SENT_576	[p31l131t406r248b463],
3	K.B.	NNP	ORGANIZATION	K.B.	conj_and	1	SENT_576	[p31l265t408r354b456],
4	&	CC	ORGANIZATION	&	_	0	SENT_576	[p31l368t408r405b456],
5	Gothert	NNP	ORGANIZATION	Gothert	conj_and	1	SENT_576	[p31l417t406r635b463],
6	,	,	O	,	_	0	SENT_576	[p31l417t406r635b463],
7	M.	NNP	O	M.	nn	10	SENT_576	[p31l650t408r709b456],
8	5-HT	NN	O	5-ht	nn	10	SENT_576	[p31l725t408r848b456],
9	receptor	NN	O	receptor	nn	10	SENT_576	[p31l862t413r1082b468],
10	regulation	NN	O	regulation	appos	1	SENT_576	[p31l1097t406r1363b469],
11	of	IN	O	of	_	0	SENT_576	[p31l1380t405r1434b456],
12	neurotransmitter	NN	O	neurotransmitter	nn	13	SENT_576	[p31l1446t408r1894b456],
13	release	NN	O	release	prep_of	10	SENT_576	[p31l1909t406r2102b456],
14	.	.	O	.	_	0	SENT_576	[p31l1909t406r2102b456],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_577	[p31l130t483r415b532],
2	.	.	O	.	_	0	SENT_577	[p31l130t483r415b532],

1	Rev.	NNP	O	Rev.	_	0	SENT_578	[p31l430t485r530b532],
2	59	CD	NUMBER	59	num	1	SENT_578	[p31l545t486r624b539],
3	,	,	O	,	_	0	SENT_578	[p31l545t486r624b539],
4	360-41	CD	NUMBER	360-41	num	1	SENT_578	[p31l639t486r820b532],
5	7	CD	NUMBER	7	number	6	SENT_578	[p31l835t487r862b531],
6	(	CD	NUMBER	(	dep	1	SENT_578	[p31l879t484r1053b539],
7	2007	CD	DATE	2007	num	8	SENT_578	[p31l879t484r1053b539],
8	)	NN	O	)	dep	6	SENT_578	[p31l879t484r1053b539],
9	.	.	O	.	_	0	SENT_578	[p31l879t484r1053b539],

1	Yeo	NNP	PERSON	Yeo	_	0	SENT_579	[p31l127t563r233b618],
2	,	,	O	,	_	0	SENT_579	[p31l127t563r233b618],
3	G.S.	NNP	ORGANIZATION	G.S.	conj_and	1	SENT_579	[p31l247t563r342b611],
4	&	CC	ORGANIZATION	&	_	0	SENT_579	[p31l356t563r393b611],
5	Heisler	NNP	ORGANIZATION	Heisler	conj_and	1	SENT_579	[p31l408t561r593b618],
6	,	,	O	,	_	0	SENT_579	[p31l408t561r593b618],
7	L.K.	NNP	O	L.K.	nn	8	SENT_579	[p31l609t563r695b611],
8	Unraveling	NNP	O	Unraveling	appos	1	SENT_579	[p31l711t561r993b624],
9	the	DT	O	the	det	11	SENT_579	[p31l1008t561r1094b611],
10	brain	NN	O	brain	nn	11	SENT_579	[p31l1110t561r1240b611],
11	regulation	NN	O	regulation	dep	8	SENT_579	[p31l1258t561r1524b624],
12	of	IN	O	of	_	0	SENT_579	[p31l1541t560r1595b611],
13	appetite	NN	O	appetite	prep_of	11	SENT_579	[p31l1605t563r1838b623],
14	:	:	O	:	_	0	SENT_579	[p31l1605t563r1838b623],
15	lessons	NNS	O	lesson	dep	1	SENT_579	[p31l1854t561r2041b611],
16	from	IN	O	from	_	0	SENT_579	[p31l129t638r251b689],
17	genetics	NNS	O	genetics	prep_from	15	SENT_579	[p31l267t641r500b702],
18	.	.	O	.	_	0	SENT_579	[p31l267t641r500b702],

1	Nat	NN	PERSON	nat	_	0	SENT_580	[p31l514t641r615b689],
2	.	.	O	.	_	0	SENT_580	[p31l514t641r615b689],

1	Neurosci	NNP	PERSON	Neurosci	_	0	SENT_581	[p31l630t641r860b689],
2	.	.	O	.	_	0	SENT_581	[p31l630t641r860b689],

1	15	CD	NUMBER	15	_	0	SENT_582	[p31l878t643r954b696],
2	,	,	O	,	_	0	SENT_582	[p31l878t643r954b696],
3	1343-1349	CD	DATE	1343-1349	number	4	SENT_582	[p31l973t642r1258b689],
4	(	CD	NUMBER	(	appos	1	SENT_582	[p31l1275t640r1448b696],
5	2012	CD	DATE	2012	num	6	SENT_582	[p31l1275t640r1448b696],
6	)	NN	O	)	dep	4	SENT_582	[p31l1275t640r1448b696],
7	.	.	O	.	_	0	SENT_582	[p31l1275t640r1448b696],

1	Heisler	NNP	PERSON	Heisler	nn	3	SENT_583	[p31l131t717r315b774],
2	,	,	O	,	_	0	SENT_583	[p31l131t717r315b774],
3	L.K.	NNP	O	L.K.	_	0	SENT_583	[p31l332t719r418b766],
4	et	FW	O	et	nn	5	SENT_583	[p31l432t724r480b767],
5	al.	FW	O	al.	dep	3	SENT_583	[p31l489t717r547b766],
6	.	.	O	.	_	0	SENT_583	[p31l489t717r547b766],

1	Activation	NN	O	activation	_	0	SENT_584	[p31l560t719r825b767],
2	of	IN	O	of	_	0	SENT_584	[p31l842t716r896b766],
3	central	JJ	O	central	amod	5	SENT_584	[p31l906t717r1081b767],
4	melanocortin	NN	O	melanocortin	nn	5	SENT_584	[p31l1101t717r1450b767],
5	pathways	NNS	O	pathway	prep_of	1	SENT_584	[p31l1468t717r1716b780],
6	by	IN	O	by	_	0	SENT_584	[p31l1733t717r1795b780],
7	fenﬂuramine	NN	O	fenﬂuramine	prep_by	1	SENT_584	[p31l129t793r478b843],
8	.	.	O	.	_	0	SENT_584	[p31l129t793r478b843],

1	Science	NNP	O	Science	_	0	SENT_585	[p31l491t795r680b843],
2	297	CD	NUMBER	297	num	1	SENT_585	[p31l693t797r808b850],
3	,	,	O	,	_	0	SENT_585	[p31l693t797r808b850],
4	609-61	CD	NUMBER	609-61	num	1	SENT_585	[p31l822t797r1004b843],
5	1	CD	NUMBER	1	number	6	SENT_585	[p31l1022t798r1036b842],
6	(	CD	NUMBER	(	dep	1	SENT_585	[p31l1063t795r1237b850],
7	2002	CD	DATE	2002	num	8	SENT_585	[p31l1063t795r1237b850],
8	)	NN	O	)	dep	6	SENT_585	[p31l1063t795r1237b850],
9	.	.	O	.	_	0	SENT_585	[p31l1063t795r1237b850],

1	Heisler	NNP	PERSON	Heisler	_	0	SENT_586	[p31l131t872r316b929],
2	,	,	O	,	_	0	SENT_586	[p31l131t872r316b929],
3	L.K.	NNP	O	L.K.	nn	4	SENT_586	[p31l332t874r418b921],
4	etal	NN	O	etal	appos	1	SENT_586	[p31l432t872r547b921],
5	.	.	O	.	_	0	SENT_586	[p31l432t872r547b921],

1	Serotonin	NN	O	serotonin	nsubj	3	SENT_587	[p31l561t873r815b921],
2	reciprocally	RB	O	reciprocally	advmod	3	SENT_587	[p31l833t872r1134b936],
3	regulates	VBZ	O	regulate	_	0	SENT_587	[p31l1149t872r1389b935],
4	melanocortin	NN	O	melanocortin	nn	5	SENT_587	[p31l1406t872r1755b921],
5	neurons	NNS	O	neuron	nsubj	7	SENT_587	[p31l1774t886r1986b921],
6	to	TO	O	to	aux	7	SENT_587	[p31l1999t879r2052b921],
7	modulate	VB	O	modulate	xcomp	3	SENT_587	[p31l132t949r383b998],
8	food	NN	O	food	nn	9	SENT_587	[p31l396t948r516b998],
9	intake	NN	O	intake	dobj	7	SENT_587	[p31l534t949r703b998],
10	.	.	O	.	_	0	SENT_587	[p31l534t949r703b998],

1	Neuron	NN	O	neuron	_	0	SENT_588	[p31l718t951r903b998],
2	51	CD	NUMBER	51	num	1	SENT_588	[p31l919t953r998b1005],
3	,	,	O	,	_	0	SENT_588	[p31l919t953r998b1005],
4	239-249	CD	NUMBER	239-249	number	5	SENT_588	[p31l1013t952r1237b998],
5	(	CD	NUMBER	(	appos	1	SENT_588	[p31l1253t950r1427b1005],
6	2006	CD	DATE	2006	num	7	SENT_588	[p31l1253t950r1427b1005],
7	)	NN	O	)	dep	5	SENT_588	[p31l1253t950r1427b1005],
8	.	.	O	.	_	0	SENT_588	[p31l1253t950r1427b1005],

1	Fleming	NNP	PERSON	Fleming	nn	5	SENT_589	[p31l131t1027r353b1090],
2	,	,	O	,	_	0	SENT_589	[p31l131t1027r353b1090],
3	J.W.	NNP	PERSON	J.W.	appos	5	SENT_589	[p31l365t1029r475b1084],
4	,	,	O	,	_	0	SENT_589	[p31l365t1029r475b1084],
5	McC	NNP	O	McC	nsubj	6	SENT_589	[p31l491t1027r805b1084],
6	|	VBD	O	|	_	0	SENT_589	[p31l491t1027r805b1084],
7	endon	NN	O	endon	dobj	6	SENT_589	[p31l491t1027r805b1084],
8	,	,	O	,	_	0	SENT_589	[p31l491t1027r805b1084],
9	K.S.	NNP	ORGANIZATION	K.S.	dobj	6	SENT_589	[p31l821t1028r908b1077],
10	&	CC	ORGANIZATION	&	_	0	SENT_589	[p31l922t1029r959b1076],
11	Riche	NNP	ORGANIZATION	Riche	conj_and	9	SENT_589	[p31l974t1027r1126b1084],
12	,	,	O	,	_	0	SENT_589	[p31l974t1027r1126b1084],
13	D.M.	NNP	PERSON	D.M.	nn	14	SENT_589	[p31l1143t1029r1254b1076],
14	New	NNP	PERSON	New	conj_and	7	SENT_589	[p31l1271t1029r1387b1076],
15	obesity	NN	O	obesity	nn	16	SENT_589	[p31l1400t1027r1593b1090],
16	agents	NNS	O	agent	dep	14	SENT_589	[p31l1605t1034r1794b1090],
17	:	:	O	:	_	0	SENT_589	[p31l1605t1034r1794b1090],
18	lorcaserin	NN	O	lorcaserin	conj_and	7	SENT_589	[p31l1810t1027r2060b1076],
19	and	CC	O	and	_	0	SENT_589	[p31l130t1104r226b1153],
20	phentermine/topiramate	NN	O	phentermine/topiramate	conj_and	7	SENT_589	[p31l244t1104r914b1165],
21	.	.	O	.	_	0	SENT_589	[p31l244t1104r914b1165],

1	Ann	NNP	PERSON	Ann	_	0	SENT_590	[p31l925t1106r1041b1153],
2	.	.	O	.	_	0	SENT_590	[p31l925t1106r1041b1153],

1	Pharmacother	NNP	O	Pharmacother	_	0	SENT_591	[p31l1055t1104r1431b1153],
2	.	.	O	.	_	0	SENT_591	[p31l1055t1104r1431b1153],

1	47	CD	NUMBER	47	_	0	SENT_592	[p31l1445t1108r1526b1160],
2	,	,	O	,	_	0	SENT_592	[p31l1445t1108r1526b1160],
3	1007-1016	CD	DATE	1007-1016	number	4	SENT_592	[p31l1544t1107r1830b1153],
4	(	CD	NUMBER	(	appos	1	SENT_592	[p31l1846t1105r2020b1160],
5	2013	CD	DATE	2013	num	6	SENT_592	[p31l1846t1105r2020b1160],
6	)	NN	O	)	dep	4	SENT_592	[p31l1846t1105r2020b1160],
7	.	.	O	.	_	0	SENT_592	[p31l1846t1105r2020b1160],

1	Saudou	NNP	MISC	Saudou	_	0	SENT_593	[p31l129t1182r341b1239],
2	,	,	O	,	_	0	SENT_593	[p31l129t1182r341b1239],
3	F.	NNP	O	F.	nn	4	SENT_593	[p31l357t1184r389b1232],
4	etal	NNP	O	etal	appos	1	SENT_593	[p31l403t1182r518b1232],
5	.	.	O	.	_	0	SENT_593	[p31l403t1182r518b1232],

1	Enhanced	VBN	O	enhance	_	0	SENT_594	[p31l535t1182r791b1232],
2	aggressive	JJ	O	aggressive	amod	3	SENT_594	[p31l807t1184r1084b1245],
3	behavior	NN	O	behavior	dobj	1	SENT_594	[p31l1100t1182r1330b1232],
4	in	IN	O	in	_	0	SENT_594	[p31l1345t1184r1388b1231],
5	mice	NNS	O	mouse	prep_in	1	SENT_594	[p31l1406t1184r1528b1232],
6	lacking	VBG	O	lack	partmod	5	SENT_594	[p31l1545t1182r1728b1245],
7	5-HT1	NN	O	5-ht1	nn	9	SENT_594	[p31l1745t1184r1889b1232],
8	B	NN	O	b	nn	9	SENT_594	[p31l1905t1184r1933b1231],
9	receptor	NN	O	receptor	dobj	6	SENT_594	[p31l132t1266r360b1320],
10	.	.	O	.	_	0	SENT_594	[p31l132t1266r360b1320],

1	Science	NNP	O	Science	_	0	SENT_595	[p31l373t1260r562b1308],
2	265	CD	NUMBER	265	num	1	SENT_595	[p31l575t1262r690b1315],
3	,	,	O	,	_	0	SENT_595	[p31l575t1262r690b1315],
4	1875-1878	CD	DATE	1875-1878	num	1	SENT_595	[p31l709t1262r994b1308],
5	(	CD	NUMBER	(	num	7	SENT_595	[p31l1010t1260r1184b1315],
6	1994	CD	DATE	1994	num	7	SENT_595	[p31l1010t1260r1184b1315],
7	)	NN	O	)	dep	1	SENT_595	[p31l1010t1260r1184b1315],
8	.	.	O	.	_	0	SENT_595	[p31l1010t1260r1184b1315],

1	Xu	NNP	O	Xu	_	0	SENT_596	[p31l128t1339r208b1394],
2	,	,	O	,	_	0	SENT_596	[p31l128t1339r208b1394],
3	Y.	NNP	O	Y.	nn	4	SENT_596	[p31l218t1339r257b1386],
4	etal	NN	O	etal	appos	1	SENT_596	[p31l271t1337r386b1386],
5	.	.	O	.	_	0	SENT_596	[p31l271t1337r386b1386],

1	5-HT2CRs	NNS	O	5-ht2cr	nsubj	6	SENT_597	[p31l401t1338r651b1386],
2	expressed	VBN	O	express	partmod	1	SENT_597	[p31l666t1337r927b1399],
3	by	IN	O	by	_	0	SENT_597	[p31l946t1337r1007b1401],
4	pro-opiomelanocortin	JJ	O	pro-opiomelanocortin	amod	5	SENT_597	[p31l1022t1337r1606b1399],
5	neurons	NNS	O	neuron	agent	2	SENT_597	[p31l1624t1351r1836b1386],
6	regulate	VBP	O	regulate	_	0	SENT_597	[p31l1853t1337r2068b1400],
7	energy	NN	O	energy	nn	8	SENT_597	[p31l130t1429r313b1479],
8	homeostasis	NN	O	homeostasis	dobj	6	SENT_597	[p31l328t1415r667b1464],
9	.	.	O	.	_	0	SENT_597	[p31l328t1415r667b1464],

1	Neuron	NN	O	neuron	_	0	SENT_598	[p31l681t1417r866b1464],
2	60	CD	NUMBER	60	num	1	SENT_598	[p31l881t1418r961b1472],
3	,	,	O	,	_	0	SENT_598	[p31l881t1418r961b1472],
4	582-589	CD	NUMBER	582-589	number	5	SENT_598	[p31l976t1418r1200b1465],
5	(	CD	NUMBER	(	appos	1	SENT_598	[p31l1216t1416r1390b1472],
6	2008	CD	DATE	2008	num	7	SENT_598	[p31l1216t1416r1390b1472],
7	)	NN	O	)	dep	5	SENT_598	[p31l1216t1416r1390b1472],
8	.	.	O	.	_	0	SENT_598	[p31l1216t1416r1390b1472],

1	Wu	NNP	O	Wu	_	0	SENT_599	[p31l127t1495r225b1550],
2	,	,	O	,	_	0	SENT_599	[p31l127t1495r225b1550],
3	Q.	NNP	O	Q.	conj_and	1	SENT_599	[p31l239t1494r304b1550],
4	,	,	O	,	_	0	SENT_599	[p31l239t1494r304b1550],
5	Clark	NNP	PERSON	Clark	conj_and	1	SENT_599	[p31l318t1493r461b1550],
6	,	,	O	,	_	0	SENT_599	[p31l318t1493r461b1550],
7	M.S.	NNP	ORGANIZATION	M.S.	conj_and	1	SENT_599	[p31l477t1494r581b1543],
8	&	CC	ORGANIZATION	&	_	0	SENT_599	[p31l595t1495r631b1543],
9	Palmiter	NNP	ORGANIZATION	Palmiter	conj_and	1	SENT_599	[p31l647t1493r869b1550],
10	,	,	O	,	_	0	SENT_599	[p31l647t1493r869b1550],
11	R.D.	NNP	PERSON	R.D.	nn	12	SENT_599	[p31l886t1495r980b1543],
12	Deciphering	NNP	PERSON	Deciphering	appos	1	SENT_599	[p31l997t1493r1317b1556],
13	a	DT	O	a	det	15	SENT_599	[p31l1334t1508r1359b1543],
14	neuronal	JJ	O	neuronal	amod	15	SENT_599	[p31l1377t1493r1607b1543],
15	circuit	NN	O	circuit	dep	12	SENT_599	[p31l1624t1495r1783b1543],
16	that	WDT	O	that	nsubj	17	SENT_599	[p31l1796t1493r1902b1543],
17	mediates	VBZ	O	mediate	rcmod	15	SENT_599	[p31l132t1570r370b1619],
18	appetite	NN	O	appetite	dobj	17	SENT_599	[p31l384t1572r616b1631],
19	.	.	O	.	_	0	SENT_599	[p31l384t1572r616b1631],

1	Nature	NNP	O	Nature	_	0	SENT_600	[p31l630t1572r804b1619],
2	483	CD	NUMBER	483	num	1	SENT_600	[p31l816t1573r932b1626],
3	,	,	O	,	_	0	SENT_600	[p31l816t1573r932b1626],
4	594-597	CD	NUMBER	594-597	num	1	SENT_600	[p31l947t1573r1170b1619],
5	(	NN	O	(	dep	1	SENT_600	[p31l1187t1571r1287b1626],
6	201	CD	NUMBER	201	number	7	SENT_600	[p31l1187t1571r1287b1626],
7	2	CD	NUMBER	2	num	8	SENT_600	[p31l1302t1571r1361b1626],
8	)	NN	O	)	dep	5	SENT_600	[p31l1302t1571r1361b1626],
9	.	.	O	.	_	0	SENT_600	[p31l1302t1571r1361b1626],

1	VOLUME	NN	O	volume	nn	3	SENT_601	[p31l543t1750r768b1792],
2	95	CD	NUMBER	95	num	3	SENT_601	[p31l785t1751r842b1792],
3	NUMBER	NN	O	number	_	0	SENT_601	[p31l863t1750r1087b1792],
4	1	CD	NUMBER	1	number	5	SENT_601	[p31l1109t1752r1122b1792],
5	|	CD	NUMBER	|	dep	3	SENT_601	[p31l1151t1746r1156b1807],
6	JANUARY	NNP	DATE	JANUARY	dep	5	SENT_601	[p31l1175t1750r1420b1792],
7	2014	CD	DATE	2014	num	6	SENT_601	[p31l1437t1751r1558b1792],
8	|	CD	NUMBER	|	num	9	SENT_601	[p31l1577t1746r1581b1807],
9	www.nature.com/cpt	NN	O	www.nature.com/cpt	dep	3	SENT_601	[p31l1600t1750r2152b1803],

1	Astrup	NNP	PERSON	Astrup	_	0	SENT_602	[p31l130t2159r316b2219],
2	,	,	O	,	_	0	SENT_602	[p31l130t2159r316b2219],
3	A.	NNP	O	A.	nn	5	SENT_602	[p31l330t2159r379b2206],
4	Drug	NNP	O	Drug	nn	5	SENT_602	[p31l396t2159r522b2220],
5	management	NN	O	management	appos	1	SENT_602	[p31l541t2164r896b2220],
6	of	IN	O	of	_	0	SENT_602	[p31l910t2156r965b2206],
7	obesity-efﬁcacy	NN	O	obesity-efﬁcacy	prep_of	5	SENT_602	[p31l974t2156r1404b2220],
8	versus	CC	O	versus	prep	7	SENT_602	[p31l1416t2171r1582b2206],
9	safety	NN	O	safety	dep	8	SENT_602	[p31l1597t2156r1761b2220],
10	.	.	O	.	_	0	SENT_602	[p31l1597t2156r1761b2220],

1	N.	NNP	O	N.	nn	2	SENT_603	[p31l1775t2159r1823b2206],
2	Engl	NNP	O	Engl	_	0	SENT_603	[p31l1838t2157r1957b2220],
3	.	.	O	.	_	0	SENT_603	[p31l1838t2157r1957b2220],

1	J.	NNP	O	J.	nn	2	SENT_604	[p31l1968t2159r2003b2206],
2	Med	NNP	O	Med	_	0	SENT_604	[p31l2017t2157r2140b2206],
3	.	.	O	.	_	0	SENT_604	[p31l2017t2157r2140b2206],

1	363	CD	NUMBER	363	_	0	SENT_605	[p31l132t2237r248b2290],
2	,	,	O	,	_	0	SENT_605	[p31l132t2237r248b2290],
3	288-290	CD	NUMBER	288-290	number	4	SENT_605	[p31l263t2237r488b2283],
4	(	CD	NUMBER	(	appos	1	SENT_605	[p31l504t2235r679b2290],
5	2010	CD	DATE	2010	num	6	SENT_605	[p31l504t2235r679b2290],
6	)	NN	O	)	dep	4	SENT_605	[p31l504t2235r679b2290],
7	.	.	O	.	_	0	SENT_605	[p31l504t2235r679b2290],

1	Halford	NNP	PERSON	Halford	_	0	SENT_606	[p31l133t2311r336b2369],
2	,	,	O	,	_	0	SENT_606	[p31l133t2311r336b2369],
3	J.C.	NNP	LOCATION	J.C.	conj_and	1	SENT_606	[p31l348t2313r446b2369],
4	,	,	O	,	_	0	SENT_606	[p31l348t2313r446b2369],
5	Boyland	NNP	PERSON	Boyland	conj_and	1	SENT_606	[p31l462t2312r686b2375],
6	,	,	O	,	_	0	SENT_606	[p31l462t2312r686b2375],
7	E.J.	NNP	LOCATION	E.J.	conj_and	1	SENT_606	[p31l703t2314r790b2369],
8	,	,	O	,	_	0	SENT_606	[p31l703t2314r790b2369],
9	Lawton	NNP	PERSON	Lawton	conj_and	1	SENT_606	[p31l807t2314r1013b2369],
10	,	,	O	,	_	0	SENT_606	[p31l807t2314r1013b2369],
11	C.L.	NNP	PERSON	C.L.	conj_and	1	SENT_606	[p31l1027t2313r1130b2369],
12	,	,	O	,	_	0	SENT_606	[p31l1027t2313r1130b2369],
13	Blundell	NNP	PERSON	Blundell	conj_and	1	SENT_606	[p31l1147t2312r1371b2369],
14	,	,	O	,	_	0	SENT_606	[p31l1147t2312r1371b2369],
15	J.E.	NNP	ORGANIZATION	J.E.	conj_and	1	SENT_606	[p31l1384t2314r1462b2361],
16	&	CC	ORGANIZATION	&	_	0	SENT_606	[p31l1477t2313r1514b2361],
17	Harrold	NNP	ORGANIZATION	Harrold	conj_and	1	SENT_606	[p31l1529t2312r1735b2369],
18	,	,	O	,	_	0	SENT_606	[p31l1529t2312r1735b2369],
19	J.A.	NNP	PERSON	J.A.	nn	20	SENT_606	[p31l1747t2314r1834b2361],
20	Serotonergic	NNP	PERSON	Serotonergic	appos	1	SENT_606	[p31l132t2391r470b2453],
21	anti-obesity	JJ	O	anti-obesity	amod	22	SENT_606	[p31l484t2390r801b2453],
22	agents	NNS	O	agent	dep	20	SENT_606	[p31l813t2397r1003b2453],
23	:	:	O	:	_	0	SENT_606	[p31l813t2397r1003b2453],
24	past	JJ	DATE	past	amod	25	SENT_606	[p31l1019t2397r1128b2452],
25	experience	NN	O	experience	dep	1	SENT_606	[p31l1142t2392r1432b2452],
26	and	CC	O	and	_	0	SENT_606	[p31l1446t2390r1543b2439],
27	future	JJ	DATE	future	amod	28	SENT_606	[p31l1558t2389r1718b2439],
28	prospects	NNS	O	prospects	conj_and	25	SENT_606	[p31l1734t2397r2002b2452],
29	.	.	O	.	_	0	SENT_606	[p31l1734t2397r2002b2452],

1	Drugs	NNS	O	drug	_	0	SENT_607	[p31l132t2470r282b2531],
2	71	CD	NUMBER	71	num	1	SENT_607	[p31l296t2472r376b2525],
3	,	,	O	,	_	0	SENT_607	[p31l296t2472r376b2525],
4	2247-2255	CD	DATE	2247-2255	num	5	SENT_607	[p31l391t2471r679b2517],
5	(	NN	O	(	appos	1	SENT_607	[p31l698t2469r799b2525],
6	201	CD	NUMBER	201	number	7	SENT_607	[p31l698t2469r799b2525],
7	1	CD	NUMBER	1	num	8	SENT_607	[p31l817t2469r872b2525],
8	)	NN	O	)	dep	5	SENT_607	[p31l817t2469r872b2525],
9	.	.	O	.	_	0	SENT_607	[p31l817t2469r872b2525],

1	Smith	NNP	PERSON	Smith	nn	4	SENT_608	[p31l131t2546r296b2603],
2	,	,	O	,	_	0	SENT_608	[p31l131t2546r296b2603],
3	S.R.	NNP	O	S.R.	appos	4	SENT_608	[p31l311t2547r399b2595],
4	etal.	NNP	O	etal.	_	0	SENT_608	[p31l413t2546r542b2603],
5	;	:	O	;	_	0	SENT_608	[p31l413t2546r542b2603],
6	Behavioral	NNP	O	Behavioral	nn	7	SENT_608	[p31l559t2546r830b2595],
7	Modiﬁcation	NNP	O	Modiﬁcation	dep	4	SENT_608	[p31l848t2545r1178b2595],
8	and	CC	O	and	_	0	SENT_608	[p31l1195t2546r1292b2595],
9	Lorcaserin	NNP	O	Lorcaserin	dep	4	SENT_608	[p31l1310t2548r1575b2595],
10	for	IN	O	for	_	0	SENT_608	[p31l1590t2545r1663b2595],
11	Overweight	NNP	O	Overweight	prep_for	7	SENT_608	[p31l1676t2546r1988b2609],
12	and	CC	O	and	_	0	SENT_608	[p31l2002t2546r2099b2595],
13	Obesity	NNP	O	Obesity	nn	16	SENT_608	[p31l132t2624r334b2687],
14	Management	NNP	O	Management	nn	16	SENT_608	[p31l348t2626r703b2687],
15	(	NNP	O	(	nn	16	SENT_608	[p31l719t2625r950b2681],
16	BLOOM	NNP	O	BLOOM	dep	4	SENT_608	[p31l719t2625r950b2681],
17	)	CD	NUMBER	)	num	19	SENT_608	[p31l719t2625r950b2681],
18	Study	NNP	O	Study	nn	19	SENT_608	[p31l967t2624r1118b2687],
19	Group	NNP	O	Group	dep	16	SENT_608	[p31l1131t2626r1307b2686],
20	.	.	O	.	_	0	SENT_608	[p31l1131t2626r1307b2686],

1	Multicenter	NNP	O	Multicenter	_	0	SENT_609	[p31l1323t2624r1635b2681],
2	,	,	O	,	_	0	SENT_609	[p31l1323t2624r1635b2681],
3	placebo-controlled	JJ	O	placebo-controlled	amod	4	SENT_609	[p31l1651t2624r2152b2686],
4	trial	NN	O	trial	appos	1	SENT_609	[p31l130t2702r228b2751],
5	of	IN	O	of	_	0	SENT_609	[p31l245t2701r300b2751],
6	lorcaserin	NN	O	lorcaserin	prep_of	4	SENT_609	[p31l312t2702r562b2751],
7	for	IN	O	for	_	0	SENT_609	[p31l577t2701r650b2751],
8	weight	NN	O	weight	nn	9	SENT_609	[p31l662t2702r846b2765],
9	management	NN	O	management	prep_for	6	SENT_609	[p31l861t2709r1229b2765],
10	.	.	O	.	_	0	SENT_609	[p31l861t2709r1229b2765],

1	N.	NNP	O	N.	nn	2	SENT_610	[p31l1243t2704r1292b2751],
2	Engl	NNP	O	Engl	_	0	SENT_610	[p31l1306t2702r1425b2765],
3	.	.	O	.	_	0	SENT_610	[p31l1306t2702r1425b2765],

1	J.	NNP	O	J.	nn	2	SENT_611	[p31l1436t2704r1471b2751],
2	Med	NNP	O	Med	_	0	SENT_611	[p31l1485t2702r1608b2751],
3	.	.	O	.	_	0	SENT_611	[p31l1485t2702r1608b2751],

1	363	CD	NUMBER	363	_	0	SENT_612	[p31l1622t2705r1738b2759],
2	,	,	O	,	_	0	SENT_612	[p31l1622t2705r1738b2759],
3	245-256	CD	NUMBER	245-256	num	4	SENT_612	[p31l1753t2705r1978b2751],
4	(	NN	O	(	appos	1	SENT_612	[p31l134t2780r234b2835],
5	201	CD	NUMBER	201	num	7	SENT_612	[p31l134t2780r234b2835],
6	O	NN	O	o	nn	7	SENT_612	[p31l249t2780r309b2835],
7	)	NN	O	)	dep	4	SENT_612	[p31l249t2780r309b2835],
8	.	.	O	.	_	0	SENT_612	[p31l249t2780r309b2835],

1	O'Neil	NNP	PERSON	O'Neil	_	0	SENT_613	[p31l130t2857r301b2914],
2	,	,	O	,	_	0	SENT_613	[p31l130t2857r301b2914],
3	P.M.	NNP	O	P.M.	nn	4	SENT_613	[p31l318t2859r414b2906],
4	etal	NN	O	etal	appos	1	SENT_613	[p31l429t2857r544b2907],
5	.	.	O	.	_	0	SENT_613	[p31l429t2857r544b2907],

1	Randomized	VBN	O	randomize	_	0	SENT_614	[p31l561t2857r889b2907],
2	placebo-controlled	JJ	O	placebo-controlled	amod	4	SENT_614	[p31l907t2857r1408b2919],
3	clinical	JJ	O	clinical	amod	4	SENT_614	[p31l1425t2857r1602b2907],
4	trial	NN	O	trial	tmod	1	SENT_614	[p31l1617t2857r1715b2907],
5	of	IN	O	of	_	0	SENT_614	[p31l1732t2856r1787b2907],
6	lorcaserin	NN	O	lorcaserin	prep_of	4	SENT_614	[p31l1799t2857r2049b2907],
7	for	IN	O	for	_	0	SENT_614	[p31l2064t2856r2137b2906],
8	weight	NN	O	weight	nn	9	SENT_614	[p31l131t2935r314b2998],
9	loss	NN	O	loss	prep_for	6	SENT_614	[p31l330t2935r425b2984],
10	in	IN	O	in	_	0	SENT_614	[p31l441t2937r484b2983],
11	type	NN	O	type	nn	14	SENT_614	[p31l499t2942r617b2998],
12	2	CD	NUMBER	2	num	14	SENT_614	[p31l632t2938r659b2983],
13	diabetes	NN	O	diabetes	nn	14	SENT_614	[p31l675t2935r899b2984],
14	mellitus	NN	O	mellitus	prep_in	9	SENT_614	[p31l916t2935r1135b2984],
15	:	:	O	:	_	0	SENT_614	[p31l916t2935r1135b2984],
16	the	DT	O	the	det	18	SENT_614	[p31l1148t2935r1234b2984],
17	BLOOM-DM	NN	O	bloom-dm	nn	18	SENT_614	[p31l1251t2936r1561b2984],
18	study	NN	O	study	dep	4	SENT_614	[p31l1577t2935r1731b2998],
19	.	.	O	.	_	0	SENT_614	[p31l1577t2935r1731b2998],

1	Obesity	NN	O	obesity	nn	4	SENT_615	[p31l1746t2935r1938b2999],
2	(	CD	NUMBER	(	num	4	SENT_615	[p31l1950t2935r2103b2992],
3	Silver	NN	O	silver	nn	4	SENT_615	[p31l1950t2935r2103b2992],
4	Spring	NN	DATE	spring	_	0	SENT_615	[p31l130t3014r311b3076],
5	)	CD	NUMBER	)	number	6	SENT_615	[p31l130t3014r311b3076],
6	20	CD	NUMBER	20	dep	4	SENT_615	[p31l327t3016r407b3070],
7	,	,	O	,	_	0	SENT_615	[p31l327t3016r407b3070],
8	1426-1436	CD	DATE	1426-1436	number	9	SENT_615	[p31l426t3016r712b3062],
9	(	CD	NUMBER	(	appos	4	SENT_615	[p31l728t3014r903b3070],
10	2012	CD	DATE	2012	num	11	SENT_615	[p31l728t3014r903b3070],
11	)	NN	O	)	dep	9	SENT_615	[p31l728t3014r903b3070],
12	.	.	O	.	_	0	SENT_615	[p31l728t3014r903b3070],

1	Fidler	NNP	PERSON	Fidler	nn	3	SENT_616	[p31l133t3091r285b3148],
2	,	,	O	,	_	0	SENT_616	[p31l133t3091r285b3148],
3	M.C.	NNP	O	M.C.	_	0	SENT_616	[p31l300t3092r410b3141],
4	et	FW	O	et	nn	5	SENT_616	[p31l424t3098r473b3140],
5	al.	FW	O	al.	dep	3	SENT_616	[p31l482t3091r553b3148],
6	;	:	O	;	_	0	SENT_616	[p31l482t3091r553b3148],
7	BLOSSOM	NNP	O	BLOSSOM	dep	3	SENT_616	[p31l569t3092r827b3141],
8	Clinical	JJ	O	clinical	amod	10	SENT_616	[p31l843t3091r1029b3141],
9	Trial	NNP	O	Trial	nn	10	SENT_616	[p31l1040t3091r1147b3140],
10	Group	NNP	O	Group	dep	7	SENT_616	[p31l1164t3093r1340b3153],
11	.	.	O	.	_	0	SENT_616	[p31l1164t3093r1340b3153],

1	A	DT	O	a	det	4	SENT_617	[p31l1354t3093r1391b3140],
2	one-year	JJ	DURATION	one-year	amod	4	SENT_617	[p31l1405t3106r1639b3155],
3	randomized	JJ	O	randomized	amod	4	SENT_617	[p31l1655t3091r1968b3141],
4	trial	NN	O	trial	_	0	SENT_617	[p31l1983t3091r2081b3141],
5	of	IN	O	of	_	0	SENT_617	[p31l2098t3090r2153b3140],
6	lorcaserin	NN	O	lorcaserin	prep_of	4	SENT_617	[p31l134t3169r384b3219],
7	for	IN	O	for	_	0	SENT_617	[p31l399t3168r472b3219],
8	weight	NN	O	weight	nn	9	SENT_617	[p31l484t3169r668b3232],
9	loss	NN	O	loss	prep_for	6	SENT_617	[p31l684t3169r778b3219],
10	in	IN	O	in	_	0	SENT_617	[p31l795t3171r837b3218],
11	obese	JJ	O	obese	amod	14	SENT_617	[p31l854t3169r1011b3219],
12	and	CC	O	and	_	0	SENT_617	[p31l1025t3169r1122b3219],
13	overweight	JJ	O	overweight	conj_and	11	SENT_617	[p31l1139t3169r1441b3232],
14	adults	NNS	O	adult	prep_in	9	SENT_617	[p31l1455t3169r1627b3219],
15	:	:	O	:	_	0	SENT_617	[p31l1455t3169r1627b3219],
16	the	DT	O	the	det	18	SENT_617	[p31l1640t3169r1726b3219],
17	BLOSSOM	NN	O	blossom	nn	18	SENT_617	[p31l1744t3170r2001b3219],
18	trial	NN	O	trial	dep	4	SENT_617	[p31l2016t3169r2128b3219],
19	.	.	O	.	_	0	SENT_617	[p31l2016t3169r2128b3219],

1	J.	NNP	PERSON	J.	nn	2	SENT_618	[p31l127t3248r162b3296],
2	Clin	NNP	PERSON	Clin	_	0	SENT_618	[p31l178t3246r283b3296],
3	.	.	O	.	_	0	SENT_618	[p31l178t3246r283b3296],

1	Endocrinol	NN	O	endocrinol	_	0	SENT_619	[p31l298t3246r580b3296],
2	.	.	O	.	_	0	SENT_619	[p31l298t3246r580b3296],

1	Metab	NNP	PERSON	Metab	_	0	SENT_620	[p31l594t3246r770b3296],
2	.	.	O	.	_	0	SENT_620	[p31l594t3246r770b3296],

1	96	CD	NUMBER	96	_	0	SENT_621	[p31l785t3249r866b3303],
2	,	,	O	,	_	0	SENT_621	[p31l785t3249r866b3303],
3	3067-3077	CD	DURATION	3067-3077	num	4	SENT_621	[p31l880t3249r1170b3296],
4	(	NN	O	(	appos	1	SENT_621	[p31l1187t3247r1288b3303],
5	201	CD	NUMBER	201	number	6	SENT_621	[p31l1187t3247r1288b3303],
6	1	CD	NUMBER	1	num	7	SENT_621	[p31l1306t3247r1362b3303],
7	)	NN	O	)	dep	4	SENT_621	[p31l1306t3247r1362b3303],
8	.	.	O	.	_	0	SENT_621	[p31l1306t3247r1362b3303],

1	34	CD	NUMBER	34	_	0	SENT_622	[p32l9t21r83b67],
2	.	.	O	.	_	0	SENT_622	[p32l9t21r83b67],

1	Wilding	NNP	PERSON	Wilding	_	0	SENT_623	[p32l129t18r344b81],
2	,	,	O	,	_	0	SENT_623	[p32l129t18r344b81],
3	J.	NNP	O	J.	appos	1	SENT_623	[p32l356t20r404b75],
4	,	,	O	,	_	0	SENT_623	[p32l356t20r404b75],
5	Van	NNP	PERSON	Van	nn	6	SENT_623	[p32l414t20r510b67],
6	Gaal	NNP	PERSON	Gaal	appos	1	SENT_623	[p32l526t18r653b75],
7	,	,	O	,	_	0	SENT_623	[p32l526t18r653b75],
8	L.	NNP	O	L.	appos	1	SENT_623	[p32l670t20r720b75],
9	,	,	O	,	_	0	SENT_623	[p32l670t20r720b75],
10	Rissanen	NNP	PERSON	Rissanen	appos	1	SENT_623	[p32l738t20r979b75],
11	,	,	O	,	_	0	SENT_623	[p32l738t20r979b75],
12	A.	NN	O	a.	appos	1	SENT_623	[p32l993t20r1358b82],
13	,	,	O	,	_	0	SENT_623	[p32l993t20r1358b82],
14	Vercruysse	NNP	PERSON	Vercruysse	appos	1	SENT_623	[p32l993t20r1358b82],
15	,	,	O	,	_	0	SENT_623	[p32l993t20r1358b82],
16	F.	NNP	ORGANIZATION	F.	conj_and	14	SENT_623	[p32l1375t20r1407b67],
17	&	CC	ORGANIZATION	&	_	0	SENT_623	[p32l1421t19r1458b67],
18	Fitchet	NNP	ORGANIZATION	Fitchet	conj_and	14	SENT_623	[p32l1473t18r1662b75],
19	,	,	O	,	_	0	SENT_623	[p32l1473t18r1662b75],
20	M.	NNP	O	M.	appos	1	SENT_623	[p32l1678t20r1751b75],
21	;	:	O	;	_	0	SENT_623	[p32l1678t20r1751b75],
22	OBES-002	NN	O	obes-002	dep	1	SENT_623	[p32l1765t19r2020b67],

1	Study	NNP	O	Study	nn	2	SENT_624	[p32l132t96r284b160],
2	Group	NNP	O	Group	_	0	SENT_624	[p32l296t98r472b158],
3	.	.	O	.	_	0	SENT_624	[p32l296t98r472b158],

1	A	DT	O	a	_	0	SENT_625	[p32l486t98r523b145],
2	randomized	VBN	O	randomize	dep	1	SENT_625	[p32l539t96r853b146],
3	double-blind	JJ	O	double-blind	amod	5	SENT_625	[p32l869t96r1213b145],
4	placebo-controlled	JJ	O	placebo-controlled	amod	5	SENT_625	[p32l1231t96r1732b158],
5	study	NN	O	study	dobj	2	SENT_625	[p32l1749t96r1895b160],
6	of	IN	O	of	_	0	SENT_625	[p32l1908t95r1962b145],
7	the	DT	O	the	det	9	SENT_625	[p32l130t174r217b224],
8	long-term	JJ	O	long-term	amod	9	SENT_625	[p32l233t174r494b237],
9	efﬁcacy	NN	O	efﬁcacy	prep_of	5	SENT_625	[p32l510t173r712b237],
10	and	CC	O	and	_	0	SENT_625	[p32l724t174r821b223],
11	safety	NN	O	safety	conj_and	2	SENT_625	[p32l838t173r993b238],
12	of	IN	O	of	dep	11	SENT_625	[p32l1006t173r1061b223],
13	topiramate	NN	O	topiramate	pobj	12	SENT_625	[p32l1069t176r1362b236],
14	in	IN	O	in	_	0	SENT_625	[p32l1378t176r1421b223],
15	the	DT	O	the	det	16	SENT_625	[p32l1436t174r1522b223],
16	treatment	NN	O	treatment	prep_in	13	SENT_625	[p32l1535t181r1801b223],
17	of	IN	O	of	_	0	SENT_625	[p32l1815t173r1869b223],
18	obese	JJ	O	obese	prep_of	13	SENT_625	[p32l1879t174r2036b224],
19	subjects	NNS	O	subject	dep	13	SENT_625	[p32l132t252r360b315],
20	.	.	O	.	_	0	SENT_625	[p32l132t252r360b315],

1	Int	NN	O	int	_	0	SENT_626	[p32l375t254r451b302],
2	.	.	O	.	_	0	SENT_626	[p32l375t254r451b302],

1	J.	NNP	O	J.	nn	2	SENT_627	[p32l462t254r497b302],
2	Obes	NNP	O	Obes	_	0	SENT_627	[p32l513t252r648b302],
3	.	.	O	.	_	0	SENT_627	[p32l513t252r648b302],

1	Relat	NNP	O	Relat	_	0	SENT_628	[p32l663t252r801b302],
2	.	.	O	.	_	0	SENT_628	[p32l663t252r801b302],

1	Metab	NNP	PERSON	Metab	_	0	SENT_629	[p32l815t252r988b302],
2	.	.	O	.	_	0	SENT_629	[p32l815t252r988b302],

1	Disord	NNP	O	Disord	_	0	SENT_630	[p32l1003t252r1180b302],
2	.	.	O	.	_	0	SENT_630	[p32l1003t252r1180b302],

1	28	CD	NUMBER	28	_	0	SENT_631	[p32l1194t255r1275b309],
2	,	,	O	,	_	0	SENT_631	[p32l1194t255r1275b309],
3	1399-1410	CD	DATE	1399-1410	number	4	SENT_631	[p32l1293t255r1580b302],
4	(	CD	NUMBER	(	appos	1	SENT_631	[p32l1596t253r1771b309],
5	2004	CD	DATE	2004	num	6	SENT_631	[p32l1596t253r1771b309],
6	)	NN	O	)	dep	4	SENT_631	[p32l1596t253r1771b309],
7	.	.	O	.	_	0	SENT_631	[p32l1596t253r1771b309],

1	35	CD	NUMBER	35	_	0	SENT_632	[p32l9t333r83b379],
2	.	.	O	.	_	0	SENT_632	[p32l9t333r83b379],

1	Astrup	NNP	PERSON	Astrup	_	0	SENT_633	[p32l129t332r316b392],
2	,	,	O	,	_	0	SENT_633	[p32l129t332r316b392],
3	A.	NNP	O	A.	nn	4	SENT_633	[p32l329t332r379b379],
4	etal	NNP	O	etal	appos	1	SENT_633	[p32l393t330r831b392],
5	.	.	O	.	_	0	SENT_633	[p32l393t330r831b392],

1	Topiramate	NNP	O	Topiramate	_	0	SENT_634	[p32l393t330r831b392],
2	:	:	O	:	_	0	SENT_634	[p32l393t330r831b392],
3	long-term	JJ	O	long-term	amod	4	SENT_634	[p32l848t330r1108b393],
4	maintenance	NN	O	maintenance	dep	1	SENT_634	[p32l1127t332r1471b379],
5	of	IN	O	of	_	0	SENT_634	[p32l1485t329r1540b379],
6	weight	NN	O	weight	nn	7	SENT_634	[p32l1548t330r1732b393],
7	loss	NN	O	loss	prep_of	4	SENT_634	[p32l1748t330r1842b379],
8	induced	VBN	O	induce	partmod	7	SENT_634	[p32l1859t330r2069b380],
9	by	IN	O	by	_	0	SENT_634	[p32l2088t330r2150b393],
10	a	DT	O	a	det	12	SENT_634	[p32l132t423r157b458],
11	low-calorie	JJ	O	low-calorie	amod	12	SENT_634	[p32l175t408r464b458],
12	diet	NN	O	diet	agent	8	SENT_634	[p32l479t408r580b458],
13	in	IN	O	in	_	0	SENT_634	[p32l595t410r638b457],
14	obese	JJ	O	obese	amod	15	SENT_634	[p32l655t408r811b458],
15	subjects	NNS	O	subject	prep_in	12	SENT_634	[p32l826t408r1055b471],
16	.	.	O	.	_	0	SENT_634	[p32l826t408r1055b471],

1	Obes	NNS	ORGANIZATION	obe	_	0	SENT_635	[p32l1070t408r1206b458],
2	.	.	O	.	_	0	SENT_635	[p32l1070t408r1206b458],

1	Res	NNP	O	Res	_	0	SENT_636	[p32l1221t410r1317b458],
2	.	.	O	.	_	0	SENT_636	[p32l1221t410r1317b458],

1	12	CD	NUMBER	12	_	0	SENT_637	[p32l1334t411r1411b465],
2	,	,	O	,	_	0	SENT_637	[p32l1334t411r1411b465],
3	1658-1669	CD	DATE	1658-1669	number	4	SENT_637	[p32l1430t411r1717b458],
4	(	CD	NUMBER	(	appos	1	SENT_637	[p32l1733t409r1908b465],
5	2004	CD	DATE	2004	num	6	SENT_637	[p32l1733t409r1908b465],
6	)	NN	O	)	dep	4	SENT_637	[p32l1733t409r1908b465],
7	.	.	O	.	_	0	SENT_637	[p32l1733t409r1908b465],

1	36	CD	NUMBER	36	_	0	SENT_638	[p32l9t489r83b535],
2	.	.	O	.	_	0	SENT_638	[p32l9t489r83b535],

1	Bray	NNP	O	Bray	_	0	SENT_639	[p32l133t488r252b549],
2	,	,	O	,	_	0	SENT_639	[p32l133t488r252b549],
3	G.A.	NNP	O	G.A.	nn	4	SENT_639	[p32l267t488r370b535],
4	etal	NN	O	etal	appos	1	SENT_639	[p32l384t486r500b535],
5	.	.	O	.	_	0	SENT_639	[p32l384t486r500b535],

1	A	DT	O	a	det	2	SENT_640	[p32l514t488r550b535],
2	6-month	JJ	DURATION	6-month	nsubj	3	SENT_640	[p32l564t486r791b535],
3	randomized	VBN	O	randomize	_	0	SENT_640	[p32l810t486r1138b543],
4	,	,	O	,	_	0	SENT_640	[p32l810t486r1138b543],
5	placebo-controlled	JJ	O	placebo-controlled	amod	8	SENT_640	[p32l1154t486r1670b548],
6	,	,	O	,	_	0	SENT_640	[p32l1154t486r1670b548],
7	dose-ranging	JJ	O	dose-ranging	amod	8	SENT_640	[p32l1685t486r2037b549],
8	trial	NN	O	trial	dobj	3	SENT_640	[p32l2052t486r2150b535],
9	of	IN	O	of	_	0	SENT_640	[p32l132t563r186b613],
10	topiramate	NN	O	topiramate	prep_of	8	SENT_640	[p32l195t566r488b626],
11	for	IN	O	for	_	0	SENT_640	[p32l500t563r573b613],
12	weight	NN	O	weight	nn	13	SENT_640	[p32l585t564r769b627],
13	loss	NN	O	loss	prep_for	10	SENT_640	[p32l785t564r879b613],
14	in	IN	O	in	_	0	SENT_640	[p32l896t566r938b613],
15	obesity	NN	O	obesity	prep_in	13	SENT_640	[p32l955t564r1157b628],
16	.	.	O	.	_	0	SENT_640	[p32l955t564r1157b628],

1	Obes	NNS	ORGANIZATION	obe	_	0	SENT_641	[p32l1172t564r1308b613],
2	.	.	O	.	_	0	SENT_641	[p32l1172t564r1308b613],

1	Res	NNP	O	Res	_	0	SENT_642	[p32l1323t566r1419b613],
2	.	.	O	.	_	0	SENT_642	[p32l1323t566r1419b613],

1	11	CD	NUMBER	11	_	0	SENT_643	[p32l1437t568r1514b621],
2	,	,	O	,	_	0	SENT_643	[p32l1437t568r1514b621],
3	722-733	CD	NUMBER	722-733	number	4	SENT_643	[p32l1529t567r1751b614],
4	(	CD	NUMBER	(	appos	1	SENT_643	[p32l1769t565r1944b621],
5	2003	CD	DATE	2003	num	6	SENT_643	[p32l1769t565r1944b621],
6	)	NN	O	)	dep	4	SENT_643	[p32l1769t565r1944b621],
7	.	.	O	.	_	0	SENT_643	[p32l1769t565r1944b621],

1	37	CD	NUMBER	37	_	0	SENT_644	[p32l9t645r83b692],
2	.	.	O	.	_	0	SENT_644	[p32l9t645r83b692],

1	Topamax	NN	O	topamax	nn	3	SENT_645	[p32l127t644r371b704],
2	(	CD	NUMBER	(	num	3	SENT_645	[p32l386t643r720b704],
3	Topiramate	NNP	O	Topiramate	_	0	SENT_645	[p32l386t643r720b704],
4	)	CD	NUMBER	)	number	5	SENT_645	[p32l386t643r720b704],
5	[	CD	NUMBER	[	dep	3	SENT_645	[p32l739t642r965b704],
6	product	NN	O	product	nn	8	SENT_645	[p32l739t642r965b704],
7	information	NN	O	information	nn	8	SENT_645	[p32l980t641r1576b699],
8	]	NN	O	]	dep	5	SENT_645	[p32l980t641r1576b699],
9	.	.	O	.	_	0	SENT_645	[p32l980t641r1576b699],

1	Titusvi	NNP	O	Titusvi	nn	2	SENT_646	[p32l980t641r1576b699],
2	|	NNP	O	|	nsubj	3	SENT_646	[p32l980t641r1576b699],
3	|	VBD	O	|	_	0	SENT_646	[p32l980t641r1576b699],
4	e	LS	O	e	dep	6	SENT_646	[p32l980t641r1576b699],
5	,	,	O	,	_	0	SENT_646	[p32l980t641r1576b699],
6	NJ	NNP	O	NJ	dobj	3	SENT_646	[p32l1593t644r1666b692],
7	:	:	O	:	_	0	SENT_646	[p32l1593t644r1666b692],
8	Janssen	NNP	PERSON	Janssen	dep	6	SENT_646	[p32l1678t644r1882b692],

1	Pharmaceuticals	NNS	O	pharmaceutical	_	0	SENT_647	[p32l134t719r577b776],
2	,	,	O	,	_	0	SENT_647	[p32l134t719r577b776],
3	2012	CD	DATE	2012	appos	1	SENT_647	[p32l592t722r732b769],
4	.	.	O	.	_	0	SENT_647	[p32l592t722r732b769],

1	38	CD	NUMBER	38	_	0	SENT_648	[p32l9t800r83b847],
2	.	.	O	.	_	0	SENT_648	[p32l9t800r83b847],

1	Richard	NNP	PERSON	Richard	_	0	SENT_649	[p32l133t797r340b854],
2	,	,	O	,	_	0	SENT_649	[p32l133t797r340b854],
3	D.	NNP	O	D.	conj_and	1	SENT_649	[p32l357t799r417b854],
4	,	,	O	,	_	0	SENT_649	[p32l357t799r417b854],
5	Ferland	NNP	PERSON	Ferland	conj_and	1	SENT_649	[p32l434t797r640b854],
6	,	,	O	,	_	0	SENT_649	[p32l434t797r640b854],
7	J.	NNP	O	J.	conj_and	1	SENT_649	[p32l653t799r700b854],
8	,	,	O	,	_	0	SENT_649	[p32l653t799r700b854],
9	Lalonde	NNP	PERSON	Lalonde	conj_and	1	SENT_649	[p32l717t797r938b854],
10	,	,	O	,	_	0	SENT_649	[p32l717t797r938b854],
11	J.	NNP	O	J.	conj_and	1	SENT_649	[p32l950t799r997b854],
12	,	,	O	,	_	0	SENT_649	[p32l950t799r997b854],
13	Samson	NNP	PERSON	Samson	conj_and	1	SENT_649	[p32l1012t798r1233b854],
14	,	,	O	,	_	0	SENT_649	[p32l1012t798r1233b854],
15	P.	NNP	ORGANIZATION	P.	conj_and	1	SENT_649	[p32l1250t799r1282b847],
16	&	CC	ORGANIZATION	&	_	0	SENT_649	[p32l1296t799r1333b847],
17	Deshaies	NNP	ORGANIZATION	Deshaies	conj_and	1	SENT_649	[p32l1348t797r1593b854],
18	,	,	O	,	_	0	SENT_649	[p32l1348t797r1593b854],
19	Y.	NNP	PERSON	Y.	nn	20	SENT_649	[p32l1603t799r1642b847],
20	Inﬂuence	NNP	PERSON	Inﬂuence	appos	1	SENT_649	[p32l1659t796r1901b847],
21	of	IN	O	of	_	0	SENT_649	[p32l1915t796r1970b847],
22	topiramate	NN	O	topiramate	prep_of	20	SENT_649	[p32l130t878r423b938],
23	in	IN	O	in	_	0	SENT_649	[p32l439t878r482b925],
24	the	DT	O	the	det	25	SENT_649	[p32l497t876r583b926],
25	regulation	NN	O	regulation	prep_in	22	SENT_649	[p32l600t876r868b939],
26	of	IN	O	of	_	0	SENT_649	[p32l884t875r939b926],
27	energy	NN	O	energy	nn	28	SENT_649	[p32l948t891r1132b939],
28	balance	NN	O	balance	prep_of	25	SENT_649	[p32l1147t876r1362b926],
29	.	.	O	.	_	0	SENT_649	[p32l1147t876r1362b926],

1	Nutrition	NNP	O	Nutrition	_	0	SENT_650	[p32l1377t878r1603b926],
2	16	CD	NUMBER	16	num	1	SENT_650	[p32l1621t879r1699b933],
3	,	,	O	,	_	0	SENT_650	[p32l1621t879r1699b933],
4	961	CD	NUMBER	961	num	1	SENT_650	[p32l1713t879r1797b926],
5	-966	CD	NUMBER	-966	number	6	SENT_650	[p32l1811t879r1938b926],
6	(	CD	NUMBER	(	dep	1	SENT_650	[p32l1954t877r2129b933],
7	2000	CD	DATE	2000	num	8	SENT_650	[p32l1954t877r2129b933],
8	)	NN	O	)	dep	6	SENT_650	[p32l1954t877r2129b933],
9	.	.	O	.	_	0	SENT_650	[p32l1954t877r2129b933],

1	39	CD	NUMBER	39	_	0	SENT_651	[p32l9t956r83b1003],
2	.	.	O	.	_	0	SENT_651	[p32l9t956r83b1003],

1	Richard	NNP	PERSON	Richard	_	0	SENT_652	[p32l132t953r340b1010],
2	,	,	O	,	_	0	SENT_652	[p32l132t953r340b1010],
3	D.	NNP	O	D.	conj_and	1	SENT_652	[p32l357t955r417b1010],
4	,	,	O	,	_	0	SENT_652	[p32l357t955r417b1010],
5	Picard	NNP	PERSON	Picard	conj_and	1	SENT_652	[p32l434t953r604b1010],
6	,	,	O	,	_	0	SENT_652	[p32l434t953r604b1010],
7	F.	NNP	O	F.	conj_and	1	SENT_652	[p32l621t955r666b1010],
8	,	,	O	,	_	0	SENT_652	[p32l621t955r666b1010],
9	Lemieux	NNP	PERSON	Lemieux	conj_and	1	SENT_652	[p32l682t955r916b1010],
10	,	,	O	,	_	0	SENT_652	[p32l682t955r916b1010],
11	C.	NNP	O	C.	conj_and	1	SENT_652	[p32l930t954r990b1010],
12	,	,	O	,	_	0	SENT_652	[p32l930t954r990b1010],
13	Lalonde	NNP	PERSON	Lalonde	conj_and	1	SENT_652	[p32l1007t953r1228b1010],
14	,	,	O	,	_	0	SENT_652	[p32l1007t953r1228b1010],
15	J.	NNP	O	J.	conj_and	1	SENT_652	[p32l1240t955r1287b1010],
16	,	,	O	,	_	0	SENT_652	[p32l1240t955r1287b1010],
17	Samson	NNP	PERSON	Samson	conj_and	1	SENT_652	[p32l1302t954r1523b1010],
18	,	,	O	,	_	0	SENT_652	[p32l1302t954r1523b1010],
19	P.	NNP	ORGANIZATION	P.	conj_and	1	SENT_652	[p32l1540t955r1572b1003],
20	&	CC	ORGANIZATION	&	_	0	SENT_652	[p32l1586t955r1623b1003],
21	Deshaies	NNP	ORGANIZATION	Deshaies	conj_and	1	SENT_652	[p32l1638t953r1883b1010],
22	,	,	O	,	_	0	SENT_652	[p32l1638t953r1883b1010],
23	Y.	NNP	O	Y.	appos	1	SENT_652	[p32l1893t955r1932b1003],
24	The	DT	O	the	det	26	SENT_652	[p32l1941t953r2039b1003],
25	effects	NNS	O	effect	nn	26	SENT_652	[p32l132t1031r304b1081],
26	oftopiramate	NN	O	oftopiramate	dep	23	SENT_652	[p32l319t1031r675b1094],
27	and	CC	O	and	_	0	SENT_652	[p32l689t1032r786b1082],
28	sex	NN	O	sex	nn	29	SENT_652	[p32l802t1047r886b1081],
29	hormones	NNS	O	hormone	appos	1	SENT_652	[p32l902t1032r1169b1082],
30	on	IN	O	on	_	0	SENT_652	[p32l1184t1047r1249b1081],
31	energy	NN	O	energy	nn	32	SENT_652	[p32l1265t1047r1449b1096],
32	balance	NN	O	balance	prep_on	29	SENT_652	[p32l1464t1032r1667b1082],
33	of	IN	O	of	_	0	SENT_652	[p32l1682t1031r1736b1081],
34	male	NN	O	male	amod	37	SENT_652	[p32l1748t1032r1873b1081],
35	and	CC	O	and	_	0	SENT_652	[p32l1888t1032r1985b1081],
36	female	JJ	O	female	amod	37	SENT_652	[p32l130t1108r309b1159],
37	rats	NNS	O	rat	prep_of	32	SENT_652	[p32l325t1116r429b1159],
38	.	.	O	.	_	0	SENT_652	[p32l325t1116r429b1159],

1	Int	NN	O	int	_	0	SENT_653	[p32l443t1111r520b1159],
2	.	.	O	.	_	0	SENT_653	[p32l443t1111r520b1159],

1	J.	NNP	O	J.	nn	2	SENT_654	[p32l531t1111r565b1159],
2	Obes	NNP	O	Obes	_	0	SENT_654	[p32l582t1109r717b1159],
3	.	.	O	.	_	0	SENT_654	[p32l582t1109r717b1159],

1	Relat	NNP	O	Relat	_	0	SENT_655	[p32l732t1109r870b1159],
2	.	.	O	.	_	0	SENT_655	[p32l732t1109r870b1159],

1	Metab	NNP	PERSON	Metab	_	0	SENT_656	[p32l884t1109r1057b1159],
2	.	.	O	.	_	0	SENT_656	[p32l884t1109r1057b1159],

1	Disord	NNP	O	Disord	_	0	SENT_657	[p32l1072t1109r1249b1159],
2	.	.	O	.	_	0	SENT_657	[p32l1072t1109r1249b1159],

1	26	CD	NUMBER	26	_	0	SENT_658	[p32l1263t1112r1343b1166],
2	,	,	O	,	_	0	SENT_658	[p32l1263t1112r1343b1166],
3	344-353	CD	NUMBER	344-353	number	4	SENT_658	[p32l1358t1112r1581b1159],
4	(	CD	NUMBER	(	appos	1	SENT_658	[p32l1599t1110r1774b1166],
5	2002	CD	DATE	2002	num	6	SENT_658	[p32l1599t1110r1774b1166],
6	)	NN	O	)	dep	4	SENT_658	[p32l1599t1110r1774b1166],
7	.	.	O	.	_	0	SENT_658	[p32l1599t1110r1774b1166],

1	40	CD	NUMBER	40	_	0	SENT_659	[p32l6t1191r83b1238],
2	.	.	O	.	_	0	SENT_659	[p32l6t1191r83b1238],

1	Picard	NNP	PERSON	Picard	nn	3	SENT_660	[p32l132t1188r302b1245],
2	,	,	O	,	_	0	SENT_660	[p32l132t1188r302b1245],
3	F.	NNP	O	F.	_	0	SENT_660	[p32l319t1190r364b1245],
4	,	,	O	,	_	0	SENT_660	[p32l319t1190r364b1245],
5	Deshaies	NNP	PERSON	Deshaies	dobj	9	SENT_660	[p32l381t1188r688b1245],
6	,	,	O	,	_	0	SENT_660	[p32l381t1188r688b1245],
7	Y.	NNP	O	Y.	appos	5	SENT_660	[p32l381t1188r688b1245],
8	,	,	O	,	_	0	SENT_660	[p32l381t1188r688b1245],
9	Lalonde	NNP	PERSON	Lalonde	dep	3	SENT_660	[p32l705t1188r926b1245],
10	,	,	O	,	_	0	SENT_660	[p32l705t1188r926b1245],
11	J.	NNP	O	J.	nsubj	21	SENT_660	[p32l938t1190r986b1245],
12	,	,	O	,	_	0	SENT_660	[p32l938t1190r986b1245],
13	Samson	NNP	PERSON	Samson	conj_and	11	SENT_660	[p32l1000t1189r1221b1245],
14	,	,	O	,	_	0	SENT_660	[p32l1000t1189r1221b1245],
15	P.	NNP	O	P.	conj_and	11	SENT_660	[p32l1238t1190r1270b1238],
16	&	CC	O	&	_	0	SENT_660	[p32l1284t1189r1321b1238],
17	Richard	NNP	PERSON	Richard	conj_and	11	SENT_660	[p32l1336t1188r1544b1245],
18	,	,	O	,	_	0	SENT_660	[p32l1336t1188r1544b1245],
19	D.	NNP	O	D.	nn	20	SENT_660	[p32l1560t1190r1918b1250],
20	Topiramate	NNP	O	Topiramate	appos	11	SENT_660	[p32l1560t1190r1918b1250],
21	reduces	VBZ	O	reduce	ccomp	9	SENT_660	[p32l1934t1188r2137b1238],
22	energy	NN	O	energy	nn	25	SENT_660	[p32l132t1281r315b1330],
23	and	CC	O	and	_	0	SENT_660	[p32l328t1266r425b1316],
24	fat	JJ	O	fat	nn	25	SENT_660	[p32l440t1265r509b1315],
25	gains	NNS	O	gain	dobj	21	SENT_660	[p32l522t1268r660b1329],
26	in	IN	O	in	dep	29	SENT_660	[p32l677t1268r720b1315],
27	lean	JJ	O	lean	amod	28	SENT_660	[p32l738t1266r844b1316],
28	(	NN	O	(	pobj	26	SENT_660	[p32l862t1267r997b1323],
29	Fa	NN	O	fa	dep	21	SENT_660	[p32l862t1267r997b1323],
30	/	:	O	/	punct	29	SENT_660	[p32l862t1267r997b1323],
31	?	.	O	?	_	0	SENT_660	[p32l862t1267r997b1323],
32	)	SYM	O	)	dep	3	SENT_660	[p32l862t1267r997b1323],

1	and	CC	O	and	cc	4	SENT_661	[p32l1014t1266r1111b1315],
2	obese	JJ	O	obese	amod	4	SENT_661	[p32l1127t1266r1284b1316],
3	(	NN	O	(	nn	4	SENT_661	[p32l1300t1265r1450b1323],
4	fa/fa	NN	O	fa/fa	_	0	SENT_661	[p32l1300t1265r1450b1323],
5	)	CD	NUMBER	)	num	7	SENT_661	[p32l1300t1265r1450b1323],
6	Zucker	NNP	PERSON	Zucker	nn	7	SENT_661	[p32l1465t1266r1645b1315],
7	rats	NNS	O	rat	dep	4	SENT_661	[p32l1661t1273r1765b1315],
8	.	.	O	.	_	0	SENT_661	[p32l1661t1273r1765b1315],

1	Obes	NNS	ORGANIZATION	obe	_	0	SENT_662	[p32l1779t1266r1915b1316],
2	.	.	O	.	_	0	SENT_662	[p32l1779t1266r1915b1316],

1	Res	NNP	O	Res	_	0	SENT_663	[p32l1930t1268r2026b1315],
2	.	.	O	.	_	0	SENT_663	[p32l1930t1268r2026b1315],

1	8	CD	NUMBER	8	_	0	SENT_664	[p32l2040t1269r2085b1323],
2	,	,	O	,	_	0	SENT_664	[p32l2040t1269r2085b1323],
3	656-663	CD	NUMBER	656-663	number	4	SENT_664	[p32l131t1345r355b1392],
4	(	CD	NUMBER	(	appos	1	SENT_664	[p32l373t1343r548b1400],
5	2000	CD	DATE	2000	num	6	SENT_664	[p32l373t1343r548b1400],
6	)	NN	O	)	dep	4	SENT_664	[p32l373t1343r548b1400],
7	.	.	O	.	_	0	SENT_664	[p32l373t1343r548b1400],

1	41	CD	NUMBER	41	_	0	SENT_665	[p32l7t1425r83b1471],
2	.	.	O	.	_	0	SENT_665	[p32l7t1425r83b1471],

1	Allison	NNP	PERSON	Allison	_	0	SENT_666	[p32l129t1421r319b1478],
2	,	,	O	,	_	0	SENT_666	[p32l129t1421r319b1478],
3	D.B.	NNP	PERSON	D.B.	nn	4	SENT_666	[p32l336t1423r430b1471],
4	etal	NNP	O	etal	appos	1	SENT_666	[p32l444t1421r560b1471],
5	.	.	O	.	_	0	SENT_666	[p32l444t1421r560b1471],

1	Contro	NNP	O	Contro	nn	3	SENT_667	[p32l574t1421r1059b1471],
2	|	NNP	O	|	nn	3	SENT_667	[p32l574t1421r1059b1471],
3	|	NNP	O	|	nsubj	4	SENT_667	[p32l574t1421r1059b1471],
4	ed	VBD	O	ed	dep	8	SENT_667	[p32l574t1421r1059b1471],
5	—	CD	NUMBER	—	num	7	SENT_667	[p32l574t1421r1059b1471],
6	re	NN	O	re	nn	7	SENT_667	[p32l574t1421r1059b1471],
7	|	NNS	O	|	dobj	4	SENT_667	[p32l574t1421r1059b1471],
8	ease	VBP	O	ease	_	0	SENT_667	[p32l574t1421r1059b1471],
9	phentermine/topiramate	NN	O	phentermine/topiramate	dobj	8	SENT_667	[p32l1075t1421r1736b1484],
10	in	IN	O	in	_	0	SENT_667	[p32l1752t1423r1795b1470],
11	severely	RB	O	severely	advmod	12	SENT_667	[p32l1812t1421r2026b1485],
12	obese	JJ	O	obese	amod	13	SENT_667	[p32l131t1499r289b1549],
13	adults	NNS	O	adult	prep_in	8	SENT_667	[p32l303t1499r476b1549],
14	:	:	O	:	_	0	SENT_667	[p32l303t1499r476b1549],
15	a	DT	O	a	dep	13	SENT_667	[p32l490t1514r516b1549],
16	randomized	VBN	O	randomize	partmod	15	SENT_667	[p32l534t1499r848b1549],
17	controlled	JJ	O	controlled	amod	18	SENT_667	[p32l864t1499r1131b1549],
18	trial	NN	O	trial	dobj	16	SENT_667	[p32l1147t1499r1244b1549],
19	(	CD	NUMBER	(	num	21	SENT_667	[p32l1263t1500r1473b1556],
20	EQUIP	NN	O	equip	nn	21	SENT_667	[p32l1263t1500r1473b1556],
21	)	NN	O	)	nsubj	8	SENT_667	[p32l1263t1500r1473b1556],
22	.	.	O	.	_	0	SENT_667	[p32l1263t1500r1473b1556],

1	Obesity	NN	O	obesity	nn	3	SENT_668	[p32l1488t1499r1681b1563],
2	(	CD	NUMBER	(	num	3	SENT_668	[p32l1692t1499r2033b1562],
3	SiIver	NNP	O	SiIver	_	0	SENT_668	[p32l1692t1499r2033b1562],
4	$	$	MONEY	$	amod	3	SENT_668	[p32l1692t1499r2033b1562],
5	pring	JJ	MONEY	pring	dep	4	SENT_668	[p32l1692t1499r2033b1562],
6	)	NN	O	)	dep	3	SENT_668	[p32l1692t1499r2033b1562],
7	20	CD	NUMBER	20	num	6	SENT_668	[p32l2048t1502r2128b1556],
8	,	,	O	,	_	0	SENT_668	[p32l2048t1502r2128b1556],
9	330-342	CD	NUMBER	330-342	number	10	SENT_668	[p32l132t1579r356b1626],
10	(	CD	NUMBER	(	appos	6	SENT_668	[p32l373t1577r548b1634],
11	2012	CD	DATE	2012	num	12	SENT_668	[p32l373t1577r548b1634],
12	)	NN	O	)	dep	10	SENT_668	[p32l373t1577r548b1634],
13	.	.	O	.	_	0	SENT_668	[p32l373t1577r548b1634],

1	42	CD	NUMBER	42	_	0	SENT_669	[p32l7t1658r83b1705],
2	.	.	O	.	_	0	SENT_669	[p32l7t1658r83b1705],

1	Gadde	NNP	O	Gadde	nn	3	SENT_670	[p32l130t1655r316b1712],
2	,	,	O	,	_	0	SENT_670	[p32l130t1655r316b1712],
3	K.M.	NNP	O	K.M.	_	0	SENT_670	[p32l332t1657r440b1705],
4	et	FW	O	et	nn	5	SENT_670	[p32l454t1663r503b1705],
5	al.	FW	O	al.	dep	3	SENT_670	[p32l512t1655r569b1705],
6	.	.	O	.	_	0	SENT_670	[p32l512t1655r569b1705],

1	Effects	NNS	O	effect	nsubj	30	SENT_671	[p32l586t1654r756b1705],
2	of	IN	O	of	_	0	SENT_671	[p32l770t1654r825b1705],
3	low	JJ	O	low	amod	5	SENT_671	[p32l837t1655r1089b1713],
4	—	NN	O	—	nn	5	SENT_671	[p32l837t1655r1089b1713],
5	dose	NN	O	dose	prep_of	1	SENT_671	[p32l837t1655r1089b1713],
6	,	,	O	,	_	0	SENT_671	[p32l837t1655r1089b1713],
7	contro	FW	O	contro	nn	13	SENT_671	[p32l1104t1655r1592b1712],
8	|	FW	O	|	nn	13	SENT_671	[p32l1104t1655r1592b1712],
9	|	FW	O	|	nn	13	SENT_671	[p32l1104t1655r1592b1712],
10	ed	FW	O	ed	nn	13	SENT_671	[p32l1104t1655r1592b1712],
11	—	FW	O	—	nn	13	SENT_671	[p32l1104t1655r1592b1712],
12	re	FW	O	re	nn	13	SENT_671	[p32l1104t1655r1592b1712],
13	|	FW	O	|	conj_and	5	SENT_671	[p32l1104t1655r1592b1712],
14	ease	NN	O	ease	dep	13	SENT_671	[p32l1104t1655r1592b1712],
15	,	,	O	,	_	0	SENT_671	[p32l1104t1655r1592b1712],
16	phentermine	NN	O	phentermine	conj_and	5	SENT_671	[p32l1608t1655r1952b1717],
17	plus	CC	O	plus	prep	16	SENT_671	[p32l133t1733r239b1795],
18	topiramate	NN	O	topiramate	nn	19	SENT_671	[p32l253t1735r545b1796],
19	combination	NN	O	combination	dep	17	SENT_671	[p32l560t1733r895b1783],
20	on	IN	O	on	_	0	SENT_671	[p32l912t1748r977b1783],
21	weight	NN	O	weight	prep_on	19	SENT_671	[p32l992t1733r1176b1796],
22	and	CC	O	and	_	0	SENT_671	[p32l1189t1733r1286b1783],
23	associated	VBN	O	associate	amod	24	SENT_671	[p32l1303t1733r1576b1783],
24	comorbidities	NNS	O	comorbidity	prep_of	1	SENT_671	[p32l1593t1733r1957b1783],
25	in	IN	O	in	_	0	SENT_671	[p32l1974t1735r2016b1782],
26	overweight	JJ	O	overweight	amod	29	SENT_671	[p32l131t1811r433b1874],
27	and	CC	O	and	_	0	SENT_671	[p32l447t1811r544b1861],
28	obese	JJ	O	obese	amod	29	SENT_671	[p32l560t1811r717b1861],
29	adults	NNS	O	adult	prep_in	24	SENT_671	[p32l732t1811r892b1861],
30	(	VBP	O	(	_	0	SENT_671	[p32l908t1812r1125b1868],
31	CONQU	NNP	O	CONQU	nn	33	SENT_671	[p32l908t1812r1125b1868],
32	ER	NN	O	er	nn	33	SENT_671	[p32l1134t1812r1225b1868],
33	)	NN	O	)	dobj	30	SENT_671	[p32l1134t1812r1225b1868],
34	:	:	O	:	_	0	SENT_671	[p32l1134t1812r1225b1868],
35	a	DT	O	a	dep	33	SENT_671	[p32l1239t1826r1264b1861],
36	randomised	VBN	O	randomise	partmod	35	SENT_671	[p32l1283t1811r1609b1868],
37	,	,	O	,	_	0	SENT_671	[p32l1283t1811r1609b1868],
38	placebo	NN	O	placebo	nn	40	SENT_671	[p32l1626t1811r2141b1873],
39	—	NN	O	—	nn	40	SENT_671	[p32l1626t1811r2141b1873],
40	contro	NN	O	contro	appos	33	SENT_671	[p32l1626t1811r2141b1873],
41	|	CD	NUMBER	|	num	42	SENT_671	[p32l1626t1811r2141b1873],
42	|	NN	O	|	nsubj	43	SENT_671	[p32l1626t1811r2141b1873],
43	ed	VBD	O	ed	rcmod	40	SENT_671	[p32l1626t1811r2141b1873],
44	,	,	O	,	_	0	SENT_671	[p32l1626t1811r2141b1873],
45	phase	NN	O	phase	nn	47	SENT_671	[p32l133t1889r288b1951],
46	3	CD	NUMBER	3	num	47	SENT_671	[p32l303t1892r330b1939],
47	trial	NN	O	trial	appos	33	SENT_671	[p32l344t1889r457b1939],
48	.	.	O	.	_	0	SENT_671	[p32l344t1889r457b1939],

1	Lancet377	NN	O	lancet377	_	0	SENT_672	[p32l472t1891r769b1946],
2	,	,	O	,	_	0	SENT_672	[p32l472t1891r769b1946],
3	1341	CD	DATE	1341	appos	1	SENT_672	[p32l788t1892r901b1939],
4	-1	CD	NUMBER	-1	number	5	SENT_672	[p32l914t1893r966b1938],
5	352	CD	NUMBER	352	num	6	SENT_672	[p32l980t1892r1073b1939],
6	(	NN	O	(	dep	3	SENT_672	[p32l1090t1890r1191b1946],
7	201	CD	NUMBER	201	number	8	SENT_672	[p32l1090t1890r1191b1946],
8	1	CD	NUMBER	1	num	9	SENT_672	[p32l1210t1890r1265b1946],
9	)	NN	O	)	dep	3	SENT_672	[p32l1210t1890r1265b1946],
10	.	.	O	.	_	0	SENT_672	[p32l1210t1890r1265b1946],

1	43	CD	NUMBER	43	_	0	SENT_673	[p32l6t1970r83b2017],
2	.	.	O	.	_	0	SENT_673	[p32l6t1970r83b2017],

1	Garvey	NNP	PERSON	Garvey	_	0	SENT_674	[p32l130t1969r324b2031],
2	,	,	O	,	_	0	SENT_674	[p32l130t1969r324b2031],
3	W.T.	NNP	PERSON	W.T.	nn	4	SENT_674	[p32l335t1969r437b2017],
4	etaI	NNP	PERSON	etaI	appos	1	SENT_674	[p32l452t1967r821b2031],
5	.	.	O	.	_	0	SENT_674	[p32l452t1967r821b2031],

1	Two	CD	NUMBER	two	num	3	SENT_675	[p32l452t1967r821b2031],
2	—	CD	NUMBER	—	num	3	SENT_675	[p32l452t1967r821b2031],
3	year	NN	NUMBER	year	nsubj	14	SENT_675	[p32l452t1967r821b2031],
4	sustained	VBD	O	sustain	rcmod	3	SENT_675	[p32l834t1967r1084b2017],
5	weight	NN	O	weight	nn	6	SENT_675	[p32l1100t1967r1283b2030],
6	loss	NN	O	loss	dobj	4	SENT_675	[p32l1299t1967r1393b2017],
7	and	CC	O	and	_	0	SENT_675	[p32l1408t1967r1505b2017],
8	metabolic	JJ	O	metabolic	amod	9	SENT_675	[p32l1524t1967r1786b2017],
9	beneﬁts	NNS	O	beneﬁts	dobj	4	SENT_675	[p32l1802t1966r2011b2017],
10	with	IN	O	with	_	0	SENT_675	[p32l2025t1967r2139b2017],
11	contro	NN	O	contro	nn	13	SENT_675	[p32l131t2045r608b2095],
12	|	CD	NUMBER	|	num	13	SENT_675	[p32l131t2045r608b2095],
13	|	NN	O	|	prep_with	4	SENT_675	[p32l131t2045r608b2095],
14	ed	VBD	O	ed	_	0	SENT_675	[p32l131t2045r608b2095],
15	—	CD	NUMBER	—	num	17	SENT_675	[p32l131t2045r608b2095],
16	re	NN	O	re	nn	17	SENT_675	[p32l131t2045r608b2095],
17	|	NNS	O	|	nsubj	18	SENT_675	[p32l131t2045r608b2095],
18	ease	VBP	O	ease	ccomp	14	SENT_675	[p32l131t2045r608b2095],
19	phentermine/topiramate	NN	O	phentermine/topiramate	nsubj	25	SENT_675	[p32l624t2045r1284b2108],
20	in	IN	O	in	_	0	SENT_675	[p32l1301t2047r1344b2094],
21	obese	JJ	O	obese	amod	24	SENT_675	[p32l1360t2045r1517b2095],
22	and	CC	O	and	_	0	SENT_675	[p32l1532t2045r1629b2095],
23	overweight	JJ	O	overweight	conj_and	21	SENT_675	[p32l1645t2045r1947b2108],
24	adults	NNS	O	adult	prep_in	19	SENT_675	[p32l1960t2045r2120b2095],
25	(	VBP	O	(	ccomp	18	SENT_675	[p32l133t2124r387b2180],
26	SEQUEL	NN	O	sequel	dobj	25	SENT_675	[p32l133t2124r387b2180],
27	)	CD	NUMBER	)	num	26	SENT_675	[p32l133t2124r387b2180],
28	:	:	O	:	_	0	SENT_675	[p32l133t2124r387b2180],
29	a	DT	O	a	dep	26	SENT_675	[p32l401t2138r427b2173],
30	randomized	VBN	O	randomize	partmod	29	SENT_675	[p32l445t2123r773b2180],
31	,	,	O	,	_	0	SENT_675	[p32l445t2123r773b2180],
32	placebo	NN	O	placebo	nn	33	SENT_675	[p32l790t2123r1305b2185],
33	—	NN	O	—	appos	26	SENT_675	[p32l790t2123r1305b2185],
34	controlled	VBN	O	control	partmod	33	SENT_675	[p32l790t2123r1305b2185],
35	,	,	O	,	_	0	SENT_675	[p32l790t2123r1305b2185],
36	phase	NN	O	phase	nn	39	SENT_675	[p32l1322t2123r1476b2185],
37	3	CD	NUMBER	3	num	39	SENT_675	[p32l1491t2126r1518b2173],
38	extension	NN	O	extension	nn	39	SENT_675	[p32l1534t2125r1790b2173],
39	study	NN	O	study	appos	26	SENT_675	[p32l1806t2123r2117b2187],
40	.	.	O	.	_	0	SENT_675	[p32l1806t2123r2117b2187],

1	Am	NNP	O	Am	_	0	SENT_676	[p32l1806t2123r2117b2187],
2	.	.	O	.	_	0	SENT_676	[p32l1806t2123r2117b2187],

1	J.	NNP	PERSON	J.	nn	2	SENT_677	[p32l1806t2123r2117b2187],
2	Clin	NNP	PERSON	Clin	_	0	SENT_677	[p32l132t2200r237b2250],
3	.	.	O	.	_	0	SENT_677	[p32l132t2200r237b2250],

1	Nutr	NNP	O	Nutr	_	0	SENT_678	[p32l252t2202r376b2250],
2	.	.	O	.	_	0	SENT_678	[p32l252t2202r376b2250],

1	95	CD	NUMBER	95	_	0	SENT_679	[p32l390t2203r471b2257],
2	,	,	O	,	_	0	SENT_679	[p32l390t2203r471b2257],
3	297-308	CD	NUMBER	297-308	number	4	SENT_679	[p32l486t2203r710b2250],
4	(	CD	NUMBER	(	appos	1	SENT_679	[p32l727t2201r901b2258],
5	2012	CD	DATE	2012	num	6	SENT_679	[p32l727t2201r901b2258],
6	)	NN	O	)	dep	4	SENT_679	[p32l727t2201r901b2258],
7	.	.	O	.	_	0	SENT_679	[p32l727t2201r901b2258],

1	44	CD	NUMBER	44	_	0	SENT_680	[p32l6t2283r83b2329],
2	.	.	O	.	_	0	SENT_680	[p32l6t2283r83b2329],

1	Vivus	NNP	O	Vivus	_	0	SENT_681	[p32l128t2281r428b2329],
2	.	.	O	.	_	0	SENT_681	[p32l128t2281r428b2329],

1	Vivus	NNP	ORGANIZATION	Vivus	nn	4	SENT_682	[p32l128t2281r428b2329],
2	Announces	NNPS	O	Announces	nn	4	SENT_682	[p32l442t2281r741b2329],
3	FDA	NNP	ORGANIZATION	FDA	nn	4	SENT_682	[p32l758t2281r864b2328],
4	Approval	NN	O	approval	_	0	SENT_682	[p32l878t2279r1115b2342],
5	of	IN	O	of	_	0	SENT_682	[p32l1132t2278r1187b2329],
6	Once	RB	DATE	once	advmod	15	SENT_682	[p32l1196t2281r1332b2329],
7	Daily	JJ	SET	daily	amod	10	SENT_682	[p32l1349t2279r1478b2343],
8	Qsymia	NN	O	qsymium	nn	10	SENT_682	[p32l1491t2281r1684b2343],
9	(	NN	O	(	nn	10	SENT_682	[p32l1702t2279r2061b2336],
10	Phentermine	NN	O	phentermine	nsubj	15	SENT_682	[p32l1702t2279r2061b2336],
11	and	CC	O	and	_	0	SENT_682	[p32l131t2357r228b2407],
12	Topiramate	NNP	O	Topiramate	nn	14	SENT_682	[p32l239t2359r540b2419],
13	Extended	NNP	O	Extended	nn	14	SENT_682	[p32l557t2357r1028b2414],
14	—	NNP	O	—	conj_and	10	SENT_682	[p32l557t2357r1028b2414],
15	re	VB	O	re	prepc_of	4	SENT_682	[p32l557t2357r1028b2414],
16	|	NNS	O	|	dobj	15	SENT_682	[p32l557t2357r1028b2414],
17	ease	VB	O	ease	dep	15	SENT_682	[p32l557t2357r1028b2414],
18	)	RB	O	)	advmod	17	SENT_682	[p32l557t2357r1028b2414],
19	Capsules	NNPS	O	Capsules	nn	20	SENT_682	[p32l1044t2357r1277b2419],
20	CIV	NNP	O	CIV	dobj	17	SENT_682	[p32l1292t2359r1386b2407],
21	.	.	O	.	_	0	SENT_682	[p32l1292t2359r1386b2407],

1	.	.	O	.	_	0	SENT_683	[p32l1402t2357r2077b2419],

1	45	CD	NUMBER	45	_	0	SENT_684	[p32l6t2439r82b2485],
2	.	.	O	.	_	0	SENT_684	[p32l6t2439r82b2485],

1	Hendricks	NNP	PERSON	Hendricks	nn	3	SENT_685	[p32l132t2435r404b2492],
2	,	,	O	,	_	0	SENT_685	[p32l132t2435r404b2492],
3	E.J.	NNP	O	E.J.	dep	4	SENT_685	[p32l420t2437r494b2485],
4	etal	JJ	O	etal	_	0	SENT_685	[p32l508t2435r624b2485],
5	.	.	O	.	_	0	SENT_685	[p32l508t2435r624b2485],

1	Addiction	NN	O	addiction	nn	2	SENT_686	[p32l638t2435r894b2485],
2	potential	NN	O	potential	nsubj	5	SENT_686	[p32l912t2435r1146b2497],
3	of	IN	O	of	_	0	SENT_686	[p32l1163t2434r1217b2485],
4	phentermine	NN	O	phentermine	prep_of	2	SENT_686	[p32l1229t2435r1572b2498],
5	prescribed	VBN	O	prescribe	_	0	SENT_686	[p32l1589t2435r1864b2498],
6	during	IN	O	during	_	0	SENT_686	[p32l1881t2435r2054b2498],
7	long	JJ	O	long	amod	10	SENT_686	[p32l134t2513r394b2576],
8	—	JJ	O	—	amod	10	SENT_686	[p32l134t2513r394b2576],
9	term	NN	O	term	nn	10	SENT_686	[p32l134t2513r394b2576],
10	treatment	NN	O	treatment	prep_during	5	SENT_686	[p32l409t2521r674b2563],
11	of	IN	O	of	_	0	SENT_686	[p32l688t2512r742b2563],
12	obesity	NN	O	obesity	prep_of	10	SENT_686	[p32l752t2513r954b2577],
13	.	.	O	.	_	0	SENT_686	[p32l752t2513r954b2577],

1	Int	NN	O	int	_	0	SENT_687	[p32l969t2515r1045b2563],
2	.	.	O	.	_	0	SENT_687	[p32l969t2515r1045b2563],

1	J.	NNP	O	J.	nn	2	SENT_688	[p32l1056t2515r1091b2563],
2	Obes	NNP	O	Obes	_	0	SENT_688	[p32l1107t2513r1242b2563],
3	.	.	O	.	_	0	SENT_688	[p32l1107t2513r1242b2563],

1	(	RB	O	(	dep	3	SENT_689	[p32l1260t2513r1431b2570],
2	Lond	JJ	O	lond	amod	3	SENT_689	[p32l1260t2513r1431b2570],
3	)	NN	O	)	_	0	SENT_689	[p32l1260t2513r1431b2570],
4	.	.	O	.	_	0	SENT_689	[p32l1260t2513r1431b2570],

1	(	RB	O	(	dep	3	SENT_690	[p32l1447t2514r1622b2570],
2	2013	CD	DATE	2013	num	3	SENT_690	[p32l1447t2514r1622b2570],
3	)	NN	O	)	_	0	SENT_690	[p32l1447t2514r1622b2570],
4	;	:	O	;	_	0	SENT_690	[p32l1447t2514r1622b2570],
5	e	SYM	O	e	dep	3	SENT_690	[p32l1637t2513r1794b2575],
6	—	CD	NUMBER	—	num	7	SENT_690	[p32l1637t2513r1794b2575],
7	pub	NN	O	pub	npadvmod	5	SENT_690	[p32l1637t2513r1794b2575],
8	ahead	RB	O	ahead	_	0	SENT_690	[p32l1808t2513r1968b2563],
9	of	IN	O	of	_	0	SENT_690	[p32l1985t2512r2039b2563],
10	print	NN	O	print	prep_ahead_of	5	SENT_690	[p32l133t2593r257b2653],
11	17	CD	DATE	17	num	10	SENT_690	[p32l275t2595r332b2640],
12	May	NNP	DATE	May	tmod	10	SENT_690	[p32l348t2593r457b2655],
13	2013	CD	DATE	2013	num	12	SENT_690	[p32l471t2594r610b2641],
14	.	.	O	.	_	0	SENT_690	[p32l471t2594r610b2641],

1	46	CD	NUMBER	46	_	0	SENT_691	[p32l6t2672r83b2719],
2	.	.	O	.	_	0	SENT_691	[p32l6t2672r83b2719],

1	Khazaa	JJ	O	khazaa	amod	2	SENT_692	[p32l132t2669r393b2726],
2	|	NN	O	|	nsubj	11	SENT_692	[p32l132t2669r393b2726],
3	,	,	O	,	_	0	SENT_692	[p32l132t2669r393b2726],
4	Y.	NNP	O	Y.	appos	2	SENT_692	[p32l132t2669r393b2726],
5	&	CC	O	&	_	0	SENT_692	[p32l408t2671r444b2719],
6	Zullino	NNP	O	Zullino	conj_and	4	SENT_692	[p32l457t2669r651b2726],
7	,	,	O	,	_	0	SENT_692	[p32l457t2669r651b2726],
8	D.F.	NNP	O	D.F.	nn	10	SENT_692	[p32l667t2669r1300b2732],
9	Topiramate	NNP	O	Topiramate	nn	10	SENT_692	[p32l667t2669r1300b2732],
10	—	NN	O	—	appos	4	SENT_692	[p32l667t2669r1300b2732],
11	induced	VBD	O	induce	_	0	SENT_692	[p32l667t2669r1300b2732],
12	weight	NN	O	weight	nn	13	SENT_692	[p32l1315t2669r1499b2732],
13	loss	NN	O	loss	nsubj	16	SENT_692	[p32l1515t2669r1610b2719],
14	is	VBZ	O	be	cop	16	SENT_692	[p32l1626t2671r1660b2719],
15	possibly	RB	O	possibly	advmod	16	SENT_692	[p32l1677t2669r1891b2733],
16	due	JJ	O	due	ccomp	11	SENT_692	[p32l1904t2669r2004b2719],
17	to	TO	O	to	_	0	SENT_692	[p32l2017t2677r2070b2719],
18	the	DT	O	the	det	19	SENT_692	[p32l130t2747r216b2797],
19	blockade	NN	O	blockade	prep_to	16	SENT_692	[p32l233t2747r472b2797],
20	of	IN	O	of	_	0	SENT_692	[p32l487t2746r541b2797],
21	conditioned	JJ	O	conditioned	amod	24	SENT_692	[p32l551t2747r870b2797],
22	and	CC	O	and	_	0	SENT_692	[p32l886t2747r983b2797],
23	automatic	JJ	O	automatic	conj_and	21	SENT_692	[p32l999t2749r1267b2797],
24	processes	NNS	O	process	prep_of	19	SENT_692	[p32l1283t2762r1549b2809],
25	.	.	O	.	_	0	SENT_692	[p32l1283t2762r1549b2809],

1	Eur	NNP	O	Eur	_	0	SENT_693	[p32l1564t2749r1652b2797],
2	.	.	O	.	_	0	SENT_693	[p32l1564t2749r1652b2797],

1	J.	NNP	PERSON	J.	nn	2	SENT_694	[p32l1663t2749r1698b2797],
2	Clin	NNP	PERSON	Clin	_	0	SENT_694	[p32l1714t2747r1819b2797],
3	.	.	O	.	_	0	SENT_694	[p32l1714t2747r1819b2797],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_695	[p32l1834t2747r2123b2797],
2	.	.	O	.	_	0	SENT_695	[p32l1834t2747r2123b2797],

1	63	CD	NUMBER	63	_	0	SENT_696	[p32l131t2828r212b2882],
2	,	,	O	,	_	0	SENT_696	[p32l131t2828r212b2882],
3	891-2	CD	NUMBER	891-2	appos	1	SENT_696	[p32l226t2828r399b2882],
4	;	:	O	;	_	0	SENT_696	[p32l226t2828r399b2882],
5	author	NN	O	author	nn	6	SENT_696	[p32l413t2825r589b2875],
6	reply	NN	O	reply	dep	1	SENT_696	[p32l605t2825r734b2889],
7	893	CD	NUMBER	893	number	8	SENT_696	[p32l747t2828r840b2875],
8	(	CD	NUMBER	(	dep	6	SENT_696	[p32l858t2826r1033b2882],
9	2007	CD	DATE	2007	num	10	SENT_696	[p32l858t2826r1033b2882],
10	)	NN	O	)	dep	8	SENT_696	[p32l858t2826r1033b2882],
11	.	.	O	.	_	0	SENT_696	[p32l858t2826r1033b2882],

1	47	CD	NUMBER	47	_	0	SENT_697	[p32l6t2907r83b2953],
2	.	.	O	.	_	0	SENT_697	[p32l6t2907r83b2953],

1	McE	NNP	O	McE	nn	3	SENT_698	[p32l131t2903r348b2967],
2	|	NNP	O	|	nn	3	SENT_698	[p32l131t2903r348b2967],
3	roy	NN	O	roy	_	0	SENT_698	[p32l131t2903r348b2967],
4	,	,	O	,	_	0	SENT_698	[p32l131t2903r348b2967],
5	S.L.	NNP	LOCATION	S.L.	nn	10	SENT_698	[p32l364t2905r460b2961],
6	,	,	O	,	_	0	SENT_698	[p32l364t2905r460b2961],
7	Hudson	NNP	LOCATION	Hudson	appos	10	SENT_698	[p32l477t2903r693b2961],
8	,	,	O	,	_	0	SENT_698	[p32l477t2903r693b2961],
9	J.	NNP	O	J.	appos	10	SENT_698	[p32l705t2906r781b2961],
10	|	NNP	O	|	appos	3	SENT_698	[p32l705t2906r781b2961],
11	.	.	O	.	_	0	SENT_698	[p32l705t2906r781b2961],

1	,	,	O	,	_	0	SENT_699	[p32l705t2906r781b2961],
2	Capece	NNP	PERSON	Capece	nn	10	SENT_699	[p32l795t2905r1000b2966],
3	,	,	O	,	_	0	SENT_699	[p32l795t2905r1000b2966],
4	J.A.	NNP	PERSON	J.A.	appos	10	SENT_699	[p32l1013t2906r1112b2961],
5	,	,	O	,	_	0	SENT_699	[p32l1013t2906r1112b2961],
6	Beyers	NNP	PERSON	Beyers	appos	10	SENT_699	[p32l1129t2905r1310b2967],
7	,	,	O	,	_	0	SENT_699	[p32l1129t2905r1310b2967],
8	K.	NNP	O	K.	appos	10	SENT_699	[p32l1327t2906r1382b2961],
9	,	,	O	,	_	0	SENT_699	[p32l1327t2906r1382b2961],
10	Fisher	NNP	PERSON	Fisher	dep	12	SENT_699	[p32l1399t2903r1561b2961],
11	,	,	O	,	_	0	SENT_699	[p32l1399t2903r1561b2961],
12	A.C.	NNP	ORGANIZATION	A.C.	dep	21	SENT_699	[p32l1574t2905r1674b2953],
13	&	CC	ORGANIZATION	&	cc	14	SENT_699	[p32l1688t2905r1725b2953],
14	Rosenthal	NNP	ORGANIZATION	Rosenthal	dep	12	SENT_699	[p32l1740t2903r2011b2961],
15	,	,	O	,	_	0	SENT_699	[p32l1740t2903r2011b2961],
16	N.R.	NNP	LOCATION	N.R.	appos	14	SENT_699	[p32l134t2983r553b3044],
17	;	:	O	;	_	0	SENT_699	[p32l134t2983r553b3044],
18	Topiramate	NNP	ORGANIZATION	Topiramate	nn	19	SENT_699	[p32l134t2983r553b3044],
19	Binge	NNP	ORGANIZATION	Binge	dep	14	SENT_699	[p32l570t2983r717b3044],
20	Eating	NNP	ORGANIZATION	Eating	nn	21	SENT_699	[p32l734t2984r895b3044],
21	Disorder	NNP	ORGANIZATION	Disorder	_	0	SENT_699	[p32l913t2981r1136b3031],
22	Research	NNP	ORGANIZATION	Research	nn	23	SENT_699	[p32l1151t2981r1382b3031],
23	Group	NNP	ORGANIZATION	Group	dep	21	SENT_699	[p32l1399t2983r1885b3044],
24	.	.	O	.	_	0	SENT_699	[p32l1399t2983r1885b3044],

1	Topiramate	NNP	O	Topiramate	nsubj	9	SENT_700	[p32l1399t2983r1885b3044],
2	for	IN	O	for	_	0	SENT_700	[p32l1898t2981r1971b3031],
3	the	DT	O	the	det	4	SENT_700	[p32l130t3059r216b3109],
4	treatment	NN	O	treatment	prep_for	1	SENT_700	[p32l229t3067r494b3109],
5	of	IN	O	of	_	0	SENT_700	[p32l508t3059r563b3109],
6	binge	NN	O	binge	nn	8	SENT_700	[p32l574t3059r723b3122],
7	eating	JJ	O	eating	amod	8	SENT_700	[p32l738t3062r902b3122],
8	disorder	NN	O	disorder	prep_of	4	SENT_700	[p32l919t3059r1137b3109],
9	associated	VBN	O	associate	_	0	SENT_700	[p32l1149t3059r1423b3109],
10	with	IN	O	with	_	0	SENT_700	[p32l1439t3059r1552b3109],
11	obesity	NN	O	obesity	prep_with	9	SENT_700	[p32l1569t3059r1775b3123],
12	:	:	O	:	_	0	SENT_700	[p32l1569t3059r1775b3123],
13	a	DT	O	a	det	15	SENT_700	[p32l1790t3074r1815b3109],
14	placebocontrolled	JJ	O	placebocontrolled	amod	15	SENT_700	[p32l1834t3059r2062b3122, p32l131t3137r399b3187],
15	study	NN	O	study	dep	11	SENT_700	[p32l415t3137r569b3201],
16	.	.	O	.	_	0	SENT_700	[p32l415t3137r569b3201],

1	Biol	NNP	O	Biol	_	0	SENT_701	[p32l584t3137r686b3187],
2	.	.	O	.	_	0	SENT_701	[p32l584t3137r686b3187],

1	Psychiatry	NNP	O	Psychiatry	_	0	SENT_702	[p32l701t3137r963b3201],
2	61	CD	NUMBER	61	num	1	SENT_702	[p32l973t3141r1032b3187],
3	,	,	O	,	_	0	SENT_702	[p32l1043t3177r1054b3195],
4	1039-1048	CD	DATE	1039-1048	num	1	SENT_702	[p32l1073t3140r1359b3187],
5	(	CD	NUMBER	(	num	7	SENT_702	[p32l1375t3138r1550b3195],
6	2007	CD	DATE	2007	num	7	SENT_702	[p32l1375t3138r1550b3195],
7	)	NN	O	)	dep	1	SENT_702	[p32l1375t3138r1550b3195],
8	.	.	O	.	_	0	SENT_702	[p32l1375t3138r1550b3195],

1	48	CD	NUMBER	48	_	0	SENT_703	[p32l6t3218r83b3265],
2	.	.	O	.	_	0	SENT_703	[p32l6t3218r83b3265],

1	Shin	NNP	PERSON	Shin	_	0	SENT_704	[p32l130t3215r256b3273],
2	,	,	O	,	_	0	SENT_704	[p32l130t3215r256b3273],
3	J.H.	NNP	ORGANIZATION	J.H.	conj_and	1	SENT_704	[p32l269t3218r358b3265],
4	&	CC	ORGANIZATION	&	_	0	SENT_704	[p32l372t3217r409b3265],
5	Gadde	NNP	ORGANIZATION	Gadde	conj_and	1	SENT_704	[p32l421t3215r607b3273],
6	,	,	O	,	_	0	SENT_704	[p32l421t3215r607b3273],
7	K.M.	NNP	O	K.M.	appos	1	SENT_704	[p32l624t3218r732b3265],
8	Clinical	JJ	O	clinical	amod	9	SENT_704	[p32l746t3215r931b3265],
9	utility	NN	O	utility	dep	1	SENT_704	[p32l950t3215r1099b3279],
10	of	IN	O	of	_	0	SENT_704	[p32l1112t3215r1166b3265],
11	phentermine/topiramate	NN	O	phentermine/topiramate	nn	13	SENT_704	[p32l1178t3215r1838b3278],
12	(	CD	NUMBER	(	num	13	SENT_704	[p32l1855t3216r2121b3279],
13	Qsymia	NNP	O	Qsymia	prep_of	9	SENT_704	[p32l1855t3216r2121b3279],
14	"	``	O	"	punct	13	SENT_704	[p32l1855t3216r2121b3279],
15	"	``	O	"	punct	16	SENT_704	[p32l1855t3216r2121b3279],
16	)	SYM	O	)	dep	13	SENT_704	[p32l1855t3216r2121b3279],

1	combination	NN	O	combination	_	0	SENT_705	[p32l131t3293r466b3343],
2	for	IN	O	for	_	0	SENT_705	[p32l481t3293r554b3343],
3	the	DT	O	the	det	4	SENT_705	[p32l566t3293r652b3343],
4	treatment	NN	O	treatment	prep_for	1	SENT_705	[p32l665t3301r930b3343],
5	of	IN	O	of	_	0	SENT_705	[p32l944t3293r999b3343],
6	obesity	NN	O	obesity	prep_of	1	SENT_705	[p32l1009t3293r1211b3357],
7	.	.	O	.	_	0	SENT_705	[p32l1009t3293r1211b3357],

1	Diabetes	NNP	O	Diabetes	_	0	SENT_706	[p32l1225t3293r1457b3343],
2	.	.	O	.	_	0	SENT_706	[p32l1225t3293r1457b3343],

1	Metab	NNP	PERSON	Metab	_	0	SENT_707	[p32l1470t3293r1644b3343],
2	.	.	O	.	_	0	SENT_707	[p32l1470t3293r1644b3343],

1	Syndr	NNP	O	Syndr	_	0	SENT_708	[p32l1658t3293r1810b3357],
2	.	.	O	.	_	0	SENT_708	[p32l1658t3293r1810b3357],

1	Obes	NNS	ORGANIZATION	obe	_	0	SENT_709	[p32l1825t3293r1964b3343],
2	.	.	O	.	_	0	SENT_709	[p32l1825t3293r1964b3343],

1	6	CD	NUMBER	6	_	0	SENT_710	[p32l1978t3297r2023b3351],
2	,	,	O	,	_	0	SENT_710	[p32l1978t3297r2023b3351],
3	131	CD	NUMBER	131	num	4	SENT_710	[p32l136t3373r216b3420],
4	-1	CD	NUMBER	-1	appos	1	SENT_710	[p32l229t3374r280b3420],
5	39	CD	NUMBER	39	num	6	SENT_710	[p32l295t3373r357b3420],
6	(	NN	O	(	dep	4	SENT_710	[p32l372t3371r473b3428],
7	201	CD	NUMBER	201	number	8	SENT_710	[p32l372t3371r473b3428],
8	3	CD	NUMBER	3	num	9	SENT_710	[p32l488t3371r547b3428],
9	)	NN	O	)	dep	6	SENT_710	[p32l488t3371r547b3428],
10	.	.	O	.	_	0	SENT_710	[p32l488t3371r547b3428],

1	49	CD	NUMBER	49	_	0	SENT_711	[p32l6t3452r83b3499],
2	.	.	O	.	_	0	SENT_711	[p32l6t3452r83b3499],

1	Krishna	NNP	PERSON	Krishna	_	0	SENT_712	[p32l132t3449r337b3507],
2	,	,	O	,	_	0	SENT_712	[p32l132t3449r337b3507],
3	R.	NNP	O	R.	nn	4	SENT_712	[p32l354t3451r396b3499],
4	etal	NN	O	etal	appos	1	SENT_712	[p32l410t3449r525b3499],
5	.	.	O	.	_	0	SENT_712	[p32l410t3449r525b3499],

1	Potent	JJ	O	potent	amod	4	SENT_713	[p32l542t3451r713b3499],
2	and	CC	O	and	_	0	SENT_713	[p32l727t3449r824b3499],
3	selective	JJ	O	selective	conj_and	1	SENT_713	[p32l840t3449r1068b3499],
4	agonism	NN	O	agonism	nsubj	16	SENT_713	[p32l1082t3452r1308b3512],
5	of	IN	O	of	_	0	SENT_713	[p32l1325t3449r1379b3499],
6	the	DT	O	the	det	8	SENT_713	[p32l1387t3449r1474b3499],
7	melanocortin	NN	O	melanocortin	nn	8	SENT_713	[p32l1490t3449r1841b3499],
8	receptor	NN	O	receptor	prep_of	4	SENT_713	[p32l1860t3457r2081b3512],
9	4	CD	NUMBER	4	dep	8	SENT_713	[p32l2093t3453r2124b3498],
10	with	IN	O	with	_	0	SENT_713	[p32l130t3527r244b3577],
11	MK	NN	O	mk	prep_with	9	SENT_713	[p32l262t3530r491b3577],
12	—	CD	NUMBER	—	number	13	SENT_713	[p32l262t3530r491b3577],
13	0493	CD	DATE	0493	num	11	SENT_713	[p32l262t3530r491b3577],
14	does	VBZ	O	do	aux	16	SENT_713	[p32l507t3527r632b3577],
15	not	RB	O	not	neg	16	SENT_713	[p32l649t3535r735b3577],
16	induce	VB	O	induce	_	0	SENT_713	[p32l750t3527r927b3577],
17	weight	NN	O	weight	nn	18	SENT_713	[p32l941t3527r1124b3590],
18	loss	NN	O	loss	dobj	16	SENT_713	[p32l1140t3527r1235b3577],
19	in	IN	O	in	_	0	SENT_713	[p32l1251t3530r1294b3576],
20	obese	JJ	O	obese	amod	22	SENT_713	[p32l1310t3527r1468b3577],
21	human	JJ	O	human	amod	22	SENT_713	[p32l1484t3527r1667b3577],
22	subjects	NNS	O	subject	prep_in	16	SENT_713	[p32l1684t3527r1913b3590],
23	:	:	O	:	_	0	SENT_713	[p32l1684t3527r1913b3590],
24	energy	NN	O	energy	nn	25	SENT_713	[p32l1928t3542r2111b3591],
25	intake	NN	O	intake	nsubj	26	SENT_713	[p32l133t3605r291b3655],
26	predicts	VBZ	O	predict	parataxis	16	SENT_713	[p32l308t3605r517b3668],
27	lack	NN	O	lack	dobj	26	SENT_713	[p32l534t3605r635b3655],
28	of	IN	O	of	_	0	SENT_713	[p32l647t3605r701b3655],
29	weight	NN	O	weight	nn	31	SENT_713	[p32l710t3605r894b3668],
30	loss	NN	O	loss	nn	31	SENT_713	[p32l910t3605r1004b3655],
31	efﬁcacy	NN	O	efﬁcacy	prep_of	27	SENT_713	[p32l1019t3605r1230b3669],
32	.	.	O	.	_	0	SENT_713	[p32l1019t3605r1230b3669],

1	Clin	NNP	O	Clin	_	0	SENT_714	[p32l1245t3605r1350b3655],
2	.	.	O	.	_	0	SENT_714	[p32l1245t3605r1350b3655],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_715	[p32l1365t3605r1651b3655],
2	.	.	O	.	_	0	SENT_715	[p32l1365t3605r1651b3655],

1	Ther	NNP	O	Ther	_	0	SENT_716	[p32l1668t3605r1789b3655],
2	.	.	O	.	_	0	SENT_716	[p32l1668t3605r1789b3655],

1	86	CD	NUMBER	86	_	0	SENT_717	[p32l1803t3608r1883b3663],
2	,	,	O	,	_	0	SENT_717	[p32l1803t3608r1883b3663],
3	659-666	CD	NUMBER	659-666	number	4	SENT_717	[p32l1898t3608r2123b3655],
4	(	CD	NUMBER	(	appos	1	SENT_717	[p32l133t3683r308b3740],
5	2009	CD	DATE	2009	num	6	SENT_717	[p32l133t3683r308b3740],
6	)	NN	O	)	dep	4	SENT_717	[p32l133t3683r308b3740],
7	.	.	O	.	_	0	SENT_717	[p32l133t3683r308b3740],

1	50	CD	NUMBER	50	_	0	SENT_718	[p33l8t21r82b67],
2	.	.	O	.	_	0	SENT_718	[p33l8t21r82b67],

1	Wikberg	NNP	PERSON	Wikberg	_	0	SENT_719	[p33l128t17r361b80],
2	,	,	O	,	_	0	SENT_719	[p33l128t17r361b80],
3	J.E.	NNP	ORGANIZATION	J.E.	conj_and	1	SENT_719	[p33l374t20r452b67],
4	&	CC	ORGANIZATION	&	_	0	SENT_719	[p33l466t19r503b67],
5	Mutulis	NNP	ORGANIZATION	Mutulis	conj_and	1	SENT_719	[p33l518t17r723b75],
6	,	,	O	,	_	0	SENT_719	[p33l518t17r723b75],
7	F.	NNP	O	F.	nn	10	SENT_719	[p33l741t20r1032b80],
8	Targeting	NN	O	targeting	nn	10	SENT_719	[p33l741t20r1032b80],
9	melanocortin	NN	O	melanocortin	nn	10	SENT_719	[p33l1051t17r1402b67],
10	receptors	NNS	O	receptor	appos	1	SENT_719	[p33l1420t25r1679b80],
11	:	:	O	:	_	0	SENT_719	[p33l1420t25r1679b80],
12	an	DT	O	a	det	13	SENT_719	[p33l1693t32r1753b67],
13	approach	NN	O	approach	dep	1	SENT_719	[p33l1770t17r2018b80],
14	to	TO	O	to	aux	15	SENT_719	[p33l130t103r183b145],
15	treat	VB	O	treat	infmod	13	SENT_719	[p33l196t103r319b145],
16	weight	NN	O	weight	nn	17	SENT_719	[p33l332t95r516b158],
17	disorders	NNS	O	disorder	dobj	15	SENT_719	[p33l529t95r771b145],
18	and	CC	O	and	_	0	SENT_719	[p33l786t95r882b145],
19	sexual	JJ	O	sexual	amod	20	SENT_719	[p33l900t95r1060b145],
20	dysfunction	NN	O	dysfunction	conj_and	17	SENT_719	[p33l1078t95r1403b159],
21	.	.	O	.	_	0	SENT_719	[p33l1078t95r1403b159],

1	Nat	NN	PERSON	nat	_	0	SENT_720	[p33l1418t98r1519b145],
2	.	.	O	.	_	0	SENT_720	[p33l1418t98r1519b145],

1	Rev.	NNP	O	Rev.	nn	3	SENT_721	[p33l1534t97r1630b145],
2	Drug	NNP	PERSON	Drug	nn	3	SENT_721	[p33l1645t97r1771b158],
3	Discov	NNP	PERSON	Discov	_	0	SENT_721	[p33l1783t97r1962b145],
4	.	.	O	.	_	0	SENT_721	[p33l1783t97r1962b145],

1	7	CD	NUMBER	7	_	0	SENT_722	[p33l1977t99r2020b153],
2	,	,	O	,	_	0	SENT_722	[p33l1977t99r2020b153],
3	307-323	CD	NUMBER	307-323	number	4	SENT_722	[p33l131t175r354b222],
4	(	CD	NUMBER	(	appos	1	SENT_722	[p33l372t173r547b230],
5	2008	CD	DATE	2008	num	6	SENT_722	[p33l372t173r547b230],
6	)	NN	O	)	dep	4	SENT_722	[p33l372t173r547b230],
7	.	.	O	.	_	0	SENT_722	[p33l372t173r547b230],

1	51	CD	NUMBER	51	_	0	SENT_723	[p33l8t255r82b301],
2	.	.	O	.	_	0	SENT_723	[p33l8t255r82b301],

1	Wessells	NNP	PERSON	Wessells	_	0	SENT_724	[p33l128t251r360b309],
2	,	,	O	,	_	0	SENT_724	[p33l128t251r360b309],
3	H.	NNP	O	H.	conj_and	1	SENT_724	[p33l377t254r438b309],
4	,	,	O	,	_	0	SENT_724	[p33l377t254r438b309],
5	Gralnek	NNP	PERSON	Gralnek	conj_and	1	SENT_724	[p33l453t251r669b309],
6	,	,	O	,	_	0	SENT_724	[p33l453t251r669b309],
7	D.	NNP	O	D.	conj_and	1	SENT_724	[p33l685t253r746b309],
8	,	,	O	,	_	0	SENT_724	[p33l685t253r746b309],
9	Dorr	NNP	PERSON	Dorr	conj_and	1	SENT_724	[p33l763t253r886b309],
10	,	,	O	,	_	0	SENT_724	[p33l763t253r886b309],
11	R.	NNP	O	R.	conj_and	1	SENT_724	[p33l903t253r957b309],
12	,	,	O	,	_	0	SENT_724	[p33l903t253r957b309],
13	Hruby	NNP	PERSON	Hruby	conj_and	1	SENT_724	[p33l974t251r1246b315],
14	,	,	O	,	_	0	SENT_724	[p33l974t251r1246b315],
15	V.J.	NNP	LOCATION	V.J.	conj_and	1	SENT_724	[p33l974t251r1246b315],
16	,	,	O	,	_	0	SENT_724	[p33l974t251r1246b315],
17	Hadley	NNP	PERSON	Hadley	conj_and	1	SENT_724	[p33l1263t251r1453b315],
18	,	,	O	,	_	0	SENT_724	[p33l1263t251r1453b315],
19	M.E.	NNP	ORGANIZATION	M.E.	conj_and	1	SENT_724	[p33l1469t254r1572b301],
20	&	CC	ORGANIZATION	&	_	0	SENT_724	[p33l1587t253r1624b301],
21	Levine	NNP	ORGANIZATION	Levine	conj_and	1	SENT_724	[p33l1639t254r1819b309],
22	,	,	O	,	_	0	SENT_724	[p33l1639t254r1819b309],
23	N.	NNP	O	N.	nn	24	SENT_724	[p33l1837t254r1885b301],
24	Effect	NN	O	effect	appos	1	SENT_724	[p33l1903t251r2047b301],
25	of	IN	O	of	_	0	SENT_724	[p33l2061t251r2116b301],
26	an	DT	O	a	det	36	SENT_724	[p33l131t344r191b379],
27	a	DT	O	a	det	33	SENT_724	[p33l208t329r687b393],
28	|	NN	O	|	nn	33	SENT_724	[p33l208t329r687b393],
29	pha	NN	O	pha	nn	33	SENT_724	[p33l208t329r687b393],
30	—	CD	NUMBER	—	num	33	SENT_724	[p33l208t329r687b393],
31	me	PRP	O	I	npadvmod	32	SENT_724	[p33l208t329r687b393],
32	|	JJ	O	|	amod	33	SENT_724	[p33l208t329r687b393],
33	anocyte	NN	O	anocyte	nn	36	SENT_724	[p33l208t329r687b393],
34	stimulating	NN	O	stimulating	nn	36	SENT_724	[p33l702t329r998b392],
35	hormone	NN	O	hormone	nn	36	SENT_724	[p33l1017t329r1259b379],
36	analog	NN	O	analog	prep_of	24	SENT_724	[p33l1274t329r1451b392],
37	on	IN	O	on	_	0	SENT_724	[p33l1467t344r1532b379],
38	penile	JJ	O	penile	amod	39	SENT_724	[p33l1551t329r1711b392],
39	erection	NN	O	erection	prep_on	36	SENT_724	[p33l1726t332r1940b379],
40	and	CC	O	and	_	0	SENT_724	[p33l1956t329r2053b379],
41	sexual	JJ	O	sexual	amod	42	SENT_724	[p33l131t407r292b457],
42	desire	NN	O	desire	conj_and	36	SENT_724	[p33l309t407r466b457],
43	in	IN	O	in	_	0	SENT_724	[p33l482t410r525b456],
44	men	NNS	O	man	prep_in	42	SENT_724	[p33l544t422r657b457],
45	with	IN	O	with	_	0	SENT_724	[p33l672t407r786b457],
46	organic	JJ	O	organic	amod	48	SENT_724	[p33l803t410r1001b470],
47	erectile	NN	O	erectile	nn	48	SENT_724	[p33l1015t407r1207b457],
48	dysfunction	NN	O	dysfunction	prep_with	44	SENT_724	[p33l1222t407r1548b471],
49	.	.	O	.	_	0	SENT_724	[p33l1222t407r1548b471],

1	Urology	NNP	O	Urology	_	0	SENT_725	[p33l1565t407r1765b471],
2	56	CD	NUMBER	56	num	1	SENT_725	[p33l1776t411r1856b465],
3	,	,	O	,	_	0	SENT_725	[p33l1776t411r1856b465],
4	641	CD	NUMBER	641	num	1	SENT_725	[p33l1870t411r1955b457],
5	-646	CD	NUMBER	-646	number	6	SENT_725	[p33l1968t411r2096b457],
6	(	CD	NUMBER	(	dep	1	SENT_725	[p33l133t485r308b542],
7	2000	CD	DATE	2000	num	8	SENT_725	[p33l133t485r308b542],
8	)	NN	O	)	dep	6	SENT_725	[p33l133t485r308b542],
9	.	.	O	.	_	0	SENT_725	[p33l133t485r308b542],

1	52	CD	NUMBER	52	_	0	SENT_726	[p33l8t566r82b613],
2	.	.	O	.	_	0	SENT_726	[p33l8t566r82b613],

1	Larhammar	NNP	O	Larhammar	nn	4	SENT_727	[p33l132t563r443b621],
2	,	,	O	,	_	0	SENT_727	[p33l132t563r443b621],
3	D.	NNP	O	D.	appos	4	SENT_727	[p33l459t565r507b613],
4	Structural	NNP	O	Structural	_	0	SENT_727	[p33l522t563r776b613],
5	diversity	NN	O	diversity	dep	4	SENT_727	[p33l793t563r1016b627],
6	of	IN	O	of	_	0	SENT_727	[p33l1029t563r1083b613],
7	receptors	NNS	O	receptor	prep_of	5	SENT_727	[p33l1096t571r1340b626],
8	for	IN	O	for	_	0	SENT_727	[p33l1353t563r1427b613],
9	neuropeptide	NN	O	neuropeptide	nn	10	SENT_727	[p33l1441t563r1803b626],
10	Y	NN	O	y	prep_for	7	SENT_727	[p33l1813t566r1852b621],
11	,	,	O	,	_	0	SENT_727	[p33l1813t566r1852b621],
12	peptide	NN	O	peptide	nn	13	SENT_727	[p33l1868t563r2072b626],
13	YY	NN	O	yy	appos	10	SENT_727	[p33l2082t566r2151b612],

1	and	CC	O	and	dep	3	SENT_728	[p33l131t641r227b691],
2	pancreatic	JJ	O	pancreatic	amod	3	SENT_728	[p33l246t644r519b704],
3	polypeptide	NN	O	polypeptide	_	0	SENT_728	[p33l535t641r868b705],
4	.	.	O	.	_	0	SENT_728	[p33l535t641r868b705],

1	Regul	NN	O	regul	_	0	SENT_729	[p33l882t641r1033b704],
2	.	.	O	.	_	0	SENT_729	[p33l882t641r1033b704],

1	Pept	NNP	O	Pept	_	0	SENT_730	[p33l1047t643r1171b704],
2	.	.	O	.	_	0	SENT_730	[p33l1047t643r1171b704],

1	65	CD	NUMBER	65	_	0	SENT_731	[p33l1185t645r1265b699],
2	,	,	O	,	_	0	SENT_731	[p33l1185t645r1265b699],
3	165-174	CD	NUMBER	165-174	number	4	SENT_731	[p33l1284t645r1506b691],
4	(	CD	NUMBER	(	appos	1	SENT_731	[p33l1521t642r1696b699],
5	1996	CD	DATE	1996	num	6	SENT_731	[p33l1521t642r1696b699],
6	)	NN	O	)	dep	4	SENT_731	[p33l1521t642r1696b699],
7	.	.	O	.	_	0	SENT_731	[p33l1521t642r1696b699],

1	53	CD	NUMBER	53	_	0	SENT_732	[p33l8t723r82b769],
2	.	.	O	.	_	0	SENT_732	[p33l8t723r82b769],

1	Omori	NNP	PERSON	Omori	_	0	SENT_733	[p33l129t721r308b777],
2	,	,	O	,	_	0	SENT_733	[p33l129t721r308b777],
3	N.	NNP	O	N.	nn	4	SENT_733	[p33l324t722r374b769],
4	etal	NN	O	etal	appos	1	SENT_733	[p33l388t719r503b769],
5	.	.	O	.	_	0	SENT_733	[p33l388t719r503b769],

1	Hit	VBN	O	hit	_	0	SENT_734	[p33l520t722r592b769],
2	to	TO	O	to	aux	3	SENT_734	[p33l605t727r658b769],
3	lead	VB	O	lead	xcomp	1	SENT_734	[p33l675t719r781b769],
4	SAR	NN	ORGANIZATION	sar	nn	5	SENT_734	[p33l798t721r900b769],
5	study	NN	O	study	dobj	3	SENT_734	[p33l914t719r1059b783],
6	on	IN	O	on	_	0	SENT_734	[p33l1072t734r1137b769],
7	benzoxazole	NN	O	benzoxazole	nn	8	SENT_734	[p33l1155t719r1484b769],
8	derivatives	NNS	O	derivative	prep_on	3	SENT_734	[p33l1499t719r1783b769],
9	for	IN	O	for	_	0	SENT_734	[p33l1796t719r1869b769],
10	an	DT	O	a	det	11	SENT_734	[p33l1882t734r1943b769],
11	NPYY5	NN	O	npyy5	prep_for	8	SENT_734	[p33l1962t721r2139b769],

1	antagonist	NN	O	antagonist	_	0	SENT_735	[p33l131t800r426b861],
2	.	.	O	.	_	0	SENT_735	[p33l131t800r426b861],

1	Bioorg	NNP	PERSON	Bioorg	_	0	SENT_736	[p33l440t799r614b861],
2	.	.	O	.	_	0	SENT_736	[p33l440t799r614b861],

1	Med	NNP	O	Med	_	0	SENT_737	[p33l628t797r748b847],
2	.	.	O	.	_	0	SENT_737	[p33l628t797r748b847],

1	Chem	NNP	O	Chem	_	0	SENT_738	[p33l765t797r921b847],
2	.	.	O	.	_	0	SENT_738	[p33l765t797r921b847],

1	Lett	NNP	PERSON	Lett	_	0	SENT_739	[p33l936t800r1041b847],
2	.	.	O	.	_	0	SENT_739	[p33l936t800r1041b847],

1	22	CD	NUMBER	22	_	0	SENT_740	[p33l1056t801r1136b855],
2	,	,	O	,	_	0	SENT_740	[p33l1056t801r1136b855],
3	2020-2023	CD	DATE	2020-2023	number	4	SENT_740	[p33l1151t801r1439b847],
4	(	CD	NUMBER	(	appos	1	SENT_740	[p33l1458t798r1633b855],
5	2012	CD	DATE	2012	num	6	SENT_740	[p33l1458t798r1633b855],
6	)	NN	O	)	dep	4	SENT_740	[p33l1458t798r1633b855],
7	.	.	O	.	_	0	SENT_740	[p33l1458t798r1633b855],

1	54	CD	NUMBER	54	_	0	SENT_741	[p33l9t879r82b925],
2	.	.	O	.	_	0	SENT_741	[p33l9t879r82b925],

1	Erondu	NNP	O	Erondu	_	0	SENT_742	[p33l132t875r332b933],
2	,	,	O	,	_	0	SENT_742	[p33l132t875r332b933],
3	N.	NNP	O	N.	nn	4	SENT_742	[p33l348t878r397b925],
4	etal	NN	O	etal	appos	1	SENT_742	[p33l411t875r527b925],
5	.	.	O	.	_	0	SENT_742	[p33l411t875r527b925],

1	Neuropeptide	NN	O	neuropeptide	nn	2	SENT_743	[p33l543t875r910b938],
2	Y5	NN	O	y5	nsubj	7	SENT_743	[p33l920t878r983b925],
3	receptor	NN	O	receptor	nn	4	SENT_743	[p33l1001t883r1222b938],
4	antagonism	NN	O	antagonism	dep	2	SENT_743	[p33l1235t878r1546b938],
5	does	VBZ	O	do	aux	7	SENT_743	[p33l1562t875r1686b925],
6	not	RB	O	not	neg	7	SENT_743	[p33l1703t883r1789b925],
7	induce	VB	O	induce	_	0	SENT_743	[p33l1805t875r1981b925],
8	clinically	RB	O	clinically	advmod	9	SENT_743	[p33l131t953r356b1017],
9	meaningful	JJ	O	meaningful	amod	11	SENT_743	[p33l371t953r669b1017],
10	weight	NN	O	weight	nn	11	SENT_743	[p33l685t953r868b1017],
11	loss	NN	O	loss	dobj	7	SENT_743	[p33l884t953r978b1003],
12	in	IN	O	in	_	0	SENT_743	[p33l994t956r1037b1002],
13	overweight	JJ	O	overweight	amod	16	SENT_743	[p33l1053t953r1354b1017],
14	and	CC	O	and	_	0	SENT_743	[p33l1368t953r1464b1003],
15	obese	JJ	O	obese	amod	16	SENT_743	[p33l1481t953r1638b1003],
16	adults	NNS	O	adult	prep_in	7	SENT_743	[p33l1652t953r1824b1003],
17	.	.	O	.	_	0	SENT_743	[p33l1652t953r1824b1003],

1	Cell	NN	O	cell	_	0	SENT_744	[p33l1839t953r1930b1003],
2	Metab	NNP	O	Metab	dep	1	SENT_744	[p33l1938t953r2115b1003],
3	.	.	O	.	_	0	SENT_744	[p33l1938t953r2115b1003],

1	4	CD	NUMBER	4	_	0	SENT_745	[p33l130t1034r176b1087],
2	,	,	O	,	_	0	SENT_745	[p33l130t1034r176b1087],
3	275-282	CD	NUMBER	275-282	number	4	SENT_745	[p33l191t1034r414b1080],
4	(	CD	NUMBER	(	appos	1	SENT_745	[p33l431t1031r605b1087],
5	2006	CD	DATE	2006	num	6	SENT_745	[p33l431t1031r605b1087],
6	)	NN	O	)	dep	4	SENT_745	[p33l431t1031r605b1087],
7	.	.	O	.	_	0	SENT_745	[p33l431t1031r605b1087],

1	55	CD	NUMBER	55	_	0	SENT_746	[p33l9t1112r82b1158],
2	.	.	O	.	_	0	SENT_746	[p33l9t1112r82b1158],

1	Sargent	NNP	PERSON	Sargent	_	0	SENT_747	[p33l130t1110r345b1172],
2	,	,	O	,	_	0	SENT_747	[p33l130t1110r345b1172],
3	B.J.	NNP	ORGANIZATION	B.J.	conj_and	1	SENT_747	[p33l362t1111r438b1158],
4	&	CC	ORGANIZATION	&	_	0	SENT_747	[p33l452t1110r489b1158],
5	Moore	NNP	ORGANIZATION	Moore	conj_and	1	SENT_747	[p33l503t1111r684b1166],
6	,	,	O	,	_	0	SENT_747	[p33l503t1111r684b1166],
7	N.A.	NNP	O	N.A.	nn	10	SENT_747	[p33l702t1111r802b1158],
8	New	NNP	O	New	nn	10	SENT_747	[p33l819t1111r935b1158],
9	central	JJ	O	central	amod	10	SENT_747	[p33l949t1108r1125b1158],
10	targets	NNS	O	target	appos	1	SENT_747	[p33l1140t1116r1323b1172],
11	for	IN	O	for	_	0	SENT_747	[p33l1336t1108r1409b1158],
12	the	DT	O	the	det	13	SENT_747	[p33l1421t1108r1506b1158],
13	treatment	NN	O	treatment	prep_for	10	SENT_747	[p33l1520t1116r1784b1158],
14	of	IN	O	of	_	0	SENT_747	[p33l1798t1108r1852b1158],
15	obesity	NN	O	obesity	prep_of	13	SENT_747	[p33l1862t1108r2063b1172],
16	.	.	O	.	_	0	SENT_747	[p33l1862t1108r2063b1172],

1	Br	NN	O	br	_	0	SENT_748	[p33l2078t1110r2136b1158],
2	.	.	O	.	_	0	SENT_748	[p33l2078t1110r2136b1158],

1	J.	NNP	PERSON	J.	nn	2	SENT_749	[p33l127t1188r162b1235],
2	Clin	NNP	PERSON	Clin	_	0	SENT_749	[p33l177t1185r282b1235],
3	.	.	O	.	_	0	SENT_749	[p33l177t1185r282b1235],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_750	[p33l297t1185r585b1235],
2	.	.	O	.	_	0	SENT_750	[p33l297t1185r585b1235],

1	68	CD	NUMBER	68	_	0	SENT_751	[p33l599t1189r680b1242],
2	,	,	O	,	_	0	SENT_751	[p33l599t1189r680b1242],
3	852-860	CD	NUMBER	852-860	number	4	SENT_751	[p33l694t1189r919b1235],
4	(	CD	NUMBER	(	appos	1	SENT_751	[p33l935t1186r1109b1242],
5	2009	CD	DATE	2009	num	6	SENT_751	[p33l935t1186r1109b1242],
6	)	NN	O	)	dep	4	SENT_751	[p33l935t1186r1109b1242],
7	.	.	O	.	_	0	SENT_751	[p33l935t1186r1109b1242],

1	56	CD	NUMBER	56	_	0	SENT_752	[p33l9t1267r82b1313],
2	.	.	O	.	_	0	SENT_752	[p33l9t1267r82b1313],

1	Greenway	NNP	O	Greenway	nn	3	SENT_753	[p33l130t1265r403b1327],
2	,	,	O	,	_	0	SENT_753	[p33l130t1265r403b1327],
3	F.L.	NNP	O	F.L.	dep	4	SENT_753	[p33l420t1266r495b1313],
4	etal	JJ	O	etal	_	0	SENT_753	[p33l509t1263r624b1313],
5	.	.	O	.	_	0	SENT_753	[p33l509t1263r624b1313],

1	Rational	JJ	O	rational	amod	7	SENT_754	[p33l641t1263r850b1313],
2	design	NN	O	design	nn	7	SENT_754	[p33l867t1263r1039b1327],
3	ofa	NN	O	ofa	nn	7	SENT_754	[p33l1056t1263r1145b1313],
4	combination	NN	O	combination	nn	7	SENT_754	[p33l1162t1263r1495b1313],
5	medication	NN	O	medication	nn	7	SENT_754	[p33l1514t1263r1807b1313],
6	forthe	NN	O	forthe	nn	7	SENT_754	[p33l1822t1263r1993b1313],
7	treatment	NN	O	treatment	_	0	SENT_754	[p33l130t1349r394b1391],
8	of	IN	O	of	_	0	SENT_754	[p33l408t1341r462b1391],
9	obesity	NN	O	obesity	prep_of	7	SENT_754	[p33l472t1341r674b1405],
10	.	.	O	.	_	0	SENT_754	[p33l472t1341r674b1405],

1	Obesity	NN	O	obesity	_	0	SENT_755	[p33l689t1341r880b1405],
2	(	CD	MONEY	(	num	5	SENT_755	[p33l892t1341r1231b1405],
3	$	$	MONEY	$	amod	5	SENT_755	[p33l892t1341r1231b1405],
4	ilverSpring	JJ	MONEY	ilverspring	dep	3	SENT_755	[p33l892t1341r1231b1405],
5	)	NN	O	)	dep	1	SENT_755	[p33l892t1341r1231b1405],
6	1	CD	NUMBER	1	number	7	SENT_755	[p33l1250t1345r1269b1390],
7	7	CD	NUMBER	7	num	5	SENT_755	[p33l1283t1345r1327b1399],
8	,	,	O	,	_	0	SENT_755	[p33l1283t1345r1327b1399],
9	30-39	CD	NUMBER	30-39	number	10	SENT_755	[p33l1341t1345r1500b1391],
10	(	CD	NUMBER	(	appos	1	SENT_755	[p33l1516t1342r1690b1399],
11	2009	CD	DATE	2009	num	12	SENT_755	[p33l1516t1342r1690b1399],
12	)	NN	O	)	dep	10	SENT_755	[p33l1516t1342r1690b1399],
13	.	.	O	.	_	0	SENT_755	[p33l1516t1342r1690b1399],

1	57	CD	NUMBER	57	_	0	SENT_756	[p33l8t1423r82b1469],
2	.	.	O	.	_	0	SENT_756	[p33l8t1423r82b1469],

1	Pittner	NNP	PERSON	Pittner	_	0	SENT_757	[p33l132t1421r313b1477],
2	,	,	O	,	_	0	SENT_757	[p33l132t1421r313b1477],
3	R.A.	NNP	PERSON	R.A.	nn	4	SENT_757	[p33l330t1421r423b1469],
4	etal	NNP	O	etal	appos	1	SENT_757	[p33l438t1419r553b1469],
5	.	.	O	.	_	0	SENT_757	[p33l438t1419r553b1469],

1	Molecular	JJ	O	molecular	amod	2	SENT_758	[p33l568t1419r828b1469],
2	physiology	NN	O	physiology	_	0	SENT_758	[p33l843t1419r1130b1483],
3	of	IN	O	of	_	0	SENT_758	[p33l1143t1419r1198b1469],
4	amylin	NN	O	amylin	prep_of	2	SENT_758	[p33l1207t1419r1440b1483],
5	.	.	O	.	_	0	SENT_758	[p33l1207t1419r1440b1483],

1	}	NN	O	}	_	0	SENT_759	[p33l1207t1419r1440b1483],
2	.	.	O	.	_	0	SENT_759	[p33l1207t1419r1440b1483],

1	Cell	NN	O	cell	_	0	SENT_760	[p33l1456t1419r1554b1469],
2	.	.	O	.	_	0	SENT_760	[p33l1456t1419r1554b1469],

1	Biochem	NNP	ORGANIZATION	Biochem	_	0	SENT_761	[p33l1569t1419r1801b1469],
2	.	.	O	.	_	0	SENT_761	[p33l1569t1419r1801b1469],

1	55	CD	NUMBER	55	_	0	SENT_762	[p33l1816t1423r1881b1469],
2	(	CD	NUMBER	(	dep	1	SENT_762	[p33l1898t1419r2102b1482],
3	suppl	NN	O	suppl	dep	2	SENT_762	[p33l1898t1419r2102b1482],
4	.	.	O	.	_	0	SENT_762	[p33l1898t1419r2102b1482],
5	)	SYM	O	)	dep	1	SENT_762	[p33l1898t1419r2102b1482],

1	,	,	O	,	_	0	SENT_763	[p33l1898t1419r2102b1482],

1	58	CD	NUMBER	58	_	0	SENT_764	[p33l8t1578r84b1624],
2	.	.	O	.	_	0	SENT_764	[p33l8t1578r84b1624],

1	Koda	NNP	PERSON	Koda	_	0	SENT_765	[p33l132t1574r279b1632],
2	,	,	O	,	_	0	SENT_765	[p33l132t1574r279b1632],
3	J.E.	NNP	PERSON	J.E.	conj_and	1	SENT_765	[p33l294t1577r388b1632],
4	,	,	O	,	_	0	SENT_765	[p33l294t1577r388b1632],
5	Fineman	NNP	PERSON	Fineman	conj_and	1	SENT_765	[p33l407t1577r652b1632],
6	,	,	O	,	_	0	SENT_765	[p33l407t1577r652b1632],
7	M.	NNP	O	M.	conj_and	1	SENT_765	[p33l669t1577r744b1632],
8	,	,	O	,	_	0	SENT_765	[p33l669t1577r744b1632],
9	Rink	NNP	O	Rink	conj_and	1	SENT_765	[p33l762t1574r992b1632],
10	,	,	O	,	_	0	SENT_765	[p33l762t1574r992b1632],
11	T.J.	NNP	LOCATION	T.J.	conj_and	1	SENT_765	[p33l762t1574r992b1632],
12	,	,	O	,	_	0	SENT_765	[p33l762t1574r992b1632],
13	Dailey	NNP	PERSON	Dailey	conj_and	1	SENT_765	[p33l1011t1574r1186b1638],
14	,	,	O	,	_	0	SENT_765	[p33l1011t1574r1186b1638],
15	G.E.	NNP	ORGANIZATION	G.E.	conj_and	1	SENT_765	[p33l1203t1576r1314b1632],
16	,	,	O	,	_	0	SENT_765	[p33l1203t1576r1314b1632],
17	Muchmore	NNP	PERSON	Muchmore	conj_and	1	SENT_765	[p33l1332t1574r1638b1632],
18	,	,	O	,	_	0	SENT_765	[p33l1332t1574r1638b1632],
19	D.B.	NNP	ORGANIZATION	D.B.	conj_and	1	SENT_765	[p33l1657t1576r1754b1624],
20	&	CC	ORGANIZATION	&	_	0	SENT_765	[p33l1770t1576r1807b1624],
21	Linarelli	NNP	ORGANIZATION	Linarelli	conj_and	1	SENT_765	[p33l1824t1574r2047b1632],
22	,	,	O	,	_	0	SENT_765	[p33l1824t1574r2047b1632],
23	L.G.	NNP	ORGANIZATION	L.G.	nn	25	SENT_765	[p33l133t1654r227b1702],
24	Amylin	NNP	ORGANIZATION	Amylin	nn	25	SENT_765	[p33l243t1652r430b1716],
25	concentrations	NNS	O	concentration	appos	1	SENT_765	[p33l448t1655r853b1702],
26	and	CC	O	and	_	0	SENT_765	[p33l870t1652r968b1702],
27	glucose	NN	O	glucose	nn	28	SENT_765	[p33l987t1652r1195b1716],
28	control	NN	O	control	appos	1	SENT_765	[p33l1212t1652r1416b1702],
29	.	.	O	.	_	0	SENT_765	[p33l1212t1652r1416b1702],

1	Lancet339	NN	O	lancet339	_	0	SENT_766	[p33l1432t1655r1738b1710],
2	,	,	O	,	_	0	SENT_766	[p33l1432t1655r1738b1710],
3	1179-1180	CD	DATE	1179-1180	number	4	SENT_766	[p33l1759t1656r2052b1702],
4	(	CD	NUMBER	(	appos	1	SENT_766	[p33l133t1730r313b1786],
5	1992	CD	DATE	1992	num	6	SENT_766	[p33l133t1730r313b1786],
6	)	NN	O	)	dep	4	SENT_766	[p33l133t1730r313b1786],
7	.	.	O	.	_	0	SENT_766	[p33l133t1730r313b1786],

1	59	CD	NUMBER	59	_	0	SENT_767	[p33l8t1811r82b1857],
2	.	.	O	.	_	0	SENT_767	[p33l8t1811r82b1857],

1	Edwards	NNP	PERSON	Edwards	nn	9	SENT_768	[p33l132t1807r364b1865],
2	,	,	O	,	_	0	SENT_768	[p33l132t1807r364b1865],
3	G.L.	NNP	O	G.L.	appos	9	SENT_768	[p33l378t1809r485b1865],
4	,	,	O	,	_	0	SENT_768	[p33l378t1809r485b1865],
5	Gedulin	NNP	LOCATION	Gedulin	appos	9	SENT_768	[p33l499t1807r719b1865],
6	,	,	O	,	_	0	SENT_768	[p33l499t1807r719b1865],
7	B.R.	NNP	LOCATION	B.R.	appos	9	SENT_768	[p33l735t1809r836b1865],
8	,	,	O	,	_	0	SENT_768	[p33l735t1809r836b1865],
9	Jod	NNP	PERSON	Jod	_	0	SENT_768	[p33l849t1807r939b1857],
10	ka	FW	O	ka	dep	9	SENT_768	[p33l948t1807r1016b1865],
11	,	,	O	,	_	0	SENT_768	[p33l948t1807r1016b1865],
12	C.	NNP	O	C.	appos	10	SENT_768	[p33l1030t1809r1090b1865],
13	,	,	O	,	_	0	SENT_768	[p33l1030t1809r1090b1865],
14	Dilts	NNP	PERSON	Dilts	appos	10	SENT_768	[p33l1107t1807r1231b1865],
15	,	,	O	,	_	0	SENT_768	[p33l1107t1807r1231b1865],
16	R.P.	NNP	LOCATION	R.P.	appos	10	SENT_768	[p33l1248t1809r1340b1865],
17	,	,	O	,	_	0	SENT_768	[p33l1248t1809r1340b1865],
18	Miller	NNP	PERSON	Miller	conj_and	12	SENT_768	[p33l1356t1807r1510b1865],
19	,	,	O	,	_	0	SENT_768	[p33l1356t1807r1510b1865],
20	C.C.	NNP	ORGANIZATION	C.C.	appos	10	SENT_768	[p33l1524t1809r1621b1857],
21	&	CC	ORGANIZATION	&	_	0	SENT_768	[p33l1635t1809r1860b1871],
22	Young	NNP	ORGANIZATION	Young	conj_and	12	SENT_768	[p33l1635t1809r1860b1871],
23	,	,	O	,	_	0	SENT_768	[p33l1635t1809r1860b1871],
24	A.	NNP	PERSON	A.	nn	25	SENT_768	[p33l1874t1810r1923b1857],
25	Area	NNP	PERSON	Area	appos	10	SENT_768	[p33l1937t1810r2054b1857],
26	postrema	NN	O	postrema	dep	9	SENT_768	[p33l133t1893r379b1948],
27	(	CD	NUMBER	(	num	30	SENT_768	[p33l397t1886r520b1943],
28	AP	NN	O	ap	nn	30	SENT_768	[p33l397t1886r520b1943],
29	)	NN	O	)	nn	30	SENT_768	[p33l397t1886r520b1943],
30	lessions	NNS	O	lession	dep	26	SENT_768	[p33l536t1885r737b1935],
31	blockthe	JJ	O	blockthe	amod	32	SENT_768	[p33l754t1885r992b1935],
32	regulation	NN	O	regulation	dep	9	SENT_768	[p33l1008t1885r1275b1949],
33	of	IN	O	of	_	0	SENT_768	[p33l1291t1885r1346b1935],
34	gastric	JJ	O	gastric	amod	35	SENT_768	[p33l1356t1888r1529b1949],
35	emptying	NN	O	emptying	prep_of	32	SENT_768	[p33l1543t1888r1796b1949],
36	by	IN	O	by	_	0	SENT_768	[p33l1815t1885r1877b1949],
37	amylin	NN	O	amylin	prep_by	35	SENT_768	[p33l1889t1885r2077b1949],
38	.	.	O	.	_	0	SENT_768	[p33l1889t1885r2077b1949],

1	Neuro	NNP	O	Neuro	_	0	SENT_769	[p33l131t1965r293b2012],
2	.	.	O	.	_	0	SENT_769	[p33l131t1965r293b2012],

1	Gastroenterol	NNP	PERSON	Gastroenterol	_	0	SENT_770	[p33l309t1962r663b2012],
2	.	.	O	.	_	0	SENT_770	[p33l309t1962r663b2012],

1	Motil	NNP	PERSON	Motil	_	0	SENT_771	[p33l677t1962r820b2012],
2	.	.	O	.	_	0	SENT_771	[p33l677t1962r820b2012],

1	10	CD	NUMBER	10	_	0	SENT_772	[p33l837t1966r914b2019],
2	,	,	O	,	_	0	SENT_772	[p33l837t1966r914b2019],
3	26	CD	NUMBER	26	number	4	SENT_772	[p33l929t1966r991b2012],
4	(	CD	NUMBER	(	appos	1	SENT_772	[p33l1006t1963r1181b2019],
5	1998	CD	DATE	1998	num	6	SENT_772	[p33l1006t1963r1181b2019],
6	)	NN	O	)	dep	4	SENT_772	[p33l1006t1963r1181b2019],
7	.	.	O	.	_	0	SENT_772	[p33l1006t1963r1181b2019],

1	60	CD	NUMBER	60	_	0	SENT_773	[p33l8t2044r82b2090],
2	.	.	O	.	_	0	SENT_773	[p33l8t2044r82b2090],

1	Lutz	NNP	PERSON	Lutz	nsubjpass	31	SENT_774	[p33l132t2043r365b2098],
2	,	,	O	,	_	0	SENT_774	[p33l132t2043r365b2098],
3	T.A.	NNP	LOCATION	T.A.	conj_and	1	SENT_774	[p33l132t2043r365b2098],
4	,	,	O	,	_	0	SENT_774	[p33l132t2043r365b2098],
5	Mollet	NNP	PERSON	Mollet	conj_and	1	SENT_774	[p33l381t2040r558b2098],
6	,	,	O	,	_	0	SENT_774	[p33l381t2040r558b2098],
7	A.	NNP	O	A.	conj_and	1	SENT_774	[p33l572t2043r634b2098],
8	,	,	O	,	_	0	SENT_774	[p33l572t2043r634b2098],
9	Rushing	NNP	O	Rushing	conj_and	1	SENT_774	[p33l651t2040r873b2104],
10	,	,	O	,	_	0	SENT_774	[p33l651t2040r873b2104],
11	P.A.	NNP	O	P.A.	conj_and	1	SENT_774	[p33l890t2042r987b2098],
12	,	,	O	,	_	0	SENT_774	[p33l890t2042r987b2098],
13	Riediger	NNP	O	Riediger	conj_and	1	SENT_774	[p33l1003t2040r1228b2104],
14	,	,	O	,	_	0	SENT_774	[p33l1003t2040r1228b2104],
15	T.	NNP	ORGANIZATION	T.	nsubjpass	31	SENT_774	[p33l1237t2043r1276b2090],
16	&	CC	ORGANIZATION	&	_	0	SENT_774	[p33l1290t2042r1327b2090],
17	Scharrer	NNP	ORGANIZATION	Scharrer	nsubjpass	31	SENT_774	[p33l1340t2040r1566b2098],
18	,	,	O	,	_	0	SENT_774	[p33l1340t2040r1566b2098],
19	E.	NNP	O	E.	nn	22	SENT_774	[p33l1583t2040r1727b2090],
20	The	NNP	O	The	nn	22	SENT_774	[p33l1583t2040r1727b2090],
21	anorectic	NN	O	anorectic	nn	22	SENT_774	[p33l1742t2043r1985b2090],
22	effect	NN	O	effect	appos	1	SENT_774	[p33l2000t2040r2147b2090],
23	of	IN	O	of	_	0	SENT_774	[p33l131t2118r186b2168],
24	a	DT	O	a	det	27	SENT_774	[p33l195t2133r220b2168],
25	chronic	JJ	O	chronic	amod	27	SENT_774	[p33l236t2118r431b2168],
26	peripheral	JJ	O	peripheral	amod	27	SENT_774	[p33l447t2118r712b2181],
27	infusion	NN	O	infusion	prep_of	22	SENT_774	[p33l731t2118r938b2168],
28	of	IN	O	of	_	0	SENT_774	[p33l954t2118r1009b2168],
29	amylin	NN	O	amylin	prep_of	27	SENT_774	[p33l1018t2118r1191b2182],
30	is	VBZ	O	be	auxpass	31	SENT_774	[p33l1209t2121r1243b2168],
31	abolished	VBN	O	abolish	_	0	SENT_774	[p33l1258t2118r1513b2168],
32	in	IN	O	in	_	0	SENT_774	[p33l1531t2121r1573b2168],
33	area	NN	O	area	nn	35	SENT_774	[p33l1590t2133r1698b2168],
34	postremal	JJ	O	postremal	amod	35	SENT_774	[p33l1716t2120r1988b2181],
35	nucleus	NN	O	nucleus	prep_in	31	SENT_774	[p33l133t2196r333b2246],
36	of	IN	O	of	_	0	SENT_774	[p33l348t2196r403b2246],
37	the	DT	O	the	det	41	SENT_774	[p33l411t2196r497b2246],
38	solitary	JJ	O	solitary	amod	41	SENT_774	[p33l512t2196r703b2260],
39	tract	NN	O	tract	nn	41	SENT_774	[p33l714t2204r835b2246],
40	(	NN	O	(	nn	41	SENT_774	[p33l851t2197r1078b2254],
41	AP/NTS	NN	O	ap/nts	prep_of	35	SENT_774	[p33l851t2197r1078b2254],
42	)	CD	NUMBER	)	num	44	SENT_774	[p33l851t2197r1078b2254],
43	lesioned	JJ	O	lesioned	amod	44	SENT_774	[p33l1097t2196r1314b2246],
44	rats	NNS	O	rat	dep	41	SENT_774	[p33l1332t2204r1436b2246],
45	.	.	O	.	_	0	SENT_774	[p33l1332t2204r1436b2246],

1	Int	NN	O	int	_	0	SENT_775	[p33l1450t2199r1526b2246],
2	.	.	O	.	_	0	SENT_775	[p33l1450t2199r1526b2246],

1	J.	NNP	O	J.	nn	2	SENT_776	[p33l1537t2199r1572b2246],
2	Obes	NNP	O	Obes	_	0	SENT_776	[p33l1587t2196r1723b2246],
3	.	.	O	.	_	0	SENT_776	[p33l1587t2196r1723b2246],

1	Relat	NNP	O	Relat	_	0	SENT_777	[p33l1738t2196r1875b2246],
2	.	.	O	.	_	0	SENT_777	[p33l1738t2196r1875b2246],

1	Metab	NNP	PERSON	Metab	_	0	SENT_778	[p33l1889t2196r2061b2246],
2	.	.	O	.	_	0	SENT_778	[p33l1889t2196r2061b2246],

1	Disord	NNP	O	Disord	_	0	SENT_779	[p33l131t2273r307b2323],
2	.	.	O	.	_	0	SENT_779	[p33l131t2273r307b2323],

1	25	CD	NUMBER	25	_	0	SENT_780	[p33l321t2277r401b2330],
2	,	,	O	,	_	0	SENT_780	[p33l321t2277r401b2330],
3	1005-101	CD	NUMBER	1005-101	number	4	SENT_780	[p33l420t2277r663b2323],
4	1	CD	NUMBER	1	appos	1	SENT_780	[p33l681t2277r696b2322],
5	(	CD	NUMBER	(	num	7	SENT_780	[p33l721t2274r896b2330],
6	2001	CD	DATE	2001	num	7	SENT_780	[p33l721t2274r896b2330],
7	)	NN	O	)	dep	4	SENT_780	[p33l721t2274r896b2330],
8	.	.	O	.	_	0	SENT_780	[p33l721t2274r896b2330],

1	61	CD	NUMBER	61	_	0	SENT_781	[p33l8t2355r82b2401],
2	.	.	O	.	_	0	SENT_781	[p33l8t2355r82b2401],

1	Maggs	NNP	PERSON	Maggs	_	0	SENT_782	[p33l131t2354r317b2415],
2	,	,	O	,	_	0	SENT_782	[p33l131t2354r317b2415],
3	D.	NNP	O	D.	conj_and	1	SENT_782	[p33l334t2353r394b2409],
4	,	,	O	,	_	0	SENT_782	[p33l334t2353r394b2409],
5	Shen	NNP	PERSON	Shen	conj_and	1	SENT_782	[p33l409t2351r552b2409],
6	,	,	O	,	_	0	SENT_782	[p33l409t2351r552b2409],
7	L.	NNP	O	L.	conj_and	1	SENT_782	[p33l569t2354r619b2409],
8	,	,	O	,	_	0	SENT_782	[p33l569t2354r619b2409],
9	Strobel	NNP	PERSON	Strobel	conj_and	1	SENT_782	[p33l634t2351r832b2409],
10	,	,	O	,	_	0	SENT_782	[p33l634t2351r832b2409],
11	S.	NNP	O	S.	conj_and	1	SENT_782	[p33l847t2353r900b2409],
12	,	,	O	,	_	0	SENT_782	[p33l847t2353r900b2409],
13	Brown	NNP	PERSON	Brown	conj_and	1	SENT_782	[p33l917t2353r1096b2409],
14	,	,	O	,	_	0	SENT_782	[p33l917t2353r1096b2409],
15	D.	NNP	O	D.	conj_and	1	SENT_782	[p33l1113t2354r1173b2409],
16	,	,	O	,	_	0	SENT_782	[p33l1113t2354r1173b2409],
17	Kolterman	NNP	LOCATION	Kolterman	conj_and	1	SENT_782	[p33l1190t2351r1474b2409],
18	,	,	O	,	_	0	SENT_782	[p33l1190t2351r1474b2409],
19	O.	NNP	ORGANIZATION	O.	conj_and	1	SENT_782	[p33l1488t2353r1540b2401],
20	&	CC	ORGANIZATION	&	_	0	SENT_782	[p33l1554t2353r1773b2415],
21	Weyer	NNP	ORGANIZATION	Weyer	conj_and	1	SENT_782	[p33l1554t2353r1773b2415],
22	,	,	O	,	_	0	SENT_782	[p33l1554t2353r1773b2415],
23	C.	NNP	O	C.	nn	24	SENT_782	[p33l1788t2353r1834b2401],
24	Effect	NN	O	effect	appos	1	SENT_782	[p33l1851t2351r1995b2401],
25	of	IN	O	of	_	0	SENT_782	[p33l2009t2351r2063b2401],
26	pramlintide	NN	O	pramlintide	prep_of	24	SENT_782	[p33l133t2430r437b2492],
27	on	IN	O	on	_	0	SENT_782	[p33l451t2444r515b2479],
28	A1	NN	O	a1	nn	29	SENT_782	[p33l531t2432r590b2479],
29	C	NN	O	c	prep_on	26	SENT_782	[p33l604t2431r637b2479],
30	and	CC	O	and	_	0	SENT_782	[p33l652t2430r748b2479],
31	body	NN	O	body	nn	32	SENT_782	[p33l766t2430r900b2493],
32	weight	NN	O	weight	prep_on	26	SENT_782	[p33l911t2430r1094b2493],
33	in	IN	O	in	_	0	SENT_782	[p33l1110t2432r1153b2479],
34	insulin-treated	JJ	O	insulin-treated	amod	35	SENT_782	[p33l1170t2430r1550b2479],
35	African	JJ	MISC	african	amod	36	SENT_782	[p33l1566t2429r1748b2479],
36	Americans	NNPS	MISC	Americans	prep_in	29	SENT_782	[p33l1764t2432r2041b2479],
37	and	CC	O	and	_	0	SENT_782	[p33l2055t2430r2152b2479],
38	Hispanics	NNPS	MISC	Hispanics	prep_in	29	SENT_782	[p33l133t2510r380b2570],
39	with	IN	O	with	_	0	SENT_782	[p33l394t2508r507b2557],
40	type	NN	O	type	nn	42	SENT_782	[p33l522t2515r640b2571],
41	2	CD	NUMBER	2	num	42	SENT_782	[p33l655t2511r682b2557],
42	diabetes	NN	O	diabetes	prep_with	36	SENT_782	[p33l698t2508r934b2557],
43	:	:	O	:	_	0	SENT_782	[p33l698t2508r934b2557],
44	a	DT	O	a	det	48	SENT_782	[p33l949t2522r974b2557],
45	pooled	JJ	O	pooled	amod	48	SENT_782	[p33l992t2508r1174b2570],
46	post	NN	O	post	amod	48	SENT_782	[p33l1192t2515r1305b2570],
47	hoc	FW	O	hoc	dep	46	SENT_782	[p33l1320t2508r1414b2557],
48	analysis	NN	O	analysis	dep	36	SENT_782	[p33l1428t2508r1643b2571],
49	.	.	O	.	_	0	SENT_782	[p33l1428t2508r1643b2571],

1	Metab	NNP	PERSON	Metab	_	0	SENT_783	[p33l1656t2508r1829b2557],
2	.	.	O	.	_	0	SENT_783	[p33l1656t2508r1829b2557],

1	Clin	NNP	O	Clin	_	0	SENT_784	[p33l1845t2508r1950b2557],
2	.	.	O	.	_	0	SENT_784	[p33l1845t2508r1950b2557],

1	Exp	NN	O	exp	_	0	SENT_785	[p33l1964t2510r2066b2570],
2	.	.	O	.	_	0	SENT_785	[p33l1964t2510r2066b2570],

1	52	CD	NUMBER	52	_	0	SENT_786	[p33l131t2588r211b2641],
2	,	,	O	,	_	0	SENT_786	[p33l131t2588r211b2641],
3	1638-1642	CD	DATE	1638-1642	number	4	SENT_786	[p33l230t2588r514b2634],
4	(	CD	NUMBER	(	appos	1	SENT_786	[p33l532t2586r706b2641],
5	2003	CD	DATE	2003	num	6	SENT_786	[p33l532t2586r706b2641],
6	)	NN	O	)	dep	4	SENT_786	[p33l532t2586r706b2641],
7	.	.	O	.	_	0	SENT_786	[p33l532t2586r706b2641],

1	62	CD	NUMBER	62	_	0	SENT_787	[p33l7t2666r82b2712],
2	.	.	O	.	_	0	SENT_787	[p33l7t2666r82b2712],

1	Montague	NNP	PERSON	Montague	_	0	SENT_788	[p33l131t2665r415b2726],
2	,	,	O	,	_	0	SENT_788	[p33l131t2665r415b2726],
3	C.T.	NNP	O	C.T.	nn	4	SENT_788	[p33l429t2664r516b2712],
4	etal	NNP	O	etal	appos	1	SENT_788	[p33l530t2663r645b2712],
5	.	.	O	.	_	0	SENT_788	[p33l530t2663r645b2712],

1	Congenital	JJ	O	congenital	amod	3	SENT_789	[p33l659t2663r945b2726],
2	leptin	NN	O	leptin	nn	3	SENT_789	[p33l964t2663r1110b2725],
3	deﬁciency	NN	O	deﬁciency	nsubjpass	5	SENT_789	[p33l1126t2662r1396b2726],
4	is	VBZ	O	be	auxpass	5	SENT_789	[p33l1410t2665r1445b2712],
5	associated	VBN	O	associate	_	0	SENT_789	[p33l1459t2663r1732b2712],
6	with	IN	O	with	_	0	SENT_789	[p33l1747t2663r1861b2712],
7	severe	JJ	O	severe	amod	9	SENT_789	[p33l1878t2677r2045b2712],
8	early-onset	JJ	O	early-onset	amod	9	SENT_789	[p33l131t2741r425b2804],
9	obesity	NN	O	obesity	prep_with	5	SENT_789	[p33l439t2741r632b2804],
10	in	IN	O	in	_	0	SENT_789	[p33l646t2743r689b2790],
11	humans	NNS	O	human	prep_in	9	SENT_789	[p33l708t2741r929b2790],
12	.	.	O	.	_	0	SENT_789	[p33l708t2741r929b2790],

1	Nature	NNP	O	Nature	_	0	SENT_790	[p33l943t2743r1117b2790],
2	387	CD	NUMBER	387	num	1	SENT_790	[p33l1130t2744r1246b2798],
3	,	,	O	,	_	0	SENT_790	[p33l1130t2744r1246b2798],
4	903-908	CD	NUMBER	903-908	num	1	SENT_790	[p33l1260t2744r1484b2790],
5	(	CD	NUMBER	(	num	7	SENT_790	[p33l1501t2742r1675b2798],
6	1997	CD	DATE	1997	num	7	SENT_790	[p33l1501t2742r1675b2798],
7	)	NN	O	)	dep	1	SENT_790	[p33l1501t2742r1675b2798],
8	.	.	O	.	_	0	SENT_790	[p33l1501t2742r1675b2798],

1	63	CD	NUMBER	63	_	0	SENT_791	[p33l7t2822r82b2868],
2	.	.	O	.	_	0	SENT_791	[p33l7t2822r82b2868],

1	Farooqi	NNP	PERSON	Farooqi	_	0	SENT_792	[p33l132t2821r339b2881],
2	,	,	O	,	_	0	SENT_792	[p33l132t2821r339b2881],
3	|	CD	NUMBER	|	appos	1	SENT_792	[p33l355t2820r421b2868],
4	.	.	O	.	_	0	SENT_792	[p33l355t2820r421b2868],

1	S.	NNP	O	S.	_	0	SENT_793	[p33l355t2820r421b2868],
2	&	CC	O	&	_	0	SENT_793	[p33l436t2820r473b2868],
3	O’Rahi	NNP	O	O’Rahi	conj_and	1	SENT_793	[p33l485t2819r726b2882],
4	|	CD	NUMBER	|	number	5	SENT_793	[p33l485t2819r726b2882],
5	|	CD	NUMBER	|	num	6	SENT_793	[p33l485t2819r726b2882],
6	y	NN	O	y	dep	1	SENT_793	[p33l485t2819r726b2882],
7	,	,	O	,	_	0	SENT_793	[p33l485t2819r726b2882],
8	S.	NNP	PERSON	S.	nn	9	SENT_793	[p33l740t2820r780b2868],
9	Monogenic	NNP	PERSON	Monogenic	appos	6	SENT_793	[p33l796t2821r1095b2882],
10	obesity	NN	O	obesity	dep	1	SENT_793	[p33l1110t2819r1302b2882],
11	in	IN	O	in	_	0	SENT_793	[p33l1316t2821r1359b2868],
12	humans	NNS	O	human	prep_in	10	SENT_793	[p33l1378t2819r1599b2868],
13	.	.	O	.	_	0	SENT_793	[p33l1378t2819r1599b2868],

1	Annu	NNP	PERSON	Annu	_	0	SENT_794	[p33l1610t2821r1759b2868],
2	.	.	O	.	_	0	SENT_794	[p33l1610t2821r1759b2868],

1	Rev.	NNP	O	Rev.	nn	2	SENT_795	[p33l1773t2821r1869b2868],
2	Med	NNP	O	Med	_	0	SENT_795	[p33l1883t2819r2006b2868],
3	.	.	O	.	_	0	SENT_795	[p33l1883t2819r2006b2868],

1	56	CD	NUMBER	56	_	0	SENT_796	[p33l2021t2822r2101b2876],
2	,	,	O	,	_	0	SENT_796	[p33l2021t2822r2101b2876],

1	64	CD	NUMBER	64	_	0	SENT_797	[p33l7t2977r82b3023],
2	.	.	O	.	_	0	SENT_797	[p33l7t2977r82b3023],

1	Ozcan	NNP	PERSON	Ozcan	_	0	SENT_798	[p33l129t2975r304b3031],
2	,	,	O	,	_	0	SENT_798	[p33l129t2975r304b3031],
3	L.	NNP	O	L.	nn	4	SENT_798	[p33l321t2976r358b3023],
4	etal	NNP	O	etal	appos	1	SENT_798	[p33l372t2974r487b3023],
5	.	.	O	.	_	0	SENT_798	[p33l372t2974r487b3023],

1	Endoplasmic	JJ	MISC	endoplasmic	amod	3	SENT_799	[p33l504t2974r840b3036],
2	reticulum	NN	O	reticulum	nn	3	SENT_799	[p33l856t2974r1103b3023],
3	stress	NN	O	stress	nsubj	4	SENT_799	[p33l1119t2981r1264b3023],
4	plays	VBZ	O	play	_	0	SENT_799	[p33l1281t2974r1411b3037],
5	a	DT	O	a	det	7	SENT_799	[p33l1425t2988r1451b3023],
6	central	JJ	O	central	amod	7	SENT_799	[p33l1467t2974r1643b3023],
7	role	NN	O	role	dobj	4	SENT_799	[p33l1662t2974r1758b3023],
8	in	IN	O	in	_	0	SENT_799	[p33l1774t2976r1816b3023],
9	development	NN	O	development	prep_in	7	SENT_799	[p33l131t3052r485b3114],
10	of	IN	O	of	_	0	SENT_799	[p33l499t3051r554b3102],
11	leptin	NN	O	leptin	nn	12	SENT_799	[p33l566t3052r712b3114],
12	resistance	NN	O	resistance	prep_of	9	SENT_799	[p33l730t3054r1001b3101],
13	.	.	O	.	_	0	SENT_799	[p33l730t3054r1001b3101],

1	Ce/lMetab	NNP	O	Ce/lMetab	_	0	SENT_800	[p33l1017t3052r1292b3101],
2	.	.	O	.	_	0	SENT_800	[p33l1017t3052r1292b3101],

1	9	CD	NUMBER	9	_	0	SENT_801	[p33l1306t3055r1351b3109],
2	,	,	O	,	_	0	SENT_801	[p33l1306t3055r1351b3109],
3	35-51	CD	NUMBER	35-51	number	4	SENT_801	[p33l1366t3055r1515b3101],
4	(	CD	NUMBER	(	appos	1	SENT_801	[p33l1541t3053r1715b3109],
5	2009	CD	DATE	2009	num	6	SENT_801	[p33l1541t3053r1715b3109],
6	)	NN	O	)	dep	4	SENT_801	[p33l1541t3053r1715b3109],
7	.	.	O	.	_	0	SENT_801	[p33l1541t3053r1715b3109],

1	65	CD	NUMBER	65	_	0	SENT_802	[p33l7t3133r82b3179],
2	.	.	O	.	_	0	SENT_802	[p33l7t3133r82b3179],

1	Roth	NNP	PERSON	Roth	_	0	SENT_803	[p33l132t3130r265b3187],
2	,	,	O	,	_	0	SENT_803	[p33l132t3130r265b3187],
3	J.D.	NNP	PERSON	J.D.	nn	4	SENT_803	[p33l277t3132r364b3179],
4	etal	NNP	O	etal	appos	1	SENT_803	[p33l378t3130r493b3179],
5	.	.	O	.	_	0	SENT_803	[p33l378t3130r493b3179],

1	Leptin	NN	O	leptin	nn	2	SENT_804	[p33l511t3132r671b3192],
2	responsiveness	NN	O	responsiveness	_	0	SENT_804	[p33l689t3132r1087b3192],
3	restored	VBN	O	restore	partmod	2	SENT_804	[p33l1103t3130r1317b3179],
4	by	IN	O	by	_	0	SENT_804	[p33l1335t3130r1397b3193],
5	amylin	NN	O	amylin	nn	6	SENT_804	[p33l1410t3130r1582b3193],
6	agonism	NN	O	agonism	agent	3	SENT_804	[p33l1599t3132r1823b3193],
7	in	IN	O	in	_	0	SENT_804	[p33l1841t3132r1884b3179],
8	dietinduced	JJ	O	dietinduced	amod	9	SENT_804	[p33l1900t3130r2020b3179, p33l132t3208r342b3257],
9	obesity	NN	O	obesity	prep_in	6	SENT_804	[p33l359t3208r564b3271],
10	:	:	O	:	_	0	SENT_804	[p33l359t3208r564b3271],
11	evidence	NN	O	evidence	dep	2	SENT_804	[p33l579t3208r816b3257],
12	from	IN	O	from	_	0	SENT_804	[p33l829t3207r951b3257],
13	nonclinical	JJ	O	nonclinical	amod	16	SENT_804	[p33l970t3208r1250b3257],
14	and	CC	O	and	_	0	SENT_804	[p33l1267t3208r1363b3257],
15	clinical	JJ	O	clinical	amod	16	SENT_804	[p33l1380t3208r1556b3257],
16	studies	NNS	O	study	prep_from	11	SENT_804	[p33l1574t3208r1771b3257],
17	.	.	O	.	_	0	SENT_804	[p33l1574t3208r1771b3257],

1	Proc	NNP	O	Proc	_	0	SENT_805	[p33l1785t3210r1904b3257],
2	.	.	O	.	_	0	SENT_805	[p33l1785t3210r1904b3257],

1	Natl.	NNP	O	Natl.	nn	2	SENT_806	[p33l1918t3208r2033b3257],
2	Acad	NNP	O	Acad	_	0	SENT_806	[p33l127t3285r265b3334],
3	.	.	O	.	_	0	SENT_806	[p33l127t3285r265b3334],

1	Sci	NNP	O	Sci	_	0	SENT_807	[p33l279t3286r360b3334],
2	.	.	O	.	_	0	SENT_807	[p33l279t3286r360b3334],

1	USA	NNP	LOCATION	USA	_	0	SENT_808	[p33l377t3286r475b3334],
2	105	CD	NUMBER	105	num	1	SENT_808	[p33l493t3288r606b3341],
3	,	,	O	,	_	0	SENT_808	[p33l493t3288r606b3341],
4	7257-7262	CD	DURATION	7257-7262	num	1	SENT_808	[p33l621t3288r909b3334],
5	(	CD	NUMBER	(	num	7	SENT_808	[p33l926t3286r1101b3341],
6	2008	CD	DATE	2008	num	7	SENT_808	[p33l926t3286r1101b3341],
7	)	NN	O	)	dep	1	SENT_808	[p33l926t3286r1101b3341],
8	.	.	O	.	_	0	SENT_808	[p33l926t3286r1101b3341],

1	66	CD	NUMBER	66	_	0	SENT_809	[p34l7t21r82b67],
2	.	.	O	.	_	0	SENT_809	[p34l7t21r82b67],

1	Ravussin	NNP	PERSON	Ravussin	_	0	SENT_810	[p34l132t20r370b75],
2	,	,	O	,	_	0	SENT_810	[p34l132t20r370b75],
3	E.	NNP	O	E.	nn	4	SENT_810	[p34l387t20r425b67],
4	etal	NN	O	etal	appos	1	SENT_810	[p34l439t18r554b67],
5	.	.	O	.	_	0	SENT_810	[p34l439t18r554b67],

1	Enhanced	VBN	O	enhance	_	0	SENT_811	[p34l571t18r827b67],
2	weight	NN	O	weight	nn	3	SENT_811	[p34l843t18r1025b81],
3	loss	NN	O	loss	nsubj	9	SENT_811	[p34l1042t18r1136b67],
4	with	IN	O	with	_	0	SENT_811	[p34l1149t18r1263b67],
5	pramlintide/metreleptinz	NN	O	pramlintide/metreleptinz	prep_with	3	SENT_811	[p34l1281t18r1932b80],
6	an	DT	O	a	det	9	SENT_811	[p34l1947t32r2007b67],
7	integrated	VBN	O	integrate	amod	9	SENT_811	[p34l132t96r402b159],
8	neurohormonal	JJ	O	neurohormonal	amod	9	SENT_811	[p34l421t96r831b145],
9	approach	NN	O	approach	xcomp	1	SENT_811	[p34l848t96r1095b158],
10	to	TO	O	to	_	0	SENT_811	[p34l1111t103r1164b145],
11	obesity	NN	O	obesity	nn	12	SENT_811	[p34l1178t96r1371b159],
12	pharmacotherapy	NN	O	pharmacotherapy	prep_to	9	SENT_811	[p34l1386t96r1866b159],
13	.	.	O	.	_	0	SENT_811	[p34l1386t96r1866b159],

1	Obesity	NN	O	obesity	nn	4	SENT_812	[p34l1882t96r2074b159],
2	(	CD	NUMBER	(	num	4	SENT_812	[p34l133t174r285b231],
3	Silver	NN	O	silver	nn	4	SENT_812	[p34l133t174r285b231],
4	Spring	NN	DATE	spring	_	0	SENT_812	[p34l293t175r472b237],
5	)	CD	NUMBER	)	number	6	SENT_812	[p34l293t175r472b237],
6	17	CD	NUMBER	17	dep	4	SENT_812	[p34l491t178r568b231],
7	,	,	O	,	_	0	SENT_812	[p34l491t178r568b231],
8	1736-1743	CD	DATE	1736-1743	number	9	SENT_812	[p34l587t177r870b223],
9	(	CD	NUMBER	(	appos	4	SENT_812	[p34l888t175r1063b231],
10	2009	CD	DATE	2009	num	11	SENT_812	[p34l888t175r1063b231],
11	)	NN	O	)	dep	9	SENT_812	[p34l888t175r1063b231],
12	.	.	O	.	_	0	SENT_812	[p34l888t175r1063b231],

1	67	CD	NUMBER	67	_	0	SENT_813	[p34l8t255r84b301],
2	.	.	O	.	_	0	SENT_813	[p34l8t255r84b301],

1	Amylin	NNP	ORGANIZATION	Amylin	nn	2	SENT_814	[p34l129t252r315b315],
2	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	_	0	SENT_814	[p34l335t252r792b301],
3	.	.	O	.	_	0	SENT_814	[p34l335t252r792b301],

1	Amylin	NNP	O	Amylin	nsubj	4	SENT_815	[p34l807t252r993b315],
2	and	CC	O	and	_	0	SENT_815	[p34l1012t252r1110b301],
3	Takeda	NNP	PERSON	Takeda	conj_and	1	SENT_815	[p34l1123t252r1312b301],
4	Voluntarily	RB	O	voluntarily	_	0	SENT_815	[p34l1326t252r1621b315],
5	Suspend	VB	O	suspend	ccomp	4	SENT_815	[p34l1636t252r1868b314],

1	Clinical	JJ	O	clinical	amod	2	SENT_816	[p34l131t330r322b379],
2	Activities	NNS	O	activity	_	0	SENT_816	[p34l341t332r587b379],
3	in	IN	O	in	_	0	SENT_816	[p34l606t332r649b379],
4	Obesity	NNP	O	Obesity	nn	5	SENT_816	[p34l668t330r875b393],
5	Trial	NNP	O	Trial	prep_in	2	SENT_816	[p34l885t330r1011b379],
6	.	.	O	.	_	0	SENT_816	[p34l885t330r1011b379],

1	(	NN	O	(	_	0	SENT_817	[p34l1029t331r1133b387],
2	201	CD	NUMBER	201	number	3	SENT_817	[p34l1029t331r1133b387],
3	1	CD	NUMBER	1	dep	1	SENT_817	[p34l1152t331r1209b387],
4	)	NN	O	)	dep	3	SENT_817	[p34l1152t331r1209b387],
5	.	.	O	.	_	0	SENT_817	[p34l1152t331r1209b387],

1	68	CD	NUMBER	68	_	0	SENT_818	[p34l7t488r82b535],
2	.	.	O	.	_	0	SENT_818	[p34l7t488r82b535],

1	M'Lil	NN	O	m'lil	nn	3	SENT_819	[p34l131t485r407b542],
2	|	CD	NUMBER	|	num	3	SENT_819	[p34l131t485r407b542],
3	er	NN	O	er	_	0	SENT_819	[p34l131t485r407b542],
4	,	,	O	,	_	0	SENT_819	[p34l131t485r407b542],
5	T.D.	NNP	O	T.D.	nn	6	SENT_819	[p34l131t485r407b542],
6	etal	NNP	O	etal	appos	3	SENT_819	[p34l421t485r535b535],
7	.	.	O	.	_	0	SENT_819	[p34l421t485r535b535],

1	Restoration	NN	O	restoration	nsubj	11	SENT_820	[p34l553t487r849b535],
2	of	IN	O	of	_	0	SENT_820	[p34l865t484r920b534],
3	leptin	NN	O	leptin	nn	4	SENT_820	[p34l932t485r1078b547],
4	responsiveness	NN	O	responsiveness	prep_of	1	SENT_820	[p34l1096t487r1494b547],
5	in	IN	O	in	_	0	SENT_820	[p34l1510t487r1553b534],
6	diet-induced	JJ	O	diet-induced	amod	8	SENT_820	[p34l1570t485r1904b535],
7	obese	JJ	O	obese	amod	8	SENT_820	[p34l1921t485r2077b535],
8	mice	NNS	O	mouse	prep_in	4	SENT_820	[p34l133t565r255b612],
9	using	VBG	O	use	partmod	8	SENT_820	[p34l272t565r410b626],
10	an	DT	O	a	dobj	9	SENT_820	[p34l426t577r487b612],
11	optimized	VBN	O	optimize	_	0	SENT_820	[p34l503t563r768b625],
12	leptin	NN	O	leptin	nn	13	SENT_820	[p34l786t563r932b625],
13	analog	NN	O	analog	dobj	11	SENT_820	[p34l949t563r1126b626],
14	in	IN	O	in	_	0	SENT_820	[p34l1144t565r1186b612],
15	combination	NN	O	combination	prep_in	11	SENT_820	[p34l1203t563r1537b612],
16	with	IN	O	with	_	0	SENT_820	[p34l1552t563r1666b612],
17	exendin-4	NN	O	exendin-4	prep_with	11	SENT_820	[p34l1682t563r1945b612],
18	or	CC	O	or	_	0	SENT_820	[p34l1959t577r2012b612],
19	FGF21	NN	O	fgf21	conj_or	17	SENT_820	[p34l133t643r286b690],
20	.	.	O	.	_	0	SENT_820	[p34l301t643r353b691],

1	J.	NNP	O	J.	nn	2	SENT_821	[p34l301t643r353b691],
2	Pept	NNP	O	Pept	_	0	SENT_821	[p34l368t643r489b703],
3	.	.	O	.	_	0	SENT_821	[p34l368t643r489b703],

1	Sci	NNP	O	Sci	_	0	SENT_822	[p34l503t642r585b691],
2	.	.	O	.	_	0	SENT_822	[p34l503t642r585b691],

1	18	CD	NUMBER	18	_	0	SENT_823	[p34l603t644r680b698],
2	,	,	O	,	_	0	SENT_823	[p34l603t644r680b698],
3	383-393	CD	NUMBER	383-393	number	4	SENT_823	[p34l694t644r917b691],
4	(	CD	NUMBER	(	appos	1	SENT_823	[p34l935t642r1109b698],
5	2012	CD	DATE	2012	num	6	SENT_823	[p34l935t642r1109b698],
6	)	NN	O	)	dep	4	SENT_823	[p34l935t642r1109b698],
7	.	.	O	.	_	0	SENT_823	[p34l935t642r1109b698],

1	69	CD	NUMBER	69	_	0	SENT_824	[p34l7t722r82b769],
2	.	.	O	.	_	0	SENT_824	[p34l7t722r82b769],

1	Drucker	NNP	PERSON	Drucker	_	0	SENT_825	[p34l132t719r345b776],
2	,	,	O	,	_	0	SENT_825	[p34l132t719r345b776],
3	D.J.	NNP	O	D.J.	nn	5	SENT_825	[p34l361t719r551b769],
4	The	NNP	O	The	nn	5	SENT_825	[p34l361t719r551b769],
5	biology	NN	O	biology	appos	1	SENT_825	[p34l567t719r765b782],
6	of	IN	O	of	_	0	SENT_825	[p34l778t718r832b769],
7	incretin	NN	O	incretin	nn	8	SENT_825	[p34l844t721r1038b769],
8	hormones	NNS	O	hormone	prep_of	5	SENT_825	[p34l1057t719r1335b769],
9	.	.	O	.	_	0	SENT_825	[p34l1057t719r1335b769],

1	Cell	NN	O	cell	_	0	SENT_826	[p34l1351t719r1443b769],
2	Metab	NNP	O	Metab	dep	1	SENT_826	[p34l1451t719r1626b769],
3	.	.	O	.	_	0	SENT_826	[p34l1451t719r1626b769],

1	3	CD	NUMBER	3	_	0	SENT_827	[p34l1641t722r1686b776],
2	,	,	O	,	_	0	SENT_827	[p34l1641t722r1686b776],
3	153-165	CD	NUMBER	153-165	number	4	SENT_827	[p34l1704t722r1922b769],
4	(	CD	NUMBER	(	appos	1	SENT_827	[p34l1940t720r2115b776],
5	2006	CD	DATE	2006	num	6	SENT_827	[p34l1940t720r2115b776],
6	)	NN	O	)	dep	4	SENT_827	[p34l1940t720r2115b776],
7	.	.	O	.	_	0	SENT_827	[p34l1940t720r2115b776],

1	70	CD	NUMBER	70	_	0	SENT_828	[p34l9t800r82b847],
2	.	.	O	.	_	0	SENT_828	[p34l9t800r82b847],

1	Meeran	NNP	MISC	Meeran	_	0	SENT_829	[p34l131t799r341b854],
2	,	,	O	,	_	0	SENT_829	[p34l131t799r341b854],
3	K.	NNP	O	K.	nn	4	SENT_829	[p34l358t799r400b847],
4	etal	NN	O	etal	appos	1	SENT_829	[p34l414t797r529b847],
5	.	.	O	.	_	0	SENT_829	[p34l414t797r529b847],

1	Repeated	JJ	O	repeated	amod	3	SENT_830	[p34l546t797r792b859],
2	intracerebroventricular	JJ	O	intracerebroventricular	amod	3	SENT_830	[p34l810t797r1415b847],
3	administration	NN	O	administration	_	0	SENT_830	[p34l1428t797r1811b847],
4	of	IN	O	of	_	0	SENT_830	[p34l1827t796r1882b847],
5	glucagon-like	JJ	O	glucagon-like	amod	6	SENT_830	[p34l131t875r489b938],
6	peptide-1	NN	O	peptide-1	prep_of	3	SENT_830	[p34l505t875r933b937],
7	-	:	O	-	_	0	SENT_830	[p34l505t875r933b937],
8	(	CD	NUMBER	(	number	9	SENT_830	[p34l505t875r933b937],
9	7-36	CD	NUMBER	7-36	dep	3	SENT_830	[p34l505t875r933b937],
10	)	NN	O	)	nn	11	SENT_830	[p34l505t875r933b937],
11	amide	NN	O	amide	dep	9	SENT_830	[p34l949t875r1112b924],
12	or	CC	O	or	_	0	SENT_830	[p34l1127t889r1180b924],
13	exendin	NN	O	exendin	dep	9	SENT_830	[p34l1193t875r1575b932],
14	-	:	O	-	_	0	SENT_830	[p34l1193t875r1575b932],
15	(	CD	NUMBER	(	dep	3	SENT_830	[p34l1193t875r1575b932],
16	9-39	CD	NUMBER	9-39	num	17	SENT_830	[p34l1193t875r1575b932],
17	)	NN	O	)	nsubj	18	SENT_830	[p34l1193t875r1575b932],
18	alters	VBZ	O	alter	rcmod	15	SENT_830	[p34l1591t875r1731b924],
19	body	NN	O	body	nn	20	SENT_830	[p34l1747t875r1881b939],
20	weight	NN	O	weight	dobj	18	SENT_830	[p34l1893t875r2076b938],
21	in	IN	O	in	_	0	SENT_830	[p34l2091t877r2133b924],
22	the	DT	O	the	det	23	SENT_830	[p34l129t953r215b1002],
23	rat	NN	O	rat	prep_in	20	SENT_830	[p34l232t960r311b1002],
24	.	.	O	.	_	0	SENT_830	[p34l232t960r311b1002],

1	Endocrinology	NN	O	endocrinology	_	0	SENT_831	[p34l325t953r695b1017],
2	140	CD	NUMBER	140	num	1	SENT_831	[p34l708t956r821b1010],
3	,	,	O	,	_	0	SENT_831	[p34l708t956r821b1010],
4	244-250	CD	NUMBER	244-250	num	5	SENT_831	[p34l835t956r1060b1002],
5	(	NN	O	(	appos	1	SENT_831	[p34l1075t954r1111b1010],
6	1	CD	NUMBER	1	num	8	SENT_831	[p34l1075t954r1111b1010],
7	999	CD	NUMBER	999	num	8	SENT_831	[p34l1125t954r1250b1010],
8	)	NN	O	)	dep	5	SENT_831	[p34l1125t954r1250b1010],
9	.	.	O	.	_	0	SENT_831	[p34l1125t954r1250b1010],

1	71	CD	NUMBER	71	_	0	SENT_832	[p34l9t1035r82b1081],
2	.	.	O	.	_	0	SENT_832	[p34l9t1035r82b1081],

1	Turton	NNP	PERSON	Turton	_	0	SENT_833	[p34l127t1033r316b1088],
2	,	,	O	,	_	0	SENT_833	[p34l127t1033r316b1088],
3	M.D.	NNP	O	M.D.	nn	4	SENT_833	[p34l331t1033r444b1081],
4	etal	NNP	O	etal	appos	1	SENT_833	[p34l459t1031r574b1081],
5	.	.	O	.	_	0	SENT_833	[p34l459t1031r574b1081],

1	A	DT	O	a	det	2	SENT_834	[p34l587t1033r624b1080],
2	role	NN	O	role	_	0	SENT_834	[p34l640t1031r736b1081],
3	for	IN	O	for	_	0	SENT_834	[p34l749t1030r821b1081],
4	glucagon-like	JJ	O	glucagon-like	amod	5	SENT_834	[p34l834t1031r1192b1094],
5	peptide-1	NN	O	peptide-1	prep_for	2	SENT_834	[p34l1209t1031r1456b1093],
6	in	IN	O	in	_	0	SENT_834	[p34l1482t1033r1524b1080],
7	the	DT	O	the	det	9	SENT_834	[p34l1539t1031r1625b1081],
8	central	JJ	O	central	amod	9	SENT_834	[p34l1640t1031r1816b1081],
9	regulation	NN	O	regulation	prep_in	2	SENT_834	[p34l1835t1031r2101b1094],
10	of	IN	O	of	_	0	SENT_834	[p34l131t1108r185b1159],
11	feeding	NN	O	feeding	prep_of	9	SENT_834	[p34l193t1108r407b1172],
12	.	.	O	.	_	0	SENT_834	[p34l193t1108r407b1172],

1	Nature	NNP	O	Nature	_	0	SENT_835	[p34l421t1111r594b1159],
2	379	CD	NUMBER	379	num	1	SENT_835	[p34l608t1112r723b1166],
3	,	,	O	,	_	0	SENT_835	[p34l608t1112r723b1166],
4	69-72	CD	NUMBER	69-72	num	1	SENT_835	[p34l737t1112r895b1159],
5	(	CD	NUMBER	(	num	7	SENT_835	[p34l912t1110r1087b1166],
6	1996	CD	DATE	1996	num	7	SENT_835	[p34l912t1110r1087b1166],
7	)	NN	O	)	dep	1	SENT_835	[p34l912t1110r1087b1166],
8	.	.	O	.	_	0	SENT_835	[p34l912t1110r1087b1166],

1	72	CD	NUMBER	72	_	0	SENT_836	[p34l9t1190r82b1237],
2	.	.	O	.	_	0	SENT_836	[p34l9t1190r82b1237],

1	Flint	NNP	O	Flint	_	0	SENT_837	[p34l132t1187r254b1244],
2	,	,	O	,	_	0	SENT_837	[p34l132t1187r254b1244],
3	A.	NN	O	a.	appos	1	SENT_837	[p34l268t1189r330b1244],
4	,	,	O	,	_	0	SENT_837	[p34l268t1189r330b1244],
5	Raben	NNP	PERSON	Raben	appos	1	SENT_837	[p34l347t1187r523b1244],
6	,	,	O	,	_	0	SENT_837	[p34l347t1187r523b1244],
7	A.	NN	O	a.	appos	1	SENT_837	[p34l537t1189r599b1244],
8	,	,	O	,	_	0	SENT_837	[p34l537t1189r599b1244],
9	Astrup	NNP	PERSON	Astrup	appos	1	SENT_837	[p34l613t1189r798b1249],
10	,	,	O	,	_	0	SENT_837	[p34l613t1189r798b1249],
11	A.	NNP	O	A.	appos	1	SENT_837	[p34l812t1189r861b1236],
12	&	CC	O	&	_	0	SENT_837	[p34l875t1188r912b1237],
13	Ho	NNP	O	Ho	appos	1	SENT_837	[p34l927t1187r1154b1244],
14	|	CD	NUMBER	|	num	15	SENT_837	[p34l927t1187r1154b1244],
15	st	NN	O	st	dep	9	SENT_837	[p34l927t1187r1154b1244],
16	,	,	O	,	_	0	SENT_837	[p34l927t1187r1154b1244],
17	J.J.	NNP	PERSON	J.J.	nn	19	SENT_837	[p34l927t1187r1154b1244],
18	Glucagon-like	JJ	PERSON	glucagon-like	amod	19	SENT_837	[p34l1168t1187r1532b1250],
19	peptide	NN	O	peptide	nsubj	21	SENT_837	[p34l1548t1187r1751b1249],
20	1	CD	NUMBER	1	num	19	SENT_837	[p34l1770t1191r1784b1236],
21	promotes	VBZ	O	promote	dep	1	SENT_837	[p34l1811t1194r2062b1249],
22	satiety	NN	O	satiety	dobj	21	SENT_837	[p34l131t1267r303b1329],
23	and	CC	O	and	_	0	SENT_837	[p34l316t1265r413b1314],
24	suppresses	VBZ	O	suppress	conj_and	21	SENT_837	[p34l429t1279r718b1327],
25	energy	NN	O	energy	nn	26	SENT_837	[p34l732t1279r915b1328],
26	intake	NN	O	intake	dobj	24	SENT_837	[p34l930t1265r1088b1314],
27	in	IN	O	in	_	0	SENT_837	[p34l1104t1267r1146b1314],
28	humans	NNS	O	human	prep_in	24	SENT_837	[p34l1165t1265r1432b1314],
29	.	.	O	.	_	0	SENT_837	[p34l1165t1265r1432b1314],

1	J.	NNP	PERSON	J.	nn	2	SENT_838	[p34l1165t1265r1432b1314],
2	Clin	NNP	PERSON	Clin	_	0	SENT_838	[p34l1448t1265r1552b1314],
3	.	.	O	.	_	0	SENT_838	[p34l1448t1265r1552b1314],

1	Invest	VB	O	invest	_	0	SENT_839	[p34l1568t1267r1726b1314],
2	.	.	O	.	_	0	SENT_839	[p34l1568t1267r1726b1314],

1	101	CD	NUMBER	101	_	0	SENT_840	[p34l1744t1268r1856b1322],
2	,	,	O	,	_	0	SENT_840	[p34l1744t1268r1856b1322],
3	515-520	CD	NUMBER	515-520	number	4	SENT_840	[p34l1871t1268r2095b1314],
4	(	CD	NUMBER	(	appos	1	SENT_840	[p34l132t1343r307b1398],
5	1998	CD	DATE	1998	num	6	SENT_840	[p34l132t1343r307b1398],
6	)	NN	O	)	dep	4	SENT_840	[p34l132t1343r307b1398],
7	.	.	O	.	_	0	SENT_840	[p34l132t1343r307b1398],

1	73	CD	NUMBER	73	_	0	SENT_841	[p34l9t1423r83b1470],
2	.	.	O	.	_	0	SENT_841	[p34l9t1423r83b1470],

1	Naslund	NNP	PERSON	Naslund	_	0	SENT_842	[p34l132t1420r362b1477],
2	,	,	O	,	_	0	SENT_842	[p34l132t1420r362b1477],
3	E.	NNP	O	E.	nn	4	SENT_842	[p34l380t1422r418b1470],
4	etal	NN	O	etal	appos	1	SENT_842	[p34l434t1420r552b1470],
5	.	.	O	.	_	0	SENT_842	[p34l434t1420r552b1470],

1	Prandial	JJ	O	prandial	amod	3	SENT_843	[p34l570t1420r782b1470],
2	subcutaneous	JJ	O	subcutaneous	amod	3	SENT_843	[p34l801t1420r1178b1470],
3	injections	NNS	O	injection	_	0	SENT_843	[p34l1196t1422r1454b1483],
4	ofglucagon-like	JJ	O	ofglucagon-like	amod	8	SENT_843	[p34l1470t1419r1902b1483],
5	peptide-1	NN	O	peptide-1	nn	8	SENT_843	[p34l133t1498r384b1560],
6	cause	NN	O	cause	nn	8	SENT_843	[p34l410t1512r560b1548],
7	weight	NN	O	weight	nn	8	SENT_843	[p34l575t1498r761b1561],
8	loss	NN	O	loss	dep	3	SENT_843	[p34l779t1498r874b1548],
9	in	IN	O	in	_	0	SENT_843	[p34l892t1500r936b1547],
10	obese	JJ	O	obese	amod	12	SENT_843	[p34l953t1498r1112b1548],
11	human	JJ	O	human	amod	12	SENT_843	[p34l1130t1498r1315b1548],
12	subjects	NNS	O	subject	prep_in	8	SENT_843	[p34l1333t1498r1566b1561],
13	.	.	O	.	_	0	SENT_843	[p34l1333t1498r1566b1561],

1	Br	NN	O	br	_	0	SENT_844	[p34l1581t1500r1689b1548],
2	.	.	O	.	_	0	SENT_844	[p34l1581t1500r1689b1548],

1	J.	NNP	O	J.	nn	2	SENT_845	[p34l1581t1500r1689b1548],
2	Nutr	NNP	O	Nutr	_	0	SENT_845	[p34l1705t1500r1831b1548],
3	.	.	O	.	_	0	SENT_845	[p34l1705t1500r1831b1548],

1	91	CD	NUMBER	91	_	0	SENT_846	[p34l1846t1501r1928b1555],
2	,	,	O	,	_	0	SENT_846	[p34l1846t1501r1928b1555],
3	439-446	CD	NUMBER	439-446	number	4	SENT_846	[p34l129t1578r359b1624],
4	(	CD	NUMBER	(	appos	1	SENT_846	[p34l376t1576r555b1631],
5	2004	CD	DATE	2004	num	6	SENT_846	[p34l376t1576r555b1631],
6	)	NN	O	)	dep	4	SENT_846	[p34l376t1576r555b1631],
7	.	.	O	.	_	0	SENT_846	[p34l376t1576r555b1631],

1	74	CD	NUMBER	74	_	0	SENT_847	[p34l9t1657r82b1703],
2	.	.	O	.	_	0	SENT_847	[p34l9t1657r82b1703],

1	Michel	NNP	PERSON	Michel	nn	10	SENT_848	[p34l130t1653r316b1710],
2	,	,	O	,	_	0	SENT_848	[p34l130t1653r316b1710],
3	M.C.	NNP	LOCATION	M.C.	nn	10	SENT_848	[p34l331t1654r454b1710],
4	,	,	O	,	_	0	SENT_848	[p34l331t1654r454b1710],
5	Fliers	NNP	O	Fliers	nn	10	SENT_848	[p34l471t1653r614b1710],
6	,	,	O	,	_	0	SENT_848	[p34l471t1653r614b1710],
7	E.	NNP	ORGANIZATION	E.	nn	10	SENT_848	[p34l631t1655r669b1703],
8	&	CC	ORGANIZATION	&	_	0	SENT_848	[p34l683t1654r824b1703],
9	Van	NNP	ORGANIZATION	Van	conj_and	1	SENT_848	[p34l683t1654r824b1703],
10	Noorden	NNP	ORGANIZATION	Noorden	_	0	SENT_848	[p34l843t1653r1086b1710],
11	,	,	O	,	_	0	SENT_848	[p34l843t1653r1086b1710],
12	C.J.	NNP	O	C.J.	nn	14	SENT_848	[p34l1100t1654r1182b1703],
13	Dipeptidyl	NNP	O	Dipeptidyl	nn	14	SENT_848	[p34l1198t1653r1469b1716],
14	peptidase	NN	O	peptidase	appos	10	SENT_848	[p34l1487t1653r1746b1715],
15	IV	CD	NUMBER	iv	num	16	SENT_848	[p34l1763t1655r1810b1702],
16	inhibitors	NNS	O	inhibitor	dep	14	SENT_848	[p34l1823t1653r2071b1703],
17	in	IN	O	in	_	0	SENT_848	[p34l132t1733r175b1780],
18	diabetes	NN	O	diabetes	prep_in	16	SENT_848	[p34l191t1731r428b1781],
19	:	:	O	:	_	0	SENT_848	[p34l191t1731r428b1781],
20	more	JJR	O	more	quantmod	21	SENT_848	[p34l444t1746r579b1781],
21	than	IN	O	than	dep	10	SENT_848	[p34l592t1731r710b1781],
22	inhibition	NN	O	inhibition	dep	21	SENT_848	[p34l729t1731r979b1781],
23	of	IN	O	of	_	0	SENT_848	[p34l995t1730r1050b1781],
24	glucagon-like	JJ	O	glucagon-like	amod	26	SENT_848	[p34l1060t1731r1418b1794],
25	peptide-1	NN	O	peptide-1	nn	26	SENT_848	[p34l1434t1731r1681b1793],
26	metabolism	NN	O	metabolism	prep_of	21	SENT_848	[p34l1707t1731r2043b1781],
27	?	.	O	?	_	0	SENT_848	[p34l1707t1731r2043b1781],

1	Naunyn	NNP	O	Naunyn	nn	3	SENT_849	[p34l130t1811r329b1873],
2	Schmiedebergs	NNP	O	Schmiedebergs	nn	3	SENT_849	[p34l341t1809r728b1872],
3	Arch	NNP	O	Arch	_	0	SENT_849	[p34l736t1809r865b1858],
4	.	.	O	.	_	0	SENT_849	[p34l736t1809r865b1858],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_850	[p34l879t1809r1167b1858],
2	.	.	O	.	_	0	SENT_850	[p34l879t1809r1167b1858],

1	377	CD	NUMBER	377	_	0	SENT_851	[p34l1182t1812r1298b1866],
2	,	,	O	,	_	0	SENT_851	[p34l1182t1812r1298b1866],
3	205-207	CD	NUMBER	205-207	number	4	SENT_851	[p34l1312t1812r1536b1858],
4	(	CD	NUMBER	(	appos	1	SENT_851	[p34l1553t1810r1727b1866],
5	2008	CD	DATE	2008	num	6	SENT_851	[p34l1553t1810r1727b1866],
6	)	NN	O	)	dep	4	SENT_851	[p34l1553t1810r1727b1866],
7	.	.	O	.	_	0	SENT_851	[p34l1553t1810r1727b1866],

1	75	CD	NUMBER	75	_	0	SENT_852	[p34l9t1891r83b1937],
2	.	.	O	.	_	0	SENT_852	[p34l9t1891r83b1937],

1	Amori	NNP	LOCATION	Amori	_	0	SENT_853	[p34l129t1889r305b1944],
2	,	,	O	,	_	0	SENT_853	[p34l129t1889r305b1944],
3	R.E.	NNP	PERSON	R.E.	conj_and	1	SENT_853	[p34l323t1889r424b1944],
4	,	,	O	,	_	0	SENT_853	[p34l323t1889r424b1944],
5	Lau	NNP	PERSON	Lau	conj_and	1	SENT_853	[p34l442t1889r546b1944],
6	,	,	O	,	_	0	SENT_853	[p34l442t1889r546b1944],
7	J.	NNP	O	J.	conj_and	1	SENT_853	[p34l560t1889r594b1937],
8	&	CC	O	&	_	0	SENT_853	[p34l610t1889r646b1937],
9	Pittas	NNP	O	Pittas	conj_and	1	SENT_853	[p34l663t1889r819b1944],
10	,	,	O	,	_	0	SENT_853	[p34l663t1889r819b1944],
11	A.G.	NNP	PERSON	A.G.	nn	12	SENT_853	[p34l833t1889r939b1936],
12	Efﬁcacy	NNP	PERSON	Efﬁcacy	conj_and	1	SENT_853	[p34l957t1886r1158b1951],
13	and	CC	O	and	_	0	SENT_853	[p34l1172t1887r1270b1937],
14	safety	NN	O	safety	conj_and	1	SENT_853	[p34l1288t1886r1446b1950],
15	of	IN	O	of	_	0	SENT_853	[p34l1460t1886r1515b1937],
16	incretin	NN	O	incretin	nn	17	SENT_853	[p34l1528t1889r1726b1937],
17	therapy	NN	O	therapy	prep_of	14	SENT_853	[p34l1743t1887r1951b1950],
18	in	IN	O	in	_	0	SENT_853	[p34l1967t1889r2010b1936],
19	type	NN	O	type	nn	21	SENT_853	[p34l2027t1894r2146b1951],
20	2	CD	NUMBER	2	num	21	SENT_853	[p34l131t1968r158b2014],
21	diabetes	NN	O	diabetes	prep_in	17	SENT_853	[p34l175t1965r417b2014],
22	:	:	O	:	_	0	SENT_853	[p34l175t1965r417b2014],
23	systematic	JJ	O	systematic	amod	24	SENT_853	[p34l433t1967r716b2029],
24	review	NN	O	review	dep	1	SENT_853	[p34l733t1967r908b2014],
25	and	CC	O	and	_	0	SENT_853	[p34l923t1965r1020b2014],
26	meta-analysis	NN	O	meta-analysis	conj_and	24	SENT_853	[p34l1040t1965r1418b2028],
27	.	.	O	.	_	0	SENT_853	[p34l1040t1965r1418b2028],

1	JAMA	NN	O	jama	_	0	SENT_854	[p34l1430t1967r1576b2014],
2	298	CD	NUMBER	298	num	1	SENT_854	[p34l1593t1968r1711b2022],
3	,	,	O	,	_	0	SENT_854	[p34l1593t1968r1711b2022],
4	194-206	CD	NUMBER	194-206	number	5	SENT_854	[p34l1731t1968r1955b2014],
5	(	CD	NUMBER	(	appos	1	SENT_854	[p34l1972t1966r2150b2022],
6	2007	CD	DATE	2007	num	7	SENT_854	[p34l1972t1966r2150b2022],
7	)	NN	O	)	dep	5	SENT_854	[p34l1972t1966r2150b2022],
8	.	.	O	.	_	0	SENT_854	[p34l1972t1966r2150b2022],

1	76	CD	NUMBER	76	_	0	SENT_855	[p34l9t2046r82b2092],
2	.	.	O	.	_	0	SENT_855	[p34l9t2046r82b2092],

1	Fakhoury	NNP	PERSON	Fakhoury	nsubj	18	SENT_856	[p34l131t2043r384b2107],
2	,	,	O	,	_	0	SENT_856	[p34l131t2043r384b2107],
3	W.K.	NNP	LOCATION	W.K.	conj_and	1	SENT_856	[p34l395t2045r517b2100],
4	,	,	O	,	_	0	SENT_856	[p34l395t2045r517b2100],
5	Lereun	NNP	PERSON	Lereun	conj_and	1	SENT_856	[p34l534t2045r725b2100],
6	,	,	O	,	_	0	SENT_856	[p34l534t2045r725b2100],
7	C.	NNP	ORGANIZATION	C.	conj_and	1	SENT_856	[p34l739t2045r785b2092],
8	&	CC	ORGANIZATION	&	_	0	SENT_856	[p34l799t2045r965b2106],
9	Wrig	NNP	ORGANIZATION	Wrig	nsubj	18	SENT_856	[p34l799t2045r965b2106],
10	ht	NN	O	ht	dep	1	SENT_856	[p34l974t2043r1037b2100],
11	,	,	O	,	_	0	SENT_856	[p34l974t2043r1037b2100],
12	D.	NNP	O	D.	nn	14	SENT_856	[p34l1053t2045r1101b2092],
13	A	NNP	O	A	nn	14	SENT_856	[p34l1115t2045r1151b2092],
14	meta-analysis	NN	O	meta-analysis	appos	1	SENT_856	[p34l1167t2043r1524b2107],
15	of	IN	O	of	_	0	SENT_856	[p34l1538t2042r1593b2093],
16	placebo	NN	O	placebo	prep_of	14	SENT_856	[p34l1605t2043r2104b2105],
17	—	CD	NUMBER	—	num	16	SENT_856	[p34l1605t2043r2104b2105],
18	controlled	JJ	O	controlled	_	0	SENT_856	[p34l1605t2043r2104b2105],
19	clinical	JJ	O	clinical	amod	20	SENT_856	[p34l130t2121r307b2170],
20	trials	NNS	O	trial	dobj	18	SENT_856	[p34l322t2121r447b2171],
21	assessing	VBG	O	assess	partmod	20	SENT_856	[p34l462t2123r705b2184],
22	the	DT	O	the	det	23	SENT_856	[p34l720t2121r806b2171],
23	efﬁcacy	NN	O	efﬁcacy	dobj	21	SENT_856	[p34l821t2120r1021b2185],
24	and	CC	O	and	_	0	SENT_856	[p34l1034t2121r1131b2170],
25	safety	NN	O	safety	conj_and	23	SENT_856	[p34l1147t2120r1302b2184],
26	of	IN	O	of	_	0	SENT_856	[p34l1315t2120r1370b2170],
27	incretin-based	JJ	O	incretin-based	amod	28	SENT_856	[p34l1381t2121r1755b2171],
28	medications	NNS	O	medication	prep_of	23	SENT_856	[p34l1773t2121r2094b2171],
29	in	IN	O	in	_	0	SENT_856	[p34l132t2200r175b2247],
30	patients	NNS	O	patient	prep_in	18	SENT_856	[p34l193t2200r403b2260],
31	with	IN	O	with	_	0	SENT_856	[p34l417t2198r530b2248],
32	type	NN	O	type	nn	34	SENT_856	[p34l545t2206r663b2262],
33	2	CD	NUMBER	2	num	34	SENT_856	[p34l678t2201r705b2247],
34	diabetes	NN	O	diabetes	prep_with	30	SENT_856	[p34l721t2198r957b2248],
35	.	.	O	.	_	0	SENT_856	[p34l721t2198r957b2248],

1	Pharmacology	NN	O	pharmacology	_	0	SENT_857	[p34l971t2198r1345b2262],
2	86	CD	NUMBER	86	num	1	SENT_857	[p34l1355t2201r1435b2255],
3	,	,	O	,	_	0	SENT_857	[p34l1355t2201r1435b2255],
4	44-57	CD	NUMBER	44-57	number	5	SENT_857	[p34l1448t2202r1608b2248],
5	(	CD	NUMBER	(	appos	1	SENT_857	[p34l1625t2199r1799b2255],
6	2010	CD	DATE	2010	num	7	SENT_857	[p34l1625t2199r1799b2255],
7	)	NN	O	)	dep	5	SENT_857	[p34l1625t2199r1799b2255],
8	.	.	O	.	_	0	SENT_857	[p34l1625t2199r1799b2255],

1	77	CD	NUMBER	77	_	0	SENT_858	[p34l8t2280r84b2326],
2	.	.	O	.	_	0	SENT_858	[p34l8t2280r84b2326],

1	Phung	NNP	PERSON	Phung	nn	9	SENT_859	[p34l131t2276r317b2339],
2	,	,	O	,	_	0	SENT_859	[p34l131t2276r317b2339],
3	O.J.	NNP	O	O.J.	appos	9	SENT_859	[p34l334t2278r438b2333],
4	,	,	O	,	_	0	SENT_859	[p34l334t2278r438b2333],
5	Scholle	NNP	PERSON	Scholle	appos	9	SENT_859	[p34l454t2276r662b2333],
6	,	,	O	,	_	0	SENT_859	[p34l454t2276r662b2333],
7	J.M.	NNP	O	J.M.	appos	9	SENT_859	[p34l676t2276r988b2333],
8	,	,	O	,	_	0	SENT_859	[p34l676t2276r988b2333],
9	Ta	NNP	O	Ta	nsubj	10	SENT_859	[p34l676t2276r988b2333],
10	|	VBD	O	|	_	0	SENT_859	[p34l676t2276r988b2333],
11	war	NN	O	war	dobj	10	SENT_859	[p34l676t2276r988b2333],
12	,	,	O	,	_	0	SENT_859	[p34l676t2276r988b2333],
13	M.	NNP	PERSON	M.	appos	11	SENT_859	[p34l1006t2278r1066b2326],
14	&	CC	PERSON	&	_	0	SENT_859	[p34l1082t2278r1119b2326],
15	Coleman	NNP	PERSON	Coleman	conj_and	13	SENT_859	[p34l1134t2276r1387b2333],
16	,	,	O	,	_	0	SENT_859	[p34l1134t2276r1387b2333],
17	C.	NNP	O	C.	nn	18	SENT_859	[p34l1404t2278r1481b2326],
18	|	NNP	O	|	appos	13	SENT_859	[p34l1404t2278r1481b2326],
19	.	.	O	.	_	0	SENT_859	[p34l1404t2278r1481b2326],

1	Effect	NN	O	effect	nsubj	6	SENT_860	[p34l1500t2275r1648b2326],
2	of	IN	O	of	_	0	SENT_860	[p34l1664t2275r1719b2326],
3	noninsulin	JJ	O	noninsulin	amod	5	SENT_860	[p34l1733t2276r2015b2326],
4	antidiabetic	JJ	O	antidiabetic	amod	5	SENT_860	[p34l130t2354r454b2404],
5	drugs	NNS	O	drug	prep_of	1	SENT_860	[p34l469t2354r622b2417],
6	added	VBD	O	add	_	0	SENT_860	[p34l638t2354r807b2404],
7	to	TO	O	to	_	0	SENT_860	[p34l825t2362r878b2404],
8	metformin	NN	O	metformin	nn	9	SENT_860	[p34l897t2353r1180b2404],
9	therapy	NN	O	therapy	prep_to	6	SENT_860	[p34l1197t2354r1408b2418],
10	on	IN	O	on	_	0	SENT_860	[p34l1423t2369r1488b2404],
11	glycemic	JJ	O	glycemic	amod	12	SENT_860	[p34l1507t2354r1747b2418],
12	control	NN	O	control	prep_on	6	SENT_860	[p34l1763t2354r1968b2411],
13	,	,	O	,	_	0	SENT_860	[p34l1763t2354r1968b2411],
14	weight	NN	O	weight	nn	15	SENT_860	[p34l129t2432r317b2495],
15	gain	NN	O	gain	conj_and	12	SENT_860	[p34l333t2434r463b2495],
16	,	,	O	,	_	0	SENT_860	[p34l333t2434r463b2495],
17	and	CC	O	and	_	0	SENT_860	[p34l479t2432r577b2482],
18	hypoglycemia	NN	O	hypoglycemia	conj_and	12	SENT_860	[p34l598t2432r975b2496],
19	in	IN	O	in	_	0	SENT_860	[p34l995t2434r1039b2481],
20	type	NN	O	type	nn	22	SENT_860	[p34l1056t2439r1176b2496],
21	2	CD	NUMBER	2	num	22	SENT_860	[p34l1193t2435r1221b2481],
22	diabetes	NN	O	diabetes	prep_in	18	SENT_860	[p34l1238t2432r1641b2482],
23	.	.	O	.	_	0	SENT_860	[p34l1238t2432r1641b2482],

1	JAMA	NN	O	jama	_	0	SENT_861	[p34l1238t2432r1641b2482],
2	303	CD	NUMBER	303	num	1	SENT_861	[p34l1659t2435r1777b2489],
3	,	,	O	,	_	0	SENT_861	[p34l1659t2435r1777b2489],
4	1410-1418	CD	DATE	1410-1418	number	5	SENT_861	[p34l1798t2435r2091b2482],
5	(	CD	NUMBER	(	appos	1	SENT_861	[p34l132t2510r312b2565],
6	2010	CD	DATE	2010	num	7	SENT_861	[p34l132t2510r312b2565],
7	)	NN	O	)	dep	5	SENT_861	[p34l132t2510r312b2565],
8	.	.	O	.	_	0	SENT_861	[p34l132t2510r312b2565],

1	78	CD	NUMBER	78	_	0	SENT_862	[p34l8t2590r82b2637],
2	.	.	O	.	_	0	SENT_862	[p34l8t2590r82b2637],

1	Pratley	NNP	LOCATION	Pratley	_	0	SENT_863	[p34l131t2587r317b2651],
2	,	,	O	,	_	0	SENT_863	[p34l131t2587r317b2651],
3	R.E.	NNP	O	R.E.	nn	4	SENT_863	[p34l334t2589r419b2637],
4	Overview	NNP	O	Overview	appos	1	SENT_863	[p34l434t2589r685b2637],
5	of	IN	O	of	_	0	SENT_863	[p34l698t2586r752b2637],
6	g	NN	O	g	nn	8	SENT_863	[p34l762t2587r1120b2650],
7	|	NN	O	|	nn	8	SENT_863	[p34l762t2587r1120b2650],
8	ucagon	NN	O	ucagon	prep_of	4	SENT_863	[p34l762t2587r1120b2650],
9	—	CD	NUMBER	—	num	13	SENT_863	[p34l762t2587r1120b2650],
10	|	NN	O	|	nn	13	SENT_863	[p34l762t2587r1120b2650],
11	ike	NN	O	ike	nn	13	SENT_863	[p34l762t2587r1120b2650],
12	peptide-1	NN	O	peptide-1	nn	13	SENT_863	[p34l1137t2587r1384b2650],
13	analogs	NNS	O	analog	dep	8	SENT_863	[p34l1408t2587r1612b2650],
14	and	CC	O	and	_	0	SENT_863	[p34l1626t2587r1722b2637],
15	dipeptidyl	NN	O	dipeptidyl	nn	16	SENT_863	[p34l1739t2587r2005b2651],
16	peptidase	NN	O	peptidase	conj_and	8	SENT_863	[p34l132t2665r445b2727],
17	—	CD	NUMBER	—	number	18	SENT_863	[p34l132t2665r445b2727],
18	4	CD	NUMBER	4	num	19	SENT_863	[p34l132t2665r445b2727],
19	inhibitors	NNS	O	inhibitor	dep	16	SENT_863	[p34l461t2665r708b2715],
20	for	IN	O	for	_	0	SENT_863	[p34l721t2664r794b2715],
21	type	NN	O	type	nn	23	SENT_863	[p34l806t2673r923b2729],
22	2	CD	NUMBER	2	num	23	SENT_863	[p34l938t2668r965b2714],
23	diabetes	NN	O	diabetes	prep_for	4	SENT_863	[p34l981t2665r1217b2715],
24	.	.	O	.	_	0	SENT_863	[p34l981t2665r1217b2715],

1	Medscapej	NNP	PERSON	Medscapej	_	0	SENT_864	[p34l1230t2665r1528b2727],
2	.	.	O	.	_	0	SENT_864	[p34l1230t2665r1528b2727],

1	Med	NNP	O	Med	_	0	SENT_865	[p34l1543t2665r1665b2715],
2	.	.	O	.	_	0	SENT_865	[p34l1543t2665r1665b2715],

1	10	CD	NUMBER	10	_	0	SENT_866	[p34l1682t2668r1760b2722],
2	,	,	O	,	_	0	SENT_866	[p34l1682t2668r1760b2722],
3	1	CD	NUMBER	1	number	4	SENT_866	[p34l1778t2669r1793b2714],
4	71	CD	NUMBER	71	appos	1	SENT_866	[p34l1808t2669r1858b2714],
5	(	CD	NUMBER	(	num	7	SENT_866	[p34l1885t2666r2059b2722],
6	2008	CD	DATE	2008	num	7	SENT_866	[p34l1885t2666r2059b2722],
7	)	NN	O	)	dep	4	SENT_866	[p34l1885t2666r2059b2722],
8	.	.	O	.	_	0	SENT_866	[p34l1885t2666r2059b2722],

1	79	CD	NUMBER	79	_	0	SENT_867	[p34l8t2746r82b2793],
2	.	.	O	.	_	0	SENT_867	[p34l8t2746r82b2793],

1	Batterham	NNP	PERSON	Batterham	_	0	SENT_868	[p34l131t2743r417b2800],
2	,	,	O	,	_	0	SENT_868	[p34l131t2743r417b2800],
3	R.L.	NNP	PERSON	R.L.	nn	4	SENT_868	[p34l434t2745r518b2793],
4	etal	NNP	O	etal	appos	1	SENT_868	[p34l533t2743r648b2793],
5	.	.	O	.	_	0	SENT_868	[p34l533t2743r648b2793],

1	Inhibition	NN	O	inhibition	_	0	SENT_869	[p34l664t2743r915b2793],
2	of	IN	O	of	_	0	SENT_869	[p34l931t2742r986b2793],
3	food	NN	O	food	nn	4	SENT_869	[p34l994t2742r1113b2793],
4	intake	NN	O	intake	prep_of	1	SENT_869	[p34l1131t2743r1289b2793],
5	in	IN	O	in	dep	1	SENT_869	[p34l1306t2745r1348b2792],
6	obese	JJ	O	obese	amod	7	SENT_869	[p34l1365t2743r1521b2793],
7	subjects	NNS	O	subject	pobj	5	SENT_869	[p34l1536t2743r1751b2806],
8	by	IN	O	by	dep	1	SENT_869	[p34l1768t2743r1830b2807],
9	peptide	NN	O	peptide	pobj	8	SENT_869	[p34l1844t2743r2047b2805],

1	YY3	NN	O	yy3	_	0	SENT_870	[p34l129t2823r326b2871],
2	—	CD	NUMBER	—	number	3	SENT_870	[p34l129t2823r326b2871],
3	36	CD	NUMBER	36	num	1	SENT_870	[p34l129t2823r326b2871],
4	.	.	O	.	_	0	SENT_870	[p34l129t2823r326b2871],

1	N.	NNP	O	N.	nn	2	SENT_871	[p34l341t2823r388b2871],
2	Engl	NNP	O	Engl	_	0	SENT_871	[p34l403t2821r522b2884],
3	.	.	O	.	_	0	SENT_871	[p34l403t2821r522b2884],

1	J.	NNP	O	J.	nn	2	SENT_872	[p34l533t2823r567b2871],
2	Med	NNP	O	Med	_	0	SENT_872	[p34l581t2821r704b2871],
3	.	.	O	.	_	0	SENT_872	[p34l581t2821r704b2871],

1	349	CD	NUMBER	349	_	0	SENT_873	[p34l718t2824r833b2878],
2	,	,	O	,	_	0	SENT_873	[p34l718t2824r833b2878],
3	941	CD	NUMBER	941	number	4	SENT_873	[p34l848t2824r932b2871],
4	-948	CD	NUMBER	-948	appos	1	SENT_873	[p34l946t2824r1072b2871],
5	(	CD	NUMBER	(	num	7	SENT_873	[p34l1089t2822r1263b2878],
6	2003	CD	DATE	2003	num	7	SENT_873	[p34l1089t2822r1263b2878],
7	)	NN	O	)	dep	4	SENT_873	[p34l1089t2822r1263b2878],
8	.	.	O	.	_	0	SENT_873	[p34l1089t2822r1263b2878],

1	80	CD	NUMBER	80	_	0	SENT_874	[p34l7t2902r82b2949],
2	.	.	O	.	_	0	SENT_874	[p34l7t2902r82b2949],

1	Sutherland	NNP	PERSON	Sutherland	_	0	SENT_875	[p34l129t2899r431b2956],
2	,	,	O	,	_	0	SENT_875	[p34l129t2899r431b2956],
3	E.W.	NNP	ORGANIZATION	E.W.	conj_and	1	SENT_875	[p34l447t2901r549b2949],
4	&	CC	ORGANIZATION	&	_	0	SENT_875	[p34l563t2901r600b2949],
5	Robison	NNP	ORGANIZATION	Robison	conj_and	1	SENT_875	[p34l615t2899r838b2956],
6	,	,	O	,	_	0	SENT_875	[p34l615t2899r838b2956],
7	G.A.	NNP	O	G.A.	appos	1	SENT_875	[p34l852t2901r955b2949],
8	.	.	O	.	_	0	SENT_875	[p34l852t2901r955b2949],

1	The	DT	O	the	det	2	SENT_876	[p34l965t2899r1062b2949],
2	role	NN	O	role	_	0	SENT_876	[p34l1078t2899r1175b2949],
3	of	IN	O	of	_	0	SENT_876	[p34l1189t2898r1243b2949],
4	cyclic	JJ	O	cyclic	amod	5	SENT_876	[p34l1253t2899r1395b2963],
5	AMP	NN	O	amp	prep_of	2	SENT_876	[p34l1409t2901r1529b2948],
6	in	IN	O	in	_	0	SENT_876	[p34l1546t2901r1589b2948],
7	the	DT	O	the	det	8	SENT_876	[p34l1604t2899r1690b2949],
8	control	NN	O	control	prep_in	2	SENT_876	[p34l1704t2899r1887b2949],
9	of	IN	O	of	_	0	SENT_876	[p34l1904t2898r1959b2949],
10	carbohydrate	NN	O	carbohydrate	nn	11	SENT_876	[p34l130t2977r482b3041],
11	metabolism	NN	O	metabolism	prep_of	8	SENT_876	[p34l498t2977r822b3027],
12	.	.	O	.	_	0	SENT_876	[p34l498t2977r822b3027],

1	Diabetes	NNP	O	Diabetes	_	0	SENT_877	[p34l836t2977r1057b3027],
2	18	CD	NUMBER	18	num	1	SENT_877	[p34l1074t2980r1151b3035],
3	,	,	O	,	_	0	SENT_877	[p34l1074t2980r1151b3035],
4	797-819	CD	NUMBER	797-819	num	1	SENT_877	[p34l1167t2980r1390b3027],
5	(	CD	NUMBER	(	num	7	SENT_877	[p34l1406t2978r1580b3034],
6	1969	CD	DATE	1969	num	7	SENT_877	[p34l1406t2978r1580b3034],
7	)	NN	O	)	dep	1	SENT_877	[p34l1406t2978r1580b3034],
8	.	.	O	.	_	0	SENT_877	[p34l1406t2978r1580b3034],

1	81	CD	NUMBER	81	_	0	SENT_878	[p34l7t3058r82b3105],
2	.	.	O	.	_	0	SENT_878	[p34l7t3058r82b3105],

1	Unger	NNP	PERSON	Unger	_	0	SENT_879	[p34l131t3057r300b3118],
2	,	,	O	,	_	0	SENT_879	[p34l131t3057r300b3118],
3	R.H.	NNP	LOCATION	R.H.	conj_and	1	SENT_879	[p34l317t3057r425b3112],
4	,	,	O	,	_	0	SENT_879	[p34l317t3057r425b3112],
5	Dobbs	NNP	LOCATION	Dobbs	conj_and	1	SENT_879	[p34l442t3055r624b3112],
6	,	,	O	,	_	0	SENT_879	[p34l442t3055r624b3112],
7	R.E.	NNP	ORGANIZATION	R.E.	conj_and	1	SENT_879	[p34l641t3057r726b3105],
8	&	CC	ORGANIZATION	&	_	0	SENT_879	[p34l740t3057r777b3105],
9	Orci	NNP	ORGANIZATION	Orci	conj_and	1	SENT_879	[p34l790t3057r907b3112],
10	,	,	O	,	_	0	SENT_879	[p34l790t3057r907b3112],
11	L.	NNP	PERSON	L.	nn	12	SENT_879	[p34l923t3057r960b3105],
12	Insulin	NN	PERSON	insulin	conj_and	1	SENT_879	[p34l977t3055r1161b3112],
13	,	,	O	,	_	0	SENT_879	[p34l977t3055r1161b3112],
14	glucagon	NN	O	glucagon	conj_and	1	SENT_879	[p34l1175t3055r1435b3118],
15	,	,	O	,	_	0	SENT_879	[p34l1175t3055r1435b3118],
16	and	CC	O	and	_	0	SENT_879	[p34l1450t3055r1546b3105],
17	somatostatin	NN	O	somatostatin	nn	18	SENT_879	[p34l1563t3057r1904b3105],
18	secretion	NN	O	secretion	conj_and	1	SENT_879	[p34l130t3135r368b3183],
19	in	IN	O	in	_	0	SENT_879	[p34l387t3135r429b3182],
20	the	DT	O	the	det	21	SENT_879	[p34l444t3133r530b3183],
21	regulation	NN	O	regulation	prep_in	18	SENT_879	[p34l547t3133r813b3196],
22	of	IN	O	of	_	0	SENT_879	[p34l830t3132r884b3183],
23	metabolism	NN	O	metabolism	prep_of	21	SENT_879	[p34l896t3133r1220b3183],
24	.	.	O	.	_	0	SENT_879	[p34l896t3133r1220b3183],

1	Annu	NNP	PERSON	Annu	_	0	SENT_880	[p34l1231t3135r1379b3183],
2	.	.	O	.	_	0	SENT_880	[p34l1231t3135r1379b3183],

1	Rev.	NNP	O	Rev.	nn	2	SENT_881	[p34l1394t3135r1490b3183],
2	Physiol	NNP	PERSON	Physiol	_	0	SENT_881	[p34l1505t3133r1694b3197],
3	.	.	O	.	_	0	SENT_881	[p34l1505t3133r1694b3197],

1	40	CD	NUMBER	40	_	0	SENT_882	[p34l1707t3136r1788b3190],
2	,	,	O	,	_	0	SENT_882	[p34l1707t3136r1788b3190],
3	307-343	CD	NUMBER	307-343	number	4	SENT_882	[p34l1803t3136r2025b3183],
4	(	CD	NUMBER	(	appos	1	SENT_882	[p34l132t3212r306b3267],
5	1978	CD	DATE	1978	num	6	SENT_882	[p34l132t3212r306b3267],
6	)	NN	O	)	dep	4	SENT_882	[p34l132t3212r306b3267],
7	.	.	O	.	_	0	SENT_882	[p34l132t3212r306b3267],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_883	[p34l21t3345r140b3366],
2	PHARMACOLOGY&THERAPEUT	NN	O	pharmacology&therapeut	dep	10	SENT_883	[p34l149t3345r601b3366],
3	|	CD	NUMBER	|	num	2	SENT_883	[p34l149t3345r601b3366],
4	CS	NNP	O	CS	nn	6	SENT_883	[p34l149t3345r601b3366],
5	|	NNP	O	|	nn	6	SENT_883	[p34l611t3343r729b3373],
6	VOLUME	NNP	O	VOLUME	dep	2	SENT_883	[p34l611t3343r729b3373],
7	95	CD	NUMBER	95	num	8	SENT_883	[p34l737t3345r764b3366],
8	NUMBER	NN	O	number	dep	10	SENT_883	[p34l774t3345r882b3366],
9	1	CD	NUMBER	1	num	10	SENT_883	[p34l892t3346r899b3366],
10	]	CD	NUMBER	]	dep	13	SENT_883	[p34l912t3343r915b3373],
11	JANUARY	NNP	DATE	JANUARY	dep	10	SENT_883	[p34l924t3345r1042b3366],
12	2014	CD	DATE	2014	num	13	SENT_883	[p34l1049t3345r1108b3366],
13	65	CD	DATE	65	_	0	SENT_883	[p34l2109t3345r2139b3366],

1	82	CD	NUMBER	82	_	0	SENT_884	[p35l7t88r82b134],
2	.	.	O	.	_	0	SENT_884	[p35l7t88r82b134],

1	Marchmont	NNP	O	Marchmont	_	0	SENT_885	[p35l130t85r450b142],
2	,	,	O	,	_	0	SENT_885	[p35l130t85r450b142],
3	R.J.	NNP	ORGANIZATION	R.J.	conj_and	1	SENT_885	[p35l467t87r544b134],
4	&	CC	ORGANIZATION	&	_	0	SENT_885	[p35l558t86r595b134],
5	Houslay	NNP	ORGANIZATION	Houslay	conj_and	1	SENT_885	[p35l610t85r827b148],
6	,	,	O	,	_	0	SENT_885	[p35l610t85r827b148],
7	M.D.	NNP	O	M.D.	appos	1	SENT_885	[p35l843t87r956b134],
8	.	.	O	.	_	0	SENT_885	[p35l843t87r956b134],

1	A	DT	O	a	det	2	SENT_886	[p35l969t87r1006b134],
2	peripheral	JJ	O	peripheral	nsubj	7	SENT_886	[p35l1022t85r1288b147],
3	and	CC	O	and	_	0	SENT_886	[p35l1304t85r1401b134],
4	an	DT	O	a	det	6	SENT_886	[p35l1417t99r1478b134],
5	intrinsic	JJ	O	intrinsic	amod	6	SENT_886	[p35l1496t87r1702b134],
6	enzyme	NN	O	enzyme	conj_and	2	SENT_886	[p35l1716t99r1924b148],
7	constitute	VBP	O	constitute	_	0	SENT_886	[p35l130t165r396b212],
8	the	DT	O	the	det	12	SENT_886	[p35l409t163r495b212],
9	cyclic	JJ	O	cyclic	amod	12	SENT_886	[p35l509t163r652b226],
10	AMP	NN	O	amp	nn	12	SENT_886	[p35l665t165r786b212],
11	phosphodiesterase	NN	O	phosphodiesterase	nn	12	SENT_886	[p35l803t163r1306b225],
12	activity	NN	O	activity	dobj	7	SENT_886	[p35l1320t165r1511b226],
13	of	IN	O	of	_	0	SENT_886	[p35l1524t162r1578b212],
14	rat	NN	O	rat	nn	17	SENT_886	[p35l1590t170r1657b212],
15	liver	NN	O	liver	nn	17	SENT_886	[p35l1673t163r1780b212],
16	plasma	NN	O	plasma	nn	17	SENT_886	[p35l1796t163r1980b225],
17	membranes	NNS	O	membrane	prep_of	12	SENT_886	[p35l132t240r458b289],
18	.	.	O	.	_	0	SENT_886	[p35l132t240r458b289],

1	Biochem	NNP	ORGANIZATION	Biochem	_	0	SENT_887	[p35l473t240r703b289],
2	.	.	O	.	_	0	SENT_887	[p35l473t240r703b289],

1	J.	NNP	O	J.	_	0	SENT_888	[p35l714t242r750b289],
2	187	CD	NUMBER	187	num	1	SENT_888	[p35l768t243r881b296],
3	,	,	O	,	_	0	SENT_888	[p35l768t243r881b296],
4	381-392	CD	NUMBER	381-392	num	1	SENT_888	[p35l896t243r1119b289],
5	(	CD	NUMBER	(	num	7	SENT_888	[p35l1136t241r1311b296],
6	1980	CD	DATE	1980	num	7	SENT_888	[p35l1136t241r1311b296],
7	)	NN	O	)	dep	1	SENT_888	[p35l1136t241r1311b296],
8	.	.	O	.	_	0	SENT_888	[p35l1136t241r1311b296],

1	83	CD	NUMBER	83	_	0	SENT_889	[p35l7t321r82b367],
2	.	.	O	.	_	0	SENT_889	[p35l7t321r82b367],

1	Zhao	NNP	PERSON	Zhao	nsubjpass	30	SENT_890	[p35l128t318r274b375],
2	,	,	O	,	_	0	SENT_890	[p35l128t318r274b375],
3	A.Z.	NNP	O	A.Z.	conj_and	1	SENT_890	[p35l288t320r398b375],
4	,	,	O	,	_	0	SENT_890	[p35l288t320r398b375],
5	Zhao	NNP	PERSON	Zhao	conj_and	1	SENT_890	[p35l412t318r557b375],
6	,	,	O	,	_	0	SENT_890	[p35l412t318r557b375],
7	H.	NNP	O	H.	conj_and	1	SENT_890	[p35l573t320r848b381],
8	,	,	O	,	_	0	SENT_890	[p35l573t320r848b381],
9	Teague	NNP	PERSON	Teague	conj_and	1	SENT_890	[p35l573t320r848b381],
10	,	,	O	,	_	0	SENT_890	[p35l573t320r848b381],
11	J.	NNP	O	J.	conj_and	1	SENT_890	[p35l861t320r908b375],
12	,	,	O	,	_	0	SENT_890	[p35l861t320r908b375],
13	Fujimoto	NNP	PERSON	Fujimoto	conj_and	1	SENT_890	[p35l925t320r1169b381],
14	,	,	O	,	_	0	SENT_890	[p35l925t320r1169b381],
15	W.	NNP	ORGANIZATION	W.	nsubjpass	30	SENT_890	[p35l1179t320r1240b367],
16	&	CC	ORGANIZATION	&	_	0	SENT_890	[p35l1254t319r1291b367],
17	Beavo	NNP	ORGANIZATION	Beavo	nsubjpass	30	SENT_890	[p35l1307t320r1474b375],
18	,	,	O	,	_	0	SENT_890	[p35l1307t320r1474b375],
19	J.A.	NNP	PERSON	J.A.	nn	20	SENT_890	[p35l1487t320r1573b367],
20	Attenuation	NN	PERSON	attenuation	appos	1	SENT_890	[p35l1587t320r1901b367],
21	of	IN	O	of	_	0	SENT_890	[p35l1918t317r1972b367],
22	insulin	NN	O	insulin	nn	23	SENT_890	[p35l1984t318r2152b367],
23	secretion	NN	O	secretion	prep_of	20	SENT_890	[p35l131t398r377b445],
24	by	IN	O	by	_	0	SENT_890	[p35l397t396r460b459],
25	insulin-like	JJ	O	insulin-like	amod	27	SENT_890	[p35l477t396r769b445],
26	growth	NN	O	growth	nn	27	SENT_890	[p35l785t396r978b459],
27	factor	NN	O	factor	prep_by	23	SENT_890	[p35l995t395r1154b445],
28	1	CD	NUMBER	1	dep	27	SENT_890	[p35l1173t400r1188b445],
29	is	VBZ	O	be	auxpass	30	SENT_890	[p35l1216t398r1251b445],
30	mediated	VBN	O	mediate	_	0	SENT_890	[p35l1270t396r1524b445],
31	through	IN	O	through	_	0	SENT_890	[p35l1541t396r1761b459],
32	activation	NN	O	activation	prep_through	30	SENT_890	[p35l1779t398r2045b445],
33	of	IN	O	of	_	0	SENT_890	[p35l2064t395r2120b445],
34	phosphodiesterase	NN	O	phosphodiesterase	nn	35	SENT_890	[p35l132t474r651b536],
35	3B	NN	O	3b	prep_of	32	SENT_890	[p35l667t476r745b523],
36	.	.	O	.	_	0	SENT_890	[p35l667t476r745b523],

1	Proc	NNP	O	Proc	_	0	SENT_891	[p35l761t476r884b523],
2	.	.	O	.	_	0	SENT_891	[p35l761t476r884b523],

1	Natl.	NNP	O	Natl.	nn	2	SENT_892	[p35l900t474r1019b523],
2	Acad	NNP	O	Acad	_	0	SENT_892	[p35l1032t474r1174b523],
3	.	.	O	.	_	0	SENT_892	[p35l1032t474r1174b523],

1	Sci	NNP	O	Sci	_	0	SENT_893	[p35l1190t475r1274b523],
2	.	.	O	.	_	0	SENT_893	[p35l1190t475r1274b523],

1	USA	NNP	O	USA	_	0	SENT_894	[p35l1293t475r1393b523],
2	94	CD	NUMBER	94	num	1	SENT_894	[p35l1410t477r1493b531],
3	,	,	O	,	_	0	SENT_894	[p35l1410t477r1493b531],
4	3223-3228	CD	DURATION	3223-3228	num	1	SENT_894	[p35l1509t477r1807b523],
5	(	CD	NUMBER	(	num	7	SENT_894	[p35l1825t475r2006b531],
6	1997	CD	DATE	1997	num	7	SENT_894	[p35l1825t475r2006b531],
7	)	NN	O	)	dep	1	SENT_894	[p35l1825t475r2006b531],
8	.	.	O	.	_	0	SENT_894	[p35l1825t475r2006b531],

1	84	CD	NUMBER	84	_	0	SENT_895	[p35l7t555r82b601],
2	.	.	O	.	_	0	SENT_895	[p35l7t555r82b601],

1	Hawley	NNP	PERSON	Hawley	_	0	SENT_896	[p35l131t552r332b615],
2	,	,	O	,	_	0	SENT_896	[p35l131t552r332b615],
3	S.A.	NNP	O	S.A.	nn	4	SENT_896	[p35l347t553r439b601],
4	etal	NN	O	etal	appos	1	SENT_896	[p35l453t552r568b601],
5	.	.	O	.	_	0	SENT_896	[p35l453t552r568b601],

1	Calmodulin-dependent	JJ	O	calmodulin-dependent	amod	4	SENT_897	[p35l583t552r1204b614],
2	protein	NN	O	protein	nn	4	SENT_897	[p35l1220t554r1406b614],
3	kinase	NN	O	kinase	nn	4	SENT_897	[p35l1425t552r1589b601],
4	kinase-beta	NN	O	kinase-beta	nsubj	9	SENT_897	[p35l1605t552r1909b601],
5	is	VBZ	O	be	cop	9	SENT_897	[p35l1926t554r1960b601],
6	an	DT	O	a	det	9	SENT_897	[p35l1975t566r2035b601],
7	alternative	JJ	O	alternative	amod	9	SENT_897	[p35l130t630r410b679],
8	upstream	JJ	O	upstream	amod	9	SENT_897	[p35l427t637r673b692],
9	kinase	NN	O	kinase	_	0	SENT_897	[p35l691t630r855b679],
10	for	IN	O	for	_	0	SENT_897	[p35l868t629r940b679],
11	AMP-activated	JJ	O	amp-activated	amod	13	SENT_897	[p35l953t630r1336b679],
12	protein	NN	O	protein	nn	13	SENT_897	[p35l1355t632r1541b692],
13	kinase	NN	O	kinase	prep_for	9	SENT_897	[p35l1560t630r1735b680],
14	.	.	O	.	_	0	SENT_897	[p35l1560t630r1735b680],

1	Cell	NN	O	cell	_	0	SENT_898	[p35l1751t630r1842b679],
2	Metab	NNP	O	Metab	dep	1	SENT_898	[p35l1851t630r2027b679],
3	.	.	O	.	_	0	SENT_898	[p35l1851t630r2027b679],

1	2	CD	NUMBER	2	_	0	SENT_899	[p35l2041t633r2086b687],
2	,	,	O	,	_	0	SENT_899	[p35l2041t633r2086b687],
3	9-19	CD	NUMBER	9-19	number	4	SENT_899	[p35l131t710r257b756],
4	(	CD	NUMBER	(	appos	1	SENT_899	[p35l273t708r448b763],
5	2005	CD	DATE	2005	num	6	SENT_899	[p35l273t708r448b763],
6	)	NN	O	)	dep	4	SENT_899	[p35l273t708r448b763],
7	.	.	O	.	_	0	SENT_899	[p35l273t708r448b763],

1	85	CD	NUMBER	85	_	0	SENT_900	[p35l7t788r82b834],
2	.	.	O	.	_	0	SENT_900	[p35l7t788r82b834],

1	Hardie	NNP	PERSON	Hardie	_	0	SENT_901	[p35l131t785r313b842],
2	,	,	O	,	_	0	SENT_901	[p35l131t785r313b842],
3	D.G.	NNP	ORGANIZATION	D.G.	conj_and	1	SENT_901	[p35l330t787r431b834],
4	&	CC	ORGANIZATION	&	_	0	SENT_901	[p35l446t786r482b834],
5	Frenguelli	NNP	ORGANIZATION	Frenguelli	conj_and	1	SENT_901	[p35l498t785r769b848],
6	,	,	O	,	_	0	SENT_901	[p35l498t785r769b848],
7	B.G.	NNP	PERSON	B.G.	appos	1	SENT_901	[p35l786t787r881b834],
8	.	.	O	.	_	0	SENT_901	[p35l786t787r881b834],

1	A	DT	O	a	det	4	SENT_902	[p35l895t787r931b834],
2	neural	JJ	O	neural	amod	4	SENT_902	[p35l947t785r1108b834],
3	protection	NN	O	protection	nn	4	SENT_902	[p35l1127t787r1399b847],
4	racket	NN	O	racket	_	0	SENT_902	[p35l1417t785r1587b834],
5	:	:	O	:	_	0	SENT_902	[p35l1417t785r1587b834],
6	AMPK	NNP	O	AMPK	dep	4	SENT_902	[p35l1601t787r1759b834],
7	and	CC	O	and	_	0	SENT_902	[p35l1771t785r1868b834],
8	the	DT	O	the	dep	4	SENT_902	[p35l1883t785r1969b834],

1	GABA	NN	O	gaba	_	0	SENT_903	[p35l130t864r350b920],
2	(	NN	O	(	nn	5	SENT_903	[p35l130t864r350b920],
3	B	NN	O	b	nn	5	SENT_903	[p35l130t864r350b920],
4	)	NN	O	)	nn	5	SENT_903	[p35l130t864r350b920],
5	receptor	NN	O	receptor	dep	1	SENT_903	[p35l368t870r597b925],
6	.	.	O	.	_	0	SENT_903	[p35l368t870r597b925],

1	Neuron	NN	O	neuron	_	0	SENT_904	[p35l611t865r797b912],
2	53	CD	NUMBER	53	num	1	SENT_904	[p35l813t866r893b920],
3	,	,	O	,	_	0	SENT_904	[p35l813t866r893b920],
4	159-162	CD	NUMBER	159-162	number	5	SENT_904	[p35l912t866r1131b912],
5	(	CD	NUMBER	(	appos	1	SENT_904	[p35l1148t864r1323b920],
6	2007	CD	DATE	2007	num	7	SENT_904	[p35l1148t864r1323b920],
7	)	NN	O	)	dep	5	SENT_904	[p35l1148t864r1323b920],
8	.	.	O	.	_	0	SENT_904	[p35l1148t864r1323b920],

1	86	CD	NUMBER	86	_	0	SENT_905	[p35l7t944r82b990],
2	.	.	O	.	_	0	SENT_905	[p35l7t944r82b990],

1	Narkar	NNP	PERSON	Narkar	nn	3	SENT_906	[p35l131t941r417b998],
2	,	,	O	,	_	0	SENT_906	[p35l131t941r417b998],
3	V.A.	NNP	O	V.A.	dep	4	SENT_906	[p35l131t941r417b998],
4	etal	JJ	O	etal	_	0	SENT_906	[p35l431t941r546b990],
5	.	.	O	.	_	0	SENT_906	[p35l431t941r546b990],

1	AMPK	NNP	ORGANIZATION	AMPK	nn	6	SENT_907	[p35l560t943r719b990],
2	and	CC	O	and	_	0	SENT_907	[p35l731t941r827b990],
3	PPARde	NNP	O	PPARde	nn	6	SENT_907	[p35l846t941r1109b990],
4	|	CD	NUMBER	|	num	6	SENT_907	[p35l846t941r1109b990],
5	ta	NN	O	ta	nn	6	SENT_907	[p35l846t941r1109b990],
6	agonists	NNS	O	agonist	nsubj	9	SENT_907	[p35l1125t943r1345b1004],
7	are	VBP	O	be	cop	9	SENT_907	[p35l1359t955r1438b990],
8	exercise	NN	O	exercise	nn	9	SENT_907	[p35l1453t943r1662b990],
9	mimetics	NNS	O	mimetic	_	0	SENT_907	[p35l1679t943r1928b990],
10	.	.	O	.	_	0	SENT_907	[p35l1679t943r1928b990],

1	Cell	NN	O	cell	_	0	SENT_908	[p35l1944t941r2035b990],

1	87	CD	NUMBER	87	_	0	SENT_909	[p35l7t1099r82b1145],
2	.	.	O	.	_	0	SENT_909	[p35l7t1099r82b1145],

1	Minokoshi	NNP	PERSON	Minokoshi	_	0	SENT_910	[p35l130t1096r466b1153],
2	,	,	O	,	_	0	SENT_910	[p35l130t1096r466b1153],
3	Y.	NNP	O	Y.	nn	4	SENT_910	[p35l130t1096r466b1153],
4	etal	NN	O	etal	appos	1	SENT_910	[p35l480t1096r595b1146],
5	.	.	O	.	_	0	SENT_910	[p35l480t1096r595b1146],

1	AMP-kinase	NN	O	amp-kinase	nsubj	2	SENT_911	[p35l609t1096r917b1145],
2	regulates	VBZ	O	regulate	_	0	SENT_911	[p35l934t1096r1174b1159],
3	food	NN	O	food	nn	4	SENT_911	[p35l1187t1095r1307b1146],
4	intake	NN	O	intake	dobj	2	SENT_911	[p35l1325t1096r1484b1145],
5	by	IN	O	by	_	0	SENT_911	[p35l1500t1096r1562b1159],
6	responding	VBG	O	respond	prepc_by	2	SENT_911	[p35l1577t1096r1875b1159],
7	to	TO	O	to	_	0	SENT_911	[p35l1891t1103r1944b1145],
8	hormonal	JJ	O	hormonal	amod	11	SENT_911	[p35l133t1174r385b1223],
9	and	CC	O	and	_	0	SENT_911	[p35l403t1174r499b1223],
10	nutrient	JJ	O	nutrient	amod	11	SENT_911	[p35l518t1176r728b1223],
11	signals	NNS	O	signal	prep_to	6	SENT_911	[p35l742t1174r919b1237],
12	in	IN	O	in	_	0	SENT_911	[p35l936t1176r979b1223],
13	the	DT	O	the	det	14	SENT_911	[p35l994t1174r1080b1223],
14	hypothalamus	NN	O	hypothalamus	prep_in	11	SENT_911	[p35l1097t1174r1486b1238],
15	.	.	O	.	_	0	SENT_911	[p35l1097t1174r1486b1238],

1	Nature	NNP	O	Nature	_	0	SENT_912	[p35l1500t1176r1674b1223],
2	428	CD	NUMBER	428	num	1	SENT_912	[p35l1686t1177r1802b1231],
3	,	,	O	,	_	0	SENT_912	[p35l1686t1177r1802b1231],
4	569-574	CD	NUMBER	569-574	num	1	SENT_912	[p35l1817t1177r2043b1223],
5	(	CD	NUMBER	(	num	7	SENT_912	[p35l132t1252r307b1307],
6	2004	CD	DATE	2004	num	7	SENT_912	[p35l132t1252r307b1307],
7	)	NN	O	)	dep	1	SENT_912	[p35l132t1252r307b1307],
8	.	.	O	.	_	0	SENT_912	[p35l132t1252r307b1307],

1	88	CD	NUMBER	88	_	0	SENT_913	[p35l7t1332r82b1378],
2	.	.	O	.	_	0	SENT_913	[p35l7t1332r82b1378],

1	Lucas	NNP	PERSON	Lucas	_	0	SENT_914	[p35l131t1331r286b1386],
2	,	,	O	,	_	0	SENT_914	[p35l131t1331r286b1386],
3	K.A.	NNP	PERSON	K.A.	nn	4	SENT_914	[p35l303t1331r398b1378],
4	etal	NNP	O	etal	appos	1	SENT_914	[p35l412t1329r527b1378],
5	.	.	O	.	_	0	SENT_914	[p35l412t1329r527b1378],

1	Guanylyl	NN	O	guanylyl	nn	2	SENT_915	[p35l542t1329r768b1393],
2	cyclases	NNS	O	cyclase	_	0	SENT_915	[p35l784t1329r996b1392],
3	and	CC	O	and	_	0	SENT_915	[p35l1011t1329r1107b1378],
4	signaling	NN	O	signaling	conj_and	2	SENT_915	[p35l1124t1329r1360b1392],
5	by	IN	O	by	_	0	SENT_915	[p35l1379t1329r1441b1393],
6	cyclic	JJ	O	cyclic	amod	8	SENT_915	[p35l1454t1329r1596b1392],
7	GMP	NNP	O	GMP	nn	8	SENT_915	[p35l1610t1331r1737b1378],
8	Pharmacol	NNP	O	Pharmacol	prep_by	2	SENT_915	[p35l1752t1329r2037b1378],
9	.	.	O	.	_	0	SENT_915	[p35l1752t1329r2037b1378],

1	Rev.	NNP	O	Rev.	_	0	SENT_916	[p35l2052t1331r2153b1378],

1	89	CD	NUMBER	89	_	0	SENT_917	[p35l7t1487r82b1533],
2	.	.	O	.	_	0	SENT_917	[p35l7t1487r82b1533],

1	Degerman	NNP	O	Degerman	_	0	SENT_918	[p35l131t1486r422b1547],
2	,	,	O	,	_	0	SENT_918	[p35l131t1486r422b1547],
3	E.	NNP	O	E.	nn	4	SENT_918	[p35l438t1486r476b1533],
4	etal	NN	O	etal	appos	1	SENT_918	[p35l491t1484r606b1534],
5	.	.	O	.	_	0	SENT_918	[p35l491t1484r606b1534],

1	From	IN	O	from	_	0	SENT_919	[p35l622t1486r752b1533],
2	PDE3B	NN	O	pde3b	pobj	1	SENT_919	[p35l771t1486r940b1533],
3	to	TO	O	to	_	0	SENT_919	[p35l954t1491r1007b1533],
4	the	DT	O	the	det	5	SENT_919	[p35l1020t1484r1106b1533],
5	regulation	NN	O	regulation	prep_to	2	SENT_919	[p35l1123t1484r1389b1547],
6	of	IN	O	of	_	0	SENT_919	[p35l1406t1483r1461b1533],
7	energy	NN	O	energy	nn	8	SENT_919	[p35l1471t1499r1654b1547],
8	homeostasis	NN	O	homeostasis	prep_of	5	SENT_919	[p35l1669t1484r2008b1534],
9	.	.	O	.	_	0	SENT_919	[p35l1669t1484r2008b1534],

1	Curr	NN	O	curr	_	0	SENT_920	[p35l2024t1486r2137b1533],
2	.	.	O	.	_	0	SENT_920	[p35l2024t1486r2137b1533],

1	Opin	NNP	PERSON	Opin	_	0	SENT_921	[p35l131t1564r263b1624],
2	.	.	O	.	_	0	SENT_921	[p35l131t1564r263b1624],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_922	[p35l278t1562r566b1612],
2	.	.	O	.	_	0	SENT_922	[p35l278t1562r566b1612],

1	1	CD	NUMBER	1	num	2	SENT_923	[p35l584t1566r604b1611],
2	1	CD	NUMBER	1	_	0	SENT_923	[p35l619t1566r661b1619],
3	,	,	O	,	_	0	SENT_923	[p35l619t1566r661b1619],
4	676-682	CD	NUMBER	676-682	num	5	SENT_923	[p35l675t1565r899b1612],
5	(	NN	O	(	appos	2	SENT_923	[p35l916t1563r1017b1619],
6	201	CD	NUMBER	201	number	7	SENT_923	[p35l916t1563r1017b1619],
7	1	CD	NUMBER	1	num	8	SENT_923	[p35l1035t1563r1091b1619],
8	)	NN	O	)	dep	5	SENT_923	[p35l1035t1563r1091b1619],
9	.	.	O	.	_	0	SENT_923	[p35l1035t1563r1091b1619],

1	90	CD	NUMBER	90	_	0	SENT_924	[p35l7t1643r81b1690],
2	.	.	O	.	_	0	SENT_924	[p35l7t1643r81b1690],

1	Nisoli	NNP	PERSON	Nisoli	_	0	SENT_925	[p35l131t1640r286b1697],
2	,	,	O	,	_	0	SENT_925	[p35l131t1640r286b1697],
3	E.	NNP	O	E.	nn	4	SENT_925	[p35l302t1642r340b1690],
4	etal	NN	O	etal	appos	1	SENT_925	[p35l355t1640r470b1690],
5	.	.	O	.	_	0	SENT_925	[p35l355t1640r470b1690],

1	Mitochondrial	JJ	O	mitochondrial	amod	2	SENT_926	[p35l485t1640r853b1690],
2	biogenesis	NN	O	biogenesis	_	0	SENT_926	[p35l872t1640r1152b1703],
3	in	IN	O	in	_	0	SENT_926	[p35l1169t1642r1212b1689],
4	mammals	NNS	O	mammal	prep_in	2	SENT_926	[p35l1230t1640r1499b1690],
5	:	:	O	:	_	0	SENT_926	[p35l1230t1640r1499b1690],
6	the	DT	O	the	det	7	SENT_926	[p35l1512t1640r1598b1690],
7	role	NN	O	role	dep	2	SENT_926	[p35l1615t1640r1711b1690],
8	of	IN	O	of	_	0	SENT_926	[p35l1726t1639r1780b1690],
9	endogenous	JJ	O	endogenous	amod	11	SENT_926	[p35l1790t1640r2123b1703],
10	nitric	JJ	O	nitric	amod	11	SENT_926	[p35l132t1719r262b1766],
11	oxide	NN	O	oxide	prep_of	7	SENT_926	[p35l277t1717r431b1766],
12	.	.	O	.	_	0	SENT_926	[p35l277t1717r431b1766],

1	Science	NNP	O	Science	_	0	SENT_927	[p35l445t1718r634b1766],
2	299	CD	NUMBER	299	num	1	SENT_927	[p35l647t1720r762b1773],
3	,	,	O	,	_	0	SENT_927	[p35l647t1720r762b1773],
4	896-899	CD	NUMBER	896-899	num	1	SENT_927	[p35l777t1720r1002b1766],
5	(	CD	NUMBER	(	num	7	SENT_927	[p35l1018t1718r1192b1773],
6	2003	CD	DATE	2003	num	7	SENT_927	[p35l1018t1718r1192b1773],
7	)	NN	O	)	dep	1	SENT_927	[p35l1018t1718r1192b1773],
8	.	.	O	.	_	0	SENT_927	[p35l1018t1718r1192b1773],

1	91	CD	NUMBER	91	_	0	SENT_928	[p35l7t1798r81b1845],
2	.	.	O	.	_	0	SENT_928	[p35l7t1798r81b1845],

1	Jang	NNP	PERSON	Jang	nn	7	SENT_929	[p35l127t1797r263b1858],
2	,	,	O	,	_	0	SENT_929	[p35l127t1797r263b1858],
3	Y.	NNP	O	Y.	appos	7	SENT_929	[p35l273t1797r325b1852],
4	,	,	O	,	_	0	SENT_929	[p35l273t1797r325b1852],
5	Wang	NNP	PERSON	Wang	appos	7	SENT_929	[p35l336t1797r499b1858],
6	,	,	O	,	_	0	SENT_929	[p35l336t1797r499b1858],
7	H.	NNP	O	H.	nsubj	25	SENT_929	[p35l516t1797r578b1852],
8	,	,	O	,	_	0	SENT_929	[p35l516t1797r578b1852],
9	Xi	NN	O	xi	appos	7	SENT_929	[p35l592t1797r653b1852],
10	,	,	O	,	_	0	SENT_929	[p35l592t1797r653b1852],
11	J.	NNP	O	J.	appos	7	SENT_929	[p35l665t1797r712b1852],
12	,	,	O	,	_	0	SENT_929	[p35l665t1797r712b1852],
13	Mueller	NNP	PERSON	Mueller	appos	7	SENT_929	[p35l728t1795r934b1852],
14	,	,	O	,	_	0	SENT_929	[p35l728t1795r934b1852],
15	R.A.	NNP	LOCATION	R.A.	conj_and	11	SENT_929	[p35l951t1797r1057b1852],
16	,	,	O	,	_	0	SENT_929	[p35l951t1797r1057b1852],
17	Norﬂeet	NNP	LOCATION	Norﬂeet	conj_and	11	SENT_929	[p35l1074t1794r1300b1852],
18	,	,	O	,	_	0	SENT_929	[p35l1074t1794r1300b1852],
19	E.A.	NNP	ORGANIZATION	E.A.	conj_and	11	SENT_929	[p35l1316t1797r1406b1845],
20	&	CC	ORGANIZATION	&	_	0	SENT_929	[p35l1420t1797r1457b1845],
21	Xu	NNP	ORGANIZATION	Xu	conj_and	11	SENT_929	[p35l1470t1797r1550b1852],
22	,	,	O	,	_	0	SENT_929	[p35l1470t1797r1550b1852],
23	Z.	NNP	O	Z.	nn	24	SENT_929	[p35l1564t1797r1609b1845],
24	NO	NN	O	no	appos	7	SENT_929	[p35l1626t1797r1706b1845],
25	mobilizes	VBZ	O	mobilize	_	0	SENT_929	[p35l1722t1795r1969b1845],
26	intracellular	JJ	O	intracellular	amod	27	SENT_929	[p35l132t1873r442b1922],
27	Zn2	NN	O	zn2	dobj	25	SENT_929	[p35l454t1875r592b1922],
28	+	CC	O	+	_	0	SENT_929	[p35l454t1875r592b1922],
29	via	IN	O	via	_	0	SENT_929	[p35l606t1875r678b1922],
30	cGMP/PKG	NN	O	cgmp/pkg	prep_via	31	SENT_929	[p35l694t1874r975b1925],
31	signaling	NN	O	signaling	dobj	25	SENT_929	[p35l991t1873r1228b1936],
32	pathway	NN	O	pathway	dep	31	SENT_929	[p35l1246t1873r1472b1937],
33	and	CC	O	and	_	0	SENT_929	[p35l1485t1873r1581b1922],
34	prevents	VBZ	O	prevent	conj_and	25	SENT_929	[p35l1600t1880r1826b1935],
35	mitochondrial	JJ	O	mitochondrial	amod	37	SENT_929	[p35l132t1951r500b2000],
36	oxidant	JJ	O	oxidant	amod	37	SENT_929	[p35l517t1951r716b2000],
37	damage	NN	O	damage	dobj	34	SENT_929	[p35l730t1951r944b2014],
38	in	IN	O	in	_	0	SENT_929	[p35l961t1953r1003b2000],
39	cardiomyocytes	NNS	O	cardiomyocyte	prep_in	37	SENT_929	[p35l1020t1951r1449b2015],
40	.	.	O	.	_	0	SENT_929	[p35l1020t1951r1449b2015],

1	Cardiovasc	NNP	O	Cardiovasc	_	0	SENT_930	[p35l1464t1951r1751b2000],
2	.	.	O	.	_	0	SENT_930	[p35l1464t1951r1751b2000],

1	Res	NNP	O	Res	_	0	SENT_931	[p35l1765t1953r1861b2000],
2	.	.	O	.	_	0	SENT_931	[p35l1765t1953r1861b2000],

1	75	CD	NUMBER	75	_	0	SENT_932	[p35l1876t1955r1956b2008],
2	,	,	O	,	_	0	SENT_932	[p35l1876t1955r1956b2008],
3	426-433	CD	NUMBER	426-433	number	4	SENT_932	[p35l129t2031r353b2077],
4	(	CD	NUMBER	(	appos	1	SENT_932	[p35l371t2029r546b2084],
5	2007	CD	DATE	2007	num	6	SENT_932	[p35l371t2029r546b2084],
6	)	NN	O	)	dep	4	SENT_932	[p35l371t2029r546b2084],
7	.	.	O	.	_	0	SENT_932	[p35l371t2029r546b2084],

1	92	CD	NUMBER	92	_	0	SENT_933	[p35l7t2109r81b2155],
2	.	.	O	.	_	0	SENT_933	[p35l7t2109r81b2155],

1	Cypess	NNP	PERSON	Cypess	_	0	SENT_934	[p35l129t2108r322b2170],
2	,	,	O	,	_	0	SENT_934	[p35l129t2108r322b2170],
3	A.M.	NNP	O	A.M.	nn	4	SENT_934	[p35l336t2108r449b2156],
4	etal	NN	O	etal	appos	1	SENT_934	[p35l463t2106r579b2155],
5	.	.	O	.	_	0	SENT_934	[p35l463t2106r579b2155],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_935	[p35l596t2105r940b2156],
2	and	CC	O	and	_	0	SENT_935	[p35l957t2106r1053b2155],
3	importance	NN	O	importance	conj_and	1	SENT_935	[p35l1072t2108r1376b2168],
4	of	IN	O	of	_	0	SENT_935	[p35l1390t2105r1445b2155],
5	brown	JJ	O	brown	amod	7	SENT_935	[p35l1456t2106r1622b2155],
6	adipose	NN	O	adipose	nn	7	SENT_935	[p35l1639t2106r1845b2168],
7	tissue	NN	O	tissue	prep_of	1	SENT_935	[p35l1858t2108r2009b2156],
8	in	IN	O	in	_	0	SENT_935	[p35l2025t2108r2068b2155],
9	adult	JJ	O	adult	amod	10	SENT_935	[p35l130t2184r265b2234],
10	humans	NNS	O	human	prep_in	1	SENT_935	[p35l281t2184r503b2234],
11	.	.	O	.	_	0	SENT_935	[p35l281t2184r503b2234],

1	N.	NNP	O	N.	nn	2	SENT_936	[p35l517t2186r565b2234],
2	Engl	NNP	O	Engl	_	0	SENT_936	[p35l580t2184r699b2247],
3	.	.	O	.	_	0	SENT_936	[p35l580t2184r699b2247],

1	J.	NNP	O	J.	nn	2	SENT_937	[p35l710t2186r744b2234],
2	Med	NNP	O	Med	_	0	SENT_937	[p35l758t2184r881b2234],
3	.	.	O	.	_	0	SENT_937	[p35l758t2184r881b2234],

1	360	CD	NUMBER	360	_	0	SENT_938	[p35l895t2187r1011b2241],
2	,	,	O	,	_	0	SENT_938	[p35l895t2187r1011b2241],
3	1509-1517	CD	DATE	1509-1517	number	4	SENT_938	[p35l1030t2187r1315b2234],
4	(	CD	NUMBER	(	appos	1	SENT_938	[p35l1332t2185r1506b2241],
5	2009	CD	DATE	2009	num	6	SENT_938	[p35l1332t2185r1506b2241],
6	)	NN	O	)	dep	4	SENT_938	[p35l1332t2185r1506b2241],
7	.	.	O	.	_	0	SENT_938	[p35l1332t2185r1506b2241],

1	93	CD	NUMBER	93	_	0	SENT_939	[p35l7t2265r81b2312],
2	.	.	O	.	_	0	SENT_939	[p35l7t2265r81b2312],

1	Trujillo	NNP	PERSON	Trujillo	_	0	SENT_940	[p35l126t2262r316b2325],
2	,	,	O	,	_	0	SENT_940	[p35l126t2262r316b2325],
3	M.E.	NNP	ORGANIZATION	M.E.	conj_and	1	SENT_940	[p35l332t2264r436b2312],
4	&	CC	ORGANIZATION	&	_	0	SENT_940	[p35l450t2264r487b2312],
5	Scherer	NNP	ORGANIZATION	Scherer	conj_and	1	SENT_940	[p35l500t2262r706b2319],
6	,	,	O	,	_	0	SENT_940	[p35l500t2262r706b2319],
7	P.E.	NNP	O	P.E.	nn	8	SENT_940	[p35l723t2264r799b2312],
8	Adipose	NNP	O	Adipose	appos	1	SENT_940	[p35l813t2262r1028b2324],
9	tissue-derived	JJ	O	tissue-derived	amod	10	SENT_940	[p35l1041t2262r1414b2312],
10	factors	NNS	O	factor	dep	8	SENT_940	[p35l1429t2261r1620b2312],
11	:	:	O	:	_	0	SENT_940	[p35l1429t2261r1620b2312],
12	impact	NN	O	impact	dep	1	SENT_940	[p35l1637t2264r1818b2324],
13	on	IN	O	on	_	0	SENT_940	[p35l1831t2277r1896b2312],
14	health	NN	O	health	prep_on	12	SENT_940	[p35l1915t2262r2076b2312],
15	and	CC	O	and	_	0	SENT_940	[p35l130t2339r227b2388],
16	disease	NN	O	disease	conj_and	14	SENT_940	[p35l243t2339r448b2388],
17	.	.	O	.	_	0	SENT_940	[p35l243t2339r448b2388],

1	Endocr	NNP	MISC	Endocr	_	0	SENT_941	[p35l462t2339r645b2388],
2	.	.	O	.	_	0	SENT_941	[p35l462t2339r645b2388],

1	Rev.	NNP	O	Rev.	_	0	SENT_942	[p35l660t2341r761b2388],
2	27	CD	NUMBER	27	num	1	SENT_942	[p35l776t2342r856b2395],
3	,	,	O	,	_	0	SENT_942	[p35l776t2342r856b2395],
4	762-778	CD	NUMBER	762-778	num	1	SENT_942	[p35l871t2342r1095b2388],
5	(	CD	NUMBER	(	num	7	SENT_942	[p35l1111t2340r1286b2395],
6	2006	CD	DATE	2006	num	7	SENT_942	[p35l1111t2340r1286b2395],
7	)	NN	O	)	dep	1	SENT_942	[p35l1111t2340r1286b2395],
8	.	.	O	.	_	0	SENT_942	[p35l1111t2340r1286b2395],

1	94	CD	NUMBER	94	_	0	SENT_943	[p35l8t2625r82b2672],
2	.	.	O	.	_	0	SENT_943	[p35l8t2625r82b2672],

1	Parker	NNP	PERSON	Parker	_	0	SENT_944	[p35l132t2622r301b2679],
2	,	,	O	,	_	0	SENT_944	[p35l132t2622r301b2679],
3	N.	NNP	O	N.	appos	1	SENT_944	[p35l318t2624r380b2679],
4	,	,	O	,	_	0	SENT_944	[p35l318t2624r380b2679],
5	Crichton	NNP	PERSON	Crichton	appos	1	SENT_944	[p35l394t2622r630b2679],
6	,	,	O	,	_	0	SENT_944	[p35l394t2622r630b2679],
7	PG.,Vidal-Puig	NN	O	pg.,vidal-puig	appos	1	SENT_944	[p35l647t2622r1035b2685],
8	,	,	O	,	_	0	SENT_944	[p35l647t2622r1035b2685],
9	A.J.	NNP	ORGANIZATION	A.J.	appos	1	SENT_944	[p35l1049t2624r1133b2672],
10	&	CC	ORGANIZATION	&	_	0	SENT_944	[p35l1148t2624r1184b2672],
11	Brand	NNP	ORGANIZATION	Brand	appos	1	SENT_944	[p35l1200t2622r1363b2679],
12	,	,	O	,	_	0	SENT_944	[p35l1200t2622r1363b2679],
13	M.D.	NNP	O	M.D.	nn	15	SENT_944	[p35l1379t2624r1491b2672],
14	Uncoupling	NN	O	uncoupling	nn	15	SENT_944	[p35l1508t2622r1811b2685],
15	protein-1	NN	O	protein-1	appos	1	SENT_944	[p35l1830t2624r2060b2684],

1	(	NN	O	(	nn	2	SENT_945	[p35l132t2701r306b2757],
2	UCP1	NN	O	ucp1	nsubj	4	SENT_945	[p35l132t2701r306b2757],
3	)	CD	NUMBER	)	dep	2	SENT_945	[p35l132t2701r306b2757],
4	contributes	VBZ	O	contribute	_	0	SENT_945	[p35l322t2700r622b2750],
5	to	TO	O	to	_	0	SENT_945	[p35l635t2707r688b2750],
6	the	DT	O	the	det	9	SENT_945	[p35l702t2700r787b2750],
7	basal	JJ	O	basal	amod	9	SENT_945	[p35l804t2700r933b2750],
8	proton	NN	O	proton	nn	9	SENT_945	[p35l952t2707r1126b2762],
9	conductance	NN	O	conductance	prep_to	4	SENT_945	[p35l1143t2700r1485b2750],
10	of	IN	O	of	_	0	SENT_945	[p35l1499t2699r1554b2750],
11	brown	JJ	O	brown	amod	14	SENT_945	[p35l1565t2700r1731b2750],
12	adipose	NN	O	adipose	nn	14	SENT_945	[p35l1747t2700r1953b2762],
13	tissue	NN	O	tissue	nn	14	SENT_945	[p35l1966t2702r2117b2750],
14	mitochondria	NN	O	mitochondrium	prep_of	9	SENT_945	[p35l133t2778r500b2828],
15	.	.	O	.	_	0	SENT_945	[p35l133t2778r500b2828],

1	J.	NNP	PERSON	J.	nn	2	SENT_946	[p35l510t2780r545b2828],
2	Bioenerg	NNP	PERSON	Bioenerg	_	0	SENT_946	[p35l559t2780r792b2841],
3	.	.	O	.	_	0	SENT_946	[p35l559t2780r792b2841],

1	Biomembr	NNP	O	Biomembr	_	0	SENT_947	[p35l807t2778r1082b2828],
2	.	.	O	.	_	0	SENT_947	[p35l807t2778r1082b2828],

1	41	CD	NUMBER	41	_	0	SENT_948	[p35l1096t2782r1177b2835],
2	,	,	O	,	_	0	SENT_948	[p35l1096t2782r1177b2835],
3	335-342	CD	NUMBER	335-342	number	4	SENT_948	[p35l1192t2781r1415b2828],
4	(	CD	NUMBER	(	appos	1	SENT_948	[p35l1431t2779r1605b2835],
5	2009	CD	DATE	2009	num	6	SENT_948	[p35l1431t2779r1605b2835],
6	)	NN	O	)	dep	4	SENT_948	[p35l1431t2779r1605b2835],
7	.	.	O	.	_	0	SENT_948	[p35l1431t2779r1605b2835],

1	95	CD	NUMBER	95	_	0	SENT_949	[p35l8t2859r82b2906],
2	.	.	O	.	_	0	SENT_949	[p35l8t2859r82b2906],

1	Kozak	NNP	PERSON	Kozak	_	0	SENT_950	[p35l132t2856r296b2913],
2	,	,	O	,	_	0	SENT_950	[p35l132t2856r296b2913],
3	L.P	NNP	O	L.P	conj_and	1	SENT_950	[p35l313t2858r387b2906],
4	&	CC	O	&	_	0	SENT_950	[p35l402t2858r438b2906],
5	Koza	NNP	PERSON	Koza	conj_and	1	SENT_950	[p35l454t2858r587b2913],
6	,	,	O	,	_	0	SENT_950	[p35l454t2858r587b2913],
7	R.A.	NNP	PERSON	R.A.	appos	1	SENT_950	[p35l604t2858r697b2906],
8	.	.	O	.	_	0	SENT_950	[p35l604t2858r697b2906],

1	The	DT	O	the	det	2	SENT_951	[p35l707t2856r804b2906],
2	genetics	NNS	O	genetics	_	0	SENT_951	[p35l818t2858r1038b2919],
3	of	IN	O	of	_	0	SENT_951	[p35l1053t2855r1107b2906],
4	brown	JJ	O	brown	amod	6	SENT_951	[p35l1119t2856r1284b2906],
5	adipose	NN	O	adipose	nn	6	SENT_951	[p35l1301t2856r1507b2918],
6	tissue	NN	O	tissue	prep_of	2	SENT_951	[p35l1520t2858r1683b2906],
7	.	.	O	.	_	0	SENT_951	[p35l1520t2858r1683b2906],

1	Prog	NN	O	prog	_	0	SENT_952	[p35l1697t2858r1822b2919],
2	.	.	O	.	_	0	SENT_952	[p35l1697t2858r1822b2919],

1	Mol	NNP	O	Mol	_	0	SENT_953	[p35l1835t2856r1941b2906],
2	.	.	O	.	_	0	SENT_953	[p35l1835t2856r1941b2906],

1	Biol	NNP	O	Biol	_	0	SENT_954	[p35l1955t2856r2057b2906],
2	.	.	O	.	_	0	SENT_954	[p35l1955t2856r2057b2906],

1	Transl	NN	O	transl	_	0	SENT_955	[p35l132t2933r288b2982],
2	.	.	O	.	_	0	SENT_955	[p35l132t2933r288b2982],

1	Sci	NNP	O	Sci	_	0	SENT_956	[p35l302t2935r384b2982],
2	.	.	O	.	_	0	SENT_956	[p35l302t2935r384b2982],

1	94	CD	NUMBER	94	_	0	SENT_957	[p35l398t2936r478b2989],
2	,	,	O	,	_	0	SENT_957	[p35l398t2936r478b2989],
3	75-123	CD	NUMBER	75-123	number	4	SENT_957	[p35l494t2936r682b2982],
4	(	CD	NUMBER	(	appos	1	SENT_957	[p35l701t2934r874b2989],
5	2010	CD	DATE	2010	num	6	SENT_957	[p35l701t2934r874b2989],
6	)	NN	O	)	dep	4	SENT_957	[p35l701t2934r874b2989],
7	.	.	O	.	_	0	SENT_957	[p35l701t2934r874b2989],

1	96	CD	NUMBER	96	_	0	SENT_958	[p35l8t3013r82b3059],
2	.	.	O	.	_	0	SENT_958	[p35l8t3013r82b3059],

1	Haas	NNP	PERSON	Haas	_	0	SENT_959	[p35l131t3012r266b3066],
2	,	,	O	,	_	0	SENT_959	[p35l131t3012r266b3066],
3	B.	NNP	O	B.	nn	4	SENT_959	[p35l282t3012r323b3059],
4	etal	NNP	O	etal	appos	1	SENT_959	[p35l337t3010r452b3059],
5	.	.	O	.	_	0	SENT_959	[p35l337t3010r452b3059],

1	Protein	NN	O	protein	nn	4	SENT_960	[p35l469t3012r651b3059],
2	kinase	NN	O	kinase	nn	4	SENT_960	[p35l670t3010r832b3059],
3	G	NN	O	g	nn	4	SENT_960	[p35l847t3012r883b3059],
4	controls	NNS	O	control	_	0	SENT_960	[p35l899t3010r1109b3059],
5	brown	JJ	O	brown	amod	8	SENT_960	[p35l1126t3010r1291b3059],
6	fat	JJ	O	fat	amod	8	SENT_960	[p35l1306t3009r1374b3059],
7	cell	NN	O	cell	nn	8	SENT_960	[p35l1388t3010r1472b3059],
8	differentiation	NN	O	differentiation	dep	4	SENT_960	[p35l1488t3009r1861b3059],
9	and	CC	O	and	_	0	SENT_960	[p35l1877t3010r1973b3059],
10	mitochondrial	JJ	O	mitochondrial	amod	11	SENT_960	[p36l133t17r499b67],
11	biogenesis	NN	O	biogenesis	conj_and	8	SENT_960	[p36l518t17r810b80],
12	.	.	O	.	_	0	SENT_960	[p36l518t17r810b80],

1	Sci	NNP	O	Sci	_	0	SENT_961	[p36l824t19r904b67],
2	.	.	O	.	_	0	SENT_961	[p36l824t19r904b67],

1	Signal	NN	O	signal	_	0	SENT_962	[p36l917t17r1087b80],
2	.	.	O	.	_	0	SENT_962	[p36l917t17r1087b80],

1	2	CD	NUMBER	2	_	0	SENT_963	[p36l1102t20r1146b74],
2	,	,	O	,	_	0	SENT_963	[p36l1102t20r1146b74],
3	ra78	CD	NUMBER	ra78	num	4	SENT_963	[p36l1162t20r1273b67],
4	(	CD	NUMBER	(	appos	1	SENT_963	[p36l1289t18r1463b74],
5	2009	CD	DATE	2009	num	6	SENT_963	[p36l1289t18r1463b74],
6	)	NN	O	)	dep	4	SENT_963	[p36l1289t18r1463b74],
7	.	.	O	.	_	0	SENT_963	[p36l1289t18r1463b74],

1	97	CD	NUMBER	97	_	0	SENT_964	[p36l8t98r82b145],
2	.	.	O	.	_	0	SENT_964	[p36l8t98r82b145],

1	Mitschke	NNP	O	Mitschke	_	0	SENT_965	[p36l130t95r376b152],
2	,	,	O	,	_	0	SENT_965	[p36l130t95r376b152],
3	M.M.	NNP	O	M.M.	nn	4	SENT_965	[p36l392t97r515b145],
4	etal	NNP	O	etal	appos	1	SENT_965	[p36l530t95r644b145],
5	.	.	O	.	_	0	SENT_965	[p36l530t95r644b145],

1	Increased	VBN	O	increase	amod	2	SENT_966	[p36l661t95r908b145],
2	cGMP	NN	O	cgmp	nsubj	3	SENT_966	[p36l925t97r1076b145],
3	promotes	VBZ	O	promote	_	0	SENT_966	[p36l1092t103r1344b157],
4	healthy	JJ	O	healthy	amod	5	SENT_966	[p36l1360t95r1554b159],
5	expansion	NN	O	expansion	dobj	3	SENT_966	[p36l1567t97r1835b157],
6	and	CC	O	and	_	0	SENT_966	[p36l1852t95r1948b145],
7	browning	NN	O	browning	dobj	3	SENT_966	[p36l132t173r384b236],
8	of	IN	O	of	_	0	SENT_966	[p36l400t172r455b223],
9	white	JJ	O	white	amod	11	SENT_966	[p36l463t173r610b223],
10	adipose	NN	O	adipose	nn	11	SENT_966	[p36l624t173r830b235],
11	tissue	NN	O	tissue	prep_of	5	SENT_966	[p36l843t175r1006b223],
12	.	.	O	.	_	0	SENT_966	[p36l843t175r1006b223],

1	FASEBJ	NN	O	fasebj	_	0	SENT_967	[p36l1020t175r1217b223],
2	.	.	O	.	_	0	SENT_967	[p36l1020t175r1217b223],

1	27	CD	NUMBER	27	_	0	SENT_968	[p36l1231t176r1311b230],
2	,	,	O	,	_	0	SENT_968	[p36l1231t176r1311b230],
3	1621-1630	CD	DATE	1621-1630	number	4	SENT_968	[p36l1330t176r1615b223],
4	(	CD	NUMBER	(	appos	1	SENT_968	[p36l1631t174r1805b230],
5	2013	CD	DATE	2013	num	6	SENT_968	[p36l1631t174r1805b230],
6	)	NN	O	)	dep	4	SENT_968	[p36l1631t174r1805b230],
7	.	.	O	.	_	0	SENT_968	[p36l1631t174r1805b230],

1	98	CD	NUMBER	98	_	0	SENT_969	[p36l8t254r82b301],
2	.	.	O	.	_	0	SENT_969	[p36l8t254r82b301],

1	Moro	NNP	MISC	Moro	_	0	SENT_970	[p36l130t253r278b308],
2	,	,	O	,	_	0	SENT_970	[p36l130t253r278b308],
3	C.	NNP	O	C.	conj_and	1	SENT_970	[p36l293t253r352b308],
4	,	,	O	,	_	0	SENT_970	[p36l293t253r352b308],
5	Galitzky	NNP	PERSON	Galitzky	conj_and	1	SENT_970	[p36l366t251r584b315],
6	,	,	O	,	_	0	SENT_970	[p36l366t251r584b315],
7	J.	NNP	O	J.	conj_and	1	SENT_970	[p36l596t253r643b308],
8	,	,	O	,	_	0	SENT_970	[p36l596t253r643b308],
9	Sengenes	NNP	O	Sengenes	conj_and	1	SENT_970	[p36l658t253r925b314],
10	,	,	O	,	_	0	SENT_970	[p36l658t253r925b314],
11	C.	NNP	O	C.	conj_and	1	SENT_970	[p36l939t253r999b308],
12	,	,	O	,	_	0	SENT_970	[p36l939t253r999b308],
13	Crampes	NNP	O	Crampes	conj_and	1	SENT_970	[p36l1013t253r1256b313],
14	,	,	O	,	_	0	SENT_970	[p36l1013t253r1256b313],
15	F.	NNP	O	F.	conj_and	1	SENT_970	[p36l1273t253r1318b308],
16	,	,	O	,	_	0	SENT_970	[p36l1273t253r1318b308],
17	Lafontan	NNP	LOCATION	Lafontan	conj_and	1	SENT_970	[p36l1334t250r1577b308],
18	,	,	O	,	_	0	SENT_970	[p36l1334t250r1577b308],
19	M.	NNP	O	M.	conj_and	1	SENT_970	[p36l1592t253r1652b301],
20	&	CC	O	&	_	0	SENT_970	[p36l1666t253r1702b301],
21	Berlan	NNP	O	Berlan	conj_and	1	SENT_970	[p36l1718t251r1893b308],
22	,	,	O	,	_	0	SENT_970	[p36l1718t251r1893b308],
23	M.	NNP	O	M.	appos	1	SENT_970	[p36l1909t253r1968b301],

1	Functional	JJ	O	functional	amod	4	SENT_971	[p36l133t329r404b379],
2	and	CC	O	and	_	0	SENT_971	[p36l421t329r517b379],
3	pharmacological	JJ	O	pharmacological	conj_and	1	SENT_971	[p36l536t329r972b392],
4	characterization	NN	O	characterization	_	0	SENT_971	[p36l989t329r1410b379],
5	ofthe	NN	O	ofthe	nn	9	SENT_971	[p36l1426t328r1575b379],
6	natriuretic	JJ	O	natriuretic	amod	9	SENT_971	[p36l1591t331r1859b379],
7	peptidedependent	JJ	O	peptidedependent	amod	9	SENT_971	[p36l1876t329r2099b392, p36l131t407r423b469],
8	lipolytic	JJ	O	lipolytic	amod	9	SENT_971	[p36l439t407r643b471],
9	pathway	NN	O	pathway	dep	4	SENT_971	[p36l659t407r884b471],
10	in	IN	O	in	_	0	SENT_971	[p36l898t409r941b456],
11	human	JJ	O	human	amod	13	SENT_971	[p36l960t407r1142b457],
12	fat	JJ	O	fat	amod	13	SENT_971	[p36l1156t406r1225b457],
13	ce	NN	O	ce	prep_in	9	SENT_971	[p36l1238t407r1406b457],
14	|	NN	O	|	dep	4	SENT_971	[p36l1238t407r1406b457],
15	|	CD	NUMBER	|	num	14	SENT_971	[p36l1238t407r1406b457],
16	s.J.	NNP	PERSON	s.J.	nn	17	SENT_971	[p36l1238t407r1406b457],
17	Pharmacol	NNP	PERSON	Pharmacol	dep	14	SENT_971	[p36l1421t407r1706b457],
18	.	.	O	.	_	0	SENT_971	[p36l1421t407r1706b457],

1	Exp	NN	O	exp	_	0	SENT_972	[p36l1721t409r1819b469],
2	.	.	O	.	_	0	SENT_972	[p36l1721t409r1819b469],

1	Ther	NNP	O	Ther	_	0	SENT_973	[p36l1836t407r1956b457],
2	.	.	O	.	_	0	SENT_973	[p36l1836t407r1956b457],

1	308	CD	NUMBER	308	_	0	SENT_974	[p36l1970t410r2085b464],
2	,	,	O	,	_	0	SENT_974	[p36l1970t410r2085b464],
3	984-992	CD	NUMBER	984-992	number	4	SENT_974	[p36l131t487r353b533],
4	(	CD	NUMBER	(	appos	1	SENT_974	[p36l371t485r545b540],
5	2004	CD	DATE	2004	num	6	SENT_974	[p36l371t485r545b540],
6	)	NN	O	)	dep	4	SENT_974	[p36l371t485r545b540],
7	.	.	O	.	_	0	SENT_974	[p36l371t485r545b540],

1	99	CD	NUMBER	99	_	0	SENT_975	[p36l8t564r82b610],
2	.	.	O	.	_	0	SENT_975	[p36l8t564r82b610],

1	Li	NNP	PERSON	Li	nn	9	SENT_976	[p36l131t563r182b618],
2	,	,	O	,	_	0	SENT_976	[p36l131t563r182b618],
3	R	NNP	O	R	appos	9	SENT_976	[p36l200t563r244b618],
4	,	,	O	,	_	0	SENT_976	[p36l200t563r244b618],
5	Lin	NNP	PERSON	Lin	appos	9	SENT_976	[p36l261t563r348b618],
6	,	,	O	,	_	0	SENT_976	[p36l261t563r348b618],
7	J.E.	NNP	PERSON	J.E.	appos	9	SENT_976	[p36l360t563r451b618],
8	,	,	O	,	_	0	SENT_976	[p36l360t563r451b618],
9	Chervoneva	NNP	O	Chervoneva	_	0	SENT_976	[p36l466t561r795b618],
10	,	,	O	,	_	0	SENT_976	[p36l466t561r795b618],
11	|	CD	NUMBER	|	appos	9	SENT_976	[p36l812t563r847b618],
12	.	.	O	.	_	0	SENT_976	[p36l812t563r847b618],

1	,	,	O	,	_	0	SENT_977	[p36l812t563r847b618],
2	Schulz	NNP	PERSON	Schulz	_	0	SENT_977	[p36l861t561r1043b618],
3	,	,	O	,	_	0	SENT_977	[p36l861t561r1043b618],
4	S.	NNP	O	S.	conj_and	2	SENT_977	[p36l1058t563r1111b618],
5	,	,	O	,	_	0	SENT_977	[p36l1058t563r1111b618],
6	Waldman	NNP	LOCATION	Waldman	conj_and	2	SENT_977	[p36l1122t561r1385b618],
7	,	,	O	,	_	0	SENT_977	[p36l1122t561r1385b618],
8	S.A.	NNP	ORGANIZATION	S.A.	conj_and	2	SENT_977	[p36l1400t563r1492b610],
9	&	CC	ORGANIZATION	&	_	0	SENT_977	[p36l1506t563r1543b610],
10	Pitari	NNP	ORGANIZATION	Pitari	conj_and	2	SENT_977	[p36l1558t563r1700b617],
11	,	,	O	,	_	0	SENT_977	[p36l1558t563r1700b617],
12	G.M.	NNP	O	G.M.	appos	2	SENT_977	[p36l1714t563r1829b610],

1	Homeostatic	JJ	O	homeostatic	amod	2	SENT_978	[p36l133t641r464b689],
2	control	NN	O	control	nsubj	20	SENT_978	[p36l479t639r661b689],
3	of	IN	O	of	_	0	SENT_978	[p36l679t638r733b689],
4	the	DT	O	the	det	5	SENT_978	[p36l741t639r827b689],
5	crypt	NN	O	crypt	prep_of	2	SENT_978	[p36l841t639r1129b703],
6	—	CD	NUMBER	—	dobj	11	SENT_978	[p36l841t639r1129b703],
7	vi	LS	O	vi	prep	6	SENT_978	[p36l841t639r1129b703],
8	|	CD	NUMBER	|	num	9	SENT_978	[p36l841t639r1129b703],
9	|	CD	NUMBER	|	dep	7	SENT_978	[p36l841t639r1129b703],
10	us	PRP	O	we	nsubj	11	SENT_978	[p36l841t639r1129b703],
11	axis	NN	O	axis	rcmod	5	SENT_978	[p36l1144t641r1240b689],
12	by	IN	O	by	_	0	SENT_978	[p36l1257t639r1318b703],
13	the	DT	O	the	det	19	SENT_978	[p36l1330t639r1416b689],
14	bacterial	JJ	O	bacterial	amod	19	SENT_978	[p36l1432t639r1654b689],
15	enterotoxin	NN	O	enterotoxin	nn	19	SENT_978	[p36l1671t641r1974b689],
16	receptor	NN	O	receptor	nn	19	SENT_978	[p36l132t725r352b779],
17	guanylyl	NN	O	guanylyl	nn	19	SENT_978	[p36l365t717r585b781],
18	cyclase	NN	O	cyclase	nn	19	SENT_978	[p36l602t717r788b781],
19	C	NN	O	c	prep_by	11	SENT_978	[p36l803t719r836b767],
20	restricts	VBZ	O	restrict	_	0	SENT_978	[p36l852t719r1055b767],
21	the	DT	O	the	det	23	SENT_978	[p36l1069t717r1154b767],
22	proliferating	VBG	O	proliferate	amod	23	SENT_978	[p36l1171t716r1491b780],
23	compartment	NN	O	compartment	dobj	20	SENT_978	[p36l1507t725r1872b779],
24	in	IN	O	in	_	0	SENT_978	[p36l1887t719r1930b766],
25	intestine	NN	O	intestine	prep_in	23	SENT_978	[p36l132t796r369b843],
26	.	.	O	.	_	0	SENT_978	[p36l132t796r369b843],

1	Am	NNP	O	Am	_	0	SENT_979	[p36l380t796r479b843],
2	.	.	O	.	_	0	SENT_979	[p36l380t796r479b843],

1	J.	NNP	PERSON	J.	nn	2	SENT_980	[p36l490t796r524b843],
2	Pathol	NNP	PERSON	Pathol	_	0	SENT_980	[p36l539t794r715b843],
3	.	.	O	.	_	0	SENT_980	[p36l539t794r715b843],

1	171	CD	NUMBER	171	_	0	SENT_981	[p36l732t798r844b851],
2	,	,	O	,	_	0	SENT_981	[p36l732t798r844b851],
3	1847-1858	CD	DATE	1847-1858	number	4	SENT_981	[p36l863t797r1148b843],
4	(	CD	NUMBER	(	appos	1	SENT_981	[p36l1164t795r1338b850],
5	2007	CD	DATE	2007	num	6	SENT_981	[p36l1164t795r1338b850],
6	)	NN	O	)	dep	4	SENT_981	[p36l1164t795r1338b850],
7	.	.	O	.	_	0	SENT_981	[p36l1164t795r1338b850],

1	100	CD	NUMBER	100	_	0	SENT_982	[p36l12t875r114b922],
2	.	.	O	.	_	0	SENT_982	[p36l12t875r114b922],

1	Li	NNP	PERSON	Li	_	0	SENT_983	[p36l131t874r183b929],
2	,	,	O	,	_	0	SENT_983	[p36l131t874r183b929],
3	P.	NNP	O	P.	nn	4	SENT_983	[p36l200t874r231b922],
4	etal	NN	O	etal	appos	1	SENT_983	[p36l245t872r360b922],
5	.	.	O	.	_	0	SENT_983	[p36l245t872r360b922],

1	Guanylyl	NNP	O	Guanylyl	nn	3	SENT_984	[p36l375t872r600b936],
2	cyclase	NN	O	cyclase	nn	3	SENT_984	[p36l616t872r803b936],
3	C	NN	O	c	nsubj	4	SENT_984	[p36l817t874r850b922],
4	suppresses	VBZ	O	suppress	_	0	SENT_984	[p36l865t887r1153b934],
5	intestinal	JJ	O	intestinal	amod	6	SENT_984	[p36l1169t872r1405b922],
6	tumorigenesis	NN	O	tumorigenesis	dobj	4	SENT_984	[p36l1421t874r1798b935],
7	by	IN	O	by	_	0	SENT_984	[p36l1815t872r1877b936],
8	restricting	VBG	O	restrict	prepc_by	4	SENT_984	[p36l132t952r394b1013],
9	proliferation	NN	O	proliferation	dobj	8	SENT_984	[p36l413t949r732b1012],
10	and	CC	O	and	_	0	SENT_984	[p36l749t950r845b1000],
11	maintaining	VBG	O	maintain	conj_and	8	SENT_984	[p36l863t952r1177b1013],
12	genomic	JJ	O	genomic	amod	13	SENT_984	[p36l1193t952r1425b1013],
13	integrity	NN	O	integrity	dobj	11	SENT_984	[p36l1440t952r1670b1014],
14	.	.	O	.	_	0	SENT_984	[p36l1440t952r1670b1014],

1	Gastroenterology	NN	O	gastroenterology	_	0	SENT_985	[p36l1685t950r2128b1014],
2	133	CD	NUMBER	133	num	1	SENT_985	[p36l134t1030r246b1083],
3	,	,	O	,	_	0	SENT_985	[p36l134t1030r246b1083],
4	599-607	CD	NUMBER	599-607	number	5	SENT_985	[p36l261t1030r483b1076],
5	(	CD	NUMBER	(	appos	1	SENT_985	[p36l500t1028r674b1084],
6	2007	CD	DATE	2007	num	7	SENT_985	[p36l500t1028r674b1084],
7	)	NN	O	)	dep	5	SENT_985	[p36l500t1028r674b1084],
8	.	.	O	.	_	0	SENT_985	[p36l500t1028r674b1084],

1	101	CD	NUMBER	101	_	0	SENT_986	[p36l12t1108r94b1155],
2	.	.	O	.	_	0	SENT_986	[p36l109t1146r117b1155],

1	Lin	NNP	PERSON	Lin	_	0	SENT_987	[p36l131t1107r221b1162],
2	,	,	O	,	_	0	SENT_987	[p36l131t1107r221b1162],
3	J.E.	NNP	PERSON	J.E.	nn	5	SENT_987	[p36l235t1107r316b1155],
4	et	NNP	O	et	nn	5	SENT_987	[p36l332t1113r382b1155],
5	aI	NNP	O	aI	appos	1	SENT_987	[p36l393t1105r562b1155],
6	.	.	O	.	_	0	SENT_987	[p36l393t1105r562b1155],

1	The	DT	O	the	det	4	SENT_988	[p36l393t1105r562b1155],
2	hormone	NN	O	hormone	nn	4	SENT_988	[p36l581t1105r827b1155],
3	receptor	NN	O	receptor	nn	4	SENT_988	[p36l846t1112r1073b1167],
4	GUCY2C	NN	O	gucy2c	nsubj	5	SENT_988	[p36l1088t1107r1313b1155],
5	suppresses	VBZ	O	suppress	_	0	SENT_988	[p36l1329t1120r1626b1168],
6	intestinal	JJ	O	intestinal	amod	8	SENT_988	[p36l1644t1105r1889b1155],
7	tumor	NN	O	tumor	nn	8	SENT_988	[p36l1906t1113r2074b1155],
8	formation	NN	O	formation	dobj	5	SENT_988	[p36l129t1182r396b1233],
9	by	IN	O	by	_	0	SENT_988	[p36l416t1183r479b1247],
10	inhibiting	VBG	O	inhibit	prepc_by	5	SENT_988	[p36l495t1183r754b1246],
11	AKT	NN	O	akt	nn	12	SENT_988	[p36l772t1185r880b1232],
12	signaling	NN	O	signaling	dobj	10	SENT_988	[p36l894t1183r1152b1246],
13	.	.	O	.	_	0	SENT_988	[p36l894t1183r1152b1246],

1	Gastroenterology	NN	O	gastroenterology	_	0	SENT_989	[p36l1169t1183r1627b1247],
2	138	CD	NUMBER	138	num	1	SENT_989	[p36l1642t1186r1757b1240],
3	,	,	O	,	_	0	SENT_989	[p36l1642t1186r1757b1240],
4	241-254	CD	NUMBER	241-254	number	5	SENT_989	[p36l1774t1186r2004b1233],
5	(	CD	NUMBER	(	appos	1	SENT_989	[p36l132t1261r312b1317],
6	2010	CD	DATE	2010	num	7	SENT_989	[p36l132t1261r312b1317],
7	)	NN	O	)	dep	5	SENT_989	[p36l132t1261r312b1317],
8	.	.	O	.	_	0	SENT_989	[p36l132t1261r312b1317],

1	102	CD	NUMBER	102	_	0	SENT_990	[p36l12t1341r114b1388],
2	.	.	O	.	_	0	SENT_990	[p36l12t1341r114b1388],

1	Lin	NNP	PERSON	Lin	_	0	SENT_991	[p36l131t1340r218b1395],
2	,	,	O	,	_	0	SENT_991	[p36l131t1340r218b1395],
3	J.E.	NNP	PERSON	J.E.	nn	4	SENT_991	[p36l231t1340r308b1388],
4	etal	NNP	O	etal	appos	1	SENT_991	[p36l322t1338r437b1388],
5	.	.	O	.	_	0	SENT_991	[p36l322t1338r437b1388],

1	GUCY2C	NN	O	gucy2c	nsubj	2	SENT_992	[p36l452t1340r672b1388],
2	opposes	VBZ	O	oppose	_	0	SENT_992	[p36l686t1353r907b1400],
3	systemic	JJ	O	systemic	amod	5	SENT_992	[p36l922t1340r1147b1402],
4	genotoxic	JJ	O	genotoxic	amod	5	SENT_992	[p36l1161t1340r1423b1401],
5	tumorigenesis	NN	O	tumorigenesis	dobj	2	SENT_992	[p36l1436t1340r1813b1401],
6	by	IN	O	by	_	0	SENT_992	[p36l1830t1338r1891b1402],
7	regulating	VBG	O	regulate	prepc_by	2	SENT_992	[p36l132t1416r399b1479],
8	AKT	NNP	O	AKT	dobj	7	SENT_992	[p36l415t1416r832b1478],
9	—	NN	O	—	nn	13	SENT_992	[p36l415t1416r832b1478],
10	dependent	JJ	O	dependent	amod	13	SENT_992	[p36l415t1416r832b1478],
11	intestinal	JJ	O	intestinal	amod	13	SENT_992	[p36l847t1416r1083b1466],
12	barrier	NN	O	barrier	nn	13	SENT_992	[p36l1102t1416r1274b1466],
13	integrity	NN	O	integrity	dep	8	SENT_992	[p36l1289t1418r1519b1480],
14	.	.	O	.	_	0	SENT_992	[p36l1289t1418r1519b1480],

1	PLoS	NN	O	plo	_	0	SENT_993	[p36l1533t1418r1653b1466],
2	ONE	CD	NUMBER	one	number	3	SENT_993	[p36l1664t1418r1777b1466],
3	7	CD	NUMBER	7	amod	1	SENT_993	[p36l1788t1420r1832b1473],
4	,	,	O	,	_	0	SENT_993	[p36l1788t1420r1832b1473],
5	e31686	CD	NUMBER	e31686	num	6	SENT_993	[p36l1846t1419r2038b1466],
6	(	CD	NUMBER	(	appos	1	SENT_993	[p36l132t1494r306b1549],
7	2012	CD	DATE	2012	num	8	SENT_993	[p36l132t1494r306b1549],
8	)	NN	O	)	dep	6	SENT_993	[p36l132t1494r306b1549],
9	.	.	O	.	_	0	SENT_993	[p36l132t1494r306b1549],

1	103	CD	NUMBER	103	_	0	SENT_994	[p36l11t1574r114b1621],
2	.	.	O	.	_	0	SENT_994	[p36l11t1574r114b1621],

1	Valentino	NNP	PERSON	Valentino	_	0	SENT_995	[p36l127t1571r388b1629],
2	,	,	O	,	_	0	SENT_995	[p36l127t1571r388b1629],
3	M.A.	NNP	O	M.A.	nn	4	SENT_995	[p36l404t1574r516b1621],
4	etal	NNP	O	etal	appos	1	SENT_995	[p36l530t1571r644b1621],
5	.	.	O	.	_	0	SENT_995	[p36l530t1571r644b1621],

1	A	DT	O	a	det	3	SENT_996	[p36l658t1574r695b1620],
2	uroguany	NN	O	uroguany	nn	3	SENT_996	[p36l710t1571r1270b1635],
3	|	NN	O	|	_	0	SENT_996	[p36l710t1571r1270b1635],
4	in	IN	O	in	prep	3	SENT_996	[p36l710t1571r1270b1635],
5	.	.	O	.	_	0	SENT_996	[p36l710t1571r1270b1635],

1	—	NN	O	—	_	0	SENT_997	[p36l710t1571r1270b1635],
2	.	.	O	.	_	0	SENT_997	[p36l710t1571r1270b1635],

1	GUCY2C	NN	O	gucy2c	nn	3	SENT_998	[p36l710t1571r1270b1635],
2	endocrine	JJ	O	endocrine	amod	3	SENT_998	[p36l1284t1571r1550b1621],
3	axis	NN	O	axis	nsubj	4	SENT_998	[p36l1564t1574r1660b1621],
4	regulates	VBZ	O	regulate	_	0	SENT_998	[p36l1677t1571r1917b1634],
5	feeding	VBG	O	feed	xcomp	4	SENT_998	[p36l1930t1571r2129b1634],
6	in	IN	O	in	_	0	SENT_998	[p36l132t1651r174b1697],
7	mice	NNS	O	mouse	prep_in	5	SENT_998	[p36l193t1651r327b1697],
8	.	.	O	.	_	0	SENT_998	[p36l193t1651r327b1697],

1	J.	NNP	PERSON	J.	nn	2	SENT_999	[p36l338t1651r372b1697],
2	Clin	NNP	PERSON	Clin	_	0	SENT_999	[p36l388t1648r493b1697],
3	.	.	O	.	_	0	SENT_999	[p36l388t1648r493b1697],

1	Invest	VB	O	invest	_	0	SENT_1000	[p36l507t1651r666b1697],
2	.	.	O	.	_	0	SENT_1000	[p36l507t1651r666b1697],

1	121	CD	NUMBER	121	_	0	SENT_1001	[p36l683t1651r796b1705],
2	,	,	O	,	_	0	SENT_1001	[p36l683t1651r796b1705],
3	3578-3588	CD	DURATION	3578-3588	num	4	SENT_1001	[p36l811t1651r1100b1697],
4	(	NN	O	(	appos	1	SENT_1001	[p36l1116t1649r1216b1705],
5	201	CD	NUMBER	201	number	6	SENT_1001	[p36l1116t1649r1216b1705],
6	1	CD	NUMBER	1	num	7	SENT_1001	[p36l1234t1649r1290b1705],
7	)	NN	O	)	dep	4	SENT_1001	[p36l1234t1649r1290b1705],
8	.	.	O	.	_	0	SENT_1001	[p36l1234t1649r1290b1705],

1	104	CD	NUMBER	104	_	0	SENT_1002	[p36l12t1729r114b1776],
2	.	.	O	.	_	0	SENT_1002	[p36l12t1729r114b1776],

1	Ray	NNP	PERSON	Ray	nn	4	SENT_1003	[p36l131t1728r231b1790],
2	,	,	O	,	_	0	SENT_1003	[p36l131t1728r231b1790],
3	K.	NNP	O	K.	appos	4	SENT_1003	[p36l247t1729r290b1776],
4	IBS	NNP	O	IBS	_	0	SENT_1003	[p36l307t1728r395b1776],
5	:	:	O	:	_	0	SENT_1003	[p36l307t1728r395b1776],
6	Linaclotide	NNP	O	Linaclotide	nsubj	7	SENT_1003	[p36l411t1726r698b1776],
7	approved	VBD	O	approve	dep	4	SENT_1003	[p36l712t1726r962b1789],
8	for	IN	O	for	_	0	SENT_1003	[p36l977t1726r1049b1776],
9	constipation	NN	O	constipation	npadvmod	11	SENT_1003	[p36l1062t1726r1760b1789],
10	—	CD	NUMBER	—	num	9	SENT_1003	[p36l1062t1726r1760b1789],
11	predominant	JJ	O	predominant	amod	12	SENT_1003	[p36l1062t1726r1760b1789],
12	IBS	NNP	O	IBS	prep_for	7	SENT_1003	[p36l1777t1728r1864b1776],
13	.	.	O	.	_	0	SENT_1003	[p36l1777t1728r1864b1776],

1	Nat	NN	PERSON	nat	_	0	SENT_1004	[p36l1878t1729r1979b1776],
2	.	.	O	.	_	0	SENT_1004	[p36l1878t1729r1979b1776],

1	Rev.	NNP	O	Rev.	_	0	SENT_1005	[p36l1994t1728r2090b1776],

1	Gastroenterol	NNP	PERSON	Gastroenterol	_	0	SENT_1006	[p36l131t1804r485b1854],
2	.	.	O	.	_	0	SENT_1006	[p36l131t1804r485b1854],

1	Hepatol	NNP	O	Hepatol	_	0	SENT_1007	[p36l500t1804r712b1867],
2	.	.	O	.	_	0	SENT_1007	[p36l500t1804r712b1867],

1	9	CD	NUMBER	9	_	0	SENT_1008	[p36l726t1808r771b1862],
2	,	,	O	,	_	0	SENT_1008	[p36l726t1808r771b1862],
3	61	CD	NUMBER	61	num	5	SENT_1008	[p36l785t1808r837b1854],
4	6	CD	NUMBER	6	num	5	SENT_1008	[p36l851t1808r880b1854],
5	(	NN	O	(	appos	1	SENT_1008	[p36l896t1805r997b1862],
6	201	CD	NUMBER	201	number	7	SENT_1008	[p36l896t1805r997b1862],
7	2	CD	NUMBER	2	num	8	SENT_1008	[p36l1011t1805r1070b1862],
8	)	NN	O	)	dep	5	SENT_1008	[p36l1011t1805r1070b1862],
9	.	.	O	.	_	0	SENT_1008	[p36l1011t1805r1070b1862],

1	VOLUME	NN	O	volume	nn	3	SENT_1009	[p36l543t2027r768b2069],
2	95	CD	NUMBER	95	num	3	SENT_1009	[p36l785t2028r842b2069],
3	NUMBER	NN	O	number	_	0	SENT_1009	[p36l863t2027r1087b2069],
4	1	CD	NUMBER	1	number	5	SENT_1009	[p36l1109t2029r1122b2069],
5	|	CD	NUMBER	|	dep	3	SENT_1009	[p36l1151t2023r1156b2084],
6	JANUARY	NNP	DATE	JANUARY	dep	5	SENT_1009	[p36l1175t2027r1421b2069],
7	2014	CD	DATE	2014	num	6	SENT_1009	[p36l1437t2028r1558b2069],
8	|	CD	NUMBER	|	num	9	SENT_1009	[p36l1577t2023r1581b2084],
9	www.nature.com/cpt	NN	O	www.nature.com/cpt	dep	3	SENT_1009	[p36l1600t2027r2152b2080],

